Citrus Sinensis ID: 008303
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 570 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SLI2 | 612 | Serine/threonine-protein | yes | no | 0.940 | 0.875 | 0.640 | 0.0 | |
| A2ZMH2 | 591 | Serine/threonine-protein | N/A | no | 0.928 | 0.895 | 0.609 | 0.0 | |
| Q2QMH1 | 591 | Serine/threonine-protein | yes | no | 0.928 | 0.895 | 0.609 | 0.0 | |
| Q9CAU7 | 606 | Serine/threonine-protein | no | no | 0.940 | 0.884 | 0.617 | 0.0 | |
| Q10GB1 | 599 | Serine/threonine-protein | no | no | 0.933 | 0.888 | 0.584 | 1e-170 | |
| Q8RXT4 | 555 | Serine/threonine-protein | no | no | 0.850 | 0.873 | 0.569 | 1e-164 | |
| Q8RX66 | 568 | Serine/threonine-protein | no | no | 0.871 | 0.875 | 0.579 | 1e-163 | |
| Q6ZEZ5 | 585 | Serine/threonine-protein | no | no | 0.910 | 0.887 | 0.556 | 1e-160 | |
| Q0WPH8 | 956 | Serine/threonine-protein | no | no | 0.370 | 0.220 | 0.691 | 1e-95 | |
| Q94CU5 | 943 | Serine/threonine-protein | no | no | 0.370 | 0.223 | 0.691 | 2e-92 |
| >sp|Q9SLI2|NEK1_ARATH Serine/threonine-protein kinase Nek1 OS=Arabidopsis thaliana GN=NEK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/571 (64%), Positives = 427/571 (74%), Gaps = 35/571 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISK+R+PFIVEYKDSWVE+ CYVCI+IG+CEGGDMA+AIKK+N F EEKLCKWLV
Sbjct: 52 MELISKMRHPFIVEYKDSWVEKACYVCIVIGYCEGGDMAQAIKKSNGVHFQEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLM L+YLH+NHILHRDVKCSNIFLTK+QDIRLGDFGLAKILTSDDL SSVVGTPSYMC
Sbjct: 112 QLLMGLEYLHSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEM LKPAFKAFDMQALINKINK+IV+PLP KYSG F
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMAYLKPAFKAFDMQALINKINKTIVSPLPAKYSGPF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL-SHWPESN-YARRT 238
RGLVKSMLRKNPE+RPSA++LLRH HLQPYVL V L+LN+ RR +L P S ++
Sbjct: 232 RGLVKSMLRKNPEVRPSASDLLRHPHLQPYVLDVKLRLNNLRRKTLPPELPSSKRIMKKA 291
Query: 239 RFSEPDNVPISSYREKQY-SFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVS 297
FSEP V ++ E+Q+ S N+R LNP E+D+ S K I +RR+S++S
Sbjct: 292 HFSEP-AVTCPAFGERQHRSLWNDRALNPE---AEEDTASSIKCI-------SRRISDLS 340
Query: 298 VESSHEGTVICKPIASKTSFVAKTPRLASSKASTNRRGSYAVKKHESHPVS-RLPSKKSI 356
+ESS +GT+ICK ++S V+K P LA S ++ R + HPVS + K I
Sbjct: 341 IESSSKGTLICKQVSSSACKVSKYP-LAKSSVTSRRIMETGRRSDHLHPVSGGGTTSKII 399
Query: 357 PSSRRASLPLPPVAAIREL-PYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYE-DTF 414
PS+RR SLPL A +E+ Y P GIL VKSP+ S+NEP++D+IA FPLA YE D F
Sbjct: 400 PSARRTSLPLTKRATNQEVAAYNPIVGILQNVKSPEYSINEPQVDKIAIFPLAPYEQDIF 459
Query: 415 FPIPKTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNE 474
F +P + SS S DRSITKDKCTVQ H WQGIQ +M N
Sbjct: 460 F-----TPMQRKTSSKSSSVSDRSITKDKCTVQ-------TH---TTWQGIQLNMVD-NI 503
Query: 475 EEGSNSSDQNATAGA-SSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDEL 533
+GS+SSDQNATAGA S SS +RR RFD SSY+QRA+ALEGLLEFSA+LLQ+ RYDEL
Sbjct: 504 SDGSSSSDQNATAGASSHTTSSSSRRCRFDPSSYRQRADALEGLLEFSARLLQEGRYDEL 563
Query: 534 GVLLKPFGPGKVSPRETAIWLTKSIKENTAK 564
VLLKPFGPGKVSPRETAIW+ KS+KEN K
Sbjct: 564 NVLLKPFGPGKVSPRETAIWIAKSLKENRDK 594
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2ZMH2|NEK2_ORYSI Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. indica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/574 (60%), Positives = 417/574 (72%), Gaps = 45/574 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
M+LI+ +RNPFIVEYKDSWVE+GCYVCI+IG+CEGGDMAEAIK+AN FSEEKLCKWLV
Sbjct: 52 MQLIATVRNPFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLHANHILHRDVKCSNIF+ +DQ IRLGDFGLAKILTSDDLASSVVGTPSYMC
Sbjct: 112 QLLMALDYLHANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYG+KSDIWSLGCCIYEMT+L+PAFKAFDMQALINKI KSIV+PLPTKYSGAF
Sbjct: 172 PELLADIPYGTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTR 239
RGL+KSMLRK+PE RPSAA+LL+H LQPYVL+V LK +SP RN L H ++ ++
Sbjct: 232 RGLIKSMLRKSPEHRPSAAQLLKHPQLQPYVLQVQLK-SSPTRNILPIHQSLTDKVKKMT 290
Query: 240 FSEPDNVPISSYRE--KQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVS 297
F P +V S+ R ++ S N R + S E++S+ ST+ I + + +S
Sbjct: 291 F--PSDVVDSARRRMARRNSLGNERTVTFSKPSPERNSVSSTRSIKEYTT--TQSVEGLS 346
Query: 298 VESSHEG-TVICKPIASKTSFVAKTPRLASSKASTNR------RGSYAVKKHESHPVSRL 350
V+SS G V K I +KTS + +TP+ +K T R + SY P
Sbjct: 347 VDSSEAGDEVTSKAIITKTSSILRTPKSLPAKTYTARNQLEPPKTSYNRTYRSELPSKTT 406
Query: 351 PSKKSIPSSRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASY 410
P+K + P +RRASLPL + E P + + IL + SPDVSVN PRIDRIAEFPLAS
Sbjct: 407 PNKIARP-ARRASLPL----STYETPTKRSISILEQLDSPDVSVNAPRIDRIAEFPLASS 461
Query: 411 EDTFFPI-PKTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSM 469
ED PI K SP GS S+P ++RSITKDKCT+Q +
Sbjct: 462 EDPLLPIHNKLSP--GHGSCSTPPFINRSITKDKCTIQ---------------------V 498
Query: 470 FQVNEEEGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQER 529
+ + + GS+SS +NATA ASSR S+D+R+ RFDTSS+QQRAEALEGLLEFSA+LLQQER
Sbjct: 499 LRTDGDNGSDSSGRNATA-ASSRGSNDSRQQRFDTSSFQQRAEALEGLLEFSAQLLQQER 557
Query: 530 YDELGVLLKPFGPGKVSPRETAIWLTKSIKENTA 563
Y+ELG+LLKPFGP K SPRETAIWLTKS KE +
Sbjct: 558 YEELGILLKPFGPEKASPRETAIWLTKSFKETAS 591
|
May be involved in plant development processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QMH1|NEK2_ORYSJ Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. japonica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/574 (60%), Positives = 417/574 (72%), Gaps = 45/574 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
M+LI+ +RNPFIVEYKDSWVE+GCYVCI+IG+CEGGDMAEAIK+AN FSEEKLCKWLV
Sbjct: 52 MQLIATVRNPFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLHANHILHRDVKCSNIF+ +DQ IRLGDFGLAKILTSDDLASSVVGTPSYMC
Sbjct: 112 QLLMALDYLHANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYG+KSDIWSLGCCIYEMT+L+PAFKAFDMQALINKI KSIV+PLPTKYSGAF
Sbjct: 172 PELLADIPYGTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTR 239
RGL+KSMLRK+PE RPSAA+LL+H LQPYVL+V LK +SP RN L H ++ ++
Sbjct: 232 RGLIKSMLRKSPEHRPSAAQLLKHPQLQPYVLQVQLK-SSPTRNILPIHQSLTDKVKKMT 290
Query: 240 FSEPDNVPISSYRE--KQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVS 297
F P +V S+ R ++ S N R + S E++S+ ST+ I + + +S
Sbjct: 291 F--PSDVVDSARRRMARRNSLGNERTVTFSKPSPERNSVSSTRSIKEYTT--TQSVKGLS 346
Query: 298 VESSHEG-TVICKPIASKTSFVAKTPRLASSKASTNR------RGSYAVKKHESHPVSRL 350
V+SS G V K I +KTS + +TP+ +K T R + SY P
Sbjct: 347 VDSSEAGDEVTSKAIITKTSSILRTPKSLPAKTYTARNQLEPPKTSYNRTYRSELPSKTT 406
Query: 351 PSKKSIPSSRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASY 410
P+K + P +RRASLPL + E P + + IL + SPDVSVN PRIDRIAEFPLAS
Sbjct: 407 PNKIARP-ARRASLPL----STYETPTKRSISILEQLDSPDVSVNAPRIDRIAEFPLASS 461
Query: 411 EDTFFPI-PKTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSM 469
ED PI K SP GS S+P ++RSITKDKCT+Q +
Sbjct: 462 EDPLLPIHNKLSP--GHGSCSTPPFINRSITKDKCTIQ---------------------V 498
Query: 470 FQVNEEEGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQER 529
+ + + GS+SS +NATA ASSR S+D+R+ RFDTSS+QQRAEALEGLLEFSA+LLQQER
Sbjct: 499 LRTDGDNGSDSSGRNATA-ASSRGSNDSRQQRFDTSSFQQRAEALEGLLEFSAQLLQQER 557
Query: 530 YDELGVLLKPFGPGKVSPRETAIWLTKSIKENTA 563
Y+ELG+LLKPFGP K SPRETAIWLTKS KE +
Sbjct: 558 YEELGILLKPFGPEKASPRETAIWLTKSFKETAS 591
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAU7|NEK2_ARATH Serine/threonine-protein kinase Nek2 OS=Arabidopsis thaliana GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 645 bits (1663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/575 (61%), Positives = 413/575 (71%), Gaps = 39/575 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISKI NPFIVEYKDSWVE+GCYVCIIIG+C+GGDMAEAIKK N F+EEKLCKWLV
Sbjct: 52 MELISKIHNPFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
Q+L+AL+YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK+LTSDDLASSVVGTPSYMC
Sbjct: 112 QILLALEYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCC+YEMT++KPAFKAFDMQ LIN+IN+SIV PLP +YS AF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL-SHWPESNYARRTR 239
RGLVKSMLRKNPELRPSAAELLR LQPY+ K+HLK+N P N L + WPES ARR
Sbjct: 232 RGLVKSMLRKNPELRPSAAELLRQPLLQPYIQKIHLKVNDPGSNVLPAQWPESESARRNS 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNR-RLSEVSV 298
F E P K +SF +R G +DS+ S K PAYLNR R ++S
Sbjct: 292 FPEQRRRPAG----KSHSFGPSR-----FRGNLEDSVSSIK--KTVPAYLNRERQVDLST 340
Query: 299 ESSHEGTVICKPIASKTSFVAKTPRLASSKASTN-RRGSYAVKKHESHPV-SRLPSKKSI 356
++S +GTV+ +TS +K+ R +AS + R PV S+L ++K
Sbjct: 341 DASGDGTVV-----RRTSEASKSSRYVPVRASASPVRPRQPRSDLGQLPVSSQLKNRKPA 395
Query: 357 PSSRRASLP--LPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDT- 413
RRAS+P P I++ Y T LH + SPDVS+N PRID+I EFPLASYE+
Sbjct: 396 ALIRRASMPSSRKPAKEIKDSLYISKTSFLHQINSPDVSMNAPRIDKI-EFPLASYEEEP 454
Query: 414 FFPI--PKTSPTSAQGSSSSP--LCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSM 469
F P+ K S++GS S P +D SITKDK T++ I ++
Sbjct: 455 FVPVVRGKKKKASSRGSYSPPPEPPLDCSITKDKFTLEPGQNREG---------AIMKAV 505
Query: 470 FQVNE--EEGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQ 527
++ + E+ S SSDQNATAGASSR SS RR RFD SSYQQRAEALEGLLEFSA+LLQ
Sbjct: 506 YEEDAYLEDRSESSDQNATAGASSRASSGVRRQRFDPSSYQQRAEALEGLLEFSARLLQD 565
Query: 528 ERYDELGVLLKPFGPGKVSPRETAIWLTKSIKENT 562
ERYDEL VLL+PFGPGKVSPRETAIWL+KS KE T
Sbjct: 566 ERYDELNVLLRPFGPGKVSPRETAIWLSKSFKETT 600
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10GB1|NEK1_ORYSJ Serine/threonine-protein kinase Nek1 OS=Oryza sativa subsp. japonica GN=NEK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 598 bits (1543), Expect = e-170, Method: Compositional matrix adjust.
Identities = 336/575 (58%), Positives = 401/575 (69%), Gaps = 43/575 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
M+LI+ +RNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIK+A FSEEKLCKWLV
Sbjct: 52 MQLIATVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKRATGDHFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLHANHILHRDVKCSNIFLT+DQ IRLGDFGLAKILTSDDLASSVVGTPSYMC
Sbjct: 112 QLLMALDYLHANHILHRDVKCSNIFLTRDQSIRLGDFGLAKILTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYG+KSDIWSLGCCIYEMT+L+PAFKAFDMQALI+KI KSIV+PLPT+YSGAF
Sbjct: 172 PELLADIPYGTKSDIWSLGCCIYEMTALRPAFKAFDMQALISKITKSIVSPLPTRYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL-SHWPESNYARRTR 239
RGL+KSMLRK+PE RPSAAELL+H HLQPYVL+VHLK +SP RN + SH + ++
Sbjct: 232 RGLIKSMLRKSPEHRPSAAELLKHPHLQPYVLQVHLK-SSPARNIIPSHQSPIDKVKKMT 290
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
F + + ++ S N R + S E+ S + I + R + ++S++
Sbjct: 291 FPTES---MCRSKGRRNSLGNERIVTFSKPSPERKFTSSIQSIKDYST--TRSVKDLSID 345
Query: 300 SSHEGTVICKPIASKTSF------VAKTPRLASSKASTN-----RRGSYAVKKHESHPVS 348
S + + ++SKT+F + KTP+ SK T + SY + + S +S
Sbjct: 346 VS-----LVEEVSSKTTFTTRTSSIVKTPKRTPSKTITTPQLEPPKVSYN-RVNRSELLS 399
Query: 349 RLPSKKSIPSSRRASLPLPPVAAIRELPYR--PNTGILHCVKSPDVSVNEPRIDRIAEFP 406
R P +S RRASLPLP ++ E P R + IL ++SPDVSVN PRIDRIAEFP
Sbjct: 400 RTPVNRSARVIRRASLPLPLPSS--ETPKRGVSSISILEQLESPDVSVNSPRIDRIAEFP 457
Query: 407 LASYEDTFFPIPKTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQ 466
LAS ED P K + + +D+SITKDKC V EA+ I
Sbjct: 458 LASSEDP--PFLKLHGRRSPTPTPQHCVIDQSITKDKCMV-------------EAFHIID 502
Query: 467 HSMFQVNEEEGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQ 526
+ S ++ A A + + +S R+ RFDTSSYQQRAEALEGLLEFSA+LLQ
Sbjct: 503 VDDDDGRSDSSSGRNNAAAAASSRAGSSESTRQRRFDTSSYQQRAEALEGLLEFSAQLLQ 562
Query: 527 QERYDELGVLLKPFGPGKVSPRETAIWLTKSIKEN 561
QERYDELGVLLKPFGP KVSPRETAIWLTKS KE
Sbjct: 563 QERYDELGVLLKPFGPEKVSPRETAIWLTKSFKET 597
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXT4|NEK4_ARATH Serine/threonine-protein kinase Nek4 OS=Arabidopsis thaliana GN=NEK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1489), Expect = e-164, Method: Compositional matrix adjust.
Identities = 328/576 (56%), Positives = 387/576 (67%), Gaps = 91/576 (15%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELIS +RNPF+VEYKDSWVE+GCYVCI+IG+C+GGDM + IK+A F EEKLC+WLV
Sbjct: 52 MELISTVRNPFVVEYKDSWVEKGCYVCIVIGYCQGGDMTDTIKRACGVHFPEEKLCQWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLH+NHILHRDVKCSNIFLTK+QDIRLGDFGLAKILTSDDL SSVVGTPSYMC
Sbjct: 112 QLLMALDYLHSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCC+YEM + KP FKA D+Q LI KI+K I+ P+P YSG+F
Sbjct: 172 PELLADIPYGSKSDIWSLGCCMYEMAAHKPPFKASDVQTLITKIHKLIMDPIPAMYSGSF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRF 240
RGL+KSMLRKNPELRPSA ELL H HLQPY+ V++KL SPRR++ +F
Sbjct: 232 RGLIKSMLRKNPELRPSANELLNHPHLQPYISMVYMKLESPRRSTFP----------LQF 281
Query: 241 SEPDNVPISSYREKQY-SFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
SE D ++ +E++ SFSN+R LNPS+S TE S+ S+ TP + R++SEV+V
Sbjct: 282 SERD----ATLKERRRSSFSNDRRLNPSVSDTEAGSVSSSGKASPTPMFNGRKVSEVTVG 337
Query: 300 SSHEGTVICK-PIASKTSFVAKTPRLA--SSKASTNRRGSYAVKKHESHPVSRLPSKKSI 356
E V + A K S A+TPR+A S+KAST R V KHE VS P+++
Sbjct: 338 VVREEIVPQRQEEAKKQSGAARTPRVAGTSAKASTQR----TVFKHELMKVSN-PTER-- 390
Query: 357 PSSRRASLPLPPVAAIRELPYRPNTGI--LHCVKSPDVSVNEPRIDRIAEFPLASYEDTF 414
RR SLPL + E PY + I L + SPDVSVN PR D+IAEFP ED F
Sbjct: 391 --RRRVSLPL-----VVENPYTYESDITALCSLNSPDVSVNTPRFDKIAEFP----EDIF 439
Query: 415 FPIPKTSPTS---AQGSSSSPLC-------VDRSITKDKCTVQKCDRASANHKFTEAWQG 464
+ + + A+ S SSP C + SITKDKCTVQK
Sbjct: 440 QNQNRETASRREVARHSFSSPPCPPHGEDNSNGSITKDKCTVQK---------------- 483
Query: 465 IQHSMFQVNEEEGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKL 524
R+ S+ ++ RFDTSSYQQRAEALEGLLEFSAKL
Sbjct: 484 ---------------------------RSVSEVKQRRFDTSSYQQRAEALEGLLEFSAKL 516
Query: 525 LQQERYDELGVLLKPFGPGKVSPRETAIWLTKSIKE 560
LQQERYDELGVLLKPFG +VS RETAIWLTKS KE
Sbjct: 517 LQQERYDELGVLLKPFGAERVSSRETAIWLTKSFKE 552
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RX66|NEK3_ARATH Serine/threonine-protein kinase Nek3 OS=Arabidopsis thaliana GN=NEK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 574 bits (1479), Expect = e-163, Method: Compositional matrix adjust.
Identities = 333/575 (57%), Positives = 385/575 (66%), Gaps = 78/575 (13%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISKIRNPFIVEYKDSWVE+GCYVCI+IG+C+GGDMAEAIKKAN FSEEKLCKWLV
Sbjct: 52 MELISKIRNPFIVEYKDSWVEKGCYVCIVIGYCKGGDMAEAIKKANGVEFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMAL+YLHA+HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC
Sbjct: 112 QLLMALEYLHASHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCC+YEMT+LKPAFKAFDMQ LIN+IN+SIVAPLP +YS AF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCMYEMTALKPAFKAFDMQGLINRINRSIVAPLPAQYSTAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRF 240
R LVKSMLRKNPELRPSA++LLR LQPYV KV LKL+ F
Sbjct: 232 RSLVKSMLRKNPELRPSASDLLRQPLLQPYVQKVLLKLS--------------------F 271
Query: 241 SEPDNVPISSYREKQYSFSNNR------NLNPSISGTEQ-DSLCSTKGIHNTPAYLNRRL 293
E D +P S R Y R + PS G +Q DS+ S K +H YL+R
Sbjct: 272 REHDTLPSESERRSSYPQQRKRTSGKSVSFGPSRFGVDQEDSVSSVKPVHT---YLHRH- 327
Query: 294 SEVSVESSHEGTVICKPIASKTSFVAKTPRLASSKASTNRRGSYAVKKHESHPVSRLPSK 353
V + ++ V+ + R A S +N V+ ++ L
Sbjct: 328 RPVDLSANDTSRVVVR-------------RPAVSSVVSNSSKYVPVRSNQPKSGGLL--- 371
Query: 354 KSIPSSRRASLPL--PPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYE 411
K +RRASLP+ P ++ Y PN GILH + SPDVSVN PRIDRI +FPLASYE
Sbjct: 372 KPAVVTRRASLPISQKPAKGTKDSLYHPNIGILHQLNSPDVSVNSPRIDRI-KFPLASYE 430
Query: 412 DT-FFPIPKTSPTSAQGSSSSP--LCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHS 468
+ F P+ + S++GS S P +D SITKDK T++
Sbjct: 431 EMPFIPVVRKKKGSSRGSYSPPPEPPLDCSITKDKFTLEP-------------------- 470
Query: 469 MFQVNEEEGSNSSDQN-ATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQ 527
E S+ SDQN +S +S +RR RFD SSY+QRAEALEGLLEFSA+LL
Sbjct: 471 ----ERETKSDLSDQNATAGASSRASSGASRRQRFDPSSYRQRAEALEGLLEFSARLLID 526
Query: 528 ERYDELGVLLKPFGPGKVSPRETAIWLTKSIKENT 562
ERYDEL VLLKPFGPGKVSPRETAIWL+KS KE++
Sbjct: 527 ERYDELNVLLKPFGPGKVSPRETAIWLSKSFKESS 561
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZEZ5|NEK3_ORYSJ Serine/threonine-protein kinase Nek3 OS=Oryza sativa subsp. japonica GN=NEK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 565 bits (1457), Expect = e-160, Method: Compositional matrix adjust.
Identities = 317/570 (55%), Positives = 394/570 (69%), Gaps = 51/570 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELI+K+RNP+IVEYKDSWVE+GCYVCI+IG+CEGGDM+EAIKKANS FSEE+LC WLV
Sbjct: 52 MELIAKVRNPYIVEYKDSWVEKGCYVCIVIGYCEGGDMSEAIKKANSNYFSEERLCMWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLH NHILHRDVKCSNIFLTKDQ+IRLGDFGLAK+LTSDDL SSVVGTPSYMC
Sbjct: 112 QLLMALDYLHVNHILHRDVKCSNIFLTKDQNIRLGDFGLAKVLTSDDLTSSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCC+YEMT+LKPAFKAFDMQ LINKI+KS++APLPT YSGAF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCLYEMTALKPAFKAFDMQTLINKISKSVLAPLPTIYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRF 240
RGL+KSMLRK+P+ RPSAAELL+H HLQP+VL++ LK +SP RN +P++N A
Sbjct: 232 RGLIKSMLRKSPDHRPSAAELLKHPHLQPFVLELQLK-SSPARNL---FPDTNKA---SC 284
Query: 241 SEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVES 300
S+ +N + Y K +SF +R + ST + L + + E+ +
Sbjct: 285 SDDENNWKAKY-SKSHSFKVDRIVKVDKVAANNGHPSSTGTAKDYQELLKQPMDELLGQL 343
Query: 301 SHEGTVICKPIASKTSFVAKTPRLASSKASTNRR------GSYAVKKHESHPVSRLPSKK 354
+ + V+ + I S V K+P +AS+ R ++ + E+ P S+ ++
Sbjct: 344 TEK--VVDEVIHGNHSRVTKSPAPTPRRASSTPRIRLEPSKTFHARAAETPP-SKCSLER 400
Query: 355 SIPSSRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTF 414
+ +RRAS PV ++ R IL +KSPDVSVN PRIDRIAEFP+ S++D
Sbjct: 401 ASQPTRRAST---PVNMLQTPEKRQGADILTRLKSPDVSVNSPRIDRIAEFPIPSFDDE- 456
Query: 415 FPIPKTSPTSAQGSSSSPLCVDRSITKDKCTVQKC-DRASANHKFTEAWQGIQHSMFQVN 473
+ PT+ + P D+SITKDKCT Q +S NH
Sbjct: 457 ----QLHPTT-KLKLYPPSITDQSITKDKCTFQVLRSDSSKNHT---------------- 495
Query: 474 EEEGSNSSDQNATAGASS---RNSSD-ARRHRFDTSSYQQRAEALEGLLEFSAKLLQQER 529
+SSD + S+ +SSD ++ RFDT+SY+QRAEALEGLLEFSA+LLQQER
Sbjct: 496 ----GDSSDPSILGTDSNPLITSSSDWMKQRRFDTTSYRQRAEALEGLLEFSAQLLQQER 551
Query: 530 YDELGVLLKPFGPGKVSPRETAIWLTKSIK 559
++ELG+LLKPFGPGK SPRETAIWL+KS K
Sbjct: 552 FEELGILLKPFGPGKASPRETAIWLSKSFK 581
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WPH8|NEK5_ARATH Serine/threonine-protein kinase Nek5 OS=Arabidopsis thaliana GN=NEK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 146/211 (69%), Positives = 184/211 (87%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
M LI+++++P+IVE+K++WVE+GCYVCI+ G+CEGGDMAE +KK+N F EEKLCKW
Sbjct: 56 MSLIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFT 115
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLL+A++YLH+N++LHRD+KCSNIFLTKDQD+RLGDFGLAK L +DDL SSVVGTP+YMC
Sbjct: 116 QLLLAVEYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMC 175
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYG KSDIWSLGCCIYEM + +PAFKAFDM LI+K+N+S + PLP YS +
Sbjct: 176 PELLADIPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSL 235
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
+ L+K MLRKNPE RP+A+E+L+H +LQPYV
Sbjct: 236 KALIKGMLRKNPEYRPNASEILKHPYLQPYV 266
|
Involved in epidermal-cell morphogenesis in hypocotyls and roots. May act on the microtubule function. May have a secondary role in trichome branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94CU5|NEK5_ORYSJ Serine/threonine-protein kinase Nek5 OS=Oryza sativa subsp. japonica GN=NEK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 146/211 (69%), Positives = 181/211 (85%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
M LI+++++P+IVE+K++WVE+GCYVCI+ G+CEGGDMAE +KKAN F EEKL KW
Sbjct: 56 MALIARLQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKANGTYFPEEKLLKWFA 115
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QL +A+DYLH+N +LHRD+KCSNIFLTKDQDIRLGDFGLAK L +DDL SSVVGTP+YMC
Sbjct: 116 QLALAVDYLHSNFVLHRDLKCSNIFLTKDQDIRLGDFGLAKTLKADDLTSSVVGTPNYMC 175
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYG KSDIWSLGCC+YEM + +PAFKAFDM LI+KIN+S + PLP YS +
Sbjct: 176 PELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPPCYSPSM 235
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
+ L+KSMLRK+PE RP+A+E+L+ +LQPYV
Sbjct: 236 KSLIKSMLRKSPEHRPTASEILKSPYLQPYV 266
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 570 | ||||||
| 224130678 | 620 | predicted protein [Populus trichocarpa] | 0.992 | 0.912 | 0.783 | 0.0 | |
| 18766642 | 621 | NIMA-related protein kinase [Populus tre | 0.992 | 0.911 | 0.781 | 0.0 | |
| 255542330 | 608 | ATP binding protein, putative [Ricinus c | 0.966 | 0.906 | 0.767 | 0.0 | |
| 225451291 | 607 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.912 | 0.723 | 0.0 | |
| 225451293 | 598 | PREDICTED: serine/threonine-protein kina | 0.956 | 0.911 | 0.718 | 0.0 | |
| 298204885 | 614 | unnamed protein product [Vitis vinifera] | 0.952 | 0.884 | 0.717 | 0.0 | |
| 356573076 | 626 | PREDICTED: serine/threonine-protein kina | 0.998 | 0.908 | 0.708 | 0.0 | |
| 356504101 | 620 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.908 | 0.710 | 0.0 | |
| 224125620 | 574 | serine/threonine protein kinase [Populus | 0.912 | 0.905 | 0.731 | 0.0 | |
| 356576692 | 619 | PREDICTED: serine/threonine-protein kina | 0.980 | 0.903 | 0.709 | 0.0 |
| >gi|224130678|ref|XP_002328349.1| predicted protein [Populus trichocarpa] gi|222838064|gb|EEE76429.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2305), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/568 (78%), Positives = 490/568 (86%), Gaps = 2/568 (0%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
ELIS+IRNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN F EEKLCKWLVQ
Sbjct: 53 ELISRIRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
LLMALDYLH NHILHRDVKCSNIFLTK +DIRLGDFGLAKILTSDDLASSVVGTPSYMCP
Sbjct: 113 LLMALDYLHMNHILHRDVKCSNIFLTKGKDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 172
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR
Sbjct: 173 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 232
Query: 182 GLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTRF 240
GLVKSMLRKNPELRP AAELLRH HLQPYVLK+HLK+NSPR+N+L WPE +Y ++T+F
Sbjct: 233 GLVKSMLRKNPELRPGAAELLRHPHLQPYVLKIHLKMNSPRQNTLPFQWPEPHYMKKTKF 292
Query: 241 SEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVES 300
P++ P+ ++REK+YS SN+R LNPSIS EQDS+CST+GIH+TP+YLNR LS+ S+ES
Sbjct: 293 LVPEDNPLKAHREKRYSLSNDRALNPSISAAEQDSVCSTEGIHDTPSYLNRSLSDSSIES 352
Query: 301 SHEGTVICKPIASKTSFVAKTPRLASSKAS-TNRRGSYAVKKHESHPVSRLPSKKSIPSS 359
SHEGTVIC+ IASK S +AKT + A +KAS T RR + VKK ES PV+R P+KKS P++
Sbjct: 353 SHEGTVICRSIASKPSNIAKTTKPAPTKASVTTRRRTEPVKKRESLPVTRTPTKKSNPTT 412
Query: 360 RRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIPK 419
RR SLPLP AI+ N IL +KSPDVSVN PRIDRIAEFPLASYE+ F P +
Sbjct: 413 RRTSLPLPSRTAIQNSARGTNNSILLQIKSPDVSVNAPRIDRIAEFPLASYEEPFLPFRR 472
Query: 420 TSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGSN 479
TS TSAQGSS+S DRSITKDKCTVQ DR SA FTEAWQGI+H MFQV+EE GSN
Sbjct: 473 TSSTSAQGSSNSLHHGDRSITKDKCTVQISDRTSAKPNFTEAWQGIEHGMFQVDEENGSN 532
Query: 480 SSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLKP 539
SS+QNATAGASS SSD RR RFDTSS+QQRAEALEGLLEFSA+LLQ RYDELGVLLKP
Sbjct: 533 SSNQNATAGASSHTSSDMRRRRFDTSSFQQRAEALEGLLEFSARLLQDARYDELGVLLKP 592
Query: 540 FGPGKVSPRETAIWLTKSIKENTAKQDD 567
FGPGKVSPRETAIWLTKS KENTAK +D
Sbjct: 593 FGPGKVSPRETAIWLTKSFKENTAKPED 620
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18766642|gb|AAL79042.1|AF469649_1 NIMA-related protein kinase [Populus tremula x Populus alba] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2303), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/568 (78%), Positives = 491/568 (86%), Gaps = 2/568 (0%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
ELIS+IRNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN F EEKLCKWLVQ
Sbjct: 53 ELISRIRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 112
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
LLMALDYLH NHILHRDVKCSNIFLTK QDIRLGDFGLAKILTSDDLASSVVGTPSYMCP
Sbjct: 113 LLMALDYLHMNHILHRDVKCSNIFLTKGQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 172
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR
Sbjct: 173 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 232
Query: 182 GLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTRF 240
GLVKSMLRKNPELRPSAAELLRH HLQPYVLK+H+K+NSPR+N+L WPE +Y ++T+F
Sbjct: 233 GLVKSMLRKNPELRPSAAELLRHPHLQPYVLKIHIKMNSPRQNTLPFQWPEPHYMKKTKF 292
Query: 241 SEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVES 300
P++ P+ ++REK+YS SN+R LNPSIS EQDS+CST+GIH+TP+YLN+ LS+ S+ES
Sbjct: 293 LVPEDNPLKAHREKRYSLSNDRALNPSISAAEQDSVCSTEGIHDTPSYLNQSLSDSSIES 352
Query: 301 SHEGTVICKPIASKTSFVAKTPRLASSKAS-TNRRGSYAVKKHESHPVSRLPSKKSIPSS 359
SHEGTVIC+ IASK S AKT + A +KAS T RR + VKK ES PV+R P+KKS P++
Sbjct: 353 SHEGTVICRSIASKPSNFAKTTKPAPTKASVTTRRRTEPVKKRESLPVTRTPTKKSNPTT 412
Query: 360 RRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIPK 419
RR SLPLP AI+ + N IL +KSPDVSVN PRIDRIAEFPLASY+ + P +
Sbjct: 413 RRTSLPLPSRTAIQNSAHGTNNSILLQIKSPDVSVNAPRIDRIAEFPLASYDKPYLPFRR 472
Query: 420 TSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGSN 479
TS TSAQGSS+S DRSITKDKCTVQ DR SA FTEAWQGI+H MFQV+EE GSN
Sbjct: 473 TSSTSAQGSSNSLHHGDRSITKDKCTVQISDRTSAKPNFTEAWQGIEHGMFQVDEENGSN 532
Query: 480 SSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLKP 539
SS+QNATAGASSR SSD RR RFDTSS+QQRAEALEGLLEFSA+LLQ RYDELGVLLKP
Sbjct: 533 SSNQNATAGASSRTSSDIRRRRFDTSSFQQRAEALEGLLEFSARLLQDARYDELGVLLKP 592
Query: 540 FGPGKVSPRETAIWLTKSIKENTAKQDD 567
FGPGKVSPRETAIWLTKS KENTAK +D
Sbjct: 593 FGPGKVSPRETAIWLTKSFKENTAKTED 620
|
Source: Populus tremula x Populus alba Species: Populus tremula x Populus alba Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542330|ref|XP_002512228.1| ATP binding protein, putative [Ricinus communis] gi|223548189|gb|EEF49680.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2252), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/572 (76%), Positives = 484/572 (84%), Gaps = 21/572 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELIS+IRNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN LF EEKLCKWLV
Sbjct: 52 MELISRIRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGMLFPEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLH NHILHRDVKCSNIFLTK+QDIRLGDFGLAKILTSDDLASSVVGTPSYMC
Sbjct: 112 QLLMALDYLHVNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL-SHWPESNYARRTR 239
RGLVKSMLRKNPELRP+AAELLRH HLQPYVLKV LK+NSPRRNSL WPESNY ++TR
Sbjct: 232 RGLVKSMLRKNPELRPNAAELLRHPHLQPYVLKVQLKMNSPRRNSLPGQWPESNYIKKTR 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
F++ D + ++SYREK++SFSN+R LNP+ S +QDSLC T+GIH RRLSE+S+
Sbjct: 292 FADSD-LALNSYREKRHSFSNDRALNPNASVADQDSLCLTRGIH-------RRLSELSLG 343
Query: 300 SSHEGTVICKPI-ASKTSFVAKTPRLASSKASTN-RRGSYAVKKHESHPVSRLPSKKSIP 357
SS+EGTVICKPI ASK S +A+ + +KAS +R + +KK ES P++R +KKS
Sbjct: 344 SSNEGTVICKPITASKPSSIARISKHTPTKASAAPKRRAEPMKKRESLPITRTSTKKSDY 403
Query: 358 SSRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPI 417
++RRAS PL + N GIL +KSPDVSVN PRID+IAEFPLASYE+ FFP
Sbjct: 404 TNRRASFPLQTKST--------NIGILQDIKSPDVSVNAPRIDKIAEFPLASYEEAFFPF 455
Query: 418 P--KTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEE 475
P KTS SAQGS SP DRSITKDKCTVQ CDR S KFT+AWQGI SMFQV+EE
Sbjct: 456 PIRKTSSASAQGSCGSPYHGDRSITKDKCTVQICDRTSTEPKFTDAWQGIDRSMFQVDEE 515
Query: 476 EGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGV 535
EGSNSS+QNATAGASS SSD R RFDTSS+QQRAEALEGLLEFSA+LLQ+ERYDELGV
Sbjct: 516 EGSNSSNQNATAGASSPTSSDPRGRRFDTSSFQQRAEALEGLLEFSARLLQEERYDELGV 575
Query: 536 LLKPFGPGKVSPRETAIWLTKSIKENTAKQDD 567
LLKPFGPGKVSPRETAIWLTKS KENT KQ+D
Sbjct: 576 LLKPFGPGKVSPRETAIWLTKSFKENTQKQED 607
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451291|ref|XP_002278173.1| PREDICTED: serine/threonine-protein kinase Nek2-like isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/572 (72%), Positives = 471/572 (82%), Gaps = 18/572 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISK+RNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN LFSEEKLCKWLV
Sbjct: 52 MELISKMRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVLFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMAL+YLH NHILHRDVKCSNIFLTKDQ+IRLGDFGLAK+L+SDDLASS+VGTPSYMC
Sbjct: 112 QLLMALEYLHMNHILHRDVKCSNIFLTKDQNIRLGDFGLAKMLSSDDLASSIVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEMTS KPAFKAFDMQALINKINKSIVAPLPTKYSGAF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMTSHKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTR 239
RGLVKSMLRKNPELRPSAAELLRH HLQ YVLK+HLK NSPR N+L W E N++++ R
Sbjct: 232 RGLVKSMLRKNPELRPSAAELLRHPHLQAYVLKIHLKSNSPRYNTLPICWSEPNHSKKFR 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
F EP++ PIS+YREK+ SF N+RNLNPSISG EQD L S + H+TP LN+RL E+S
Sbjct: 292 FPEPEDAPISTYREKRQSFCNDRNLNPSISGAEQDFLSSAQRKHSTPVCLNQRLVEISFG 351
Query: 300 SSHEGTVICKPIASKTSFVAKTPRLASSKAS-TNRRGSYAVKKHESHPVSRLPSKKSIPS 358
S+HE T I + +ASK++ + KTPRL +KAS T +R + K E S+ P KKS P+
Sbjct: 352 STHEETTIIRSVASKSTNITKTPRLTPAKASATPKRWTEPSKDRELFRASQTPVKKSAPA 411
Query: 359 SRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIP 418
+RRASLPLP + ++E R G+LH + SPDVSVN PRIDRIAEFPLASY+ FFP+P
Sbjct: 412 ARRASLPLPRRSTVKESACRSKIGLLHHINSPDVSVNAPRIDRIAEFPLASYDSPFFPVP 471
Query: 419 KTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGS 478
KTS TSAQGSS+S + D SITKDKCT+Q Q +MF+V+ E+
Sbjct: 472 KTSSTSAQGSSNS-IIGDHSITKDKCTIQVL---------------TQGTMFEVDGEDAG 515
Query: 479 NSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLK 538
N SDQNATAGASS+ SSD RR RFDTSS++QRAEALEGLLEFSA+L+ +ERY+ELGVLLK
Sbjct: 516 NCSDQNATAGASSQASSDLRRRRFDTSSHRQRAEALEGLLEFSARLMHEERYEELGVLLK 575
Query: 539 PFGPGKVSPRETAIWLTKSIKENTAKQDDQHP 570
PFGPGKVSPRETAIWLTKS KENT KQ+DQ P
Sbjct: 576 PFGPGKVSPRETAIWLTKSFKENTGKQEDQCP 607
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451293|ref|XP_002278153.1| PREDICTED: serine/threonine-protein kinase Nek2-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 821 bits (2121), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/572 (71%), Positives = 466/572 (81%), Gaps = 27/572 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISK+RNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN LFSEEKLCKWLV
Sbjct: 52 MELISKMRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVLFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMAL+YLH NHILHRDVKCSNIFLTKDQ+IRLGDFGLAK+L+SDDLASS+VGTPSYMC
Sbjct: 112 QLLMALEYLHMNHILHRDVKCSNIFLTKDQNIRLGDFGLAKMLSSDDLASSIVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEMTS KPAFKAFDMQALINKINKSIVAPLPTKYSGAF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMTSHKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTR 239
RGLVKSMLRKNPELRPSAAELLRH HLQ YVLK+HLK NSPR N+L W E N++++ R
Sbjct: 232 RGLVKSMLRKNPELRPSAAELLRHPHLQAYVLKIHLKSNSPRYNTLPICWSEPNHSKKFR 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
F EP++ PIS+YREK+ SF N+RNLNPSISG EQD L S + H+TP LN+RL E+S
Sbjct: 292 FPEPEDAPISTYREKRQSFCNDRNLNPSISGAEQDFLSSAQRKHSTPVCLNQRLVEISFG 351
Query: 300 SSHEGTVICKPIASKTSFVAKTPRLASSKAS-TNRRGSYAVKKHESHPVSRLPSKKSIPS 358
S+HE T I + +ASK++ + KTPRL +KAS T +R + K E S+ P KKS P+
Sbjct: 352 STHEETTIIRSVASKSTNITKTPRLTPAKASATPKRWTEPSKDRELFRASQTPVKKSAPA 411
Query: 359 SRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIP 418
+RRASLPLP + ++E R G+LH + SPDVSVN PRIDRIAEFPLASY+ FFP+P
Sbjct: 412 ARRASLPLPRRSTVKESACRSKIGLLHHINSPDVSVNAPRIDRIAEFPLASYDSPFFPVP 471
Query: 419 KTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGS 478
KTS TSAQGSS+S + D SITKDKCT+ QV+ E+
Sbjct: 472 KTSSTSAQGSSNS-IIGDHSITKDKCTI------------------------QVDGEDAG 506
Query: 479 NSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLK 538
N SDQNATAGASS+ SSD RR RFDTSS++QRAEALEGLLEFSA+L+ +ERY+ELGVLLK
Sbjct: 507 NCSDQNATAGASSQASSDLRRRRFDTSSHRQRAEALEGLLEFSARLMHEERYEELGVLLK 566
Query: 539 PFGPGKVSPRETAIWLTKSIKENTAKQDDQHP 570
PFGPGKVSPRETAIWLTKS KENT KQ+DQ P
Sbjct: 567 PFGPGKVSPRETAIWLTKSFKENTGKQEDQCP 598
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204885|emb|CBI34192.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 818 bits (2113), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/570 (71%), Positives = 464/570 (81%), Gaps = 27/570 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISK+RNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN LFSEEKLCKWLV
Sbjct: 52 MELISKMRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVLFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMAL+YLH NHILHRDVKCSNIFLTKDQ+IRLGDFGLAK+L+SDDLASS+VGTPSYMC
Sbjct: 112 QLLMALEYLHMNHILHRDVKCSNIFLTKDQNIRLGDFGLAKMLSSDDLASSIVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEMTS KPAFKAFDMQALINKINKSIVAPLPTKYSGAF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMTSHKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTR 239
RGLVKSMLRKNPELRPSAAELLRH HLQ YVLK+HLK NSPR N+L W E N++++ R
Sbjct: 232 RGLVKSMLRKNPELRPSAAELLRHPHLQAYVLKIHLKSNSPRYNTLPICWSEPNHSKKFR 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
F EP++ PIS+YREK+ SF N+RNLNPSISG EQD L S + H+TP LN+RL E+S
Sbjct: 292 FPEPEDAPISTYREKRQSFCNDRNLNPSISGAEQDFLSSAQRKHSTPVCLNQRLVEISFG 351
Query: 300 SSHEGTVICKPIASKTSFVAKTPRLASSKAS-TNRRGSYAVKKHESHPVSRLPSKKSIPS 358
S+HE T I + +ASK++ + KTPRL +KAS T +R + K E S+ P KKS P+
Sbjct: 352 STHEETTIIRSVASKSTNITKTPRLTPAKASATPKRWTEPSKDRELFRASQTPVKKSAPA 411
Query: 359 SRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIP 418
+RRASLPLP + ++E R G+LH + SPDVSVN PRIDRIAEFPLASY+ FFP+P
Sbjct: 412 ARRASLPLPRRSTVKESACRSKIGLLHHINSPDVSVNAPRIDRIAEFPLASYDSPFFPVP 471
Query: 419 KTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGS 478
KTS TSAQGSS+S + D SITKDKCT+ QV+ E+
Sbjct: 472 KTSSTSAQGSSNS-IIGDHSITKDKCTI------------------------QVDGEDAG 506
Query: 479 NSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLK 538
N SDQNATAGASS+ SSD RR RFDTSS++QRAEALEGLLEFSA+L+ +ERY+ELGVLLK
Sbjct: 507 NCSDQNATAGASSQASSDLRRRRFDTSSHRQRAEALEGLLEFSARLMHEERYEELGVLLK 566
Query: 539 PFGPGKVSPRETAIWLTKSIKENTAKQDDQ 568
PFGPGKVSPRETAIWLTKS KENT KQ+D
Sbjct: 567 PFGPGKVSPRETAIWLTKSFKENTGKQEDH 596
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573076|ref|XP_003554691.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2110), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/572 (70%), Positives = 468/572 (81%), Gaps = 3/572 (0%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MEL+SK+RNPF+VEYKDSWVE+GCYV IIIG+CEGGDMAEAIKKA+ +F EEKLCKWLV
Sbjct: 52 MELLSKLRNPFLVEYKDSWVEKGCYVFIIIGYCEGGDMAEAIKKASGVMFPEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLH NHILHRDVKCSNIFLTKD DIRLGDFGLAK+LTSDDL SSVVGTPSYMC
Sbjct: 112 QLLMALDYLHVNHILHRDVKCSNIFLTKDHDIRLGDFGLAKMLTSDDLTSSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD+QALINKINKSIVAPLPTKYSGAF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDIQALINKINKSIVAPLPTKYSGAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL-SHWPESNYARRTR 239
RGLVKSMLRKNPELRPSAAELL H HLQPYVLKVHLK+NSPRR++L HWPESNY +TR
Sbjct: 232 RGLVKSMLRKNPELRPSAAELLGHQHLQPYVLKVHLKINSPRRSTLPGHWPESNYMEKTR 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
F + ++ P+S K++SFS +R LNPSISG EQDSLCST I TP LN+R +E+SV
Sbjct: 292 FLKSEDDPVSFSGNKRHSFSYDRTLNPSISGAEQDSLCSTLEIDCTPDNLNQRFAELSVG 351
Query: 300 SSHEGTVICKPIASKTSFVAKTPRLASSKASTN-RRGSYAVKKHESHPVSRLPSKKSIPS 358
+H+ + KP+AS+TS A+TPRL +SKAS ++ + K H++ PVS K+ + +
Sbjct: 352 DNHDVKSLHKPVASRTSSKARTPRLTASKASAAPKKSMVSSKNHKTLPVSH-NMKEPVHT 410
Query: 359 SRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIP 418
+RRASLP P I++ P R + G+L V S ++SVN PRIDRIAEFPLASYED FPI
Sbjct: 411 TRRASLPFPRSCTIQQPPRRASIGLLDHVNSLNISVNSPRIDRIAEFPLASYEDQLFPIN 470
Query: 419 KTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGS 478
+SP SAQGSS P C + S DKCT++ CD + T+AWQGI +SMF+ N+E+ S
Sbjct: 471 SSSPNSAQGSSGFPPCGNDSTLIDKCTIKVCDTSYVRPGCTDAWQGITNSMFKKNDEDKS 530
Query: 479 NSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLK 538
SSDQNATAGASS NSSD R +FDTSS++QRAEALEGLLEFSA+LLQQERY ELGVLLK
Sbjct: 531 GSSDQNATAGASSHNSSDLRHRQFDTSSFRQRAEALEGLLEFSARLLQQERYGELGVLLK 590
Query: 539 PFGPGKVSPRETAIWLTKSIKENTAKQDDQHP 570
PFGPGK SPRETAIWL+KS+KENT ++ P
Sbjct: 591 PFGPGKASPRETAIWLSKSLKENTFSREQSTP 622
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504101|ref|XP_003520837.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2087), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/573 (71%), Positives = 469/573 (81%), Gaps = 10/573 (1%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MEL+SK+RNPFIVEYKDSWVE+GCYVCIIIG+C+GGDMAEAIKKA+ +F EEKLCKWLV
Sbjct: 52 MELLSKLRNPFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKASGVMFPEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLH NHILHRDVKCSNIFLTK+ DIRLGDFGLAK+LTSDDL SSVVGTPSYMC
Sbjct: 112 QLLMALDYLHVNHILHRDVKCSNIFLTKNHDIRLGDFGLAKMLTSDDLTSSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD+QALINKINKSIVAPLPTKYSG+F
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDIQALINKINKSIVAPLPTKYSGSF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRF 240
RGLVKSMLRKNPELRPSAAELL H HLQPYVLKVHLK+NSPRR++L PESNY ++TRF
Sbjct: 232 RGLVKSMLRKNPELRPSAAELLGHHHLQPYVLKVHLKINSPRRSTL---PESNYMKKTRF 288
Query: 241 --SEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSV 298
SE D+V +S K +SFS +R LNPS+SG EQDSLCST I TP LN+R +E+SV
Sbjct: 289 LKSEDDHVSLSG--NKWHSFSYDRTLNPSVSGAEQDSLCSTLEIDCTPDNLNQRFAELSV 346
Query: 299 ESSHEGTVICKPIASKTSFVAKTPRLASSKASTNRRGSYAV-KKHESHPVSRLPSKKSIP 357
+ + + KP S+TS AKTPRLA+SKAS + S K H++ PVS +K+ +
Sbjct: 347 GDNPDVKSLHKPAVSRTSINAKTPRLAASKASATPKKSMVFSKNHKTLPVS-YNTKEPVH 405
Query: 358 SSRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPI 417
++RRASLP P AI++ P RP+ G+L V SP++SVN PRIDRIAEFPLASYED FPI
Sbjct: 406 TTRRASLPFPRSCAIQQPPRRPSIGLLDHVNSPNISVNSPRIDRIAEFPLASYEDQLFPI 465
Query: 418 PKTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEG 477
++SP SAQGS+ SP C + S DKCT++ CD + T+AWQGI+ S F+ N+E+
Sbjct: 466 NRSSPNSAQGSAGSP-CGNDSTLIDKCTIKVCDTSYVRPGCTDAWQGIKRSRFKKNDEDK 524
Query: 478 SNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLL 537
S SSDQNAT GASS NSSD RR +FDTSS++QRAEALEGLLEFSA+LLQQERY ELGVLL
Sbjct: 525 SGSSDQNATTGASSHNSSDLRRRQFDTSSFRQRAEALEGLLEFSARLLQQERYGELGVLL 584
Query: 538 KPFGPGKVSPRETAIWLTKSIKENTAKQDDQHP 570
KPFGPGK SPRETAIWL+KS+KENT + P
Sbjct: 585 KPFGPGKASPRETAIWLSKSLKENTFSAGNNSP 617
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125620|ref|XP_002319634.1| serine/threonine protein kinase [Populus trichocarpa] gi|222858010|gb|EEE95557.1| serine/threonine protein kinase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2087), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/563 (73%), Positives = 454/563 (80%), Gaps = 43/563 (7%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
ELIS+IR+PFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN LFSEEKLCKWLVQ
Sbjct: 53 ELISRIRSPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGMLFSEEKLCKWLVQ 112
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
LLMALDYLH NHILHRDVKCSNIFLTK QDIRLGDFGLAKILTSDDLASSVVGTPSYMCP
Sbjct: 113 LLMALDYLHMNHILHRDVKCSNIFLTKQQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 172
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
ELLADIPYGSKSDIWSLGCCIYEMTSL+PAFKAFDMQALINKINKSIVAPLPTKYSGAFR
Sbjct: 173 ELLADIPYGSKSDIWSLGCCIYEMTSLRPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 232
Query: 182 GLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESNYARRTRF 240
GLVKSMLRKNPELRP AAELLRH LQPYVLK+HLK++SPR+N+L WPE +Y ++TRF
Sbjct: 233 GLVKSMLRKNPELRPGAAELLRHPQLQPYVLKIHLKMSSPRQNTLPFQWPEPHYMKKTRF 292
Query: 241 SEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVES 300
P++ P +R+K+YS N+R LNPSIS EQDS+CST+GIH+TP YLNRRLS+ S+E
Sbjct: 293 LVPEDNPRKVHRDKRYSLGNDRALNPSISVAEQDSVCSTEGIHDTPIYLNRRLSDSSIEC 352
Query: 301 SHEGTVICKPIASKTSFVAKTPRLASSKASTNRRGSYAVKKHESHPVSR-LPSKKSIPSS 359
S +GTVIC+ IASK S AKTP+L +KAS PV+R P+KKS PS+
Sbjct: 353 S-QGTVICRSIASKPSNSAKTPKLTPTKASL--------------PVTRKTPTKKSNPSA 397
Query: 360 RRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIPK 419
RRAS PLP I+ P N IL +KSPDVSVN PRIDR+AEFPLASY++ F PI K
Sbjct: 398 RRASFPLPSKGRIQNSPSGTNISILSQIKSPDVSVNAPRIDRMAEFPLASYDEPFLPIRK 457
Query: 420 TSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGSN 479
TS TSA+GSS+S D SITKDKCT V+EE GSN
Sbjct: 458 TSSTSARGSSNSLRHGDCSITKDKCT--------------------------VDEENGSN 491
Query: 480 SSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLKP 539
SS+QNATAGASSR SSD R+ RFDTSS QQRAEALEGLLEFSA+LLQ RYDELGVLLKP
Sbjct: 492 SSNQNATAGASSRTSSDTRQRRFDTSSLQQRAEALEGLLEFSARLLQAARYDELGVLLKP 551
Query: 540 FGPGKVSPRETAIWLTKSIKENT 562
FGPGKVSPRETAIWLTKS KENT
Sbjct: 552 FGPGKVSPRETAIWLTKSFKENT 574
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576692|ref|XP_003556464.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2054), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/564 (70%), Positives = 465/564 (82%), Gaps = 5/564 (0%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISK+RNPFIVEYKDSWVE+GCYVCIIIG+CEGGDMAEAIKKAN LF EEKLCKWLV
Sbjct: 52 MELISKLRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVLFPEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLH NHILHRDVKCSNIFLTKD DIRLGDFGLAK+LTSDDLASSVVGTPSYMC
Sbjct: 112 QLLMALDYLHMNHILHRDVKCSNIFLTKDHDIRLGDFGLAKMLTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEMT+ KPAFKAFD+QALINKINKSIVAPLPTKYS +F
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMTAHKPAFKAFDIQALINKINKSIVAPLPTKYSSSF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL-SHWPESNYARRTR 239
RGLVKSMLRKNPELRP A+ELL H HLQPYVLKVHLK+NSPRR++L HWPESNY ++TR
Sbjct: 232 RGLVKSMLRKNPELRPRASELLGHPHLQPYVLKVHLKINSPRRSTLPVHWPESNYMKKTR 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
F P++ P+S YR+K++SF+N+R LNPS+SG +QDS+CST I TP +LN+RL+E+ +
Sbjct: 292 FLVPEDDPVSIYRDKRHSFTNDRTLNPSVSGADQDSVCSTLEIDCTPDHLNQRLAELRIG 351
Query: 300 SSHEGTVICKPIASKTSFVAKTPRLASSKAS-TNRRGSYAVKKHESHPVSRLPSKKSIPS 358
SH+ I KP+ S+TS + KTP+ ASSK S TN++ + K ++ P+S+ + KS +
Sbjct: 352 DSHQVKSIQKPVVSRTSSIVKTPKFASSKVSATNKKSMKSSKNCKTLPLSQ-NTTKSANT 410
Query: 359 SRRASLPLPPVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIP 418
+RRAS PLP R+ P R + +L V SPD+SVN PRID++AEFPL SYED+ FPI
Sbjct: 411 NRRASFPLPTRGGNRQPPCR-SVSLLSHVSSPDISVNSPRIDKMAEFPLTSYEDSLFPIN 469
Query: 419 KTSPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSMFQVNEEEGS 478
KTS +SA+GSS P + S DKCTV+ RAS +AWQGI+ S+ + +E+ S
Sbjct: 470 KTS-SSARGSSGFPSHSNHSTVIDKCTVEVYGRASNKPGSMDAWQGIKQSVLKEIDEDKS 528
Query: 479 NSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQERYDELGVLLK 538
SSDQNATAGASS SSD RR +FD SS+QQRAEALEGLLEFSA+LLQQ RYDELGVLLK
Sbjct: 529 GSSDQNATAGASSHTSSDLRRRQFDPSSFQQRAEALEGLLEFSARLLQQARYDELGVLLK 588
Query: 539 PFGPGKVSPRETAIWLTKSIKENT 562
PFGPGKVSPRETAIWL+KS KENT
Sbjct: 589 PFGPGKVSPRETAIWLSKSFKENT 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 570 | ||||||
| TAIR|locus:2114885 | 606 | NEK2 "NIMA-related kinase 2" [ | 0.940 | 0.884 | 0.601 | 4.5e-162 | |
| TAIR|locus:2185314 | 568 | NEK3 "NIMA-related kinase 3" [ | 0.587 | 0.589 | 0.644 | 1.9e-140 | |
| TAIR|locus:2077274 | 555 | NEK4 "NIMA-related kinase 4" [ | 0.587 | 0.603 | 0.631 | 1.7e-139 | |
| TAIR|locus:2020148 | 612 | NEK1 "NIMA-related serine/thre | 0.747 | 0.696 | 0.606 | 1.1e-133 | |
| TAIR|locus:2081383 | 956 | NEK6 ""NIMA (never in mitosis, | 0.614 | 0.366 | 0.5 | 5e-110 | |
| UNIPROTKB|E1C5S2 | 786 | NEK4 "Uncharacterized protein" | 0.459 | 0.333 | 0.397 | 9.1e-55 | |
| ZFIN|ZDB-GENE-040426-1392 | 849 | nek4 "NIMA (never in mitosis g | 0.361 | 0.242 | 0.464 | 2.6e-54 | |
| UNIPROTKB|E1BWZ5 | 838 | NEK4 "Uncharacterized protein" | 0.459 | 0.312 | 0.397 | 3.8e-54 | |
| MGI|MGI:1344404 | 792 | Nek4 "NIMA (never in mitosis g | 0.371 | 0.267 | 0.454 | 1.8e-53 | |
| RGD|1304995 | 309 | Nek4 "NIMA-related kinase 4" [ | 0.371 | 0.686 | 0.454 | 5.6e-52 |
| TAIR|locus:2114885 NEK2 "NIMA-related kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1578 (560.5 bits), Expect = 4.5e-162, P = 4.5e-162
Identities = 346/575 (60%), Positives = 402/575 (69%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISKI NPFIVEYKDSWVE+GCYVCIIIG+C+GGDMAEAIKK N F+EEKLCKWLV
Sbjct: 52 MELISKIHNPFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
Q+L+AL+YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK+LTSDDLASSVVGTPSYMC
Sbjct: 112 QILLALEYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCC+YEMT++KPAFKAFDMQ LIN+IN+SIV PLP +YS AF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL-SHWPESNYARRTR 239
RGLVKSMLRKNPELRPSAAELLR LQPY+ K+HLK+N P N L + WPES ARR
Sbjct: 232 RGLVKSMLRKNPELRPSAAELLRQPLLQPYIQKIHLKVNDPGSNVLPAQWPESESARRNS 291
Query: 240 FSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNR-RLSEVSV 298
F E P K +SF +R G +DS+ S K PAYLNR R ++S
Sbjct: 292 FPEQRRRPAG----KSHSFGPSR-----FRGNLEDSVSSIK--KTVPAYLNRERQVDLST 340
Query: 299 ESSHEGTVICKPIASKTSFVAKTPRLASSKASTNR-RGSYAVKKHESHPVS-RLPSKKXX 356
++S +GTV+ +TS +K+ R +AS + R PVS +L ++K
Sbjct: 341 DASGDGTVV-----RRTSEASKSSRYVPVRASASPVRPRQPRSDLGQLPVSSQLKNRKPA 395
Query: 357 XXXXXXXXXXXXVAA--IRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDT- 413
A I++ Y T LH + SPDVS+N PRID+I EFPLASYE+
Sbjct: 396 ALIRRASMPSSRKPAKEIKDSLYISKTSFLHQINSPDVSMNAPRIDKI-EFPLASYEEEP 454
Query: 414 FFPI----PKXXXXXXXXXXXXXLCVDRSITKDKCTVQKCDRASANHKFTEAWQGIQHSM 469
F P+ K +D SITKDK T++ N + I ++
Sbjct: 455 FVPVVRGKKKKASSRGSYSPPPEPPLDCSITKDKFTLEP----GQNRE-----GAIMKAV 505
Query: 470 FQVNE--EEGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLLQQ 527
++ + E+ S SSDQNATAGASSR SS RR RFD SSYQQRAEALEGLLEFSA+LLQ
Sbjct: 506 YEEDAYLEDRSESSDQNATAGASSRASSGVRRQRFDPSSYQQRAEALEGLLEFSARLLQD 565
Query: 528 ERYDELGVLLKPFGPGKVSPRETAIWLTKSIKENT 562
ERYDEL VLL+PFGPGKVSPRETAIWL+KS KE T
Sbjct: 566 ERYDELNVLLRPFGPGKVSPRETAIWLSKSFKETT 600
|
|
| TAIR|locus:2185314 NEK3 "NIMA-related kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 1.9e-140, Sum P(2) = 1.9e-140
Identities = 230/357 (64%), Positives = 267/357 (74%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISKIRNPFIVEYKDSWVE+GCYVCI+IG+C+GGDMAEAIKKAN FSEEKLCKWLV
Sbjct: 52 MELISKIRNPFIVEYKDSWVEKGCYVCIVIGYCKGGDMAEAIKKANGVEFSEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMAL+YLHA+HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC
Sbjct: 112 QLLMALEYLHASHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCC+YEMT+LKPAFKAFDMQ LIN+IN+SIVAPLP +YS AF
Sbjct: 172 PELLADIPYGSKSDIWSLGCCMYEMTALKPAFKAFDMQGLINRINRSIVAPLPAQYSTAF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRF 240
R LVKSMLRKNPELRPSA++LLR LQPYV KV LKL+ ++L P S RR+ +
Sbjct: 232 RSLVKSMLRKNPELRPSASDLLRQPLLQPYVQKVLLKLSFREHDTL---P-SESERRSSY 287
Query: 241 SEPDNVPISSYREKQYSFSNNRNLNPSISGTEQ-DSLCSTKGIHNTPAYLNR-RLSEVSV 298
P +S K SF PS G +Q DS+ S K +H YL+R R ++S
Sbjct: 288 --PQQRKRTS--GKSVSFG------PSRFGVDQEDSVSSVKPVHT---YLHRHRPVDLSA 334
Query: 299 ESSHEGTVICKP-IASKTSFVAK-TPRLASSKASTNRRGSYAVKKHESHPVSRLPSK 353
+ V+ +P ++S S +K P ++ S V + S P+S+ P+K
Sbjct: 335 NDTSR-VVVRRPAVSSVVSNSSKYVPVRSNQPKSGGLLKPAVVTRRASLPISQKPAK 390
|
|
| TAIR|locus:2077274 NEK4 "NIMA-related kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 1.7e-139, Sum P(2) = 1.7e-139
Identities = 226/358 (63%), Positives = 272/358 (75%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELIS +RNPF+VEYKDSWVE+GCYVCI+IG+C+GGDM + IK+A F EEKLC+WLV
Sbjct: 52 MELISTVRNPFVVEYKDSWVEKGCYVCIVIGYCQGGDMTDTIKRACGVHFPEEKLCQWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLMALDYLH+NHILHRDVKCSNIFLTK+QDIRLGDFGLAKILTSDDL SSVVGTPSYMC
Sbjct: 112 QLLMALDYLHSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCC+YEM + KP FKA D+Q LI KI+K I+ P+P YSG+F
Sbjct: 172 PELLADIPYGSKSDIWSLGCCMYEMAAHKPPFKASDVQTLITKIHKLIMDPIPAMYSGSF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRF 240
RGL+KSMLRKNPELRPSA ELL H HLQPY+ V++KL SPRR++ +P +F
Sbjct: 232 RGLIKSMLRKNPELRPSANELLNHPHLQPYISMVYMKLESPRRST---FP-------LQF 281
Query: 241 SEPDNVPISSYREKQYS-FSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVE 299
SE D ++ +E++ S FSN+R LNPS+S TE S+ S+ TP + R++SEV+V
Sbjct: 282 SERD----ATLKERRRSSFSNDRRLNPSVSDTEAGSVSSSGKASPTPMFNGRKVSEVTVG 337
Query: 300 SSHEGTVICKPI-ASKTSFVAKTPRLA--SSKASTNRRGSYAVKKHESHPVSRLPSKK 354
E V + A K S A+TPR+A S+KAST R V KHE VS P+++
Sbjct: 338 VVREEIVPQRQEEAKKQSGAARTPRVAGTSAKASTQR----TVFKHELMKVSN-PTER 390
|
|
| TAIR|locus:2020148 NEK1 "NIMA-related serine/threonine kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1310 (466.2 bits), Expect = 1.1e-133, P = 1.1e-133
Identities = 277/457 (60%), Positives = 324/457 (70%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
MELISK+R+PFIVEYKDSWVE+ CYVCI+IG+CEGGDMA+AIKK+N F EEKLCKWLV
Sbjct: 52 MELISKMRHPFIVEYKDSWVEKACYVCIVIGYCEGGDMAQAIKKSNGVHFQEEKLCKWLV 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLLM L+YLH+NHILHRDVKCSNIFLTK+QDIRLGDFGLAKILTSDDL SSVVGTPSYMC
Sbjct: 112 QLLMGLEYLHSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMC 171
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYGSKSDIWSLGCCIYEM LKPAFKAFDMQALINKINK+IV+PLP KYSG F
Sbjct: 172 PELLADIPYGSKSDIWSLGCCIYEMAYLKPAFKAFDMQALINKINKTIVSPLPAKYSGPF 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLS-HWPESN-YARRT 238
RGLVKSMLRKNPE+RPSA++LLRH HLQPYVL V L+LN+ RR +L P S ++
Sbjct: 232 RGLVKSMLRKNPEVRPSASDLLRHPHLQPYVLDVKLRLNNLRRKTLPPELPSSKRIMKKA 291
Query: 239 RFSEPDNVPISSYREKQY-SFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVS 297
FSEP V ++ E+Q+ S N+R LNP E+D+ S K I +RR+S++S
Sbjct: 292 HFSEPA-VTCPAFGERQHRSLWNDRALNPE---AEEDTASSIKCI-------SRRISDLS 340
Query: 298 VESSHEGTVICKPIASKTSFVAKTPRLASSKASTNRRGSYAVKKHESHPVSR-------L 350
+ESS +GT+ICK ++S V+K P LA S ++ R + HPVS +
Sbjct: 341 IESSSKGTLICKQVSSSACKVSKYP-LAKSSVTSRRIMETGRRSDHLHPVSGGGTTSKII 399
Query: 351 PSKKXXXXXXXXXXXXXXVAAIRELPYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASY 410
PS + VAA Y P GIL VKSP+ S+NEP++D+IA FPLA Y
Sbjct: 400 PSARRTSLPLTKRATNQEVAA-----YNPIVGILQNVKSPEYSINEPQVDKIAIFPLAPY 454
Query: 411 EDTFFPIPKXXXXXXXXXXXXXLCVDRSITKDKCTVQ 447
E F P DRSITKDKCTVQ
Sbjct: 455 EQDIFFTPMQRKTSSKSSSVS----DRSITKDKCTVQ 487
|
|
| TAIR|locus:2081383 NEK6 ""NIMA (never in mitosis, gene A)-related 6"" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 878 (314.1 bits), Expect = 5.0e-110, Sum P(3) = 5.0e-110
Identities = 184/368 (50%), Positives = 246/368 (66%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
M LI+++++P+IVE+K++WVE+GCYVCI+ G+CEGGDMAE +KK+N F EEKLCKW
Sbjct: 56 MSLIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFT 115
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLL+A++YLH+N++LHRD+KCSNIFLTKDQD+RLGDFGLAK L +DDL SSVVGTP+YMC
Sbjct: 116 QLLLAVEYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMC 175
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PELLADIPYG KSDIWSLGCCIYEM + +PAFKAFDM LI+K+N+S + PLP YS +
Sbjct: 176 PELLADIPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSL 235
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRF 240
+ L+K MLRKNPE RP+A+E+L+H +LQPYV + L++ + P ++ R
Sbjct: 236 KALIKGMLRKNPEYRPNASEILKHPYLQPYVEQYRPTLSAA--SITPEKPLNSREGRRSM 293
Query: 241 SEPDNVPISSYREKQY-SFSNNRNLNPSISG--TEQDS-LCSTKGI--HNTPAYLNRRLS 294
+E N SS ++ Y S N R + PS TE DS + I H + N L
Sbjct: 294 AESQNSNSSSEKDNFYVSDKNIRYVVPSNGNKVTETDSGFVDDEDILDHVQQSAENGNLQ 353
Query: 295 EVSVESSHEGTVICKPIAS--KTSFVA----KTPR--LASSKASTNRRGSYAVKKHESHP 346
VS + +G I KP+ S + + KT R + K R ++ + S P
Sbjct: 354 SVSA-TKPDGHGILKPVHSDQRPDVIQPRHPKTIRNIMMVLKEEKARENGSPMRSNRSRP 412
Query: 347 VSRLPSKK 354
S +P++K
Sbjct: 413 -SSVPTQK 419
|
|
| UNIPROTKB|E1C5S2 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 9.1e-55, Sum P(2) = 9.1e-55
Identities = 111/279 (39%), Positives = 173/279 (62%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+L+S++++P IV Y++SW + I++GFCEGGD+ +K+ KL E ++ +W VQ
Sbjct: 55 QLLSQLKHPNIVAYRESWQGEDGLLYIVMGFCEGGDLYHRLKEQKGKLLPENQVVEWFVQ 114
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMC 120
+ MAL YLH HILHRD+K N+FLT+ I++GD G+A++L + D+AS+++GTP YM
Sbjct: 115 IAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 174
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PEL ++ PY KSD+W+LGCC+YEM +LK AF A DM +L+ +I + + P+P YS
Sbjct: 175 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPQL 234
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVL-KVHLKLNSPRRNSL-SHWPESNYARRT 238
++++ML K PE RPS +LR QPY+ ++ L L + + + SH + +
Sbjct: 235 VEIIQTMLSKRPEQRPSVKSILR----QPYIKHQISLFLEATKMKAAKSHKKMAGSKLKD 290
Query: 239 RFSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLC 277
S VP+ + S+N+N+ P S +EQ C
Sbjct: 291 SSSV---VPVKNE-------SHNKNVIPPDSSSEQGRKC 319
|
|
| ZFIN|ZDB-GENE-040426-1392 nek4 "NIMA (never in mitosis gene a)-related kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 538 (194.4 bits), Expect = 2.6e-54, Sum P(2) = 2.6e-54
Identities = 98/211 (46%), Positives = 145/211 (68%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+L+S++++P IV Y++SW C + I++GFCEGGD+ +K+ +L E ++ +W VQ
Sbjct: 53 QLLSQLKHPNIVMYRESWEGEDCQLYIVMGFCEGGDLYHRLKQQKGELLPERQVVEWFVQ 112
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMC 120
+ MAL YLH HILHRD+K NIFLTK I++GD G+A++L + +D+AS+++GTP YM
Sbjct: 113 IAMALQYLHEKHILHRDLKTQNIFLTKTNIIKVGDLGIARVLENQNDMASTLIGTPYYMS 172
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PEL ++ PY KSD+W+LGCC+YEM +LK AF A DM +L+ +I + + +P+KY
Sbjct: 173 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIVEGKLPQMPSKYDPQL 232
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
L+K ML K PE RP +LR QPY+
Sbjct: 233 GELIKRMLCKKPEDRPDVKHILR----QPYI 259
|
|
| UNIPROTKB|E1BWZ5 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 3.8e-54, Sum P(2) = 3.8e-54
Identities = 111/279 (39%), Positives = 173/279 (62%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+L+S++++P IV Y++SW + I++GFCEGGD+ +K+ KL E ++ +W VQ
Sbjct: 55 QLLSQLKHPNIVAYRESWQGEDGLLYIVMGFCEGGDLYHRLKEQKGKLLPENQVVEWFVQ 114
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMC 120
+ MAL YLH HILHRD+K N+FLT+ I++GD G+A++L + D+AS+++GTP YM
Sbjct: 115 IAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 174
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PEL ++ PY KSD+W+LGCC+YEM +LK AF A DM +L+ +I + + P+P YS
Sbjct: 175 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPQL 234
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVL-KVHLKLNSPRRNSL-SHWPESNYARRT 238
++++ML K PE RPS +LR QPY+ ++ L L + + + SH + +
Sbjct: 235 VEIIQTMLSKRPEQRPSVKSILR----QPYIKHQISLFLEATKMKAAKSHKKMAGSKLKD 290
Query: 239 RFSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLC 277
S VP+ + S+N+N+ P S +EQ C
Sbjct: 291 SSSV---VPVKNE-------SHNKNVIPPDSSSEQGRKC 319
|
|
| MGI|MGI:1344404 Nek4 "NIMA (never in mitosis gene a)-related expressed kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 1.8e-53, Sum P(2) = 1.8e-53
Identities = 99/218 (45%), Positives = 149/218 (68%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+L+S++++P IV YK+SW + I++GFCEGGD+ +K+ +L E ++ +W VQ
Sbjct: 55 QLLSQLKHPNIVTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPESQVVEWFVQ 114
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMC 120
+ MAL YLH HILHRD+K N+FLT+ I++GD G+A++L + D+AS+++GTP YM
Sbjct: 115 IAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHGDMASTLIGTPYYMS 174
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PEL ++ PY KSD+W+LGCC+YEM +LK AF A DM +L+ +I + + P+P YS
Sbjct: 175 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKVYSTEL 234
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKL 218
L+++ML + PE RPS +LR QPY+ K H+ L
Sbjct: 235 AELIRTMLSRRPEERPSVRSILR----QPYI-KHHISL 267
|
|
| RGD|1304995 Nek4 "NIMA-related kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 5.6e-52, P = 5.6e-52
Identities = 99/218 (45%), Positives = 149/218 (68%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+L+S++++P IV YK+SW + I++GFCEGGD+ +K+ +L E ++ +W VQ
Sbjct: 55 QLLSQLKHPNIVTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPESQVVEWFVQ 114
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMC 120
+ MAL YLH HILHRD+K N+FLT+ I++GD G+A++L + D+AS+++GTP YM
Sbjct: 115 IAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHSDMASTLIGTPYYMS 174
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PEL ++ PY KSD+W+LGCC+YEM +LK AF A DM +L+ +I + + P+P YS
Sbjct: 175 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKVYSAEL 234
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKL 218
L+++ML + PE RPS +LR QPY+ K H+ L
Sbjct: 235 AELIRTMLSRRPEERPSVRSILR----QPYI-KHHISL 267
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q2QMH1 | NEK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6097 | 0.9280 | 0.8950 | yes | no |
| A2ZMH2 | NEK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.6097 | 0.9280 | 0.8950 | N/A | no |
| Q9SLI2 | NEK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6409 | 0.9403 | 0.8758 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 570 | |||
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-100 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-68 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-65 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-63 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-57 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-57 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-56 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-56 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-56 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-55 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-47 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-46 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-44 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-42 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-42 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-39 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-38 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-38 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-37 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-37 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-33 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-33 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-32 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-31 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-30 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-30 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-29 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-29 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-27 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-27 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-26 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-25 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-24 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-24 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-23 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-23 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-23 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-22 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-22 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-21 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 96/205 (46%), Positives = 144/205 (70%), Gaps = 4/205 (1%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--KLFSEEKLCKWL 59
+++ K+ +P I++Y +S+ E+G +CI++ + +GGD+++ IKK K F EE++ W
Sbjct: 51 KILKKLNHPNIIKYYESFEEKG-KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF 109
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSY 118
VQL +AL YLH+ ILHRD+K NIFLT + ++LGDFG++K+L+S DLA +VVGTP Y
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSG 178
+ PEL + PY KSDIWSLGC +YE+ +LK F+ ++ L KI K P+P++YS
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSS 229
Query: 179 AFRGLVKSMLRKNPELRPSAAELLR 203
R LV S+L+K+PE RPS A++L+
Sbjct: 230 ELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 5e-70
Identities = 97/211 (45%), Positives = 144/211 (68%), Gaps = 5/211 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+L+S++++P IV Y++SW + I++GFCEGGD+ +K+ KL E ++ +W VQ
Sbjct: 51 QLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ 110
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMC 120
+ MAL YLH HILHRD+K N+FLT+ I++GD G+A++L + D+AS+++GTP YM
Sbjct: 111 IAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PEL ++ PY KSD+W+LGCC+YEM +LK AF A DM +L+ +I + + P+P YS
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPEL 230
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
L+ +ML K PE RPS +LR QPY+
Sbjct: 231 GELIATMLSKRPEKRPSVKSILR----QPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 2e-68
Identities = 77/207 (37%), Positives = 121/207 (58%), Gaps = 6/207 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++ K+++P IV D + + + +++ +CEGGD+ + +KK SE++ +L
Sbjct: 48 IKILKKLKHPNIVRLYDVFEDED-KLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLR 104
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
Q+L AL+YLH+ I+HRD+K NI L +D ++L DFGLA+ L + ++ VGTP YM
Sbjct: 105 QILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMA 164
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPLP--TKYS 177
PE+L YG DIWSLG +YE+ + KP F D + L KI K P S
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L++ +L K+PE R +A E L+H
Sbjct: 225 PEAKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 4e-65
Identities = 90/211 (42%), Positives = 128/211 (60%), Gaps = 9/211 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVC-IIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWL 59
++ ++++P IV Y D ++R I++ +CEGGD+A+ I+K K EE + + L
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 60 VQLLMALDYLH-----ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVV 113
QLL+AL H N +LHRD+K +NIFL + +++LGDFGLAKIL D A + V
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLP 173
GTP YM PE L + Y KSDIWSLGC IYE+ +L P F A + L +KI + +P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+YS ++KSML +P+ RPS ELL+
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 4e-63
Identities = 88/204 (43%), Positives = 137/204 (67%), Gaps = 2/204 (0%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++S +++P IV+Y++S+ E G + I++ +CEGGD+ + I LF E+++ W V
Sbjct: 50 VAVLSNMKHPNIVQYQESFEENGN-LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYM 119
Q+ +AL ++H ILHRD+K NIFLTKD I+LGDFG+A++L S +LA + +GTP Y+
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE+ + PY +KSDIW+LGC +YEM +LK AF+A +M+ L+ KI + P+ + YS
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYD 228
Query: 180 FRGLVKSMLRKNPELRPSAAELLR 203
R LV + ++NP RPS +L
Sbjct: 229 LRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 3e-57
Identities = 86/201 (42%), Positives = 136/201 (67%), Gaps = 2/201 (0%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L++K+++P IV +K+S+ G ++ I++ +C+GGD+ + IK KLF E+ + +W VQ+
Sbjct: 51 LLAKMKHPNIVAFKESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM 109
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCP 121
+ + ++H +LHRD+K NIFLT++ ++LGDFG A++LTS A + VGTP Y+ P
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+ ++PY +KSDIWSLGC +YE+ +LK F+A + LI K+ + PLP+ YS R
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 182 GLVKSMLRKNPELRPSAAELL 202
L+K M ++NP RPSA +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 3e-57
Identities = 82/203 (40%), Positives = 129/203 (63%), Gaps = 2/203 (0%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++S +++P I+ Y + +++ + I + + GG + + I + +LF EE + +L
Sbjct: 50 IVILSLLQHPNIIAYYNHFMDDNTLL-IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYM 119
Q++ A+ Y+H ILHRD+K NIFLTK I+LGDFG++KIL S+ +A +VVGTP YM
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYM 168
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PEL + Y KSDIW+LGC +YE+ +LK F A + L+ KI + P+ + YS
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE 228
Query: 180 FRGLVKSMLRKNPELRPSAAELL 202
LV S+L+++PE RP+A E+L
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 91/205 (44%), Positives = 135/205 (65%), Gaps = 5/205 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK--KANSKLFSEEKLCKWL 59
+L+SK+ +P IV++ S++ER + CII +CEG D+ ++ K K SE ++C+W
Sbjct: 54 QLLSKLDHPAIVKFHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF 112
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSY 118
+QLL+ + Y+H ILHRD+K NIFL K+ +++GDFG++++L S DLA++ GTP Y
Sbjct: 113 IQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSG 178
M PE L Y SKSDIWSLGC +YEM L AF+ + +++ +I + LP YS
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSR 231
Query: 179 AFRGLVKSMLRKNPELRPSAAELLR 203
+++SML K+P LRPSAAE+LR
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 76/204 (37%), Positives = 127/204 (62%), Gaps = 4/204 (1%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLV 60
+++ + +P I+ YK+++++ G +CI++ + GD+++AI K KL E+++ + +
Sbjct: 52 ILASVNHPNIISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
QLL L LH ILHRD+K +NI L + +++GD G++K+L + +A + +GTP YM
Sbjct: 111 QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMA 169
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE+ PY KSDIWSLGC +YEM + P F+A MQ L K+ + P+P YS
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL 229
Query: 181 RGLVKSMLRKNPELRPSAAELLRH 204
+ ++SML+ P+LRP+ ++L
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 2e-56
Identities = 70/202 (34%), Positives = 125/202 (61%), Gaps = 2/202 (0%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
+++K+ + +I+ Y +S++++G + I++ + E GD+ + +K + E+++ ++ +Q+
Sbjct: 52 VLAKLDSSYIIRYYESFLDKG-KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQI 110
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL-TSDDLASSVVGTPSYMCP 121
L+ L +LH+ ILHRD+K N+FL ++++GD G+AK+L + + A+++VGTP Y+ P
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
EL D PY KSD+W+LG +YE + K F A + ALI KI + + P+ YS
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA 230
Query: 182 GLVKSMLRKNPELRPSAAELLR 203
L+ L K+ RP +LLR
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-55
Identities = 74/206 (35%), Positives = 126/206 (61%), Gaps = 4/206 (1%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++ K ++P IV+Y S++++ + I++ FC GG + + +K + ++ +E ++
Sbjct: 48 IQILKKCKHPNIVKYYGSYLKKD-ELWIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCK 105
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
+LL L+YLH+N I+HRD+K +NI LT D +++L DFGL+ L+ +++VGTP +M
Sbjct: 106 ELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMA 165
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL--PTKYSG 178
PE++ PY K+DIWSLG E+ KP + + KI + L P K+S
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSD 225
Query: 179 AFRGLVKSMLRKNPELRPSAAELLRH 204
F+ +K L+KNPE RP+A +LL+H
Sbjct: 226 EFKDFLKKCLQKNPEKRPTAEQLLKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 2e-54
Identities = 82/204 (40%), Positives = 131/204 (64%), Gaps = 2/204 (0%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ + +P I+EY ++++E + I++ + GG +AE I+K + L E+ + + VQ
Sbjct: 51 QVLKLLSHPNIIEYYENFLEDKA-LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ 109
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDI-RLGDFGLAKILTSDDLASSVVGTPSYMC 120
+L+AL ++H ILHRD+K NI L K + + ++GDFG++KIL+S A +VVGTP Y+
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYIS 169
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PEL PY KSDIW+LGC +YE+ SLK AF+A ++ AL+ KI AP+ +YS
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDL 229
Query: 181 RGLVKSMLRKNPELRPSAAELLRH 204
R L+ SML +P RP ++++
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 2e-54
Identities = 75/211 (35%), Positives = 122/211 (57%), Gaps = 11/211 (5%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++ ++ +P IV D++ ++ ++ +++ +CEGGD+ + + + SE++ K +Q
Sbjct: 50 RILRRLSHPNIVRLIDAFEDKD-HLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQ 106
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMC 120
+L L+YLH+N I+HRD+K NI L ++ +++ DFGLAK L S ++ VGTP YM
Sbjct: 107 ILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166
Query: 121 PELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAF---KAFDMQALINKINKSIV-APLPTK 175
PE+L YG K D+WSLG +YE+ + KP F D LI +I + P
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 176 YSG--AFRGLVKSMLRKNPELRPSAAELLRH 204
SG + L+K L K+P RP+A E+L+H
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 74/209 (35%), Positives = 114/209 (54%), Gaps = 8/209 (3%)
Query: 2 ELISKIRNPFIVEYKDS-WVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++S +++P IV Y S E + I + + GG ++ +KK E + K+
Sbjct: 51 RILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTR 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPS 117
Q+L L YLH+N I+HRD+K +NI + D ++L DFG AK L + SV GTP
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-DMQALINKINKSIVAP-LPTK 175
+M PE++ YG +DIWSLGC + EM + KP + + A + KI S P +P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH 228
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + ++ LR++P+ RP+A ELL+H
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRPTADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 74/207 (35%), Positives = 116/207 (56%), Gaps = 37/207 (17%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+E++ K+ +P IV+ + + +++ +CEGG + + +K+ N SE+++ + L+
Sbjct: 42 IEILKKLNHPNIVKLYGVFEDENHL-YLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILL 99
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQD-IRLGDFGLAKILTSD-DLASSVVGTPSY 118
Q+L L+YLH+N I+HRD+K NI L D ++L DFGL+K+LTSD L ++VGTP+Y
Sbjct: 100 QILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159
Query: 119 MCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
M PE+L Y KSDIWSLG +YE+
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYELPE------------------------------ 189
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L++ ML+K+PE RPSA E+L H
Sbjct: 190 --LKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 79/203 (38%), Positives = 131/203 (64%), Gaps = 3/203 (1%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L++K+++P IV + S+ E G + I++ +C+GGD+ + I + LFSE+++ W VQ+
Sbjct: 52 LLAKMKHPNIVTFFASFQENG-RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDI-RLGDFGLAKILT-SDDLASSVVGTPSYMC 120
+ L ++H ILHRD+K NIFL+K+ + +LGDFG+A+ L S +LA + VGTP Y+
Sbjct: 111 SLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLS 170
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE+ + PY +K+DIWSLGC +YE+ +LK F+ ++ L+ KI + AP+ +S
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL 230
Query: 181 RGLVKSMLRKNPELRPSAAELLR 203
R L+ + + +P RPS +L+
Sbjct: 231 RSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 75/212 (35%), Positives = 115/212 (54%), Gaps = 18/212 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++L+ +++P IV+Y S +E + II+ + E G + + IKK F E + ++
Sbjct: 50 IDLLKNLKHPNIVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVY 106
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-SVVGTPSYM 119
Q+L L YLH ++HRD+K +NI TKD ++L DFG+A L SVVGTP +M
Sbjct: 107 QVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM 166
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD---MQALINKINKSIVA----PL 172
PE++ + SDIWSLGC + E+ + P + +D M AL IV PL
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPPY--YDLNPMAALFR-----IVQDDHPPL 219
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
P S + + +K+P LRP+A +LL+H
Sbjct: 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 76/211 (36%), Positives = 121/211 (57%), Gaps = 9/211 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+SK+++P IV+Y + E + I + GG +A+ +KK S F E + + Q+
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDN-LYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQI 111
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
L+ L+YLH + +HRD+K +NI + + ++L DFG+AK + A S G+P +M PE
Sbjct: 112 LLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 123 LLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP-LPTKYSGAF 180
++A YG +DIWSLGC + EM + KP + + A + KI +S P +P S
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
+ + L+++P LRP+AAELL H P+V
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLEH----PFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 76/208 (36%), Positives = 121/208 (58%), Gaps = 7/208 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--KLFSEEKLCKW 58
++L+ ++ +P +++Y S++E + I++ + GD++ IK +L E + K+
Sbjct: 53 IDLLKQLDHPNVIKYLASFIENN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-SVVGTPS 117
VQL AL+++H+ I+HRD+K +N+F+T ++LGD GL + +S A+ S+VGTP
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ--ALINKINKSIVAPLPTK 175
YM PE + + Y KSDIWSLGC +YEM +L+ F M +L KI K PLP
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD 231
Query: 176 -YSGAFRGLVKSMLRKNPELRPSAAELL 202
YS R LV + +PE RP + +L
Sbjct: 232 HYSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 2e-43
Identities = 72/205 (35%), Positives = 114/205 (55%), Gaps = 8/205 (3%)
Query: 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLL 63
+S+I +PFIV+ ++ + +++ + GG++ + K FSEE+ + +++
Sbjct: 47 LSRINHPFIVKLHYAFQTEE-KLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIV 103
Query: 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPE 122
+AL+YLH+ I++RD+K NI L D I+L DFGLAK L+S+ ++ GTP Y+ PE
Sbjct: 104 LALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRG 182
+L YG D WSLG +YEM + KP F A D + + KI K + P S R
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR-FPEFLSPEARD 222
Query: 183 LVKSMLRKNPELR---PSAAELLRH 204
L+ +L+K+P R A E+ H
Sbjct: 223 LISGLLQKDPTKRLGSGGAEEIKAH 247
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 6e-42
Identities = 74/208 (35%), Positives = 120/208 (57%), Gaps = 7/208 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ ++P IV+Y DS++ + +++ + +GG + + I + N +E ++
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGD-ELWVVMEYMDGGSLTDIITQ-NFVRMNEPQIAYVCR 123
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYM 119
++L L+YLH+ +++HRD+K NI L+KD ++L DFG A LT + +SVVGTP +M
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM 183
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPL--PTKY 176
PE++ YG K DIWSLG EM +P + ++AL I + PL P K+
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKW 242
Query: 177 SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S F+ + L K+PE RPSA ELL+H
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 72/204 (35%), Positives = 115/204 (56%), Gaps = 8/204 (3%)
Query: 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLL 63
+S+ R+P+I +Y S+++ G + II+ +C GG + +K E + L ++L
Sbjct: 53 LSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVL 108
Query: 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPE 122
+ L+YLH +HRD+K +NI L+++ D++L DFG++ LTS ++ VGTP +M PE
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPLP-TKYSGAF 180
++ Y K+DIWSLG E+ +P M+ L I K+ L K+S F
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPF 227
Query: 181 RGLVKSMLRKNPELRPSAAELLRH 204
+ V L K+P+ RPSA ELL+H
Sbjct: 228 KDFVSLCLNKDPKERPSAKELLKH 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 71/195 (36%), Positives = 115/195 (58%), Gaps = 5/195 (2%)
Query: 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK--KANSKLFSEEKLCKWLVQLL 63
++R+P IV Y +++E + I++ EG + E K + F+EE++ VQ++
Sbjct: 65 QLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 64 MALDYLHA-NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
+AL YLH I+HRD+ +NI L +D + + DFGLAK + +SVVGT Y CPE
Sbjct: 124 LALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPE 183
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTK-YSGAFR 181
++ + PYG K+D+W+ GC +Y+M +L+P F + +M +L KI +++ PLP YS
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVT 243
Query: 182 GLVKSMLRKNPELRP 196
++ S L + E RP
Sbjct: 244 DVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 78/211 (36%), Positives = 118/211 (55%), Gaps = 27/211 (12%)
Query: 8 RNPFIVEYKDSWVERGCY-----VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
+P+IV+Y G Y + I++ +C G +++ +K +K +EE++ L Q
Sbjct: 56 DSPYIVKYY------GSYFKNTDLWIVMEYCGAGSVSDIMK-ITNKTLTEEEIAAILYQT 108
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCP 121
L L+YLH+N +HRD+K NI L ++ +L DFG++ LT ++V+GTP +M P
Sbjct: 109 LKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD---MQALINKINKSIVAPLPT---- 174
E++ +I Y +K+DIWSLG EM KP + D M+A+ NK P PT
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPY--SDIHPMRAIFMIPNK----PPPTLSDP 222
Query: 175 -KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
K+S F VK L K+PE RPSA +LL+H
Sbjct: 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 71/209 (33%), Positives = 116/209 (55%), Gaps = 8/209 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++L+ +++ IV+Y + + I + + GG + + +K + +E K+
Sbjct: 55 IQLLKNLQHERIVQYYGCLRDDE-TLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTR 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK----ILTSDDLASSVVGTP 116
Q+L ++YLH+N I+HRD+K +NI +++LGDFG +K I +S SV GTP
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP-LPTK 175
+M PE+++ YG K+D+WS+GC + EM + KP + F+ A I KI P LP+
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH 231
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRH 204
S R ++ +N + RPSA ELLRH
Sbjct: 232 VSPDARNFLRRTFVENAKKRPSAEELLRH 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 9e-40
Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 9/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ + +P++V+ + + + I++ + +GG +A+ +KK E L
Sbjct: 50 LKTLRSCESPYVVKCYGA-FYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIAR 106
Query: 61 QLLMALDYLHAN-HILHRDVKCSNIFLTKDQDIRLGDFGLAKIL-TSDDLASSVVGTPSY 118
Q+L LDYLH HI+HRD+K SN+ + ++++ DFG++K+L + D ++ VGT +Y
Sbjct: 107 QILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY 166
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQ--ALINKINKSIVAPLP-T 174
M PE + Y +DIWSLG + E P L+ I LP
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
++S FR + + L+K+P+ RPSAAELL+H
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 30/202 (14%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV-QLLMALDYLHANHILHRDVKCSNIFLT 87
++ + G++ + I+K S E K ++ ++L+AL+YLH+ I+HRD+K NI L
Sbjct: 80 VLEYAPNGELLQYIRKYGS--LDE-KCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136
Query: 88 KDQDIRLGDFGLAKILTSDDL---------------------ASSVVGTPSYMCPELLAD 126
KD I++ DFG AK+L + +S VGT Y+ PELL +
Sbjct: 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196
Query: 127 IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKS 186
P G SD+W+LGC IY+M + KP F+ + KI K + P + + L++
Sbjct: 197 KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-LEYSFPPNFPPDAKDLIEK 255
Query: 187 MLRKNPELRP----SAAELLRH 204
+L +P+ R EL H
Sbjct: 256 LLVLDPQDRLGVNEGYDELKAH 277
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 74/202 (36%), Positives = 123/202 (60%), Gaps = 7/202 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK--KANSKLFSEEKLCKW 58
++L+ ++ +P +++Y DS++E + I++ + GD+++ IK K +L E + K+
Sbjct: 53 IDLLKQLNHPNVIKYLDSFIEDN-ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-SVVGTPS 117
VQL A++++H+ ++HRD+K +N+F+T ++LGD GL + +S A+ S+VGTP
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ--ALINKINKSIVAPLPTK 175
YM PE + + Y KSDIWSLGC +YEM +L+ F M +L KI + PLPT+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTE 231
Query: 176 -YSGAFRGLVKSMLRKNPELRP 196
YS R LV + +P+ RP
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 75/212 (35%), Positives = 129/212 (60%), Gaps = 10/212 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++S+ ++P IV +++ + I+I FC+GG + ++I + +E ++
Sbjct: 53 IDILSECKHPNIVGLYEAYFYEN-KLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCR 110
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYM 119
Q+L AL++LH++ ++HRD+K NI LT D D++L DFG+ AK ++ + +GTP +M
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWM 170
Query: 120 CPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL-- 172
PE++A D PY K+DIWSLG + E+ ++P + ++ KI KS L
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
P+K+S +F +KS L K+P+ RP+AAELL+H
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 70/213 (32%), Positives = 118/213 (55%), Gaps = 12/213 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++L+ +++ IV+Y + ++ + I + F GG ++ + + E CK+
Sbjct: 53 VDLLKSLKHVNIVQYLGTCLDD-NTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTK 109
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL-------TSDDLASSVV 113
Q+L + YLH N ++HRD+K +N+ L + I+L DFG A+ L T ++ S+
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI--NKSIVAP 171
GTP +M PE++ + YG KSDIWS+GC ++EM + KP + D A + I ++ ++
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
LP +S A V S L ++ RPSA +LLRH
Sbjct: 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 74/215 (34%), Positives = 127/215 (59%), Gaps = 10/215 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK--KANSKLFSEEKLCKW 58
++L+ ++ +P +++Y S++E + I++ + GD++ IK K +L E+ + K+
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-SVVGTPS 117
VQL AL+++H+ ++HRD+K +N+F+T ++LGD GL + +S A+ S+VGTP
Sbjct: 112 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF--KAFDMQALINKINKSIVAPLPTK 175
YM PE + + Y KSDIWSLGC +YEM +L+ F ++ +L KI + PLP+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231
Query: 176 -YSGAFRGLVKSMLRKNPELRPSAA---ELLRHVH 206
YS R LV + +PE RP ++ + +H
Sbjct: 232 HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 77/210 (36%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
R+P IV Y S++ R + I++ +C GG + + + L SE ++ + L L
Sbjct: 58 RHPNIVAYFGSYLRRD-KLWIVMEYCGGGSLQDIYQVTRGPL-SELQIAYVCRETLKGLA 115
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLA 125
YLH +HRD+K +NI LT+D D++L DFG++ LT+ +A S +GTP +M PE+ A
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-TIAKRKSFIGTPYWMAPEVAA 174
Query: 126 ---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD---MQALINKINKSIVAPLPT----- 174
Y K DIW+LG E+ L+P FD M+AL I+KS P P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPM--FDLHPMRALF-LISKSNFPP-PKLKDKE 230
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
K+S F +K L K+P+ RP+A +LL+H
Sbjct: 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 84/222 (37%), Positives = 128/222 (57%), Gaps = 14/222 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+E+++ +P+IV+ ++ G + I+I FC GG + +AI + +E ++
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDG-KLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICR 117
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYM 119
Q+L AL YLH+ I+HRD+K N+ LT D DI+L DFG+ AK + + S +GTP +M
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177
Query: 120 CPEL-----LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL-- 172
PE+ + D PY K+DIWSLG + EM ++P + ++ KI KS L
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ 237
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKV 214
P+K+S FR +K+ L K+PE RPSAA+LL H P+V V
Sbjct: 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH----PFVSSV 275
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 68/215 (31%), Positives = 113/215 (52%), Gaps = 19/215 (8%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKL-CKWLVQLL 63
S+ +P +V+Y S+V + +++ + GG + + +K + + +E + L ++L
Sbjct: 54 SQCNHPNVVKYYTSFVVGDE-LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLAS----SVVGTPSY 118
L+YLH+N +HRD+K NI L +D +++ DFG+ A + D + VGTP +
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 119 MCPELLA-DIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAP--LPT 174
M PE++ Y K+DIWS G E+ T P K M+ L+ + P L T
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLET 229
Query: 175 -----KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
KYS +FR ++ L+K+P RP+A ELL+H
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 69/215 (32%), Positives = 119/215 (55%), Gaps = 14/215 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
M+++ +++P +V+Y V R V I + +C GG + E ++ + ++ E + + +
Sbjct: 50 MKVLELLKHPNLVKYYGVEVHRE-KVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTL 106
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-----SSVVGT 115
QLL L YLH++ I+HRD+K +NIFL + I+LGDFG A L ++ S+ GT
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 116 PSYMCPELLADIP---YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ-ALINKINKSIVAP 171
P+YM PE++ +G +DIWSLGC + EM + K + D + ++ + P
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP 226
Query: 172 LPT--KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+P + S + + L +P+ RP+A+ELL+H
Sbjct: 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ L++++ +P I+ + E + + + + GG ++ + K + F E + +
Sbjct: 54 IRLMARLNHPHIIRMLGATCEDSHF-NLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTE 110
Query: 61 QLLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLGDFGLAKILTSD-----DLASSVVG 114
QLL L YLH N I+HRDVK +N+ + + Q +R+ DFG A L + + ++G
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 115 TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ---ALINKINKSIVAP 171
T ++M PE+L YG D+WS+GC I EM + KP + A ALI KI + AP
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230
Query: 172 -LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+P S R + L PE RP + ELL+H
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 77/227 (33%), Positives = 112/227 (49%), Gaps = 26/227 (11%)
Query: 1 MEL--ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
EL + K +P+IV + ++ + I + + +GG + + I K E L K
Sbjct: 48 RELDILHKCNSPYIVGFYGAFY-NNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKI 105
Query: 59 LVQLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
V +L L YLH H I+HRDVK SNI + I+L DFG++ L + LA + VGT S
Sbjct: 106 AVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFVGTSS 164
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLK--------PAFKAFD-MQALINKINKSI 168
YM PE + Y KSDIWSLG + E+ + + P F+ +Q ++N+
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE----- 219
Query: 169 VAPLPT----KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
P P K+S F+ V L K+P RPS ELL H ++ Y
Sbjct: 220 --PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 66/186 (35%), Positives = 96/186 (51%), Gaps = 16/186 (8%)
Query: 32 FCEGG---DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
C GG D+ + ++K +L EE + L + L L YLH N ++HRD+K NI LTK
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRL-KEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK 148
Query: 89 DQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCI 142
+ +++L DFG++ L S ++ +GTP +M PE++A D Y ++SD+WSLG
Sbjct: 149 NAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208
Query: 143 YEMTSLKPAFKAFDMQAL--INKI--NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA 198
E+ KP DM + + KI N P +S F + L KN E RP
Sbjct: 209 IELADGKPPL--CDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM 266
Query: 199 AELLRH 204
ELL H
Sbjct: 267 EELLEH 272
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 57/195 (29%), Positives = 102/195 (52%), Gaps = 14/195 (7%)
Query: 5 SKIRNPFIVE----YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
IR+PF+V ++D + +++ + GG++ ++K S F E +
Sbjct: 56 QSIRHPFLVNLYGSFQDDS-----NLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAA 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
Q+++AL+YLH+ I++RD+K N+ L D I++ DFG AK + ++ GTP Y+
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLA 166
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE++ YG D W+LG IYEM + P F + + KI + V P+ +S
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR-FPSFFSPDA 225
Query: 181 RGLVKSMLRKNPELR 195
+ L++++L+ + R
Sbjct: 226 KDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 3e-32
Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+ ++++P IV+ D + ++ +C+ D+ + + K S + + QL
Sbjct: 51 LLKELKHPNIVKLLDVIHTERK-LYLVFEYCDM-DLKKYLDK-RPGPLSPNLIKSIMYQL 107
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCP 121
L L Y H++ ILHRD+K NI + +D ++L DFGLA+ + V T Y P
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167
Query: 122 E-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI---------------- 164
E LL Y + DIWS+GC EM + KP F + KI
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227
Query: 165 ---NKSIVAP----------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
+ P LP L+ ML+ NP R SA E L+H PY
Sbjct: 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGID-LLSKMLQYNPAKRISAKEALKH----PY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++S+ ++P++V+ S+ + + +++ + GGD+A ++ S E+ ++ +
Sbjct: 45 DILSQAQSPYVVKLYYSFQGKK-NLYLVMEYLPGGDLASLLENVGS--LDEDVARIYIAE 101
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK---------ILTSDDLASSV 112
+++AL+YLH+N I+HRD+K NI + + ++L DFGL+K + + +
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 113 VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-NKSIVAP 171
VGTP Y+ PE++ + D WSLGC +YE P F + + I N I P
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRP---SAAELLRH 204
+ S L+ +L +PE R S E+ H
Sbjct: 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 2 ELISKIRNPFIVE----YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
E++ + +PFIV+ +KD Y+ +++ +C GG++ ++ LF E
Sbjct: 45 EILEECNHPFIVKLYRTFKDKK-----YIYMLMEYCLGGELWTILRDRG--LFDEYTARF 97
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
++ +++A +YLH I++RD+K N+ L + ++L DFG AK L S + GTP
Sbjct: 98 YIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI--NKINKSI-VAPLPT 174
Y+ PE++ + Y D WSLG +YE+ + +P F D + N I K P
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
Query: 175 KYSGAFRGLVKSMLRKNPELR 195
A + L+K +LR+NPE R
Sbjct: 218 YIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 30/199 (15%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLV-QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLG 95
D+A + K E + K L+ QLL +D+LH++ I+HRD+K NI +T D +++
Sbjct: 91 DLATYLSKCPKPGLPPETI-KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIA 149
Query: 96 DFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
DFGLA+I + + +SVV T Y PE+L Y + D+WS+GC E+ +P F+
Sbjct: 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209
Query: 156 -DMQALINKINKSI-----------VAPLPTKYSGAFRG---------------LVKSML 188
+ L +KI I V+ + + L+K ML
Sbjct: 210 SEADQL-DKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKML 268
Query: 189 RKNPELRPSAAELLRHVHL 207
NP R SA E L+H +
Sbjct: 269 TFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 2 ELISKIRNPFIV----EYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
++ ++ +PF+V ++D E Y +++ GGD+ + + FSEE++
Sbjct: 52 RILQELNHPFLVNLWYSFQD---EENMY--LVVDLLLGGDLRYHLSQK--VKFSEEQVKF 104
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
W+ ++++AL+YLH+ I+HRD+K NI L + + + DF +A +T D L +S GTP
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA------- 170
YM PE+L Y D WSLG YE K ++ I I A
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS-----RTIRDQIRAKQETADV 219
Query: 171 PLPTKYSGAFRGLVKSMLRKNPELR 195
P +S + +L ++P+ R
Sbjct: 220 LYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 69/210 (32%), Positives = 115/210 (54%), Gaps = 15/210 (7%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
P IVE S++ G + +++ F EGG + + + +EE++ + +L AL +L
Sbjct: 76 PNIVEMYSSYLV-GDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFL 131
Query: 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIP 128
HA ++HRD+K +I LT D ++L DFG ++ + S+VGTP +M PE+++ +P
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 129 YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL--INKINKSIVAPL--PTKYSGAFRGLV 184
YG++ DIWSLG + EM +P + F+ L + +I ++ L K S R +
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY--FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249
Query: 185 KSMLRKNPELRPSAAELLRHVHLQPYVLKV 214
ML ++P R +AAELL H P++ K
Sbjct: 250 DRMLVRDPAQRATAAELLNH----PFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-31
Identities = 70/225 (31%), Positives = 117/225 (52%), Gaps = 5/225 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++S+ +P+I Y S++ +G + II+ + GG + +K E + L
Sbjct: 53 ITVLSQCDSPYITRYYGSYL-KGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILR 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYM 119
++L LDYLH+ +HRD+K +N+ L++ D++L DFG+A LT + ++ VGTP +M
Sbjct: 109 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE++ Y K+DIWSLG E+ +P ++ I K+ L +YS
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP 228
Query: 180 FRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRN 224
F+ V++ L K+P RP+A ELL+H + Y K R
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRY 273
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 61/183 (33%), Positives = 110/183 (60%), Gaps = 7/183 (3%)
Query: 26 VCIIIGFCEGGDMAEAIK---KANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82
+ +++ + GD+ + IK K N + F E + +Q+L+A+ ++H+ H++HRD+K +
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 83 NIFLTKDQDIRLGDFGLAKILT---SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLG 139
NI L + ++LGDFG +K+ SDD+ + GTP Y+ PE+ PY K+D++SLG
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 140 CCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA 199
+YE+ +LK F +M+ +++K PLP S + +V ++L +P+ RPS++
Sbjct: 233 VLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292
Query: 200 ELL 202
+LL
Sbjct: 293 KLL 295
|
Length = 496 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 71/207 (34%), Positives = 117/207 (56%), Gaps = 10/207 (4%)
Query: 3 LISKIRN---PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
L+S++R P I +Y S+++ G + II+ + EGG + +K + +E+ + +
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLK-GPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISVII 107
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSY 118
++L+AL Y+H ++HRD+K +NI +T +++L DFG+A +L + S+ VGTP +
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYW 167
Query: 119 MCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLP-TKY 176
M PE++ + Y +K+DIWSLG IYEM + P + D + I KS L Y
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY 227
Query: 177 SGAFRGLVKSMLRKNPELRPSAAELLR 203
S R V + L + P+ R SA ELL+
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 4e-30
Identities = 65/205 (31%), Positives = 116/205 (56%), Gaps = 5/205 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++S+ +P++ +Y S++ +G + II+ + GG + ++ F E ++ L
Sbjct: 53 ITVLSQCDSPYVTKYYGSYL-KGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLK 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYM 119
++L LDYLH+ +HRD+K +N+ L++ D++L DFG+A LT + ++ VGTP +M
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE++ Y SK+DIWSLG E+ +P ++ I K+ L ++S
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH 204
F+ + + L K+P RP+A ELL+H
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 74/223 (33%), Positives = 116/223 (52%), Gaps = 32/223 (14%)
Query: 4 ISKIRNPFIVEYKDSWVERGCYV-----CIIIGFCEG--GDMAEAIKKANSKLFSEEKLC 56
+ ++R+P +EYK GCY+ +++ +C G D+ E KK E ++
Sbjct: 69 LQQLRHPNTIEYK------GCYLREHTAWLVMEYCLGSASDILEVHKKP----LQEVEIA 118
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP 116
L L YLH++ +HRD+K NI LT+ ++L DFG A ++ A+S VGTP
Sbjct: 119 AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSFVGTP 175
Query: 117 SYMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL--INKINKSIVAP 171
+M PE++ + Y K D+WSLG E+ KP F+M A+ + I ++
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNDSPT 233
Query: 172 LPT-KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213
L + +S FR V S L+K P+ RPS+ ELL+H +VL+
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH----RFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 65/239 (27%), Positives = 106/239 (44%), Gaps = 38/239 (15%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+ ++ +P I++ D + +G + ++ F + D+ + IK + E + +L QL
Sbjct: 51 LLKELNHPNIIKLLDVFRHKG-DLYLVFEFMDT-DLYKLIK-DRQRGLPESLIKSYLYQL 107
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCP 121
L L + H++ ILHRD+K N+ + + ++L DFGLA+ S + V T Y P
Sbjct: 108 LQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167
Query: 122 E-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP--------- 171
E LL D Y + DIWS+GC E+ S +P F + KI +++ P
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227
Query: 172 -----------------LPTKYSGA---FRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
LP + A L+ ML +P R +A + L H PY
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH----PY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-29
Identities = 70/210 (33%), Positives = 113/210 (53%), Gaps = 9/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
++L+ +++ IV+Y +R + I + + GG + + +K + +E K+
Sbjct: 55 IQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYT 112
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK----ILTSDDLASSVVGT 115
Q+L + YLH+N I+HRD+K +NI +++LGDFG +K I S SV GT
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-NKSIVAPLPT 174
P +M PE+++ YG K+D+WSLGC + EM + KP + ++ A I KI + LP+
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 232
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
S R + + + RPSA ELLRH
Sbjct: 233 HISEHARDFLGCIFVEARH-RPSAEELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 75/220 (34%), Positives = 121/220 (55%), Gaps = 16/220 (7%)
Query: 1 MELISKIRNPFIVEYKDS-WVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
+++++ +P IV+ D+ + E + I+I FC GG + +A+ + +E ++
Sbjct: 53 IDILASCDHPNIVKLLDAFYYENNLW--ILIEFCAGGAV-DAVMLELERPLTEPQIRVVC 109
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSY 118
Q L AL+YLH N I+HRD+K NI T D DI+L DFG+ AK + S +GTP +
Sbjct: 110 KQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 119 MCPELL-----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL- 172
M PE++ D PY K+D+WSLG + EM ++P + ++ KI KS L
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA 229
Query: 173 -PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
P+++S F+ +K L KN + R + +LL+H P+V
Sbjct: 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH----PFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-29
Identities = 69/189 (36%), Positives = 106/189 (56%), Gaps = 6/189 (3%)
Query: 28 IIIGFCEGGDMAEAIK-KANSKL-FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+I+ + GGD+ + IK + L F E ++ Q+++ALD +H+ ++HRD+K +NIF
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 86 LTKDQDIRLGDFGLAKILT---SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCI 142
L I+LGDFG +K + S D+ASS GTP Y+ PEL Y K+D+WSLG +
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 143 YEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
YE+ +L FK + ++ ++ P P S + L+ +L KNP LRP+ +LL
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
Query: 203 RHVHLQPYV 211
H YV
Sbjct: 322 -HTEFLKYV 329
|
Length = 478 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 34/228 (14%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
+P IV+ K+ + E + + + EG ++ + +K K FSE + + Q+L L
Sbjct: 56 EHPNIVKLKEVFRENDE-LYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE-LLAD 126
++H + HRD+K N+ ++ + +++ DFGLA+ + S + V T Y PE LL
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 127 IPYGSKSDIWSLGCCIYEMTSLKPAFK---AFDM-------------------QALINKI 164
Y S DIW+LGC + E+ +L+P F D L +K+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 165 N--------KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
S+ +P A L+K MLR +P+ RP+A++ L+H
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAID-LIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 82/286 (28%), Positives = 133/286 (46%), Gaps = 26/286 (9%)
Query: 9 NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL-FSEEKLCKWLVQLLMALD 67
P IV+ D + + G + +++ + +GG + + +KK K SE + L Q+L AL+
Sbjct: 57 PPNIVKLYDFFQDEG-SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 68 YLHANHILHRDVKCSNIFLTKD-QDIRLGDFGLAKILTSDD-------LASSVVGTPSYM 119
YLH+ I+HRD+K NI L +D + ++L DFGLAK+L L S+ VGTP YM
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 120 CPELLADI---PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI-------- 168
PE+L + S SDIWSLG +YE+ + P F+ + ++ K I
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 169 ----VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH-VHLQPYVLKVHLKLNSPRR 223
P S A L+K +L K+P+ R S++ L H + + + L
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 224 NSLSHWPESNYARRTRFSEPDNVPISSYREKQYSFSNNRNLNPSIS 269
+S + S +++ IS K + ++ L P+
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGV 341
|
Length = 384 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 69/183 (37%), Positives = 102/183 (55%), Gaps = 8/183 (4%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
I + GG + + +K + +E K+ Q+L + YLH+N I+HRD+K +NI
Sbjct: 83 IFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140
Query: 88 KDQDIRLGDFGLAKILTSDDLAS----SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143
+++LGDFG +K L + L+ SV GTP +M PE+++ YG K+DIWS+GC +
Sbjct: 141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVV 200
Query: 144 EMTSLKPAFKAFDMQALINKINKSIVAP-LPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
EM + KP + F+ A I KI P LP S R +K + + +LRPSA ELL
Sbjct: 201 EMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVE-AKLRPSADELL 259
Query: 203 RHV 205
RH
Sbjct: 260 RHT 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 70/216 (32%), Positives = 113/216 (52%), Gaps = 21/216 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-------VCIIIGFCEGGDMAEAIKKANSKLFSEE 53
++L+ +R+ IV+Y GC + I + + GG + + +K + +E
Sbjct: 55 IQLLKNLRHDRIVQY------YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTEN 106
Query: 54 KLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK----ILTSDDLA 109
++ Q+L + YLH+N I+HRD+K +NI +++LGDFG +K I S
Sbjct: 107 VTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 110 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV 169
SV GTP +M PE+++ YG K+D+WS+ C + EM + KP + ++ A I KI
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226
Query: 170 AP-LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
P LP S A R +K + + + RP+A LLRH
Sbjct: 227 KPMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 69/229 (30%), Positives = 104/229 (45%), Gaps = 39/229 (17%)
Query: 9 NPFIVEYKDSWVER--GCYVCIIIGFCEGGDMA--EAIKKANSKLFSEEKLCKWLVQLLM 64
+P I+ + +R G + E DM E IK + E+++ ++ QLL
Sbjct: 57 HPNILRLIEVLFDRKTGRLALV----FELMDMNLYELIKG-RKRPLPEKRVKSYMYQLLK 111
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE-L 123
+LD++H N I HRD+K NI L KD ++L DFG + + S + + T Y PE L
Sbjct: 112 SLDHMHRNGIFHRDIKPENI-LIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170
Query: 124 LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP------------ 171
L D YG K DIW++GC +E+ SL P F + I KI+ + P
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230
Query: 172 -----LPTKYSGAFRGLV-----------KSMLRKNPELRPSAAELLRH 204
P+K R L+ K +L +P+ R +A + LRH
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-27
Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 5/205 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++S+ +P++ +Y S++ + + II+ + GG + ++ E ++ L
Sbjct: 53 ITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILR 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV-VGTPSYM 119
++L LDYLH+ +HRD+K +N+ L++ +++L DFG+A LT + + VGTP +M
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE++ Y SK+DIWSLG E+ +P ++ I K+ L YS
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 228
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH 204
+ V++ L K P RP+A ELL+H
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYV-----CIIIGFCEGGDMAEAIKKA-------NSK 48
++ K+ +P +V G +++ + EGGD+ + ++K+
Sbjct: 47 ARVMKKLGHPNVVRL------LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100
Query: 49 LFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL 108
S + L + +Q+ ++YL + +HRD+ N + +D +++ DFGL++ + DD
Sbjct: 101 TLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160
Query: 109 ASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINK 163
G +M PE L D + SKSD+WS G ++E+ +L P + + ++
Sbjct: 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEY 219
Query: 164 INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ K P P L+ S + +PE RP+ +EL+
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 57/230 (24%), Positives = 108/230 (46%), Gaps = 35/230 (15%)
Query: 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66
++P++V+ D + +V +++ + D++E ++ + E ++ ++ LL +
Sbjct: 56 CQHPYVVKLLDVFPHGSGFV-LVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGV 112
Query: 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELL 124
Y+HAN I+HRD+K +N+ ++ D +++ DFGLA++ + ++ L S V T Y PELL
Sbjct: 113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 125 ADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSG----- 178
Y D+W++GC E+ + P F + + + +++ P + G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 179 -----AFR-------------------GLVKSMLRKNPELRPSAAELLRH 204
F L+K +L +P R SAAE LRH
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 42/238 (17%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++L+ ++++P I+ D + + + ++ F E D+ E + K S + + + +++
Sbjct: 53 IKLLQELKHPNIIGLLDVFGHKSN-INLVFEFMET-DL-EKVIKDKSIVLTPADIKSYML 109
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSY 118
L L+YLH+N ILHRD+K +N+ + D ++L DFGLA+ S + + VV T Y
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168
Query: 119 MCPELLADIPYGSKS-----DIWSLGCCIYEMTSLKP-------------AFKAF----- 155
PELL +G++ D+WS+GC E+ P F+A
Sbjct: 169 RAPELL----FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224
Query: 156 ----DMQALINKINKSIVAPLPTKY-----SGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ +L + + P P K S L++ +L NP R +A + L H
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
++ K+ +P IV+ G + I++ + GGD+ + ++K K S L
Sbjct: 52 ARIMRKLDHPNIVKLL------GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDL 105
Query: 56 CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115
+ +Q+ ++YL + + +HRD+ N + ++ +++ DFGL++ L DD G
Sbjct: 106 LSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK 165
Query: 116 -P-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPL 172
P +M PE L + + SKSD+WS G ++E+ +L + + ++ + K P
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK 225
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
P L+ ++PE RP+ +EL+
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 58/189 (30%), Positives = 86/189 (45%), Gaps = 35/189 (18%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD--- 106
F+E ++ ++ QLL L YLH+N ILHRD+K SNI + D ++L DFGLA+ T
Sbjct: 97 FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156
Query: 107 DLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI- 164
D + V+ T Y PELL YG + D+WS+GC + E+ KP F+ + KI
Sbjct: 157 DYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF 215
Query: 165 -------------------------NKSIVAPLPTKYSG----AFRGLVKSMLRKNPELR 195
K L + + L+ +L +P+ R
Sbjct: 216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275
Query: 196 PSAAELLRH 204
SA + L+H
Sbjct: 276 ISADQALQH 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 7e-27
Identities = 70/203 (34%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 12 IVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA 71
+VE +S++ G + +++ F EGG + + + +EE++ + +L AL LHA
Sbjct: 79 VVEMYNSYLV-GDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHA 134
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCPELLADIPYG 130
++HRD+K +I LT D ++L DFG A++ S+VGTP +M PEL++ +PYG
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 131 SKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPT------KYSGAFRGLV 184
+ DIWSLG + EM +P + F+ L K K I LP K S + +G +
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY--FNEPPL--KAMKMIRDNLPPKLKNLHKVSPSLKGFL 250
Query: 185 KSMLRKNPELRPSAAELLRHVHL 207
+L ++P R +AAELL+H L
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 8e-27
Identities = 64/185 (34%), Positives = 103/185 (55%), Gaps = 8/185 (4%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+++ F EGG + + + +EE++ + +L AL YLH ++HRD+K +I LT
Sbjct: 96 VVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 88 KDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146
D I+L DFG A++ S+VGTP +M PE+++ +PYG++ DIWSLG + EM
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 147 SLKPA-FKAFDMQALINKINKSIVAPLPT--KYSGAFRGLVKSMLRKNPELRPSAAELLR 203
+P F +QA+ +I ++ + K S RG + ML + P R +A ELL+
Sbjct: 213 DGEPPYFNEPPLQAM-RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271
Query: 204 HVHLQ 208
H L+
Sbjct: 272 HPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 70/215 (32%), Positives = 112/215 (52%), Gaps = 24/215 (11%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYV-----CIIIGFCEGG--DMAEAIKKANSKLFSEE 53
++ + ++++P +EYK GCY+ +++ +C G D+ E KK E
Sbjct: 72 VKFLQQLKHPNTIEYK------GCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEV 121
Query: 54 KLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVV 113
++ L L YLH+++++HRD+K NI LT+ ++L DFG A + A+S V
Sbjct: 122 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFV 178
Query: 114 GTPSYMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIV 169
GTP +M PE++ + Y K D+WSLG E+ KP F M AL +
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238
Query: 170 APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+++ +FRG V L+K P+ RP++AELLRH
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 15/218 (6%)
Query: 1 MELISKIRNPFIVEYKDSWV-ERGCYVCIIIGFCEGGDMAEAIKKANSK--LFSEEKLCK 57
+E+ ++P+IV+Y +++ E + I + +CEGG + KK + E+ L K
Sbjct: 50 LEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK 109
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
+L L YLH+ I+HRD+K SNI LT+ ++L DFG++ L + LA + GT
Sbjct: 110 IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-SLAGTFTGTSF 168
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL--INKINKSIVAPLP-- 173
YM PE + PY SD+WSLG + E+ + F L I ++ + P P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228
Query: 174 -------TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
K+S F+ +K L K+P RP+ ++L H
Sbjct: 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYV-----CIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
+ + K+R+P ++Y RGCY+ +++ +C G A + + + K E ++
Sbjct: 66 VRFLQKLRHPNTIQY------RGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEI 117
Query: 56 CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115
L L YLH+++++HRDVK NI L++ ++LGDFG A I+ A+ VGT
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGT 174
Query: 116 PSYMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIVAP 171
P +M PE++ + Y K D+WSLG E+ KP F M AL + A
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
+S FR V S L+K P+ RP++ LL+H +
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 62/195 (31%), Positives = 105/195 (53%), Gaps = 16/195 (8%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+++ F +GG + + + + +EE++ +L AL YLH+ ++HRD+K +I LT
Sbjct: 95 VLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT 151
Query: 88 KDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146
D ++L DFG ++ D S+VGTP +M PE+++ PYG++ DIWSLG + EM
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 147 SLKPAFKAFDMQALINKINKSIVAPLPT-----KYSGAFRGLVKSMLRKNPELRPSAAEL 201
+P + + + ++ S P P K S R ++ ML + P+ R +A EL
Sbjct: 212 DGEPPYFSDSPVQAMKRLRDS---PPPKLKNAHKISPVLRDFLERMLTREPQERATAQEL 268
Query: 202 LRHVHLQPYVLKVHL 216
L H P++L+ L
Sbjct: 269 LDH----PFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 53/172 (30%), Positives = 89/172 (51%), Gaps = 6/172 (3%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ ++ + GGD+ I++ S F E + + ++++ L +LH I++RD+K N+
Sbjct: 71 LFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVL 128
Query: 86 LTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYE 144
L + I++ DFG+ K + S+ GTP Y+ PE+L+ PYG D W+LG +YE
Sbjct: 129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 145 MTSLKPAFKAFDMQALINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
M + + F+ D L I + P S + ++KS L KNPE R
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 68/204 (33%), Positives = 108/204 (52%), Gaps = 7/204 (3%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
++P IV Y DS++ G + +++ + GG + + + + +C+ + L AL+
Sbjct: 74 KHPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---ECLQALE 129
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCPELLAD 126
+LH+N ++HRD+K NI L D ++L DFG A+I S++VGTP +M PE++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 127 IPYGSKSDIWSLGCCIYEMTSLKPAF-KAFDMQAL-INKINKSIVAPLPTKYSGAFRGLV 184
YG K DIWSLG EM +P + ++AL + N + P K S FR +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249
Query: 185 KSMLRKNPELRPSAAELLRHVHLQ 208
L + E R SA ELL+H L+
Sbjct: 250 NRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 51/212 (24%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
++ K+ +P +V+ G + I++ + EGGD+ ++K KL S L
Sbjct: 52 ARIMRKLDHPNVVKLL------GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL-SLSDL 104
Query: 56 CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115
+ +Q+ ++YL + + +HRD+ N + ++ +++ DFGL++ L DD G
Sbjct: 105 LSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-RKRGG 163
Query: 116 PS---YMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAP 171
+M PE L + + SKSD+WS G ++E+ +L + + + ++ + P
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLP 223
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
P L+ ++PE RP+ +EL+
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 52/209 (24%), Positives = 102/209 (48%), Gaps = 8/209 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ K+ +P IV +G + I+ + GGD+ + ++K KL + + L + +
Sbjct: 52 ASIMKKLSHPNIVRLL-GVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-TLKDLLQMAL 109
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS--- 117
Q+ ++YL + + +HRD+ N +T++ +++ DFGL++ + DD G
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK 169
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTK 175
+M PE L D + SKSD+WS G ++E+ +L +P + + ++ + P P
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-YPGMSNEEVLELLEDGYRLPRPEN 228
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRH 204
L+ +PE RP+ +EL+
Sbjct: 229 CPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 68/204 (33%), Positives = 108/204 (52%), Gaps = 7/204 (3%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
+NP IV Y DS++ G + +++ + GG + + + + E ++ + L ALD
Sbjct: 74 KNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALD 129
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCPELLAD 126
+LH+N ++HRD+K NI L D ++L DFG A+I S++VGTP +M PE++
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 127 IPYGSKSDIWSLGCCIYEMTSLKPAF-KAFDMQAL-INKINKSIVAPLPTKYSGAFRGLV 184
YG K DIWSLG EM +P + ++AL + N + P + S FR +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249
Query: 185 KSMLRKNPELRPSAAELLRHVHLQ 208
L + + R SA ELL+H L+
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 7/204 (3%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
+NP IV Y DS++ G + +++ + GG + + + + E ++ + L AL+
Sbjct: 75 KNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALE 130
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCPELLAD 126
+LH+N ++HRD+K NI L D ++L DFG A+I S++VGTP +M PE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 127 IPYGSKSDIWSLGCCIYEMTSLKPAF-KAFDMQAL-INKINKSIVAPLPTKYSGAFRGLV 184
YG K DIWSLG EM +P + ++AL + N + P K S FR +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 185 KSMLRKNPELRPSAAELLRHVHLQ 208
L + E R SA ELL+H L+
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/209 (32%), Positives = 112/209 (53%), Gaps = 7/209 (3%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++ +++NP IV + DS++ G + +++ + GG + + + + E ++ +
Sbjct: 69 VMKELKNPNIVNFLDSFLV-GDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCREC 124
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCP 121
L AL++LHAN ++HRD+K N+ L D ++L DFG A+I S++VGTP +M P
Sbjct: 125 LQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAF-KAFDMQAL-INKINKSIVAPLPTKYSGA 179
E++ YG K DIWSLG EM +P + ++AL + N + P K S
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244
Query: 180 FRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
FR + L + E R SA ELL+H L+
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 69/214 (32%), Positives = 112/214 (52%), Gaps = 20/214 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYV-----CIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
++ + +I++P +EYK GCY+ +++ +C G A + + + K E ++
Sbjct: 76 VKFLQRIKHPNSIEYK------GCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEI 127
Query: 56 CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115
L L YLH+++++HRD+K NI LT+ ++L DFG A I + A+S VGT
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGT 184
Query: 116 PSYMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIVAP 171
P +M PE++ + Y K D+WSLG E+ KP F M AL +
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
++S FR V S L+K P+ RP++ ELL+H+
Sbjct: 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
R+PF+ K S+ +C ++ + GG++ + + ++FSE++ + +++ AL
Sbjct: 53 RHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALG 109
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD 126
YLH+ +++RD+K N+ L KD I++ DFGL K SD + GTP Y+ PE+L D
Sbjct: 110 YLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169
Query: 127 IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKS 186
YG D W LG +YEM + F D + L I + P S + L+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FPRTLSPEAKSLLAG 228
Query: 187 MLRKNPELR-----PSAAELLRH 204
+L+K+P+ R A E++ H
Sbjct: 229 LLKKDPKQRLGGGPEDAKEIMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 14/213 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ L+ ++++ IV+Y S ++ ++ I + + GG +A + + EE L + V
Sbjct: 57 IALLKELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFV 112
Query: 61 -QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-------SV 112
Q+L L+YLH I+HRD+K +NI + I++ DFG++K L ++ L++ S+
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 113 VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAP 171
G+ +M PE++ Y K+DIWSLGC + EM T P +QA I KI ++
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFKIGENASPE 231
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+P+ S ++ + RP+AAELL+H
Sbjct: 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 68/236 (28%), Positives = 96/236 (40%), Gaps = 54/236 (22%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV------VG 114
QLL AL Y+H+ +++HRD+K SNI L D ++L DFGLA+ L+ + V
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 115 TPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAF-------------------KA 154
T Y PE LL Y D+WS+GC + EM KP F A
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 155 FDMQAL--------INKINKSIVAPLPTKYSGAFR---GLVKSMLRKNPELRPSAAELLR 203
D++++ ++ + PL A L+K +L NP R +A E L
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
Query: 204 HVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNV--PISSYREKQYS 257
H PYV + H + E DNV ++ YR K Y
Sbjct: 295 H----PYVAQFH-----------NPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYE 335
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 4/197 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ K+ + FIV ++ E +C+++ GGD+ I F E + + Q
Sbjct: 45 KILEKVSSRFIVSLAYAF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ 103
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
++ L++LH I++RD+K N+ L ++R+ D GLA L GTP YM P
Sbjct: 104 IICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAP 163
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL---INKINKSIVAPLPTKYSG 178
E+L Y D ++LGC +YEM + + F+ + + + + P K+S
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSP 223
Query: 179 AFRGLVKSMLRKNPELR 195
+ L +++L+K+PE R
Sbjct: 224 EAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ K+ + F+V ++ E +C+++ GGD+ I + F EE+ + +
Sbjct: 52 QILEKVNSQFVVNLAYAY-ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
+L L+ LH + ++RD+K NI L IR+ D GLA + + VGT YM P
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAP 170
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP---LPTKYSG 178
E+L + Y D W LGC IYEM + F+ + ++++ ++ K+S
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSE 230
Query: 179 AFRGLVKSMLRKNPELR-----PSAAELLRHVHLQPYVLKVHLK 217
+ + K +L K+P+ R A E+ RH P+ ++ K
Sbjct: 231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH----PFFRNMNFK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCY-----VCIIIGFCEGGDMAEAIKKANSKLFSEEKLC 56
E + R+PF+V C+ VC ++ + GGD+ I +FSE +
Sbjct: 54 ETANSERHPFLVNL------FACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAV 104
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGT 115
+ +++ L YLH N I++RD+K N+ L + +++ DFGL K + D S+ GT
Sbjct: 105 FYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGT 164
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-NKSIVAP--L 172
P ++ PE+L + Y D W LG IYEM + F D + + + I N + P L
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 224
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAE 200
+ R L LR+NPE R + E
Sbjct: 225 SREAISIMRRL----LRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 41/214 (19%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + IK + L +++ + +L Q+L L YLH+ +++HRD+K SNI + + D+++ D
Sbjct: 89 DLHKVIK-SPQPL-TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICD 146
Query: 97 FGLAKILTSDDLASSV----VGTPSYMCPELLADIPYGSKS-DIWSLGCCIYEMTSLKPA 151
FGLA+ + D+ V T Y PELL +K+ DIWS+GC E+ + KP
Sbjct: 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206
Query: 152 FK-------------------AFDMQALIN-KINKSIVA-------PLPTKYSGA---FR 181
F D++ + + K + + PL + GA
Sbjct: 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAI 266
Query: 182 GLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
L++ ML +P+ R +A E L H PY+ ++H
Sbjct: 267 DLLEKMLVFDPKKRITADEALAH----PYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 10/208 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++ R+PF+ K S+ + +C ++ + GG++ + + ++FSE++ + ++
Sbjct: 48 VLKNTRHPFLTSLKYSFQTKD-RLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEI 104
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCP 121
+ ALDYLH+ I++RD+K N+ L KD I++ DFGL K +T + GTP Y+ P
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAP 164
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+L D YG D W LG +YEM + F D + L I + P S +
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK-FPRTLSADAK 223
Query: 182 GLVKSMLRKNPELR-----PSAAELLRH 204
L+ +L K+P R A E++RH
Sbjct: 224 SLLSGLLIKDPNKRLGGGPDDAKEIMRH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 71/211 (33%), Positives = 109/211 (51%), Gaps = 13/211 (6%)
Query: 3 LISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++ + ++ IV Y S++ R ++C+ +C GG + + I L SE ++ +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICM--EYCGGGSLQD-IYHVTGPL-SELQIAYVCRE 114
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMC 120
L L YLH+ +HRD+K +NI LT + D++L DFG+ AKI + S +GTP +M
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 121 PELLA---DIPYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIVAPL---P 173
PE+ A + Y DIW++G E+ L+P F M+AL + P
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
TK+S F VK L KNP+ RP+A LL H
Sbjct: 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 5/140 (3%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
Y+ +++ + GGD A IK E+ +++ ++++ ++ LH I+HRD+K N+
Sbjct: 71 YLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENL 128
Query: 85 FLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYE 144
+ + ++L DFGL++ VGTP Y+ PE + + SD WSLGC I+E
Sbjct: 129 LIDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
Query: 145 MTSLKPAFKAFDMQALINKI 164
P F A A+ + I
Sbjct: 186 FLFGYPPFHAETPDAVFDNI 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 8/208 (3%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV-Q 61
L S +++ IV+Y S E G + I + GG ++ ++ L E+ + Q
Sbjct: 58 LHSYLKHRNIVQYLGSDSENG-FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 62 LLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYM 119
+L L YLH N I+HRD+K N+ + T +++ DFG +K L + + GT YM
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYM 176
Query: 120 CPELLADIP--YGSKSDIWSLGCCIYEMTSLKPAFKAF-DMQALINKINKSIVAP-LPTK 175
PE++ P YG+ +DIWSLGC I EM + KP F + QA + K+ + P +P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLR 203
S + + +P+ R SA +LL+
Sbjct: 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 10/208 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++ +++PFIV+ ++ + G + +I+ + GG++ +++ +F E+ C +L ++
Sbjct: 53 ILEAVKHPFIVDLIYAF-QTGGKLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEI 109
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK-ILTSDDLASSVVGTPSYMCP 121
+AL++LH I++RD+K NI L ++L DFGL K + + + GT YM P
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+L +G D WSLG +Y+M + P F A + + I+KI K + LP + R
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN-LPPYLTPEAR 228
Query: 182 GLVKSMLRKNPELR----PS-AAELLRH 204
L+K +L++NP R P AAE+ H
Sbjct: 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSH 256
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 10/208 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++ R+PF+ K ++ +C ++ + GG++ + + ++F+EE+ + ++
Sbjct: 48 VLQNTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEI 104
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCP 121
+ AL+YLH+ +++RD+K N+ L KD I++ DFGL K ++ + GTP Y+ P
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+L D YG D W LG +YEM + F D + L I + P S +
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FPRTLSPEAK 223
Query: 182 GLVKSMLRKNPELR----PS-AAELLRH 204
L+ +L+K+P+ R PS A E++ H
Sbjct: 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV-QLLMALDYLHANHILHRDVKCSN 83
++ +++ + GGD+ + + + +F E+ ++ + +L++ALD +H +HRD+K N
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRKD--VF-PEETARFYIAELVLALDSVHKLGFIHRDIKPDN 131
Query: 84 IFLTKDQDIRLGDFGLAKILTSDD------------------------------LASSVV 113
I + D I+L DFGL K + A+S V
Sbjct: 132 ILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTV 191
Query: 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI---NKSIVA 170
GTP Y+ PE+L PYG + D WSLG +YEM P F + +Q NKI +S+
Sbjct: 192 GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRF 251
Query: 171 PLPTKYSGAFRGLVKSMLRKNPELR-PSAAELLRH 204
P S L+ +L +PE R S E+ H
Sbjct: 252 PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 72/246 (29%), Positives = 114/246 (46%), Gaps = 42/246 (17%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++ + +P+IV + ++ G + I + +GG + + +KKA E L K +
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKA--GRIPENILGKISI 106
Query: 61 QLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
+L L YL H I+HRDVK SNI + +I+L DFG++ L D +A+S VGT SYM
Sbjct: 107 AVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYM 165
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLK---PAFKAFDMQALINKINKSIVAP----- 171
PE L Y +SDIWSLG + EM + P A +++A+ + A
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 172 ----------------------------LPTK-YSGAFRGLVKSMLRKNPELRPSAAELL 202
LP+ +S F+ V L+KNP+ R EL
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285
Query: 203 RHVHLQ 208
+H ++
Sbjct: 286 KHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 2 ELISKIRNPFIV------EYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
+++ K+ + F+V E KD+ +C+++ GGD+ I + F EE+
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDA-------LCLVLTLMNGGDLKFHIYNMGNPGFDEERA 104
Query: 56 CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115
+ ++ L+ LH I++RD+K NI L IR+ D GLA + + VGT
Sbjct: 105 VFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTK 175
YM PE++ + Y D W LGC IYEM K F+ + ++ + V +
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VKEDQEE 223
Query: 176 YSGAF----RGLVKSMLRKNPELR-----PSAAELLRH 204
YS F R + + +L K+P R A E+ H
Sbjct: 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 14/200 (7%)
Query: 20 VERGCYVCIIIGFCEGG---DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76
V+ G + +++ C GG D+ + K ++ E + L + LM L +LH N +H
Sbjct: 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM-EEPIIAYILHEALMGLQHLHVNKTIH 147
Query: 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLA-----DIPYG 130
RDVK +NI LT + ++L DFG++ LTS L ++ VGTP +M PE++A D Y
Sbjct: 148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYD 207
Query: 131 SKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPL--PTKYSGAFRGLVKSM 187
++ D+WSLG E+ P M+AL KI ++ L P +S F ++
Sbjct: 208 ARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPPTLHQPELWSNEFNDFIRKC 266
Query: 188 LRKNPELRPSAAELLRHVHL 207
L K+ E RP+ ++LL+HV +
Sbjct: 267 LTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 36/207 (17%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRL 94
G D+ +K + S++ + + Q+L L Y+H+ I+HRD+K SNI + +D ++++
Sbjct: 103 GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159
Query: 95 GDFGLAKILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFK 153
DFGLA+ DD + V T Y PE +L + Y DIWS+GC + E+ + K F
Sbjct: 160 LDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217
Query: 154 AFD--------MQ-------ALINKIN----KSIVAPLPTK----YSGAFRG-------L 183
D M L+ KI+ ++ + LP + F G L
Sbjct: 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDL 277
Query: 184 VKSMLRKNPELRPSAAELLRHVHLQPY 210
++ ML +P+ R +AAE L H +L Y
Sbjct: 278 LEKMLVLDPDKRITAAEALAHPYLAEY 304
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 66/190 (34%), Positives = 99/190 (52%), Gaps = 16/190 (8%)
Query: 28 IIIGFCEGGDMAEAIK---KANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
+++ C GG + E +K +L E + L L+ L +LH N I+HRDVK +NI
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRL-DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159
Query: 85 FLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLA-----DIPYGSKSDIWSL 138
LT + ++L DFG++ LTS L ++ VGTP +M PE++A D Y ++ D+WSL
Sbjct: 160 LLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219
Query: 139 GCCIYEMTSLKPAFKAFDMQAL--INKINKSIVAPL--PTKYSGAFRGLVKSMLRKNPEL 194
G E+ P FDM + + KI ++ L P K+ +F + L K+ E
Sbjct: 220 GITAIELGDGDPPL--FDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEA 277
Query: 195 RPSAAELLRH 204
RPS LL H
Sbjct: 278 RPSVTHLLEH 287
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 10 PFIVEYKDSWVERGCYVCII-----------IGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
P+IV+ CY I + C + + K E+ L K
Sbjct: 74 PYIVK---------CYGYFITDSDVFICMELMSTC-----LDKLLKRIQGPIPEDILGKM 119
Query: 59 LVQLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
V ++ AL YL H ++HRDVK SNI L +++L DFG++ L + G +
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 118 YMCPELLADIP-----YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ-ALINKI--NKSIV 169
YM PE + D P Y ++D+WSLG + E+ + + +K + ++ KI +
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238
Query: 170 APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
P +S F V L K+ RP ELL+H ++ Y
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 32/187 (17%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-- 107
FSE+ + ++ QLL L+Y H + LHRD+KCSNI L I+L DFGLA++ S++
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 108 LASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK 166
++ V T Y PE LL + YG D+WS GC + E+ + KP F+A A + I++
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232
Query: 167 SIVAPLPTKYSGAFR-----------------------------GLVKSMLRKNPELRPS 197
+P P + + L+ ML +P R +
Sbjct: 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292
Query: 198 AAELLRH 204
A E L
Sbjct: 293 AEEALNS 299
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
+++++ PFIV K S+ + +++ F GG++ +++ F + + +L
Sbjct: 46 VLAQVNCPFIVPLKFSFQSPE-KLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAEL 102
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCP 121
L AL+ LH ++++RD+K NI L I L DFGL K+ + DD ++ GTP Y+ P
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAP 162
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL--PTKYSGA 179
ELL Y D W+LG +YEM + P F ++ + KI + PL P +
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI---LQEPLRFPDGFDRD 219
Query: 180 FRGLVKSMLRKNPELR 195
+ L+ +L ++P R
Sbjct: 220 AKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 32/185 (17%)
Query: 52 EEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS-DDLAS 110
E ++ K+L Q+L +++ H+++I+HRD+K NI +++ ++L DFG A+ L + ++ +
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
Query: 111 SVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI- 168
V T Y PELL D YG DIW++GC + EM + +P F + I K +
Sbjct: 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218
Query: 169 --------------------------VAPLPTKY---SGAFRGLVKSMLRKNPELRPSAA 199
+ PL ++ SG L K LR +P+ RPS++
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 200 ELLRH 204
+LL H
Sbjct: 279 QLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
PFIV K S+ + + ++ + GG++ ++K FSE++ ++ +L++AL++L
Sbjct: 56 PFIVGLKFSF-QTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHL 112
Query: 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPE-LLADI 127
H I++RD+K NI L I L DFGL+K LT + ++ GT Y+ PE LL +
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 128 PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSM 187
Y D WSLG ++EM F A D Q + I V S R VK +
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232
Query: 188 LRKNPELR----PSAAELLRH 204
L +NP+ R A EL H
Sbjct: 233 LNRNPQHRLGAHRDAVELKEH 253
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 35/180 (19%)
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS--DDLASSVVGTP 116
++QLL + +LH N ILHRD+K SN+ L +++ DFGLA+ S VV T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TL 170
Query: 117 SYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP---- 171
Y PELL Y + D+WS+GC E+ + KP F +NKI K + P
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230
Query: 172 ------LP-------TKYSGA-----FR---------GLVKSMLRKNPELRPSAAELLRH 204
LP TKY F L+ +L +P R SA + L+H
Sbjct: 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 63/209 (30%), Positives = 116/209 (55%), Gaps = 10/209 (4%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++++++ +PFIV+ ++ G + +I+ F GGD+ + K +F+EE + +L +
Sbjct: 50 DILAEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAE 106
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK-ILTSDDLASSVVGTPSYMC 120
L +ALD+LH+ I++RD+K NI L ++ I+L DFGL+K + + A S GT YM
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE++ + +D WS G ++EM + F+ D + + I K+ + +P S
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-MPQFLSPEA 225
Query: 181 RGLVKSMLRKNPELRPSAA-----ELLRH 204
+ L++++ ++NP R A E+ RH
Sbjct: 226 QSLLRALFKRNPANRLGAGPDGVEEIKRH 254
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-22
Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 9/185 (4%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+++ FC G + + IK EE + ++L L +LH + ++HRD+K N+ LT
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145
Query: 88 KDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCC 141
++ +++L DFG+ A++ + ++ +GTP +M PE++A D Y KSD+WSLG
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 205
Query: 142 IYEMTSLKPAF-KAFDMQALINKINKSIVAPLPT-KYSGAFRGLVKSMLRKNPELRPSAA 199
EM P M+AL I ++ L + K+S F+ ++S L KN RP+
Sbjct: 206 AIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTE 264
Query: 200 ELLRH 204
+L++H
Sbjct: 265 QLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 50/168 (29%), Positives = 90/168 (53%), Gaps = 4/168 (2%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
++ + GGD+ I+++ + F E + + ++ +AL +LH + +++RD+K NI L
Sbjct: 74 VMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA 131
Query: 89 DQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ +L DFG+ K + + ++ GTP Y+ PE+L ++ YG D W+LG +YEM +
Sbjct: 132 EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA 191
Query: 148 LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
+P F+A + L I V P S ++K+ + KNP R
Sbjct: 192 GQPPFEADNEDDLFESILHDDVL-YPVWLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
R+PF+ K S+ +C ++ + GG++ + + ++FSE++ + +++ ALD
Sbjct: 53 RHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALD 109
Query: 68 YLHAN-HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCPELLA 125
YLH+ ++++RD+K N+ L KD I++ DFGL K D + GTP Y+ PE+L
Sbjct: 110 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 126 DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVK 185
D YG D W LG +YEM + F D + L I + P S + L+
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FPRTLSPEAKSLLS 228
Query: 186 SMLRKNPELR-----PSAAELLRH 204
+L+K+P+ R A E+++H
Sbjct: 229 GLLKKDPKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++ ++ IV Y S++ R + I + FC GG + + I L SE ++ +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRD-KLWICMEFCGGGSLQD-IYHVTGPL-SESQIAYVSRET 115
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCP 121
L L YLH+ +HRD+K +NI LT + ++L DFG+ A+I + S +GTP +M P
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 122 ELLA---DIPYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIVAPL---PT 174
E+ A Y DIW++G E+ L+P F M+AL + P
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
K+S +F VK L KNP+ RP+A +LL+H
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 49/152 (32%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 2 ELISKIRNPFIVE-YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ ++ +PFI+ + +R Y +++ + GG++ ++ NS FS +
Sbjct: 53 RVLKEVSHPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLR--NSGRFSNSTGLFYAS 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
+++ AL+YLH+ I++RD+K NI L K+ I+L DFG AK L D ++ GTP Y+
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLA 166
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152
PE++ + D W+LG IYEM P F
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 58/185 (31%), Positives = 99/185 (53%), Gaps = 9/185 (4%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+++ FC G + + +K E+ + ++L L +LHA+ ++HRD+K N+ LT
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155
Query: 88 KDQDIRLGDFGL-AKILTSDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCC 141
++ +++L DFG+ A++ + ++ +GTP +M PE++A D Y +SDIWSLG
Sbjct: 156 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT 215
Query: 142 IYEMTSLKPAF-KAFDMQALINKINKSIVAPLPT-KYSGAFRGLVKSMLRKNPELRPSAA 199
EM P M+AL I ++ L + K+S F ++ L KN RPS
Sbjct: 216 AIEMAEGAPPLCDMHPMRALF-LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTE 274
Query: 200 ELLRH 204
+LL+H
Sbjct: 275 QLLKH 279
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 6/169 (3%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
++ F GGD+ I+K S+ F E + + ++ AL +LH I++RD+K N+ L
Sbjct: 74 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH 131
Query: 89 DQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ +L DFG+ K + S+ GTP Y+ PE+L ++ YG D W++G +YEM
Sbjct: 132 EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
Query: 148 LKPAFKAFDMQALINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
F+A + L I N +V P ++K+ + KNP +R
Sbjct: 192 GHAPFEAENEDDLFEAILNDEVVYPTWLSQDAV--DILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 6/173 (3%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
++ ++ + GGD+ I+ +S F E + + +++ L +LH I++RD+K N+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNV 127
Query: 85 FLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143
L KD I++ DFG+ K + + AS+ GTP Y+ PE+L Y D WS G +Y
Sbjct: 128 LLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLY 187
Query: 144 EMTSLKPAFKAFDMQALINKINKSIVAP-LPTKYSGAFRGLVKSMLRKNPELR 195
EM + F D L + I P P S + + + ++P R
Sbjct: 188 EMLIGQSPFHGEDEDELFDSILNDR--PHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 40/191 (20%)
Query: 54 KLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT--SDDLASS 111
+ W QLL A+ Y H+++I+HRD+K NI +++ ++L DFG A+ L +
Sbjct: 103 RSYIW--QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 112 VVGTPSYMCPELL-ADIPYGSKSDIWSLGCCIYEMTSLKPAF-------------KAF-- 155
V T Y PELL D YG D+W++GC + E+ +P F K
Sbjct: 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220
Query: 156 ---DMQALINK---------INKSIVAPLPTKYSGAFRG----LVKSMLRKNPELRPSAA 199
Q L + S L +Y G +K+ LR +P+ R +
Sbjct: 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280
Query: 200 ELLRHVHLQPY 210
ELL+H PY
Sbjct: 281 ELLQH----PY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 38/239 (15%)
Query: 2 ELISKIRNPFIVE-YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
E+++ + +PF+ Y E Y+C+++ +C GG++ +++ K SEE +
Sbjct: 53 EILATLDHPFLPTLYASFQTET--YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS--------------- 105
++L+AL+YLH I++RD+K NI L + I L DF L+K
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 106 -------DDLAS--------SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150
+ S S VGT Y+ PE+++ +GS D W+LG +YEM
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 151 AFKAFDMQA-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELR----PSAAELLRH 204
FK + N + K + P S + R L++ +L K+P R AAE+ +H
Sbjct: 231 PFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 60/192 (31%), Positives = 83/192 (43%), Gaps = 32/192 (16%)
Query: 45 ANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT 104
N + E + K + Q L A+++ H ++ +HRDVK NI +TK I+L DFG A+ILT
Sbjct: 92 KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT 151
Query: 105 S-DDLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCIYEMTS---LKPAFKAFDMQA 159
D + V T Y PELL D YG D+W++GC E+ + L P D
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
Query: 160 LI-----------------NKINKSIVAPLPT----------KYSGAFRGLVKSMLRKNP 192
LI N+ K + P P S +K L+ +P
Sbjct: 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDP 271
Query: 193 ELRPSAAELLRH 204
R S ELL H
Sbjct: 272 TERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL--FSEEKLCKWLV 60
+++K+ + FIV ++ + +C+++ GGD+ I + + F E + C +
Sbjct: 46 ILAKVHSRFIVSLAYAF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA 104
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA-KILTSDDLASSVVGTPSYM 119
Q++ L++LH I++RD+K N+ L D ++R+ D GLA ++ GTP +M
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA----FDMQALINKINKSIVAPLPTK 175
PELL Y D ++LG +YEM + + F+A + + L +I V P K
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT-YPDK 223
Query: 176 YSGAFRGLVKSMLRKNPELR 195
+S A + +++L K+PE R
Sbjct: 224 FSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-21
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 20/222 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+E++ + +P +V+ D + + + +++ F +GG + + + E+ L
Sbjct: 123 IEILRDVNHPNVVKCHDMF-DHNGEIQVLLEFMDGGSLE------GTHIADEQFLADVAR 175
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYM 119
Q+L + YLH HI+HRD+K SN+ + +++++ DFG+++IL D +S VGT +YM
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 235
Query: 120 CPEL----LADIPY-GSKSDIWSLGCCIYEMTSLKPAF---KAFDMQALINKINKSIVAP 171
PE L Y G DIWSLG I E + F + D +L+ I S
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE 295
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213
P S FR + L++ P R SA +LL+H P++L+
Sbjct: 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH----PFILR 333
|
Length = 353 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
+E + + + IV+Y E Y+ I + + GG + ++ F EE+L ++
Sbjct: 59 IETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGR--F-EEQLVRFF 113
Query: 60 V-QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVV 113
Q+L L YLH+ ILHRD+K N+ + D ++ DFG++K SDD+ S+
Sbjct: 114 TEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQ 171
Query: 114 GTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP 171
G+ +M PE++ Y +K DIWSLGC + EM + + + + A + K+ AP
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP 231
Query: 172 -----LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
+ S + + NP+ RP+A ELL+H
Sbjct: 232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 40/208 (19%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL- 108
+EE + +L QLL L Y+H+ +++HRD+K SN+ + +D ++R+GDFG+A+ L+S
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 109 ----ASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDM------ 157
+ V T Y PELL +P Y + D+WS+GC EM + F +
Sbjct: 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223
Query: 158 ---------QALINKINKSIV------------APLPTKYSGA---FRGLVKSMLRKNPE 193
+ ++N+I V P + A L+ ML+ +PE
Sbjct: 224 ILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE 283
Query: 194 LRPSAAELLRHVHLQPYVLKVHLKLNSP 221
R + + L+H P++ + H + P
Sbjct: 284 ERITVEQALQH----PFLAQYHDPDDEP 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 4e-21
Identities = 78/233 (33%), Positives = 121/233 (51%), Gaps = 33/233 (14%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-VCIIIGFCEGGDMAEAIKKANSKLF---SEEKLC 56
+ ++ ++++ IV Y D ++ + + I++ FC+ GD++ I+K K+F E +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC-YKMFGKIEEHAIV 121
Query: 57 KWLVQLLMALDYLH-------ANHILHRDVKCSNIFL-TKDQDI---------------- 92
QLL AL Y H +LHRD+K NIFL T + I
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 93 RLGDFGLAKILTSDDLASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCIYEMTSLKP 150
++GDFGL+K + + +A S VGTP Y PELL Y KSD+W+LGC IYE+ S K
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 151 AF-KAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
F KA + LI+++ + P+ K S L+K++L + + RPSA + L
Sbjct: 242 PFHKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 51/168 (30%), Positives = 97/168 (57%), Gaps = 5/168 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++++ I +PF V S+ + Y+ +++ F GG+ +++ +K F + C + Q
Sbjct: 83 KILNYINHPFCVNLYGSFKDES-YLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQ 139
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
+++ +YL + +I++RD+K N+ L KD I++ DFG AK++ D ++ GTP Y+ P
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAP 197
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV 169
E+L ++ +G +D W+LG IYE+ P F A + + KI + I+
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII 245
|
Length = 340 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
R+P+IV + +++ +C+ + F + G + KK E L K V ++ L
Sbjct: 61 RSPYIVSFYGAFLNEN-NICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLT 117
Query: 68 YLH-ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD 126
YL+ + I+HRD+K SNI + I+L DFG++ L + +A + VGT +YM PE +
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-NSIADTFVGTSTYMSPERIQG 176
Query: 127 IPYGSKSDIWSLGCCIYEMTSLKPAF-------KAFDMQALINKINKSIV-APLPTKYSG 178
Y KSD+WSLG I E+ K F D I + + IV P P S
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236
Query: 179 AF----RGLVKSMLRKNPELRPSAAELLRH 204
F R V + L K+P RP+ +L
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 9/175 (5%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+I+ + GG++ + + F+E ++ ++ ++++ALD+LH I++RD+K NI L
Sbjct: 82 LILDYVNGGELFTHL--YQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139
Query: 88 KDQDIRLGDFGLAKILTSD--DLASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCIY 143
+ + L DFGL+K ++ + A S GT YM PE++ + D WSLG +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 144 EMTSLKPAFKAFDMQALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELR 195
E+ + F Q ++I++ I+ P P S R ++ +L K+P+ R
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 62/225 (27%), Positives = 113/225 (50%), Gaps = 19/225 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-YVCIIIGFCEGGDMAEAI-KKANSKLFSEEKLCKW 58
++++ K +P+IV++ ++ G Y+C+ + + G + + ++ E+ L +
Sbjct: 50 LDILHKAVSPYIVDFYGAFFIEGAVYMCM--EYMDAGSLDKLYAGGVATEGIPEDVLRRI 107
Query: 59 LVQLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
++ L +L H I+HRDVK +N+ + + ++L DFG++ L + LA + +G S
Sbjct: 108 TYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQS 166
Query: 118 YMCPELL------ADIPYGSKSDIWSLGCCIYEMTSLK---PAFKAFDMQALINKINKSI 168
YM PE + + Y +SD+WSLG I EM + P ++ A ++ I
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226
Query: 169 VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213
LP+ YS + V L K P RP+ A+LL H P+++K
Sbjct: 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH----PWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 32/225 (14%)
Query: 9 NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDY 68
NPF+V S+ + ++C+++ + EGGD A +K + ++ + + ++AL+Y
Sbjct: 60 NPFVVSMFCSFETKR-HLCMVMEYVEGGDCATLLKNIGALPVDMARM--YFAETVLALEY 116
Query: 69 LHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI----------------LTSDDLASSV 112
LH I+HRD+K N+ +T I+L DFGL+KI T + L V
Sbjct: 117 LHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 113 VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINK-INKSIVAP 171
GTP Y+ PE++ YG D W++G +YE F + L + I+ I P
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236
Query: 172 -----LPTKYSGAFRGLVKSMLRKNPELR---PSAAELLRHVHLQ 208
LP + L+ +LR+NP R A E+ +H
Sbjct: 237 EGDEALPADA----QDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 13/168 (7%)
Query: 52 EEKLCKWLVQLLMALDYLHAN-HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS 110
E+ L K V ++ AL+YLH+ ++HRDVK SN+ + ++ ++L DFG++ L D +A
Sbjct: 102 EDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAK 160
Query: 111 SV-VGTPSYMCPEL----LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKIN 165
++ G YM PE L Y KSD+WSLG + E+ + + F + ++
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLK 218
Query: 166 KSIVAPLPT----KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209
+ + P P K+S F+ V L+KN + RP+ ELL+H +
Sbjct: 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 57/194 (29%), Positives = 83/194 (42%), Gaps = 26/194 (13%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + K E + + QLL LD+LH++ ++HRD+K NI +T I+L D
Sbjct: 94 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF---- 152
FGLA+I + +SVV T Y PE+L Y + D+WS+GC EM KP F
Sbjct: 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213
Query: 153 ------KAFDMQALINK--------INKSIVAPLPTKYSGAF--------RGLVKSMLRK 190
K D+ L + + + + F + L+ L
Sbjct: 214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 273
Query: 191 NPELRPSAAELLRH 204
NP R SA L H
Sbjct: 274 NPAKRISAYSALSH 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 4/165 (2%)
Query: 32 FCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
+ GGD+ I++ F E + ++ + L +LH+ I++RD+K N+ L +
Sbjct: 82 YVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH 139
Query: 92 IRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150
I++ DFG+ K + + GTP Y+ PE++A PYG D W+ G +YEM + +P
Sbjct: 140 IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 151 AFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
F D L I + V+ P S + K +L K+P R
Sbjct: 200 PFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 5/198 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
E++ K+ +PFIV ++ E ++C+++ GGD+ I + E++ + Q
Sbjct: 45 EILEKVNSPFIVNLAYAF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ 103
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
+ + +LH+ I++RD+K N+ L + RL D GLA L + GT YM P
Sbjct: 104 ITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF----DMQALINKINKSIVAPLPTKYS 177
E+L + PY D +++GC IYEM + + FK + L + + V ++
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFT 223
Query: 178 GAFRGLVKSMLRKNPELR 195
+ + + L K PE R
Sbjct: 224 EESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 45/119 (37%), Positives = 70/119 (58%), Gaps = 10/119 (8%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCK-WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIR 93
GGD+ + K +L E + + +L ++++A+D +H +HRD+K N+ L K+ IR
Sbjct: 85 GGDLLTLLSKFEDRL--PEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR 142
Query: 94 LGDFG-LAKILTSDDLASSV-VGTPSYMCPELLADIP-----YGSKSDIWSLGCCIYEM 145
L DFG ++L + S+V VGTP Y+ PE+L + YG + D WSLG C+YEM
Sbjct: 143 LADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 6/198 (3%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ K+ + F+V ++ E +C+++ GGD+ I F E + + +
Sbjct: 52 QILEKVNSRFVVSLAYAY-ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE 110
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
+ L+ LH I++RD+K NI L IR+ D GLA + VGT YM P
Sbjct: 111 ICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF- 180
E++ + Y D W+LGC +YEM + + F+ + ++ + +V + +YS F
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVQEEYSEKFS 229
Query: 181 ---RGLVKSMLRKNPELR 195
R L K +L K+P+ R
Sbjct: 230 PDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 1 MELISKIRNPFIVE-YKDSWVERGCYVCIIIGFCEGG--DMAEAIKKANSKLFSEEKLCK 57
+E++ K +P+I+ Y +VE +C F +GG D+ I E L +
Sbjct: 50 LEILYKCDSPYIIGFYGAFFVENRISICT--EFMDGGSLDVYRKI--------PEHVLGR 99
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
V ++ L YL + ILHRDVK SN+ + ++L DFG++ L + +A + VGT +
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYVGTNA 158
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLK-PAFKAFDMQALINKIN--KSIV--AP- 171
YM PE ++ YG SD+WSLG E+ + P + Q + + + IV P
Sbjct: 159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218
Query: 172 -LPT-KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
LP ++S F + +RK P+ RP+ L+ H + Y
Sbjct: 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 48/131 (36%), Positives = 66/131 (50%), Gaps = 13/131 (9%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
YV GGD + N + SE+ ++ ++ A+D LH +HRD+K N
Sbjct: 82 YVP-------GGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132
Query: 85 FLTKDQDIRLGDFGLAK-ILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143
+ I+L DFGL+K I+T A+SVVG+P YM PE+L Y D WSLGC +Y
Sbjct: 133 LIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLY 189
Query: 144 EMTSLKPAFKA 154
E P F
Sbjct: 190 EFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 65/255 (25%), Positives = 118/255 (46%), Gaps = 40/255 (15%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN------SKLFSEEKLC 56
++ ++ +PFIV S+ + V ++ F GG++ ++KA +K + E
Sbjct: 71 ILMELSHPFIVNMMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE--- 126
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP 116
L++A +YLH+ I++RD+K N+ L +++ DFG AK + D ++ GTP
Sbjct: 127 -----LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTP 179
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA---PLP 173
Y+ PE++ +G D W++G +YE + P F FD +I + I+A P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF--FDDTPF--RIYEKILAGRLKFP 235
Query: 174 TKYSGAFRGLVKSMLRKNP-----ELRPSAAELLRH---------VHLQPYV-LKVHLKL 218
+ G R LVK +L+ + L+ A++ H Y + +++
Sbjct: 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRV 295
Query: 219 NSPRRNS-LSHWPES 232
SP S +P+S
Sbjct: 296 KSPGDTSNFEKYPDS 310
|
Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 4/197 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++ K+ + F+V ++ E +C+++ GGD+ I + F E++ + +
Sbjct: 52 RILEKVNSRFVVSLAYAY-ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE 110
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
L L+ L I++RD+K NI L IR+ D GLA + + VGT YM P
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPT---KYSG 178
E++ + Y D W LGC IYEM + F+ + ++++ + K+S
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSE 230
Query: 179 AFRGLVKSMLRKNPELR 195
+ + + +L KNP+ R
Sbjct: 231 DAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 61/184 (33%), Positives = 85/184 (46%), Gaps = 33/184 (17%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
+L Q+L L Y+H+ ++HRD+K SNI + ++ D+++ DFGLA+I D + V T
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRY 170
Query: 118 YMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM---------------QALI 161
Y PE +L Y + DIWS GC EM KP F D +I
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230
Query: 162 NKINKS----IVAPLPTKYSGAF-----------RGLVKSMLRKNPELRPSAAELLRHVH 206
N I V LP + F L++ ML +P+ R SAAE L H +
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
Query: 207 LQPY 210
L PY
Sbjct: 291 LAPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 11/216 (5%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L+ +++PF+V S+ ++ +V + + GG++ +++ + F E + +
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFV---LDYVNGGELFFHLQR--ERSFPEPRARFYAA 103
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
++ AL YLH+ +I++RD+K NI L + L DFGL K + S+ GTP Y+
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-NKSIVAPLPTKYSG 178
PE+L PY D W LG +YEM P F + D + + I NK + L S
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISV 221
Query: 179 AFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKV 214
+ R L++ +L+K+ R A + + + +
Sbjct: 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/196 (32%), Positives = 87/196 (44%), Gaps = 30/196 (15%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + K E + + Q L LD+LHAN I+HRD+K NI +T ++L D
Sbjct: 92 DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLAD 151
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF---- 152
FGLA+I + + VV T Y PE+L Y + D+WS+GC EM KP F
Sbjct: 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211
Query: 153 ------KAFDMQAL-----------INKINKSIVAPLPTK-------YSGAFRGLVKSML 188
K FD+ L + + S P P + SGA L+ ML
Sbjct: 212 EADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGA--QLLLEML 269
Query: 189 RKNPELRPSAAELLRH 204
NP R SA L+H
Sbjct: 270 TFNPHKRISAFRALQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 54/146 (36%), Positives = 85/146 (58%), Gaps = 5/146 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++ + +P+IV + ++ G + I + +GG + + +K+A K EE L K +
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSI 110
Query: 61 QLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
+L L YL H I+HRDVK SNI + +I+L DFG++ L D +A+S VGT SYM
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYM 169
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEM 145
PE L Y +SDIWS+G + E+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 47/124 (37%), Positives = 69/124 (55%), Gaps = 8/124 (6%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
++ FCE D+A + N K F+ ++ K + LL L Y+H N ILHRD+K +NI +T
Sbjct: 96 LVFEFCEH-DLAGLLSNKNVK-FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT 153
Query: 88 KDQDIRLGDFGLAK-----ILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCC 141
KD ++L DFGLA+ + + ++ V T Y PE LL + YG D+W GC
Sbjct: 154 KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCI 213
Query: 142 IYEM 145
+ EM
Sbjct: 214 MAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 9/211 (4%)
Query: 3 LISKIRNPFIV--EYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L+ +++PF+V Y E+ +V + F GG++ +++ S F E + +
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFV---LDFVNGGELFFHLQRERS--FPEPRARFYAA 103
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
++ AL YLH+ +I++RD+K NI L + L DFGL K + D ++ GTP Y+
Sbjct: 104 EIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE++ PY + D W LG +YEM P F D+ + + I + P A
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTA 223
Query: 180 FRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
+ +++ +L K+ + R A E + P+
Sbjct: 224 W-SILEELLEKDRQRRLGAKEDFLEIQEHPF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 4/168 (2%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
++ + GGD+ I++ F E + ++ + L +LH+ I++RD+K N+ L
Sbjct: 79 VMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136
Query: 89 DQDIRLGDFGLAKILTSDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ I++ DFG+ K D + + + GTP Y+ PE++A PYG D W+ G +YEM +
Sbjct: 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 148 LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
+ F+ D L I + VA P S + K ++ K+P R
Sbjct: 197 GQAPFEGEDEDELFQSIMEHNVA-YPKSMSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 5/146 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++ + +P+IV + ++ G + I + +GG + + +KKA E+ L K +
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSI 110
Query: 61 QLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
++ L YL H I+HRDVK SNI + +I+L DFG++ L D +A+S VGT SYM
Sbjct: 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYM 169
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEM 145
PE L Y +SDIWS+G + EM
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 42/246 (17%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVG 114
+L Q+L L YLH+ ILHRD+K N+ + + +++ DFGLA++ D+ + VV
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV- 166
Query: 115 TPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLP 173
T Y PE+L Y S DIWS+GC E+ + F+A ++ I + P
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 174 TKYSGAFRGLVKSMLRK-------------------------------NPELRPSAAELL 202
A G +LR +P+ R SAA+ L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 203 RHVHLQPYVLKVH------LKLNSPRRNSLSHWPESNYARRTRFSEPDNVPISSYREKQY 256
H +L L+ H S R S + S E + + +E+ +
Sbjct: 287 AHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELH 346
Query: 257 SFSNNR 262
F +
Sbjct: 347 QFILEQ 352
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 4/168 (2%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
++ + GGD+ I++ F E + + ++ + L +LH I++RD+K N+ L
Sbjct: 79 VMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 89 DQDIRLGDFGLAKILTSDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ I++ DFG+ K D + + + GTP Y+ PE++A PYG D W+ G +YEM +
Sbjct: 137 EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 196
Query: 148 LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
+P F D L I + V+ P S + K ++ K+P R
Sbjct: 197 GQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + IK ++ S + + +L Q+L L Y+H+ ++LHRD+K SN+ L + D+++ D
Sbjct: 93 DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICD 149
Query: 97 FGLAKILTSDDLASSV----VGTPSYMCPELLADIPYGSKS-DIWSLGCCIYEMTSLKPA 151
FGLA+I + + V T Y PE++ + +K+ DIWS+GC + EM S +P
Sbjct: 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
Query: 152 F-------------------KAFDMQALINKINKSIVAPLPTKYSGAFRG---------- 182
F D+ +I+ ++ + LP K +
Sbjct: 210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKAL 269
Query: 183 -LVKSMLRKNPELRPSAAELLRHVHLQPY 210
L+ ML NP R + E L H +L+ Y
Sbjct: 270 DLLDKMLTFNPHKRITVEEALAHPYLEQY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 52/177 (29%), Positives = 99/177 (55%), Gaps = 6/177 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++ ++ IVE K+++ RG + ++ + E +M E +++ + + EK+ ++
Sbjct: 51 LKMLRTLKQENIVELKEAFRRRG-KLYLVFEYVEK-NMLELLEEMPNGV-PPEKVRSYIY 107
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT--SDDLASSVVGTPSY 118
QL+ A+ + H N I+HRD+K N+ ++ + ++L DFG A+ L+ S+ + V T Y
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTK 175
PELL PYG D+WS+GC + E++ +P F + I K ++ PLP +
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK-VLGPLPAE 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 49/147 (33%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
Y+ +++ + GGD+ + K +L E+ ++ ++++A+ +H H +HRD+K N+
Sbjct: 75 YLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 85 FLTKDQDIRLGDFG-LAKILTSDDLASSV-VGTPSYMCPELLADI-----PYGSKSDIWS 137
L + IRL DFG K+ + SSV VGTP Y+ PE+L + YG + D WS
Sbjct: 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193
Query: 138 LGCCIYEMTSLKPAFKAFDMQALINKI 164
LG C+YEM + F A + KI
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 69/239 (28%), Positives = 112/239 (46%), Gaps = 36/239 (15%)
Query: 3 LISKIRNPFIVEYKDSWVERGC-YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
L+ +R+P IVE K+ V + + +++ +CE D+A + FSE ++ ++Q
Sbjct: 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN-MPTPFSESQVKCLMLQ 116
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI--LTSDDLASSVVGTPSYM 119
LL L YLH N I+HRD+K SN+ LT +++ DFGLA+ L + + VV T Y
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175
Query: 120 CPELL-ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-------NKSI--- 168
PELL Y + D+W++GC + E+ + KP ++ I N+SI
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 169 VAPLP-------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
+ LP S A L+ +L +P+ R +A E L + +
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 40/111 (36%), Positives = 60/111 (54%), Gaps = 23/111 (20%)
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQD----IRLGDFGLAKI-------LTSDD 107
L Q+L + YLH+N +LHRD+K +NI + + +++GD GLA++ L D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 108 LASSVVGTPSYMCPELLADIPYGSKS-----DIWSLGCCIYEMTSLKPAFK 153
VV T Y PELL G++ DIW++GC E+ +L+P FK
Sbjct: 174 ---PVVVTIWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 9/212 (4%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+ +++PF+V S+ + + ++ + GG++ +++ + F E + + ++
Sbjct: 49 LLKNLKHPFLVGLHYSF-QTAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEV 105
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCP 121
A+ YLH+ +I++RD+K NI L + L DFGL K + ++ S+ GTP Y+ P
Sbjct: 106 ASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+L PY D W LG +YEM P F + D+ + + I + LP + A
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ-LPGGKTVAAC 224
Query: 182 GLVKSMLRKNPELRPSAA----ELLRHVHLQP 209
L+ +L K+ R A E+ HV P
Sbjct: 225 DLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCK-WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIR 93
GGD+ + + + +E + + +L +L++A+ +H +HRD+K N+ + + I+
Sbjct: 85 GGDLLSLLNRYEDQF--DEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIK 142
Query: 94 LGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI------PYGSKSDIWSLGCCIYEM 145
L DFG A LT++ + VGTP Y+ PE+L + YG + D WSLG YEM
Sbjct: 143 LADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 146 TSLKPAFKAFDMQALINKI---NKSIVAPLPTKYSGAFRGLVKSML 188
+ F N I + + P K S F L++S+L
Sbjct: 203 IYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 58/171 (33%), Positives = 88/171 (51%), Gaps = 11/171 (6%)
Query: 50 FSEEKLCKWLVQLLMALDYLHAN-HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL 108
EE L K V + AL+YL I+HRDVK SNI L ++ +I+L DFG++ L D +
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSI 162
Query: 109 ASSV-VGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLK---PAFKA-FDMQAL 160
A + G YM PE + Y +SD+WSLG +YE+ + K P + + FD
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ 222
Query: 161 INKINKSIVAPLPTK-YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
+ K + I++ + +S +F + L K+ RP ELL H ++ Y
Sbjct: 223 VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 8/144 (5%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+++ + GGD+ + K +L E+ +L ++++A+D +H H +HRD+K NI +
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 88 KDQDIRLGDFG-LAKILTSDDLASSV-VGTPSYMCPELLADIP-----YGSKSDIWSLGC 140
+ IRL DFG K++ + SSV VGTP Y+ PE+L + YG + D WSLG
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV 196
Query: 141 CIYEMTSLKPAFKAFDMQALINKI 164
C+YEM + F A + KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 34/176 (19%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI--LTSDDLASSVVGTPSY 118
QLL + + H N +LHRD+K N+ + K +++L DFGLA+ + + ++ VV T Y
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWY 166
Query: 119 MCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP------ 171
P+ LL Y + DIWS+GC + EM + +P F + + + KI + + P
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226
Query: 172 ----LPTKYSGAFR-------------------GLVKSMLRKNPELRPSAAELLRH 204
LP +Y F L+ +L+ NPELR SA + L+H
Sbjct: 227 GISQLP-EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 49/187 (26%), Positives = 73/187 (39%), Gaps = 44/187 (23%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-------------D 107
QLL ++YLH NHILHRD+K +NI + +++ DFGLA+
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 108 LASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAF----------KAFD 156
+ VV T Y PELL + Y + DIW +GC EM + +P F
Sbjct: 183 YTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 157 M------------QALINKINKSIVAPLPTKYSGAFR-------GLVKSMLRKNPELRPS 197
+ ++L P F L+ +L +P R +
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301
Query: 198 AAELLRH 204
A++ L H
Sbjct: 302 ASDALEH 308
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 11/213 (5%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+ +++PF+V S+ + + ++ + GG++ +++ + F E + + ++
Sbjct: 49 LLKNVKHPFLVGLHFSF-QTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEI 105
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCP 121
AL YLH+ +I++RD+K NI L I L DFGL K + + S+ GTP Y+ P
Sbjct: 106 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-NKSIVAPLPTKYSGAF 180
E+L PY D W LG +YEM P F + + + + I NK + L + +
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSA 223
Query: 181 RGLVKSMLRKNPELRPSAA----ELLRHVHLQP 209
R L++ +L+K+ R A E+ H+ P
Sbjct: 224 RHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 44/202 (21%)
Query: 41 AIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL- 99
+ N +LF L QLL L Y H +LHRD+K N+ +++ +++L DFGL
Sbjct: 99 GLSMHNVRLF--------LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
Query: 100 -AKILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-D 156
AK + S ++ VV T Y P+ LL Y + D+W +GC YEM + +P F D
Sbjct: 151 RAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 157 MQALINKINKSI----------VAPLPTKYSGAFR---------------------GLVK 185
++ ++KI + + V+ P +F L
Sbjct: 210 VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELAL 269
Query: 186 SMLRKNPELRPSAAELLRHVHL 207
L+ P+ R SAAE ++H +
Sbjct: 270 KFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 9 NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDY 68
NPF+V S + + ++I + GGD+ +++ + EE + ++ +AL++
Sbjct: 55 NPFLVGLH-SCFQTTSRLFLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNF 111
Query: 69 LHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADI 127
LH I++RD+K N+ L D I+L D+G+ K L D S+ GTP+Y+ PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 128 PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINK--------INKSIVAP--LPTKYS 177
YG D W+LG ++EM + + F +N + K I P L K S
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS 231
Query: 178 GAFRGLVKSMLRKNPELR 195
+G L K+P+ R
Sbjct: 232 HVLKGF----LNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 67/257 (26%), Positives = 109/257 (42%), Gaps = 33/257 (12%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
++ + GGD+ I+ + F + + +++ L +LH+ I++RD+K NI L
Sbjct: 74 VMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 89 DQDIRLGDFGLAK-ILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
D I++ DFG+ K + D + GTP Y+ PE+L Y + D WS G +YEM
Sbjct: 132 DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191
Query: 148 LKPAFKAFDMQALINKIN--------------KSIVAPL----PTKYSGAFRGLVKSMLR 189
+ F D + L I K I+ L P + G VK +R
Sbjct: 192 GQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG-----VKGDIR 246
Query: 190 KNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPIS 249
++P R L ++P K+ S N S++ + + R S D + I+
Sbjct: 247 QHPFFREIDWSALEEREIEP---PFKPKVKSA--NDCSNFDKEFLNEKPRLSVTDRMLIN 301
Query: 250 SYREKQYSFSNNRNLNP 266
S Q F N +NP
Sbjct: 302 SM--DQNMFENFSFINP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 42/87 (48%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA-KILTSDDLASSV--VGTPSY 118
LL AL YLH I+HRDVK NIFL + ++ LGDFG A K+ D GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEM 145
PELLA PY +K+DIWS G ++EM
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 4/157 (2%)
Query: 9 NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDY 68
NPF+ ++ + ++ ++ F GGD+ I+ F + + +++ L +
Sbjct: 55 NPFLTHLYCTFQTKE-HLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQF 111
Query: 69 LHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADI 127
LH+ I++RD+K N+ L +D I++ DFG+ K + D+ AS+ GTP Y+ PE+L +
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 128 PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI 164
Y D WS G +YEM + F D L I
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 40/104 (38%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 56 CKWLV-QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVV 113
C++ + QLL L Y+H+ ++LHRD+K SN+ L + D+++ DFGLA+ D + V
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV 169
Query: 114 GTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFD 156
T Y PELL + Y + D+WS+GC E+ KP F D
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 63/237 (26%), Positives = 117/237 (49%), Gaps = 16/237 (6%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+I+ + GG+M + + ++ FSE+++ + ++++AL++LH I++RD+K NI L
Sbjct: 82 LILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139
Query: 88 KDQDIRLGDFGLAKILTSD--DLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCIYE 144
+ + L DFGL+K S+ + S GT YM PE++ +G D WSLG I+E
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199
Query: 145 MTSLKPAFKAFDMQALINKINKSIV---APLPTKYSGAFRGLVKSMLRKNPELR----PS 197
+ + F + +++++ I+ P P+ + L+ +LRK+P+ R P
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259
Query: 198 AAELLR-HVHLQ--PYVLKVHLKLNSPRRNSL-SHWPESNYARRTRFSEPDNVPISS 250
A ++ H + + K+N P R S+ + N+A EP P +
Sbjct: 260 GASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGT 316
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 32/122 (26%), Positives = 55/122 (45%), Gaps = 8/122 (6%)
Query: 32 FCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
G + + ++K F LC + VQ+ + YL + +HRD+ NI L D
Sbjct: 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK 135
Query: 92 IRLGDFGLAKILTSDDLASSVVGTP------SYMCPELLADIPYGSKSDIWSLGCCIYEM 145
+++GDFGL + L ++ V ++ PE L + SD+W G ++EM
Sbjct: 136 VKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
Query: 146 TS 147
+
Sbjct: 194 FT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 67/246 (27%), Positives = 102/246 (41%), Gaps = 52/246 (21%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+ + +P ++ KD+ V G C+++ D+ + K + L ++ L Q+
Sbjct: 110 LLQNVNHPSVIRMKDTLV-SGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALII-EKQI 166
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
L L YLHA I+HRDVK NIF+ + +GD G A+ + GT PE
Sbjct: 167 LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE 226
Query: 123 LLADIPYGSKSDIWSLGCCIYEM------------TSLKPAFKAFDMQALINKINKSIVA 170
+LA Y SK+DIWS G ++EM ++ + K+ L+ I+ V
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH-LLKIISTLKVH 285
Query: 171 P--LP----------------------TKY----------SGAFRGLVKSMLRKNPELRP 196
P P T+Y G F LV ML + +RP
Sbjct: 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEF--LVHKMLTFDAAMRP 343
Query: 197 SAAELL 202
SA E+L
Sbjct: 344 SAEEIL 349
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 53/193 (27%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+I+ + GG++ + + + F E+++ + ++++AL++LH I++RD+K NI L
Sbjct: 82 LILDYINGGELFTHL--SQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 88 KDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCIY 143
+ + L DFGL+K D++ A S GT YM P+++ D + D WS+G +Y
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 144 EMTSLKPAFKAFDMQALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELR----P 196
E+ + F + +I++ I+ P P + S + +++ +L K+P+ R P
Sbjct: 200 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGP 259
Query: 197 SAA-ELLRHVHLQ 208
S A E+ +H Q
Sbjct: 260 SDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV 112
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + +
Sbjct: 118 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 113 VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL 172
V T Y PE++ + Y DIWS+GC + EM F D NKI + + P
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 173 P-----------------TKYSG-AF------------------------RGLVKSMLRK 190
KY+G +F R L+ ML
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 191 NPELRPSAAELLRHVHLQPYV 211
+PE R S + L+H PY+
Sbjct: 298 DPEKRISVDDALQH----PYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 15/178 (8%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
+I F GGD+ +++ + EE + ++ +AL++LH I++RD+K N+ L
Sbjct: 74 VIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 89 DQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ I+L D+G+ K + D S+ GTP+Y+ PE+L YG D W+LG ++EM +
Sbjct: 132 EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 148 LKPAFKAFDMQALINK----------INKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
+ F M ++ + K I +P S ++K L K+P+ R
Sbjct: 192 GRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 65/259 (25%), Positives = 120/259 (46%), Gaps = 53/259 (20%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSK-LFSEEKLCKWL 59
++++++I++ I+ D +VE ++ +++ D+ + + + K +E ++ L
Sbjct: 71 LKIMNEIKHENIMGLVDVYVEGD-FINLVMDIMAS-DLKKVV---DRKIRLTESQVKCIL 125
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK--------ILTSDD---- 107
+Q+L L+ LH + +HRD+ +NIF+ ++ DFGLA+ S D
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 108 ----LASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCIYEMTSLKPAF--------- 152
+ S VV T Y PELL A+ Y D+WS+GC E+ + KP F
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 153 -KAFDMQALINKIN--KSIVAPLPTKYSGAFR---------------GLVKSMLRKNPEL 194
+ F++ N+ N ++ PL T+++ L++S+L+ NP
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303
Query: 195 RPSAAELLRHVHLQPYVLK 213
R SA E L+H + + L
Sbjct: 304 RISAKEALKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 40/212 (18%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRL 94
G D+ + +K + KL SE+++ + Q+L L Y+HA I+HRD+K N+ + +D ++++
Sbjct: 103 GTDLGKLMK--HEKL-SEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKI 159
Query: 95 GDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFK 153
DFGLA+ +D + V T Y PE++ + + Y DIWS+GC + EM + KP FK
Sbjct: 160 LDFGLAR--QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
Query: 154 AFD-------------------MQALINKINKSIVAPLPTKYSGAFRGLVKS-------- 186
D +Q L ++ K+ V LP FR L+ +
Sbjct: 218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNV 277
Query: 187 ---MLRKNPELRPSAAELLRHVHLQPYVLKVH 215
ML + E R +AAE L H PY + H
Sbjct: 278 LEKMLVLDAESRITAAEALAH----PYFEEFH 305
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 44/206 (21%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
Y+ +I+ + GGDM + K ++ F+EE+ ++ + ++A+D +H +HRD+K N+
Sbjct: 75 YLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132
Query: 85 FLTKDQDIRLGDFGLAKILTSD-------------------------------------- 106
L I+L DFGL L
Sbjct: 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNR 192
Query: 107 -DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI- 164
LA S VGTP Y+ PE+ Y + D WSLG +YEM P F + + Q KI
Sbjct: 193 RALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII 252
Query: 165 --NKSIVAPLPTKYSGAFRGLVKSML 188
+++ P S + L+K +
Sbjct: 253 NWKETLQFPDEVPLSPEAKDLIKRLC 278
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 6/178 (3%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
I++ G++ ++ N L + QL AL YL + +HRD+ N+ ++
Sbjct: 83 IVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS 141
Query: 88 KDQDIRLGDFGLAKILTSDDL-ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEM 145
++LGDFGL++ L + +S P +M PE + + S SD+W G C++E+
Sbjct: 142 SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201
Query: 146 TSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
L KP F+ +I +I P+P L+ +P RP EL
Sbjct: 202 LMLGVKP-FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 33/204 (16%)
Query: 38 MAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDF 97
M ++K SE+K+ + Q+L L Y+H+ I+HRD+K N+ + +D ++++ DF
Sbjct: 102 MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDF 161
Query: 98 GLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156
GLA+ +D + V T Y PE++ + + Y DIWS+GC + EM + K FK D
Sbjct: 162 GLAR--HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
Query: 157 -------------------MQALINKINKSIVAPLPT-----------KYSGAFRGLVKS 186
+Q L +K KS + LP K S L++
Sbjct: 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK 279
Query: 187 MLRKNPELRPSAAELLRHVHLQPY 210
ML + + R +A E L H + +
Sbjct: 280 MLELDVDKRLTATEALEHPYFDSF 303
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 78/296 (26%), Positives = 125/296 (42%), Gaps = 56/296 (18%)
Query: 1 MELISKIRNPFIVEYKDSWVE------RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEK 54
++L+ +R+P IVE K + + YV + D+ + IK AN L + E
Sbjct: 50 IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL---MESDLHQVIK-ANDDL-TPEH 104
Query: 55 LCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LAS 110
+L QLL AL Y+H ++ HRD+K NI D +++ DFGLA++ +D +
Sbjct: 105 HQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164
Query: 111 SVVGTPSYMCPELLADI--PYGSKSDIWSLGCCIYEMTSLKPAFKAFDM----------- 157
V T Y PEL Y DIWS+GC E+ + KP F ++
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224
Query: 158 ----------------QALINKINKSIVAPLPTKYSG----AFRGLVKSMLRKNPELRPS 197
+ ++ + K P K+ A R L++ +L +P+ RP+
Sbjct: 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALR-LLERLLAFDPKDRPT 283
Query: 198 AAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPISSYRE 253
A E L PY + P ++ E + RR R ++ ++V YRE
Sbjct: 284 AEEALAD----PYFKGLAKVEREPSAQPITKL-EFEFERR-RLTK-EDVRELIYRE 332
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRL 94
G D+ +K + S+E + + QLL L Y+H+ I+HRD+K SN+ + +D ++R+
Sbjct: 103 GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159
Query: 95 GDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFK 153
DFGLA+ +DD + V T Y PE++ + + Y DIWS+GC + E+ K F
Sbjct: 160 LDFGLAR--QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217
Query: 154 AFDMQALINKINKSIVAPLPT-----------KY------------SGAFRG-------L 183
D + +I + + P P KY FRG L
Sbjct: 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDL 277
Query: 184 VKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPES 232
++ ML + + R SA+E L H PY + H + P PE+
Sbjct: 278 LEKMLVLDSDKRISASEALAH----PYFSQYHDPEDEPEAEPYDESPEN 322
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 8e-16
Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 21/181 (11%)
Query: 29 IIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK 88
+I + GGD+ +++ + EE + ++ +AL+YLH I++RD+K N+ L
Sbjct: 74 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 89 DQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ I+L D+G+ K L D S+ GTP+Y+ PE+L YG D W+LG ++EM +
Sbjct: 132 EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 148 LKPAF-------------KAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPEL 194
+ F + + Q ++ K + +P S ++KS L K+P+
Sbjct: 192 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----IPRSLSVKAASVLKSFLNKDPKE 246
Query: 195 R 195
R
Sbjct: 247 R 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 39/202 (19%)
Query: 46 NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLGDFGLAKILT 104
SEE ++ QLL L Y+H+ ++LHRD+K +N+F+ T+D +++GDFGLA+I+
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 105 SD-----DLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158
L+ +V T Y P LL+ Y D+W+ GC EM + KP F
Sbjct: 167 PHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
Query: 159 ALINKINKSI-------------VAP-----------------LPTKYSGAFRGLVKSML 188
+ I +S+ V P LP A ++ +L
Sbjct: 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL-DFLEQIL 284
Query: 189 RKNPELRPSAAELLRHVHLQPY 210
NP R +A E L H ++ Y
Sbjct: 285 TFNPMDRLTAEEALMHPYMSCY 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-16
Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 5/152 (3%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA 109
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + +
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 110 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV 169
+ V T Y PE++ + Y DIWS+GC + EM K F D NK+ + +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 170 APLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
P P F ++ +R E RP A L
Sbjct: 236 TPCPE-----FMKKLQPTVRNYVENRPKYAGL 262
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 52/200 (26%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 1 MELISKIRNPFIV--EYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
+ L+S PFIV Y ++ + I+ GGD+ + + +FSE ++ +
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDK---LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFY 102
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY 118
++++ L+++H +++RD+K +NI L + +R+ D GLA + +S VGT Y
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGY 161
Query: 119 MCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA--LINKINKSIVAPLPTK 175
M PE+L + Y S +D +SLGC ++++ F+ + I+++ ++ LP
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 176 YSGAFRGLVKSMLRKNPELR 195
+S R L++ +L+++ R
Sbjct: 222 FSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 31/179 (17%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV-QLLMALDYLHANHILHRDVKCSNIFL 86
+I+ + + GD+ + +KK KL E K ++ QL+ AL+ LH ++I+H D+K N+
Sbjct: 86 LIMDYIKDGDLFDLLKK-EGKL--SEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142
Query: 87 T--KDQDIRLGDFGLAKILTSDDLASSVVGTPS-------YMCPELLADIPYGSKSDIWS 137
KD+ I L D+GL KI +GTPS Y PE + Y D W+
Sbjct: 143 DRAKDR-IYLCDYGLCKI----------IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWA 191
Query: 138 LGCCIYEMTSLKPAFKA-----FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKN 191
+G YE+ + K FK D+++L+ + K + P S V+SML+ N
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL--PFIKNVSKNANDFVQSMLKYN 248
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 45/173 (26%), Positives = 94/173 (54%), Gaps = 6/173 (3%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+C I+ GGD+ + + +FSE+++ + ++++ L+++H +++RD+K +NI
Sbjct: 72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL 129
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYE 144
L + +R+ D GLA + +S VGT YM PE+L Y S +D +SLGC +++
Sbjct: 130 LDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFK 188
Query: 145 MTSLKPAFKAFDMQAL--INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
+ F+ + I+++ ++ LP +S + L++ +L+++ R
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV---- 112
+L QLL + Y H++ +LHRD+K N+ + ++ ++L DFGLA+ A V
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-------AFGVPVRT 155
Query: 113 ----VGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152
V T Y PE LL Y + DIWS+GC EM + +P F
Sbjct: 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 45/200 (22%)
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV 112
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ ++ + +
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY 182
Query: 113 VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP- 171
V T Y PE++ + Y DIWS+GC + E+ F+ D NK+ + + P
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 172 -------LPT---------KYSG-AF-----------------------RGLVKSMLRKN 191
PT +Y G +F R L+ ML +
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302
Query: 192 PELRPSAAELLRHVHLQPYV 211
P+ R S E LRH PY+
Sbjct: 303 PDKRISVDEALRH----PYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 38/88 (43%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA--KILTSDDLASSVVGTPSYM 119
+L A+ YLH N I+HRD+K NIF+ D+ LGDFG A + + + GT +
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTS 147
PELLA PYG DIWS G ++EM +
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 5/147 (3%)
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV 112
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + +
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 185
Query: 113 VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL 172
V T Y PE++ + Y DIWS+GC + EM F D NK+ + + P
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAA 199
P F ++ +R E RP A
Sbjct: 246 P-----EFMKKLQPTVRTYVENRPKYA 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 54/153 (35%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA--KILTSDDLASSVVGT 115
++ QLL L Y+H HILHRD+K N+ ++ +++L DFGLA K + S +S VV T
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-T 166
Query: 116 PSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-DMQALINKINKSIVAPLP 173
Y P+ LL Y S DIW GC EM +PAF D+ + KI + P
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226
Query: 174 TKYSGAFRGLVKSMLRKNPEL-RPSAAELLRHV 205
+ G V + PE P + LR V
Sbjct: 227 DTWPG-----VSKLPNYKPEWFLPCKPQQLRVV 254
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 40/194 (20%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT-----SDDLASSV 112
++ Q+L L Y+H+ ++LHRD+K N+ + D ++++ DFGLA+ + + +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 113 VGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP 171
V T Y PE +L+ Y D+WS+GC + E+ KP FK D +N+I + + P
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229
Query: 172 -------------------LPT----KYSGAFRG-------LVKSMLRKNPELRPSAAEL 201
LP + F L++ +L +P R S E
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289
Query: 202 LRHVHLQPYVLKVH 215
L H PY+ H
Sbjct: 290 LEH----PYLAIWH 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 54/208 (25%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ K+ +P +V+ ER +C++ F E G +++ ++ A FS+E L +
Sbjct: 51 QVMMKLSHPKLVQLYGVCTERSP-ICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLD 108
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP---SY 118
+ + YL +++++HRD+ N + ++Q +++ DFG+ + + D SS GT +
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKW 167
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE+ + Y SKSD+WS G ++E+ S K ++ ++ IN P S
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLAS 227
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRHV 205
+ L++ ++ PE RPS + LL +
Sbjct: 228 QSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 39/156 (25%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 1 MELISKIRNPFIVEYK---DSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
+E++ + + IV+YK + R + +I+ + G + + +++ ++ + ++L
Sbjct: 57 IEILRTLDHENIVKYKGVCEKPGGRS--LRLIMEYLPSGSLRDYLQRHRDQI-NLKRLLL 113
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
+ Q+ +DYL + +HRD+ NI + + +++ DFGLAK+L D V P
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK-DYYYVKEPG 172
Query: 118 -----YMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+ PE L + S SD+WS G +YE+ +
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 2 ELISKIRNPFIVEYKD-------SWV-------ERGCYVCIIIGFCEGGDMAEAIKKANS 47
E+I + + F E +D WV + Y+ +++ + GGD+ + S
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----S 135
Query: 48 KLFSEEKLCK-WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD 106
EK + + ++++ALD +H+ +HRDVK N+ L K ++L DFG + +
Sbjct: 136 NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195
Query: 107 DLA--SSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160
+ + VGTP Y+ PE+L D YG + D WS+G +YEM F A +
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255
Query: 161 INKI---NKSIVAPLPTKYSGAFRGLVKSML--RKNPELRPSAAELLRH 204
+KI S+ P S + L+ + L R+ R E+ RH
Sbjct: 256 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D +I N KLF L QLL L+Y H +LHRD+K N+ + + +++L D
Sbjct: 96 DCGNSINMHNVKLF--------LFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLAD 147
Query: 97 FGL--AKILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFK 153
FGL AK + + ++ VV T Y P+ LL Y ++ D+W +GC YEM++ +P F
Sbjct: 148 FGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206
Query: 154 AFDMQALINKINKSIVAPLPTKYSG 178
++ ++ I + + P + G
Sbjct: 207 GSTVEEQLHFIFRILGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 2/178 (1%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
V II E G + ++ ++ L Q+ + YL + +HRD+ NI
Sbjct: 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYE 144
+ +D ++ DFGLA+++ D SS P + PE + + +KSD+WS G +YE
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYE 196
Query: 145 MTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
M + + + + + ++I P P K ++ PE RPS L
Sbjct: 197 MFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 31/178 (17%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL-TSDDLASSVVGTP 116
++ QLL L + H++++LHRD+K N+ + K+ +++L DFGLA+ S+ V T
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL 163
Query: 117 SYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAP--- 171
Y P+ L Y + D+WS GC E+ + +P F D+ + +I + + P
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223
Query: 172 -------LP------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
LP K + R L++++L NP R SA E L+H
Sbjct: 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 6/184 (3%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I+ + G + ++ E L + A++YL +N +HRD+ N
Sbjct: 74 IFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCL 132
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCI 142
+ +D +++ DFGLA+ + D SS GT + PE+ + SKSD+WS G +
Sbjct: 133 VGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLM 191
Query: 143 YEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
+E+ S K ++ F ++ ++ P ++ S + PE RP+ +L
Sbjct: 192 WEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251
Query: 202 LRHV 205
L +
Sbjct: 252 LSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 10/108 (9%)
Query: 57 KW----LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--AS 110
KW ++++ALD +H+ +HRDVK N+ L K ++L DFG + ++ +
Sbjct: 142 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 111 SVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154
+ VGTP Y+ PE+L D YG + D WS+G +YEM F A
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 37/87 (42%), Positives = 47/87 (54%), Gaps = 3/87 (3%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT---SDDLASSVVGTPS 117
QLL A+DY+H I+HRD+K N+ + +DI LGDFG A S + GT
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYE 144
PE+LA PY DIWS G I+E
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 9 NPFIVEYKDSWVERGCYVCIIIGFCEGGD-MAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
N ++V+ S+ ++ + ++ + GGD M+ I+ +F E+ ++ +L A++
Sbjct: 60 NEWVVKLYYSFQDKDN-LYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIE 115
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGL---------AKILTSDD----------- 107
+H +HRD+K NI + +D I+L DFGL +K D
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 108 ------------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143
LA S+VGTP+Y+ PE+L Y D WS+G +Y
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 144 EMTSLKPAFKA 154
EM +P F A
Sbjct: 236 EMLVGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 56/196 (28%), Positives = 82/196 (41%), Gaps = 47/196 (23%)
Query: 2 ELISKIR--NPFIVEYKDSWVERGCY-------VCIIIGFCEGGDMAEAIKKANSKLFSE 52
E ++ IR +VE +WV + Y + +I+ F GGDM + K ++ SE
Sbjct: 43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSE 100
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT-------- 104
E ++ + ++A+D +H +HRD+K N+ L ++L DFGL L
Sbjct: 101 EATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 105 --------SD--------------------DLASSVVGTPSYMCPELLADIPYGSKSDIW 136
SD LA S VGTP Y+ PE+ Y D W
Sbjct: 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 137 SLGCCIYEMTSLKPAF 152
SLG +YEM P F
Sbjct: 221 SLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 33/183 (18%)
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY 118
+ Q+L L Y+H+ I+HRD+K SN+ + +D ++++ DFGLA+ +DD + V T Y
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWY 183
Query: 119 MCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM---------------QALIN 162
PE++ + + Y DIWS+GC + E+ + + F D L+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
Query: 163 KIN----KSIVAPLP----TKYSGAFRG-------LVKSMLRKNPELRPSAAELLRHVHL 207
KI+ ++ + L ++ F G L++ ML + + R +AA+ L H +
Sbjct: 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
Query: 208 QPY 210
Y
Sbjct: 304 AQY 306
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 59/245 (24%), Positives = 92/245 (37%), Gaps = 52/245 (21%)
Query: 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLL 63
I FIV DS + YV + G + +K + E + L +L
Sbjct: 61 ILPYVTSFIV---DSEL----YV--VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVL 111
Query: 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA--------KILTSDDLASSVVGT 115
ALDY+H+ +HR VK S+I L+ D + L + + D S V
Sbjct: 112 NALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 116 PSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQALINKI-------- 164
++ PE+L Y KSDI+S+G E+ + P Q L+ K+
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLL 231
Query: 165 --------------------NKSIVAPLPTKY----SGAFRGLVKSMLRKNPELRPSAAE 200
+ + + Y S F V+ L+++PE RPSA++
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
Query: 201 LLRHV 205
LL H
Sbjct: 292 LLNHS 296
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 56/179 (31%), Positives = 78/179 (43%), Gaps = 34/179 (18%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI--LTSDDLASSVVGT 115
+L QLL L + H++ +LHRD+K N+ + + I+L DFGLA+ + VV T
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-T 163
Query: 116 PSYMCPELLADIPYGSKS-DIWSLGCCIYEMTS---LKPA-------FKAFDMQALINKI 164
Y PE+L Y S + DIWSLGC EM + L P F+ F +++
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223
Query: 165 NKSIVAPLPTKYSGAF-------------------RGLVKSMLRKNPELRPSAAELLRH 204
V LP Y +F R L+ ML +P R SA L H
Sbjct: 224 VWPGVTSLP-DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 63/248 (25%), Positives = 97/248 (39%), Gaps = 61/248 (24%)
Query: 6 KIRNPFIVEYKDSWVERGCY-------VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
K + E + WV R Y + ++ + GGDM + + +F E+ +
Sbjct: 49 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFY 106
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL---------AKILTSDD-- 107
+ +L A++ +H +HRD+K NI + +D I+L DFGL +K S D
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 108 -------------------------------------LASSVVGTPSYMCPELLADIPYG 130
LA S+VGTP+Y+ PE+L Y
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 131 SKSDIWSLGCCIYEMTSLKPAFKA---FDMQALINKINKSIVAPLPTKYSGAFRGLVKSM 187
D WS+G +YEM +P F A + Q + S+ P K S L+ +
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286
Query: 188 LRKNPELR 195
R PE R
Sbjct: 287 CR-GPEDR 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 40/124 (32%), Positives = 67/124 (54%), Gaps = 4/124 (3%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL--AKILTSDDLASSVVGT 115
++ QLL L Y H ILHRD+K N+ + + +++L DFGL AK + + ++ VV T
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-T 166
Query: 116 PSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPT 174
Y P+ LL Y + D+W +GC +YEM + +P F ++ ++ I + + P
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226
Query: 175 KYSG 178
+ G
Sbjct: 227 TWPG 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 52/184 (28%), Positives = 77/184 (41%), Gaps = 45/184 (24%)
Query: 12 IVEYKDSWVERGCY-------VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+VE WV + Y + +I+ F GGDM + K ++ +EE+ ++ + ++
Sbjct: 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVL 112
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK----------------ILTSD-- 106
A+D +H +HRD+K N+ L ++L DFGL L SD
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 107 ------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
LA S VGTP Y+ PE+ Y D WSLG +YEM
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 149 KPAF 152
P F
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK-WLVQLLMALDYLHANHILHRDVKCSN 83
Y+ +++ + GGD+ + S EK K + ++++ALD +H+ ++HRDVK N
Sbjct: 117 YLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 172
Query: 84 IFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELL----ADIPYGSKSDIWS 137
+ L K ++L DFG + + + VGTP Y+ PE+L D YG + D WS
Sbjct: 173 MLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 138 LGCCIYEMTSLKPAFKAFDMQALINKI 164
+G ++EM F A + +KI
Sbjct: 233 VGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 33/190 (17%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL--AKILTSDDLASSVVGT 115
+L Q+L L Y H +LHRD+K N+ + + +++L DFGL AK + + ++ VV T
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-T 167
Query: 116 PSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPT 174
Y P+ LL Y ++ D+W +GC +EM S +P F ++ ++ I + + P
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227
Query: 175 KYSG-----AFRG------------------------LVKSMLRKNPELRPSAAELLRHV 205
+ G F+ L+ L+ + R SA E ++H
Sbjct: 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 206 HLQPYVLKVH 215
+ + ++H
Sbjct: 288 YFRSLGTRIH 297
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 14/154 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
+E++ + + IV+YK E G + +I+ F G + E + + +K+ + ++ K+
Sbjct: 57 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI-NLKQQLKYA 115
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS--------DDLASS 111
VQ+ +DYL + +HRD+ N+ + + +++GDFGL K + + DDL S
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 112 VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145
V + PE L + SD+WS G +YE+
Sbjct: 176 VF----WYAPECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 6/155 (3%)
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK-ILTSDDLASS 111
+K + ++ + YL A +HRD+ N + +D +++GDFG+ + I +D
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 112 VVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKS 167
G P +M PE L D + +KSD+WS G ++EM +L +P ++ + ++ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP-YQGLSNEEVLKFVIDG 237
Query: 168 IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
LP L++ + NP++RP+ E++
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 46/208 (22%), Positives = 99/208 (47%), Gaps = 8/208 (3%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
+++++R+ +V+ VE + I+ + G + + ++ + + L K+ + +
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCP 121
A++YL AN+ +HRD+ N+ +++D ++ DFGL K +S D V + P
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAP 168
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
E L + + +KSD+WS G ++E+ S + + ++ ++ ++ K P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228
Query: 181 RGLVKSMLRKNPELRPSAAEL---LRHV 205
++K + RPS +L L H+
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 20/199 (10%)
Query: 25 YVCIIIGFCEGG------DMAE--AIKK--ANSKLFSEEKLCKWLVQLLMALDYLHANHI 74
Y+ +IG CE ++AE + K +K +E+ + + + Q+ M + YL +
Sbjct: 57 YIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP----SYMCPELLADIPYG 130
+HRD+ N+ L ++ DFGL+K L +D+ + PE + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 131 SKSDIWSLGCCIYEMTS--LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSML 188
SKSD+WS G ++E S KP +K + I P + L+K
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP-YKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235
Query: 189 RKNPELRP--SAAEL-LRH 204
+ RP + EL LR+
Sbjct: 236 TYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 38/145 (26%), Positives = 73/145 (50%), Gaps = 5/145 (3%)
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP---SYMCP 121
+ YL + +HRD+ N + +++ DFGL++ + D+ SS VG+ + P
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPP 170
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
E+L + SKSD+W+ G ++E+ SL K ++ F+ + K+++ + P S
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKV 230
Query: 181 RGLVKSMLRKNPELRPSAAELLRHV 205
++ S + E RP+ +LL +
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 12 IVEYKDSWVERGCY-VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH 70
IV+YK E+G + +I+ + G + + + K L +L + Q+ + YLH
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL---AQLLLFAQQICEGMAYLH 124
Query: 71 ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL--------TSDDLASSVVGTPSYMCPE 122
+ H +HRD+ N+ L D+ +++GDFGLAK + +D S V + E
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVE 180
Query: 123 LLADIPYGSKSDIWSLGCCIYEM-----TSLKPAFKAFDM----QALINKI------NKS 167
L + + SD+WS G +YE+ + P K +M Q + + +
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240
Query: 168 IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
+ P P L+K+ + RP+ L+
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 52/189 (27%)
Query: 25 YVCIIIGFCEGGD-MAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSN 83
Y+ +I+ F GGD M IK FSE+ ++ + ++A++ +H +HRD+K N
Sbjct: 75 YLYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDN 131
Query: 84 IFLTKDQDIRLGDFGLA-------------KILTSDD----------------------- 107
I + + I+L DFGL+ K+L
Sbjct: 132 ILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSK 191
Query: 108 ------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
+A S VGTP Y+ PE+ YG + D WSLG ++E P F +
Sbjct: 192 DQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE 251
Query: 156 DMQALINKI 164
+ KI
Sbjct: 252 NSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 18/143 (12%)
Query: 25 YVCIIIGFC------------EGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN 72
+VC ++G C G + + +++ + S+ L W VQ+ ++YL
Sbjct: 70 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-LLNWCVQIAKGMNYLEER 128
Query: 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG--TP-SYMCPELLADIPY 129
++HRD+ N+ + Q +++ DFGLAK+L +D+ G P +M E + Y
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 130 GSKSDIWSLGCCIYEMTS--LKP 150
+SD+WS G ++E+ + KP
Sbjct: 189 THQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-12
Identities = 50/223 (22%), Positives = 95/223 (42%), Gaps = 18/223 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L +++ +P IV DS + + + G + E + A + + ++
Sbjct: 29 TALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL--AADGALPAGETGRLML 86
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIR---LGDFGLAKIL--------TSDDLA 109
Q+L AL H I+HRD+K NI +++ + DFG+ +L +
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 110 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV 169
+ V+GTP+Y PE L P SD+++ G E + + + + ++ + +
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVD 206
Query: 170 APLPTKYSGAFRG-LVKSMLRKNPELRPSAAELL----RHVHL 207
LP +G G +++ L K+P R ++A L R + L
Sbjct: 207 VSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERFRALEL 249
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 52/189 (27%), Positives = 78/189 (41%), Gaps = 46/189 (24%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA-------KILTSDDLAS 110
+L Q+L + + H+ +LHRD+K N+ + I+L DFGLA ++ T +
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE---- 161
Query: 111 SVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA-------FDMQALIN 162
V T Y PE LL Y + DIWS+G EM + KP F F + ++
Sbjct: 162 --VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG 219
Query: 163 KINKSI---VAPLPT------KYSGAFRG------------LVKSMLRKNPELRPSAAEL 201
+ + V LP K+ L++ ML +P R SA +
Sbjct: 220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279
Query: 202 LRHVHLQPY 210
L H PY
Sbjct: 280 LNH----PY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 43/179 (24%), Positives = 87/179 (48%), Gaps = 7/179 (3%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
II F G++ + +++ N + + L Q+ A++YL + +HRD+ N +
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138
Query: 88 KDQDIRLGDFGLAKILTSDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCIYE 144
++ +++ DFGL++++T D ++ G + PE LA + KSD+W+ G ++E
Sbjct: 139 ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 197
Query: 145 MTS--LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
+ + + P + D+ + + K P L+++ + NP RPS AE+
Sbjct: 198 IATYGMSP-YPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 38/89 (42%), Positives = 50/89 (56%), Gaps = 2/89 (2%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV--VGTPSY 118
QLL A++Y+H ++HRD+K NIFL D I LGDFG A + A VGT +
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTS 147
PE+LA Y +DIWS G + +M S
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+S +P IV+ + II+ EGGD+ ++ A + F L L +L
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKEL 108
Query: 63 L-MALD------YLHANHILHRDVKCSNIFLT-----KDQDIRLGDFGLAKILTSDDLAS 110
L + LD YL H +HRD+ N ++ D+ +++GDFGLA+ + D
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-Y 167
Query: 111 SVVGTP----SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKIN 165
G +M PE L D + ++SD+WS G ++E+ +L + + A + Q ++ +
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
Query: 166 KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS 197
P L+ + ++P RP+
Sbjct: 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 39/138 (28%), Positives = 67/138 (48%), Gaps = 16/138 (11%)
Query: 25 YVCIIIGFCEG------------GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN 72
Y+ ++G C G G + + +++ L ++L W VQ+ + YL +
Sbjct: 70 YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSL-DPQRLLNWCVQIAKGMYYLEEH 128
Query: 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTP-SYMCPELLADIPY 129
++HR++ NI L D +++ DFG+A +L DD S TP +M E + Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 130 GSKSDIWSLGCCIYEMTS 147
+SD+WS G ++EM S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTP 116
+Q+ ++YL ++H +HRD+ N + + +++ DFGL++ + S D + S +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTS--LKPAFKAFDMQALINKINKSIVAPLPT 174
+M PE + + ++SDIWS G ++E+ S L+P + F Q +I I + P P
Sbjct: 191 RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIEMIRSRQLLPCPE 249
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207
L+ + P RP ++ H L
Sbjct: 250 DCPARVYALMIECWNEIPARRPRFKDI--HTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 5/125 (4%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
V +I G + + ++ + S+ L W VQ+ + YL ++HRD+ N+
Sbjct: 83 VQLITQLMPLGCLLDYVRNHKDNIGSQY-LLNWCVQIAKGMSYLEEKRLVHRDLAARNVL 141
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVG--TP-SYMCPELLADIPYGSKSDIWSLGCCI 142
+ Q +++ DFGLAK+L D+ G P +M E + Y KSD+WS G +
Sbjct: 142 VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201
Query: 143 YE-MT 146
+E MT
Sbjct: 202 WELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 41/111 (36%), Positives = 61/111 (54%), Gaps = 5/111 (4%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL--AKILTSDDLASSVVGT 115
+L QLL L Y+H +ILHRD+K N+ ++ +++L DFGL AK + S ++ VV T
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-T 166
Query: 116 PSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-DMQALINKI 164
Y P+ LL Y + D+W +GC EM AF D+Q + +I
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 34/129 (26%), Positives = 68/129 (52%), Gaps = 9/129 (6%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ +I +C GD+ +++ + E L + Q+ + +L + + +HRD+ N+
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL 173
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPS------YMCPELLADIPYGSKSDIWSLG 139
LT + +++ DFGLA+ + +D S+ V + +M PE + + Y +SD+WS G
Sbjct: 174 LTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 230
Query: 140 CCIYEMTSL 148
++E+ SL
Sbjct: 231 ILLWEIFSL 239
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 43/199 (21%), Positives = 93/199 (46%), Gaps = 5/199 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ K+R+ +V+ E Y I+ + G + + +K K +L Q
Sbjct: 53 QVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTP-SYM 119
+ + Y+ + +HRD++ +NI + ++ ++ DFGLA+++ ++ A P +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSG 178
PE + KSD+WS G + E+T+ + + + +++++ + P P +
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 230
Query: 179 AFRGLVKSMLRKNPELRPS 197
+ L+ RK PE RP+
Sbjct: 231 SLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD-IRLGDFGLAKI--LTSDDLASSVVG 114
+L Q+L + Y H++ +LHRD+K N+ + + + ++L DFGLA+ + VV
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV- 165
Query: 115 TPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152
T Y PE LL Y + DIWS+GC EM + KP F
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 35/145 (24%), Positives = 71/145 (48%), Gaps = 4/145 (2%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTP-S 117
Q+ + YL ++HRD+ N+ + + + +++ DFGL++ + +D + S P
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIVAPLPTKY 176
+M E L D Y ++SD+WS G ++E+ +L + + L N + P
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENC 254
Query: 177 SGAFRGLVKSMLRKNPELRPSAAEL 201
S L+ + ++ P+ RP+ A++
Sbjct: 255 SEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 42/198 (21%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 20 VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSE--------EKLCKWLVQLLMALDYLHA 71
V +G +I+ GD+ ++ ++ + +K+ + ++ + YL+A
Sbjct: 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAK-ILTSDDLASSVVG--TPSYMCPELLADIP 128
N +HRD+ N + +D +++GDFG+ + I +D G +M PE L D
Sbjct: 138 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 197
Query: 129 YGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSM 187
+ + SD+WS G ++E+ +L + ++ + ++ + + + P L++
Sbjct: 198 FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMC 257
Query: 188 LRKNPELRPSAAELLRHV 205
+ NP++RPS E++ +
Sbjct: 258 WQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 20 VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79
V + V II F E G + ++ + N F+ +L L + + YL + +HRD+
Sbjct: 74 VTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDL 132
Query: 80 KCSNIFLTKDQDIRLGDFGLAKIL---TSDDLASSVVGTP---SYMCPELLADIPYGSKS 133
NI + + ++ DFGL++ L TSD +S +G + PE +A + S S
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSAS 192
Query: 134 DIWSLGCCIYEMTSL--KPAFKAFDM--QALINKINKSIVAPLPTKYSGAFRGLVKSMLR 189
D+WS G ++E+ S +P +DM Q +IN I + P P A L+ +
Sbjct: 193 DVWSYGIVMWEVMSYGERP---YWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQ 249
Query: 190 KNPELRPSAAELL 202
K+ RP +++
Sbjct: 250 KDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 30/171 (17%)
Query: 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA--KILTSDDLASS------------ 111
++Y+H+ +LHRD+K NI L ++ + D+G A K L +DL
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 112 -----VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINK--- 163
+VGTP YM PE L +P +DI++LG +Y+M +L ++ + + +
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI 245
Query: 164 INKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
++ VAP +P S + L +P R S+ + L+ L+P++
Sbjct: 246 LSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQELK-QDLEPHL 291
|
Length = 932 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
QL AL Y+H+ I HRD+K N+ + ++L DFG AK L + + S + + Y
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 120 CPEL-LADIPYGSKSDIWSLGCCIYEMTSLKPAF 152
PEL L Y + D+WSLGC I EM P F
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY------VCIIIGFCEGGDMAEAIKKANSKLFSEEK 54
+E++ +++ IV+YK CY + +++ + G + + ++K +L K
Sbjct: 56 IEILKSLQHDNIVKYKGV-----CYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-K 109
Query: 55 LCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG 114
L + Q+ ++YL + +HRD+ NI + + +++GDFGL K+L D V
Sbjct: 110 LLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVR 168
Query: 115 TPS-----YMCPELLADIPYGSKSDIWSLGCCIYEM-----TSLKPAFKAFDMQA----- 159
P + PE L + + SD+WS G +YE+ S P + M
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228
Query: 160 ------LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
LI + + P P ++K +P RPS +EL V
Sbjct: 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 4/181 (2%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
I+ F E G + +++ K S++ L + ++YL N +HRD+ N ++
Sbjct: 76 IVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS 134
Query: 88 KDQDIRLGDFGLAKILTSDDLASSVVGT-PSYMC-PELLADIPYGSKSDIWSLGCCIYEM 145
+++ DFG+ + + D+ SS P PE+ Y SKSD+WS G ++E+
Sbjct: 135 STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
Query: 146 -TSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
T K F+ ++ I++ P S ++ S + PE RP+ AELLR
Sbjct: 195 FTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRA 254
Query: 205 V 205
+
Sbjct: 255 I 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 41/175 (23%), Positives = 83/175 (47%), Gaps = 3/175 (1%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
I++ G++ ++ L S +L ++ + + ++YL + ++HRD+ NI ++
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134
Query: 88 KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+D ++ DFGLA++ S + +S + + PE L + SKSD+WS G ++E+ S
Sbjct: 135 EDGVAKVSDFGLARV-GSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
Query: 148 L-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
+ + ++ + + K P L+ S P+ RPS +L
Sbjct: 193 YGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 25 YVCIIIGFC------------EGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN 72
YVC ++G C G + + +++ ++ S++ L W VQ+ + YL
Sbjct: 70 YVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQD-LLNWCVQIAKGMSYLEEV 128
Query: 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP---SYMCPELLADIPY 129
++HRD+ N+ + +++ DFGLA++L D+ G +M E + +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 130 GSKSDIWSLGCCIYEMTSL--KP--AFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVK 185
+SD+WS G ++E+ + KP A ++ L+ K + P+ T + +VK
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI--DVYMIMVK 246
Query: 186 SMLRKNPELRPSAAELL 202
+ + E RP EL+
Sbjct: 247 CWM-IDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 36/159 (22%), Positives = 73/159 (45%), Gaps = 4/159 (2%)
Query: 48 KLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD 107
+ S + L Q+ ++YL + +HRD+ N+ +T+D +++ DFGLA+ + D
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 194
Query: 108 LASSVVG---TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINK 163
+M PE L D Y +SD+WS G ++E+ +L + + ++ L
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
Query: 164 INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
+ + P+ + +++ P RP+ +L+
Sbjct: 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 29/161 (18%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN----SKLFSEEK--- 54
E++ ++ NP+IV +IG CE + ++ A+ +K S +K
Sbjct: 47 EIMHQLDNPYIVR--------------MIGVCEAEALMLVMEMASGGPLNKFLSGKKDEI 92
Query: 55 ----LCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--- 107
+ + + Q+ M + YL + +HRD+ N+ L ++ DFGL+K L +DD
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152
Query: 108 LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
A S P + PE + + S+SD+WS G ++E S
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 7/111 (6%)
Query: 48 KLFSEEKLCKWLV----QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103
KL E+ K LV Q+ ++YL + +HRD+ N+ +T+D +++ DFGLA+ +
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 104 TSDDLASSVVG---TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151
+ D +M PE L D Y +SD+WS G ++E+ +L +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 37/156 (23%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTP 116
+Q+ ++YL ++ +H+D+ NI + + +++ D GL++ + S D + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTS--LKPAFKAFDMQALINKINKSIVAPLPT 174
+M PE + + S SDIWS G ++E+ S L+P + F Q +I + K + P
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEVIEMVRKRQLLPCSE 249
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
L+ ++ P RP ++ H L+ +
Sbjct: 250 DCPPRMYSLMTECWQEGPSRRPRFKDI--HTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 24/229 (10%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDM---------AEAIKKANSKLFS 51
++++S++++P I+ + +C+I + E GD+ EA +KA+ S
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 52 EEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---L 108
L Q+ + YL + + +HRD+ N + K+ I++ DFG+++ L S D +
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 109 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL---KPAFKAFDMQALINK-- 163
V +M E + + + SD+W+ G ++E+ +L +P + D Q + N
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248
Query: 164 ----INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
+ + P P + L+ S R+N + RPS E+ H L
Sbjct: 249 FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI--HATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 38/104 (36%), Positives = 58/104 (55%), Gaps = 11/104 (10%)
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQD----IRLGDFGLAKILTSD-----DLA 109
L Q+L + YLHAN +LHRD+K +NI + + +++ D G A++ S DL
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL- 172
Query: 110 SSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCIYEMTSLKPAF 152
VV T Y PELL + +K+ DIW++GC E+ + +P F
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 37/115 (32%), Positives = 66/115 (57%), Gaps = 4/115 (3%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
++PFIV S ++ V +++ + GGD+ + F EE K++ ++ +ALD
Sbjct: 62 KSPFIVHLYYS-LQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALD 118
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCP 121
YLH + I+HRD+K N+ ++ + I+L DFGL+K+ + +L ++ TPS P
Sbjct: 119 YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 38/186 (20%)
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD-IRLGDFGLAKILT--SDDLASSVV 113
++ QLL + + H + ++HRD+K N+ + K + +++ D GL + + +V
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 114 GTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA-FDMQALINKINKSIVAP 171
T Y PE LL Y + DIWS+GC EM+ +P F ++Q L+ I K + P
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTP 231
Query: 172 LPTKYSG--AFRG-------------------------LVKSMLRKNPELRPSAAELLRH 204
+ G R L++ MLR +P R SA L H
Sbjct: 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291
Query: 205 VHLQPY 210
PY
Sbjct: 292 ----PY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 7/175 (4%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
I++ +GGD ++ +L +E L + + ++YL + H +HRD+ N +T
Sbjct: 70 IVMELVQGGDFLTFLRTEGPRLKVKE-LIQMVENAAAGMEYLESKHCIHRDLAARNCLVT 128
Query: 88 KDQDIRLGDFGLAKILTSDDLASSVVGTPS----YMCPELLADIPYGSKSDIWSLGCCIY 143
+ +++ DFG+++ D + +S G + PE L Y S+SD+WS G ++
Sbjct: 129 EKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLW 187
Query: 144 EMTSLKPA-FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS 197
E SL + Q I + + P P A L++ +P RPS
Sbjct: 188 EAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 38/104 (36%), Positives = 58/104 (55%), Gaps = 11/104 (10%)
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQD----IRLGDFGLAKILTSD-----DLA 109
L Q+L + YLHAN +LHRD+K +NI + + +++ D G A++ S DL
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL- 172
Query: 110 SSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCIYEMTSLKPAF 152
VV T Y PELL + +K+ DIW++GC E+ + +P F
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 3/103 (2%)
Query: 46 NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS 105
+ + L K++V + + ++YL + +HRD+ N L +D + + DFGL+K + S
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 106 DDL--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEM 145
D + P ++ E LAD Y SKSD+W+ G ++E+
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 57/204 (27%)
Query: 6 KIRNPFIVEYKDSWVERGCY-------VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
K + E + WV + Y + ++ + GGDM + + ++F E +
Sbjct: 49 KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFY 106
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA------------------ 100
+ +L +A++ +H +HRD+K NI + D I+L DFGL
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 101 ---------------------KILTSDD---------LASSVVGTPSYMCPELLADIPYG 130
++ T + LA S+VGTP+Y+ PE+L Y
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 131 SKSDIWSLGCCIYEMTSLKPAFKA 154
D WS+G ++EM +P F A
Sbjct: 227 QLCDWWSVGVILFEMLVGQPPFLA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 27/199 (13%)
Query: 24 CYVCIIIGFCEG------------GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA 71
+ +IG C+G G + + +KK + L + Q+ M + YL +
Sbjct: 56 PCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLES 113
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTP-SYMCPELLADI 127
H +HRD+ N+ L ++ DFG+++ L + A++ P + PE I
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC---I 170
Query: 128 PYG---SKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRG 182
YG SKSD+WS G ++E S KP + +I + P P +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP-YGEMKGAEVIAMLESGERLPRPEECPQEIYS 229
Query: 183 LVKSMLRKNPELRPSAAEL 201
++ S + PE RP+ +EL
Sbjct: 230 IMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 60/245 (24%)
Query: 23 GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82
G ++ +I F G +K + SE + L L L+YLH N +HR++K S
Sbjct: 71 GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKAS 130
Query: 83 NIFLTKDQDIRL-GDFGLAKILTSDDLASSVVGTPSY-------MCPELLADIPYG--SK 132
+I ++ D + L G L ++ + A V P + + PELL YG K
Sbjct: 131 HILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVK 190
Query: 133 SDIWSLGCCIYEMTSLKPAFKAFDM---QALINK-------------------------- 163
SDI+S+G E+ + + F+ DM Q L+ K
Sbjct: 191 SDIYSVGITACELATGRVPFQ--DMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQS 248
Query: 164 -----INKSIVA--------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
I +S+VA P +S AF+ LV+ L+++PE RPSA+ LL H
Sbjct: 249 GVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308
Query: 205 VHLQP 209
+
Sbjct: 309 AFFKQ 313
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 7/93 (7%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS--- 117
Q+ +D+L + + +HRDV N+ LT + ++ DFGLA+ + +D ++ VV +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND--SNYVVKGNARLP 277
Query: 118 --YMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+M PE + D Y +SD+WS G ++E+ SL
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 310
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 10/184 (5%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
II + E G + + +K + KL Q+ + ++ + +HRD++ +NI ++
Sbjct: 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136
Query: 88 KDQDIRLGDFGLAKILTSDD-LASSVVGTP-SYMCPELLADIPYGS---KSDIWSLGCCI 142
+ ++ DFGLA+++ ++ A P + PE I YG+ KSD+WS G +
Sbjct: 137 ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA---INYGTFTIKSDVWSFGILL 193
Query: 143 YEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
E+ T + + +I + + P P L++ ++ PE RP+ E
Sbjct: 194 TEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPT-FEY 252
Query: 202 LRHV 205
LR V
Sbjct: 253 LRSV 256
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 43/199 (21%), Positives = 92/199 (46%), Gaps = 5/199 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ K+R+ +V E Y I+ F G + + +K+ + K +L Q
Sbjct: 53 QIMKKLRHDKLVPLYAVVSEEPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTP-SYM 119
+ + Y+ + +HRD++ +NI + + ++ DFGLA+++ ++ A P +
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYSG 178
PE + KSD+WS G + E+ T + + + ++ ++ + P P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230
Query: 179 AFRGLVKSMLRKNPELRPS 197
+ L+K +K+P+ RP+
Sbjct: 231 SLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 3/117 (2%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRL 94
G D I K + S + L Q+ ++YL + +HRD+ N+ +T+D +++
Sbjct: 116 GPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKI 175
Query: 95 GDFGLAKILTSDDL--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
DFGLA+ + D +S P +M PE L D Y +SD+WS G ++E+ +L
Sbjct: 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 38/157 (24%), Positives = 73/157 (46%), Gaps = 4/157 (2%)
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--AS 110
+ L K++ + ++YL + +HRD+ N L ++ ++ + DFGL+K + + D
Sbjct: 112 QMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171
Query: 111 SVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSI 168
+ P ++ E LAD Y +KSD+WS G ++E+ T + + + + + + +
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 169 VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
P L+ S NP+ RPS L +
Sbjct: 232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 27/91 (29%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG---TPS 117
Q+ ++YL + +HRD+ N+ +T++ +++ DFGLA+ + + D
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+M PE L D Y +SD+WS G ++E+ +L
Sbjct: 205 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 11 FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH 70
FI++ D + +I+ +C G + E + K EK + +L MA+D
Sbjct: 86 FIIDIVDDL----PRLSLILEYCTRGYLREVLDK--------EKDLSFKTKLDMAIDCCK 133
Query: 71 ANHILHRDVK------CSNIFL-TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPEL 123
+ L++ S FL T++ +++ GL KIL+S V Y ++
Sbjct: 134 GLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKM 191
Query: 124 LADI--PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA-PLPTKYSGAF 180
L DI Y K DI+SLG ++E+ + K F+ + + + I + LP
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI 251
Query: 181 RGLVKSMLRKNPELRPSAAELLRHVHL 207
+ +V++ + RP+ E+L ++ L
Sbjct: 252 KCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 44/185 (23%), Positives = 82/185 (44%), Gaps = 8/185 (4%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I++ GGD ++K +L ++L K+ + + YL + + +HRD+ N
Sbjct: 67 IYIVMELVPGGDFLSFLRKKKDEL-KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCL 125
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPS----YMCPELLADIPYGSKSDIWSLGCC 141
+ ++ +++ DFG+++ DD S G + PE L Y S+SD+WS G
Sbjct: 126 VGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGIL 183
Query: 142 IYEMTSLKPA-FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE 200
++E SL + Q ++ K P K +++ PE RP +E
Sbjct: 184 LWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSE 243
Query: 201 LLRHV 205
L + +
Sbjct: 244 LQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 29/231 (12%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK----KANSKLFSEEKLCKW 58
L+++ +P IV+ G +C++ + GD+ E ++ +A L +
Sbjct: 61 LMAEFDHPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 59 ----------LVQLLMALD------YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102
QL +A YL +HRD+ N + ++ +++ DFGL++
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 103 LTSDDL--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTS--LKPAFKAFDM 157
+ S D AS P +M PE + Y ++SD+W+ G ++E+ S ++P +
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY-GMAH 238
Query: 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
+ +I + V P L++ K P RPS A + + LQ
Sbjct: 239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI--NRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 41/199 (20%), Positives = 89/199 (44%), Gaps = 5/199 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+++ K+R+ +V+ E Y I+ + G + + +K + L Q
Sbjct: 53 QIMKKLRHDKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTP-SYM 119
+ + Y+ + +HRD++ +NI + ++ DFGLA+++ ++ A P +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYSG 178
PE + KSD+WS G + E+ T + + + + ++ ++ + P P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI 230
Query: 179 AFRGLVKSMLRKNPELRPS 197
+ L+ +K+PE RP+
Sbjct: 231 SLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 66/261 (25%), Positives = 103/261 (39%), Gaps = 65/261 (24%)
Query: 4 ISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
+SK+ N P IV Y+ +++ + ++ F G + I SE + L +
Sbjct: 52 VSKLFNHPNIVPYRATFIADN-ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGV 110
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS----------DDLASSV 112
L ALDY+H +HR VK S+I ++ D + L GL L+ D
Sbjct: 111 LKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYS 168
Query: 113 VGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM---QALINKINKS 167
V ++ PE+L Y +KSDI+S+G E+ + FK DM Q L+ K+N +
Sbjct: 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK--DMPATQMLLEKLNGT 226
Query: 168 IVAPLPT--------------------------------------------KYSGAFRGL 183
+ L T +S F
Sbjct: 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286
Query: 184 VKSMLRKNPELRPSAAELLRH 204
V+ L++NP+ RPSA+ LL H
Sbjct: 287 VEQCLQRNPDARPSASTLLNH 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 27/97 (27%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 55 LCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG 114
L W VQ+ + YL ++HRD+ N+ + +++ DFGLA++L D+ + G
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 115 TP---SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+M E + + +SD+WS G I+E+ +
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 39/167 (23%), Positives = 76/167 (45%), Gaps = 23/167 (13%)
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV 112
E L + Q+ +++L + +HRD+ NI L+++ +++ DFGLA+ + D
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD------ 226
Query: 113 VGTPSY------------MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA-FKAFDM-Q 158
P Y M PE + D Y ++SD+WS G ++E+ SL + + + +
Sbjct: 227 ---PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
Query: 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
++ + P + ++ NPE RP+ +EL+ +
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 36/139 (25%), Positives = 68/139 (48%), Gaps = 4/139 (2%)
Query: 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK-ILTSDDLASSVVG--TPSYMCPELL 124
YL+A +HRD+ N + D +++GDFG+ + I +D G +M PE L
Sbjct: 134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
Query: 125 ADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGL 183
D + + SD+WS G ++E+TSL + ++ + ++ + P L
Sbjct: 194 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDL 253
Query: 184 VKSMLRKNPELRPSAAELL 202
++ + NP++RP+ E++
Sbjct: 254 MRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 54/230 (23%), Positives = 93/230 (40%), Gaps = 37/230 (16%)
Query: 1 ME--LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
ME ++SK + IV ER I++ GGD+ +++ + L
Sbjct: 58 MEALIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLT-- 114
Query: 59 LVQLLM-ALD------YLHANHILHRDVKCSNIFLT---KDQDIRLGDFGLAK-ILTSD- 106
+ LL A D YL NH +HRD+ N LT + ++ DFG+A+ I +
Sbjct: 115 MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 107 ----DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-------KPAFKAF 155
A + +M PE D + SK+D+WS G ++E+ SL + +
Sbjct: 175 YRKGGRAMLPI---KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
+ +++ P G ++ + PE RP+ A +L +
Sbjct: 232 EFVTGGGRLDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
II F G + + +K KL + Q+ + ++ + +HRD++ +NI ++
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136
Query: 88 KDQDIRLGDFGLAKILTSDD-LASSVVGTP-SYMCPELLADIPYGS---KSDIWSLGCCI 142
++ DFGLA+++ ++ A P + PE I +GS KSD+WS G +
Sbjct: 137 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA---INFGSFTIKSDVWSFGILL 193
Query: 143 YEMTS 147
E+ +
Sbjct: 194 MEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 38/161 (23%), Positives = 78/161 (48%), Gaps = 6/161 (3%)
Query: 47 SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD 106
S L E+ +C + Q+ +++L + +HRD+ NI L+++ +++ DFGLA+ + D
Sbjct: 169 SPLTMEDLIC-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 107 D--LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALI 161
+ P +M PE + D Y ++SD+WS G ++E+ SL P +
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287
Query: 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
++ P + ++ + + +P+ RP+ + L+
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 26/101 (25%), Positives = 53/101 (52%), Gaps = 3/101 (2%)
Query: 51 SEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-- 108
+ L ++++ + ++YL + + +HRD+ N L ++ + + DFGL+K + S D
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170
Query: 109 ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
P ++ E LAD Y + SD+W+ G ++E+ +
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 8/189 (4%)
Query: 20 VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79
V + V I+ + E G + ++K + + F+ +L L + + YL +HRD+
Sbjct: 74 VTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMGYVHRDL 132
Query: 80 KCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTP---SYMCPELLADIPYGSKSDI 135
NI + + ++ DFGL+++L D + A + G + PE +A + S SD+
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDV 192
Query: 136 WSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPE 193
WS G ++E+ S +P ++ + Q +I I + P P A L+ +K+
Sbjct: 193 WSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRN 251
Query: 194 LRPSAAELL 202
RP +++
Sbjct: 252 ERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 38/176 (21%), Positives = 80/176 (45%), Gaps = 9/176 (5%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
II + G + + +K KL + Q+ + Y+ + +HRD++ +N+ ++
Sbjct: 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137
Query: 88 KDQDIRLGDFGLAKILTSDDL-ASSVVGTP-SYMCPELLADIPYGS---KSDIWSLGCCI 142
+ ++ DFGLA+++ ++ A P + PE I +GS KSD+WS G +
Sbjct: 138 ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA---INFGSFTIKSDVWSFGILL 194
Query: 143 YEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS 197
YE+ + K + +++ + + P ++K+ ++ E RP+
Sbjct: 195 YEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 33/117 (28%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ I + + E L + Q+ + +L + + +HRD+ NI LT + ++ D
Sbjct: 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICD 257
Query: 97 FGLAKILTSDDLASSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
FGLA+ + +D ++ VV + +M PE + + Y +SD+WS G ++E+ SL
Sbjct: 258 FGLARDIRND--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 312
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 7/170 (4%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D A AI + + S ++L + + +DYL +HRD+ NI + ++ ++ D
Sbjct: 108 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 167
Query: 97 FGLAK---ILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAF 152
FGL++ + + V +M E L Y + SD+WS G ++E+ SL +
Sbjct: 168 FGLSRGQEVYVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
Query: 153 KAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
L K+ + P L++ R+ P RPS A++L
Sbjct: 225 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 35/138 (25%), Positives = 67/138 (48%), Gaps = 17/138 (12%)
Query: 28 IIIGFCEGGDMAEAIK---------KANSKLFSEEKL-CKWLV----QLLMALDYLHANH 73
+++ + G++ + ++ + EE L K LV Q+ +++L +
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152
Query: 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG--TP-SYMCPELLADIPYG 130
+HRD+ N+ +T+D +++ DFGLA+ + D P +M PE L D Y
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT 212
Query: 131 SKSDIWSLGCCIYEMTSL 148
+SD+WS G ++E+ +L
Sbjct: 213 HQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 3/104 (2%)
Query: 48 KLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD 107
K+ + E L + Q+ +++L + +HRD+ NI L+++ +++ DFGLA+ + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233
Query: 108 --LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+ P +M PE + D Y +SD+WS G ++E+ SL
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 41/181 (22%), Positives = 82/181 (45%), Gaps = 8/181 (4%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
II + E G + + ++ + + FS +L L + + YL + +HRD+ NI +
Sbjct: 83 IITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN 141
Query: 88 KDQDIRLGDFGLAKILTSDDLASSVVGTPS----YMCPELLADIPYGSKSDIWSLGCCIY 143
+ + ++ DFGL+++L D + + PE +A + S SD+WS G ++
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
E+ S +P + + ++ IN P P A L+ +++ RP ++
Sbjct: 202 EVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260
Query: 202 L 202
+
Sbjct: 261 V 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 5/167 (2%)
Query: 36 GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLG 95
++ + S+ + L + Q+ +++L + + +HRD+ N+ L + + +++
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 96 DFGLAKILTSDDLASSVVGT---PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KP 150
DFGLA+ + D S T +M PE + D Y + SD+WS G ++E+ SL P
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339
Query: 151 AFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS 197
NKI P + ++ PE RPS
Sbjct: 340 YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 11/153 (7%)
Query: 61 QLLMALD------YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG 114
QL ALD YL + +HRD+ N+ +++D ++ DFGLAK + S +
Sbjct: 104 QLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-GQDSGKL- 161
Query: 115 TP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIVAPL 172
P + PE L + + +KSD+WS G ++E+ S + ++ ++ + K
Sbjct: 162 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA 220
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
P ++K +P RP+ +L +
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 35/164 (21%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK------------KANSKL 49
EL++ ++ IV++ E + ++ + E GD+ + ++ +
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-- 107
+ +L + VQ+ + YL + H +HRD+ N + D +++GDFG+++ + + D
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 108 -LASSVVGTPSYMCPELLADIPYG---SKSDIWSLGCCIYEMTS 147
+ + +M PE I Y ++SD+WS G ++E+ +
Sbjct: 179 RVGGHTMLPIRWMPPE---SIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 40/187 (21%), Positives = 88/187 (47%), Gaps = 11/187 (5%)
Query: 27 CIIIGFCEGGDMAE---AIKKANSKLFSEEKLCKWLV----QLLMALDYLHANHILHRDV 79
+I+ + + GD+ + A K + KL K V Q+ + +D+L +HRD+
Sbjct: 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143
Query: 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWS 137
N ++ +++++ L+K + + + + + ++ PE + + + +KSD+WS
Sbjct: 144 AARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWS 203
Query: 138 LGCCIYEM-TSLKPAFKAFDMQALINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELR 195
G ++E+ T + F + ++N++ + P+P L+ NP+ R
Sbjct: 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDR 263
Query: 196 PSAAELL 202
PS +EL+
Sbjct: 264 PSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/192 (22%), Positives = 87/192 (45%), Gaps = 7/192 (3%)
Query: 20 VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79
V + V II + E G + + +++ + K F+ +L L + + YL + +HRD+
Sbjct: 74 VTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132
Query: 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS---YMCPELLADIPYGSKSDIW 136
NI + + ++ DFGL++ L + + G + PE +A + S SD+W
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVW 192
Query: 137 SLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPEL 194
S G ++E+ S +P + Q +I + P P A L+ +K+
Sbjct: 193 SFGIVMWEVMSYGERP-YWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNE 251
Query: 195 RPSAAELLRHVH 206
RP+ ++++ +
Sbjct: 252 RPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 42/208 (20%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD------YLHANHILHRDVKC 81
+++ FC GD+ ++ ++ + V MA + +LH +H D+
Sbjct: 72 LVLEFCPLGDLKNYLRSNRG---MVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLAL 128
Query: 82 SNIFLTKDQDIRLGDFGLA-------KILTSDDLASSVVGTPSYMCPELL---------A 125
N LT D +++GD+GLA +T D A + ++ PEL+
Sbjct: 129 RNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL----RWLAPELVEIRGQDLLPK 184
Query: 126 DIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKI-NKSIVAPLPT---KYSGA 179
D KS+IWSLG ++E+ + +P D Q L + + I P P KYS
Sbjct: 185 DQT--KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDR 242
Query: 180 FRGLVKSMLRKNPELRPSAAELLRHVHL 207
+ V +PE RP+A E VH
Sbjct: 243 WYE-VMQFCWLDPETRPTAEE----VHE 265
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 27/110 (24%), Positives = 54/110 (49%), Gaps = 3/110 (2%)
Query: 42 IKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK 101
+ N + S ++L +Q+ + YLH ++H+D+ N + ++ +++ D L++
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165
Query: 102 ILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
L D L + +M E L + Y S SD+WS G ++E+ +L
Sbjct: 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 35/158 (22%), Positives = 82/158 (51%), Gaps = 15/158 (9%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSE------- 52
EL++ +++ IV++ VE G + ++ + + GD+ + ++ ++ L +E
Sbjct: 59 ELLTNLQHEHIVKFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAEL 117
Query: 53 --EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--- 107
++ Q+ + YL + H +HRD+ N + ++ +++GDFG+++ + S D
Sbjct: 118 TQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 108 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145
+ + +M PE + + ++SD+WSLG ++E+
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 6/143 (4%)
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGT 115
+ Q+ +++L ++H++H+D+ N+ + ++++ D GL + + + D L + +
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTS--LKPAFKAFDMQALINKINKSIVAPLP 173
+M PE + + SDIWS G ++E+ S L+P + + Q +I I V P P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQDVIEMIRNRQVLPCP 248
Query: 174 TKYSGAFRGLVKSMLRKNPELRP 196
L+ + P RP
Sbjct: 249 DDCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 38/161 (23%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDM----------AEAIKKANSKLF 50
++++S+++NP I+ V +C+I + E GD+ + N
Sbjct: 68 IKIMSRLKNPNIIRLLGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 51 SEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--- 107
S L VQ+ + YL + + +HRD+ N + I++ DFG+++ L S D
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 108 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+ V +M E + + + SD+W+ G ++EM +L
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 33/166 (19%), Positives = 73/166 (43%), Gaps = 5/166 (3%)
Query: 36 GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLG 95
G + E ++ + +L Q+ + YL A + +HRD+ N+ + ++ ++
Sbjct: 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVA 145
Query: 96 DFGLAKILTSDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCIYE-MTSLKPA 151
DFGLA+++ D + G + PE + KSD+WS G + E +T +
Sbjct: 146 DFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
Query: 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS 197
+ ++ ++++ P P ++ +++P+ RP+
Sbjct: 205 YPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 22/199 (11%)
Query: 28 IIIGFCEGGDMA---EAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
+++ FC GD+ + +KA L + ++ + L +LH N+ +H D+ N
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131
Query: 85 FLTKDQDIRLGDFGLAKILTSDD--LASSVVGTP-SYMCPELLADI-------PYGSKSD 134
LT D +++GD+GL+ +D + + P ++ PEL+ ++ +S+
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 135 IWSLGCCIYEMTSL--KPAFKAFDMQALINKI-NKSIVAPLPT-KYSGAFRGL-VKSMLR 189
+WSLG I+E+ L +P D Q L + + + P P K + R V
Sbjct: 192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW 251
Query: 190 KNPELRPSAAELLRHVHLQ 208
PE RPSA E VHL
Sbjct: 252 LQPEQRPSAEE----VHLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 33/137 (24%), Positives = 65/137 (47%), Gaps = 26/137 (18%)
Query: 28 IIIGFCEGGDM-----AEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82
++ +CE GD+ E + NS+L +++ ++ + ++H ++ LH D+
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMA---CEIAAGVTHMHKHNFLHSDLALR 128
Query: 83 NIFLTKDQDIRLGDFGLA-------KILTSDDLASSVVGTPSYMCPELLADIPYG----- 130
N FLT D +++GD+G+ I T DD ++ PEL+ + G
Sbjct: 129 NCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD----KCVPLRWLAPELVGEFHGGLITAE 184
Query: 131 --SKSDIWSLGCCIYEM 145
S++W+LG ++E+
Sbjct: 185 QTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 45/220 (20%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA-------------- 45
+E++ K+ +P I+ + RG Y+ I I + G++ + ++K+
Sbjct: 53 LEVLCKLGHHPNIINLLGACENRG-YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111
Query: 46 NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK---I 102
+ + ++L ++ + + YL +HRD+ N+ + ++ ++ DFGL++ +
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171
Query: 103 LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALI 161
+ V +M E L Y +KSD+WS G ++E+ SL + L
Sbjct: 172 YVKKTMGRLPV---RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228
Query: 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
K+ + P L++ R P RP A++
Sbjct: 229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 7/174 (4%)
Query: 34 EGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIR 93
E I S S L + Q+ +++L + + +HRD+ N+ + + + ++
Sbjct: 222 ERTRRDTLIN--ESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 94 LGDFGLAKILTSDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-K 149
+ DFGLA+ + D S T P +M PE + + Y + SD+WS G ++E+ +L
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
Query: 150 PAFKAFDMQALI-NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
+ M N I + P S +++ + E+RP ++L+
Sbjct: 340 TPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 112 VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYE-MTSLKPAFKAFDMQALINKINKSIVA 170
++GTP Y+ PELL P+G D W+LG C++E +T + P Q N +N+ I
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597
Query: 171 PLP---TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206
P P K S + ++ +L +P R EL +H
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 47/220 (21%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA-------------- 45
+E++ K+ +P I+ + RG Y+ + I + G++ + ++K+
Sbjct: 46 LEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104
Query: 46 NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK---I 102
+ S ++L + + +DYL +HRD+ NI + ++ ++ DFGL++ +
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164
Query: 103 LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALI 161
+ V +M E L Y + SD+WS G ++E+ SL + L
Sbjct: 165 YVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 221
Query: 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
K+ + P L++ R+ P RPS A++
Sbjct: 222 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 41/166 (24%), Positives = 60/166 (36%), Gaps = 25/166 (15%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA 109
+EE++ W V L L L LHR K NI LT D L G T
Sbjct: 14 LNEEEI--WAV-CLQCLGALRE---LHRQAKSGNILLTWD--GLLKLDGSVAFKT----P 61
Query: 110 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI- 168
P +M PE++ Y K+DI+SLG +YE + + + L + +
Sbjct: 62 EQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP--YNEERELSAILEILLN 119
Query: 169 --------VAPLPTKYSGA--FRGLVKSMLRKNPELRPSAAELLRH 204
S A F ++ + P+ R +A L H
Sbjct: 120 GMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAH 165
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 23/88 (26%), Positives = 48/88 (54%), Gaps = 3/88 (3%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPS 117
Q+ + YL + H +HRD+ N + + +++GDFG+++ + S D + +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEM 145
+M PE + + ++SD+WS G ++E+
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 24/88 (27%), Positives = 48/88 (54%), Gaps = 3/88 (3%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPS 117
Q+ + YL + H +HRD+ N + + +++GDFG+++ + S D + +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEM 145
+M PE + + ++SDIWS G ++E+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 24/148 (16%)
Query: 50 FSEEKLCKWLVQLLMALDYLHAN-HILHRDVKCSNIFL-TKDQDI--------------- 92
FS L + + Q +ALDY H H++H D+K NI + T D +
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 93 RLGDFGLAKILTSDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150
R+ D G D+ S ++V T Y PE++ + + +D+WS+GC IYE+ + K
Sbjct: 288 RICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 151 AFKAFDMQALINKINKSIVAPLPTKYSG 178
+ D ++ + K++ LP++++G
Sbjct: 344 LYDTHDNLEHLHLMEKTL-GRLPSEWAG 370
|
Length = 467 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 11/176 (6%)
Query: 26 VCIIIGFCEGGDMAEAI-KKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
V +++ EGG + I K N EE + +W ++++ALD LH I+ RD+ +NI
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 85 FLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYE 144
L I+L F + +D Y PE+ D WSLG ++E
Sbjct: 117 LLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFE 174
Query: 145 MTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE 200
+ + K ++ + IN +P S R L++ +L+ NP R A
Sbjct: 175 LLTGKTL-----VECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 6/152 (3%)
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS----SVVGT 115
+Q+ ++YL + +HRD+ N L + +++ DFGLA+ + + S +
Sbjct: 105 LQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 116 P-SYMCPELLADIPYGSKSDIWSLGCCIYE-MTSLKPAFKAFDMQALINKINKSIVAPLP 173
P +M E L + +KSD+WS G ++E MT P + D + + + P
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP 224
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
++ S PE+RP+ +EL+ +
Sbjct: 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 42/186 (22%), Positives = 83/186 (44%), Gaps = 9/186 (4%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I++ GG + ++K ++L + +KL + + ++YL + + +HRD+ N
Sbjct: 67 IYIVMELVPGGSLLTFLRKKKNRL-TVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCL 125
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVG----TP-SYMCPELLADIPYGSKSDIWSLGC 140
+ ++ +++ DFG+++ + +V P + PE L Y S+SD+WS G
Sbjct: 126 VGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGI 183
Query: 141 CIYEMTSLKPA-FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA 199
++E SL + Q +I P P L+ +PE RPS +
Sbjct: 184 LLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFS 243
Query: 200 ELLRHV 205
E+ +
Sbjct: 244 EIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 12/88 (13%)
Query: 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT--P-SYMC 120
MA YL + + +HRD+ NI + ++ ++ DFGLA+++ DD ++ G P +
Sbjct: 116 MA--YLESRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTA 172
Query: 121 PELLADIPYGS---KSDIWSLGCCIYEM 145
PE YG KSD+WS G + E+
Sbjct: 173 PEA---ANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 48/239 (20%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAI-------KKANSK----- 48
++++S++++P I+ V+ +C+I + E GD+ + + K+ N
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDP-LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 49 -----LFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103
S L +Q+ + YL + + +HRD+ N + ++ I++ DFG+++ L
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 104 TSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL---KPAFKAFDM 157
+ D + V +M E + + + SD+W+ G ++E+ L +P + D
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 158 QALIN----------KINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSAAELLR 203
Q + N ++ P P +GL + ML+ ++ RPS +++
Sbjct: 249 QVIENAGEFFRDQGRQVYLFRPPPCP-------QGLYELMLQCWSRDCRERPSFSDIHA 300
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 31/152 (20%), Positives = 51/152 (33%), Gaps = 13/152 (8%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQ-------DIRLGDFGLAK-ILTSDDLASSV 112
QL AL YL ++H +V NI + + I+L D G+ +L+ ++ +
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI 168
Query: 113 VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQALINKINKSIVAP 171
A + +D WS G + E+ S P
Sbjct: 169 PWIAPECIRNGQASL--TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
+P L+ +P RPS +LR
Sbjct: 227 MPD--CAELANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 27 CIIIGFCEGGDMAEAIKKA---------NSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77
C+I+ + E GD+ + ++K NSK S L Q+ + YL + + +HR
Sbjct: 95 CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHR 154
Query: 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP----SYMCPELLADIPYGSKS 133
D+ N + K+ I++ DFG+++ L S D V G +M E + + +KS
Sbjct: 155 DLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKS 213
Query: 134 DIWSLGCCIYEMTSL---KPAFKAFDMQALINKINKS------IVAPLPTKYSGAFRGLV 184
D+W+ G ++E+ +L +P D Q + N + I P P + +
Sbjct: 214 DVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP---NCPKDIY 270
Query: 185 KSML---RKNPELRPSAAELLRHVHLQ 208
+ ML R++ E RP+ E+ H+ LQ
Sbjct: 271 ELMLECWRRDEEDRPTFREI--HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 19/41 (46%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 61 QLLMALDYLHANHILHRDVKCSN-IFLTKDQDIRLGDFGLA 100
Q+L ALD LH+ I+HRDVK N IF ++ D G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 570 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.67 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.63 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.62 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.6 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.57 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.54 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.51 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.5 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.35 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.33 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.07 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.81 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.8 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.52 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.23 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.08 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.02 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.73 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.95 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.94 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.93 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.59 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.51 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.38 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.37 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.38 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.31 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 92.99 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 92.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.34 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.8 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 91.8 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 91.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 91.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 91.03 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.18 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 89.95 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.88 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 88.92 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 88.72 | |
| PTZ00384 | 383 | choline kinase; Provisional | 88.57 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.27 | |
| PLN02236 | 344 | choline kinase | 88.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 87.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 86.71 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 85.86 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 83.77 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 83.11 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 82.56 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 82.2 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 82.09 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=389.83 Aligned_cols=206 Identities=34% Similarity=0.520 Sum_probs=183.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++||++|+|||||+++++|.. ..+.||||||++||+|.+++-.+ +.+.++..+.+++||+.||.|||++||+|||||
T Consensus 227 ieILkkL~HP~IV~~~d~f~~-~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiK 303 (475)
T KOG0615|consen 227 IEILKKLSHPNIVRIKDFFEV-PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIK 303 (475)
T ss_pred HHHHHhcCCCCEEEEeeeeec-CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCC
Confidence 479999999999999998855 45789999999999999999874 458999999999999999999999999999999
Q ss_pred CCcEEEcCC---CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC---CCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKD---QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY---GSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||+..+ ..+||.|||+|+..+...++.+.|||+.|+|||++...++ ..++||||||||+|.+++|.+||..
T Consensus 304 PeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 304 PENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred cceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 999999876 5699999999999999999999999999999999986653 4588999999999999999999987
Q ss_pred cCHHH-HHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 FDMQA-LINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~-~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
..... +.+.|.++. ..+.+..++++.++||++||..||++|||++|+|+||||+.
T Consensus 384 ~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 384 EYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred ccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 54443 566666654 44567789999999999999999999999999999999973
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=373.89 Aligned_cols=208 Identities=32% Similarity=0.608 Sum_probs=193.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDL 79 (570)
|+||++.+|||||.+||+|..++..++|+||||+||+|.++++.. +.++|..+.+|+.+|++||.|||+ ++||||||
T Consensus 128 l~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDI 205 (364)
T KOG0581|consen 128 LEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDI 205 (364)
T ss_pred HHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccC
Confidence 478999999999999999987664699999999999999999875 459999999999999999999996 89999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc----
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF---- 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~---- 155 (570)
||+|||++..|.|||||||.++.+... +..+++||..|||||.+.+..|+.++||||||+.++||+.|+.||...
T Consensus 206 KPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~ 284 (364)
T KOG0581|consen 206 KPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY 284 (364)
T ss_pred CHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence 999999999999999999999998766 788999999999999999999999999999999999999999999774
Q ss_pred -CHHHHHHHHHhccCCCCCCC-CcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 156 -DMQALINKINKSIVAPLPTK-YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 156 -~~~~~~~~i~~~~~~p~p~~-~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
+..+++..|..+....+|.. +|+++++||..||++||.+|+++.|+|+|||++.+.
T Consensus 285 ~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 285 LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 67788899998888888887 999999999999999999999999999999997653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=384.42 Aligned_cols=219 Identities=61% Similarity=1.089 Sum_probs=209.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+.++++++|||||.|++.|+++++++||||+||+||+|.+.|++..+..|+|+.++.|+.|++.||.|||+++|+|||||
T Consensus 54 ~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK 133 (426)
T KOG0589|consen 54 MDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLK 133 (426)
T ss_pred HHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccch
Confidence 46899999999999999999999889999999999999999998888899999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+.|||+++++.|||+|||+|+.++... +..+++||+.||+||++.+.+|+.++|||||||++|||++.++.|.+.+...
T Consensus 134 ~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~ 213 (426)
T KOG0589|consen 134 CANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE 213 (426)
T ss_pred hhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence 999999999999999999999998877 8899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhhhhhcccC
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLN 219 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~k~~~~~~ 219 (570)
++.+|......+++..++.+++.||+.||.++|..||++.++|.+|.++.+..+......
T Consensus 214 Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~~~~~~~~~ 273 (426)
T KOG0589|consen 214 LILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYLVESQELET 273 (426)
T ss_pred HHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHHHhhhcccc
Confidence 999999999999999999999999999999999999999999999999888755554443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=388.72 Aligned_cols=204 Identities=33% Similarity=0.646 Sum_probs=191.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+|-++|+|||||+++++|++. .++|||+|+|..++|..+++++ +.|+|.+++.+++||+.||.|||+++|+|||||
T Consensus 69 IeIHr~L~HpnIV~f~~~FEDs-~nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK 145 (592)
T KOG0575|consen 69 IEIHRSLKHPNIVQFYHFFEDS-NNVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK 145 (592)
T ss_pred HHHHHhcCCCcEEeeeeEeecC-CceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccc
Confidence 5788999999999999998654 5899999999999999999964 569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
..||||+++.+|||+|||+|..+..+ +...+.||||.|.|||++...+++..+||||+|||||.|+.|+|||...+.++
T Consensus 146 LGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke 225 (592)
T KOG0575|consen 146 LGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE 225 (592)
T ss_pred hhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH
Confidence 99999999999999999999998854 66778999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.+.+|....+. +|..++.++++||.+||+.||.+|||+++||+|+||.
T Consensus 226 ty~~Ik~~~Y~-~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 226 TYNKIKLNEYS-MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHHHhcCcc-cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 99999776654 6789999999999999999999999999999999993
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=350.55 Aligned_cols=198 Identities=39% Similarity=0.734 Sum_probs=183.6
Q ss_pred CHHhhhcCCCcccccce-EEEeeCcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--
Q 008303 1 MELISKIRNPFIVEYKD-SWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHA--NH-- 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~-~f~~~~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs--~g-- 73 (570)
|.||++|+|||||+|++ .|.+++.-++||||||++|+|..+|+. ..++.++|..+|+++.|++.||..||. .+
T Consensus 69 i~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~ 148 (375)
T KOG0591|consen 69 ISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGT 148 (375)
T ss_pred HHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccc
Confidence 57999999999999999 555556558999999999999999985 345789999999999999999999999 45
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|+||||||.||||+.+|.|||+|||+++.+... ....+++|||.||+||.+.+.+|+.++|||||||++|||+..++||
T Consensus 149 VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 149 VMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999999998754 4567899999999999999999999999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCCCC-CCCcHHHHHHHHHhhccCCCCCcCH
Q 008303 153 KAFDMQALINKINKSIVAPLP-TKYSGAFRGLVKSMLRKNPELRPSA 198 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p~p-~~~s~~l~dLI~~~L~~dP~~RPTa 198 (570)
.+.+...+..+|..+...++| ..||.++..||..|+..|++.||+.
T Consensus 229 ~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999999999999999998888 7899999999999999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=372.99 Aligned_cols=207 Identities=26% Similarity=0.578 Sum_probs=194.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|-||+-|.||||+++|++|.+ +.++|+|.||++||.|++++-+++ .|++.++.++++||+.||.|||..||+|||||
T Consensus 63 IviMkLi~HpnVl~LydVwe~-~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLK 139 (786)
T KOG0588|consen 63 IVIMKLIEHPNVLRLYDVWEN-KQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLK 139 (786)
T ss_pred hHHHHHhcCCCeeeeeeeecc-CceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCC
Confidence 457888899999999999965 458999999999999999998754 59999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|+|||..++|||+|||+|....++.+..+.||+|.|.|||++.+.+| +.++||||.|||||.|++|+.||++.+...
T Consensus 140 pENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~ 219 (786)
T KOG0588|consen 140 PENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV 219 (786)
T ss_pred chhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH
Confidence 9999999999999999999999989999999999999999999999999 789999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
++.++..+.+. +|..++.++++||.+||..||.+|+|.+||++|||++.+.
T Consensus 220 LLlKV~~G~f~-MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 220 LLLKVQRGVFE-MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHcCccc-CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 99999887654 7899999999999999999999999999999999998664
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.85 Aligned_cols=205 Identities=31% Similarity=0.589 Sum_probs=188.6
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
.+|++++ ||||+++++++.... ++|+|||||.||+|.++|.+ .+.+.|..++.+++||+.||+|||++||+|||||
T Consensus 71 ~~~~~~~~HpnI~~l~ev~~t~~-~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK 147 (370)
T KOG0583|consen 71 SILRRLRSHPNIIRLLEVFATPT-KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK 147 (370)
T ss_pred HHHHHhccCCCEeEEEEEEecCC-eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 5789997 999999999987655 59999999999999999998 3569999999999999999999999999999999
Q ss_pred CCcEEEcCC-CCEEEeecCCceec-cCCCCCccccCCCCCCCcccccCCC-C-CCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKD-QDIRLGDFGLAKIL-TSDDLASSVVGTPSYMCPELLADIP-Y-GSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~-g~vKL~DFGla~~~-~~~~~~~~~~GT~~Y~APE~l~~~~-~-t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.+ +++||+|||++... .......+.|||+.|+|||++.+.. | +.++||||+|++||.|++|+.||...+
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 999999999 99999999999998 5677888999999999999999988 8 689999999999999999999999988
Q ss_pred HHHHHHHHHhccCCCCCCCC-cHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 157 MQALINKINKSIVAPLPTKY-SGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~-s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+..+|..+.. .+|..+ +.++++||.+||..||.+|+++.+|+.|+||+..
T Consensus 228 ~~~l~~ki~~~~~-~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 228 VPNLYRKIRKGEF-KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHHHhcCCc-cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 8888888766544 366777 9999999999999999999999999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=361.33 Aligned_cols=208 Identities=28% Similarity=0.480 Sum_probs=190.5
Q ss_pred CHHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
|.-|++|+ |||||++++++.+....+|+|||||+. +|.++|+.+ +..|++..|+.|++||+.||+|+|++|++||||
T Consensus 59 vksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDl 136 (538)
T KOG0661|consen 59 VKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDL 136 (538)
T ss_pred HHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccC
Confidence 35688997 999999999998876689999999986 999999988 679999999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
||+|||+.....|||+|||+|+.+.....++.++.|.||+|||++.. .-|+.+.|||++|||++|+.+-++.|.+.+..
T Consensus 137 KPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~ 216 (538)
T KOG0661|consen 137 KPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI 216 (538)
T ss_pred ChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH
Confidence 99999999999999999999999999999999999999999999864 55799999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCC-----------------------------CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAPLPT-----------------------------KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~-----------------------------~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+++.+|+..++.|... .++.++.+||.+||.+||++||||.|+|+||||+.
T Consensus 217 Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 217 DQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 9999988766655221 35679999999999999999999999999999985
Q ss_pred h
Q 008303 210 Y 210 (570)
Q Consensus 210 ~ 210 (570)
-
T Consensus 297 ~ 297 (538)
T KOG0661|consen 297 G 297 (538)
T ss_pred c
Confidence 3
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.20 Aligned_cols=206 Identities=32% Similarity=0.643 Sum_probs=189.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|.||+.|+|||||.+++++.. ++++|+|||||+||||.++|++++ .++|..++.++.||+.||++||+++|||||||
T Consensus 60 i~iLkel~H~nIV~l~d~~~~-~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLK 136 (429)
T KOG0595|consen 60 IKILKELKHPNIVRLLDCIED-DDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLK 136 (429)
T ss_pred HHHHHhcCCcceeeEEEEEec-CCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 479999999999999997755 458999999999999999999865 59999999999999999999999999999999
Q ss_pred CCcEEEcCC------CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKD------QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~------g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+||||+.. -.+||+|||+|+.+....+..+.||++.|||||++....|+.|+|+||+|+|+|+|++|++||..
T Consensus 137 PQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 137 PQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred cceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999864 45899999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCHHHHHHHHHhcc--CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSI--VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~--~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+..++...+.++. ...++..++....+|+...|..++.+|.+.++.+.|+++..
T Consensus 217 ~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 217 ETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred cCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 99999988776653 44566778889999999999999999999999999988753
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.09 Aligned_cols=206 Identities=34% Similarity=0.590 Sum_probs=190.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+||.+++||+||+++-.|.+ +.++|+|+||+.||+|+..|++. +.|+|..++.++..|+.||.|||++|||||||||
T Consensus 77 ~IL~~v~hPFiv~l~ysFQt-~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKP 153 (357)
T KOG0598|consen 77 NILSKIKHPFIVKLIYSFQT-EEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKP 153 (357)
T ss_pred HHHHhCCCCcEeeeEEeccc-CCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCH
Confidence 58999999999999988865 45899999999999999999874 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||||.+|.|+|+|||+++..- ......+.|||+.|||||++.+.+|+..+|.||||+++|+|++|.+||.+.+....
T Consensus 154 ENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 154 ENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred HHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 99999999999999999999644 44566778999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP----Ta~eIL~hp~fq~~ 210 (570)
+++|.+......+..++.+.+++|+++|+.||++|. .+++|-+||||...
T Consensus 234 ~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 234 YDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999998886667777999999999999999999995 89999999999753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=360.40 Aligned_cols=205 Identities=34% Similarity=0.598 Sum_probs=188.2
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|.+| +||.|++|+-.|.+. ..+|+|+||+++|+|.++|++.+ .|++...+.++.||+.||+|||++||||||||
T Consensus 125 ~~l~~L~~hPgivkLy~TFQD~-~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlK 201 (604)
T KOG0592|consen 125 EALTQLSGHPGIVKLYFTFQDE-ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLK 201 (604)
T ss_pred HHHHHhhCCCCeEEEEEEeecc-cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCC
Confidence 468888 999999999888654 57999999999999999999875 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--------------CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhh
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--------------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--------------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl 146 (570)
|+|||||++|.+||.|||.|+.+..... ...++||..|++||+|.+...+..+|||+||||+|.|+
T Consensus 202 PENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQml 281 (604)
T KOG0592|consen 202 PENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQML 281 (604)
T ss_pred hhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHh
Confidence 9999999999999999999998763221 14589999999999999999999999999999999999
Q ss_pred ccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 147 SLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 147 tG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.|.+||.+.+...++++|....+. ++.++++.+++||+++|..||.+|+|++||.+||||...
T Consensus 282 aG~PPFra~NeyliFqkI~~l~y~-fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 282 AGQPPFRAANEYLIFQKIQALDYE-FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred cCCCCCccccHHHHHHHHHHhccc-CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 999999999999999999776554 788999999999999999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.84 Aligned_cols=210 Identities=26% Similarity=0.507 Sum_probs=183.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|++|++|+|+|+|.++++|..+. .+++|+|||+. ++.+.+++... .++.+.+.++++|++.|+.|||+++|+|||||
T Consensus 52 IrmLKqLkH~NLVnLiEVFrrkr-klhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIK 128 (396)
T KOG0593|consen 52 IRMLKQLKHENLVNLIEVFRRKR-KLHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIK 128 (396)
T ss_pred HHHHHhcccchHHHHHHHHHhcc-eeEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCC
Confidence 57899999999999999996554 79999999987 66666666543 48999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+||||+.+|.+||||||+|+.+. ..+.++.++.|.||.|||++.+ .+|+..+|||++||++.||++|.+.|.+....
T Consensus 129 PENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 129 PENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred hhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 999999999999999999999988 6778888999999999999976 78999999999999999999999999998887
Q ss_pred HHHHHHHhccCCCCC------------------------------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 159 ALINKINKSIVAPLP------------------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p------------------------------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
++...|.+....-+| ..++.-+.+|++.||..||.+|++-+|+|.|+||.
T Consensus 209 DQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 209 DQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 776665443221111 14467889999999999999999999999999998
Q ss_pred hhhhh
Q 008303 209 PYVLK 213 (570)
Q Consensus 209 ~~~~k 213 (570)
.+..+
T Consensus 289 ~~~er 293 (396)
T KOG0593|consen 289 GFIER 293 (396)
T ss_pred HHHHH
Confidence 77655
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=343.44 Aligned_cols=209 Identities=34% Similarity=0.613 Sum_probs=179.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCc-EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGC-YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~-~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+.||++|+|||||+++|....... .++|+|||+.||+|.+++++.++ .|+|..++.+.+||+.||.|||++|||||||
T Consensus 65 i~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~Di 143 (313)
T KOG0198|consen 65 IRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDI 143 (313)
T ss_pred HHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCc
Confidence 468999999999999997544443 78999999999999999999776 7999999999999999999999999999999
Q ss_pred cCCcEEEcC-CCCEEEeecCCceeccC----CCCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCc
Q 008303 80 KCSNIFLTK-DQDIRLGDFGLAKILTS----DDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 80 KP~NILld~-~g~vKL~DFGla~~~~~----~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
||+|||++. ++.+||+|||+++.... ........||+.|||||++.++. ...++|||||||++.||++|++||.
T Consensus 144 K~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 144 KPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 999999999 79999999999988763 12244678999999999998633 3459999999999999999999998
Q ss_pred c-cCHHHHHHHH-HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 154 A-FDMQALINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 154 ~-~~~~~~~~~i-~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
. ......+..+ .....+.+|..++.++++||.+||.++|++||||+++|+|||.+..
T Consensus 224 ~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 224 EFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred hhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 7 3433333333 3333456888999999999999999999999999999999998753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=331.74 Aligned_cols=210 Identities=24% Similarity=0.489 Sum_probs=190.6
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+.||+++ .||||+.+.|+|..+ .++++|+|.|..|.|+|++... ..++|...+.|++||++|+.|||.++||||||
T Consensus 73 v~ILRqv~GHP~II~l~D~yes~-sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDL 149 (411)
T KOG0599|consen 73 ISILRQVMGHPYIIDLQDVYESD-AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDL 149 (411)
T ss_pred HHHHHHhcCCCcEEEeeeeccCc-chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhccc
Confidence 4789998 999999999999654 5899999999999999999764 45999999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc------CCCCCCcccccchhhhHHHhhccCCCCc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
||+|||++++.+|||.|||+++.+..+......||||+|+|||.+. ..+|+..+|+|++|+|||.|+.|.+||.
T Consensus 150 KpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 150 KPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 9999999999999999999999999999999999999999999984 3468899999999999999999999998
Q ss_pred ccCHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhhh
Q 008303 154 AFDMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~k 213 (570)
.....-+...|..+. ..+-|.+++...++||.+||+.||.+|+|++|+|.||||+++...
T Consensus 230 HRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 230 HRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred HHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 877666666666553 456778999999999999999999999999999999999887643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=353.51 Aligned_cols=204 Identities=31% Similarity=0.568 Sum_probs=184.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|.||+.++|+|||++++.|..++ .+|+||||++||+|.|.+... .++|.+|..|.++++.||+|||.+||+|||||
T Consensus 321 i~Vm~~~~H~NiVnfl~Sylv~d-eLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIK 396 (550)
T KOG0578|consen 321 ILVMRDLHHPNIVNFLDSYLVGD-ELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIK 396 (550)
T ss_pred HHHHHhccchHHHHHHHHhcccc-eeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccc
Confidence 46899999999999999998764 799999999999999999864 48999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
.+|||++.+|.+||+|||++..+.... ...+.+|||.|||||++....|+.+.||||||++++||+.|.+||-..+...
T Consensus 397 SDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr 476 (550)
T KOG0578|consen 397 SDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 476 (550)
T ss_pred cceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence 999999999999999999998887655 5677899999999999999999999999999999999999999998777766
Q ss_pred HHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 160 LINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 160 ~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.+..|...... ..+..+|..+++|+.+||+.|+++|+++.|||+||||+
T Consensus 477 AlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 477 ALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred HHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 66666444333 34678999999999999999999999999999999995
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=320.44 Aligned_cols=205 Identities=31% Similarity=0.531 Sum_probs=186.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.|-+.|+|||||+|.+.+.+.+ +.|||+|+++|++|..-|-++ ..++|..+-.+++||++||.|||.+||||||+||
T Consensus 62 rIC~~LqHP~IvrL~~ti~~~~-~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP 138 (355)
T KOG0033|consen 62 RICRKLQHPNIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKP 138 (355)
T ss_pred HHHHhcCCCcEeehhhhhcccc-eeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCCh
Confidence 4567789999999999886554 889999999999998877665 4589999999999999999999999999999999
Q ss_pred CcEEEcCCC---CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFLTKDQ---DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|+|+.... -+||+|||++..+.........+|||+||+||++...+|+..+|||+.|+|+|.|+.|++||.+.+..
T Consensus 139 ~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~ 218 (355)
T KOG0033|consen 139 ENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 218 (355)
T ss_pred hheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence 999997543 49999999999999777788899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccC---CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIV---APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~---~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+++.|..+.+ .+.+..++++.++||++||..||.+|+|+.|+|+|||+.+
T Consensus 219 rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 219 RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 99999987754 3456789999999999999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.70 Aligned_cols=202 Identities=26% Similarity=0.538 Sum_probs=188.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.||+.+.||+|+++++.|.+. .++|+||||+.||.|+.++++.+ .|++..++.++.||+.||+|||+++|++|||||
T Consensus 96 ~vL~~v~~PFlv~l~~t~~d~-~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKP 172 (355)
T KOG0616|consen 96 RVLKAVSHPFLVKLYGTFKDN-SNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKP 172 (355)
T ss_pred HHHhhccCceeEEEEEeeccC-CeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCCh
Confidence 589999999999999998765 58999999999999999999854 599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||+|++|.+||+|||+|+..... ..+.||||.|+|||++...+|+.++|.|+|||++|||+.|.+||...+...+.
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH
Confidence 9999999999999999999997654 67899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
++|..+... +|..++.++++||+.+|+.|-.+|. -.++|.+|+||..
T Consensus 251 ~KI~~~~v~-fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 251 EKILEGKVK-FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHhCccc-CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 999887654 6888999999999999999999994 4679999999985
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.33 Aligned_cols=205 Identities=29% Similarity=0.560 Sum_probs=181.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... .++|||||||.||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 47 ~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp 123 (323)
T cd05571 47 RVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKL 123 (323)
T ss_pred HHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH
Confidence 578899999999999988654 5899999999999999999764 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 124 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 203 (323)
T cd05571 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (323)
T ss_pred HHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH
Confidence 99999999999999999987643 22334456899999999999999999999999999999999999999998888777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
...+.... ..++..++.++.+||++||..||++|| ++.+|++|+||...
T Consensus 204 ~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 204 FELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 76665443 345678999999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=331.82 Aligned_cols=203 Identities=27% Similarity=0.580 Sum_probs=190.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+||+.|+||||+.+|++|..++ .+.|||||..+|+|.|||..++ .|+|.+++.+++||+.|+.|||+++++|||||
T Consensus 104 IeIMSsLNHPhII~IyEVFENkd-KIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLK 180 (668)
T KOG0611|consen 104 IEIMSSLNHPHIIQIYEVFENKD-KIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLK 180 (668)
T ss_pred HHHHhhcCCCceeehhhhhcCCc-eEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccc
Confidence 58999999999999999996554 7999999999999999998864 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
.+|||+|.++++||+|||++..+....+..++||++-|.+||++++.+| ++.+|-||||++||.|+.|..||++.+...
T Consensus 181 LENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~ 260 (668)
T KOG0611|consen 181 LENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR 260 (668)
T ss_pred hhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence 9999999999999999999999999999999999999999999999999 889999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
++..|..+.+... .-+..+..||++||..||++|.|+++|-.|-|++
T Consensus 261 lvrQIs~GaYrEP--~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 261 LVRQISRGAYREP--ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHhhcccccCC--CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 9999988876532 3467889999999999999999999999998875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.14 Aligned_cols=206 Identities=26% Similarity=0.479 Sum_probs=183.7
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
|.||++|+|||||+|.+..++. .+.+|+|+|||+. ||.-++.. .+..|++.+|+.++.||+.||+|||++||+||||
T Consensus 167 I~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDI 244 (560)
T KOG0600|consen 167 IKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDI 244 (560)
T ss_pred HHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccc
Confidence 5799999999999999999887 6789999999987 89888875 3457999999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|.+|||||.+|++||+|||+|+++.... .++..+-|.||.|||+|.+. .|+.++|+||+||||.||+.|++.|.+.+
T Consensus 245 K~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 245 KGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred cccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 9999999999999999999999876543 56778889999999999865 59999999999999999999999999999
Q ss_pred HHHHHHHHHhccCCCCC----------------------------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 157 MQALINKINKSIVAPLP----------------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p----------------------------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
..+++.+|.+....|.. ..++....+|+..||..||.+|.||.++|++.||.
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 99988888665444321 13467888999999999999999999999999994
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=332.51 Aligned_cols=205 Identities=24% Similarity=0.495 Sum_probs=182.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH-ILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g-IvHrDL 79 (570)
+.+|++|+|||||+++|++.+....++|||||+.+|+|.+++.+.....|+...+..|+.||+.|+.|||+++ ||||||
T Consensus 90 ~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDL 169 (362)
T KOG0192|consen 90 ASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDL 169 (362)
T ss_pred HHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeeccc
Confidence 3689999999999999999765436899999999999999998754567999999999999999999999999 999999
Q ss_pred cCCcEEEcCCC-CEEEeecCCceeccCC-CCCccccCCCCCCCccccc--CCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQ-DIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g-~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~--~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|++|||++.++ .+||+|||+++..... .......||+.|||||++. ...|+.++||||||+++|||++|+.||...
T Consensus 170 K~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~ 249 (362)
T KOG0192|consen 170 KSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL 249 (362)
T ss_pred ChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence 99999999998 9999999999887654 3344478999999999999 568999999999999999999999999998
Q ss_pred CHHHHHHHHH-hccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKIN-KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~-~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
........+. ......++..+++.+..||.+||..||.+||++.+|+..+
T Consensus 250 ~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 250 APVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 8866665554 5566667888999999999999999999999999998763
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.55 Aligned_cols=202 Identities=27% Similarity=0.508 Sum_probs=181.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.++ ..+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 70 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp 146 (329)
T PTZ00263 70 SILMELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKP 146 (329)
T ss_pred HHHHhCCCCCCCcEEEEEEcC-CEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence 578999999999999998665 4799999999999999999874 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.++.+||+|||++....... ...+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....
T Consensus 147 ~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 224 (329)
T PTZ00263 147 ENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224 (329)
T ss_pred HHEEECCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999999999999998765432 3468999999999999999999999999999999999999999988877777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccCh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQP 209 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~ 209 (570)
..+.... ..++..++..+++||++||..||.+|++ +++|++||||..
T Consensus 225 ~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 225 EKILAGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhcCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 7775543 3456778999999999999999999996 799999999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=318.50 Aligned_cols=209 Identities=26% Similarity=0.464 Sum_probs=179.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+.++++|.++ .++|+|||||.+|+|.+++.......+++..++.++.||+.||+|||++||+|||||
T Consensus 51 ~~il~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dik 129 (285)
T cd05631 51 KRILEKVNSRFVVSLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK 129 (285)
T ss_pred HHHHHhcCCCcEEEEEEEEccC-CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence 3688999999999999988655 479999999999999998876555569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+|||++.++.+||+|||++............+|+..|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 130 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 130 PENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred HHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 99999999999999999999886544444566899999999999999999999999999999999999999987553222
Q ss_pred HHHH---HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 161 INKI---NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i---~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
...+ ........+..++.++.+||++||..||.+|++ ++++++|+||...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 210 REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 2222 222333456678999999999999999999997 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=322.91 Aligned_cols=205 Identities=29% Similarity=0.513 Sum_probs=181.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+|||||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 45 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp 121 (312)
T cd05585 45 TVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKP 121 (312)
T ss_pred HHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH
Confidence 578899999999999988654 5799999999999999999864 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 122 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~ 201 (312)
T cd05585 122 ENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201 (312)
T ss_pred HHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH
Confidence 999999999999999999876432 2234456899999999999999999999999999999999999999998887777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc---CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP---SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP---Ta~eIL~hp~fq~~ 210 (570)
...+.... ..++..++..+.+||.+||..||.+|+ ++.++|+||||...
T Consensus 202 ~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 202 YRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 77665443 345678999999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=320.09 Aligned_cols=202 Identities=26% Similarity=0.465 Sum_probs=180.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+. .++|+|||||.+|+|.+++.+. +.+++..+..|+.||+.||+|||++||+||||||
T Consensus 53 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 129 (291)
T cd05612 53 RVLKEVSHPFIIRLFWTEHDQ-RFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKP 129 (291)
T ss_pred HHHHhCCCCcHhhhHhhhccC-CeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence 678999999999999988654 5899999999999999999874 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.+|.+||+|||++...... ....+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 130 ~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~ 207 (291)
T cd05612 130 ENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207 (291)
T ss_pred HHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999999876432 23467999999999999989999999999999999999999999988887777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccCh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQP 209 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~ 209 (570)
..+.... ..++..++..+++||++||..||.+|++ ++++++|+||+.
T Consensus 208 ~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 208 EKILAGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHhCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 7765543 3456678999999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.06 Aligned_cols=204 Identities=31% Similarity=0.579 Sum_probs=179.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|..+ ..+|||||||.+|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 47 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp 123 (328)
T cd05593 47 RVLKNTRHPFLTSLKYSFQTK-DRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKL 123 (328)
T ss_pred HHHHhCCCCCCcceEEEEEcC-CEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCH
Confidence 578899999999999988654 4799999999999999998764 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 124 ~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~ 203 (328)
T cd05593 124 ENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (328)
T ss_pred HHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH
Confidence 999999999999999999876432 2233456899999999999988999999999999999999999999988887776
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
...+.... ..++..++.++.+||++||.+||.+|+ ++.+|++|+||..
T Consensus 204 ~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 204 FELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 66654433 346778999999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.50 Aligned_cols=202 Identities=28% Similarity=0.551 Sum_probs=181.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. .++|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp 159 (340)
T PTZ00426 83 KILNYINHPFCVNLYGSFKDE-SYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKP 159 (340)
T ss_pred HHHHhCCCCCCcceEEEEEeC-CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCH
Confidence 578899999999999998655 4799999999999999999874 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....
T Consensus 160 ~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 237 (340)
T PTZ00426 160 ENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237 (340)
T ss_pred HHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999999999876432 24568999999999999888999999999999999999999999998887777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
..+..... .++..++..+.++|++||..+|.+|+ +++++++||||..
T Consensus 238 ~~i~~~~~-~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 238 QKILEGII-YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 77765543 35677899999999999999999996 8999999999985
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.43 Aligned_cols=202 Identities=31% Similarity=0.450 Sum_probs=173.6
Q ss_pred hhcCCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 5 SKIRNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++||||++++++|.. .+..+|+||||+. ++|.+++.......+++..++.|+.||+.||.|||++||+|||||
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 34479999999998852 3456899999997 599999987665668999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+|||++.++.+||+|||++.............|++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~ 217 (290)
T cd07862 138 PQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217 (290)
T ss_pred HHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 99999999999999999999887655555567899999999999988999999999999999999999999998877666
Q ss_pred HHHHHhccCCC--------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 161 INKINKSIVAP--------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 161 ~~~i~~~~~~p--------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+..+......+ ....++..+++||.+||..||++|||+.++|+||||
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 218 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 65554332111 112467888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.26 Aligned_cols=205 Identities=31% Similarity=0.564 Sum_probs=182.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|..++ .+|+|||||.||+|.+++.+. +.+.+..++.++.||+.||+|||++||+||||||
T Consensus 52 ~il~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 128 (323)
T cd05584 52 NILEAVKHPFIVDLIYAFQTGG-KLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKP 128 (323)
T ss_pred HHHHhCCCCchhceeeEEecCC-eEEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 6799999999999999987654 799999999999999999764 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||+++.... .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 129 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~ 208 (323)
T cd05584 129 ENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT 208 (323)
T ss_pred HHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999999875432 2334456899999999999988899999999999999999999999998888777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
...+.... ..++..++..+.+||++||.++|++|+ +++++++|+||...
T Consensus 209 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 209 IDKILKGK-LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 77776543 346778899999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=323.69 Aligned_cols=208 Identities=31% Similarity=0.505 Sum_probs=180.9
Q ss_pred CHHhhhcCCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
|.+|+.++|+||+.+++++.. +-+.+|+|+|+++ .+|...|+.. +.|+++.++.+++||+.||+|+|+.||+|
T Consensus 72 lklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViH 148 (359)
T KOG0660|consen 72 LKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIH 148 (359)
T ss_pred HHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccc
Confidence 468999999999999999864 3457999999995 5999999874 34999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccC---CCCCccccCCCCCCCccccc-CCCCCCcccccchhhhHHHhhccCCCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTS---DDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~---~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|||||.|+|++.+..+||+|||+|+.... ....+.++.|.||.|||++. ...|+...||||+|||+.||++|++.|
T Consensus 149 RDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 149 RDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred cccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 99999999999999999999999999863 55667889999999999985 457999999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHH
Q 008303 153 KAFDMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL 202 (570)
.+.+...++..|....+.+ +..+.++.+.+|+.+||..||.+|+|++|+|
T Consensus 229 pG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 229 PGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred CCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 9988766665554433322 1135678999999999999999999999999
Q ss_pred HhhccChhh
Q 008303 203 RHVHLQPYV 211 (570)
Q Consensus 203 ~hp~fq~~~ 211 (570)
.|||+.+|-
T Consensus 309 ~hPYl~~~h 317 (359)
T KOG0660|consen 309 AHPYLAPYH 317 (359)
T ss_pred cChhhhhhc
Confidence 999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.77 Aligned_cols=207 Identities=33% Similarity=0.608 Sum_probs=189.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+|+++|+|||||.++++|+.. .++|+|+|||.| +|+.+|...+ .++|+.++.|+.|++.||.|||+++|+|||+|
T Consensus 52 v~i~r~lkHpniv~m~esfEt~-~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~k 127 (808)
T KOG0597|consen 52 VRILRSLKHPNIVEMLESFETS-AHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMK 127 (808)
T ss_pred HHHHHhcCCcchhhHHHhhccc-ceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence 5799999999999999998655 479999999987 9999999854 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|.|||++..|.+|+||||+|+..... .+...+-|||.|||||++.+.+|+..+|+||||||+|||+.|++||.......
T Consensus 128 PqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~ 207 (808)
T KOG0597|consen 128 PQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ 207 (808)
T ss_pred cceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence 99999999999999999999987654 35667889999999999999999999999999999999999999999999989
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~ 212 (570)
+...|.+.... +|...+..+..|++.+|.+||.+|.+..+++.|+|++..+.
T Consensus 208 Lv~~I~~d~v~-~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 208 LVKSILKDPVK-PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred HHHHHhcCCCC-CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 98888776554 46689999999999999999999999999999999876544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.99 Aligned_cols=204 Identities=29% Similarity=0.577 Sum_probs=180.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|..+ ..+|||||||.||+|..++.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 47 ~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp 123 (323)
T cd05595 47 RVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 123 (323)
T ss_pred HHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 578899999999999988655 4899999999999999988764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 124 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~ 203 (323)
T cd05595 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203 (323)
T ss_pred HHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999876432 2233456799999999999998999999999999999999999999998887777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
...+..... .++..+++++.+||.+||..||.+|+ ++.++++|+||..
T Consensus 204 ~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 204 FELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHhcCCC-CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 766654433 35678999999999999999999998 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.19 Aligned_cols=206 Identities=30% Similarity=0.563 Sum_probs=189.2
Q ss_pred CHHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
|+||++|. |||||.++++|.... .+++|||+|.||.|++.|.+. .++|..+..++.||+.|++|||+.||+||||
T Consensus 86 v~il~~l~~hpniv~l~~~~e~~~-~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDl 161 (382)
T KOG0032|consen 86 VAILQQLSGHPNIVQLKDAFEDPD-SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDL 161 (382)
T ss_pred HHHHHhccCCCCEEEEEEEEEcCC-eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Confidence 57999997 999999999997655 899999999999999999876 3999999999999999999999999999999
Q ss_pred cCCcEEEcCC----CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKD----QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~----g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|+|+... +.+|++|||++............+||+.|+|||++...+|+..+||||+|+++|.|++|.+||.+.
T Consensus 162 KpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 162 KPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred CHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 9999999653 479999999999998877788899999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+......++..+. ..+.+..++..++++|+.||..||.+|+|+.++|+|||++..
T Consensus 242 ~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 242 TEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9888887887663 445677889999999999999999999999999999998754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.38 Aligned_cols=205 Identities=30% Similarity=0.570 Sum_probs=179.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLK 80 (570)
++|++++||||++++++|... ..+|||||||.||+|.+++.+. ..+++..++.|+.||+.||+|||+ +||+|||||
T Consensus 47 ~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDik 123 (325)
T cd05594 47 RVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 123 (325)
T ss_pred HHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence 578889999999999988654 4899999999999999988764 458999999999999999999997 799999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 124 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~ 203 (325)
T cd05594 124 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203 (325)
T ss_pred CCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH
Confidence 9999999999999999999876432 223345679999999999999899999999999999999999999998888777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
....+.... ..++..++.++.+||++||..||.+|+ ++.++++|+||...
T Consensus 204 ~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 204 LFELILMEE-IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 766665433 335678899999999999999999997 99999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.19 Aligned_cols=206 Identities=28% Similarity=0.518 Sum_probs=182.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+.|+.++|+||+.++|+|-..+ .+.||+||++. +|...|+.. ...|+...++.|+.+++.||+|||++.|+|||||
T Consensus 52 IK~Lqel~h~nIi~LiD~F~~~~-~l~lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlK 128 (318)
T KOG0659|consen 52 IKLLQELKHPNIIELIDVFPHKS-NLSLVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLK 128 (318)
T ss_pred HHHHHHccCcchhhhhhhccCCC-ceEEEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCC
Confidence 46899999999999999997665 58899999975 999999875 4689999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|+|++.+|.+||+|||+++.+..... ....+-|.||.|||++.+ ..|+..+||||+|||+.||+.+.|.|.+.+..
T Consensus 129 PnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 129 PNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred ccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 9999999999999999999999875543 334488999999999865 46899999999999999999999999999998
Q ss_pred HHHHHHHhccCCCCCCC---------------------------CcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAPLPTK---------------------------YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~---------------------------~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
++...|......|-+.. .+.++.+|+.+||.+||.+|+++.|+|+|+||..
T Consensus 209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 88888877666553332 3457899999999999999999999999999974
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.25 Aligned_cols=205 Identities=30% Similarity=0.517 Sum_probs=181.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 50 ~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 126 (318)
T cd05582 50 DILAEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP 126 (318)
T ss_pred HHHHhCCCCCcccEEEEEEcC-CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 588999999999999988654 4789999999999999999764 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++...... ......+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 127 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 206 (318)
T cd05582 127 ENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206 (318)
T ss_pred HHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH
Confidence 9999999999999999999875443 233456899999999999988899999999999999999999999998887777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
...+..... ..+..++..+.+||++||+.||.+||+ ++++++|+||+..
T Consensus 207 ~~~i~~~~~-~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 207 MTMILKAKL-GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 776655433 356778999999999999999999999 7889999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.31 Aligned_cols=208 Identities=30% Similarity=0.454 Sum_probs=184.2
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
|+||.+++|||||.+..+.+.. .+.+|||||||+. ||..+|+... +.|...+++-++.|++.||+|||.+.|+||||
T Consensus 126 IniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDL 203 (419)
T KOG0663|consen 126 INILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDL 203 (419)
T ss_pred HHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEeccc
Confidence 5789999999999999998754 3579999999986 9999998865 67999999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|++|+|++..|.+||+|||+|+.++.. ...+..+-|.||.|||++.+.+ |+.+.|+||+|||+.||+.+++.|.+...
T Consensus 204 K~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 204 KTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred chhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 999999999999999999999998765 3456778899999999998764 89999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCC---C----------------------------CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 158 QALINKINKSIVAPLP---T----------------------------KYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p---~----------------------------~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
.+++.+|......|-. . .+++...+|++.+|.+||.+|.||+|.|+|.|
T Consensus 284 ~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 284 IDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred HHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 8888888665444311 0 14578889999999999999999999999999
Q ss_pred cChh
Q 008303 207 LQPY 210 (570)
Q Consensus 207 fq~~ 210 (570)
|...
T Consensus 364 F~e~ 367 (419)
T KOG0663|consen 364 FRET 367 (419)
T ss_pred cccC
Confidence 9753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.28 Aligned_cols=205 Identities=28% Similarity=0.523 Sum_probs=179.9
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|.++ +||||++++++|... ..+|+|||||.||+|.+++.+. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 47 ~~l~~~~~h~~iv~~~~~~~~~-~~~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlk 123 (320)
T cd05590 47 RILSLARNHPFLTQLYCCFQTP-DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLK 123 (320)
T ss_pred HHHHhccCCCchhceeeEEEcC-CEEEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence 355555 799999999988654 5799999999999999999864 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 124 p~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 203 (320)
T cd05590 124 LDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203 (320)
T ss_pred HHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 999999999999999999987643 2233445689999999999999899999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH------HHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA------AELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa------~eIL~hp~fq~~ 210 (570)
+...+..... ..+..++.++.+||++||..||.+|+++ +++++|+||...
T Consensus 204 ~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 204 LFEAILNDEV-VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 8777765433 3566789999999999999999999998 999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=318.09 Aligned_cols=204 Identities=25% Similarity=0.465 Sum_probs=178.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|.+++||||++++++|.+ +.++|||||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 53 ~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 129 (333)
T cd05600 53 DILTTTKSEWLVKLLYAFQD-DEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKP 129 (333)
T ss_pred HHHHhCCCCCCccEEEEEEc-CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH
Confidence 57888999999999998865 45899999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.++.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 130 ~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 207 (333)
T cd05600 130 ENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207 (333)
T ss_pred HHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence 999999999999999999987543 344568999999999999989999999999999999999999999988877766
Q ss_pred HHHHhcc---CCCCC----CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 162 NKINKSI---VAPLP----TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~---~~p~p----~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+.... ..+.. ..++.++.+||.+||..+|.+|++++++++|+||...
T Consensus 208 ~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 208 ENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 6554321 11111 1568999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.73 Aligned_cols=205 Identities=26% Similarity=0.510 Sum_probs=180.1
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|..+ +||||++++++|... ..+|+|||||.||+|..++.+. ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 47 ~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDik 123 (321)
T cd05591 47 RILALAAKHPFLTALHCCFQTK-DRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLK 123 (321)
T ss_pred HHHHhccCCCCccceeeEEEcC-CeEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 355555 899999999998655 4799999999999999999764 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++..... .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 124 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~ 203 (321)
T cd05591 124 LDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203 (321)
T ss_pred HHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999999876432 233445679999999999999899999999999999999999999999998888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-------CHHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-------SAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-------Ta~eIL~hp~fq~~ 210 (570)
....+..... ..+..++.++.+||++||..||++|+ +++++++|+||..+
T Consensus 204 ~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 204 LFESILHDDV-LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 8877765443 34566899999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.26 Aligned_cols=205 Identities=27% Similarity=0.446 Sum_probs=180.4
Q ss_pred CCCcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcE
Q 008303 8 RNPFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84 (570)
Q Consensus 8 ~HPnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NI 84 (570)
.|||||.++|+|.+ ....+.||||+++||+|+..|+.++.+.|+|.++..|++||..||.|||+.+|.||||||+|+
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENL 192 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENL 192 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhe
Confidence 69999999999963 234477999999999999999999889999999999999999999999999999999999999
Q ss_pred EEcCC---CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH---
Q 008303 85 FLTKD---QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ--- 158 (570)
Q Consensus 85 Lld~~---g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~--- 158 (570)
|.+.. ..+||+|||+|+.-.......+.|.||.|+|||++...+|+..+|+||||+++|.|++|.+||..+...
T Consensus 193 Lyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais 272 (400)
T KOG0604|consen 193 LYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272 (400)
T ss_pred eeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC
Confidence 99764 469999999999987667777889999999999999999999999999999999999999999765432
Q ss_pred -HHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhh
Q 008303 159 -ALINKINKS---IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 159 -~~~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~ 212 (570)
.+..+|..+ +..+-|..+|++.+++|+.+|+.+|.+|.|++++|+|||+.++..
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 233444443 344556788999999999999999999999999999999987653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.81 Aligned_cols=204 Identities=27% Similarity=0.479 Sum_probs=169.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|..+ ..+|+|||||.++.|..+... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 51 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk 127 (287)
T cd07848 51 LKMLRTLKQENIVELKEAFRRR-GKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127 (287)
T ss_pred HHHHHhCCCccccchhhhEecC-CEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 3678999999999999998654 479999999998777655443 2458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|++||...+..
T Consensus 128 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~ 207 (287)
T cd07848 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207 (287)
T ss_pred HHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999998764322 223467899999999999888999999999999999999999999877654
Q ss_pred HHHHHHHhccC--------------------CC-----------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIV--------------------AP-----------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~--------------------~p-----------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+....+..... .+ ....++.++.+||++||++||++|||++++|+||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 208 DQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 43332221100 00 012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.40 Aligned_cols=208 Identities=31% Similarity=0.522 Sum_probs=184.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+||+.++||+++.||+.|.. .++.|+|||||.||+|..+.+++.++.|++..++.++.+++.||+|||..|||+|||||
T Consensus 129 eIL~~lDHPFlPTLYa~fet-~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP 207 (459)
T KOG0610|consen 129 EILSLLDHPFLPTLYASFET-DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP 207 (459)
T ss_pred HHHHhcCCCccchhhheeec-cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc
Confidence 68999999999999999965 45999999999999999999999999999999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-----------------------------------C--------------------
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-----------------------------------D-------------------- 106 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-----------------------------------~-------------------- 106 (570)
+||||.++|.|.|.||.++..... .
T Consensus 208 ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep 287 (459)
T KOG0610|consen 208 ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEP 287 (459)
T ss_pred ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCC
Confidence 999999999999999998753210 0
Q ss_pred --CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccC-CCCCCCCcHHHHHH
Q 008303 107 --DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV-APLPTKYSGAFRGL 183 (570)
Q Consensus 107 --~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~-~p~p~~~s~~l~dL 183 (570)
.....++||-.|+|||++.+.+++.++|.|+|||++|||+.|..||.+.+..+.+.+|..... .+....++..++||
T Consensus 288 ~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 288 TGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDL 367 (459)
T ss_pred CCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHH
Confidence 001236899999999999999999999999999999999999999999998888777765432 33334678999999
Q ss_pred HHHhhccCCCCCcC----HHHHHHhhccChh
Q 008303 184 VKSMLRKNPELRPS----AAELLRHVHLQPY 210 (570)
Q Consensus 184 I~~~L~~dP~~RPT----a~eIL~hp~fq~~ 210 (570)
|+++|.+||.+|.- +.||-+||||+..
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccCC
Confidence 99999999999998 9999999999853
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.62 Aligned_cols=203 Identities=29% Similarity=0.539 Sum_probs=178.5
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
++++++||||++++++|... ..+|+|||||.||+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 55 ~~~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~ 130 (324)
T cd05589 55 TANSERHPFLVNLFACFQTE-DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLD 130 (324)
T ss_pred hccccCCCChhceeeEEEcC-CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHH
Confidence 34567899999999988654 589999999999999988864 35899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
|||++.++.+||+|||++..... .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 131 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 131 NLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred HeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999875432 23344578999999999999989999999999999999999999999998888877
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
..+..... ..+..++..+.+||++||..||.+|| ++.++++|+||...
T Consensus 211 ~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 211 DSIVNDEV-RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhCCC-CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 77765433 35677899999999999999999999 79999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=335.40 Aligned_cols=209 Identities=32% Similarity=0.566 Sum_probs=186.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|++++|||||+++++|... +.+|||||||.||+|.+++... ....+++..+..++.||+.||.|||++||+|||
T Consensus 116 ~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD 194 (478)
T PTZ00267 116 LHCLAACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194 (478)
T ss_pred HHHHHhCCCCCEeEEEEEEEEC-CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECC
Confidence 3688999999999999998665 4799999999999999988653 234689999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||+|||++.++.+||+|||+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 195 lkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765432 244567999999999999999999999999999999999999999988
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+..++...+......+.+..++.++++||.+||..+|++||++++++.|+|++..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 275 SQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred CHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 8888888877776667778899999999999999999999999999999998643
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.84 Aligned_cols=204 Identities=29% Similarity=0.512 Sum_probs=178.9
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
+++.++||||++++++|.+. ..+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 49 ~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~ 125 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPE 125 (323)
T ss_pred HHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHH
Confidence 45778999999999988654 5789999999999999999764 45899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
|||++.++.+||+|||++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 126 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 205 (323)
T cd05575 126 NILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205 (323)
T ss_pred HeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 9999999999999999987543 223344568999999999999999999999999999999999999999998888777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH----HHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA----AELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa----~eIL~hp~fq~~ 210 (570)
..+..... ..+..++..+.++|++||..||.+||++ .++++|+||...
T Consensus 206 ~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 206 DNILNKPL-RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHHHcCCC-CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 77765433 3456789999999999999999999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.59 Aligned_cols=205 Identities=30% Similarity=0.507 Sum_probs=176.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||++++++|.+. .++|||||||.||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 53 ~il~~l~h~~iv~~~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp 129 (364)
T cd05599 53 DILAEADNPWVVKLYYSFQDE-NYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKP 129 (364)
T ss_pred HHHHhCCCCCCcceEEEEEcC-CeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH
Confidence 678899999999999988654 5899999999999999999864 3599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC---------------------------------------CCccccCCCCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD---------------------------------------LASSVVGTPSYMCPE 122 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~---------------------------------------~~~~~~GT~~Y~APE 122 (570)
+|||++.+|.+||+|||++..+.... .....+||+.|+|||
T Consensus 130 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred HHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 99999999999999999987643211 112357999999999
Q ss_pred cccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCcC--
Q 008303 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRPS-- 197 (570)
Q Consensus 123 ~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-- 197 (570)
++....++.++|||||||++|+|++|..||...+.......+.... ..+....++.++++||++||. +|.+|++
T Consensus 210 ~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~ 288 (364)
T cd05599 210 VFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNN 288 (364)
T ss_pred HHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCC
Confidence 9999999999999999999999999999999888777666654322 122223578999999999997 8999998
Q ss_pred -HHHHHHhhccChh
Q 008303 198 -AAELLRHVHLQPY 210 (570)
Q Consensus 198 -a~eIL~hp~fq~~ 210 (570)
+++++.|+||...
T Consensus 289 ~~~~ll~h~~~~~~ 302 (364)
T cd05599 289 GVNEIKSHPFFKGV 302 (364)
T ss_pred CHHHHhcCCCcCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.01 Aligned_cols=205 Identities=32% Similarity=0.550 Sum_probs=179.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|.+++|+||++++++|.++ .++|+|||||.||+|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 53 ~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp 129 (350)
T cd05573 53 DILADADSPWIVKLYYSFQDE-EHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKP 129 (350)
T ss_pred HHHHhcCCCCccchhhheecC-CeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 578889999999999988654 5899999999999999999875 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC------------------------------CCccccCCCCCCCcccccCCCCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD------------------------------LASSVVGTPSYMCPELLADIPYGS 131 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~------------------------------~~~~~~GT~~Y~APE~l~~~~~t~ 131 (570)
+|||++.++.+||+|||++....... .....+||+.|+|||++.+..++.
T Consensus 130 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 209 (350)
T cd05573 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL 209 (350)
T ss_pred HHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC
Confidence 99999999999999999998765433 233467999999999999999999
Q ss_pred cccccchhhhHHHhhccCCCCcccCHHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-HHHHHHhhcc
Q 008303 132 KSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK---SIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-AAELLRHVHL 207 (570)
Q Consensus 132 ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~---~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-a~eIL~hp~f 207 (570)
++|||||||++|+|++|+.||...+......++.. ....+....++.++.+||.+||. +|.+|++ ++++++||||
T Consensus 210 ~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 210 ECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred ceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 99999999999999999999998887776666654 22233334579999999999997 9999999 9999999999
Q ss_pred Chh
Q 008303 208 QPY 210 (570)
Q Consensus 208 q~~ 210 (570)
+..
T Consensus 289 ~~~ 291 (350)
T cd05573 289 KGI 291 (350)
T ss_pred CCC
Confidence 864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=317.48 Aligned_cols=204 Identities=26% Similarity=0.503 Sum_probs=173.1
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
.+++++ +||||++++++|... ..+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 47 ~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 123 (329)
T cd05588 47 HVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLK 123 (329)
T ss_pred HHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 456677 799999999988654 4799999999999999998764 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceec-cCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC---
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKIL-TSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD--- 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~--- 156 (570)
|+|||++.++.+||+|||+++.. .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 124 p~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~ 203 (329)
T cd05588 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203 (329)
T ss_pred HHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccc
Confidence 99999999999999999998753 22333445789999999999999999999999999999999999999996321
Q ss_pred -----HHH-HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC------HHHHHHhhccCh
Q 008303 157 -----MQA-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS------AAELLRHVHLQP 209 (570)
Q Consensus 157 -----~~~-~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT------a~eIL~hp~fq~ 209 (570)
..+ ....+. ......+..++..+.+||++||..||.+|++ ++++++||||..
T Consensus 204 ~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 204 NPDQNTEDYLFQVIL-EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred cccccchHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 112 223332 3334467788999999999999999999997 799999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=309.10 Aligned_cols=208 Identities=26% Similarity=0.477 Sum_probs=176.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.. +.++|+||||+.||+|.+++.......+++..+..++.||+.||+|||++||+||||||
T Consensus 45 ~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp 123 (277)
T cd05607 45 EILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKP 123 (277)
T ss_pred HHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCCh
Confidence 68999999999999998865 45899999999999999998766555689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH----
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM---- 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~---- 157 (570)
+|||++.++.++|+|||++.............|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 124 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~ 203 (277)
T cd05607 124 ENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203 (277)
T ss_pred HhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH
Confidence 9999999999999999999877654444456789999999999988899999999999999999999999976532
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH----HHHHHhhccChh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA----AELLRHVHLQPY 210 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa----~eIL~hp~fq~~ 210 (570)
..+...............++.++++||++||++||.+||++ +++++|+||+.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 204 EELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 22222222222222234689999999999999999999999 678899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=327.35 Aligned_cols=205 Identities=30% Similarity=0.553 Sum_probs=179.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+||...++|+||+|+-.|.+ ..++||||||++|||+..+|.+. ..|+++.++.++.+++.||.-||+.|+|||||||
T Consensus 193 diL~~~ds~~vVKLyYsFQD-~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKP 269 (550)
T KOG0605|consen 193 DILAEVDSPWVVKLYYSFQD-KEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKP 269 (550)
T ss_pred HHhhhcCCCcEEEEEEEecC-CCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCCh
Confidence 46777899999999988854 56999999999999999999875 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC----------------------CC--------------------------CCcccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS----------------------DD--------------------------LASSVV 113 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~----------------------~~--------------------------~~~~~~ 113 (570)
+|+|||..|.|||.|||++.-+.. .. +....+
T Consensus 270 dNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StV 349 (550)
T KOG0605|consen 270 DNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTV 349 (550)
T ss_pred hheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhccc
Confidence 999999999999999999853211 00 112368
Q ss_pred CCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhcc
Q 008303 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKS---IVAPLPTKYSGAFRGLVKSMLRK 190 (570)
Q Consensus 114 GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~ 190 (570)
|||.|+|||++.+.+|+..+|.||||||+|||+.|.+||.+.+..+...+|... ...|-...++.+++|||.+||+
T Consensus 350 GTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 350 GTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-
Confidence 999999999999999999999999999999999999999999999988887443 3334445678999999999999
Q ss_pred CCCCCc---CHHHHHHhhccChh
Q 008303 191 NPELRP---SAAELLRHVHLQPY 210 (570)
Q Consensus 191 dP~~RP---Ta~eIL~hp~fq~~ 210 (570)
||++|. .++||..||||...
T Consensus 429 d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred CHHHhcCcccHHHHhcCCccccC
Confidence 999999 59999999999853
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=321.48 Aligned_cols=206 Identities=26% Similarity=0.438 Sum_probs=174.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|.+++|+||++++++|.+. ..+|||||||.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 53 ~il~~~~~~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp 129 (363)
T cd05628 53 DILVEADSLWVVKMFYSFQDK-LNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKP 129 (363)
T ss_pred HHHHhCCCCCcceEEEEEecC-CeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCH
Confidence 578889999999999988654 5799999999999999999874 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC------------------------------------CCccccCCCCCCCccccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD------------------------------------LASSVVGTPSYMCPELLA 125 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~------------------------------------~~~~~~GT~~Y~APE~l~ 125 (570)
+|||++.++.+||+|||+++.+.... .....+||+.|+|||++.
T Consensus 130 ~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred HHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 99999999999999999987543210 112458999999999999
Q ss_pred CCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhcc--CCCCCcCHHH
Q 008303 126 DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRK--NPELRPSAAE 200 (570)
Q Consensus 126 ~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~--dP~~RPTa~e 200 (570)
+..++.++|||||||++|+|++|+.||.+.+..+...++.... ..+....++.++++||.+|+.. ++..||+++|
T Consensus 210 ~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~e 289 (363)
T cd05628 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence 9999999999999999999999999999888877777765422 1222235789999999998762 2334689999
Q ss_pred HHHhhccChh
Q 008303 201 LLRHVHLQPY 210 (570)
Q Consensus 201 IL~hp~fq~~ 210 (570)
|++||||+..
T Consensus 290 i~~hp~f~~~ 299 (363)
T cd05628 290 IKTNPFFEGV 299 (363)
T ss_pred HhCCCCCCCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.50 Aligned_cols=205 Identities=28% Similarity=0.496 Sum_probs=172.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||+++++|.+. .++|||||||.||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 53 ~il~~l~hp~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp 129 (377)
T cd05629 53 DVLAESDSPWVVSLYYSFQDA-QYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129 (377)
T ss_pred HHHHhCCCCCcceEEEEEEcC-CeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 678899999999999988654 5899999999999999999764 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC------------------------------------------------CCcccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD------------------------------------------------LASSVV 113 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~------------------------------------------------~~~~~~ 113 (570)
+|||++.++.+||+|||+++.+.... .....+
T Consensus 130 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred HHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 99999999999999999986432100 001357
Q ss_pred CCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhcc
Q 008303 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKS---IVAPLPTKYSGAFRGLVKSMLRK 190 (570)
Q Consensus 114 GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~ 190 (570)
||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+... ...+....++.++++||.+||.
T Consensus 210 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred CCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-
Confidence 999999999999989999999999999999999999999888776666665432 1222223578999999999998
Q ss_pred CCCCC---cCHHHHHHhhccChh
Q 008303 191 NPELR---PSAAELLRHVHLQPY 210 (570)
Q Consensus 191 dP~~R---PTa~eIL~hp~fq~~ 210 (570)
+|.+| +++.+++.|+||...
T Consensus 289 ~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 289 NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred CHhhcCCCCCHHHHhcCCCcCCC
Confidence 66665 599999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=315.86 Aligned_cols=207 Identities=29% Similarity=0.452 Sum_probs=169.1
Q ss_pred CHHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++||||+++++++...+ ..+|+|||||. ++|.+++... ..+++..++.|+.||+.||.|||++||+|
T Consensus 50 ~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 126 (338)
T cd07859 50 IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFH 126 (338)
T ss_pred HHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 36789999999999999886432 35899999995 6999998764 35899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccC--CCCCCcccccchhhhHHHhhccCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
|||||+|||++.++.+||+|||+++...... .....+|++.|+|||++.+ ..++.++|||||||++|+|++|++
T Consensus 127 ~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred CCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999997653221 2234679999999999875 578999999999999999999999
Q ss_pred CCcccCHHHHHHHHHhc---------------------------cCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHH
Q 008303 151 AFKAFDMQALINKINKS---------------------------IVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAE 200 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~---------------------------~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~e 200 (570)
||.+.+.......+... ...+ ....++..+.+||.+||..||++|||++|
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e 286 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286 (338)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence 99876543332221110 0000 11246788999999999999999999999
Q ss_pred HHHhhccChh
Q 008303 201 LLRHVHLQPY 210 (570)
Q Consensus 201 IL~hp~fq~~ 210 (570)
+|+||||+..
T Consensus 287 ~l~hp~f~~~ 296 (338)
T cd07859 287 ALADPYFKGL 296 (338)
T ss_pred HhcCchhhhc
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.84 Aligned_cols=210 Identities=32% Similarity=0.543 Sum_probs=179.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
..|+.++||||+.++..|+.+. .+|+||.||.+|++.++|+..-...|.|..|..|+++++.||.|||.+|.||||||+
T Consensus 76 ~~msl~~HPNIv~~~~sFvv~~-~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKA 154 (516)
T KOG0582|consen 76 QTMSLIDHPNIVTYHCSFVVDS-ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKA 154 (516)
T ss_pred HHhhhcCCCCcceEEEEEEecc-eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccccc
Confidence 5678889999999999998765 799999999999999999986666799999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC----CC-ccccCCCCCCCccccc--CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD----LA-SSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~----~~-~~~~GT~~Y~APE~l~--~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
.||||+.+|.|||+|||.+..+.... .. .+.+||++|||||++. ..+|+.|+||||||+...||..|..||..
T Consensus 155 gnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 155 GNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred ccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 99999999999999999876554321 11 5679999999999964 44799999999999999999999999998
Q ss_pred cCHHHH-HHHHHhccCCCC--------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhh
Q 008303 155 FDMQAL-INKINKSIVAPL--------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 155 ~~~~~~-~~~i~~~~~~p~--------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~ 212 (570)
+...++ ..++.+..+.+. ...++..++.+|..||.+||.+|||++++|+|+||+....
T Consensus 235 ~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 235 YPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 876654 445544433111 1256789999999999999999999999999999986543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.79 Aligned_cols=204 Identities=26% Similarity=0.459 Sum_probs=170.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++... ...|+|||||.+ +|.+++.... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 54 ~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk 130 (288)
T cd07871 54 VSLLKNLKHANIVTLHDIIHTE-RCLTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130 (288)
T ss_pred HHHHHhCCCCCEeeEEEEEcCC-CeEEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 3688999999999999988654 478999999985 9999987643 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||+++...... ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 131 p~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred HHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999997654322 2344578999999999865 56899999999999999999999999887766
Q ss_pred HHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+....+......+ ....++.++++||++||..||.+|||++|+|+||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 5554443211110 112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.19 Aligned_cols=205 Identities=28% Similarity=0.478 Sum_probs=174.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+|||+++++|.++ .++|+|||||.||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||
T Consensus 53 ~il~~~~h~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp 129 (382)
T cd05625 53 DILAEADNEWVVRLYYSFQDK-DNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKP 129 (382)
T ss_pred HHHHhCCCCcCCeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 578999999999999998755 4899999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC------------------------------------------------CCCcccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD------------------------------------------------DLASSVV 113 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~------------------------------------------------~~~~~~~ 113 (570)
+|||++.+|.+||+|||++..+... ......+
T Consensus 130 ~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (382)
T cd05625 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV 209 (382)
T ss_pred HHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 9999999999999999997532100 0112357
Q ss_pred CCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhcc
Q 008303 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKS---IVAPLPTKYSGAFRGLVKSMLRK 190 (570)
Q Consensus 114 GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~ 190 (570)
||+.|+|||++.+..|+.++|||||||++|+|++|++||...+..+...++... ...+....+++++.++|.+|+ .
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 210 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-R 288 (382)
T ss_pred cCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-c
Confidence 999999999999999999999999999999999999999988776655555432 222334568999999999986 5
Q ss_pred CCCCCcC---HHHHHHhhccChh
Q 008303 191 NPELRPS---AAELLRHVHLQPY 210 (570)
Q Consensus 191 dP~~RPT---a~eIL~hp~fq~~ 210 (570)
+|.+|++ ++++++|+||+..
T Consensus 289 ~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 289 GPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred CHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.49 Aligned_cols=204 Identities=28% Similarity=0.500 Sum_probs=172.9
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +|+||+.++++|..+ +.+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 56 ~~l~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlk 132 (332)
T cd05614 56 NVLEHVRQSPFLVTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIK 132 (332)
T ss_pred HHHHhccCCCCcccEEEEEecC-CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Confidence 578888 699999999988654 4789999999999999999764 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccC-
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFD- 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~- 156 (570)
|+|||++.++.+||+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 133 p~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred HHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 999999999999999999998654322 23356899999999999865 47899999999999999999999996432
Q ss_pred ---HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 157 ---MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 157 ---~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
...+...+.. ...+.+..++..+.+||.+||..||++|| +++++++|+||+.
T Consensus 213 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 213 RNTQSEVSRRILK-CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 2333333332 33456678999999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.82 Aligned_cols=206 Identities=46% Similarity=0.929 Sum_probs=183.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||+++++.|...++.+|+|||||.+++|.+++.......+++..++.++.||+.||.|||++||+|+||||
T Consensus 51 ~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p 130 (257)
T cd08223 51 QLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKT 130 (257)
T ss_pred HHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCc
Confidence 67889999999999998865566789999999999999999875556789999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.++|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 131 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 210 (257)
T cd08223 131 QNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210 (257)
T ss_pred hhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999999876432 233456789999999999998899999999999999999999999988887776
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
...+..+.....+..++..+.+||.+||..+|++||++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 211 VYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 66666665555677899999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.33 Aligned_cols=204 Identities=25% Similarity=0.489 Sum_probs=177.3
Q ss_pred Hhhh-cCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 3 LISK-IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 3 IL~k-L~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+|.. ++||||++++++|.++ .++|+|||||.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 48 ~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp 124 (316)
T cd05620 48 VLALAWENPFLTHLYCTFQTK-EHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKL 124 (316)
T ss_pred HHHhccCCCCccCeeEEEEeC-CEEEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 4544 4899999999998665 4899999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~ 204 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999987532 22234457899999999999999999999999999999999999999998888777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH-HHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA-AELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa-~eIL~hp~fq~~ 210 (570)
...+.... ...+..++.++++||++||..||.+|+++ +++++|+||...
T Consensus 205 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 205 FESIRVDT-PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HHHHHhCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 77665443 33566789999999999999999999997 588899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.00 Aligned_cols=202 Identities=31% Similarity=0.438 Sum_probs=171.7
Q ss_pred hhcCCCcccccceEEEee----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 5 SKIRNPFIVEYKDSWVER----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~~----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++||||++++++|... +..+|+||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+|||||
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 135 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 135 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 345799999999988642 3568999999985 89999987655569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+|||++.++.+||+|||++.............|+..|+|||++.+..++.++|||||||++|+|++|+++|........
T Consensus 136 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~ 215 (288)
T cd07863 136 PENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 215 (288)
T ss_pred HHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH
Confidence 99999999999999999999877655445566889999999999988999999999999999999999999987766555
Q ss_pred HHHHHhccCC--------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 161 INKINKSIVA--------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 161 ~~~i~~~~~~--------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
..++...... .....++..+.+||.+||.+||++|||+.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 216 LGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 5444321110 0112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.05 Aligned_cols=204 Identities=29% Similarity=0.518 Sum_probs=178.0
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
+++.++||||++++++|.+. +.+|+|||||.||+|..++.+. ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 49 ~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~ 125 (321)
T cd05603 49 LLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPE 125 (321)
T ss_pred HHHhCCCCCccceeeEEEcC-CEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH
Confidence 56788999999999988654 5899999999999999988764 45899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
|||++.+|.+||+|||++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.....
T Consensus 126 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (321)
T cd05603 126 NILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205 (321)
T ss_pred HeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 9999999999999999987532 223344568999999999999889999999999999999999999999988877777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH----HHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA----AELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa----~eIL~hp~fq~~ 210 (570)
..+.... ...+...+..+.++|.+||..+|.+|+++ .++++|+||...
T Consensus 206 ~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 206 DNILHKP-LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHHhcCC-CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 7665443 34566789999999999999999999865 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=323.40 Aligned_cols=207 Identities=27% Similarity=0.475 Sum_probs=189.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+.|+-++|||||+||++. +....+|+|+|+-+||+|++||.++. ..+.|+.+++++.||+.|+.|||+.++||||||
T Consensus 68 VRCMKLVQHpNiVRLYEVi-DTQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLK 145 (864)
T KOG4717|consen 68 VRCMKLVQHPNIVRLYEVI-DTQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLK 145 (864)
T ss_pred HHHHHHhcCcCeeeeeehh-cccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCC
Confidence 3567778999999999975 55668999999999999999998875 459999999999999999999999999999999
Q ss_pred CCcEEEc-CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|+.+. +-|.|||.|||++..+.+.....+.||+..|.|||++.+..| .+++||||||+|||.|++|++||...+..
T Consensus 146 PENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 146 PENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred cceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 9998664 578999999999999998888999999999999999999999 57899999999999999999999998888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+...+|....+. .|..++.++++||..||..||.+|.+.++|..++|+|..
T Consensus 226 ETLTmImDCKYt-vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 226 ETLTMIMDCKYT-VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred hhhhhhhccccc-CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 888888776654 688999999999999999999999999999999999854
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.21 Aligned_cols=205 Identities=28% Similarity=0.455 Sum_probs=174.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++.|.++ +++|||||||.||+|.++|.+. +.+++..++.|+.||+.||+|||++||+||||||
T Consensus 53 ~il~~l~h~~iv~~~~~~~~~-~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp 129 (376)
T cd05598 53 DILAEADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 129 (376)
T ss_pred HHHHhCCCCCcceEEEEEEcC-CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCH
Confidence 588999999999999988654 5899999999999999999874 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC--------------------------------------------CCCccccCCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD--------------------------------------------DLASSVVGTPS 117 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~--------------------------------------------~~~~~~~GT~~ 117 (570)
+|||++.++.+||+|||++..+... ......+||+.
T Consensus 130 ~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred HHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 9999999999999999997532100 01123579999
Q ss_pred CCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhccCCCC
Q 008303 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKS---IVAPLPTKYSGAFRGLVKSMLRKNPEL 194 (570)
Q Consensus 118 Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~dP~~ 194 (570)
|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+....++.++.+||.+|+ .+|.+
T Consensus 210 y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~ 288 (376)
T cd05598 210 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAED 288 (376)
T ss_pred ccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhh
Confidence 99999999999999999999999999999999999988776665554332 122233468999999999977 59999
Q ss_pred Cc---CHHHHHHhhccChh
Q 008303 195 RP---SAAELLRHVHLQPY 210 (570)
Q Consensus 195 RP---Ta~eIL~hp~fq~~ 210 (570)
|+ ++.++++|+||+..
T Consensus 289 R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 289 RLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred cCCCCCHHHHhCCCCcCCC
Confidence 99 99999999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.47 Aligned_cols=206 Identities=26% Similarity=0.435 Sum_probs=172.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||++++++|.+. .++|+|||||.||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 53 ~il~~l~h~~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp 129 (381)
T cd05626 53 DILAEADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKP 129 (381)
T ss_pred HHHHhcCCCCeeeeEEEEecC-CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcH
Confidence 678999999999999998754 5799999999999999999874 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC------------------------------------------------CCCcccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD------------------------------------------------DLASSVV 113 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~------------------------------------------------~~~~~~~ 113 (570)
+||||+.++.+||+|||++..+... ......+
T Consensus 130 ~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (381)
T cd05626 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209 (381)
T ss_pred HHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccccccc
Confidence 9999999999999999997543100 0112457
Q ss_pred CCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHh-c--cCCCCCCCCcHHHHHHHHHhhcc
Q 008303 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK-S--IVAPLPTKYSGAFRGLVKSMLRK 190 (570)
Q Consensus 114 GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~-~--~~~p~p~~~s~~l~dLI~~~L~~ 190 (570)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+......++.. . ...+....++.++++||.+||..
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred CCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccC
Confidence 99999999999998999999999999999999999999988776655544432 1 22233346899999999996654
Q ss_pred --CCCCCcCHHHHHHhhccChh
Q 008303 191 --NPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 191 --dP~~RPTa~eIL~hp~fq~~ 210 (570)
++..|+++++|++|+||+..
T Consensus 290 ~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 290 AEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred cccccCCCCHHHHhcCcccCCC
Confidence 45559999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.17 Aligned_cols=208 Identities=28% Similarity=0.501 Sum_probs=178.5
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKL-FSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~-Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
|.||++|+|||||+|+++..+- ..++|||+|||..|.+...- ..+. |++.++++|+++++.||+|||.+||+|||
T Consensus 159 IailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRD 235 (576)
T KOG0585|consen 159 IAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRD 235 (576)
T ss_pred HHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 5799999999999999976432 46899999999998876532 2344 89999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceecc------CCCCCccccCCCCCCCcccccCC---CC-CCcccccchhhhHHHhhcc
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILT------SDDLASSVVGTPSYMCPELLADI---PY-GSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~------~~~~~~~~~GT~~Y~APE~l~~~---~~-t~ksDIWSLG~IlyeLltG 148 (570)
|||.|+||+++|.|||+|||.+.... ........+|||.|+|||.+.++ .| +.+.|||+|||.||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 99999999999999999999998762 23334458999999999999773 33 7799999999999999999
Q ss_pred CCCCcccCHHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 149 KPAFKAFDMQALINKINKSIV-APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
+.||-+....+++.+|..... .|....+..++++||.+||.+||++|+++.+|..|||.....
T Consensus 316 ~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 999999998999999866533 333345789999999999999999999999999999987653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=336.02 Aligned_cols=203 Identities=29% Similarity=0.549 Sum_probs=183.4
Q ss_pred Hhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 3 LISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 3 IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
|+.-. +||+++.++.+|..+ .++|+||||+.||+|..+++. ..|++..++.++..|+.||.|||++||||||||.
T Consensus 421 I~~la~~HPFL~~L~~~fQT~-~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKL 496 (694)
T KOG0694|consen 421 IFELANRHPFLVNLFSCFQTK-EHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKL 496 (694)
T ss_pred HHHHhccCCeEeecccccccC-CeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecch
Confidence 44444 799999999998655 489999999999996655543 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||||.+|.+||+|||+++..- .+..+.++||||.|||||++.+..|+..+|.|+|||+||||+.|..||.+.+.+++
T Consensus 497 dNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~ 576 (694)
T KOG0694|consen 497 DNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV 576 (694)
T ss_pred hheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99999999999999999999765 56678899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-C----HHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-S----AAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-T----a~eIL~hp~fq~~ 210 (570)
++.|....+. .|..++.++.++++++|.++|++|. + +++|..||||+..
T Consensus 577 FdsI~~d~~~-yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 577 FDSIVNDEVR-YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHhcCCCC-CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 9999766543 5778999999999999999999999 4 7999999999853
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.91 Aligned_cols=204 Identities=25% Similarity=0.489 Sum_probs=177.9
Q ss_pred Hhhh-cCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 3 LISK-IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 3 IL~k-L~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++.. ++||||++++++|... .++|+|||||.||+|.++++... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 48 ~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp 124 (316)
T cd05592 48 VLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKL 124 (316)
T ss_pred HHHhccCCCCccceeeEEEcC-CEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 3443 3899999999988654 58999999999999999997643 589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~ 204 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999986532 2334456899999999999998999999999999999999999999999888777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH-HHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA-AELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa-~eIL~hp~fq~~ 210 (570)
...+... ....+..++.++.+||.+||..+|.+|+++ .++++|+||...
T Consensus 205 ~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 205 FDSILND-RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 7776543 334567789999999999999999999986 588899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.31 Aligned_cols=204 Identities=28% Similarity=0.520 Sum_probs=177.8
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
+|+.++|+||++++++|... ..+|+|||||.||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 49 ~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~ 125 (325)
T cd05602 49 LLKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 125 (325)
T ss_pred HHHhCCCCCCCceeEEEEcC-CeEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence 46778999999999988655 4789999999999999999864 35899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+..
T Consensus 126 Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (325)
T cd05602 126 NILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205 (325)
T ss_pred HeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999999987543 223344568999999999999999999999999999999999999999988887777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHH----HHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA----ELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~----eIL~hp~fq~~ 210 (570)
..+.... ...+..++..+.++|++||+++|.+|+++. ++++|+||..+
T Consensus 206 ~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 206 DNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHHHhCC-cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 7665443 234567899999999999999999999865 89999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.20 Aligned_cols=205 Identities=31% Similarity=0.527 Sum_probs=173.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDL 79 (570)
+++|++++||||++++++|..++ .+|+|||||+||+|.+++.... .+++..+..++.|++.||.|||++ +|+||||
T Consensus 54 ~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dl 130 (331)
T cd06649 54 LQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130 (331)
T ss_pred HHHHHHCCCCCCCeEEEEEEECC-EEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCC
Confidence 36889999999999999987654 7899999999999999998743 589999999999999999999986 6999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
||+|||++.++.+||+|||++..+... .....+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 131 kp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 131 KPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred ChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999999776432 3345679999999999998899999999999999999999999997665544
Q ss_pred HHHHHHh----------------------------------------------ccCCCC-CCCCcHHHHHHHHHhhccCC
Q 008303 160 LINKINK----------------------------------------------SIVAPL-PTKYSGAFRGLVKSMLRKNP 192 (570)
Q Consensus 160 ~~~~i~~----------------------------------------------~~~~p~-p~~~s~~l~dLI~~~L~~dP 192 (570)
+...+.. ...... ...++.++++||.+||.+||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCc
Confidence 3322211 111111 12478899999999999999
Q ss_pred CCCcCHHHHHHhhccCh
Q 008303 193 ELRPSAAELLRHVHLQP 209 (570)
Q Consensus 193 ~~RPTa~eIL~hp~fq~ 209 (570)
++|||+++||+|+||+.
T Consensus 290 ~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 290 AERADLKMLMNHTFIKR 306 (331)
T ss_pred ccCCCHHHHhcChHHhh
Confidence 99999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.51 Aligned_cols=204 Identities=27% Similarity=0.505 Sum_probs=172.1
Q ss_pred Hhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 3 LISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 3 IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++.++ +||||++++++|... ..+|+|||||.+|+|..++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 48 ~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp 124 (329)
T cd05618 48 VFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 124 (329)
T ss_pred HHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCH
Confidence 45555 899999999988665 4799999999999999988764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc-----
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF----- 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~----- 155 (570)
+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 125 ~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 204 (329)
T cd05618 125 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204 (329)
T ss_pred HHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC
Confidence 99999999999999999987542 223344568999999999999999999999999999999999999999521
Q ss_pred ----CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC------HHHHHHhhccChh
Q 008303 156 ----DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS------AAELLRHVHLQPY 210 (570)
Q Consensus 156 ----~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT------a~eIL~hp~fq~~ 210 (570)
........+. .....+|..++..+.+||++||..||.+|++ ++++++||||+..
T Consensus 205 ~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 205 PDQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred cccccHHHHHHHHh-cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 1112223332 2334467788999999999999999999998 5899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=295.29 Aligned_cols=206 Identities=34% Similarity=0.691 Sum_probs=185.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++.++ +..|+||||+.|++|.+++.......+++..++.++.||+.||.|||++||+|+|||
T Consensus 50 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~ 128 (256)
T cd08529 50 ARVLAKLDSSYIIRYYESFLDK-GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIK 128 (256)
T ss_pred HHHHHhcCCCCeehheeeeccC-CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 3578999999999999998765 478999999999999999987655679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||+++.++.++|+|||++..+.... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 129 ~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 208 (256)
T cd08529 129 SLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208 (256)
T ss_pred cceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999998765433 2334578899999999999889999999999999999999999999888777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+......+.+..++..+.++|.+||..+|++||++.++++|+|+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 209 LILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 777777776666777889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.39 Aligned_cols=205 Identities=27% Similarity=0.541 Sum_probs=179.6
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|..+ +||||++++++|... +++|+|||||.||+|.+++.+. ..+++..+..|+.||+.||.|||++||+|||||
T Consensus 47 ~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 123 (318)
T cd05570 47 RVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLK 123 (318)
T ss_pred HHHHhccCCCCccceeeEEEcC-CEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCC
Confidence 456666 799999999988654 4799999999999999998764 359999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++.... ........+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 124 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~ 203 (318)
T cd05570 124 LDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203 (318)
T ss_pred HHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH
Confidence 999999999999999999987532 2223345679999999999999999999999999999999999999999888777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH-----HHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA-----AELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa-----~eIL~hp~fq~~ 210 (570)
....+..... ..+..++..+.+||++||..||.+||++ .+++.|+||...
T Consensus 204 ~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 204 LFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHHHHHcCCC-CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 7776654433 3566789999999999999999999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.01 Aligned_cols=204 Identities=25% Similarity=0.457 Sum_probs=176.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+ +.++|+|||||.||+|.+++... .+++..+..++.||+.||+|||++||+||||||
T Consensus 95 ~il~~~~h~~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp 170 (370)
T cd05596 95 DIMAHANSEWIVQLHYAFQD-DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170 (370)
T ss_pred HHHHhCCCCCcceEEEEEec-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 57889999999999998865 45899999999999999998753 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC----CCCCcccccchhhhHHHhhccCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI----PYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~----~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
+|||++.++.+||+|||++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 171 ~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 99999999999999999998765432 22356899999999998653 3789999999999999999999999998
Q ss_pred CHHHHHHHHHhccC---CCCCCCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccCh
Q 008303 156 DMQALINKINKSIV---APLPTKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQP 209 (570)
Q Consensus 156 ~~~~~~~~i~~~~~---~p~p~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~ 209 (570)
+......++..... .+....++.++++||++||..+|.+ |+++++|++|+||+.
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 251 SLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 88777777754321 2222368999999999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.18 Aligned_cols=208 Identities=28% Similarity=0.498 Sum_probs=179.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+.++++|... .++|+|||||.||+|.+++.......+++..+..++.||+.||.|||++||+|||||
T Consensus 51 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 129 (285)
T cd05605 51 KQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK 129 (285)
T ss_pred HHHHHhcCCCCEeeeeeeecCC-CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Confidence 3678999999999999988654 489999999999999999876555569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+||++++++.++|+|||++............+|+..|+|||++.+..++.++||||+||++|+|++|..||.+.+....
T Consensus 130 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 130 PENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred HHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence 99999999999999999999876544444456899999999999988899999999999999999999999987665433
Q ss_pred HHHHH---hccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 161 INKIN---KSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~---~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
...+. .......+..++..+.+||.+||..||.+|| +++++++|+||..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 22222 1222334567899999999999999999999 9999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.89 Aligned_cols=199 Identities=32% Similarity=0.487 Sum_probs=173.5
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+||||+.++++|... ..+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 54 ~~p~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~ 130 (330)
T cd05586 54 ESPFIVGLKFSFQTD-SDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130 (330)
T ss_pred CCCcCcceEEEEecC-CeEEEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence 799999999988654 4789999999999999998764 4589999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHH
Q 008303 88 KDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKIN 165 (570)
Q Consensus 88 ~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~ 165 (570)
.++.+||+|||++..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.
T Consensus 131 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~ 210 (330)
T cd05586 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210 (330)
T ss_pred CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence 999999999999876432 3334467899999999999754 47999999999999999999999999888887777776
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCc----CHHHHHHhhccCh
Q 008303 166 KSIVAPLPTKYSGAFRGLVKSMLRKNPELRP----SAAELLRHVHLQP 209 (570)
Q Consensus 166 ~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP----Ta~eIL~hp~fq~ 209 (570)
..........++.++.+||++||..||.+|| +++++++|+||..
T Consensus 211 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 211 FGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 5543333345799999999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=316.02 Aligned_cols=211 Identities=25% Similarity=0.409 Sum_probs=183.9
Q ss_pred CHHhhhcCCCcccccceEEEeeC-c---EEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-C---YVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-~---~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
++||++++|||||+++-+|.... . +.++||||++. +|..+++. ..++.++...++-+.+||++||.|||+.||
T Consensus 68 l~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~I 146 (364)
T KOG0658|consen 68 LQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGI 146 (364)
T ss_pred HHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCc
Confidence 47899999999999998886432 2 45689999975 99999985 235679999999999999999999999999
Q ss_pred ccceecCCcEEEcCC-CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCC
Q 008303 75 LHRDVKCSNIFLTKD-QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 75 vHrDLKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
+||||||+|||+|.+ |.+||||||.|+.+.......++..|..|+|||++.+. .|+.+.||||.|||+.||+-|++.|
T Consensus 147 cHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF 226 (364)
T KOG0658|consen 147 CHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF 226 (364)
T ss_pred ccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence 999999999999976 99999999999999888888888999999999999765 5899999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 153 KAFDMQALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.+..++...|.+.++.| .....++++.+|+.++|.++|.+|.++.|+|.|
T Consensus 227 pG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 227 PGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 9988877777665544433 123457899999999999999999999999999
Q ss_pred hccChhhh
Q 008303 205 VHLQPYVL 212 (570)
Q Consensus 205 p~fq~~~~ 212 (570)
+||.....
T Consensus 307 ~fFdelr~ 314 (364)
T KOG0658|consen 307 PFFDELRD 314 (364)
T ss_pred hhhHHhhC
Confidence 99987643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=304.97 Aligned_cols=207 Identities=29% Similarity=0.534 Sum_probs=174.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++|+||++++++|..+ ..+|+|||||.||+|.+++... ....+++..++.++.||+.||.|||++||+||||
T Consensus 45 ~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 123 (280)
T cd05608 45 RILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDL 123 (280)
T ss_pred HHHHhCCCCcEeeeeEEEcCC-CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 578999999999999988654 4789999999999999888542 2346899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
||+|||++.++.+||+|||++..+.... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 124 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 203 (280)
T cd05608 124 KPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 203 (280)
T ss_pred CHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 9999999999999999999998765432 233467899999999999999999999999999999999999999765422
Q ss_pred ----HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 159 ----ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 159 ----~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
.....+... ....+..++..+.+++.+||+.||.+|+ +++++++|+||+..
T Consensus 204 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 204 VENKELKQRILND-SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred hhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 222222221 2234567899999999999999999999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.29 Aligned_cols=203 Identities=28% Similarity=0.503 Sum_probs=177.4
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
+++.++||||++++++|..+ ..+|+|||||.||+|..++.+. ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 49 ~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~ 125 (325)
T cd05604 49 LLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPE 125 (325)
T ss_pred HHHhCCCCCCccEEEEEecC-CEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 46778999999999988655 4789999999999999998764 45899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
|||++.++.+||+|||+++... ........+|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 126 NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~ 205 (325)
T cd05604 126 NILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205 (325)
T ss_pred HeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH
Confidence 9999999999999999987542 223344568999999999999999999999999999999999999999988887777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH----HHHHHhhccCh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA----AELLRHVHLQP 209 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa----~eIL~hp~fq~ 209 (570)
..+..... ..+..++..+.++|++||..+|.+||++ .++++|+||..
T Consensus 206 ~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 206 DNILHKPL-VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHcCCc-cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 76655432 3345689999999999999999999976 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.72 Aligned_cols=202 Identities=22% Similarity=0.441 Sum_probs=183.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++||++|+|+|||+|++++...+ .+||||||+..|+|.++++..++..+.......++.||++|++||+++++|||||.
T Consensus 252 a~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLA 330 (468)
T KOG0197|consen 252 AQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLA 330 (468)
T ss_pred HHHHHhCcccCeEEEEEEEecCC-ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhh
Confidence 37999999999999999986544 79999999999999999998777889999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccc--cCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSV--VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~--~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
..||||+++..+||+|||+|+.+.++...... --...|.|||.+....|+.++|||||||+||||++ |+.||.+++.
T Consensus 331 ARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 331 ARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred hhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 99999999999999999999965544432221 12345999999999999999999999999999976 8899999999
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
.++++.+..+...+.|..|++++.++++.||..+|++|||++.+..
T Consensus 411 ~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 411 EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 9999999999999999999999999999999999999999996654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=309.31 Aligned_cols=206 Identities=27% Similarity=0.472 Sum_probs=176.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||++++++|.+. ..+|||||||+||+|.+++.+.. ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 53 ~i~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp 130 (330)
T cd05601 53 DILSISNSPWIPQLQYAFQDK-DNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKP 130 (330)
T ss_pred HHHHhCCCCCCcceeeEEecC-CeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCch
Confidence 577888999999999988654 57999999999999999998753 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCccccc------CCCCCCcccccchhhhHHHhhccCCCCc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~------~~~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
+|||++.++.+||+|||++..+..... ....+||+.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 131 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 131 ENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred HheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 999999999999999999987654332 23357999999999986 4567899999999999999999999998
Q ss_pred ccCHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 154 AFDMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+.......+.... ..+....++..+.+||++||. +|.+||++++++.|+||...
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 211 EGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 887776666664432 122234689999999999998 99999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.64 Aligned_cols=209 Identities=26% Similarity=0.409 Sum_probs=181.8
Q ss_pred CHHhhhcCCCc-ccccceEEEeeCc-----EEEEEEeccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 1 MELISKIRNPF-IVEYKDSWVERGC-----YVCIIIGFCEGGDMAEAIKKANS--KLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 1 v~IL~kL~HPn-IV~l~~~f~~~~~-----~i~IV~Ey~~gGsL~d~I~~~~~--~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
+-+|++|+|+| ||.+++++...+. .+++|+||++. +|..+++.... +.++...++.+++||+.||+|||++
T Consensus 61 isllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~ 139 (323)
T KOG0594|consen 61 ISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH 139 (323)
T ss_pred HHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35799999999 9999999865543 78999999975 99999998653 3688899999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCC
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
||+||||||+||||+.+|.+||+|||+|+.+. +.......++|.||.|||++.+. .|+...||||+|||++||+++++
T Consensus 140 ~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 140 GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999999877 34446778999999999999877 68999999999999999999999
Q ss_pred CCcccCHHHHHHHHHhccCCCCCC-----------------------------CCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 151 AFKAFDMQALINKINKSIVAPLPT-----------------------------KYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~~~~p~p~-----------------------------~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
.|.+....++...|......|-.. ..+....+++.+||+++|.+|.|++.+
T Consensus 220 LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a 299 (323)
T KOG0594|consen 220 LFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA 299 (323)
T ss_pred CCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence 999999888877776544443111 112488899999999999999999999
Q ss_pred HHhhccChh
Q 008303 202 LRHVHLQPY 210 (570)
Q Consensus 202 L~hp~fq~~ 210 (570)
|.|+||+..
T Consensus 300 l~h~yf~~~ 308 (323)
T KOG0594|consen 300 LTHPYFSEL 308 (323)
T ss_pred hcChhhccc
Confidence 999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.05 Aligned_cols=206 Identities=25% Similarity=0.468 Sum_probs=190.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+|-..|+||||+++|++|.++ ..+|+++||..+|+|...+.......|++...+.+++|++.||.|||.++|+|||||
T Consensus 73 iEIqs~L~hpnilrlY~~fhd~-~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiK 151 (281)
T KOG0580|consen 73 IEIQSHLRHPNILRLYGYFHDS-KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIK 151 (281)
T ss_pred eEeecccCCccHHhhhhheecc-ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCC
Confidence 4677889999999999999655 589999999999999999986666779999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+|+|++..|.+||+|||.+-.-. .....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+.
T Consensus 152 penlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et 230 (281)
T KOG0580|consen 152 PENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET 230 (281)
T ss_pred HHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH
Confidence 999999999999999999987755 5566789999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+.+|.+.... +|..++.++.|+|.+||.++|.+|....|++.|||+..
T Consensus 231 YkrI~k~~~~-~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 231 YKRIRKVDLK-FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHcccc-CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9998776543 57899999999999999999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=306.46 Aligned_cols=206 Identities=27% Similarity=0.419 Sum_probs=167.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+. ...|+|||||. ++|.+++.+.. ..++++.++.++.||+.||+|||++||+||||||
T Consensus 55 ~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp 131 (303)
T cd07869 55 SLLKGLKHANIVLLHDIIHTK-ETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKP 131 (303)
T ss_pred HHHhhCCCCCcCeEEEEEecC-CeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 578999999999999988654 57999999996 58888887643 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCH-H
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM-Q 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~-~ 158 (570)
+|||++.++.+||+|||++...... ......+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .
T Consensus 132 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 132 QNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred HHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 9999999999999999998765422 22345678999999999865 4578999999999999999999999976532 2
Q ss_pred HHHHHHHhccCCC----------------------CC---------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVAP----------------------LP---------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~p----------------------~p---------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.....+......+ .+ ..++..+.+||++||+.||.+|+|+.|+|+|+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 212 DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 3332222111000 00 1245788999999999999999999999999999
Q ss_pred Chh
Q 008303 208 QPY 210 (570)
Q Consensus 208 q~~ 210 (570)
+..
T Consensus 292 ~~~ 294 (303)
T cd07869 292 SDL 294 (303)
T ss_pred ccC
Confidence 864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=310.68 Aligned_cols=206 Identities=25% Similarity=0.501 Sum_probs=173.7
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
.++.++ +|+||+.++++|... ..+|+|||||.||+|..++.+. ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 47 ~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlk 123 (327)
T cd05617 47 HVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLK 123 (327)
T ss_pred HHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 356677 799999999988654 5799999999999999998764 359999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc----
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF---- 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~---- 155 (570)
|+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 124 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~ 203 (327)
T cd05617 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP 203 (327)
T ss_pred HHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc
Confidence 999999999999999999987532 233344578999999999999999999999999999999999999999532
Q ss_pred --CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC------HHHHHHhhccChh
Q 008303 156 --DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS------AAELLRHVHLQPY 210 (570)
Q Consensus 156 --~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT------a~eIL~hp~fq~~ 210 (570)
...+.............+..++..+.++|++||..||.+|++ ++++++|+||...
T Consensus 204 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 204 DMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred ccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 222222233233344467788999999999999999999997 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=326.13 Aligned_cols=210 Identities=23% Similarity=0.375 Sum_probs=173.6
Q ss_pred CHHhhhcCCCcccccceEEEee-------CcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVER-------GCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHA 71 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-------~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs 71 (570)
+.+|++++|+|||+++++|... ..++|+|||||.+ +|.+++.. .....+++..++.|+.||+.||+|||+
T Consensus 110 i~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~ 188 (440)
T PTZ00036 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188 (440)
T ss_pred HHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3689999999999999987431 2367899999975 78777754 234579999999999999999999999
Q ss_pred CCcccceecCCcEEEcCCC-CEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccC
Q 008303 72 NHILHRDVKCSNIFLTKDQ-DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~ 149 (570)
+||+||||||+|||++.++ .+||+|||+++.+.........+||+.|+|||++.+. .|+.++|||||||++|+|++|.
T Consensus 189 ~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred CCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999665 6999999999887655555567889999999998754 6899999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhccCC----------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 150 PAFKAFDMQALINKINKSIVA----------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~----------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
+||.+.+..+.+..+...... .++...+.++++||.+||.+||.+|+|+.|+
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~ 348 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 999887665554444322111 1233567899999999999999999999999
Q ss_pred HHhhccChhh
Q 008303 202 LRHVHLQPYV 211 (570)
Q Consensus 202 L~hp~fq~~~ 211 (570)
|+||||....
T Consensus 349 l~hp~f~~~~ 358 (440)
T PTZ00036 349 LADPFFDDLR 358 (440)
T ss_pred hCChhHHhhh
Confidence 9999997653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=309.87 Aligned_cols=204 Identities=20% Similarity=0.414 Sum_probs=171.2
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---------------------------------
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------------------------- 46 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------------------------- 46 (570)
+++|+++ +|||||+++++|...++.+|+|||||+||+|.+++....
T Consensus 61 ~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (338)
T cd05102 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAG 140 (338)
T ss_pred HHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccc
Confidence 3578888 899999999988766667899999999999999997532
Q ss_pred ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCC
Q 008303 47 ---------------------------SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL 99 (570)
Q Consensus 47 ---------------------------~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGl 99 (570)
...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~ 220 (338)
T cd05102 141 QASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL 220 (338)
T ss_pred cCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccc
Confidence 13478899999999999999999999999999999999999999999999999
Q ss_pred ceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH-HHHHHHHhccCCCCCC
Q 008303 100 AKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ-ALINKINKSIVAPLPT 174 (570)
Q Consensus 100 a~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~-~~~~~i~~~~~~p~p~ 174 (570)
++.+.... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....+........+.
T Consensus 221 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (338)
T cd05102 221 ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE 300 (338)
T ss_pred ccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCC
Confidence 98654321 1223345678999999998899999999999999999986 99999875533 3334444444444567
Q ss_pred CCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 175 ~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.++..+.+||.+||..||.+|||+.+|++.
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~ 330 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEI 330 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=316.63 Aligned_cols=204 Identities=25% Similarity=0.472 Sum_probs=174.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++++.++||||++++++|.. +.++|+|||||.||+|.+++... .+++..+..++.||+.||+|||++||+||||||
T Consensus 95 ~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp 170 (370)
T cd05621 95 DIMAFANSPWVVQLFCAFQD-DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 170 (370)
T ss_pred HHHHhCCCCCEeeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 57888899999999998865 45899999999999999999753 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCC----CCCcccccchhhhHHHhhccCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~----~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
+|||++.++.+||+|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 171 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred HHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 999999999999999999987654332 24568999999999997543 788999999999999999999999988
Q ss_pred CHHHHHHHHHhccC-CCCC--CCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccCh
Q 008303 156 DMQALINKINKSIV-APLP--TKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQP 209 (570)
Q Consensus 156 ~~~~~~~~i~~~~~-~p~p--~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~ 209 (570)
+.......+..... ...+ ..++..++++|..||..++.+ |++++++++||||+.
T Consensus 251 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 87777777654321 2223 357999999999999866544 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=308.69 Aligned_cols=204 Identities=24% Similarity=0.478 Sum_probs=177.8
Q ss_pred Hhhh-cCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 3 LISK-IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 3 IL~k-L~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+|.. ++||||++++++|.++ ..+|+|||||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 48 ~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp 124 (316)
T cd05619 48 VLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKL 124 (316)
T ss_pred HHHhccCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH
Confidence 4554 4999999999998665 4799999999999999999864 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~ 204 (316)
T cd05619 125 DNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204 (316)
T ss_pred HHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999876432 2233456799999999999998999999999999999999999999998888777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHH-HHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA-ELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~-eIL~hp~fq~~ 210 (570)
...+.... ...+..++.++++||.+||..||.+|+++. ++++|+||...
T Consensus 205 ~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 205 FQSIRMDN-PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 77765443 234567899999999999999999999996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=313.14 Aligned_cols=205 Identities=26% Similarity=0.428 Sum_probs=170.0
Q ss_pred HHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
.+|++++||||++++++|...+ ..+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+|
T Consensus 72 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH 146 (359)
T cd07876 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIH 146 (359)
T ss_pred HHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5788999999999999886432 357999999976 67766643 3789999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||||+|||++.+|.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 147 rDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 147 RDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999987655555556789999999999999999999999999999999999999998776
Q ss_pred HHHHHHHHHhccCCC-----------------------------------------CCCCCcHHHHHHHHHhhccCCCCC
Q 008303 157 MQALINKINKSIVAP-----------------------------------------LPTKYSGAFRGLVKSMLRKNPELR 195 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p-----------------------------------------~p~~~s~~l~dLI~~~L~~dP~~R 195 (570)
.......+......+ .....+..+++||.+||..||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 543332221111000 111245789999999999999999
Q ss_pred cCHHHHHHhhccChhh
Q 008303 196 PSAAELLRHVHLQPYV 211 (570)
Q Consensus 196 PTa~eIL~hp~fq~~~ 211 (570)
||+.|+|+||||+.|.
T Consensus 307 ~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 307 ISVDEALRHPYITVWY 322 (359)
T ss_pred CCHHHHhcCchhhhhc
Confidence 9999999999998664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.11 Aligned_cols=205 Identities=28% Similarity=0.458 Sum_probs=174.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|.+++|+||++++++|.++ .++|||||||.||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 53 ~~l~~l~~~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp 129 (360)
T cd05627 53 DILVEADGAWVVKMFYSFQDK-RNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKP 129 (360)
T ss_pred HHHHhCCCCCEeeEEEEEEcC-CEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCH
Confidence 578889999999999988654 5799999999999999999864 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC------------------------------------CCccccCCCCCCCccccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD------------------------------------LASSVVGTPSYMCPELLA 125 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~------------------------------------~~~~~~GT~~Y~APE~l~ 125 (570)
+|||++.+|.+||+|||++..+.... .....+||+.|+|||++.
T Consensus 130 ~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred HHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 99999999999999999987543210 112457999999999999
Q ss_pred CCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCc---CHH
Q 008303 126 DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRP---SAA 199 (570)
Q Consensus 126 ~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RP---Ta~ 199 (570)
+..++.++|||||||++|+|++|+.||...+......++.... ..+....++.++++||.+|+. +|.+|+ +++
T Consensus 210 ~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ 288 (360)
T cd05627 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVE 288 (360)
T ss_pred CCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHH
Confidence 9999999999999999999999999999888877766665421 112223478999999999874 999998 589
Q ss_pred HHHHhhccChh
Q 008303 200 ELLRHVHLQPY 210 (570)
Q Consensus 200 eIL~hp~fq~~ 210 (570)
++++||||+..
T Consensus 289 ei~~hp~f~~~ 299 (360)
T cd05627 289 EIKSHPFFEGV 299 (360)
T ss_pred HHhcCCCCCCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=308.51 Aligned_cols=203 Identities=25% Similarity=0.495 Sum_probs=178.0
Q ss_pred Hhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 3 LISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 3 IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++..+ +|++|+.++++|... ..+|+|||||.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 53 ~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 129 (323)
T cd05616 53 VLALSGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129 (323)
T ss_pred HHHhccCCCeEeeEEEEEecC-CEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCH
Confidence 45555 689999999988654 5799999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+
T Consensus 130 ~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 209 (323)
T cd05616 130 DNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209 (323)
T ss_pred HHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999976432 2233456899999999999999999999999999999999999999999888887
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~ 209 (570)
...+..... ..+..++.++.+||.+||.++|.+|++ ..++++|+||+.
T Consensus 210 ~~~i~~~~~-~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 210 FQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHhCCC-CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 777765433 356789999999999999999999997 489999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.91 Aligned_cols=203 Identities=34% Similarity=0.608 Sum_probs=175.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+.+ .+|+|+||+.|++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|
T Consensus 56 ~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p 132 (263)
T cd06625 56 QLLKNLQHERIVQYYGCLRDDE-TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKG 132 (263)
T ss_pred HHHHhCCCCCeeeeEEEEccCC-eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 5788999999999999987654 899999999999999999875 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC----ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~----~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+||+++.++.++|+|||++......... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 133 ~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 133 ANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred HHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 9999999999999999999876432211 235688899999999998899999999999999999999999987655
Q ss_pred HHHHHHHH-hccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 158 QALINKIN-KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 158 ~~~~~~i~-~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
......+. .......+..++..+.++|.+||..+|++|||+.++++|+||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 213 MAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 54443332 233444667889999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.52 Aligned_cols=207 Identities=36% Similarity=0.646 Sum_probs=186.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+||...+||+||+|++.|..++ .++|++|||.||-....+-..+ ..|.+..|..+.+|+|.||.|||+++|||||||
T Consensus 80 IeILa~CdHP~ivkLl~ayy~en-kLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLK 157 (1187)
T KOG0579|consen 80 IEILAECDHPVIVKLLSAYYFEN-KLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLK 157 (1187)
T ss_pred hhhhhcCCChHHHHHHHHHhccC-ceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhcc
Confidence 68999999999999999887665 6899999999999998887654 569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccc-----cCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELL-----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l-----~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
..|||++-+|.|+|+|||.+-.... ......++|||+|||||++ .+.+|++++||||||+.|.||..+.+|-..
T Consensus 158 AGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 158 AGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 9999999999999999998754432 2345678999999999987 467899999999999999999999999999
Q ss_pred cCHHHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+...++-+|.+..++. -|..|+..+.||+++||.+||..||++.+||+|||++.
T Consensus 238 lnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 238 LNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred cchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999998876654 36789999999999999999999999999999999973
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=313.66 Aligned_cols=205 Identities=26% Similarity=0.394 Sum_probs=172.7
Q ss_pred HHhhhcCCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
.+|+.++||||++++++|... ...+|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||++||+|
T Consensus 75 ~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH 149 (364)
T cd07875 75 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIH 149 (364)
T ss_pred HHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 578889999999999988532 2357999999975 78777753 3789999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||||+|||++.++.+||+|||+++............||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 150 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999987765555566789999999999999999999999999999999999999998877
Q ss_pred HHHHHHHHHhccCCCC-----------------------------------------CCCCcHHHHHHHHHhhccCCCCC
Q 008303 157 MQALINKINKSIVAPL-----------------------------------------PTKYSGAFRGLVKSMLRKNPELR 195 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~-----------------------------------------p~~~s~~l~dLI~~~L~~dP~~R 195 (570)
..+...++......+. ....+..+++||.+||..||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 6665554433221111 01134678999999999999999
Q ss_pred cCHHHHHHhhccChhh
Q 008303 196 PSAAELLRHVHLQPYV 211 (570)
Q Consensus 196 PTa~eIL~hp~fq~~~ 211 (570)
||++++|+||||+.+.
T Consensus 310 ~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 310 ISVDEALQHPYINVWY 325 (364)
T ss_pred CCHHHHhcCccccccc
Confidence 9999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.69 Aligned_cols=208 Identities=27% Similarity=0.489 Sum_probs=177.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+.+++.+..+ .++|+||||+.|++|.+++.......+++..+..|+.|++.||.|||++||+||||||
T Consensus 52 ~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp 130 (285)
T cd05630 52 QILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP 130 (285)
T ss_pred HHHHhCCCCCeeeeeEEEecC-CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH
Confidence 588999999999999988655 4899999999999999999765555699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH---
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ--- 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~--- 158 (570)
+||+++.++.++|+|||++............+|+..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~ 210 (285)
T cd05630 131 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 210 (285)
T ss_pred HHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH
Confidence 99999999999999999998765444344568999999999999989999999999999999999999999764321
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
.....+........+..++.++++||.+||+.||.+|+| ++|+++|+||...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 211 EEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 222222222223345678999999999999999999999 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.81 Aligned_cols=204 Identities=25% Similarity=0.512 Sum_probs=177.2
Q ss_pred HHhhhcCC-CcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~H-PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|..++| ++|+.++++|... +.+|+|||||.||+|.+++... ..+++..+..|+.||+.||.|||++||+|||||
T Consensus 52 ~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk 128 (324)
T cd05587 52 RVLALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128 (324)
T ss_pred HHHHhcCCCCceeeeEEEEEcC-CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 46677755 5688888887654 4799999999999999999764 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 129 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~ 208 (324)
T cd05587 129 LDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208 (324)
T ss_pred HHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999987532 2223345679999999999999999999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH-----HHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA-----AELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa-----~eIL~hp~fq~ 209 (570)
....+.... ...+..++.++.++|.+||.+||.+|++. +++++||||..
T Consensus 209 ~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 209 LFQSIMEHN-VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 877776543 34567899999999999999999999976 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=291.18 Aligned_cols=206 Identities=40% Similarity=0.714 Sum_probs=184.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|.+. +.+++|||||.+|+|.+++.+.....+++..+..++.|++.||.|||+.||+|+||+
T Consensus 50 ~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~ 128 (256)
T cd08221 50 IVILSLLQHPNIIAYYNHFMDD-NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIK 128 (256)
T ss_pred HHHHHhCCCCCeeEEEeEEecC-CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence 3689999999999999998764 578999999999999999987655678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||+++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 129 p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 129 TLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred hHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999999999999998765433 3345678999999999988889999999999999999999999999888777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+......+.+..++.++.++|.+||..+|.+||++.++|+|+|+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 209 LVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 777776666666667789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.08 Aligned_cols=203 Identities=30% Similarity=0.503 Sum_probs=168.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|.++ +.+|+|||||.+|+|... ..+.+..+..|+.||+.||.|||++||+|||||
T Consensus 123 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 195 (353)
T PLN00034 123 IEILRDVNHPNVVKCHDMFDHN-GEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIK 195 (353)
T ss_pred HHHHHhCCCCCcceeeeEeccC-CeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 3688999999999999988654 478999999999998653 235788899999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-----CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.++.+||+|||++..+.... .....+||..|+|||++.. ..++.++|||||||++|+|++|+.||..
T Consensus 196 p~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred HHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998765332 2345689999999998843 2235689999999999999999999974
Q ss_pred cC---HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 155 FD---MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 155 ~~---~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.. .......+........+..++.++++||.+||..||++||++.|||+|+||...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 32 233333444444445566789999999999999999999999999999999753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.40 Aligned_cols=205 Identities=26% Similarity=0.422 Sum_probs=170.9
Q ss_pred HHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
.+|+.++||||++++++|.... ..+|+|||||++ +|.+.+.. .+++..++.++.||+.||.|||++||+|
T Consensus 68 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givH 142 (355)
T cd07874 68 VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIH 142 (355)
T ss_pred HHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5788899999999999886432 357999999976 67777653 3789999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 143 rDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred CCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999987765555566789999999999999899999999999999999999999998776
Q ss_pred HHHHHHHHHhccCCC-----------------------------------------CCCCCcHHHHHHHHHhhccCCCCC
Q 008303 157 MQALINKINKSIVAP-----------------------------------------LPTKYSGAFRGLVKSMLRKNPELR 195 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p-----------------------------------------~p~~~s~~l~dLI~~~L~~dP~~R 195 (570)
.......+......+ .....+.++++||.+||..||.+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 302 (355)
T cd07874 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhc
Confidence 544333222111100 112235678999999999999999
Q ss_pred cCHHHHHHhhccChhh
Q 008303 196 PSAAELLRHVHLQPYV 211 (570)
Q Consensus 196 PTa~eIL~hp~fq~~~ 211 (570)
||+.|+|+||||+.+.
T Consensus 303 ps~~ell~hp~~~~~~ 318 (355)
T cd07874 303 ISVDEALQHPYINVWY 318 (355)
T ss_pred CCHHHHhcCcchhccc
Confidence 9999999999998664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.63 Aligned_cols=204 Identities=25% Similarity=0.478 Sum_probs=174.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++++.++||||++++++|.. +.++|+|||||.||+|.+++... .+++..+..++.||+.||+|||++||+||||||
T Consensus 95 ~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp 170 (371)
T cd05622 95 DIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170 (371)
T ss_pred HHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 56788899999999998865 45899999999999999999753 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCC----CCCcccccchhhhHHHhhccCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~----~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
+|||++.++.+||+|||++....... .....+||+.|+|||++.... ++.++|||||||++|+|++|..||...
T Consensus 171 ~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred HHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 99999999999999999998765432 223568999999999997543 789999999999999999999999998
Q ss_pred CHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccCh
Q 008303 156 DMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQP 209 (570)
Q Consensus 156 ~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~ 209 (570)
+......++.... ..+....++..+++||.+||..++.+ |+++++|++|+||..
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 251 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 8877777775432 22233468999999999999855443 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.32 Aligned_cols=206 Identities=35% Similarity=0.646 Sum_probs=188.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|.+|.+++++||.+||+.|.. +..++|+||||.||++.++++.. ..+.|..+.-|+++++.||.|||.++.+|||||
T Consensus 62 i~~Ls~~~~~~it~yygsyl~-g~~LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIK 138 (467)
T KOG0201|consen 62 ISVLSQCDSPNITEYYGSYLK-GTKLWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIK 138 (467)
T ss_pred HHHHHhcCcchHHhhhhheee-cccHHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceeccccc
Confidence 468899999999999999975 45899999999999999999863 346999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+.|||+..+|.+||+|||.+-.+..... ..+++||+.|||||++.+..|+.++||||||++.+||++|.+|+.......
T Consensus 139 aanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 139 AANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred ccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 9999999999999999999998876543 378899999999999999999999999999999999999999999988877
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+...|.+..++.+...+++.+++||..||++||+.||+|.++|+|.|++.
T Consensus 219 vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 219 VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 77777777777777799999999999999999999999999999999875
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=289.86 Aligned_cols=205 Identities=40% Similarity=0.741 Sum_probs=183.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++.+..+ ...|+||||+.|++|.+++....+..+++..++.++.|++.||+|||++||+|+||+|
T Consensus 51 ~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~ 129 (256)
T cd08220 51 QVLKLLSHPNIIEYYENFLED-KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKT 129 (256)
T ss_pred HHHhhCCCCchhheeeeEecC-CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 578999999999999988654 5789999999999999999876556689999999999999999999999999999999
Q ss_pred CcEEEcCCC-CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQ-DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++ .+||+|||++.............|+..|+|||.+.+..++.++||||||+++|+|++|..+|...+....
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 209 (256)
T cd08220 130 QNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209 (256)
T ss_pred HHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence 999998654 5899999999887655544556789999999999988889999999999999999999999998887777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
...+......+.+..++.++.++|.+||..+|.+|||+.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 210 VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 77776666666777899999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=295.58 Aligned_cols=203 Identities=23% Similarity=0.430 Sum_probs=179.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--------------KLFSEEKLCKWLVQLLMALD 67 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--------------~~Lse~~i~~I~~QLl~aL~ 67 (570)
++|++++||||+++++++... ...|++|||+.+|+|.+++..... ..+++..+..++.||+.||.
T Consensus 60 ~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~ 138 (283)
T cd05048 60 ELMSDLQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGME 138 (283)
T ss_pred HHHHhcCCcccceEEEEEcCC-CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 578899999999999988654 478999999999999999976421 45889999999999999999
Q ss_pred HHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHH
Q 008303 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 68 yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ilye 144 (570)
|||++||+|+||||+|||++.++.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+
T Consensus 139 ~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 139 YLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred HHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999999999998654322 2334466888999999998899999999999999999
Q ss_pred hhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 145 MTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 145 Llt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|++ |..||.+....+....+......+.+..++.++.+|+.+||+.||.+||++.+|++++
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 219 IFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 997 9999998888888888877777777888999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.36 Aligned_cols=206 Identities=24% Similarity=0.431 Sum_probs=162.7
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKAN-------SKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~-------~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
+++|++++||||++++++|... +..+|+||||+.+ +|.+++.... ...+++..++.|+.||+.||.|||++
T Consensus 49 ~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 127 (317)
T cd07868 49 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127 (317)
T ss_pred HHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3689999999999999988643 4578999999964 8988886421 23589999999999999999999999
Q ss_pred CcccceecCCcEEE----cCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCC-CCCCcccccchhhhHH
Q 008303 73 HILHRDVKCSNIFL----TKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIY 143 (570)
Q Consensus 73 gIvHrDLKP~NILl----d~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~Ily 143 (570)
||+||||||+|||+ +..+.+||+|||+++.+.... .....+||+.|+|||++.+. .++.++|||||||++|
T Consensus 128 ~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (317)
T cd07868 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHH
Confidence 99999999999999 456789999999998765322 23356889999999999764 5899999999999999
Q ss_pred HhhccCCCCcccCH---------HHHHHHHHhccCCC-------------------------------------CCCCCc
Q 008303 144 EMTSLKPAFKAFDM---------QALINKINKSIVAP-------------------------------------LPTKYS 177 (570)
Q Consensus 144 eLltG~~pf~~~~~---------~~~~~~i~~~~~~p-------------------------------------~p~~~s 177 (570)
+|++|++||..... ......+......+ .....+
T Consensus 208 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (317)
T cd07868 208 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 287 (317)
T ss_pred HHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCC
Confidence 99999999964321 11111111110000 011234
Q ss_pred HHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 178 GAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 178 ~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
..+.+||++||+.||.+|||++|+|+||||
T Consensus 288 ~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 288 SKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=292.99 Aligned_cols=203 Identities=31% Similarity=0.548 Sum_probs=177.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+. .+.|+||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||+|
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p 134 (267)
T cd06628 58 ALLKELQHENIVQYLGSSLDA-DHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKG 134 (267)
T ss_pred HHHHhcCCCCeeeEEEEEEeC-CccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCH
Confidence 578999999999999988665 4789999999999999999875 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
+||+++.++.+||+|||+++...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 135 ANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred HHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999988765221 11234688899999999988899999999999999999999999987
Q ss_pred cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 155 FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.+....+..+........+..++..+.++|++||+.+|.+||++.+|++|+||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 215 CTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 76655555555554555677889999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=299.50 Aligned_cols=201 Identities=20% Similarity=0.290 Sum_probs=175.1
Q ss_pred CHHhhhcCCCcccccceEEEe--e-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Q 008303 1 MELISKIRNPFIVEYKDSWVE--R-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~--~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvH 76 (570)
+++|++++|||||+++++|.+ . ..++|+|||||.||+|.+++.+. +.+++.....++.|++.||.|||+. +++|
T Consensus 69 ~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~H 146 (283)
T PHA02988 69 IKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146 (283)
T ss_pred HHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 368999999999999999876 2 35789999999999999999864 4589999999999999999999984 9999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC--CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|||||+|||++.++.+||+|||+++...... ...+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 147 rdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred CcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999998754332 34578999999999976 6789999999999999999999999998
Q ss_pred cCHHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 155 FDMQALINKINKS-IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 155 ~~~~~~~~~i~~~-~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+..++...+... ...+.+..++..+++||.+||..||++|||+.++++..
T Consensus 225 ~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 225 LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 8877777666433 33445557899999999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.57 Aligned_cols=206 Identities=29% Similarity=0.434 Sum_probs=165.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|..+ .+.|+|||++. ++|..++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 134 ~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiK 209 (391)
T PHA03212 134 AHILRAINHPSIIQLKGTFTYN-KFTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIK 209 (391)
T ss_pred HHHHHhCCCCCCCCEeEEEEEC-CeeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 3689999999999999998654 57899999995 6899888764 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC--CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC--
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD--DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-- 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~-- 156 (570)
|+|||++.++.+||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+
T Consensus 210 P~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~ 289 (391)
T PHA03212 210 AENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289 (391)
T ss_pred hHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccc
Confidence 99999999999999999999754321 22335689999999999999999999999999999999999987653221
Q ss_pred -----HHHHHHHHHhcc---------------------------CCC----CC---CCCcHHHHHHHHHhhccCCCCCcC
Q 008303 157 -----MQALINKINKSI---------------------------VAP----LP---TKYSGAFRGLVKSMLRKNPELRPS 197 (570)
Q Consensus 157 -----~~~~~~~i~~~~---------------------------~~p----~p---~~~s~~l~dLI~~~L~~dP~~RPT 197 (570)
....+..+.... ..+ .+ ..++.++.+||.+||..||.+|||
T Consensus 290 ~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt 369 (391)
T PHA03212 290 DGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS 369 (391)
T ss_pred cccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC
Confidence 111111111100 000 00 134668999999999999999999
Q ss_pred HHHHHHhhccChh
Q 008303 198 AAELLRHVHLQPY 210 (570)
Q Consensus 198 a~eIL~hp~fq~~ 210 (570)
++|+|+|+||+..
T Consensus 370 a~elL~hp~f~~~ 382 (391)
T PHA03212 370 AEALLDFAAFQDI 382 (391)
T ss_pred HHHHhcChhhccC
Confidence 9999999999763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.38 Aligned_cols=202 Identities=31% Similarity=0.633 Sum_probs=182.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+=|++|+|+||+.++|+|....+ +|||||||..|.|...++.. ..+....+..|..+|+.|+.|||.+.|||||||
T Consensus 163 IKHLRkLkH~NII~FkGVCtqsPc-yCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLK 239 (904)
T KOG4721|consen 163 IKHLRKLKHPNIITFKGVCTQSPC-YCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLK 239 (904)
T ss_pred HHHHHhccCcceeeEeeeecCCce-eEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccC
Confidence 356899999999999999987775 79999999999999999874 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
.-||||+.+..|||+|||-++.+......-.++||..|||||++...+.++|+||||||||||||++|..||...+...+
T Consensus 240 SPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 240 SPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred CCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 99999999999999999999998766555678999999999999999999999999999999999999999988776554
Q ss_pred HHHH-HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 161 INKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 161 ~~~i-~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.-+ .+....+.|..+++.|+-||++||+-.|..||++.+||.|+
T Consensus 320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 4332 23345678899999999999999999999999999999997
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=324.92 Aligned_cols=206 Identities=26% Similarity=0.413 Sum_probs=177.3
Q ss_pred CHHhhhcC-CC-----cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKIR-NP-----FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL~-HP-----nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
|.||+.|+ |. |||+++|+|..++ ++|||+|++.. +|.++|+.++...|+...++.|+.||+.||.+||+.||
T Consensus 233 i~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~I 310 (586)
T KOG0667|consen 233 IRILELLNKHDPDDKYNIVRMLDYFYFRN-HLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGI 310 (586)
T ss_pred HHHHHHHhccCCCCCeeEEEeeecccccc-ceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46788885 43 8999999998776 79999999965 99999999888889999999999999999999999999
Q ss_pred ccceecCCcEEEcCCC--CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC
Q 008303 75 LHRDVKCSNIFLTKDQ--DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 75 vHrDLKP~NILld~~g--~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
||+||||+||||.+.+ .|||+|||.++....... .++.+..|.|||++.+.+|+.+.||||||||++||++|.+.|
T Consensus 311 IHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 311 IHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred eeccCChhheeeccCCcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 9999999999997644 699999999998654433 889999999999999999999999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCC---------------------------------------------------CC--------
Q 008303 153 KAFDMQALINKINKSIVAP---------------------------------------------------LP-------- 173 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p---------------------------------------------------~p-------- 173 (570)
.+.+..+++..|......| .|
T Consensus 389 pG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~ 468 (586)
T KOG0667|consen 389 PGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLES 468 (586)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccch
Confidence 9998887776664422211 00
Q ss_pred ---CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 174 ---TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 174 ---~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..-...+.+||++||..||.+|+|+.++|+||||...
T Consensus 469 ~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 469 GLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred hcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 0112468899999999999999999999999999753
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.35 Aligned_cols=205 Identities=31% Similarity=0.520 Sum_probs=171.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDL 79 (570)
+++|++++|+||++++++|.++ +++|+|||||.||+|.++++.. +.+++..+..++.||+.||.|||++ +|+|+||
T Consensus 54 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dl 130 (333)
T cd06650 54 LQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130 (333)
T ss_pred HHHHHHCCCCcccceeEEEEEC-CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCC
Confidence 3688999999999999998765 4899999999999999999864 3589999999999999999999985 7999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
||+|||++.++.+||+|||++..+... .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 131 kp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 131 KPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred ChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 999999999999999999998765332 2345679999999999998889999999999999999999999987654433
Q ss_pred HHHHH--------------------------------------------HhccCCCCC-CCCcHHHHHHHHHhhccCCCC
Q 008303 160 LINKI--------------------------------------------NKSIVAPLP-TKYSGAFRGLVKSMLRKNPEL 194 (570)
Q Consensus 160 ~~~~i--------------------------------------------~~~~~~p~p-~~~s~~l~dLI~~~L~~dP~~ 194 (570)
....+ ........+ ..++.++++||.+||.+||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCccc
Confidence 22111 111111111 136789999999999999999
Q ss_pred CcCHHHHHHhhccCh
Q 008303 195 RPSAAELLRHVHLQP 209 (570)
Q Consensus 195 RPTa~eIL~hp~fq~ 209 (570)
|||+.|++.|+||+.
T Consensus 290 Rpt~~ell~h~~~~~ 304 (333)
T cd06650 290 RADLKQLMVHAFIKR 304 (333)
T ss_pred CcCHHHHhhCHHHhc
Confidence 999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.12 Aligned_cols=208 Identities=26% Similarity=0.423 Sum_probs=169.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++++.++||||++++++|..++ .+|+|||||.+|+|.+++..+....+++..++.|+.||+.||+|||++||+||||||
T Consensus 51 ~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp 129 (327)
T cd08227 51 HVSKLFNHPNIVPYRATFIADN-ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKA 129 (327)
T ss_pred HHHHhcCCCCeeeEEEEEEECC-EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCh
Confidence 5788899999999999987654 789999999999999999876555689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC--------CCCccccCCCCCCCcccccC--CCCCCcccccchhhhHHHhhccCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD--------DLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~--------~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
+|||++.++.+++.|||........ .......++..|+|||++.+ ..|+.++|||||||++|+|++|+.|
T Consensus 130 ~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 209 (327)
T cd08227 130 SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209 (327)
T ss_pred hhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999865443211 11223456788999999976 4689999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCC---------------------------------------------CCCCCCcHHHHHHHHH
Q 008303 152 FKAFDMQALINKINKSIVA---------------------------------------------PLPTKYSGAFRGLVKS 186 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~---------------------------------------------p~p~~~s~~l~dLI~~ 186 (570)
|.................. +....+++.+.+||++
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 289 (327)
T cd08227 210 FKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQ 289 (327)
T ss_pred CCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHH
Confidence 9765543332222111100 0112356789999999
Q ss_pred hhccCCCCCcCHHHHHHhhccChh
Q 008303 187 MLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 187 ~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
||..||++|||++++++||||++.
T Consensus 290 ~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 290 CLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred HHhhCchhcCCHHHHhcChhhhhc
Confidence 999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=291.02 Aligned_cols=206 Identities=28% Similarity=0.529 Sum_probs=173.5
Q ss_pred HHhhhc-CCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKI-RNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++|+++ +|+||++++++|... ...+|+|||||.+|+|.+++.......+++..++.++.||+.||+|||++||+
T Consensus 54 ~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~iv 133 (272)
T cd06637 54 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133 (272)
T ss_pred HHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 567788 799999999998753 24689999999999999999875556799999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccC
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~ 149 (570)
|+||||+||+++.++.+||+|||++...... .......|+..|+|||++. +..++.++|||||||++|+|++|.
T Consensus 134 h~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred cCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999876432 2233467899999999986 345788999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 150 PAFKAFDMQALINKINKSI-VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~-~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.||...........+.... .......++..+.+||.+||..+|.+|||+.++++|+||
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 214 PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9997766544444333222 222344678999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=288.54 Aligned_cols=206 Identities=42% Similarity=0.812 Sum_probs=183.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++... .+.|+||||+.+++|.+++.......+++..+..|+.||+.||.|||++|++|+||+
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~ 128 (256)
T cd08218 50 VAVLSNMKHPNIVQYQESFEEN-GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIK 128 (256)
T ss_pred HHHHHhCCCCCeeeeEeeecCC-CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 3688999999999999988654 488999999999999999987555568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.++|+|||++........ .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 129 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 129 SQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred HHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 9999999999999999999987654322 234568899999999998889999999999999999999999998888777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+..+...+.+..++.++.++|.+||+.+|.+||++.++++|+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 209 LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 777776666666777889999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=296.00 Aligned_cols=210 Identities=27% Similarity=0.495 Sum_probs=180.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+.++++|..+ ..+|+||||+.+++|.+++.......+++..+..|+.|++.||.|||++||+|||||
T Consensus 51 ~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dik 129 (285)
T cd05632 51 KQILEKVNSQFVVNLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK 129 (285)
T ss_pred HHHHHHcCCcCceeEEEEEecC-CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence 3688999999999999988654 489999999999999999876555569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+||+++.++.+||+|||++.............|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 130 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 130 PENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred HHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999999776544444556899999999999988899999999999999999999999987765443
Q ss_pred HHHHHhc---cCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChhh
Q 008303 161 INKINKS---IVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPYV 211 (570)
Q Consensus 161 ~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~~ 211 (570)
...+... .....+..++.++.+|+..||..||.+||+ +.++++|+||....
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 210 REEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 3333222 122345678899999999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=287.75 Aligned_cols=207 Identities=43% Similarity=0.765 Sum_probs=185.4
Q ss_pred CHHhhhcCCCcccccceEEEe-eCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH-----HC
Q 008303 1 MELISKIRNPFIVEYKDSWVE-RGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLH-----AN 72 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLH-----s~ 72 (570)
+++|++++|+||+++++++.. .+..+|++||||.+++|.+++... ....+++..++.++.||+.||.||| +.
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~ 129 (265)
T cd08217 50 VNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129 (265)
T ss_pred HHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC
Confidence 367899999999999998864 356789999999999999999763 2356899999999999999999999 99
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCC
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
+|+|+||+|+||+++.++.+||+|||++........ .....|+..|+|||++....++.++||||||+++|+|++|..|
T Consensus 130 ~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 209 (265)
T cd08217 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209 (265)
T ss_pred cceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999999988765443 4456789999999999988899999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
|...+.......+........+..++..+.+++.+||..+|++||++.+|++|||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 210 FTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99888778778887777777788899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=292.16 Aligned_cols=205 Identities=33% Similarity=0.632 Sum_probs=180.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++++|+||++++++|.++ ..+|+|+||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||+
T Consensus 50 ~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 125 (274)
T cd06609 50 IQFLSQCRSPYITKYYGSFLKG-SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125 (274)
T ss_pred HHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 3678899999999999988765 5899999999999999999764 68999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||+++.++.++|+|||++..+... .......++..|++||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 126 p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 126 AANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred HHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 99999999999999999999887644 22345678899999999998889999999999999999999999998777666
Q ss_pred HHHHHHhccCCCCCCC-CcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTK-YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~-~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+........... ++.++.++|.+||..+|++||+++++++|+||+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 206 VLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred HHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 6655555544444444 8999999999999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.24 Aligned_cols=208 Identities=24% Similarity=0.430 Sum_probs=172.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++..++ ..|+||||+.+ +|.+++...+ ..+++..++.++.||+.||.|||++||+|||||
T Consensus 55 ~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlk 131 (309)
T cd07872 55 VSLLKDLKHANIVTLHDIVHTDK-SLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131 (309)
T ss_pred HHHHHhCCCCCcceEEEEEeeCC-eEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 36788999999999999886554 78999999975 8888887643 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 132 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 211 (309)
T cd07872 132 PQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211 (309)
T ss_pred HHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999999997654322 2334578999999999865 45799999999999999999999999887665
Q ss_pred HHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+....+......+ ....++.++++||.+||..||.+|||++|+|+|+||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 212 DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred HHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 4443332211100 11246889999999999999999999999999999986
Q ss_pred hh
Q 008303 210 YV 211 (570)
Q Consensus 210 ~~ 211 (570)
..
T Consensus 292 ~~ 293 (309)
T cd07872 292 LG 293 (309)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=302.18 Aligned_cols=205 Identities=25% Similarity=0.509 Sum_probs=177.0
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++..+ +|++|+.++++|... ..+|+|||||.||+|.+++.+. ..+++..+..|+.||+.||.|||++||+|||||
T Consensus 52 ~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDik 128 (323)
T cd05615 52 RVLALQDKPPFLTQLHSCFQTV-DRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLK 128 (323)
T ss_pred HHHHhccCCCchhheeeEEecC-CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 355566 567888899887654 4799999999999999999764 359999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 129 p~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~ 208 (323)
T cd05615 129 LDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208 (323)
T ss_pred HHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999998764322 22345679999999999998899999999999999999999999999988877
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
....+..... ..+..++.++.+++.+||.++|.+|++ .+++++|+||+..
T Consensus 209 ~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 209 LFQSIMEHNV-SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHHhCCC-CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 7777665433 356778999999999999999999997 5899999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=322.35 Aligned_cols=210 Identities=28% Similarity=0.583 Sum_probs=185.7
Q ss_pred HHhhhcCCCcccccceEEEeeC-------cEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-------CYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-------~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
.+|..++|+||+++++.|...+ ..+++||||+.+|+|.++|+.. ....+++..+..|+.||+.||+|||++
T Consensus 83 ~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~ 162 (496)
T PTZ00283 83 CCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162 (496)
T ss_pred HHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4677889999999998775322 2478999999999999999753 235699999999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccC
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~ 149 (570)
||+||||||+|||++.++.+||+|||+++.+... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+
T Consensus 163 ~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999999876432 2334578999999999999999999999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.||...+..++...+......+++..++.++.+||.+||..+|.+||++.++++|+|++.+.
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 99999988888888877777778889999999999999999999999999999999987654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=289.88 Aligned_cols=206 Identities=30% Similarity=0.571 Sum_probs=180.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.+ +..+|+||||+.+++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|
T Consensus 45 ~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~ 121 (262)
T cd05572 45 EILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121 (262)
T ss_pred HHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCH
Confidence 57889999999999998765 45789999999999999999874 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC--HHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD--MQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~--~~~ 159 (570)
+||+++.++.++|+|||++.............|+..|++||.+.+..++.++|||+||+++|+|++|..||...+ ...
T Consensus 122 ~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 201 (262)
T cd05572 122 ENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201 (262)
T ss_pred HHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH
Confidence 999999999999999999988765444445678999999999988889999999999999999999999998776 555
Q ss_pred HHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 160 LINKINK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
...++.. ......+..++.++.++|.+||..+|++|++ ++|+++||||..+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 202 IYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred HHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 5555543 2344456667899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.62 Aligned_cols=207 Identities=26% Similarity=0.467 Sum_probs=172.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++.+++|+||+.++++|.++ .++|+|||||.||+|.+++.+.. ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 53 ~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 130 (331)
T cd05597 53 DVLVNGDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKP 130 (331)
T ss_pred HHHHhCCCCCCCceEEEEecC-CeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCH
Confidence 467788999999999988654 58999999999999999997643 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccC-----CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~-----~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
+|||++.++.+||+|||++..+..... ....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||..
T Consensus 131 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred HHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 999999999999999999877654322 223579999999999963 4578899999999999999999999988
Q ss_pred cCHHHHHHHHHhcc-C---CCCCCCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccChh
Q 008303 155 FDMQALINKINKSI-V---APLPTKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQPY 210 (570)
Q Consensus 155 ~~~~~~~~~i~~~~-~---~p~p~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~~ 210 (570)
.+..+....+.... . .+....++..+++||++||..++++ |++++++++|+||...
T Consensus 211 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 211 ESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 87766666654321 1 1122357999999999999765544 7899999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.03 Aligned_cols=206 Identities=26% Similarity=0.473 Sum_probs=173.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++.+++|+||+.++++|.+. ..+|+|||||.||+|.+++.+.. ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 53 ~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp 130 (332)
T cd05623 53 DVLVNGDNQWITTLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP 130 (332)
T ss_pred HHHhhCCCCCEeeEEEEEecC-CEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 467788999999999988654 57999999999999999998643 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
+|||++.++.+||+|||++..+.... .....+||+.|+|||++. ...++.++|||||||++|+|++|+.||..
T Consensus 131 ~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred HHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 99999999999999999987654322 223467999999999986 34578999999999999999999999998
Q ss_pred cCHHHHHHHHHhccC----CCCCCCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSIV----APLPTKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~----~p~p~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~ 209 (570)
.+..+...++..... ......++.++++||++||..++++ |++++++++|+||+.
T Consensus 211 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 211 ESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 887777777654321 1122467999999999999765554 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.49 Aligned_cols=203 Identities=28% Similarity=0.531 Sum_probs=180.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+. ..+|+|||||.+++|.+++.+. ..+++..+..++.||+.||.|||++||+|+||+|
T Consensus 53 ~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p 129 (290)
T cd05580 53 RILQSIRHPFLVNLYGSFQDD-SNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKP 129 (290)
T ss_pred HHHHhCCCCCccceeeEEEcC-CeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 678999999999999988654 5789999999999999999875 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
.|||++.++.+||+|||++...... ....+|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.....
T Consensus 130 ~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 207 (290)
T cd05580 130 ENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY 207 (290)
T ss_pred HHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999999876544 34567899999999998888899999999999999999999999888766666
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
..+... ...++..++..++++|++||..+|.+|+ +++++++|+||+..
T Consensus 208 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 208 EKILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHhcC-CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 665533 3346677899999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.77 Aligned_cols=202 Identities=42% Similarity=0.830 Sum_probs=181.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||++++++|..+ .++|+||||+++|+|.+++....+..+++..+..|+.||+.||.|||++||+|+||||
T Consensus 50 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p 128 (255)
T cd08219 50 VLLAKMKHPNIVAFKESFEAD-GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKS 128 (255)
T ss_pred HHHHhCCCCCcceEEEEEEEC-CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCc
Confidence 578899999999999998655 5899999999999999999865556789999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus 129 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 129 KNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred ceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 99999999999999999998765432 33456789999999999988899999999999999999999999998888777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
...+......+.+..++..+.+||.+||..||++||++.+|+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 ILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 77777776667778899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.49 Aligned_cols=204 Identities=34% Similarity=0.637 Sum_probs=175.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|.+. ..+|+||||+.|++|.+++.+.. .+++..++.++.||+.||+|||+.||+|+||+
T Consensus 53 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 129 (265)
T cd06631 53 VDLLKSLKHVNIVQYLGTCLDD-NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK 129 (265)
T ss_pred HHHHHhcCCCCEeeEeeEeecC-CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcC
Confidence 3678899999999999998665 58999999999999999997643 48999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC-------CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS-------DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~-------~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
|+||+++.++.++|+|||++..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 130 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred HHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 9999999999999999999876532 112234568999999999998889999999999999999999999998
Q ss_pred ccCHHHHHHHHHh--ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 154 AFDMQALINKINK--SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 154 ~~~~~~~~~~i~~--~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
..+.......+.. ......+..++.++.++|++||..+|.+||++.+++.|+||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 210 SMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred cCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 7665444333322 23344667899999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=319.49 Aligned_cols=198 Identities=23% Similarity=0.377 Sum_probs=162.2
Q ss_pred CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceecCCcEEEc
Q 008303 9 NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVKCSNIFLT 87 (570)
Q Consensus 9 HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLKP~NILld 87 (570)
|.+|+.++++|.....++|||||++ |++|.+++.+. ..+++..++.|+.||+.||.|||+ .|||||||||+|||++
T Consensus 190 ~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 190 RFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME 266 (467)
T ss_pred CcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe
Confidence 4458899998876667899999998 67999998765 359999999999999999999998 5999999999999998
Q ss_pred CCC----------------CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCC
Q 008303 88 KDQ----------------DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 88 ~~g----------------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
.++ .+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 765 49999999876532 223457899999999999999999999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCC-------------------------C----------------CCCCcHHHHHHHHHhhcc
Q 008303 152 FKAFDMQALINKINKSIVAP-------------------------L----------------PTKYSGAFRGLVKSMLRK 190 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p-------------------------~----------------p~~~s~~l~dLI~~~L~~ 190 (570)
|.+.+..+....+....... . .......+.+||.+||++
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 98877655443332211100 0 001135678999999999
Q ss_pred CCCCCcCHHHHHHhhccChhh
Q 008303 191 NPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 191 dP~~RPTa~eIL~hp~fq~~~ 211 (570)
||.+|||++|||+||||+.+.
T Consensus 425 dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred ChhhCCCHHHHhcCccccccC
Confidence 999999999999999998754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=304.38 Aligned_cols=204 Identities=27% Similarity=0.465 Sum_probs=169.1
Q ss_pred CHHhhhcCCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++|+||++++++|... ...+|+++|++ +++|.++++. ..+++..++.|+.||+.||.|||++||+
T Consensus 65 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~iv 140 (343)
T cd07878 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGII 140 (343)
T ss_pred HHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3689999999999999988532 13578999998 7799988764 3589999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+|||++.++.+||+|||+++..... ....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 141 Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 141 HRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred cccCChhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999876432 345679999999999976 5689999999999999999999999987
Q ss_pred cCHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+......+ ....+++.+.+||.+||..||.+|||+.|+|.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 66544443332211100 112356678999999999999999999999999
Q ss_pred hccChh
Q 008303 205 VHLQPY 210 (570)
Q Consensus 205 p~fq~~ 210 (570)
|||..+
T Consensus 299 p~~~~~ 304 (343)
T cd07878 299 PYFSQY 304 (343)
T ss_pred cchhcc
Confidence 999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=283.52 Aligned_cols=203 Identities=24% Similarity=0.462 Sum_probs=181.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-------SKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-------~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
+++++++|+||+++++++.. +..+++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||
T Consensus 48 ~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 126 (262)
T cd00192 48 RVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKF 126 (262)
T ss_pred HHHhhcCCCChheeeeeecC-CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 57888999999999998876 557999999999999999998752 3568999999999999999999999999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCC
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKP 150 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~ 150 (570)
+|+||+|+||+++.++.+||+|||.+....... ......++..|+|||.+....++.++|||||||++|+|++ |..
T Consensus 127 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999998776432 2334567889999999988889999999999999999998 699
Q ss_pred CCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 151 AFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||...........+........+..++.++.+++.+||..+|.+||++.+++++.
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 207 PYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 9999888888888877766677888999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.95 Aligned_cols=206 Identities=28% Similarity=0.513 Sum_probs=172.6
Q ss_pred HHhhhc-CCCcccccceEEEe-----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKI-RNPFIVEYKDSWVE-----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~-----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
.+++++ +|+||++++++|.. .+.++|+|||||.+|+|.+++.......+++..++.++.||+.||.|||++||+
T Consensus 64 ~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv 143 (282)
T cd06636 64 NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVI 143 (282)
T ss_pred HHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 467777 79999999999863 245789999999999999999876556789999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccC
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~ 149 (570)
|+||+|+||+++.++.++|+|||++...... .......|+..|+|||++. +..++.++|||||||++|+|++|.
T Consensus 144 H~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred cCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 9999999999999999999999998765422 2233467899999999986 345788999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 150 PAFKAFDMQALINKINKSIV-APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.||...........+..... ......++..+.+||.+||..||.+||++.|||+|+||
T Consensus 224 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 224 PPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99977655444433333222 22334689999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.62 Aligned_cols=207 Identities=26% Similarity=0.404 Sum_probs=172.3
Q ss_pred CHHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|+.++|+||+++++++...+ ..+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+|
T Consensus 50 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 126 (372)
T cd07853 50 LKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILH 126 (372)
T ss_pred HHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 36788999999999999986543 26899999996 5888888653 45999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
|||||+|||++.++.+||+|||++....... .....++++.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 127 ~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred CCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999998754322 23345789999999999874 47899999999999999999999998
Q ss_pred ccCHHHHHHHHHhccCC-------------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHH
Q 008303 154 AFDMQALINKINKSIVA-------------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~~~-------------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL 202 (570)
+.+.......+...... .....++.++.+||.+||..||.+|||+.|+|
T Consensus 207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 87766555444321110 12234578999999999999999999999999
Q ss_pred HhhccChh
Q 008303 203 RHVHLQPY 210 (570)
Q Consensus 203 ~hp~fq~~ 210 (570)
+|+||+..
T Consensus 287 ~hp~~~~~ 294 (372)
T cd07853 287 AHPYLDEG 294 (372)
T ss_pred cCHhhCCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.17 Aligned_cols=207 Identities=33% Similarity=0.602 Sum_probs=176.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|... +..|+||||+.+++|..++.+. ...+++..+..++.||+.||.|||+.||+|||||
T Consensus 53 ~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlk 130 (282)
T cd06643 53 IDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK 130 (282)
T ss_pred HHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 3578899999999999998765 4789999999999999988653 2468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.++.+||+|||++...... .......++..|+|||++. +..++.++|||||||++|+|++|.+||..
T Consensus 131 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 131 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 99999999999999999998765332 1233457899999999984 34577899999999999999999999988
Q ss_pred cCHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+.......+...... ..+..++.++++||.+||..+|.+||+++++++|+||..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred cCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 8776665555443322 235578999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=285.98 Aligned_cols=202 Identities=21% Similarity=0.419 Sum_probs=178.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++...+..+|+||||+.+++|.+++.+.....+++..+..++.||+.||+|||++||+||||||
T Consensus 51 ~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 130 (256)
T cd05082 51 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130 (256)
T ss_pred HHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccch
Confidence 57899999999999998776666789999999999999999876656689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++....... ....++..|+|||++....++.++|||||||++|+|++ |+.||...+....
T Consensus 131 ~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 131 RNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred heEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999999987654322 23345678999999998889999999999999999997 9999988888887
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
...+........+..++..+.++|.+||..+|++|||+.++++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 209 VPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 777776666666778899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.93 Aligned_cols=207 Identities=31% Similarity=0.538 Sum_probs=178.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.+ +.+.|+|||||.|++|.+++.+..+..+++..++.++.||+.||.|||+.||+|+||||
T Consensus 53 ~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 131 (316)
T cd05574 53 EILATLDHPFLPTLYASFQT-ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKP 131 (316)
T ss_pred HHHHhCCCCCchhheeeeec-CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCCh
Confidence 67889999999999998865 45899999999999999999876556799999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC------------------------------CCccccCCCCCCCcccccCCCCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD------------------------------LASSVVGTPSYMCPELLADIPYGS 131 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~------------------------------~~~~~~GT~~Y~APE~l~~~~~t~ 131 (570)
+|||++.++.++|+|||++....... .....+|+..|+|||++.+..++.
T Consensus 132 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 211 (316)
T cd05574 132 ENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS 211 (316)
T ss_pred HHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc
Confidence 99999999999999999987543211 112346889999999999888999
Q ss_pred cccccchhhhHHHhhccCCCCcccCHHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCcC----HHHHHHhhc
Q 008303 132 KSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI-VAPLPTKYSGAFRGLVKSMLRKNPELRPS----AAELLRHVH 206 (570)
Q Consensus 132 ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~-~~p~p~~~s~~l~dLI~~~L~~dP~~RPT----a~eIL~hp~ 206 (570)
++||||||+++|+|++|..||...+.......+.... ..+....++..+.++|++||..+|++||+ ++++|+|+|
T Consensus 212 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 212 AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 9999999999999999999998887766665554322 22222337899999999999999999999 999999999
Q ss_pred cCh
Q 008303 207 LQP 209 (570)
Q Consensus 207 fq~ 209 (570)
|+.
T Consensus 292 ~~~ 294 (316)
T cd05574 292 FRG 294 (316)
T ss_pred hhc
Confidence 975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=289.20 Aligned_cols=206 Identities=33% Similarity=0.565 Sum_probs=175.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLK 80 (570)
++|++++||||+++++++... +..|+|+||+.+++|.+++.... ..+++..+..++.||+.||+|||+ .||+|+|||
T Consensus 51 ~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~ 128 (265)
T cd06605 51 DILHKCNSPYIVGFYGAFYNN-GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128 (265)
T ss_pred HHHHHCCCCchhhhheeeecC-CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCC
Confidence 578889999999999998765 57899999999999999998753 568999999999999999999999 999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc-----
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF----- 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~----- 155 (570)
|+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 129 ~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 207 (265)
T cd06605 129 PSNILVNSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207 (265)
T ss_pred HHHEEECCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc
Confidence 9999999999999999999876643222 2267889999999999989999999999999999999999998654
Q ss_pred CHHHHHHHHHhccCCCCCCC-CcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVAPLPTK-YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~-~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
........+........+.. ++.++.++|.+||..+|++|||+.+++.||||+.|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 208 GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 22333444433333334444 88999999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.51 Aligned_cols=206 Identities=28% Similarity=0.517 Sum_probs=176.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... +.+|+||||++|++|.+++.+.....+++..+..|+.||+.||.|||++||+||||+|
T Consensus 45 ~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p 123 (277)
T cd05577 45 KILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKP 123 (277)
T ss_pred HHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 678999999999999988654 4789999999999999999876555799999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH----
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM---- 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~---- 157 (570)
+||+++.++.+||+|||++.............++..|++||.+.+..++.++|||||||++|+|++|+.||.....
T Consensus 124 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 203 (277)
T cd05577 124 ENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203 (277)
T ss_pred HHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH
Confidence 9999999999999999998776544344456788899999999888899999999999999999999999976543
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
..+...+ .......+..+++.+.++|.+||..+|.+|| ++.++++|+||..
T Consensus 204 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 204 EELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHhcc-ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 2222222 2223345667899999999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.11 Aligned_cols=208 Identities=35% Similarity=0.630 Sum_probs=178.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++... ..+|+||||+.+++|.+++.+.. ..+++..++.++.|++.||.|||++||+|+|||
T Consensus 53 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 130 (280)
T cd06611 53 IDILSECKHPNIVGLYEAYFYE-NKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130 (280)
T ss_pred HHHHHhCCCCceeEEEEEEecC-CeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 3688999999999999998754 47899999999999999997653 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+||+++.++.++|+|||++....... ......|+..|++||++. ...++.++|||||||++|+|++|+.||..
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 131 AGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred hhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999987654322 233457899999999985 34467899999999999999999999988
Q ss_pred cCHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 155 FDMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.+.......+...... ..+..++.++.++|.+||..+|.+||+++++++|+||...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 211 LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 8776666666544322 2345789999999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.21 Aligned_cols=204 Identities=26% Similarity=0.406 Sum_probs=167.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||+++++++.+. ..+|+|||||. ++|.+++..... ..+++..++.|+.||+.||.|||++||+|+|||
T Consensus 51 ~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~ 128 (285)
T cd07861 51 SLLKELQHPNIVCLQDVLMQE-SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLK 128 (285)
T ss_pred HHHHhcCCCCEeeeEEEEeeC-CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence 578899999999999998764 47899999997 589998876432 568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....
T Consensus 129 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 129 PQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred HHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999999997654322 22344678999999998654 4788999999999999999999999876543
Q ss_pred HHHHHHHhcc----------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSI----------------------------VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~----------------------------~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.....+.... .......++.++++||++||..||.+|||+.+|++|+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 3222111100 001123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=286.76 Aligned_cols=203 Identities=22% Similarity=0.403 Sum_probs=178.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++..++ .+++||||+.+++|.+++.......+++..++.++.|++.||.|||++||+|||||
T Consensus 53 ~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk 131 (263)
T cd05052 53 AAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 131 (263)
T ss_pred HHHHHhCCCCChhheEEEEcCCC-CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC
Confidence 36788999999999999886654 68999999999999999987655678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCc--cccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||++.......... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 132 p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 132 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred cceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999998765432211 1234567999999998899999999999999999997 9999998888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++....+........+..++..+.++|.+||..+|++||++.++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 212 SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 88877777666666778899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=289.45 Aligned_cols=203 Identities=38% Similarity=0.666 Sum_probs=170.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++++++|+||+++++++.. ...+|+|||||.+++|.+++.+. ..+++..++.++.||+.||.|||++||+|+||||
T Consensus 50 ~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp 126 (260)
T PF00069_consen 50 KILRRLRHPNIVQILDVFQD-DNYLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKP 126 (260)
T ss_dssp HHHHHHTBTTBCHEEEEEEE-SSEEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSG
T ss_pred hccccccccccccccccccc-ccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 57889999999999999876 45789999999999999999854 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceec-cCCCCCccccCCCCCCCccccc-CCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKIL-TSDDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~-~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|||++.++.++|+|||.+... ..........++..|+|||++. +..++.++||||||+++|+|++|..||.......
T Consensus 127 ~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 127 ENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp GGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 9999999999999999999863 3334455678899999999998 7788999999999999999999999998874333
Q ss_pred HHHHHHhccC----CCC--CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIV----APL--PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~----~p~--p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+..... ... .......+.++|.+||..||++||++.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 207 QLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 2222221111 111 11234899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.13 Aligned_cols=208 Identities=24% Similarity=0.424 Sum_probs=172.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|+||+++++++... ..+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+|||
T Consensus 55 ~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlk 131 (301)
T cd07873 55 VSLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131 (301)
T ss_pred HHHHHhcCCCCcceEEEEEecC-CeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 3678999999999999998654 47899999997 58998887643 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..
T Consensus 132 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~ 211 (301)
T cd07873 132 PQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE 211 (301)
T ss_pred HHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999987654322 22345678999999998654 4788999999999999999999999887765
Q ss_pred HHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+....+......+ ....++..+++||.+||+.||.+|||++|+|+|+||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 212 EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred HHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 5544332211100 11246889999999999999999999999999999986
Q ss_pred hh
Q 008303 210 YV 211 (570)
Q Consensus 210 ~~ 211 (570)
..
T Consensus 292 ~~ 293 (301)
T cd07873 292 LG 293 (301)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.10 Aligned_cols=206 Identities=25% Similarity=0.490 Sum_probs=173.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++.+++|+||+.++++|.+. .++|+|||||.||+|.+++.+.. ..+++..+..|+.||+.||+|||++||+||||||
T Consensus 53 ~~l~~~~~~~i~~l~~~~~~~-~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp 130 (331)
T cd05624 53 NVLVNGDCQWITTLHYAFQDE-NYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130 (331)
T ss_pred HHHHhCCCCCEeeEEEEEEcC-CEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCch
Confidence 467788999999999988654 58999999999999999998743 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccC-----CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~-----~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
+|||++.++.+||+|||++........ ....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 131 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 999999999999999999987654332 223579999999999875 4678899999999999999999999988
Q ss_pred cCHHHHHHHHHhcc-CCCCC---CCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSI-VAPLP---TKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~-~~p~p---~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~ 209 (570)
.+..+...++.... ..+.+ ..++.++++||.+||..++.+ |++++++++|+||+.
T Consensus 211 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 211 ESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 87777666664432 11222 356899999999999876654 569999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=284.88 Aligned_cols=204 Identities=33% Similarity=0.570 Sum_probs=173.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++... ..+|++|||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+|+||+
T Consensus 51 ~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 128 (262)
T cd06613 51 ISMLKECRHPNIVAYFGSYLRR-DKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIK 128 (262)
T ss_pred HHHHHhCCCCChhceEEEEEeC-CEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Confidence 3678999999999999988654 57999999999999999987642 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC---CCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~---~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+||+++.++.+||+|||++..+.... ......++..|++||.+... .++.++|||||||++|+|++|.+||...+
T Consensus 129 p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 129 GANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred hhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999988765432 23345788999999999776 78999999999999999999999998876
Q ss_pred HHHHHHHHHhccCC----CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 157 MQALINKINKSIVA----PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 157 ~~~~~~~i~~~~~~----p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
.......+...... .....++.++.+||++||..+|..|||+.+|+.|+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 209 PMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 55554444333111 123356789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.49 Aligned_cols=205 Identities=28% Similarity=0.439 Sum_probs=168.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|... ..+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 137 ~~il~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk 212 (392)
T PHA03207 137 IDILKTISHRAIINLIHAYRWK-STVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212 (392)
T ss_pred HHHHHhcCCCCccceeeeEeeC-CEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 4689999999999999988654 47999999996 5899998543 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||++..+.... .....+||+.|+|||++....|+.++|||||||++|+|++|+.||.+...
T Consensus 213 p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999999997765332 22346799999999999998999999999999999999999999865431
Q ss_pred ---HHHHHHHHhc--------------------------cCC--CCC-----CCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 158 ---QALINKINKS--------------------------IVA--PLP-----TKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 158 ---~~~~~~i~~~--------------------------~~~--p~p-----~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
...+..+.+. ... ..+ ..++.++.+||++||..||++||++.++
T Consensus 293 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~ 372 (392)
T PHA03207 293 KSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372 (392)
T ss_pred CCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence 1111111110 000 001 2356789999999999999999999999
Q ss_pred HHhhccCh
Q 008303 202 LRHVHLQP 209 (570)
Q Consensus 202 L~hp~fq~ 209 (570)
|.||||..
T Consensus 373 l~~p~f~~ 380 (392)
T PHA03207 373 LSLPLFTK 380 (392)
T ss_pred hhCchhhc
Confidence 99999964
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=284.64 Aligned_cols=205 Identities=29% Similarity=0.568 Sum_probs=175.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+.++|+||+++++.+..+ +..|+|||||.|++|.+++..... ..+++..++.++.||+.||.|||++||+|+||+
T Consensus 51 ~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~ 129 (267)
T cd06610 51 QAMSQCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIK 129 (267)
T ss_pred HHHHhcCCCCEEEEEEEEeeC-CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 578889999999999988654 578999999999999999986433 568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+||++++++.++|+|||++..+.... .....+|+..|++||++... .++.++|+|||||++|+|++|+.||..
T Consensus 130 p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 130 AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred HHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 999999999999999999987765432 22345789999999999877 789999999999999999999999987
Q ss_pred cCHHHHHHHHHhccCCCCC-----CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 155 FDMQALINKINKSIVAPLP-----TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~p-----~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.+......++......... ..++..+.+++.+||..||++||++.+|++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 210 YPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 7765555554443222221 2578899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=287.29 Aligned_cols=203 Identities=19% Similarity=0.384 Sum_probs=178.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN------------SKLFSEEKLCKWLVQLLMALDY 68 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~------------~~~Lse~~i~~I~~QLl~aL~y 68 (570)
+++|++++|+||+++++++... ...|+||||+.|++|.++|...+ ...+++..+..++.||+.||.|
T Consensus 59 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 137 (280)
T cd05049 59 AELLTNFQHENIVKFYGVCTEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVY 137 (280)
T ss_pred HHHHHhcCCCCchheeeEEecC-CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 3688999999999999998765 57899999999999999997643 2357899999999999999999
Q ss_pred HHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 69 LHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 69 LHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
||++||+||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|
T Consensus 138 lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 138 LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred HhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999999997653322 12334567889999999999999999999999999999
Q ss_pred hc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 146 TS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 146 lt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++ |..||...+.......+........+..++..+.++|.+||..||++||++.|+++.
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 277 (280)
T cd05049 218 FTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277 (280)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 98 999998888888877777766666677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.16 Aligned_cols=205 Identities=28% Similarity=0.436 Sum_probs=164.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++|+||++++++|...+ ..|+||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 109 ~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 185 (357)
T PHA03209 109 MLLQNVNHPSVIRMKDTLVSGA-ITCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKT 185 (357)
T ss_pred HHHHhCCCCCCcChhheEEeCC-eeEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 5789999999999999987654 7899999996 58888887643 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccC-CCCcccCH---
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLK-PAFKAFDM--- 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~-~pf~~~~~--- 157 (570)
+|||++.++.+||+|||++.............||..|+|||++.+..++.++|||||||++|+|+++. ++|.....
T Consensus 186 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~ 265 (357)
T PHA03209 186 ENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265 (357)
T ss_pred HHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHH
Confidence 99999999999999999997654444444567999999999999999999999999999999998754 44433211
Q ss_pred ------HHHHHHHHhcc---CCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCcCH
Q 008303 158 ------QALINKINKSI---VAPL------------------------------PTKYSGAFRGLVKSMLRKNPELRPSA 198 (570)
Q Consensus 158 ------~~~~~~i~~~~---~~p~------------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa 198 (570)
...+..+.... ...+ ...++.++.+||.+||+.||.+|||+
T Consensus 266 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta 345 (357)
T PHA03209 266 EYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345 (357)
T ss_pred HHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH
Confidence 01111111100 0000 01456678889999999999999999
Q ss_pred HHHHHhhccCh
Q 008303 199 AELLRHVHLQP 209 (570)
Q Consensus 199 ~eIL~hp~fq~ 209 (570)
.|+|+||||++
T Consensus 346 ~e~l~hp~f~~ 356 (357)
T PHA03209 346 EEILNYPMFAQ 356 (357)
T ss_pred HHHhcCchhcc
Confidence 99999999975
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=288.28 Aligned_cols=204 Identities=28% Similarity=0.479 Sum_probs=169.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|... ..+|+||||++++.|..++... ..+++..++.++.||+.||.|||++||+|+|||
T Consensus 51 ~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~ 127 (286)
T cd07847 51 IRMLKQLKHPNLVNLIEVFRRK-RKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127 (286)
T ss_pred HHHHHhCCCCCEeeeeeEEeeC-CEEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 3588999999999999998654 5789999999998888877653 348999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+||+++.++.+||+|||++..+.... ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 128 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 128 PENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred hhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999999998775443 2334568899999999875 45789999999999999999999999877654
Q ss_pred HHHHHHHhccC--------------------CCC----------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIV--------------------APL----------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~--------------------~p~----------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+....+..... .+. ...++..+.+||.+||..+|++||++.|++.|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 208 DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 44333221100 000 12467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=281.12 Aligned_cols=205 Identities=46% Similarity=0.862 Sum_probs=185.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++++++|+||+++++.+... ...++|+||+++++|.+++.... +..+++..++.|+.||+.||.|||++|++|+||
T Consensus 51 ~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl 129 (258)
T cd08215 51 KILKKLNHPNIIKYYESFEEK-GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDI 129 (258)
T ss_pred HHHHhcCCCChhheEEEEecC-CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccC
Confidence 578899999999999988765 58999999999999999998753 367999999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|+||+++.++.++|+|||++....... ......|++.|+|||.+.+..++.++|||++|+++|+|++|..||...+..
T Consensus 130 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 209 (258)
T cd08215 130 KPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL 209 (258)
T ss_pred ChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence 9999999999999999999998765543 344567899999999999888999999999999999999999999888877
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.....+......+++..++..+.++|++||..+|.+||++.++|+||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 210 ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 7777777776777788899999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.33 Aligned_cols=208 Identities=32% Similarity=0.612 Sum_probs=179.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|..+ ...|+|||||.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||+
T Consensus 53 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~ 128 (277)
T cd06642 53 ITVLSQCDSPYITRYYGSYLKG-TKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIK 128 (277)
T ss_pred HHHHHcCCCCccHhhhcccccC-CceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCC
Confidence 3678899999999999988654 478999999999999999864 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||+++.++.++|+|||++..+..... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 129 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred hheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 9999999999999999999987654322 223468899999999998889999999999999999999999998766555
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~ 212 (570)
....+...........++..+.++|.+||..+|++||++.++++|+||..+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 209 VLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred HHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 55555444444455678899999999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=288.14 Aligned_cols=201 Identities=16% Similarity=0.274 Sum_probs=175.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++..+ ..+|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 58 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp 135 (266)
T cd05064 58 LTLGQFDHSNIVRLEGVITRG-NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAA 135 (266)
T ss_pred HHHhcCCCCCcCeEEEEEecC-CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccH
Confidence 578889999999999988654 47899999999999999998643 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCc--cccCCCCCCCcccccCCCCCCcccccchhhhHHHhh-ccCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT-SLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl-tG~~pf~~~~~~ 158 (570)
+|||++.++.+|++|||.+.......... ...++..|+|||++.+..++.++|||||||++|+|+ .|..||...+..
T Consensus 136 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~ 215 (266)
T cd05064 136 HKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215 (266)
T ss_pred hhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 99999999999999999876543322221 233467899999999999999999999999999976 599999988888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+....+......+.+..++..+.+++.+||..+|.+||++++|++-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~ 261 (266)
T cd05064 216 DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSI 261 (266)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHH
Confidence 8888887776667788899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=283.37 Aligned_cols=205 Identities=36% Similarity=0.647 Sum_probs=175.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++++|+||+++++++... .++|+++||+.+++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+
T Consensus 49 ~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~ 126 (256)
T cd06612 49 ISILKQCDSPYIVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126 (256)
T ss_pred HHHHHhCCCCcEeeeeeeeecC-CcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 3678899999999999998765 57899999999999999997643 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|.||+++.++.+||+|||++....... ......|+..|++||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 127 ~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 127 AGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred cceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 999999999999999999998765443 2334568899999999998889999999999999999999999998766554
Q ss_pred HHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+...... ..+..++.++.++|.+||..+|++|||+.++|.|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 207 AIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 43333222111 1234678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=282.45 Aligned_cols=204 Identities=35% Similarity=0.651 Sum_probs=177.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.. +..+|+|+||+++++|.+++.+.. .+++..++.++.||+.||+|||+.||+|+||+
T Consensus 53 ~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 129 (258)
T cd06632 53 IALLSKLQHPNIVQYLGTERE-EDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK 129 (258)
T ss_pred HHHHHhcCCCCchheeeeEec-CCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 367889999999999998765 457899999999999999998643 48999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||+++.++.+||+|||++.............|+..|++||.+.... ++.++|+|||||++|+|++|..||.......
T Consensus 130 ~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~ 209 (258)
T cd06632 130 GANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA 209 (258)
T ss_pred HHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH
Confidence 999999999999999999998765544445667899999999997766 8999999999999999999999998776555
Q ss_pred HHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+.. ......+..++..+.+++.+||..+|++||++.+++.|||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 210 AVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 4444443 33344566789999999999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=285.52 Aligned_cols=202 Identities=32% Similarity=0.547 Sum_probs=167.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++++++||||+++++++... ..+|+|||||.+++|.+++... +.+++..++.++.||+.||.|||++||+|+||||
T Consensus 58 ~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 134 (267)
T cd06645 58 IMMKDCKHSNIVAYFGSYLRR-DKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKG 134 (267)
T ss_pred HHHHhCCCCCeeeEEEEEEeC-CEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 578889999999999988654 5789999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+|||++.++.+||+|||++....... ......|+..|+|||++. ...++.++|||||||++|+|++|..||.....
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 135 ANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred HHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 99999999999999999987664322 223457899999999984 45578999999999999999999999865543
Q ss_pred HHHHHHHHhccCC-C-C--CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 158 QALINKINKSIVA-P-L--PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 158 ~~~~~~i~~~~~~-p-~--p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
............. + . ...++..+.++|.+||..+|++||++++|++|+|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 215 MRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 3332222222111 1 1 1257889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=284.46 Aligned_cols=206 Identities=32% Similarity=0.572 Sum_probs=172.4
Q ss_pred HHhhhc-CCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 2 ELISKI-RNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
++++++ +|+||++++++|... +..+|+|||||.+++|.+++.... +..+++..++.++.||+.||.|||++|
T Consensus 54 ~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~ 133 (275)
T cd06608 54 NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133 (275)
T ss_pred HHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 578888 799999999998753 346899999999999999987643 457899999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-----CCCCCcccccchhhhHHHhhc
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIWSLG~IlyeLlt 147 (570)
|+|+||+|+||+++.++.+||+|||++....... ......|+..|+|||++.. ..++.++|||||||++|+|++
T Consensus 134 i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 134 VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred cccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 9999999999999999999999999987654322 2334568999999999853 346789999999999999999
Q ss_pred cCCCCcccCHHHHHHHHHhccCCCC--CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 148 LKPAFKAFDMQALINKINKSIVAPL--PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~~p~--p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
|..||...........+........ +..++.++.+||++||..||++|||+++++.|||+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 9999987665555555544333222 23478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.57 Aligned_cols=206 Identities=33% Similarity=0.551 Sum_probs=172.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDL 79 (570)
+++|++++||||++++++|..+ +++|+||||++|++|.+++++. ..+++..+..|+.||+.||.|||+ .+|+|+||
T Consensus 50 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl 126 (308)
T cd06615 50 LKVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDV 126 (308)
T ss_pred HHHHHhCCCCCCCeEEEEEeeC-CEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCC
Confidence 3688999999999999998765 4899999999999999999875 458999999999999999999997 59999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
||+|||++.++.+||+|||++...... .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 127 ~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 205 (308)
T cd06615 127 KPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205 (308)
T ss_pred ChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 999999999999999999998765332 2345688999999999988889999999999999999999999987655433
Q ss_pred HHHHHHhcc------------------------------------CCCCC-CCCcHHHHHHHHHhhccCCCCCcCHHHHH
Q 008303 160 LINKINKSI------------------------------------VAPLP-TKYSGAFRGLVKSMLRKNPELRPSAAELL 202 (570)
Q Consensus 160 ~~~~i~~~~------------------------------------~~p~p-~~~s~~l~dLI~~~L~~dP~~RPTa~eIL 202 (570)
....+.... ....+ ..++.++++||.+||..+|++||++.+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 332221110 00011 23678999999999999999999999999
Q ss_pred HhhccChh
Q 008303 203 RHVHLQPY 210 (570)
Q Consensus 203 ~hp~fq~~ 210 (570)
+|+||..+
T Consensus 286 ~~~~~~~~ 293 (308)
T cd06615 286 KHPFIKRA 293 (308)
T ss_pred cChhhhhc
Confidence 99999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=288.89 Aligned_cols=207 Identities=30% Similarity=0.540 Sum_probs=172.9
Q ss_pred HHhhhc-CCCcccccceEEEee----CcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 2 ELISKI-RNPFIVEYKDSWVER----GCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~----~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
++++++ +||||++++++|... +...|+||||+.||+|.++++.. ....+++..++.++.|++.||+|||++||
T Consensus 70 ~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 149 (291)
T cd06639 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI 149 (291)
T ss_pred HHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 567788 899999999998643 24689999999999999998642 23568999999999999999999999999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-----CCCCcccccchhhhHHHhhcc
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-----PYGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-----~~t~ksDIWSLG~IlyeLltG 148 (570)
+|+||||+||+++.++.+||+|||++....... ......|+..|+|||++... .++.++|||||||++|+|++|
T Consensus 150 vH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred eccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 999999999999999999999999988765332 22345788999999998543 368899999999999999999
Q ss_pred CCCCcccCHHHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 149 KPAFKAFDMQALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
+.||...+.......+....... .+..++..+.+||.+||..+|++||++.+|++||||+
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 99998877655555554333222 2446778999999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=287.34 Aligned_cols=204 Identities=27% Similarity=0.522 Sum_probs=171.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||+++++++.. +...|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||
T Consensus 51 ~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p 127 (286)
T cd07832 51 KALQACQHPYVVKLLDVFPH-GSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKP 127 (286)
T ss_pred HHHHhCCCCCCcceeeEEec-CCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCH
Confidence 57889999999999999865 45789999999 999999997654 5699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+||+++.++.++|+|||++....... ......|+..|+|||.+.+. .++.++|||||||++|+|++|.++|.+.+..
T Consensus 128 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 128 ANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred HHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 99999999999999999998765433 23345789999999998654 4689999999999999999999999776655
Q ss_pred HHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 159 ALINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 159 ~~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.....+......+ ....++..+.+||++||..+|++||+++++|+|+||.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 5444433221110 1124578999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=283.14 Aligned_cols=202 Identities=23% Similarity=0.390 Sum_probs=175.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|.+. ..+|+||||+.||+|.+++.... ..+++..+..++.||+.||+|||++||+|+|||
T Consensus 50 ~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05114 50 AKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127 (256)
T ss_pred HHHHHHCCCCCceeEEEEEccC-CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 3689999999999999988654 47899999999999999997643 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC--ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||+++........ ....++..|+|||++....++.++||||||+++|+|++ |+.||...+.
T Consensus 128 p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 128 ARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred cceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999998765432221 12234567999999998889999999999999999999 8999998888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+....+........+...+..+.+++.+||..+|++||+++++++.
T Consensus 208 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 208 YEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 88888887666555667788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=283.66 Aligned_cols=200 Identities=22% Similarity=0.384 Sum_probs=175.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++. +...++||||+.+|+|.+++.+. ..+++..+..|+.||+.||+|||++||+||||||
T Consensus 48 ~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp 123 (257)
T cd05116 48 NVMQQLDNPYIVRMIGICE--AESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAA 123 (257)
T ss_pred HHHHhCCCCCcceEEEEEc--CCCcEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccch
Confidence 5788999999999999874 33578999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
.|||++.++.+||+|||++........ .....++..|+|||.+....++.++|||||||++|+|++ |..||...+
T Consensus 124 ~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 124 RNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred hhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987653321 122234578999999988889999999999999999997 999999888
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.......+......+.+..++.++.+||.+||+.||++||++++|...+
T Consensus 204 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 204 GNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 8888888887776677888999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.51 Aligned_cols=206 Identities=24% Similarity=0.425 Sum_probs=161.7
Q ss_pred CHHhhhcCCCcccccceEEEe-eCcEEEEEEeccCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 1 MELISKIRNPFIVEYKDSWVE-RGCYVCIIIGFCEGGDMAEAIKKAN-------SKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-~~~~i~IV~Ey~~gGsL~d~I~~~~-------~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
+++|++++||||++++++|.. .+..+|+||||+.+ +|.+++.... ...+++..++.|+.||+.||.|||++
T Consensus 49 ~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~ 127 (317)
T cd07867 49 IALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127 (317)
T ss_pred HHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 368899999999999998864 35678999999975 8888875321 23589999999999999999999999
Q ss_pred CcccceecCCcEEE----cCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCC-CCCCcccccchhhhHH
Q 008303 73 HILHRDVKCSNIFL----TKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIY 143 (570)
Q Consensus 73 gIvHrDLKP~NILl----d~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~Ily 143 (570)
||+||||||+|||+ +.++.+||+|||+++.+.... .....+||+.|+|||++.+. .++.++|||||||++|
T Consensus 128 ~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 207 (317)
T cd07867 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHH
Confidence 99999999999999 456789999999998765332 22345789999999999764 5799999999999999
Q ss_pred HhhccCCCCcccCHH---------HHHHHHHhccC-------------------------------------CCCCCCCc
Q 008303 144 EMTSLKPAFKAFDMQ---------ALINKINKSIV-------------------------------------APLPTKYS 177 (570)
Q Consensus 144 eLltG~~pf~~~~~~---------~~~~~i~~~~~-------------------------------------~p~p~~~s 177 (570)
+|++|.+||...... .....+..... .......+
T Consensus 208 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (317)
T cd07867 208 ELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287 (317)
T ss_pred HHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCC
Confidence 999999999643211 11111110000 00111235
Q ss_pred HHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 178 GAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 178 ~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
..+.+||.+||..||.+|||++|+|+||||
T Consensus 288 ~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=282.99 Aligned_cols=203 Identities=18% Similarity=0.357 Sum_probs=177.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++++|+||+++++++... ...|+||||+.+|+|.++++......+++..+..++.||+.||+|||++|++|||||
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~ 130 (261)
T cd05072 52 ANLMKTLQHDKLVRLYAVVTKE-EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR 130 (261)
T ss_pred HHHHHhCCCCCeeeEEEEEcCC-CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 3678999999999999988654 468999999999999999987666678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||++........ .....++..|+|||++....++.++|||||||++|+|++ |..||.....
T Consensus 131 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred hhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 9999999999999999999987654321 122345678999999988889999999999999999997 9999988888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+....++.++.++|.+||..+|++||+++++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 257 (261)
T cd05072 211 SDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSV 257 (261)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 88777777666656667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=287.69 Aligned_cols=203 Identities=19% Similarity=0.440 Sum_probs=176.2
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--------------NSKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--------------~~~~Lse~~i~~I~~QLl~aL 66 (570)
++|+++ +|+||+++++++..++ .+|+||||+.+|+|.++++.. ....+++..+..|+.||+.||
T Consensus 67 ~~l~~l~~h~~i~~~~~~~~~~~-~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 145 (293)
T cd05053 67 EMMKMIGKHKNIINLLGVCTQEG-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM 145 (293)
T ss_pred HHHHhhcCCCCeeeEEEEEcCCC-CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 577888 8999999999886554 789999999999999999752 235689999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|
T Consensus 146 ~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 146 EFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred HHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 999999999999999999999999999999999987654322 12223456799999999889999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||......+....+........+..++..+.+|+.+||..+|++|||+.++++++
T Consensus 226 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 226 EIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 9986 9999998888887777776665566778899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=288.08 Aligned_cols=207 Identities=37% Similarity=0.643 Sum_probs=174.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||++++++|..++ .+|+||||+.|++|..++.+.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 61 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp 138 (292)
T cd06644 61 EILATCNHPYIVKLLGAFYWDG-KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138 (292)
T ss_pred HHHHhCCCCcEeeeEEEEEeCC-eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCc
Confidence 5788999999999999986654 7899999999999998886543 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
+||+++.++.+||+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++|.+||...
T Consensus 139 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 99999999999999999987643322 223456889999999985 345688999999999999999999999887
Q ss_pred CHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+......++...... ..+..++.++.++|.+||..+|++||+++++++|+||...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 219 NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred cHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 766555555433222 2345688999999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=290.85 Aligned_cols=203 Identities=21% Similarity=0.403 Sum_probs=174.0
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL 66 (570)
++++++ +||||+++++++.+.+ .+|+||||+.+|+|.+++.+.. ...+++..++.|+.||+.||
T Consensus 54 ~~l~~l~~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 132 (297)
T cd05089 54 EVLCKLGHHPNIINLLGACENRG-YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGM 132 (297)
T ss_pred HHHHhhcCCCchhheEEEEccCC-cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHH
Confidence 567888 7999999999886554 6899999999999999997532 13588999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhh
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl 146 (570)
+|||++||+||||||+|||++.++.+||+|||++..............+..|+|||++....++.++|||||||++|+|+
T Consensus 133 ~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 133 QYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred HHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999999999986432211111222345799999999888999999999999999999
Q ss_pred c-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 147 S-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 147 t-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+ |..||..........++........+..++..+.+||.+||..+|.+||+++++++.+
T Consensus 213 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7 9999998888888877776666666778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=281.89 Aligned_cols=205 Identities=38% Similarity=0.771 Sum_probs=179.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++.+.. +...|+|+||+.+++|.+++....+..+++..+..|+.||+.||.|||++||+|+||||
T Consensus 51 ~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~ 129 (257)
T cd08225 51 ILLAKMKHPNIVTFFASFQE-NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKS 129 (257)
T ss_pred HHHHhCCCCChhhhhheecc-CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCH
Confidence 57889999999999998865 45899999999999999999876555689999999999999999999999999999999
Q ss_pred CcEEEcCCCC-EEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQD-IRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~-vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+||+++.++. +||+|||.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred HHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 9999998864 6999999998765432 2233468899999999988889999999999999999999999998877777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+......+....++..+.++|.+||..+|++|||+.++++|+||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 210 LVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 666666655555666789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=285.23 Aligned_cols=204 Identities=34% Similarity=0.581 Sum_probs=172.6
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++|+||+++++++.+. +..+++++||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||+
T Consensus 56 ~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~ 133 (266)
T cd06651 56 QLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIK 133 (266)
T ss_pred HHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 588999999999999988653 46789999999999999999764 348999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC----CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD----DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+||+++.++.+||+|||++..+... .......++..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 134 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 134 GANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred HHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 99999999999999999998765321 11223568899999999998889999999999999999999999998776
Q ss_pred HHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 157 MQALINKINKSI-VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 157 ~~~~~~~i~~~~-~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.......+.... ....+..++..++++| +||..+|++||+++||++||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 214 AMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 555444443322 2334566788999999 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=338.92 Aligned_cols=205 Identities=32% Similarity=0.584 Sum_probs=181.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|.||+.|+|||||+|+|+-+++. .++|.||||+||+|.++++. ++..+|.....+..|++.||.|||++||||||||
T Consensus 1285 m~vlE~lnHpNlV~YyGVEvHRe-kv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK 1361 (1509)
T KOG4645|consen 1285 MKVLEGLNHPNLVRYYGVEVHRE-KVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIK 1361 (1509)
T ss_pred HHHHHhccCccccccCceeecHH-HHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCC
Confidence 47899999999999999987765 68999999999999999986 3458888899999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCC---CCCCcccccchhhhHHHhhccCCCC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~---~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|.|||++.+|.||++|||.|..+.... -....+||+.|||||++.+. +...+.||||||||+.||++|+.||
T Consensus 1362 ~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1362 PANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred ccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence 999999999999999999998875432 23457899999999999754 4678999999999999999999999
Q ss_pred cccCHH-HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 153 KAFDMQ-ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 153 ~~~~~~-~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
..++.+ .++.++..+..+.+|..++.+.++||..||..||.+|.++.|||.|-|-.
T Consensus 1442 ~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1442 AELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred hhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 887765 45566666777788999999999999999999999999999999997754
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=287.45 Aligned_cols=206 Identities=31% Similarity=0.610 Sum_probs=179.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++++++.|+||+++++++.++ +++|+||||+.||+|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|
T Consensus 54 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p 129 (277)
T cd06640 54 TVLSQCDSPYVTKYYGSYLKG-TKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 129 (277)
T ss_pred HHHHhCCCCCEeeEEEEEEEC-CEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCCh
Confidence 578889999999999988664 589999999999999999875 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.++|+|||++..+..... .....++..|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 130 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 209 (277)
T cd06640 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV 209 (277)
T ss_pred hhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH
Confidence 999999999999999999987654332 2335688899999999888899999999999999999999999988776666
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
...+........+..++..+.++|.+||..+|++||+++++++|+||....
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 210 LFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred hhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 555544444445567889999999999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=283.90 Aligned_cols=203 Identities=20% Similarity=0.381 Sum_probs=175.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++.+. ..+|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+|+|||
T Consensus 50 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05113 50 AKVMMKLSHEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA 127 (256)
T ss_pred HHHHhcCCCCCeeeEEEEEccC-CCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 3678999999999999988654 46899999999999999997643 368999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCc--cccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|.|||++.++.+||+|||+++......... ...++..|++||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 128 p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred cceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 999999999999999999988664332211 1234567999999988889999999999999999998 9999988887
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
......+........+...+..+++++.+||..+|.+||++.+|+.+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 208 SETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 777777766665556677899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=285.08 Aligned_cols=203 Identities=28% Similarity=0.543 Sum_probs=177.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|.+ +...|+|+||+.|++|.+++.+. ..+++..+..|+.||+.||.|||++||+|+||+
T Consensus 51 ~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~ 127 (258)
T cd05578 51 RRILQELNHPFLVNLWYSFQD-EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIK 127 (258)
T ss_pred HHHHHhCCCCChHHHHHhhcC-CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 367899999999999998865 45799999999999999999875 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH---
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM--- 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~--- 157 (570)
|+||+++.++.++|+|||++.............|+..|++||++....++.++||||||+++|+|++|..||...+.
T Consensus 128 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 207 (258)
T cd05578 128 PDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR 207 (258)
T ss_pred HHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH
Confidence 99999999999999999999877655444556788999999999988899999999999999999999999987763
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH--HHHHHhhcc
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA--AELLRHVHL 207 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa--~eIL~hp~f 207 (570)
..+..... ......+..++..+.++|.+||..+|.+||++ .|+++|+||
T Consensus 208 ~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 208 DQIRAKQE-TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHhc-cccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 33333333 23445667889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=282.62 Aligned_cols=204 Identities=22% Similarity=0.388 Sum_probs=179.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+. ...|+|||||.+|+|.+++....+..+++..+..|+.||+.||.|||++||+|+||+
T Consensus 53 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~ 131 (261)
T cd05148 53 VQALKRLRHKHLISLFAVCSVG-EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLA 131 (261)
T ss_pred HHHHhcCCCcchhheeeeEecC-CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC
Confidence 3678999999999999988654 478999999999999999987656678999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++........ .....++..|++||++....++.++||||||+++|+|++ |+.||...+..
T Consensus 132 ~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 132 ARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred cceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999999987643322 122345678999999998889999999999999999998 89999888887
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+....+......+.+..++..+.++|.+||+.+|.+|||+.+|++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 212 EVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 77777777666667788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=288.79 Aligned_cols=204 Identities=26% Similarity=0.449 Sum_probs=166.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+. +.+|+|+|||.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 50 i~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~ 126 (284)
T cd07839 50 ICLLKELKHKNIVRLYDVLHSD-KKLTLVFEYCDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK 126 (284)
T ss_pred HHHHHhcCCCCeeeHHHHhccC-CceEEEEecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence 3578999999999999998755 478999999975 8888876543 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCC-CcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPA-FKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~p-f~~~~~ 157 (570)
|+|||++.++.+||+|||++....... ......++..|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.
T Consensus 127 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~ 206 (284)
T cd07839 127 PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206 (284)
T ss_pred HHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH
Confidence 999999999999999999998654322 223456789999999987644 68999999999999999988766 455554
Q ss_pred HHHHHHHHhccCC----------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 158 QALINKINKSIVA----------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 158 ~~~~~~i~~~~~~----------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.+....+...... .....++.++++||++||..||.+|||++++++|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 207 DDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 4444333221100 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=287.72 Aligned_cols=203 Identities=20% Similarity=0.398 Sum_probs=176.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-----------SKLFSEEKLCKWLVQLLMALDYL 69 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-----------~~~Lse~~i~~I~~QLl~aL~yL 69 (570)
+++|++++|+||+++++++... +..|+||||+.+++|.++|.... ...+++..++.++.||+.||+||
T Consensus 58 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l 136 (288)
T cd05093 58 AELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL 136 (288)
T ss_pred HHHHHhCCCCCcceEEEEEecC-CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999988654 57899999999999999997542 12489999999999999999999
Q ss_pred HHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhh
Q 008303 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146 (570)
Q Consensus 70 Hs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl 146 (570)
|++||+||||||+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|+
T Consensus 137 H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~ 216 (288)
T cd05093 137 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216 (288)
T ss_pred HhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999999986543221 22334577899999999888999999999999999999
Q ss_pred c-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 147 S-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 147 t-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+ |..||...........+........+..++.++.+|+.+||..||.+|||+.+++..
T Consensus 217 t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~ 275 (288)
T cd05093 217 TYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 8 999998888888878887766666677889999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=288.20 Aligned_cols=204 Identities=18% Similarity=0.365 Sum_probs=177.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL 66 (570)
+++|++++|+||+++++++... ...++||||+.+++|.+++..+. ...+++..++.|+.||+.||
T Consensus 58 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 136 (291)
T cd05094 58 AELLTNLQHEHIVKFYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 136 (291)
T ss_pred HHHHhcCCCCCcceEEEEEccC-CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHH
Confidence 3678999999999999988654 47899999999999999997643 23489999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|
T Consensus 137 ~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 216 (291)
T cd05094 137 VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216 (291)
T ss_pred HHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999999999997654332 223455678899999999889999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||...+..+..+.+........+..++..+.+++.+||..+|++||++.++++..
T Consensus 217 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 217 EIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 9999988888777777776666556677899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=281.97 Aligned_cols=202 Identities=22% Similarity=0.388 Sum_probs=175.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++... .+.|+||||++|++|.+++.... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05059 50 AKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA 127 (256)
T ss_pred HHHHHhCCCCCEEEEEEEEcCC-CceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 3678999999999999988654 47899999999999999998654 368999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCc--cccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||+++......... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 128 p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred HhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 999999999999999999987664332211 1123457999999998899999999999999999998 8999988888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+....+........+..++.++.+++.+||..+|++|||+.++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 208 SEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 87777777666666677899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=290.60 Aligned_cols=204 Identities=32% Similarity=0.548 Sum_probs=173.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+++.|+||+++++.|... .+.|+||||+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||
T Consensus 69 ~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp 144 (296)
T cd06654 69 LVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144 (296)
T ss_pred HHHHhCCCCCEeeEEEEEEeC-CEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 578889999999999988654 589999999999999999865 3479999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++....... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....
T Consensus 145 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~ 224 (296)
T cd06654 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (296)
T ss_pred HHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh
Confidence 99999999999999999987654332 22345789999999999988899999999999999999999999987765443
Q ss_pred HHHHHhccC--CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIV--APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~--~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+..... .+.+..++..+.+||.+||..+|++||++.+|++|+||..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 333322221 1235568899999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=311.23 Aligned_cols=206 Identities=29% Similarity=0.421 Sum_probs=165.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|+|||++++++...+ ..|+||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 211 ~~iL~~L~HpnIv~l~~~~~~~~-~~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLK 287 (461)
T PHA03211 211 ARLLRRLSHPAVLALLDVRVVGG-LTCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIK 287 (461)
T ss_pred HHHHHHCCCCCCCcEEEEEEECC-EEEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCC
Confidence 36899999999999999886654 7899999995 69998887643 369999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC-ccc-
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF-KAF- 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf-~~~- 155 (570)
|+||||+.++.+||+|||+++.+.... .....+||..|+|||++.+..++.++|||||||++|||++|..++ ...
T Consensus 288 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~ 367 (461)
T PHA03211 288 TENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASR 367 (461)
T ss_pred HHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCc
Confidence 999999999999999999998764322 223457999999999999999999999999999999998876543 221
Q ss_pred ------CHHHHHHHHHhccC--CCC----------------------------C---CCCcHHHHHHHHHhhccCCCCCc
Q 008303 156 ------DMQALINKINKSIV--APL----------------------------P---TKYSGAFRGLVKSMLRKNPELRP 196 (570)
Q Consensus 156 ------~~~~~~~~i~~~~~--~p~----------------------------p---~~~s~~l~dLI~~~L~~dP~~RP 196 (570)
....+...+..... ..+ + ..++..+.+||.+||..||.+||
T Consensus 368 ~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP 447 (461)
T PHA03211 368 GDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP 447 (461)
T ss_pred ccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc
Confidence 11222222221110 000 0 13456899999999999999999
Q ss_pred CHHHHHHhhccCh
Q 008303 197 SAAELLRHVHLQP 209 (570)
Q Consensus 197 Ta~eIL~hp~fq~ 209 (570)
|+.|||+|+||+.
T Consensus 448 sa~elL~hp~f~~ 460 (461)
T PHA03211 448 SAAELLRLPLFQS 460 (461)
T ss_pred CHHHHhhCcccCC
Confidence 9999999999974
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=281.03 Aligned_cols=206 Identities=32% Similarity=0.584 Sum_probs=181.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLK 80 (570)
+++.+++|+||++++++|... ...|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+ +|++|+||+
T Consensus 51 ~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~ 127 (264)
T cd06623 51 KTLRSCESPYVVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK 127 (264)
T ss_pred HHHHhcCCCCeeeEEEEEccC-CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCC
Confidence 578889999999999988765 5799999999999999999875 458999999999999999999999 999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC-ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc---C
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF---D 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~---~ 156 (570)
|+||+++.++.++|+|||++......... ....++..|+|||.+....++.++|||+||+++|+|++|..||... .
T Consensus 128 ~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 207 (264)
T cd06623 128 PSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207 (264)
T ss_pred HHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence 99999999999999999999877544332 2567889999999999888999999999999999999999999776 4
Q ss_pred HHHHHHHHHhccCCCCCCC-CcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 157 MQALINKINKSIVAPLPTK-YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~-~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+....+........+.. ++..+.++|++||..+|++||++.++++|+|++.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 208 FFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 5556666665555555666 89999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=291.58 Aligned_cols=204 Identities=23% Similarity=0.417 Sum_probs=172.8
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~a 65 (570)
+++|.++ +|+||+++++++..++ ++|+||||+.+|+|.+++.+.. ...+++..++.++.||+.|
T Consensus 58 i~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 136 (303)
T cd05088 58 LEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 136 (303)
T ss_pred HHHHHHhcCCCCcceEEEEECCCC-CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHH
Confidence 3578888 8999999999886554 7899999999999999997542 2358899999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
|+|||++||+||||||+|||++.++.+||+|||++.............++..|+|||++.+..++.++|||||||++|+|
T Consensus 137 l~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 216 (303)
T cd05088 137 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216 (303)
T ss_pred HHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHH
Confidence 99999999999999999999999999999999998643221111222345679999999888899999999999999999
Q ss_pred hc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 146 TS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 146 lt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
++ |..||...+..+....+........+..++..+.+||.+||..+|++||++++++.++
T Consensus 217 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 217 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 97 9999988877777766655544445667889999999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.57 Aligned_cols=203 Identities=21% Similarity=0.417 Sum_probs=176.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN---------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~---------------~~~Lse~~i~~I~~QLl~aL 66 (570)
++|++++||||+++++++... ...|+||||+.+++|.+++.... ...+++..+..++.||+.||
T Consensus 59 ~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 137 (283)
T cd05090 59 SLMAELHHPNIVCLLGVVTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGM 137 (283)
T ss_pred HHHhhCCCCCeeeEEEEEecC-CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 688999999999999988654 47899999999999999986321 13478999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|
T Consensus 138 ~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 217 (283)
T cd05090 138 EYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLW 217 (283)
T ss_pred HHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHH
Confidence 99999999999999999999999999999999998764322 123344567899999998888999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||.+.........+......+.+..++..+.++|.+||+.+|.+||++.+|+++.
T Consensus 218 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 218 EIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 9998 9999988887777777777666667788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=280.70 Aligned_cols=202 Identities=21% Similarity=0.380 Sum_probs=173.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|... ..+|+||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+|||||
T Consensus 44 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~ 121 (252)
T cd05084 44 ARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121 (252)
T ss_pred HHHHHhCCCCCcceEEEEEcCC-CCeEEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 3678999999999999988654 47899999999999999997643 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCc---cccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLAS---SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~---~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
|+|||++.++.+||+|||++.......... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 122 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred hheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999987654322111 1122456999999998889999999999999999997 889998877
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.......+......+.+..++..+.+|+.+||..+|++||++.++++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 202 NQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred HHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777766666665666777889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=291.75 Aligned_cols=210 Identities=25% Similarity=0.443 Sum_probs=171.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|.+. +.+|++||||.+|+|.+++.......+++..+..++.||+.||+|||++||+|||||
T Consensus 50 i~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk 128 (314)
T cd08216 50 IITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVK 128 (314)
T ss_pred HHHHHhcCCcchhhhhheeecC-CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 3678899999999999998765 478999999999999999987655669999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--------CCccccCCCCCCCcccccC--CCCCCcccccchhhhHHHhhccCC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
|+|||++.++.+||+|||.+....... ......++..|+|||++.. ..++.++||||+||++|+|++|..
T Consensus 129 ~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred cceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 999999999999999999887553221 1233457788999999875 358899999999999999999999
Q ss_pred CCcccCHHHH-HHHHHhccC--------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCcC
Q 008303 151 AFKAFDMQAL-INKINKSIV--------------------------------APLPTKYSGAFRGLVKSMLRKNPELRPS 197 (570)
Q Consensus 151 pf~~~~~~~~-~~~i~~~~~--------------------------------~p~p~~~s~~l~dLI~~~L~~dP~~RPT 197 (570)
||........ ..++..... ......++.++.+||.+||..||++|||
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 288 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence 9987654332 222211100 0011234578999999999999999999
Q ss_pred HHHHHHhhccChhh
Q 008303 198 AAELLRHVHLQPYV 211 (570)
Q Consensus 198 a~eIL~hp~fq~~~ 211 (570)
++++|+||||+...
T Consensus 289 ~~~ll~~p~~~~~~ 302 (314)
T cd08216 289 ASQLLNHSFFKQCK 302 (314)
T ss_pred HHHHhcCchHhhhc
Confidence 99999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=291.92 Aligned_cols=204 Identities=30% Similarity=0.573 Sum_probs=175.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++++++|+||+++++.|... ++.|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||
T Consensus 71 ~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 146 (292)
T cd06658 71 VIMRDYHHENVVDMYNSYLVG-DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146 (292)
T ss_pred HHHHhCCCCcHHHHHHheecC-CeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 578889999999999988654 588999999999999998864 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred HHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999987653322 22345789999999999988899999999999999999999999988776665
Q ss_pred HHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+....... ....++..+.++|.+||..+|.+|||++++++|+||..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 55554433222 22357889999999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.10 Aligned_cols=206 Identities=30% Similarity=0.559 Sum_probs=171.0
Q ss_pred HHhhhc-CCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 2 ELISKI-RNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
++++++ +|+||++++++|.. .+.++|+|||||+|++|.+++... ....+++..++.++.|++.||.|||+++|
T Consensus 66 ~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 145 (286)
T cd06638 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT 145 (286)
T ss_pred HHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCc
Confidence 567888 79999999998852 345789999999999999988642 23468999999999999999999999999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-----CCCCCcccccchhhhHHHhhcc
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIWSLG~IlyeLltG 148 (570)
+||||||+||+++.++.+||+|||++....... ......|+..|+|||++.. ..++.++|||||||++|+|++|
T Consensus 146 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g 225 (286)
T cd06638 146 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225 (286)
T ss_pred cccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcC
Confidence 999999999999999999999999998765432 2234578999999999853 4578899999999999999999
Q ss_pred CCCCcccCHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 149 KPAFKAFDMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+.||...........+...... ..+..++..+.+||.+||..+|++|||+.+|++|+||
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 226 DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 9999876654444333332211 2345578899999999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.16 Aligned_cols=202 Identities=19% Similarity=0.383 Sum_probs=173.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--------KLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--------~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
.++++++|+||+++++++.+. ...|+||||+.+|+|.+++.+... ..+++..+..++.|++.||.|||++|
T Consensus 61 ~~l~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 139 (277)
T cd05062 61 SVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK 139 (277)
T ss_pred HHHHhCCCCCeeeEEEEEcCC-CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 578889999999999988654 478999999999999999975321 23678889999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
++|+||||+|||++.++.++|+|||+++.+..... .....++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876543221 112355778999999998889999999999999999998 78
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.||...........+........+..++..+.++|.+||..+|++|||+.|++++
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 220 QPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8998888877777666655556677889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=283.75 Aligned_cols=202 Identities=19% Similarity=0.386 Sum_probs=176.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------SKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
++|++++|+||+++++++... ...|+||||+.+|+|.+++.... ...+++..++.|+.||+.||.|||++|
T Consensus 61 ~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 139 (277)
T cd05032 61 SVMKEFNCHHVVRLLGVVSTG-QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK 139 (277)
T ss_pred HHHHhCCCCceeEEEEEEcCC-CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578889999999999988655 57899999999999999997532 124788899999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
|+||||||+|||++.++.+||+|||+++.+..... .....++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 140 i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 99999999999999999999999999876543322 233456788999999988889999999999999999997 99
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.||...+.......+........+..++.++.++|.+||+.+|++|||+.+|+..
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 220 QPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9998888888877777666666778889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=283.77 Aligned_cols=202 Identities=33% Similarity=0.545 Sum_probs=167.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||++++++|... ..+|+||||+.+++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|
T Consensus 58 ~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 134 (267)
T cd06646 58 FMVKECKHCNIVAYFGSYLSR-EKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKG 134 (267)
T ss_pred HHHHhcCCCCeeeeeEEEEeC-CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH
Confidence 578899999999999998765 4789999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+||+++.++.+||+|||++....... ......|+..|+|||.+. ...++.++||||+||++|+|++|+.||.....
T Consensus 135 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 135 ANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred HHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 99999999999999999998764322 223457889999999984 34578899999999999999999999865544
Q ss_pred HHHHHHHHhccCC-C---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 158 QALINKINKSIVA-P---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 158 ~~~~~~i~~~~~~-p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
......+...... + ....++..+.+||++||..+|++||++++|++|+|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 215 MRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 3332222222111 1 12357899999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.73 Aligned_cols=205 Identities=31% Similarity=0.548 Sum_probs=176.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||++++++|... ..+|+|+||+.+++|..++... .+++..+..++.|++.||.|||++||+|+||||
T Consensus 68 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p 143 (296)
T cd06655 68 LVMKELKNPNIVNFLDSFLVG-DELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKS 143 (296)
T ss_pred HHHHhcCCCceeeeeeeEecC-ceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 578889999999999988654 5789999999999999998753 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.+||+|||++........ .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+....
T Consensus 144 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred HHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999877654332 3345788999999999988899999999999999999999999988776554
Q ss_pred HHHHHhccC--CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSIV--APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~--~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+..... ...+..++..+.+||++||..+|.+||++.+|+.|+||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 224 LYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 444433221 22456789999999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=297.87 Aligned_cols=207 Identities=26% Similarity=0.416 Sum_probs=173.0
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++|+||++++++|.... .+.|+|||||.+ +|.+.+... +++..+..++.||+.||+|||++||+
T Consensus 66 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~ 140 (353)
T cd07850 66 LVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGII 140 (353)
T ss_pred HHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 36788999999999999886332 357999999965 888888642 89999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||||||+|||++.++.+||+|||++.............++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 141 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999998876554445567899999999999999999999999999999999999999877
Q ss_pred CHHHHHHHHHhccCCCC------------------------------------------CCCCcHHHHHHHHHhhccCCC
Q 008303 156 DMQALINKINKSIVAPL------------------------------------------PTKYSGAFRGLVKSMLRKNPE 193 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~------------------------------------------p~~~s~~l~dLI~~~L~~dP~ 193 (570)
+......++......+. +...+..+++||.+||..||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 300 (353)
T cd07850 221 DHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300 (353)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh
Confidence 65444433322111100 113466789999999999999
Q ss_pred CCcCHHHHHHhhccChhhh
Q 008303 194 LRPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 194 ~RPTa~eIL~hp~fq~~~~ 212 (570)
+|||+.|+|.|+||+.|..
T Consensus 301 ~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 301 KRISVDDALQHPYINVWYD 319 (353)
T ss_pred hCcCHHHHhcChhHhhccC
Confidence 9999999999999987754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.17 Aligned_cols=209 Identities=22% Similarity=0.485 Sum_probs=189.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|+||+.|+|||||+++.+.... ..+|+||||+.+|.+++++.+++. +.+..+..++.|++.|++|||+++|||||||
T Consensus 106 v~imk~l~HPnIvkl~~v~~t~-~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk 182 (596)
T KOG0586|consen 106 VDIMKSLNHPNIVKLFSVIETE-ATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLK 182 (596)
T ss_pred HHHHHhcCCcceeeeeeeeeec-ceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccc
Confidence 5789999999999999988644 479999999999999999998654 7889999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
.+||||+.+.++||+|||++..+....+..+.||++.|.|||++.+..| ++.+|+|++|+++|.|+.|..||++.+...
T Consensus 183 ~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 183 AENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred hhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 9999999999999999999999999999999999999999999999998 789999999999999999999999988777
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhhh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~k 213 (570)
+......+.+. ++.-++.++.++|+++|.++|.+|++.++|+.|.|+......
T Consensus 263 Lr~rvl~gk~r-Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 263 LRPRVLRGKYR-IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ccchheeeeec-ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 66655444332 566789999999999999999999999999999998765443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.79 Aligned_cols=203 Identities=19% Similarity=0.383 Sum_probs=167.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-----------------CCCCCHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-----------------SKLFSEEKLCKWLVQLL 63 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-----------------~~~Lse~~i~~I~~QLl 63 (570)
+++|++++||||++++++|.+.+ .+|+|||||.+|+|.+++.... ...+++..++.|+.||+
T Consensus 70 ~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 148 (304)
T cd05096 70 VKILSRLKDPNIIRLLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIA 148 (304)
T ss_pred HHHHhhcCCCCeeEEEEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 36788999999999999987654 6899999999999999986532 12467889999999999
Q ss_pred HHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhh
Q 008303 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 140 (570)
Q Consensus 64 ~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~ 140 (570)
.||.|||++||+||||||+|||++.++.+||+|||+++.+.... ......++..|+|||++....++.++|||||||
T Consensus 149 ~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 149 SGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred HHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 99999999999999999999999999999999999998654332 122345578899999998888999999999999
Q ss_pred hHHHhhc--cCCCCcccCHHHHHHHHHhc-------cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 141 CIYEMTS--LKPAFKAFDMQALINKINKS-------IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 141 IlyeLlt--G~~pf~~~~~~~~~~~i~~~-------~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++|+|++ +..||...+.......+... .....+..++..+.+||.+||..+|.+|||+++|.+.
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999975 56788777666555443221 1122345678999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=280.77 Aligned_cols=203 Identities=18% Similarity=0.369 Sum_probs=176.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++... +..|+||||+.+++|.+++....+..+++..+..++.|++.||.|||++||+|||||
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 130 (261)
T cd05068 52 AQIMKKLRHPKLIQLYAVCTLE-EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130 (261)
T ss_pred HHHHHHCCCCCccceeEEEecC-CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3678999999999999987654 478999999999999999987655578999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCc--cccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||++.......... ...++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.
T Consensus 131 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred cceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999998875332211 1122357999999998889999999999999999998 9999998888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+.+..++..+.+++.+||+.+|++||++++|+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~ 257 (261)
T cd05068 211 AEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWK 257 (261)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 77777776665555667889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.99 Aligned_cols=207 Identities=28% Similarity=0.495 Sum_probs=174.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-SKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDL 79 (570)
++|++++|+||++++++|... ..+|+|||||+|++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||
T Consensus 51 ~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl 129 (286)
T cd06622 51 DILHKAVSPYIVDFYGAFFIE-GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDV 129 (286)
T ss_pred HHHHhcCCCcHHhhhhheecC-CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCC
Confidence 678899999999999988765 47899999999999999987631 2368999999999999999999997 59999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC------CCCCcccccchhhhHHHhhccCCCCc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI------PYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
||+|||++.++.+||+|||++..+... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 130 ~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 130 KPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred CHHHEEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999998766432 23345788999999998544 35789999999999999999999997
Q ss_pred ccCHHHHHH---HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 154 AFDMQALIN---KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 154 ~~~~~~~~~---~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
......... .+........+..++.++.+||.+||..+|.+||+++++++|+||..+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 209 PETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 655444333 333444455667799999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=287.39 Aligned_cols=203 Identities=26% Similarity=0.532 Sum_probs=169.3
Q ss_pred hhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCc
Q 008303 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSN 83 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~N 83 (570)
+...+|+||+.++++|...+ ..|+||||+.||+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~N 127 (279)
T cd05633 51 VSTGDCPFIVCMTYAFHTPD-KLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPAN 127 (279)
T ss_pred HhhCCCCcEeEEEEEEecCC-eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHH
Confidence 33447999999999886544 789999999999999999764 359999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc-CCCCCCcccccchhhhHHHhhccCCCCcccCH--HHH
Q 008303 84 IFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM--QAL 160 (570)
Q Consensus 84 ILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~--~~~ 160 (570)
||++.++.++|+|||++....... .....|+..|+|||.+. +..++.++||||+||++|+|++|..||..... ...
T Consensus 128 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 206 (279)
T cd05633 128 ILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (279)
T ss_pred EEECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence 999999999999999987654332 23457899999999986 45689999999999999999999999965432 122
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
............+..++.++.++|++||..||.+|+ ++.++++|+||+.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 207 IDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 222222233345677899999999999999999999 69999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=282.84 Aligned_cols=205 Identities=30% Similarity=0.586 Sum_probs=171.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+. ..+++||||+.|++|.+++.+. ..+++..+..|+.||+.||.|||++||+|+||+
T Consensus 54 ~~~l~~l~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~ 130 (268)
T cd06630 54 IRLMARLNHPHIIRMLGATCED-SHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK 130 (268)
T ss_pred HHHHHHcCCCceehhhceeccC-CeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 3578889999999999998655 4789999999999999999764 358999999999999999999999999999999
Q ss_pred CCcEEEcCCC-CEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQ-DIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g-~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+||+++.++ .+||+|||++....... ......|+..|+|||++.+..++.++|||+|||++|+|++|..||..
T Consensus 131 ~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred HHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 9999998776 59999999987765321 12345688999999999888899999999999999999999999975
Q ss_pred cCHHHHHHHH---Hh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 155 FDMQALINKI---NK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 155 ~~~~~~~~~i---~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.........+ .. ......+..++.++.+++.+||..+|.+||++.++++|+||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 211 EKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 4432222222 11 222345567889999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=284.58 Aligned_cols=202 Identities=20% Similarity=0.387 Sum_probs=176.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMALD 67 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL~ 67 (570)
+++++++||||+++++++...+ ..++++||+.+++|.+++.... ...+++..++.++.|++.||.
T Consensus 60 ~~~~~l~h~~iv~~~~~~~~~~-~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~ 138 (283)
T cd05091 60 MMRSRLQHPNIVCLLGVVTKEQ-PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGME 138 (283)
T ss_pred HHHhcCCCCCcCeEEEEEcCCC-ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 4678899999999999886554 6899999999999999985321 234888999999999999999
Q ss_pred HHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHH
Q 008303 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 68 yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ilye 144 (570)
|||++||+||||||+|||+++++.+||+|||+++...... ......+++.|+|||++....++.++|||||||++|+
T Consensus 139 ~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 139 FLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred HHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 9999999999999999999999999999999988654322 1233456788999999988889999999999999999
Q ss_pred hhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 145 MTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 145 Llt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|++ |..||.+....+....+......+.+..++..+.+|+.+||+.+|.+||++++|+..
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 219 VFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 997 888999888888888888877777788999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.04 Aligned_cols=204 Identities=23% Similarity=0.417 Sum_probs=172.8
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~a 65 (570)
++++.++ +||||++++++|..++ .+|+||||+.+|+|.+++.... ...+++..+..++.|++.|
T Consensus 46 ~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a 124 (270)
T cd05047 46 LEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 124 (270)
T ss_pred HHHHHhhccCCCeeeEEEEEecCC-CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHH
Confidence 3578888 8999999999987654 6899999999999999997532 1347899999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
|+|||++||+||||||+|||++.++.+||+|||++..............+..|+|||++....++.++|||||||++|+|
T Consensus 125 l~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el 204 (270)
T cd05047 125 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204 (270)
T ss_pred HHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999999999998643221111122335679999999888899999999999999999
Q ss_pred hc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 146 TS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 146 lt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
++ |..||...+.......+........+..++.++.+|+.+||..+|.+|||+++++..+
T Consensus 205 ~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 205 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred HcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 96 9999988887777777766555556667889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=280.24 Aligned_cols=204 Identities=27% Similarity=0.542 Sum_probs=177.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++.+.. +...|+||||+.|++|.+++.+.. .+++..+..|+.||+.||.|||++||+|+||+|
T Consensus 45 ~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~ 121 (265)
T cd05579 45 DILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121 (265)
T ss_pred HHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCH
Confidence 57889999999999998865 457899999999999999998754 589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC---------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD---------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~---------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
+|||++.++.++|+|||++....... ......++..|++||.+....++.++||||||+++|+|++|..||
T Consensus 122 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 201 (265)
T cd05579 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201 (265)
T ss_pred HHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999987654331 223456888999999998888999999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCCCCCC--CcHHHHHHHHHhhccCCCCCcCH---HHHHHhhccCh
Q 008303 153 KAFDMQALINKINKSIVAPLPTK--YSGAFRGLVKSMLRKNPELRPSA---AELLRHVHLQP 209 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p~p~~--~s~~l~dLI~~~L~~dP~~RPTa---~eIL~hp~fq~ 209 (570)
...........+..... ..+.. ++..+.++|.+||+.+|.+|||+ .++|+|+||..
T Consensus 202 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 202 HGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 98888777766655332 23333 48999999999999999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=288.44 Aligned_cols=207 Identities=28% Similarity=0.461 Sum_probs=172.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+ +.++|+||||+ +|+|.+++.... ..+++..+..|+.||+.||.|||++||+|+||+
T Consensus 53 ~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~ 129 (298)
T cd07841 53 IKLLQELKHPNIIGLLDVFGH-KSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLK 129 (298)
T ss_pred HHHHhhcCCCCChhhhheeec-CCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence 357889999999999999876 45899999999 889999997643 369999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|.++|.+.+..
T Consensus 130 p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 130 PNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred hhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 999999999999999999998765432 2333467888999999854 45789999999999999999999988876655
Q ss_pred HHHHHHHhccCCC---------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAP---------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p---------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+...++......+ .....+..+.+||.+||..+|++|||+.++|+|+||+..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 210 DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 5444443221111 113457889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=280.62 Aligned_cols=202 Identities=21% Similarity=0.391 Sum_probs=176.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++|+||+++++++... ...|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||
T Consensus 57 ~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p 134 (266)
T cd05033 57 SIMGQFDHPNIIRLEGVVTKS-RPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAA 134 (266)
T ss_pred HHHHhCCCCCcceEeEEEecC-CceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence 578899999999999988654 47899999999999999997643 3689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-C--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-L--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.++|+|||++....... . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 135 RNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred ceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 99999999999999999998875211 1 112234578999999998889999999999999999987 9999988888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
......+......+.+..++..+.+|+.+||..+|++||++.+|+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 215 QDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 888877777666667778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=284.38 Aligned_cols=203 Identities=23% Similarity=0.351 Sum_probs=174.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-----KLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-----~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
.+|++++|+||+++++++.+.+ ..|+||||+.|++|.+++..... ..+++..+..++.||+.||+|||++|++|
T Consensus 61 ~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 139 (277)
T cd05036 61 LIMSKFNHQNIVRLIGVSFERL-PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIH 139 (277)
T ss_pred HHHHhCCCCCEeeEEEEEccCC-CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 5788999999999999886654 67899999999999999976532 25899999999999999999999999999
Q ss_pred ceecCCcEEEcCCC---CEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 77 RDVKCSNIFLTKDQ---DIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 77 rDLKP~NILld~~g---~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
|||||+|||++.++ .+||+|||+++.+...... ....++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 140 ~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~ 219 (277)
T cd05036 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219 (277)
T ss_pred cccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999998765 5999999999876432221 12233567999999998889999999999999999986 99
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.||...+.+.....+........+..++..+.+++.+||..+|++||++.++++|.
T Consensus 220 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 220 MPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 99998888887777766555566778899999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=288.30 Aligned_cols=203 Identities=30% Similarity=0.565 Sum_probs=173.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++|++...+ ..++|||||.+|+|.++|.......+++..+..|+.||+.||.|||+++|+|+||+
T Consensus 52 ~~~l~~l~h~ni~~~~g~~~~~~-~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~ 130 (259)
T PF07714_consen 52 IQILRKLRHPNIVKLYGFCIENE-PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLS 130 (259)
T ss_dssp HHHHHTHSBTTBE-EEEEEESSS-SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 36788999999999999997444 58899999999999999998755679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+.|||++.++.+||+|||++....... ......+...|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 131 ~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 131 PSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp GGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999998873222 1233456778999999998889999999999999999999 789999999
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..++..++......+.+..++..+.++|.+||..+|++||++.+|++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 211 NEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp HHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHH
T ss_pred cccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhc
Confidence 999888888877777788899999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.27 Aligned_cols=204 Identities=37% Similarity=0.764 Sum_probs=183.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++|+||+++++++.+. ...|+||||+.+++|.+++.+.. +..+++..++.++.||+.||.|||++|++|+||
T Consensus 51 ~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l 129 (256)
T cd08530 51 RILASVNHPNIISYKEAFLDG-NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDL 129 (256)
T ss_pred HHHHhCCCCCchhhhhhhccC-CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCC
Confidence 578999999999999998765 57899999999999999987622 346899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|.||+++.++.+||+|||++...... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 130 ~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 130 KSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred CcceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999999877654 3445678999999999999889999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+......+.+..++.+++++|.+||..+|++||++.++++||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 209 LRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 777777777667777899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.10 Aligned_cols=205 Identities=26% Similarity=0.417 Sum_probs=169.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++.+. ...|+||||+. ++|..++.......+++..+..++.||+.||+|||++||+|+||+
T Consensus 50 ~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~ 127 (284)
T cd07860 50 ISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 127 (284)
T ss_pred HHHHHhcCCCCCcchhhhcccC-CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 3688999999999999998654 57899999996 589999877655679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+||+++.++.+||+|||++..+.... ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+..
T Consensus 128 p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 207 (284)
T cd07860 128 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207 (284)
T ss_pred HHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999999987654322 223346788999999987654 588999999999999999999999776654
Q ss_pred HHHHHHHhccCC----------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVA----------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~----------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.....+...... .....++.+++++|.+||..||.+|||++++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 208 DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 433332211110 0123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.14 Aligned_cols=202 Identities=31% Similarity=0.584 Sum_probs=176.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|..|++|+|||+|.|.|+|.- .+..|+|||||-| +-.|+++-+ .++|-+.+|..|..+.+.||.|||+.+.||||||
T Consensus 77 VrFL~~l~HPntieYkgCyLr-e~TaWLVMEYClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiK 153 (948)
T KOG0577|consen 77 VRFLRQLRHPNTIEYKGCYLR-EHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIK 153 (948)
T ss_pred HHHHHhccCCCcccccceeec-cchHHHHHHHHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhcc
Confidence 467899999999999999964 4467899999965 889998865 3679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
..|||+++.|.|||+|||.|.+.. ...+++|||.|||||++. .+.|+.++|||||||...||...+||+-.++.
T Consensus 154 AGNILLse~g~VKLaDFGSAsi~~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 154 AGNILLSEPGLVKLADFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred ccceEecCCCeeeeccccchhhcC---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 999999999999999999998754 456889999999999985 56799999999999999999999999877766
Q ss_pred HHHHHHHHhccCCCC-CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 158 QALINKINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~-p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.....-|.....+.+ ...|+..|+.||..||++-|.+|||.+++|+|+|+.
T Consensus 231 MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 555555554443333 457999999999999999999999999999999975
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.88 Aligned_cols=203 Identities=29% Similarity=0.486 Sum_probs=168.0
Q ss_pred HHhhhc-CCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKI-RNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|+++ +|+||+++++++.+. ++.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||
T Consensus 49 ~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl 126 (282)
T cd07831 49 QALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDI 126 (282)
T ss_pred HHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence 457777 599999999998764 2578999999974 8888887543 46899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|+||+++. +.+||+|||++..+..........++..|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 127 ~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~ 205 (282)
T cd07831 127 KPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL 205 (282)
T ss_pred CHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence 999999999 9999999999987765544455678999999998754 45688999999999999999999999877655
Q ss_pred HHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+....+......+ ....++..+.+||.+||.++|++||+++++++|+||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 206 DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 5444332211100 112568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=285.94 Aligned_cols=205 Identities=32% Similarity=0.583 Sum_probs=176.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++++++|+||+++++++... ++.|+|+||+.|++|.+++.. ..+++..++.|+.||+.||+|||++||+||||+|
T Consensus 68 ~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p 143 (285)
T cd06648 68 VIMRDYQHPNIVEMYSSYLVG-DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143 (285)
T ss_pred HHHHHcCCCChheEEEEEEcC-CeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCh
Confidence 578889999999999988654 578999999999999999976 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+....
T Consensus 144 ~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~ 223 (285)
T cd06648 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223 (285)
T ss_pred hhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 99999999999999999887654322 22345689999999999888899999999999999999999999988776666
Q ss_pred HHHHHhccCCCC--CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSIVAPL--PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~--p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+........ +..++..+.+||++||..+|++||++.++++|+||...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 224 MKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 666655432222 23478999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=277.80 Aligned_cols=202 Identities=20% Similarity=0.418 Sum_probs=174.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+ ...++||||+.+|+|.+++.+.....+++..++.++.|++.||.|||++||+|+|||
T Consensus 47 ~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~ 124 (257)
T cd05040 47 AAIMHSLDHENLIRLYGVVLT--HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLA 124 (257)
T ss_pred HHHHhhcCCCCccceeEEEcC--CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence 367899999999999999876 578999999999999999987543568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+|||++.++.+||+|||++..+.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 125 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 125 ARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998765422 1123456788999999998899999999999999999998 99999877
Q ss_pred CHHHHHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALINKINK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~~~i~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+..+....+.. ......+..++..+.+++.+||..+|.+||++.++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 205 SGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred CHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 77776666553 22333456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=279.24 Aligned_cols=204 Identities=22% Similarity=0.391 Sum_probs=175.9
Q ss_pred HHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKA----NSKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~----~~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
++|++++|+||+++++++.... ...++||||+.+|+|..++... ....+++..++.++.||+.||.|||++
T Consensus 53 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~ 132 (273)
T cd05035 53 ACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR 132 (273)
T ss_pred HHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5788899999999999876433 2478999999999999998543 224689999999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-c
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-L 148 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G 148 (570)
||+||||||+||++++++.+||+|||+++........ ....++..|++||.+....++.++|||||||++|+|++ |
T Consensus 133 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 133 NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCC
Confidence 9999999999999999999999999999876433211 11234678999999988889999999999999999998 8
Q ss_pred CCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 149 KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..||.+....+....+........+..++..+.++|.+||..||++||++.+++++.
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 213 QTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 899988888888887777766667788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=283.45 Aligned_cols=202 Identities=18% Similarity=0.354 Sum_probs=174.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-------------KLFSEEKLCKWLVQLLMALDY 68 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-------------~~Lse~~i~~I~~QLl~aL~y 68 (570)
++|++++|+||+++++++.+. +..|+||||+.+|+|.+++..... ..+++..+..++.||+.||+|
T Consensus 59 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 137 (280)
T cd05092 59 ELLTVLQHQHIVRFYGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVY 137 (280)
T ss_pred HHHhcCCCCCCceEEEEEecC-CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHH
Confidence 678899999999999988654 478999999999999999976431 358899999999999999999
Q ss_pred HHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 69 LHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 69 LHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
||++||+||||||+|||+++++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|
T Consensus 138 LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 138 LASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred HHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999999976543221 2233456789999999988999999999999999999
Q ss_pred hc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 146 TS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 146 lt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++ |.+||...........+........+..++..+.+||.+||+.||.+||++++|+..
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~ 277 (280)
T cd05092 218 FTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSR 277 (280)
T ss_pred HcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 97 999998877777777776665555667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=281.02 Aligned_cols=204 Identities=35% Similarity=0.581 Sum_probs=173.2
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++|+||++++++|.+. +..+|+||||+.|++|.+++.+. ..+++..+..++.||+.||.|||++||+|+|||
T Consensus 56 ~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 133 (265)
T cd06652 56 QLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIK 133 (265)
T ss_pred HHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 578999999999999988653 45788999999999999999864 348999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 134 p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 134 GANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred HHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 999999999999999999987654221 1233568899999999988889999999999999999999999998776
Q ss_pred HHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 157 MQALINKINKSI-VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 157 ~~~~~~~i~~~~-~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.......+.... ....+..++..+.++|.+||. +|++||++++|++|+|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 214 AMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 555444443332 233456778899999999995 899999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=284.50 Aligned_cols=202 Identities=28% Similarity=0.514 Sum_probs=168.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|...+ ..++||||+++++|..+. .+++..+..++.||+.||.|||++||+|+|||
T Consensus 50 ~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 122 (279)
T cd06619 50 LEILYKCDSPYIIGFYGAFFVEN-RISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122 (279)
T ss_pred HHHHHhCCCCCeeeEEEEEEECC-EEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCC
Confidence 35788999999999999987654 788999999999996542 37899999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH---
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM--- 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~--- 157 (570)
|+|||++.++.++|+|||++..+... .....+|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 123 p~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 201 (279)
T cd06619 123 PSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201 (279)
T ss_pred HHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc
Confidence 99999999999999999999876433 23456899999999999988999999999999999999999999865321
Q ss_pred ----HHHHHHHHhccCCC-CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 158 ----QALINKINKSIVAP-LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 158 ----~~~~~~i~~~~~~p-~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
......+....... ....++.++.++|.+||..+|.+||+++++++|+||+..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 202 SLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 12222222222222 233578899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=278.08 Aligned_cols=201 Identities=19% Similarity=0.404 Sum_probs=177.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.+ +...|+||||+.+++|.++++......+++..++.++.|++.||.|||++||+|+||||
T Consensus 52 ~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p 130 (256)
T cd05039 52 SVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAA 130 (256)
T ss_pred HHHHhcCCcceeeeEEEEcC-CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhccc
Confidence 57899999999999998865 45789999999999999999876655799999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||.+........ ...++..|+|||++....++.++||||||+++|+|++ |..||...+....
T Consensus 131 ~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05039 131 RNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred ceEEEeCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999999987643222 3345667999999988889999999999999999997 9999998888887
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
...+........+..++..+.++|.+||..+|.+||++.+++...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 777766655556677899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.15 Aligned_cols=206 Identities=29% Similarity=0.497 Sum_probs=174.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+.++||||+++++.|..+ .++|+||||+.|++|.++++.. ..+++..+..++.|++.||.|||++||+||||||
T Consensus 53 ~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p 129 (305)
T cd05609 53 DILTFAENPFVVSMFCSFETK-RHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKP 129 (305)
T ss_pred HHHHhCCCCCeeeeEEEEecC-CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 578889999999999988654 5899999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC----------------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD----------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~----------------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
.|||++.++.+||+|||+++...... ......|+..|+|||.+.+..++.++|||||||++|+|
T Consensus 130 ~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el 209 (305)
T cd05609 130 DNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEF 209 (305)
T ss_pred HHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999986421100 11124678899999999888899999999999999999
Q ss_pred hccCCCCcccCHHHHHHHHHhccCC-C-CCCCCcHHHHHHHHHhhccCCCCCcC---HHHHHHhhccChh
Q 008303 146 TSLKPAFKAFDMQALINKINKSIVA-P-LPTKYSGAFRGLVKSMLRKNPELRPS---AAELLRHVHLQPY 210 (570)
Q Consensus 146 ltG~~pf~~~~~~~~~~~i~~~~~~-p-~p~~~s~~l~dLI~~~L~~dP~~RPT---a~eIL~hp~fq~~ 210 (570)
++|..||.+.+..+....+...... + ....++.++.++|++||..+|++||+ +.++|+|+||...
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 210 LVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 9999999888777776666544321 1 22357899999999999999999997 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=322.74 Aligned_cols=209 Identities=33% Similarity=0.564 Sum_probs=174.2
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-----
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHAN----- 72 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~----- 72 (570)
+++|++|+|||||+++++|.+. +..+|||||||.+|+|.++|.... ...+++..++.|+.||+.||.|||..
T Consensus 63 I~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~ 142 (1021)
T PTZ00266 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN 142 (1021)
T ss_pred HHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccc
Confidence 4689999999999999998654 457899999999999999997532 24699999999999999999999985
Q ss_pred --CcccceecCCcEEEcC-----------------CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC--CCCCC
Q 008303 73 --HILHRDVKCSNIFLTK-----------------DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD--IPYGS 131 (570)
Q Consensus 73 --gIvHrDLKP~NILld~-----------------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ 131 (570)
+||||||||+||||+. .+.+||+|||++..+.........+||+.|+|||++.+ ..++.
T Consensus 143 ~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~ 222 (1021)
T PTZ00266 143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222 (1021)
T ss_pred cCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCc
Confidence 4999999999999964 23489999999988765555566789999999999864 45789
Q ss_pred cccccchhhhHHHhhccCCCCcccCH-HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 132 KSDIWSLGCCIYEMTSLKPAFKAFDM-QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 132 ksDIWSLG~IlyeLltG~~pf~~~~~-~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
++||||||||+|+|++|..||...+. ..++..+.... ......++.++.+||..||..+|.+||++.|+|.|+|+...
T Consensus 223 KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 223 KSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99999999999999999999976543 33344443322 22234578999999999999999999999999999998754
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=303.38 Aligned_cols=206 Identities=31% Similarity=0.490 Sum_probs=166.1
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
|++|.+| .|.+||+|+||-+.++ ++|+||||-+. +|..+|++... .++.-.++.+..|+|.|++++|.+||||.||
T Consensus 410 I~lL~KLkg~~~IIqL~DYEv~d~-~lYmvmE~Gd~-DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDL 486 (677)
T KOG0596|consen 410 IALLNKLKGHDKIIQLYDYEVTDG-YLYMVMECGDI-DLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDL 486 (677)
T ss_pred HHHHHHhcCCceEEEEeeeeccCc-eEEEEeecccc-cHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCC
Confidence 4688999 7999999999877654 99999999764 99999998654 3443489999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCC-----------CCCcccccchhhhHHHh
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIP-----------YGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~-----------~t~ksDIWSLG~IlyeL 145 (570)
||.|+|+- .|.+||+|||+|..+..+. .....+||+.||+||.+.+.. .+.++||||||||||+|
T Consensus 487 KPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM 565 (677)
T KOG0596|consen 487 KPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM 565 (677)
T ss_pred CcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence 99999987 6899999999999886543 455679999999999986433 45789999999999999
Q ss_pred hccCCCCcccCH-HHHHHHHHhc-cCCCCCCCCc-HHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 146 TSLKPAFKAFDM-QALINKINKS-IVAPLPTKYS-GAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 146 ltG~~pf~~~~~-~~~~~~i~~~-~~~p~p~~~s-~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+.|++||..+.. ..-+..|... ..-++|..-+ .++.++++.||..||++||++.++|+|||++..
T Consensus 566 vYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 566 VYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred HhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 999999987542 2222233222 1112222222 239999999999999999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=279.42 Aligned_cols=201 Identities=22% Similarity=0.389 Sum_probs=174.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.. ...|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 47 ~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 123 (257)
T cd05115 47 EIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAA 123 (257)
T ss_pred HHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccch
Confidence 67899999999999998743 3678999999999999998753 34689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.+||+|||++........ .....++..|+|||++....++.++|||||||++|+|++ |..||....
T Consensus 124 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 124 RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred heEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 999999999999999999976543321 111223568999999988889999999999999999986 999999888
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.......+........+..++.++.++|.+||..+|++||++.+|++..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 204 GPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 8888877877766667788899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=273.07 Aligned_cols=204 Identities=36% Similarity=0.681 Sum_probs=175.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|..+ ...|+++||+.|++|.+++.... ..+++..+..++.|++.||+|||++|++||||+
T Consensus 48 ~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~ 125 (253)
T cd05122 48 IQILKKCKHPNIVKYYGSYLKK-DELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK 125 (253)
T ss_pred HHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCC
Confidence 3678899999999999988665 47899999999999999998753 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+||+++.++.++|+|||.+.............++..|++||.+....++.++||||||+++|+|++|..||...+....
T Consensus 126 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 205 (253)
T cd05122 126 AANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA 205 (253)
T ss_pred HHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 99999999999999999999887654434456789999999999888889999999999999999999999987755444
Q ss_pred HHHHHhccCCCCCC--CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 161 INKINKSIVAPLPT--KYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 161 ~~~i~~~~~~p~p~--~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
............+. .++..+.++|.+||..||.+|||+.+++.|+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 206 LFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 44443333322332 34899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=277.60 Aligned_cols=200 Identities=22% Similarity=0.374 Sum_probs=174.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++. +...++||||+.+|+|.++|.+.. .+++..+..|+.|++.||.|||.+||+|+|||
T Consensus 47 ~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~ 122 (257)
T cd05060 47 ASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLA 122 (257)
T ss_pred HHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcc
Confidence 36788999999999999774 335789999999999999998754 58999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC----ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~----~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+|||++.++.+||+|||+++........ ....++..|+|||.+....++.++|||||||++|+|++ |.+||...
T Consensus 123 p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 123 ARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999876433211 11123457999999998889999999999999999997 99999888
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+..+....+......+.+..++..++++|.+||..+|++||++.++++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~ 251 (257)
T cd05060 203 KGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELEST 251 (257)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 8877777777766666778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=279.00 Aligned_cols=198 Identities=26% Similarity=0.470 Sum_probs=171.6
Q ss_pred hcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEE
Q 008303 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85 (570)
Q Consensus 6 kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NIL 85 (570)
.++|+||++++++|.. +..+|+|+|||.|++|.++++.. ..+++..+..|+.||+.||.|||+.||+|+||+|.|||
T Consensus 53 ~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil 129 (260)
T cd05611 53 QGESPYVAKLYYSFQS-KDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129 (260)
T ss_pred cCCCCCeeeeeeeEEc-CCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 4489999999999865 45899999999999999999864 35899999999999999999999999999999999999
Q ss_pred EcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHH
Q 008303 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKIN 165 (570)
Q Consensus 86 ld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~ 165 (570)
++.++.+||+|||++..... .....|+..|++||.+.+..++.++||||||+++|+|++|..||...+.......+.
T Consensus 130 ~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 130 IDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred ECCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999999999876543 234568899999999988888999999999999999999999998887777666654
Q ss_pred hccC---CCCCCCCcHHHHHHHHHhhccCCCCCc---CHHHHHHhhccCh
Q 008303 166 KSIV---APLPTKYSGAFRGLVKSMLRKNPELRP---SAAELLRHVHLQP 209 (570)
Q Consensus 166 ~~~~---~p~p~~~s~~l~dLI~~~L~~dP~~RP---Ta~eIL~hp~fq~ 209 (570)
.... ......++.++.++|.+||..+|++|| +++|+|.||||..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred hcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 4322 123346789999999999999999999 5589999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.43 Aligned_cols=205 Identities=31% Similarity=0.544 Sum_probs=173.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++|+||++++++|... .+.|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||
T Consensus 68 ~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p 143 (297)
T cd06656 68 LVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKS 143 (297)
T ss_pred HHHHhCCCCCEeeEEEEEecC-CEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 578889999999999998654 578999999999999999975 3479999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.++|+|||++....... ......+++.|++||.+.+..++.++|||||||++|+|++|..||...+....
T Consensus 144 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~ 223 (297)
T cd06656 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (297)
T ss_pred HHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence 99999999999999999988765432 22345788999999999988899999999999999999999999977654333
Q ss_pred HHHHHhcc--CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSI--VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~--~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+.... ....+..++..+++||.+||..+|++||+++++++|+||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 224 LYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred eeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 22222211 112345678999999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=279.12 Aligned_cols=203 Identities=20% Similarity=0.376 Sum_probs=172.8
Q ss_pred HHhhhcCCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 2 ELISKIRNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKA----NSKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~----~~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
++|++++|+||+++++++... ....++||||+.+|+|.+++... ....+++..+..++.||+.||+|||++
T Consensus 52 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 131 (272)
T cd05075 52 VCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK 131 (272)
T ss_pred HHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 578899999999999977532 12468999999999999988532 224589999999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-c
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-L 148 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G 148 (570)
||+||||||+|||++.++.+||+|||+++....... .....+++.|++||.+.+..++.++|||||||++|+|++ |
T Consensus 132 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 132 SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999987643321 122345678999999998899999999999999999998 8
Q ss_pred CCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 149 KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..||...........+......+.+..++..+.++|.+||..+|++|||+++|+++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 212 QTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 89998887777777776665555667889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=277.89 Aligned_cols=202 Identities=19% Similarity=0.361 Sum_probs=171.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||+++++++...+...|+||||+.+|+|.+++.+.. ..+.+..+..++.||+.||.|||++||+||||||
T Consensus 48 ~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~ 126 (262)
T cd05058 48 IIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAA 126 (262)
T ss_pred HHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCc
Confidence 567889999999999987655556889999999999999997643 3467888999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC-----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
+|||++.++.+||+|||+++....... .....++..|+|||.+....++.++|||||||++|+|++ |.+||...
T Consensus 127 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred ceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999976543211 123345678999999988889999999999999999998 56778877
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+.......+........+..++..+.+++.+||..+|++||++.++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 207 DSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 7777666666555555566788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=277.97 Aligned_cols=202 Identities=18% Similarity=0.380 Sum_probs=175.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++. . ...|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+|||||
T Consensus 52 ~~~l~~l~~~~i~~~~~~~~-~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 129 (260)
T cd05070 52 AQIMKKLRHDKLVQLYAVVS-E-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129 (260)
T ss_pred HHHHHhcCCCceEEEEeEEC-C-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 36899999999999999774 3 357899999999999999987555568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC--ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+|||+++++.++|+|||++......... ....++..|+|||++....++.++||||||+++|+|++ |..||.+.+.
T Consensus 130 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred cceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999999876543211 12335567999999988889999999999999999998 8999988888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+....+......+.+..++..+.+|+.+||.++|.+|||+++++.-
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 256 (260)
T cd05070 210 REVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSF 256 (260)
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77777777666666777889999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.21 Aligned_cols=208 Identities=31% Similarity=0.483 Sum_probs=172.8
Q ss_pred CHHhhhcCCCcccccceEEEeeC-cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++|+||+++++++.+.. ..+|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||
T Consensus 57 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 134 (309)
T cd07845 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDL 134 (309)
T ss_pred HHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 36889999999999999987543 568999999975 8998887643 46899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
||+||+++.++.+||+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus 135 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 135 KVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred CHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999998765432 2233456888999999865 4578999999999999999999999988877
Q ss_pred HHHHHHHHhccCCC------------------C-----------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 158 QALINKINKSIVAP------------------L-----------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 158 ~~~~~~i~~~~~~p------------------~-----------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.+....+......+ . ...++..+.+||++||..||++|||++++++|+||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 66655554321110 0 012578899999999999999999999999999997
Q ss_pred hh
Q 008303 209 PY 210 (570)
Q Consensus 209 ~~ 210 (570)
..
T Consensus 295 ~~ 296 (309)
T cd07845 295 EK 296 (309)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=284.84 Aligned_cols=204 Identities=30% Similarity=0.460 Sum_probs=170.7
Q ss_pred HHhhhcCCCcccccceEEEeeC-cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||+++++++...+ ...|+||||+.+ +|.+++.... ..+++..++.|+.||+.||+|||++||+|+|||
T Consensus 56 ~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~ 133 (293)
T cd07843 56 NILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLK 133 (293)
T ss_pred HHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 5788999999999999887542 689999999975 9999987643 368999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|.+||...+..
T Consensus 134 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 134 TSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred HHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999999876543 2334456789999999987654 688999999999999999999999877665
Q ss_pred HHHHHHHhccC------------------------------CCCCCC-CcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIV------------------------------APLPTK-YSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~------------------------------~p~p~~-~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....++..... ...+.. ++..+.+||++||..+|++|||+.|+|.|+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 55444332111 011122 58889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=278.48 Aligned_cols=202 Identities=19% Similarity=0.382 Sum_probs=175.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++. . +..|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+|+|||
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~-~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~ 129 (260)
T cd05069 52 AQIMKKLRHDKLVPLYAVVS-E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129 (260)
T ss_pred HHHHHhCCCCCeeeEEEEEc-C-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC
Confidence 36889999999999998774 3 357899999999999999987655668999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+|||+++++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 130 ~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred cceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999987643321 122345678999999988889999999999999999998 8999988877
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+....+......+.+..++..+.++|++||.++|++||+++++++-
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 256 (260)
T cd05069 210 REVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSF 256 (260)
T ss_pred HHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 77777776665555667889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=283.43 Aligned_cols=201 Identities=18% Similarity=0.374 Sum_probs=172.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------SKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
.+|++++|+||+++++++.+. ...|+|||||.+|+|.+++.+.. ...+....+..++.||+.||.|||++|
T Consensus 61 ~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 139 (288)
T cd05061 61 SVMKGFTCHHVVRLLGVVSKG-QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 139 (288)
T ss_pred HHHHhCCCCCeeeEEEEEcCC-CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578899999999999988654 47899999999999999997632 134567889999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
|+||||||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999886543221 112345678999999998889999999999999999998 78
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
.||.+....+....+........+..++..+.++|.+||+.+|++|||+.++++
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 220 QPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899888877777777666555566778899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=279.41 Aligned_cols=204 Identities=30% Similarity=0.522 Sum_probs=168.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLF--SEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~L--se~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++|+||+++++++... +.+|+|+||+.+++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||
T Consensus 57 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl 134 (268)
T cd06624 57 ALHSYLKHRNIVQYLGSDSEN-GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134 (268)
T ss_pred HHHHhcCCCCeeeeeeeeccC-CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCC
Confidence 678899999999999988654 58999999999999999998642 234 88899999999999999999999999999
Q ss_pred cCCcEEEcC-CCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCC--CCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTK-DQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~-~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~--~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++. ++.++|+|||++....... ......|+..|+|||++.... ++.++||||||+++|+|++|..||...
T Consensus 135 ~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999986 6789999999987664322 223346889999999986543 789999999999999999999999764
Q ss_pred CHHH--HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 156 DMQA--LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 156 ~~~~--~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.... .............+..++.++++|+++||..+|.+|||+.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 215 GEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 4322 111112223344567789999999999999999999999999999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=283.21 Aligned_cols=202 Identities=26% Similarity=0.505 Sum_probs=171.0
Q ss_pred hhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCc
Q 008303 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSN 83 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~N 83 (570)
++...||||+.++++|... ..+|+|||||.||+|.+++.+. ..+++..++.|+.|++.||.|||++||+||||||+|
T Consensus 51 ~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~n 127 (278)
T cd05606 51 VSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN 127 (278)
T ss_pred HHhCCCCcEeeeeeeeecC-CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHH
Confidence 4445899999999988654 4789999999999999998764 469999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCccc---CHHH
Q 008303 84 IFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAF---DMQA 159 (570)
Q Consensus 84 ILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~---~~~~ 159 (570)
|+++.++.+||+|||++..+.... ....+|+..|+|||++.+. .++.++||||+||++|+|++|+.||... ....
T Consensus 128 ili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~ 206 (278)
T cd05606 128 ILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (278)
T ss_pred EEECCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH
Confidence 999999999999999987654322 2345799999999999754 6899999999999999999999999765 3233
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
.. .........++..++..+.++|.+||..+|.+|+ ++.++++|+||...
T Consensus 207 ~~-~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 207 ID-RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HH-HHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 22 2223333446667899999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=273.58 Aligned_cols=204 Identities=34% Similarity=0.615 Sum_probs=179.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+. ...|+||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||+
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 126 (254)
T cd06627 50 IDLLKNLKHPNIVKYIGSIETS-DSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK 126 (254)
T ss_pred HHHHHhCCCCCccEEEEEEEeC-CEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 3678899999999999988654 5889999999999999999875 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||+++.++.++|+|||++........ .....++..|++||.+.+..++.++|||+||+++|+|++|..||...+...
T Consensus 127 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~ 206 (254)
T cd06627 127 AANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206 (254)
T ss_pred HHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 9999999999999999999988764432 234578899999999988888999999999999999999999998777655
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+........+..++..+.++|.+||..+|++||++.+++.|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 207 ALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 555555555566777889999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=281.55 Aligned_cols=204 Identities=26% Similarity=0.452 Sum_probs=169.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|.. ++..|+||||+.++.|..++.+. ..+++..++.++.||+.||.|||++||+|+||+
T Consensus 51 ~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~ 127 (288)
T cd07833 51 VKVLRQLRHENIVNLKEAFRR-KGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK 127 (288)
T ss_pred HHHHHhcCCCCeeehhheEEE-CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 367889999999999999876 45799999999987776666543 348999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||++....... ......++..|+|||++... .++.++||||||+++|+|++|+++|...+.
T Consensus 128 ~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 128 PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred HHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999998766443 33456789999999999887 789999999999999999999999987655
Q ss_pred HHHHHHHHhccC-------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 158 QALINKINKSIV-------------------------------APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 158 ~~~~~~i~~~~~-------------------------------~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
.+....+..... ...+..++.++++||++||..+|++||+++++++|+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred HHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 443322211000 0012235889999999999999999999999999999
Q ss_pred c
Q 008303 207 L 207 (570)
Q Consensus 207 f 207 (570)
|
T Consensus 288 f 288 (288)
T cd07833 288 F 288 (288)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=283.37 Aligned_cols=202 Identities=19% Similarity=0.428 Sum_probs=175.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC----------------------CCCCCHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN----------------------SKLFSEEKLCKWL 59 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~----------------------~~~Lse~~i~~I~ 59 (570)
++|++++||||+++++.|..++ ..|+|||||.+|+|.+++.... ...+++..++.++
T Consensus 55 ~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 133 (290)
T cd05045 55 NLLKQVNHPHVIKLYGACSQDG-PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFA 133 (290)
T ss_pred HHHhhCCCCCEeeEEEEEecCC-CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHH
Confidence 5788999999999999886554 6889999999999999987521 1357899999999
Q ss_pred HHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCccccc
Q 008303 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 60 ~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
.|++.||.|||++||+||||||+|||+++++.+||+|||+++.+..... .....++..|+|||.+.+..++.++|||
T Consensus 134 ~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 134 WQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred HHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 9999999999999999999999999999999999999999976543221 1223456789999999888899999999
Q ss_pred chhhhHHHhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 137 SLGCCIYEMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 137 SLG~IlyeLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
||||++|+|++ |..||.+...+.+.+.+......+.+..++.++.++|.+||+.+|++||++.++++.
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 99999999998 999999888888877777666666677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=273.25 Aligned_cols=205 Identities=35% Similarity=0.619 Sum_probs=177.9
Q ss_pred CHHhhhcCCCcccccceEEEeeC-cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++++++++|+||+++++.+.... ..+++|+||+.+++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl 127 (260)
T cd06606 50 IRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127 (260)
T ss_pred HHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 36789999999999999887651 57899999999999999998754 6899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
+|+||+++.++.++|+|||.+........ .....++..|++||.+....++.++||||||+++|+|++|..||...+
T Consensus 128 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred CHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999988765543 445678999999999988889999999999999999999999998766
Q ss_pred -HHHHHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 157 -MQALINKINK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 157 -~~~~~~~i~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.......+.. ......+..++..+.++|.+||..+|++||++.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 208 NPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred chHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 2222233322 33445667789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=308.35 Aligned_cols=205 Identities=29% Similarity=0.550 Sum_probs=178.6
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccc
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--ILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--IvHr 77 (570)
+.+|+.|+|+|||++|++|++. +..+.+|+|++..|+|..|++++.. ++...++.|++|||.||.|||++. |+||
T Consensus 92 v~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHR 169 (632)
T KOG0584|consen 92 VHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHR 169 (632)
T ss_pred HHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCcccc
Confidence 4689999999999999999864 4567899999999999999998754 899999999999999999999996 9999
Q ss_pred eecCCcEEEcC-CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 78 DVKCSNIFLTK-DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 78 DLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||++||||+. .|.|||+|+|+|....... ...++|||.|||||++- ..|++.+||||||+||.||+++..||....
T Consensus 170 DLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 170 DLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred ccccceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 99999999986 5899999999999876543 44589999999999997 789999999999999999999999997654
Q ss_pred -HHHHHHHHHhccCCCCC-CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 157 -MQALINKINKSIVAPLP-TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 157 -~~~~~~~i~~~~~~p~p-~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...++.++..+..+... ..-.+++++||.+||.. ...|+|+.|||.|+||...
T Consensus 248 n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 248 NPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 45566666666544322 23368999999999999 9999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=288.23 Aligned_cols=201 Identities=20% Similarity=0.374 Sum_probs=174.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||+++++++... ..++|+||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 61 ~~l~~l~h~niv~~~g~~~~~--~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp 137 (316)
T cd05108 61 YVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAA 137 (316)
T ss_pred HHHHhCCCCCCCeEEEEEcCC--CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence 578899999999999988653 4679999999999999998643 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.+||+|||+++.+...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 138 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 138 RNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred hheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999999876543221 12234667999999999999999999999999999987 9999988877
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.++...+......+.+..++..+.++|.+||..+|.+||++.+++.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l 265 (316)
T cd05108 218 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265 (316)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 776666666666666778899999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=284.73 Aligned_cols=204 Identities=20% Similarity=0.413 Sum_probs=176.6
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~a 65 (570)
+++|+.+ +||||++++++|... ..+|+||||+.+|+|.++|.+.. ...+++..+..++.||+.|
T Consensus 71 ~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 149 (304)
T cd05101 71 MEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG 149 (304)
T ss_pred HHHHHhhccCCCchheeEEEecC-CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHH
Confidence 3578888 899999999988654 47899999999999999997642 2357888999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhH
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCI 142 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Il 142 (570)
|.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++
T Consensus 150 l~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 229 (304)
T cd05101 150 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229 (304)
T ss_pred HHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHH
Confidence 9999999999999999999999999999999999987653221 2223456789999999988899999999999999
Q ss_pred HHhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 143 YEMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 143 yeLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|+|++ |..||.+.+..++...+........+..++..+.+||.+||..+|.+||++.++++.+
T Consensus 230 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 230 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 99997 7889988888888888776665556778899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.54 Aligned_cols=203 Identities=23% Similarity=0.406 Sum_probs=168.6
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---------------------------------
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------------------------- 46 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------------------------- 46 (570)
+++|+++ +|+|||+++++|...+ .+|+|||||.+|+|.+++.+..
T Consensus 92 ~~il~~l~~h~nIv~~~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (374)
T cd05106 92 LKILSHLGQHKNIVNLLGACTHGG-PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSD 170 (374)
T ss_pred HHHHHhhccCCceeeEeeEecCCC-CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccc
Confidence 3678888 8999999999986654 7899999999999999986531
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCC
Q 008303 47 -----------------------------------SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91 (570)
Q Consensus 47 -----------------------------------~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~ 91 (570)
...+++..++.|+.||+.||.|||++||+||||||+|||++.++.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~ 250 (374)
T cd05106 171 SGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV 250 (374)
T ss_pred ccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe
Confidence 124788999999999999999999999999999999999999999
Q ss_pred EEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHHHH-HHHHh
Q 008303 92 IRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQALI-NKINK 166 (570)
Q Consensus 92 vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~~~-~~i~~ 166 (570)
+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......... ..+..
T Consensus 251 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~ 330 (374)
T cd05106 251 AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330 (374)
T ss_pred EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc
Confidence 99999999987543221 112334567999999998899999999999999999996 99999876544333 33333
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 167 SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 167 ~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+..++.++.++|.+||..+|.+||++.+|++.
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 331 GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33444556679999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=292.18 Aligned_cols=205 Identities=20% Similarity=0.431 Sum_probs=172.5
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------------------------
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-------------------------------- 47 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-------------------------------- 47 (570)
++++.++ +|+||++++++|...+..+++||||+.+++|.++|.....
T Consensus 61 ~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (337)
T cd05054 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQ 140 (337)
T ss_pred HHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccc
Confidence 3678888 8999999999887767789999999999999999864321
Q ss_pred ---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCc
Q 008303 48 ---------------------------KLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA 100 (570)
Q Consensus 48 ---------------------------~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla 100 (570)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 141 SSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred cccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccc
Confidence 25899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH-HHHHHHHhccCCCCCCC
Q 008303 101 KILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ-ALINKINKSIVAPLPTK 175 (570)
Q Consensus 101 ~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~-~~~~~i~~~~~~p~p~~ 175 (570)
..+..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....+........+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEY 300 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 87643221 223455678999999999999999999999999999997 99999765433 33344444444445667
Q ss_pred CcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 176 YSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 176 ~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
++.++.+++.+||+.+|++||++++|++|+
T Consensus 301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~l 330 (337)
T cd05054 301 ATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330 (337)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 889999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=286.77 Aligned_cols=205 Identities=30% Similarity=0.541 Sum_probs=175.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||++++++|... +..|+||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 70 ~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p 145 (297)
T cd06659 70 VIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145 (297)
T ss_pred HHHHhCCCCchhhhhhheeeC-CeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 578889999999999988654 578999999999999998865 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++..+.... .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 146 ~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 225 (297)
T cd06659 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 225 (297)
T ss_pred HHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999987654322 22346789999999999988899999999999999999999999987776665
Q ss_pred HHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+...... ..+..++..+.++|.+||..+|.+||++.++++|+||...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 226 MKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 5555433221 1234678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=273.88 Aligned_cols=203 Identities=25% Similarity=0.465 Sum_probs=178.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+. ...|+||||+.+++|.+++.......+++..+..++.||+.||.|||++|++|+|||
T Consensus 52 ~~~l~~l~~~~i~~~~~~~~~~-~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~ 130 (258)
T smart00219 52 ARIMRKLDHPNIVKLLGVCTEE-EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130 (258)
T ss_pred HHHHHhcCCCchheEEEEEcCC-CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccc
Confidence 3678889999999999988765 478999999999999999986543338999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCcc--ccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASS--VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~--~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.++|+|||++........... ..++..|++||.+....++.++|||||||++|+|++ |.+||...+.
T Consensus 131 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~ 210 (258)
T smart00219 131 ARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN 210 (258)
T ss_pred cceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999987765432221 236789999999988889999999999999999987 8899988888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+........+..++.++.+++.+||..+|.+|||+.++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 211 EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 88888887776666777899999999999999999999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=286.04 Aligned_cols=203 Identities=22% Similarity=0.407 Sum_probs=174.6
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL 66 (570)
++|+++ +||||+++++++.+. ..+|+||||+.+|+|.++|.... ...+++..+..++.||+.||
T Consensus 69 ~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 69 ELMKLIGKHKNIINLLGVCTQE-GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred HHHHhccCCCCeeeEEEEEccC-CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHH
Confidence 577888 699999999988654 47899999999999999997642 23588999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 999999999999999999999999999999999986543221 11223446799999999888999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||...+.......+........+..++.+++++|.+||..+|++||++.++++..
T Consensus 228 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 228 EIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9998 8899998888888877776655556778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=293.11 Aligned_cols=207 Identities=30% Similarity=0.574 Sum_probs=182.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|.||.+.+.++||+|||.|+.+. .+|||||||..|+..+.|+.++ +.|+|.+|..+++..+.||+|||...-+|||||
T Consensus 79 ISIMQQC~S~yVVKYYGSYFK~s-DLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIK 156 (502)
T KOG0574|consen 79 ISIMQQCKSKYVVKYYGSYFKHS-DLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIK 156 (502)
T ss_pred HHHHHHcCCchhhhhhhhhccCC-ceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcc
Confidence 46899999999999999997544 6899999999999999998764 679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
..|||++.+|..||+|||.+..+...- ...+++||+.|||||++...+|+.++||||||+...||..|++||.......
T Consensus 157 AGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 157 AGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred cccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 999999999999999999998886542 3567899999999999999999999999999999999999999998766555
Q ss_pred HHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+..|-..... ..|..|+.++-+||++||.++|++|-|+-++++|+|++.
T Consensus 237 AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 237 AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 44444322221 235689999999999999999999999999999999863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.75 Aligned_cols=204 Identities=21% Similarity=0.386 Sum_probs=169.5
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---------------------------------
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------------------------- 46 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------------------------- 46 (570)
+++|+++ +|||||+++++|...+ ..|+|||||+||+|.+++....
T Consensus 89 i~il~~l~~HpnIv~l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (375)
T cd05104 89 LKVLSYLGNHINIVNLLGACTVGG-PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNE 167 (375)
T ss_pred HHHHHHhcCCcceeeeeeeeccCC-cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhh
Confidence 3578888 8999999999986554 7899999999999999997532
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEE
Q 008303 47 ----------------------------------------SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL 86 (570)
Q Consensus 47 ----------------------------------------~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILl 86 (570)
...+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill 247 (375)
T cd05104 168 YMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247 (375)
T ss_pred hhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE
Confidence 1247889999999999999999999999999999999999
Q ss_pred cCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH-HHH
Q 008303 87 TKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ-ALI 161 (570)
Q Consensus 87 d~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~-~~~ 161 (570)
+.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 248 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~ 327 (375)
T cd05104 248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327 (375)
T ss_pred ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH
Confidence 9999999999999987653321 112334567999999999999999999999999999987 88888776543 344
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..+........+...+.++.+||.+||..||++||++.+|++.+
T Consensus 328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred HHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 44444444445566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=275.33 Aligned_cols=204 Identities=33% Similarity=0.639 Sum_probs=171.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++++|+||+++++++.. .+.+++|+||+.+++|.+++.+. ..+++..++.|+.|++.||.|||++||+|+||+
T Consensus 50 ~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~ 126 (264)
T cd06626 50 MKVLELLKHPNLVKYYGVEVH-REKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126 (264)
T ss_pred HHHHHhCCCCChhheeeeEec-CCEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 368899999999999998754 45789999999999999999764 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-----CccccCCCCCCCcccccCCC---CCCcccccchhhhHHHhhccCCCC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~---~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|+||+++.++.+||+|||++........ .....++..|++||++.+.. ++.++|||+||+++|+|++|+.||
T Consensus 127 ~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf 206 (264)
T cd06626 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206 (264)
T ss_pred HHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999987654322 12356788999999998766 889999999999999999999999
Q ss_pred cccC-HHHHHHHHHhccCCCCCC--CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 153 KAFD-MQALINKINKSIVAPLPT--KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 153 ~~~~-~~~~~~~i~~~~~~p~p~--~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
...+ .......+........+. .++..+.++|++||+.+|.+||++.+++.|+|+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 207 SELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 7653 333333333333333333 348999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=280.89 Aligned_cols=206 Identities=31% Similarity=0.611 Sum_probs=179.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||++++++|..+ ++.|+|||||.+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||+|
T Consensus 54 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p 129 (277)
T cd06641 54 TVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129 (277)
T ss_pred HHHHhcCCCCEeEEEEEEEeC-CeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCH
Confidence 578889999999999998654 578999999999999999875 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.++|+|||++..+..... .....++..|++||.+.+..++.++|||||||++|+|++|..||........
T Consensus 130 ~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 209 (277)
T cd06641 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV 209 (277)
T ss_pred HhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH
Confidence 999999999999999999877654322 2335688999999999888889999999999999999999999987776666
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
...+...........++.++.++|.+||..+|.+||++.++++|+||....
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 210 LFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 666554444445667899999999999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=282.04 Aligned_cols=209 Identities=32% Similarity=0.567 Sum_probs=172.4
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
+++|++++||||++++++|... ++.+|+|||||+|++|.+++.. .....+++..+..|+.||+.||.|||+.|++|+
T Consensus 50 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~ 129 (287)
T cd06621 50 LEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR 129 (287)
T ss_pred HHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 4688999999999999988643 4578999999999999998764 223568999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc--
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-- 155 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~-- 155 (570)
||+|.||+++.++.++|+|||++....... .....++..|++||.+.+..++.++|||+|||++|+|++|..||...
T Consensus 130 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (287)
T cd06621 130 DIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208 (287)
T ss_pred CCCHHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence 999999999999999999999987654322 23456788999999999889999999999999999999999999765
Q ss_pred ---CHHHHHHHHHhccCCCCC------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 ---DMQALINKINKSIVAPLP------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ---~~~~~~~~i~~~~~~p~p------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+....+.......++ ..++..+.+||.+||..+|.+|||+.|+++|+||+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 209 PPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 223333333321111111 2457899999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=274.20 Aligned_cols=202 Identities=35% Similarity=0.603 Sum_probs=179.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++.+.. +..+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|
T Consensus 45 ~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p 121 (250)
T cd05123 45 NILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121 (250)
T ss_pred HHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc
Confidence 57899999999999998865 458999999999999999998753 589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.++|+|||++...... .......++..|++||.+.+..++.++|+|+||+++|+|++|..||...+....
T Consensus 122 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~ 201 (250)
T cd05123 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI 201 (250)
T ss_pred ceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999999999999876543 234456788999999999888889999999999999999999999988877666
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH---HHHHHhhcc
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA---AELLRHVHL 207 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa---~eIL~hp~f 207 (570)
...+.. .....+..++..+.++|++||..||++||++ +++++|+||
T Consensus 202 ~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 202 YEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 666654 3345677789999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=277.87 Aligned_cols=202 Identities=20% Similarity=0.386 Sum_probs=174.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++++|+||+++++++.+ .+.|+||||+.+|+|.+++.+.....+++..+..++.|++.||.|||++||+|+|||
T Consensus 52 ~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (262)
T cd05071 52 AQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129 (262)
T ss_pred HHHHHhCCCCCcceEEEEECC--CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 368899999999999997743 357899999999999999987555568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC--ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||.+..+...... ....++..|++||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 130 p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred cccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 99999999999999999999876543321 23345678999999988889999999999999999998 8889988877
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+.+..++..+.++|.+||..+|.+||++.+++.-
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 210 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 77777776655555566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=275.20 Aligned_cols=200 Identities=21% Similarity=0.411 Sum_probs=175.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++..++ .|+||||+.+++|.+++.......+++..++.++.|++.||.|||++|++|||||
T Consensus 50 ~~~l~~~~~~~i~~~~~~~~~~~--~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~ 127 (254)
T cd05083 50 TAVMTKLHHKNLVRLLGVILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127 (254)
T ss_pred HHHHHhCCCCCcCeEEEEEcCCC--cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 36788999999999999886543 6899999999999999987655568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++...... ......+..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+
T Consensus 128 p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 128 ARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred cceEEEcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 99999999999999999998765322 122334567999999988889999999999999999997 999999888888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
....+........+..++..+.++|.+||..+|++||++++++..
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 206 VKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777777666555667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=285.33 Aligned_cols=204 Identities=21% Similarity=0.428 Sum_probs=175.8
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--------------KLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--------------~~Lse~~i~~I~~QLl~a 65 (570)
+++++++ +|+||+++++++...+ .+|+|||||.+|+|.++|..... ..+++..++.|+.||+.|
T Consensus 74 ~~~l~~l~~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 152 (307)
T cd05098 74 MEMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARG 152 (307)
T ss_pred HHHHHHhcCCCCEeeEEEEEecCC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHH
Confidence 3577888 8999999999886554 78999999999999999976421 348899999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhH
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCI 142 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Il 142 (570)
|+|||++||+||||||+|||++.++.+||+|||++......... ....++..|+|||++.+..++.++|||||||++
T Consensus 153 L~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 232 (307)
T cd05098 153 MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 232 (307)
T ss_pred HHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHH
Confidence 99999999999999999999999999999999998766432211 122345689999999988899999999999999
Q ss_pred HHhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 143 YEMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 143 yeLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|+|++ |..||...+..+....+........+..++.++.+||.+||..+|.+||++.+++++.
T Consensus 233 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 233 WEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99997 8899988888777777776666566778899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=273.08 Aligned_cols=201 Identities=21% Similarity=0.377 Sum_probs=174.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++...+ ..|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||
T Consensus 44 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p 121 (250)
T cd05085 44 RILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121 (250)
T ss_pred HHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCh
Confidence 5788999999999999886554 7899999999999999987643 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC--ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+||+++.++.+||+|||++......... ....++..|+|||++....++.++||||||+++|+|++ |..||......
T Consensus 122 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred heEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999999998765432221 12234567999999998889999999999999999998 99999888877
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.....+........+..++..+.+++.+||..+|++||++.++++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 202 QAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 7777776666556677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=279.77 Aligned_cols=205 Identities=28% Similarity=0.502 Sum_probs=167.8
Q ss_pred hhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccceec
Q 008303 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDVK 80 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDLK 80 (570)
++.++||||+++++++..++ .+|+||||++ |+|.+++... ....+++..++.++.||+.||+|||++ +|+|||||
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~-~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlk 131 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREG-DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK 131 (283)
T ss_pred HHHcCCCCeeeeeEEEecCC-cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence 55669999999999986554 7899999997 5888888652 235689999999999999999999998 99999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC----CCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD----IPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++.+||+|||++..+..........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 132 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 132 PSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211 (283)
T ss_pred HHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999987654433344678999999998864 456889999999999999999999996532
Q ss_pred -HHHHHHHHHhccCCCCC-CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 157 -MQALINKINKSIVAPLP-TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 157 -~~~~~~~i~~~~~~p~p-~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+....+........+ ..++.++.+||.+||..+|.+||++++++.|+||+..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 212 TPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred cCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 12222233233222222 4588999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=277.04 Aligned_cols=203 Identities=23% Similarity=0.419 Sum_probs=173.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-----SKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-----~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|++++||||++++++|...+ ..|+||||+.+++|.+++.... ...+++..+..++.||+.||+|||++||+|
T Consensus 51 ~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 129 (269)
T cd05044 51 HLMSNFNHPNIVKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIH 129 (269)
T ss_pred HHHHhcCCCCeeeEeeeecCCC-CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 6788999999999999886544 6899999999999999997532 234889999999999999999999999999
Q ss_pred ceecCCcEEEcCCC-----CEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-
Q 008303 77 RDVKCSNIFLTKDQ-----DIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS- 147 (570)
Q Consensus 77 rDLKP~NILld~~g-----~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt- 147 (570)
+||||+|||++.++ .++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++
T Consensus 130 ~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~ 209 (269)
T cd05044 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209 (269)
T ss_pred CCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHc
Confidence 99999999999877 899999999876543221 122345678999999998899999999999999999997
Q ss_pred cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 148 LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|..||...+..+....+........+..++..+.++|.+||..+|.+||++++|++..
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 210 GQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred CCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 9999988777777666655544456677899999999999999999999999998763
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=281.11 Aligned_cols=205 Identities=30% Similarity=0.542 Sum_probs=172.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDL 79 (570)
++++++++||||+++++++... ..+|+||||+.+++|.+++.+. +.+++..+..++.|++.||.|||+ .||+||||
T Consensus 54 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl 130 (284)
T cd06620 54 LQIMHECRSPYIVSFYGAFLNE-NNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130 (284)
T ss_pred HHHHHHcCCCCcceEeeeEecC-CEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCC
Confidence 3678899999999999998765 4789999999999999998764 358999999999999999999997 69999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH-
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ- 158 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~- 158 (570)
+|+||+++.++.++|+|||++...... .....+|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 131 ~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 209 (284)
T cd06620 131 KPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209 (284)
T ss_pred CHHHEEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhh
Confidence 999999999999999999998765322 223467899999999998888999999999999999999999999765431
Q ss_pred ----------HHHHHHHhccCCCCCC-CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ----------ALINKINKSIVAPLPT-KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ----------~~~~~i~~~~~~p~p~-~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+....+.......++. .++..+.+||.+||..||++|||+.|+++|+||.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 210 DGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 2222332222222333 37889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=275.66 Aligned_cols=202 Identities=19% Similarity=0.395 Sum_probs=177.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++. . ...|+||||+.+++|.+++....+..+++..+..|+.|++.||+|||+.||+|||||
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~-~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~ 129 (260)
T cd05067 52 ANLMKQLQHPRLVRLYAVVT-Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLR 129 (260)
T ss_pred HHHHHhcCCcCeeeEEEEEc-c-CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence 36889999999999999764 3 358999999999999999987666679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.++|+|||++........ .....++..|+|||++....++.++||||||+++|+|++ |+.||.+.+.
T Consensus 130 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 130 AANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred HHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 9999999999999999999987653222 122345678999999998889999999999999999998 9999988887
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+.+..++.++.++|.+||..+|++||++++++..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05067 210 PEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSV 256 (260)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 77777777666666777889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=281.58 Aligned_cols=204 Identities=26% Similarity=0.457 Sum_probs=164.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.++ .+.|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 54 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~ 130 (291)
T cd07844 54 ASLLKDLKHANIVTLHDIIHTK-KTLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLK 130 (291)
T ss_pred HHHHhhCCCcceeeEEEEEecC-CeEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Confidence 3678999999999999998654 589999999985 9999987654 368999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccC-H
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-M 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~-~ 157 (570)
|+|||++.++.+||+|||++....... ......++..|+|||++.+ ..++.++||||+||++|+|++|+.+|.... .
T Consensus 131 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 210 (291)
T cd07844 131 PQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV 210 (291)
T ss_pred HHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 999999999999999999987643221 1223456889999999875 458899999999999999999999997654 2
Q ss_pred HHHHHHHHhccCCC-----------------------------CCCCCc--HHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 158 QALINKINKSIVAP-----------------------------LPTKYS--GAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 158 ~~~~~~i~~~~~~p-----------------------------~p~~~s--~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
.+....+......+ ....++ .++.++|.+||..+|.+||++.+++.|+|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 211 EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 22222221110000 001233 78899999999999999999999999999
Q ss_pred c
Q 008303 207 L 207 (570)
Q Consensus 207 f 207 (570)
|
T Consensus 291 f 291 (291)
T cd07844 291 F 291 (291)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=279.37 Aligned_cols=199 Identities=21% Similarity=0.376 Sum_probs=172.8
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
++++++||||+++++++. +...++|+||+.+|+|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+
T Consensus 62 ~l~~l~h~~iv~~~~~~~--~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 62 AMGSLDHAYIVRLLGICP--GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred HHhcCCCCCcceEEEEEC--CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 567889999999999874 335789999999999999997643 46899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
|||++.++.+||+|||+++...... ......++..|++||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 139 nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred eEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998764332 1223456778999999998899999999999999999997 99999888777
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.....+......+.+..++..+.+++.+||..+|.+||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 219 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7766666665556667788899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=279.06 Aligned_cols=204 Identities=34% Similarity=0.602 Sum_probs=173.0
Q ss_pred HHhhhcC---CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIR---NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~---HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++++++ ||||++++++|..+ .+.|+||||+.|++|.++++.. .+++..++.++.||+.||.|||+.||+|+|
T Consensus 51 ~~l~~l~~~~~~~vi~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~d 126 (277)
T cd06917 51 ALLSQLRQSQPPNITKYYGSYLKG-PRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRD 126 (277)
T ss_pred HHHHHhccCCCCCeeeEeeeeeeC-CEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 4677775 99999999988654 5789999999999999998653 589999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|+||+++.++.++|+|||++....... ......|+..|+|||.+... .++.++|||||||++|+|++|..||...+
T Consensus 127 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred cCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765433 23345789999999998654 46899999999999999999999998877
Q ss_pred HHHHHHHHHhccCCCCCC-CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 157 MQALINKINKSIVAPLPT-KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~-~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.......+.......++. .++.++.++|.+||..||++||++.++++|+||+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 207 AFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred hhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 665554443333333333 37899999999999999999999999999999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=279.86 Aligned_cols=207 Identities=35% Similarity=0.626 Sum_probs=177.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||++++++|... ...|+|+||+.|++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+
T Consensus 66 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~ 143 (286)
T cd06614 66 ILIMKDCKHPNIVDYYDSYLVG-DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIK 143 (286)
T ss_pred HHHHHHCCCCCeeEEEEEEEEC-CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 3678999999999999998765 57899999999999999998754 368999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||+++.++.++|+|||++....... ......++..|++||++.+..++.++||||||+++|+|++|..||...+...
T Consensus 144 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 144 SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred hhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999987654322 2233467889999999988889999999999999999999999998877665
Q ss_pred HHHHHHhccCCCC--CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPL--PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~--p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+........ +..++..+.++|.+||..+|.+||++.+++.|+||..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 224 ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 5544443332222 2348899999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=280.11 Aligned_cols=195 Identities=29% Similarity=0.454 Sum_probs=166.5
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+|+||++++++|...+ .+|+||||+.|++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+||+++
T Consensus 67 ~h~~iv~~~~~~~~~~-~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 67 DNPNFIKLYYSVTTLK-GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143 (267)
T ss_pred cCCCEEEEEEEEecCC-eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence 7999999999987655 7999999999999999998753 699999999999999999999999999999999999999
Q ss_pred CCC-CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH-HHHHH
Q 008303 88 KDQ-DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL-INKIN 165 (570)
Q Consensus 88 ~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~-~~~i~ 165 (570)
.++ .++|+|||++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||.....+.. ...+.
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220 (267)
T ss_pred CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence 988 9999999998876433 234688999999999988999999999999999999999999975543221 11111
Q ss_pred h--ccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-HHHHHHhhccC
Q 008303 166 K--SIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-AAELLRHVHLQ 208 (570)
Q Consensus 166 ~--~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-a~eIL~hp~fq 208 (570)
. ......+..++..+.+||.+||+.+|.+|++ +++||+|+||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 221 KRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 1 2222345578999999999999999999995 69999999986
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=274.88 Aligned_cols=203 Identities=20% Similarity=0.390 Sum_probs=177.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++... ...|+||||+.+++|.+++....+..+++..+..|+.||+.||.|||++||+|+|||
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~ 130 (261)
T cd05034 52 AQIMKKLRHDKLVQLYAVCSEE-EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA 130 (261)
T ss_pred HHHHhhCCCCCEeeeeeeeecC-CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 3678999999999999987544 578999999999999999987655679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC--ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||++..+...... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+.
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999999876532211 12234568999999998889999999999999999998 9999998888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+.+..++.++.+++.+||..+|.+||++++++.-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 211 REVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888887776666777889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=277.00 Aligned_cols=202 Identities=31% Similarity=0.469 Sum_probs=170.6
Q ss_pred hhcCCCcccccceEEEeeCc----EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 5 SKIRNPFIVEYKDSWVERGC----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~~~~----~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++|+||+++++++...+. .+|++|||+.+ +|.+++.......+++..++.++.||+.||.|||++||+|+||+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~ 134 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK 134 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 34479999999999875442 38999999975 89999887554569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+||+++.++.+||+|||++.............++..|+|||++.+..++.++|||||||++|+|++|.++|......+.
T Consensus 135 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~ 214 (287)
T cd07838 135 PQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ 214 (287)
T ss_pred hhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH
Confidence 99999999999999999999887655444555688999999999988899999999999999999999999988877666
Q ss_pred HHHHHhccCCC--------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 161 INKINKSIVAP--------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 161 ~~~i~~~~~~p--------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
..++......+ ....++..+.++|.+||..||.+||++++++.|+||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 215 LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 55553321100 011346788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=272.86 Aligned_cols=202 Identities=21% Similarity=0.378 Sum_probs=174.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++++|+||+++++++.+.+ ..|+||||+.|++|.+++.+.. ..+++..+..++.|++.||.|||++||+||||+
T Consensus 43 ~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~ 120 (251)
T cd05041 43 AEILKQYDHPNIVKLIGVCVQKQ-PIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120 (251)
T ss_pred HHHHHhCCCCCeEEEEEEEecCC-CeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcC
Confidence 36789999999999999886554 7899999999999999997643 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
|+|||++.++.+||+|||++......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 121 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 121 ARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 99999999999999999999865422211 12233567999999988889999999999999999998 889998888
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.......+......+.+..++.++.++|.+||..+|.+||++.++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 201 NQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 777777776655555677889999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=276.59 Aligned_cols=204 Identities=43% Similarity=0.849 Sum_probs=176.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++++++||||+++++++.+.. ..|+||||+.+++|.+++.. .....+++..++.++.|++.||.|||++||+|+||
T Consensus 54 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l 132 (260)
T cd08222 54 QLLSKLDHPAIVKFHASFLERD-AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDL 132 (260)
T ss_pred HHHHhCCCCcHHHHHHHHhcCC-ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCC
Confidence 5788899999999999886554 68999999999999999864 22356899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|+||+++. +.+||+|||++...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..+|......
T Consensus 133 ~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~ 211 (260)
T cd08222 133 KAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL 211 (260)
T ss_pred ChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 999999975 56999999998776432 2333456889999999998888899999999999999999999999887776
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.....+........+..++.++.++|.+||..+|++||++.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 212 SVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 6666665555555667889999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=288.96 Aligned_cols=210 Identities=26% Similarity=0.374 Sum_probs=167.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+++.++||||++++++|... .++|+||||+.+++|.+++.+.....+++..+..++.||+.||.|||++||+||||||
T Consensus 51 ~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp 129 (328)
T cd08226 51 VLSHFFRHPNIMTSWTVFTTG-SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKA 129 (328)
T ss_pred HHHHhCCCCCcceEeeeEecC-CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 456778999999999998764 4789999999999999999876555689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--------CccccCCCCCCCcccccCC--CCCCcccccchhhhHHHhhccCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--------ASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~~--~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
+|||++.++.++++||+.+........ .....++..|++||++.+. .++.++|||||||++|+|++|..|
T Consensus 130 ~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p 209 (328)
T cd08226 130 SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209 (328)
T ss_pred HHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999986533211110 1112345679999999763 478999999999999999999999
Q ss_pred CcccCHHHHHHHHHhcc----------------------------------------------CCCCCCCCcHHHHHHHH
Q 008303 152 FKAFDMQALINKINKSI----------------------------------------------VAPLPTKYSGAFRGLVK 185 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~----------------------------------------------~~p~p~~~s~~l~dLI~ 185 (570)
|................ ..+.+..++..+.+||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 289 (328)
T cd08226 210 FQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289 (328)
T ss_pred CCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHH
Confidence 98765443322221110 01112346778999999
Q ss_pred HhhccCCCCCcCHHHHHHhhccChhhh
Q 008303 186 SMLRKNPELRPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 186 ~~L~~dP~~RPTa~eIL~hp~fq~~~~ 212 (570)
+||..||++|||++++|+|+||.....
T Consensus 290 ~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 290 LCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred HHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.21 Aligned_cols=204 Identities=30% Similarity=0.581 Sum_probs=185.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+..+||++..|.-.|.. +.++|+||||..||.|+..+.+. ..|+|+..+.+...|+.||.|||+++||+||||.
T Consensus 220 RVL~~~~HPFLt~LKYsFQt-~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKL 296 (516)
T KOG0690|consen 220 RVLQNCRHPFLTSLKYSFQT-QDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKL 296 (516)
T ss_pred HHHHhccCcHHHHhhhhhcc-CceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechh
Confidence 47888899999999977754 45899999999999999888763 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceec-cCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKIL-TSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|+|+|++|.|||.|||+.+.. .......++||||.|+|||++.+..|+.++|.|.+|+++|||++|+.||...+.+.+
T Consensus 297 ENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL 376 (516)
T KOG0690|consen 297 ENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL 376 (516)
T ss_pred hhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence 9999999999999999999864 344567789999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
+.-|..... .+|..++++++.|+..+|.+||.+|. .+.||++|.||..
T Consensus 377 FeLIl~ed~-kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 377 FELILMEDL-KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHHhhhc-cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 888866543 36889999999999999999999997 6899999999974
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=278.30 Aligned_cols=201 Identities=23% Similarity=0.414 Sum_probs=166.2
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++||||+++++++... +..+|+||||+.+|+|.+++... .+++..++.|+.|++.||.|||++||+||||
T Consensus 57 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dl 133 (283)
T cd05080 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133 (283)
T ss_pred HHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 3688999999999999987654 45689999999999999999763 3899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.++.+||+|||++........ .....++..|++||.+.+..++.++|||||||++|+|++|..||...
T Consensus 134 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 134 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred ChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987653221 12234566799999998888999999999999999999999887543
Q ss_pred CH---------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DM---------------QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~---------------~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.. ......+......+.+..++..+.+++.+||..+|++|||+++++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~ 277 (283)
T cd05080 214 PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI 277 (283)
T ss_pred cchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 21 11112222233334466788999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.83 Aligned_cols=196 Identities=28% Similarity=0.466 Sum_probs=170.1
Q ss_pred Hhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 3 LISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 3 IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++... +||||+.++++|. ++.++|+|||++.|+.|.+.|.... ....++..|++||+.||.|||++|||||||||
T Consensus 368 ~~~~~~~h~niv~~~~v~~-~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp 443 (612)
T KOG0603|consen 368 ISLLVRDHPNIVKSHDVYE-DGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKP 443 (612)
T ss_pred hhhhhcCCCcceeecceec-CCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCCh
Confidence 44444 8999999999984 5668999999999999999887643 23377888999999999999999999999999
Q ss_pred CcEEE-cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH-H
Q 008303 82 SNIFL-TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ-A 159 (570)
Q Consensus 82 ~NILl-d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~-~ 159 (570)
+|||+ +..|+++|+|||.++..... ..+.+-|..|.|||++...+|++++||||||++||+|++|+.||.....+ +
T Consensus 444 ~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 444 GNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred hheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 99999 58899999999999987655 34557789999999999999999999999999999999999999887766 4
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+...+.. .+....+|.++++||++||+.||.+|+++.+++.|+||
T Consensus 522 i~~~i~~---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 IHTRIQM---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhhcC---CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 4444432 22347899999999999999999999999999999999
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=280.49 Aligned_cols=204 Identities=28% Similarity=0.501 Sum_probs=168.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|.. +...|+||||+.++.|..++... ..+++..++.++.||+.||.|||+.||+|+||+
T Consensus 51 ~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~ 127 (286)
T cd07846 51 IRMLKQLRHENLVNLIEVFRR-KKRLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK 127 (286)
T ss_pred HHHHHhcCCcchhhHHHhccc-CCeEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 367889999999999999865 45789999999999988877653 348999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+||+++.++.++|+|||++..+... .......++..|+|||++.+ ..++.++|||||||++|+|++|.++|......
T Consensus 128 p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~ 207 (286)
T cd07846 128 PENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207 (286)
T ss_pred HHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH
Confidence 99999999999999999998876433 22334578899999999875 34688999999999999999999999766543
Q ss_pred HHHHHHHhccC--------------------C----------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIV--------------------A----------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~--------------------~----------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+....+..... . .....++..+.+|+.+||..+|++||++.+++.|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 208 DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 33222221000 0 0123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=307.80 Aligned_cols=207 Identities=31% Similarity=0.553 Sum_probs=178.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLF--SEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~L--se~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
.+=++|+|.|||+|+|.+.++| ++-|.||-++||+|.++++...+ ++ .|..+..+.+||++||+|||++.||||||
T Consensus 624 aLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDI 701 (1226)
T KOG4279|consen 624 ALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDI 701 (1226)
T ss_pred HHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccc
Confidence 3456789999999999986554 88999999999999999987654 45 88999999999999999999999999999
Q ss_pred cCCcEEEcC-CCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCC--CCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTK-DQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~-~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|-+|+||+. .|.+||.|||-++.+.. .....++.||.-|||||++..+ +|+.++|||||||.+.||.+|+|||...
T Consensus 702 KGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 702 KGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred cCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 999999976 68999999999988754 4456678999999999999755 5899999999999999999999999754
Q ss_pred C-HHHHHHHH-HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 D-MQALINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~-~~~~~~~i-~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
. .+..+.++ .....+++|..++.+++.||.+|+..+|.+||++.++|.+||++.-
T Consensus 782 gspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 782 GSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 3 33333332 3345677899999999999999999999999999999999999853
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=278.30 Aligned_cols=205 Identities=25% Similarity=0.415 Sum_probs=169.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+. .+.|+||||+. ++|.+++.......+++..+..|+.||+.||.|||++|++||||+
T Consensus 49 ~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~ 126 (283)
T cd07835 49 ISLLKELNHPNIVRLLDVVHSE-NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLK 126 (283)
T ss_pred HHHHHhcCCCCccCHhheeccC-CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 3678899999999999998654 58999999995 699999987654568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+||+++.++.++|+|||++....... ......++..|+|||++.+. .++.++||||||+++|+|++|++||...+..
T Consensus 127 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 206 (283)
T cd07835 127 PQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI 206 (283)
T ss_pred HHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999997654322 22334668899999988664 4688999999999999999999999876654
Q ss_pred HHHHHHHhccC----------------------------CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIV----------------------------APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~----------------------------~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....++..... ......++..+.++|.+||+.+|.+|||+++++.|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 207 DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 43332221110 01124567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=277.74 Aligned_cols=203 Identities=18% Similarity=0.346 Sum_probs=176.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS------KLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~------~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++|++|+|+||+++++++...+...++++||+.+|+|.+++..... ..+++..++.++.||+.||+|||++||+
T Consensus 60 ~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~ 139 (280)
T cd05043 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVI 139 (280)
T ss_pred HHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 5788999999999999887766678999999999999999976422 4589999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCC
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPA 151 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~p 151 (570)
|+||||+|||+++++.+||+|||+++.+..... .....++..|+|||++.+..++.++|||||||++|+|++ |+.|
T Consensus 140 H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 219 (280)
T cd05043 140 HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219 (280)
T ss_pred ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCC
Confidence 999999999999999999999999986543321 122345678999999988889999999999999999998 9999
Q ss_pred CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|...+..+....+........+..++.++.+++.+||..+|++|||+.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 272 (280)
T cd05043 220 YVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQC 272 (280)
T ss_pred cCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 98888777777766665555566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=278.35 Aligned_cols=204 Identities=29% Similarity=0.468 Sum_probs=172.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++... ..+|+|+||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|+|||
T Consensus 49 ~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~ 125 (283)
T cd05118 49 IKLLKELNHPNIIKLLDVFRHK-GDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125 (283)
T ss_pred HHHHHHhcCCCcchHHHhhccC-CCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcC
Confidence 3578899999999999988654 578999999975 8888887653 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.+|...+..
T Consensus 126 p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 205 (283)
T cd05118 126 PENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205 (283)
T ss_pred HHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999998776543 23345688899999999776 6899999999999999999999999887765
Q ss_pred HHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+...++......+ ....++.+++++|.+||..||.+||++.+++.|+||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 206 DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 5544443221111 122467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=280.27 Aligned_cols=208 Identities=25% Similarity=0.407 Sum_probs=169.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.+. .+.|+||||+. ++|.+++.......+++..++.++.||+.||+|||++||+|+||+
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~ 129 (294)
T PLN00009 52 ISLLKEMQHGNIVRLQDVVHSE-KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK 129 (294)
T ss_pred HHHHHhccCCCEeeEEEEEecC-CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 3678999999999999998654 58999999996 588888876555557899999999999999999999999999999
Q ss_pred CCcEEEcC-CCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTK-DQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~-~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+||+++. ++.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+.
T Consensus 130 p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~ 209 (294)
T PLN00009 130 PQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209 (294)
T ss_pred cceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999985 4579999999997654322 22345678999999998664 578999999999999999999999987765
Q ss_pred HHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+...++......+ ....++.++.++|.+||+.+|++||++.++++|+||..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 210 IDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred HHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 54444332211100 11346789999999999999999999999999999986
Q ss_pred h
Q 008303 210 Y 210 (570)
Q Consensus 210 ~ 210 (570)
+
T Consensus 290 ~ 290 (294)
T PLN00009 290 L 290 (294)
T ss_pred H
Confidence 5
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=278.52 Aligned_cols=206 Identities=23% Similarity=0.380 Sum_probs=166.4
Q ss_pred HHhhhc-CCCcccccceEEEeeCc----EEEEEEeccCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGC----YVCIIIGFCEGGDMAEAIKKAN---SKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~----~i~IV~Ey~~gGsL~d~I~~~~---~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
++|+++ +|+||+++++++..... .+|+|||||.+ +|.+++.... ...+++..++.++.||+.||.|||++|
T Consensus 52 ~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 130 (295)
T cd07837 52 SLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG 130 (295)
T ss_pred HHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 578888 57999999998865432 47999999986 8998886542 246899999999999999999999999
Q ss_pred cccceecCCcEEEcC-CCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCC
Q 008303 74 ILHRDVKCSNIFLTK-DQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 74 IvHrDLKP~NILld~-~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
|+||||+|+|||++. ++.+||+|||++..+... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 131 i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 210 (295)
T cd07837 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210 (295)
T ss_pred eeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence 999999999999998 889999999998865432 22233467889999998865 457899999999999999999999
Q ss_pred CCcccCHHHHHHHHHhccCCC---------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 151 AFKAFDMQALINKINKSIVAP---------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~~~~p---------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
||.+.+......++......+ ....++..+.+||.+||..||.+||+++++|.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 211 LFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 998766544333332211000 01347889999999999999999999999999
Q ss_pred hhccC
Q 008303 204 HVHLQ 208 (570)
Q Consensus 204 hp~fq 208 (570)
|+||+
T Consensus 291 ~~~~~ 295 (295)
T cd07837 291 HPYFD 295 (295)
T ss_pred CCCcC
Confidence 99985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=278.21 Aligned_cols=204 Identities=23% Similarity=0.402 Sum_probs=170.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN---------SKLFSEEKLCKWLVQLLMALDYLHA 71 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~---------~~~Lse~~i~~I~~QLl~aL~yLHs 71 (570)
+++|++++|+||++++++|..+ ..+|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||+
T Consensus 70 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~ 148 (296)
T cd05051 70 VKILSRLSDPNIARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES 148 (296)
T ss_pred HHHHHhcCCCCEeEEEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999988665 47899999999999999997643 1258999999999999999999999
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS- 147 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt- 147 (570)
+||+|+||||+|||++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++
T Consensus 149 ~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 149 LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred cCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 999999999999999999999999999998754332 2234456788999999988889999999999999999987
Q ss_pred -cCCCCcccCHHHHHHHHHhc-------cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 148 -LKPAFKAFDMQALINKINKS-------IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 148 -G~~pf~~~~~~~~~~~i~~~-------~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+..||...+....+..+... ...+.+..++.++.++|.+||..+|.+|||+.+|++.+
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred CCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 67788776666655554322 11223456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=275.12 Aligned_cols=201 Identities=23% Similarity=0.425 Sum_probs=174.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.+ ...|+|||||.+|+|.+++.+.. ..+++..++.++.||+.||+|||++|++|+||||
T Consensus 59 ~~l~~~~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p 135 (270)
T cd05056 59 YIMRQFDHPHIVKLIGVITE--NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAA 135 (270)
T ss_pred HHHHhCCCCchhceeEEEcC--CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCh
Confidence 57899999999999998754 35789999999999999997643 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC--ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||+++........ ....++..|+|||.+....++.++|||||||++|+|++ |..||...+..
T Consensus 136 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~ 215 (270)
T cd05056 136 RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215 (270)
T ss_pred heEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 9999999999999999999876543221 12234567999999988889999999999999999885 99999888877
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+....+......+.+..++..+.++|.+||..+|.+|||+.+++..+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 216 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 77777777666667788999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=300.62 Aligned_cols=214 Identities=29% Similarity=0.418 Sum_probs=185.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|.||.+++||.||.+.-+|+. .+.+++|||-+.| ++.++|-....+.|++...+.++.||+.||+|||.+||+|+|||
T Consensus 614 VaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLK 691 (888)
T KOG4236|consen 614 VAILQNLHHPGIVNLECMFET-PERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLK 691 (888)
T ss_pred HHHHHhcCCCCeeEEEEeecC-CceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCC
Confidence 579999999999999988854 4589999999975 77777776667889999999999999999999999999999999
Q ss_pred CCcEEEcCC---CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc-C
Q 008303 81 CSNIFLTKD---QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-D 156 (570)
Q Consensus 81 P~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~-~ 156 (570)
|+|||+.+. -++||||||+|+++++..+...++|||.|+|||++...+|+...|+||+|+|+|.-+.|..||... +
T Consensus 692 PENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 692 PENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred chheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 999999764 369999999999999999999999999999999999999999999999999999999999998543 2
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhhhhhc
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHL 216 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~k~~~ 216 (570)
..++++...--.....|..++.++.+||+.+|+..-.+|.+.++.|.|+|+|.|.....+
T Consensus 772 IndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DL 831 (888)
T KOG4236|consen 772 INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDL 831 (888)
T ss_pred hhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHH
Confidence 333333332223444567899999999999999999999999999999999987665544
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=271.70 Aligned_cols=202 Identities=24% Similarity=0.462 Sum_probs=174.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++... ...|+||||+.+++|.+++.... ..++++.++.++.|++.||+|||++||+|+|||
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~ 127 (256)
T cd05112 50 AQVMMKLSHPKLVQLYGVCTER-SPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127 (256)
T ss_pred HHHHHhCCCCCeeeEEEEEccC-CceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 3688999999999999988654 47899999999999999997643 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC--ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||++......... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 128 p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05112 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207 (256)
T ss_pred cceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999999998866433221 12234578999999988889999999999999999998 9999988887
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+........+...+..+.+|+.+||..+|++||++.+++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 208 SEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 77777776655444566789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=276.67 Aligned_cols=200 Identities=18% Similarity=0.376 Sum_probs=172.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++++++|+||+++++++... ..++++||+.+|+|.+++.... ..+++..+..|+.||+.||+|||++||+||||||
T Consensus 61 ~~l~~~~~~~i~~~~~~~~~~--~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp 137 (279)
T cd05109 61 YVMAGVGSPYVCRLLGICLTS--TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAA 137 (279)
T ss_pred HHHHhcCCCCCceEEEEEcCC--CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 467888999999999988643 4679999999999999997643 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||+++++.+||+|||+++........ ....++..|++||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 138 ~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 138 RNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999999876533221 12234678999999998899999999999999999987 8999988877
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+.+..++..+.++|.+||..||++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 218 REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77777676665556677889999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=273.79 Aligned_cols=201 Identities=21% Similarity=0.381 Sum_probs=174.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++...+ ..|+||||+.+++|.+++.... ..+++..+..|+.|++.||+|||++||+|+||||
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp 135 (268)
T cd05063 58 SIMGQFSHHNIIRLEGVVTKFK-PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAA 135 (268)
T ss_pred HHHhcCCCCCeeEEEEEEccCC-CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccch
Confidence 5788999999999999886554 7899999999999999997643 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC----ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~----~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+||+++.++.+||+|||++......... .....+..|+|||++....++.++|||||||++|+|++ |..||...+
T Consensus 136 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 136 RNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred hhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 9999999999999999998776432211 11123457999999988889999999999999999887 999998888
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.......+......+.+..++..+.+++.+||..+|++||++.++++.
T Consensus 216 ~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 216 NHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 888888877666666667789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=273.82 Aligned_cols=204 Identities=34% Similarity=0.660 Sum_probs=171.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|++++||||++++++|... +..|+|+||+.+|+|.+++... ....+++..+..++.||+.||.|||++||+|+|
T Consensus 53 ~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~d 131 (267)
T cd08228 53 IDLLKQLNHPNVIKYLDSFIED-NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRD 131 (267)
T ss_pred HHHHHhCCCcceeeeeeeEEEC-CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCC
Confidence 3678999999999999998765 4789999999999999998642 234589999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC-
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD- 156 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~- 156 (570)
|||+|||++.++.++|+|||++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 132 l~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 211 (267)
T cd08228 132 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred CCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc
Confidence 999999999999999999999887654322 234568899999999988889999999999999999999999986543
Q ss_pred -HHHHHHHHHhccCCCC-CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 -MQALINKINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 -~~~~~~~i~~~~~~p~-p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.......+......+. ...++..+.++|.+||..+|.+||++.++++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 212 NLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred cHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 3344455544333333 246788999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=271.86 Aligned_cols=203 Identities=37% Similarity=0.704 Sum_probs=173.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|++++|+||++++++|..+ +..++||||+.+|+|.+++... .+..+++..++.|+.||+.||.|||+.||+|||
T Consensus 53 i~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~d 131 (267)
T cd08224 53 IDLLKQLDHPNVIKYLASFIEN-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRD 131 (267)
T ss_pred HHHHHhCCCCCeeeeeeeeecC-CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 3678999999999999998765 4789999999999999998753 235689999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc--
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-- 155 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~-- 155 (570)
|+|+||+++.++.++|+|||++..+.... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 132 l~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08224 132 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred cChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc
Confidence 99999999999999999999987664332 233457889999999999888999999999999999999999998544
Q ss_pred CHHHHHHHHHhccCCCCCC-CCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALINKINKSIVAPLPT-KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~-~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+.......+......+.+. .++..+.++|.+||..+|++||++.+|++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~ 261 (267)
T cd08224 212 NLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261 (267)
T ss_pred cHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3344555555555555555 788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=276.77 Aligned_cols=204 Identities=22% Similarity=0.442 Sum_probs=168.0
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++|+||+++++++... +..+|+||||++|++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||
T Consensus 57 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dl 135 (284)
T cd05079 57 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDL 135 (284)
T ss_pred HHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 3678999999999999988765 357899999999999999997643 35899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc-
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA- 154 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~- 154 (570)
||+|||++.++.+||+|||++..+..... .....++..|+|||.+.+..++.++|||||||++|+|++++.++..
T Consensus 136 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~ 215 (284)
T cd05079 136 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSP 215 (284)
T ss_pred chheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccc
Confidence 99999999999999999999987653321 2234567789999999888899999999999999999987654321
Q ss_pred --------------cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 155 --------------FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 155 --------------~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.........+......+.+..++..+.+||.+||+.+|++||++++++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 216 MTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred cchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 111222233333444455677899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=274.71 Aligned_cols=201 Identities=22% Similarity=0.390 Sum_probs=173.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++..+ +.+|+||||+.+++|.+++.... ..+++..+..|+.|++.||.|||++||+||||||
T Consensus 57 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp 134 (267)
T cd05066 57 SIMGQFDHPNIIHLEGVVTKS-KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 134 (267)
T ss_pred HHHHhCCCCCcceEEEEEecC-CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhch
Confidence 578899999999999988654 57899999999999999998653 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC----ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~----~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.++|+|||++......... ....++..|++||++.+..++.++|||+|||++|+|++ |..||....
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 135 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred hcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 9999999999999999999876533211 11223567999999998889999999999999999876 999998887
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..+....+......+.+..++..+.+++.+||..+|.+||++.++++-
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 215 NQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred HHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 777777776665556667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=272.17 Aligned_cols=202 Identities=17% Similarity=0.362 Sum_probs=176.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|+||+++++++.. ...|+||||+.+++|.+++.+.....+++..+..|+.||+.||.|||++|++|+|||
T Consensus 52 ~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (260)
T cd05073 52 ANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129 (260)
T ss_pred HHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence 368999999999999998865 467899999999999999987655668999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||+++.++.+||+|||++..+..... .....++..|+|||++....++.++|||||||++|+|++ |..||...+.
T Consensus 130 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred cceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999987653321 122345677999999988889999999999999999998 9999998887
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+.+..++.++.+++.+||..+|++||++.+++..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05073 210 PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSV 256 (260)
T ss_pred HHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77777777666666677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=274.93 Aligned_cols=203 Identities=29% Similarity=0.504 Sum_probs=169.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.. +..+++||||+.|++|.+++.+. ..+++..+..++.||+.||.|||++|++||||+|
T Consensus 60 ~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~ 136 (272)
T cd06629 60 ETLKDLDHLNIVQYLGFETT-EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKA 136 (272)
T ss_pred HHHHhcCCCCcceEEEEecc-CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCCh
Confidence 57888999999999998765 45789999999999999999875 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCC--CCCcccccchhhhHHHhhccCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~--~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
+||+++.++.++|+|||++....... ......|+..|++||++.... ++.++|+||||+++|+|++|..||...+
T Consensus 137 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 137 DNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred hhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 99999999999999999987653221 123456889999999987654 7899999999999999999999997655
Q ss_pred HHHHHHHHHh-ccCCCCC----CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 157 MQALINKINK-SIVAPLP----TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 157 ~~~~~~~i~~-~~~~p~p----~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.......+.. ......+ ..++..+.++|.+||..+|++||+++++|+|+|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 4433333221 1122222 3568999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=314.52 Aligned_cols=203 Identities=29% Similarity=0.560 Sum_probs=168.4
Q ss_pred CHHhhhc-CCCcccccce-EEEee-----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKI-RNPFIVEYKD-SWVER-----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~-~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
|++|++| .|+|||.|+| ..... ...++|+||||.||.|-|++.++....|+|.+|++|++|+++||.+||...
T Consensus 85 I~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~ 164 (738)
T KOG1989|consen 85 IDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK 164 (738)
T ss_pred HHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC
Confidence 5799999 5999999999 44321 245779999999999999998776667999999999999999999999998
Q ss_pred --cccceecCCcEEEcCCCCEEEeecCCceeccCCC-CC---------ccccCCCCCCCcccc---cCCCCCCcccccch
Q 008303 74 --ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LA---------SSVVGTPSYMCPELL---ADIPYGSKSDIWSL 138 (570)
Q Consensus 74 --IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~---------~~~~GT~~Y~APE~l---~~~~~t~ksDIWSL 138 (570)
|||||||-|||||+.+|.+||||||.+....... .. -...-|+.|++||.+ .+.+.++|+|||+|
T Consensus 165 pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWAL 244 (738)
T KOG1989|consen 165 PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWAL 244 (738)
T ss_pred CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHH
Confidence 9999999999999999999999999987543221 00 113468999999987 46778999999999
Q ss_pred hhhHHHhhccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 139 GCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 139 G~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
||+||-|+....||+......+ +...+..|....|+..+++||+.||+.||++||++.|++.+.+
T Consensus 245 GclLYkLCy~t~PFe~sg~laI---lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 245 GCLLYKLCYFTTPFEESGKLAI---LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred HHHHHHHHHhCCCcCcCcceeE---EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 9999999999999987533222 2222333444689999999999999999999999999998754
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=273.69 Aligned_cols=196 Identities=20% Similarity=0.339 Sum_probs=163.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|+++.||||+++++++...+ ..++|||||.+|+|.++++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 51 ~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp 128 (258)
T cd05078 51 SMMSQLSHKHLVLNYGVCVCGD-ESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCA 128 (258)
T ss_pred HHHHhCCCCChhheeeEEEeCC-CcEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 5778899999999999987644 6889999999999999998643 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCC--------EEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhcc-CCC
Q 008303 82 SNIFLTKDQD--------IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSL-KPA 151 (570)
Q Consensus 82 ~NILld~~g~--------vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG-~~p 151 (570)
+|||++.++. ++++|||++...... ....++..|+|||++.+. .++.++|||||||++|+|++| .+|
T Consensus 129 ~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 129 KNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred ceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999987764 699999998765432 235688899999999864 578999999999999999998 567
Q ss_pred CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|...+.......... ....+...+.++.+||.+||+.+|++|||+++|++.
T Consensus 206 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 206 LSALDSQKKLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred hhhccHHHHHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 766665544333222 234555677899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.01 Aligned_cols=207 Identities=27% Similarity=0.487 Sum_probs=185.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.||++++.++||.+--.|... ..+|+||..|+||+|.-.|-+.++..|++..+..++.+|+.||++||..+||+|||||
T Consensus 237 ~iL~kV~s~FiVslaYAfeTk-d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKP 315 (591)
T KOG0986|consen 237 QILEKVSSPFIVSLAYAFETK-DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKP 315 (591)
T ss_pred HHHHHhccCcEEEEeeeecCC-CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCCh
Confidence 588999999999988777554 4799999999999999999988878899999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH---
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ--- 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~--- 158 (570)
+|||+|+.|+|+|+|+|+|..+.........+||.+|||||++.+..|+...|.|+|||++|+|+.|+.||......
T Consensus 316 eNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~ 395 (591)
T KOG0986|consen 316 ENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR 395 (591)
T ss_pred hheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH
Confidence 99999999999999999999999888888889999999999999999999999999999999999999999765432
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
+-++..........+..+|+++++|.+.+|.+||.+|. .++++.+||||+.
T Consensus 396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 22333334445557789999999999999999999997 6789999999986
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=274.07 Aligned_cols=201 Identities=23% Similarity=0.410 Sum_probs=173.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.. +...|+||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++|++|+||||
T Consensus 57 ~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p 134 (269)
T cd05065 57 SIMGQFDHPNIIHLEGVVTK-SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAA 134 (269)
T ss_pred HHHHhCCCcCcceEEEEECC-CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCh
Confidence 57889999999999998855 447899999999999999997643 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCcc----cc--CCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASS----VV--GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKA 154 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~----~~--GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~ 154 (570)
+||+++.++.+||+|||++........... .. .+..|++||.+....++.++|||||||++|||++ |..||..
T Consensus 135 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 135 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred heEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 999999999999999999876543221111 11 2357999999998899999999999999999875 9999988
Q ss_pred cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+......+.+..++..+.+++.+||..+|.+||++++|+..
T Consensus 215 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 215 MSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred CCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88887777776665566677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.79 Aligned_cols=204 Identities=20% Similarity=0.427 Sum_probs=176.4
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~a 65 (570)
+++++++ +|+||++++++|.+.+ .+|+||||+.+|+|.++|.+.. ...++...+..++.||+.|
T Consensus 68 ~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (334)
T cd05100 68 MEMMKMIGKHKNIINLLGACTQDG-PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARG 146 (334)
T ss_pred HHHHHhhcCCCCeeeeeEEEccCC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHH
Confidence 3678888 8999999999886654 7899999999999999997632 1347888999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhH
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCI 142 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Il 142 (570)
|.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++
T Consensus 147 l~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 226 (334)
T cd05100 147 MEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 226 (334)
T ss_pred HHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHH
Confidence 9999999999999999999999999999999999987643221 1222345679999999998999999999999999
Q ss_pred HHhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 143 YEMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 143 yeLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|+|++ |..||.+.+.++....+........+..++.++.+||.+||..+|++||++.++++++
T Consensus 227 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 227 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99997 8899998888888887776666666778899999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=277.52 Aligned_cols=203 Identities=21% Similarity=0.346 Sum_probs=173.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------------CCCCCHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------------SKLFSEEKLCKWLV 60 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------------~~~Lse~~i~~I~~ 60 (570)
+++|++++||||+++++++..+ ...|+||||+.+|+|.+++.... ...+++..++.++.
T Consensus 59 i~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 137 (288)
T cd05050 59 AALMAEFDHPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAK 137 (288)
T ss_pred HHHHHhcCCCchheEEEEEcCC-CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHH
Confidence 3678899999999999988654 47899999999999999997532 12478899999999
Q ss_pred HHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccc
Q 008303 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWS 137 (570)
Q Consensus 61 QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWS 137 (570)
||+.||.|||++|++||||||+|||++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||
T Consensus 138 ~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (288)
T cd05050 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA 217 (288)
T ss_pred HHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence 999999999999999999999999999999999999999876543321 12234466799999999889999999999
Q ss_pred hhhhHHHhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 138 LGCCIYEMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 138 LG~IlyeLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|||++|+|++ |..||.+.+..+....+......+.+..++.++.+||.+||+.+|.+|||+.|+++-
T Consensus 218 lG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~ 285 (288)
T cd05050 218 YGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999999997 888888877777777777666656677889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=280.83 Aligned_cols=203 Identities=20% Similarity=0.416 Sum_probs=171.0
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|+++ +|+||+++++++...+ .+|+||||+.+|+|.+++.......+++..+..|+.||+.||.|||++||+|+||
T Consensus 89 ~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 89 LKIMSHLGNHENIVNLLGACTIGG-PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred HHHHHhccCCCCcceEEEEEecCC-ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 3678899 8999999999886554 7899999999999999998654455899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
||+|||++.++.++|+|||++..+.... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 168 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 168 AARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 9999999999999999999998654322 1222345778999999998889999999999999999997 99998776
Q ss_pred CHHHHH-HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALI-NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~-~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
...... ..+........+..++..+.+|+.+||..+|++||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 248 PVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 654433 3333333334456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.54 Aligned_cols=206 Identities=27% Similarity=0.424 Sum_probs=171.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||++++++|... .++|+||||+. |+|.+++... ..+++..+..|+.||+.||+|||++||+|+||+|
T Consensus 72 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~ 147 (335)
T PTZ00024 72 KIMNEIKHENIMGLVDVYVEG-DFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSP 147 (335)
T ss_pred HHHHhCCCcceeeeeEEEecC-CcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 578899999999999998654 58999999997 5999998764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC---------------CCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHh
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD---------------DLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~---------------~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeL 145 (570)
+|||++.++.+||+|||++...... .......++..|+|||.+.+.. ++.++|||||||++|+|
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999776511 1112345688999999987644 68999999999999999
Q ss_pred hccCCCCcccCHHHHHHHHHhccCCC---------------------------CCCCCcHHHHHHHHHhhccCCCCCcCH
Q 008303 146 TSLKPAFKAFDMQALINKINKSIVAP---------------------------LPTKYSGAFRGLVKSMLRKNPELRPSA 198 (570)
Q Consensus 146 ltG~~pf~~~~~~~~~~~i~~~~~~p---------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa 198 (570)
++|.+||.+.+..+....+......+ ....++..+.++|++||..+|.+||++
T Consensus 228 ~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 307 (335)
T PTZ00024 228 LTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307 (335)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence 99999998887666554443321111 012457889999999999999999999
Q ss_pred HHHHHhhccChhh
Q 008303 199 AELLRHVHLQPYV 211 (570)
Q Consensus 199 ~eIL~hp~fq~~~ 211 (570)
+++|.|+||+.+.
T Consensus 308 ~~~l~~~~~~~~~ 320 (335)
T PTZ00024 308 KEALKHEYFKSDP 320 (335)
T ss_pred HHHhcCcccCCCC
Confidence 9999999998653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.53 Aligned_cols=208 Identities=26% Similarity=0.323 Sum_probs=162.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN---SKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~---~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
+++|++|+|+|||++++++...+ ..|+|+|++. ++|.+++.... ........++.|+.||+.||.|||++||+||
T Consensus 214 i~il~~l~HpnIv~l~~~~~~~~-~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHr 291 (501)
T PHA03210 214 ILALGRLNHENILKIEEILRSEA-NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291 (501)
T ss_pred HHHHHhCCCCCcCcEeEEEEECC-eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 36889999999999999986554 7899999996 47777765321 1224467788999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCC-Ccc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA-FKA 154 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~p-f~~ 154 (570)
||||+|||++.++.+||+|||+++.+.... .....+||..|+|||++.+..|+.++|||||||++|+|++|..+ |..
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 999999999999999999999998775432 23346899999999999999999999999999999999988754 332
Q ss_pred c--CHHHHHHHHHhcc----------------------CCCC---------CCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 155 F--DMQALINKINKSI----------------------VAPL---------PTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 155 ~--~~~~~~~~i~~~~----------------------~~p~---------p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
. .....+.++.... .... ...++..+.++|.+||..||.+|||+.|+
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 2 1111111111100 0000 01356678889999999999999999999
Q ss_pred HHhhccChh
Q 008303 202 LRHVHLQPY 210 (570)
Q Consensus 202 L~hp~fq~~ 210 (570)
|.||||...
T Consensus 452 L~hp~f~~~ 460 (501)
T PHA03210 452 LALPLFSAE 460 (501)
T ss_pred hhChhhhcC
Confidence 999999753
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=271.46 Aligned_cols=195 Identities=20% Similarity=0.274 Sum_probs=162.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.. ...|+|||||.+|+|.+++..... .+++..+..++.||+.||.|||++||+||||||
T Consensus 53 ~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp 129 (259)
T cd05037 53 SLMSQLSHKHLVKLYGVCVR--DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCG 129 (259)
T ss_pred HHHHcCCCcchhheeeEEec--CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCcc
Confidence 57899999999999998876 357899999999999999987542 689999999999999999999999999999999
Q ss_pred CcEEEcCCC-------CEEEeecCCceeccCCCCCccccCCCCCCCcccccCC--CCCCcccccchhhhHHHhhc-cCCC
Q 008303 82 SNIFLTKDQ-------DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCIYEMTS-LKPA 151 (570)
Q Consensus 82 ~NILld~~g-------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIWSLG~IlyeLlt-G~~p 151 (570)
+|||++.++ .+||+|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 130 ~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p 206 (259)
T cd05037 130 KNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206 (259)
T ss_pred ceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCC
Confidence 999999887 799999999987654 2234567889999999876 78999999999999999988 5777
Q ss_pred CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|...+............. .+......+.++|.+||..+|.+||++.++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 207 LSTLSSSEKERFYQDQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred cccCCchhHHHHHhcCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 876654443333332222 222334899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.70 Aligned_cols=206 Identities=27% Similarity=0.497 Sum_probs=192.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+||.+.+.|+||++|-.|.+ ..++|++||-|-||.|+..++.+ +.|.+...+.++.-+++|++|||++|||+|||||
T Consensus 472 ~Im~~~~s~fIvrLYrTfrd-~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP 548 (732)
T KOG0614|consen 472 NIMMECRSDFIVRLYRTFRD-SKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP 548 (732)
T ss_pred HHHHhcCchHHHHHHHHhcc-chhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence 57888899999999999965 45999999999999999999875 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|+|++.+|-+||.|||+|+.+.....+.++||||.|+|||++.+.+++.++|+|+||+++|||++|.+||.+.+....+
T Consensus 549 ENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY 628 (732)
T KOG0614|consen 549 ENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY 628 (732)
T ss_pred hheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 162 NKINKSIV-APLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
+.|.+++. ..+|..+.....+||+++...+|.+|.- +.+|-+|-||..+
T Consensus 629 n~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 629 NLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 88888763 4578899999999999999999999985 8899999999753
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=274.16 Aligned_cols=201 Identities=21% Similarity=0.410 Sum_probs=162.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS---KLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~---~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++++++|+||+++++++... ..+|+||||+.+|+|.+++..... ..+++..+..|+.||+.||+|||++||+|||
T Consensus 47 ~~~~~l~h~nii~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 125 (269)
T cd05042 47 QPYRELNHPNVLQCLGQCIES-IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSD 125 (269)
T ss_pred HHHHhCCCCCcceEEEEECCC-CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEeccc
Confidence 567888999999999988655 478999999999999999976432 3356888999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccC-------CCCCCcccccchhhhHHHhhc-
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLAD-------IPYGSKSDIWSLGCCIYEMTS- 147 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~-------~~~t~ksDIWSLG~IlyeLlt- 147 (570)
|||+|||++.++.+||+|||++........ .....++..|+|||++.. ..++.++|||||||++|+|++
T Consensus 126 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred ccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhC
Confidence 999999999999999999999875432211 123345678999999742 356789999999999999998
Q ss_pred cCCCCcccCHHHHHHHHHhccCC-----CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 148 LKPAFKAFDMQALINKINKSIVA-----PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~~-----p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|..||......+....+...... ..+..++..+.+++..|+ .||++|||+++|++.
T Consensus 206 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 206 ADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 78888877666555544333222 234468899999999998 599999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=276.57 Aligned_cols=205 Identities=27% Similarity=0.453 Sum_probs=169.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-SKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++|+||++++++|.+.+ ..|+||||+.+ +|.+++.... ...+++..+..++.||+.||.|||++||+||||
T Consensus 49 ~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl 126 (284)
T cd07836 49 ISLMKELKHENIVRLHDVIHTEN-KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDL 126 (284)
T ss_pred HHHHHhhcCCCEeeeeeeEeeCC-cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 36889999999999999987654 78999999985 8999887643 246899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+|+||+++.++.++|+|||++....... ......++..|++||++.+. .++.++|||+|||++|+|++|..||.+.+.
T Consensus 127 ~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 127 KPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred CHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999999997654322 22345678999999998654 468899999999999999999999987765
Q ss_pred HHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 158 QALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 158 ~~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
.+....+......+ ....++..++++|.+||+.||.+||++.++++|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 207 EDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 55444332211000 112457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=275.86 Aligned_cols=202 Identities=32% Similarity=0.598 Sum_probs=176.1
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++. |+||++++++|..+ ...|+||||+.+++|.+++.+.. .+++..++.|+.||+.||.|||++|++|+||+
T Consensus 53 ~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~ 129 (280)
T cd05581 53 EVLTRLNGHPGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLK 129 (280)
T ss_pred HHHHhcccCCCchhHHHHhcCC-ceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 5778887 99999999988654 57899999999999999998753 59999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC---------------------CccccCCCCCCCcccccCCCCCCcccccchh
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL---------------------ASSVVGTPSYMCPELLADIPYGSKSDIWSLG 139 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~---------------------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG 139 (570)
|+||+++.++.++|+|||++........ .....++..|++||++....++.++||||||
T Consensus 130 ~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG 209 (280)
T cd05581 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG 209 (280)
T ss_pred HHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHH
Confidence 9999999999999999999887653221 2234678899999999888899999999999
Q ss_pred hhHHHhhccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH----HHHHHhhcc
Q 008303 140 CCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA----AELLRHVHL 207 (570)
Q Consensus 140 ~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa----~eIL~hp~f 207 (570)
+++++|++|+.||...+.......+.. .....+..++..+.+||.+||+.+|.+||++ +++++|+||
T Consensus 210 ~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 210 CIIYQMLTGKPPFRGSNEYLTFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHhCCCCCCCccHHHHHHHHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999999988776655555543 3334667889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=281.57 Aligned_cols=206 Identities=28% Similarity=0.473 Sum_probs=164.2
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKAN---SKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~---~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++||||++++++|.+. +..+|+|||||.+ +|.+++.... ...+++..++.|+.||+.||.|||++||+|
T Consensus 53 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h 131 (316)
T cd07842 53 IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLH 131 (316)
T ss_pred HHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 3578999999999999998765 2579999999975 7877775422 236899999999999999999999999999
Q ss_pred ceecCCcEEEcC----CCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhc
Q 008303 77 RDVKCSNIFLTK----DQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 77 rDLKP~NILld~----~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLlt 147 (570)
|||||+|||++. ++.+||+|||++..+..... ....+++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 132 ~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 132 RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred CCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999 89999999999887643221 2345788999999988664 57899999999999999999
Q ss_pred cCCCCcccCHHH---------HHHHHHh------------------------cc-CCCCC-----------CCCcHHHHH
Q 008303 148 LKPAFKAFDMQA---------LINKINK------------------------SI-VAPLP-----------TKYSGAFRG 182 (570)
Q Consensus 148 G~~pf~~~~~~~---------~~~~i~~------------------------~~-~~p~p-----------~~~s~~l~d 182 (570)
|++||....... ....+.. .. ....+ ...+..+.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (316)
T cd07842 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291 (316)
T ss_pred cCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHH
Confidence 999997554321 1111100 00 00011 146678999
Q ss_pred HHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 183 LVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 183 LI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+|.+||..||++|||+.|++.||||
T Consensus 292 ~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 292 LLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHhcCCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=279.20 Aligned_cols=207 Identities=28% Similarity=0.465 Sum_probs=166.4
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHH---HHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAI---KKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILH 76 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I---~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvH 76 (570)
++|.++. |+||+++++++...+ ..+++|||+.+ +|.++. .......+++..+..++.|++.||+|||+. ||+|
T Consensus 54 ~~l~~~~~~~~iv~~~~~~~~~~-~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H 131 (288)
T cd06616 54 DVVMRSSDCPYIVKFYGALFREG-DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIH 131 (288)
T ss_pred HHHHHhcCCCCEeeeeeEEecCC-cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence 4677885 999999999886644 67899999964 655543 333345699999999999999999999985 9999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC---CCCCcccccchhhhHHHhhccCCCCc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
|||||+|||++.++.+||+|||++..+..........|+..|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 132 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 999999999999999999999999776544444455789999999999766 68999999999999999999999997
Q ss_pred ccCH-HHHHHHHHhccCCC----CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 154 AFDM-QALINKINKSIVAP----LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 154 ~~~~-~~~~~~i~~~~~~p----~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.... ......+....... .+..++.++.+||.+||..+|++|||+++|+.|+||+.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 212 KWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred hcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 6542 11222222211111 123478999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=272.39 Aligned_cols=202 Identities=36% Similarity=0.676 Sum_probs=169.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++|+||++++++|.+++ ..++||||+.|++|.+++... ....+++..++.|+.||+.||.|||++||+|+||
T Consensus 54 ~~l~~~~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl 132 (267)
T cd08229 54 DLLKQLNHPNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDI 132 (267)
T ss_pred HHHHHccCCchhhhhheeEeCC-eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 5788999999999999987654 789999999999999998742 2346899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH-
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM- 157 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~- 157 (570)
||+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 212 (267)
T cd08229 133 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212 (267)
T ss_pred CHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch
Confidence 9999999999999999999987764332 22345789999999999988899999999999999999999999865433
Q ss_pred -HHHHHHHHhccCCCC-CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 -QALINKINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 -~~~~~~i~~~~~~p~-p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......+. +..++..+.++|.+||..+|++|||+.+|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 213 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHH
Confidence 334444443333333 34588999999999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=278.13 Aligned_cols=205 Identities=29% Similarity=0.448 Sum_probs=164.9
Q ss_pred CHHhhhcCCCcccccceEEEeeC-------cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-------CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-------~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
+++|++++||||+++++++...+ ...|+|||||.+ +|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 62 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ 139 (310)
T cd07865 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK 139 (310)
T ss_pred HHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 36788999999999999876432 356999999965 8888887643 35899999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhc
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLlt 147 (570)
|+|+||||+||+++.++.+||+|||++....... ......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 140 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t 219 (310)
T cd07865 140 ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219 (310)
T ss_pred eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999997664322 12234678899999988654 46889999999999999999
Q ss_pred cCCCCcccCHHHHHHHHHhccC---CC---------------C-------------CCCCcHHHHHHHHHhhccCCCCCc
Q 008303 148 LKPAFKAFDMQALINKINKSIV---AP---------------L-------------PTKYSGAFRGLVKSMLRKNPELRP 196 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~---~p---------------~-------------p~~~s~~l~dLI~~~L~~dP~~RP 196 (570)
|+++|...+.......+..... .. . +...+..+++||.+||..||.+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~ 299 (310)
T cd07865 220 RSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299 (310)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc
Confidence 9999987765544333222110 00 0 112356788999999999999999
Q ss_pred CHHHHHHhhcc
Q 008303 197 SAAELLRHVHL 207 (570)
Q Consensus 197 Ta~eIL~hp~f 207 (570)
|++++|+|+||
T Consensus 300 t~~e~l~h~~f 310 (310)
T cd07865 300 DADTALNHDFF 310 (310)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=272.35 Aligned_cols=203 Identities=32% Similarity=0.575 Sum_probs=173.7
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++|+||+++++++.+. +..+++|+||+.+++|.+++.... .+++..+..|+.||+.||.|||++||+|+|||
T Consensus 56 ~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~ 133 (264)
T cd06653 56 QLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIK 133 (264)
T ss_pred HHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 578999999999999988654 456889999999999999997643 48999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC----CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD----DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+||+++.++.++|+|||++...... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 134 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 134 GANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred HHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 99999999999999999999865421 11234568999999999998889999999999999999999999998776
Q ss_pred HHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 157 MQALINKINKS-IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 157 ~~~~~~~i~~~-~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
....+.++... .....+..++..+.++|.+||. ++.+||++.++++|||.
T Consensus 214 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 214 AMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 55555444432 2344677899999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.62 Aligned_cols=208 Identities=29% Similarity=0.492 Sum_probs=169.7
Q ss_pred CHHhhhcCCCcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 1 MELISKIRNPFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
+++|++++||||++++++|.. .+..+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 55 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 131 (334)
T cd07855 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHR 131 (334)
T ss_pred HHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 368899999999999998753 2357899999996 5899988754 349999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCC
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
||||+|||++.++.+||+|||++....... .....+|+.+|+|||.+.+ ..++.++|||||||++|+|++|+.|
T Consensus 132 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~p 211 (334)
T cd07855 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211 (334)
T ss_pred CCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCc
Confidence 999999999999999999999997754322 1234578999999999865 4579999999999999999999999
Q ss_pred CcccCHHHHHHHHHhc-----------------------cC--CC-----CCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 152 FKAFDMQALINKINKS-----------------------IV--AP-----LPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~-----------------------~~--~p-----~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
|...+.......+... .. .. ....++.++.++|++||+.+|.+||+++++
T Consensus 212 f~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 291 (334)
T cd07855 212 FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291 (334)
T ss_pred cCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9776543332221111 00 00 113468899999999999999999999999
Q ss_pred HHhhccChhh
Q 008303 202 LRHVHLQPYV 211 (570)
Q Consensus 202 L~hp~fq~~~ 211 (570)
+.||||..+.
T Consensus 292 l~~~~~~~~~ 301 (334)
T cd07855 292 LQHPFLAQYH 301 (334)
T ss_pred HhChhhhhcc
Confidence 9999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=279.45 Aligned_cols=206 Identities=30% Similarity=0.548 Sum_probs=176.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++|+||++++++|... ++.|+||||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+|+||+|
T Consensus 69 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p 144 (292)
T cd06657 69 VIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144 (292)
T ss_pred HHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 578889999999999988654 588999999999999998754 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.++|+|||++....... ......|+..|++||++.+..++.++||||+|+++|+|++|..||...+....
T Consensus 145 ~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~ 224 (292)
T cd06657 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224 (292)
T ss_pred HHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999987654332 22345789999999999888889999999999999999999999988776665
Q ss_pred HHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 161 INKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 161 ~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
...+....... ....++..+.++|.+||..+|.+||++.+++.|+||....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 225 MKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 55554433222 2345789999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.90 Aligned_cols=208 Identities=31% Similarity=0.469 Sum_probs=176.1
Q ss_pred CHHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++|+||+++++++...+ ..+|+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+|
T Consensus 50 ~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H 126 (330)
T cd07834 50 IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIH 126 (330)
T ss_pred HHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 36788999999999999886543 468999999974 8999887643 6999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|||||+|||++.++.++|+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus 127 ~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred CCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999998875543 23456789999999999887 789999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 152 FKAFDMQALINKINKSIVAPL------------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~------------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
|...+..+....+......+. ...++..+.+||.+||..+|.+||+++++
T Consensus 207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 286 (330)
T cd07834 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286 (330)
T ss_pred cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 988776665554433221111 12367889999999999999999999999
Q ss_pred HHhhccChhh
Q 008303 202 LRHVHLQPYV 211 (570)
Q Consensus 202 L~hp~fq~~~ 211 (570)
+.|+||+.+.
T Consensus 287 l~~~~~~~~~ 296 (330)
T cd07834 287 LAHPYLAQLH 296 (330)
T ss_pred HhCccHHhhc
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=273.94 Aligned_cols=204 Identities=30% Similarity=0.508 Sum_probs=170.6
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+.+++++ |+||+++++++.. +...|+||||+ +|+|.+++....+..+++..+..++.||+.+|.|||++||+|+||+
T Consensus 49 ~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~ 126 (283)
T cd07830 49 KSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLK 126 (283)
T ss_pred HHHHhccCCCCchhHHHHhhc-CCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 4677887 9999999999876 45789999999 7899999887654578999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|.||+++.++.++|+|||++.............++..|+|||++.. ..++.++||||||+++++|++|+++|......+
T Consensus 127 ~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~ 206 (283)
T cd07830 127 PENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206 (283)
T ss_pred hhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence 9999999999999999999988765544555678999999998854 457899999999999999999999997766544
Q ss_pred HHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
...++......+ .....+..+.+||++||..+|++|||++|++.|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 443332211110 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=274.19 Aligned_cols=196 Identities=20% Similarity=0.288 Sum_probs=161.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||+++++++..+. ..++|||||.+|+|..++.+.. ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 56 ~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 133 (262)
T cd05077 56 SMMRQVSHKHIVLLYGVCVRDV-ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCT 133 (262)
T ss_pred HHHHhCCCCCEeeEEEEEecCC-CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCc
Confidence 4788899999999999887554 6789999999999999887543 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCC-------EEEeecCCceeccCCCCCccccCCCCCCCccccc-CCCCCCcccccchhhhHHHhh-ccCCCC
Q 008303 82 SNIFLTKDQD-------IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMT-SLKPAF 152 (570)
Q Consensus 82 ~NILld~~g~-------vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIWSLG~IlyeLl-tG~~pf 152 (570)
+|||++.++. ++++|||++...... ....++..|+|||++. +..++.++|||||||++|+|+ .|..||
T Consensus 134 ~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 134 KNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred ccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999987664 899999998765322 2346788999999987 456899999999999999997 688888
Q ss_pred cccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 153 KAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+......... ......+.++.+||.+||..||.+||++.+|+++
T Consensus 211 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 211 KDKTLAEKERFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCcchhHHHHHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 7665544332222211 2233456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=285.71 Aligned_cols=207 Identities=30% Similarity=0.488 Sum_probs=167.9
Q ss_pred CHHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++|+||+++++++.... ..+|+|+||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+|
T Consensus 54 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH 129 (336)
T cd07849 54 IKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLH 129 (336)
T ss_pred HHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 35788999999999999875432 358999999975 88888754 35899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|||||+|||++.++.+||+|||++....... .....+|+..|+|||.+.+ ..++.++|||||||++|+|++|++|
T Consensus 130 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~ 209 (336)
T cd07849 130 RDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209 (336)
T ss_pred cCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998764322 1234578999999998754 4689999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCC---------------------------C---CCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 152 FKAFDMQALINKINKSIVA---------------------------P---LPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~---------------------------p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
|.+.+.......+...... + ....++.++.+||.+||..+|++|||+.++
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 9776543332222111000 0 112457889999999999999999999999
Q ss_pred HHhhccChhh
Q 008303 202 LRHVHLQPYV 211 (570)
Q Consensus 202 L~hp~fq~~~ 211 (570)
++|+||..+.
T Consensus 290 l~hp~~~~~~ 299 (336)
T cd07849 290 LAHPYLEQYH 299 (336)
T ss_pred hcCccccccC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=273.47 Aligned_cols=200 Identities=21% Similarity=0.381 Sum_probs=175.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.. ...|+||||+.+|+|.+++.... ..+++..+..|+.||+.||+|||++||+|+||||
T Consensus 61 ~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p 137 (279)
T cd05057 61 YVMASVDHPHVVRLLGICLS--SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA 137 (279)
T ss_pred HHHHhCCCCCcceEEEEEec--CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence 57889999999999998865 47899999999999999998643 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCc---cccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLAS---SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~---~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.+||+|||+++.+....... ...++..|++||.+....++.++|||||||++|+|++ |..||.....
T Consensus 138 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 138 RNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred ceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 99999999999999999998765332211 1223567999999988889999999999999999998 9999999888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.++...+......+.+..++..+.+++.+||..+|+.||++.++++-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~ 264 (279)
T cd05057 218 VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINE 264 (279)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 88888887766666677789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=272.59 Aligned_cols=193 Identities=25% Similarity=0.334 Sum_probs=162.8
Q ss_pred hhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcE
Q 008303 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NI 84 (570)
....||||+++++++.+. ..+|+||||+.||+|.+++.+.. .+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 40 ~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni 116 (237)
T cd05576 40 IPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116 (237)
T ss_pred HhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 344799999999988654 57899999999999999997653 489999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHH
Q 008303 85 FLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI 164 (570)
Q Consensus 85 Lld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i 164 (570)
+++.++.++++|||.+...... .....++..|+|||.+....++.++||||+||++|+|++|..++...... +
T Consensus 117 l~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~ 189 (237)
T cd05576 117 LLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I 189 (237)
T ss_pred EEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c
Confidence 9999999999999987665432 22345677899999998888999999999999999999999887543221 1
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH-----HHHHHhhcc
Q 008303 165 NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA-----AELLRHVHL 207 (570)
Q Consensus 165 ~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa-----~eIL~hp~f 207 (570)
.......++..++..++++|.+||+.||.+|+++ +++++||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 190 NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1111223556789999999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=278.50 Aligned_cols=203 Identities=30% Similarity=0.575 Sum_probs=171.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|... +..|+||||+. |+|.+++.... ..+++..+..++.||+.||.|||++||+|+||+
T Consensus 66 i~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~ 142 (307)
T cd06607 66 VRFLQQLRHPNTIEYKGCYLRE-HTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIK 142 (307)
T ss_pred HHHHHhCCCCCEEEEEEEEEeC-CeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 3578899999999999998765 47899999997 57877776533 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|.||+++.++.+||+|||++...... ....++..|+|||++. ...++.++||||||+++|+|++|.+||...+.
T Consensus 143 p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 143 AGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred cccEEECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 99999999999999999998765432 3457888999999984 45678999999999999999999999987776
Q ss_pred HHHHHHHHhccCCC-CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVAP-LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p-~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
......+....... ....++..+.++|.+||..+|++||++.+|+.|+||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 220 MSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 65554444332222 23457889999999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=285.31 Aligned_cols=206 Identities=29% Similarity=0.461 Sum_probs=169.5
Q ss_pred HHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
++|++++|+||+++++++.... ..+|+|+||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 56 ~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~ 132 (337)
T cd07858 56 KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHR 132 (337)
T ss_pred HHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 5788999999999999886432 35899999996 6899988764 459999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||||+|||++.++.+||+|||++...... .......++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 133 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999876543 33345678999999999865 45889999999999999999999999776
Q ss_pred CHHHHHHHHHhccC------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIV------------------------------APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~------------------------------~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.......+..... ......++.++.+||++||+.+|.+|||++++++|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 213 DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 54332222211000 011235788999999999999999999999999999
Q ss_pred ccChh
Q 008303 206 HLQPY 210 (570)
Q Consensus 206 ~fq~~ 210 (570)
||...
T Consensus 293 ~~~~~ 297 (337)
T cd07858 293 YLASL 297 (337)
T ss_pred chhhh
Confidence 99764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=273.28 Aligned_cols=204 Identities=31% Similarity=0.500 Sum_probs=170.1
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++++++|+||+++++++... +...|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++|++|+||+
T Consensus 50 ~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~ 127 (287)
T cd07840 50 KLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIK 127 (287)
T ss_pred HHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCc
Confidence 578899999999999998765 2589999999975 8999887643 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||+++++.+||+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 128 p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 128 GSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred HHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999998765443 2334567889999998764 4578999999999999999999999988776
Q ss_pred HHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 158 QALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 158 ~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
......+......+ ....++..+.++|++||..+|.+||++.+++.|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 55544443321110 001137899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.00 Aligned_cols=205 Identities=31% Similarity=0.540 Sum_probs=173.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++++++||||++++++|... +..|+|+||+.+++|.+++.+. .+++..+..++.||+.||.|||++|++|+||+|
T Consensus 68 ~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p 143 (293)
T cd06647 68 LVMRENKHPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143 (293)
T ss_pred HHHhhcCCCCeeehhheeeeC-CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCH
Confidence 578899999999999998654 4789999999999999999753 478999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+||+++.++.+||+|||++....... ......|++.|++||.+....++.++|||||||++|+|++|+.||...+....
T Consensus 144 ~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~ 223 (293)
T cd06647 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (293)
T ss_pred HHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 99999999999999999887654332 22345688999999999888899999999999999999999999987665443
Q ss_pred HHHHHhccC--CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSIV--APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~--~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+..... ...+..++..++++|++||..+|++||++.+++.|+||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 224 LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred eeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 332222111 12234578899999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=274.04 Aligned_cols=197 Identities=22% Similarity=0.285 Sum_probs=162.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++||||+++++++...+ ..|+|||||++|+|..++.+. ...+++..+..|+.||+.||+|||++||+||||||
T Consensus 68 ~~~~~l~h~niv~~~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp 145 (274)
T cd05076 68 SLMSQVSHIHLAFVHGVCVRGS-ENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCA 145 (274)
T ss_pred HHHhcCCCCCeeeEEEEEEeCC-ceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCc
Confidence 4788899999999999987654 789999999999999998753 34689999999999999999999999999999999
Q ss_pred CcEEEcCCC-------CEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHh-hccCCCC
Q 008303 82 SNIFLTKDQ-------DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEM-TSLKPAF 152 (570)
Q Consensus 82 ~NILld~~g-------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeL-ltG~~pf 152 (570)
.|||++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+| +.|..||
T Consensus 146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 222 (274)
T cd05076 146 KNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222 (274)
T ss_pred ccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCc
Confidence 999998654 3899999988654322 23457888999999865 5579999999999999998 5789999
Q ss_pred cccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 153 KAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
...........+... ...+......+.++|.+||..+|.+||++.+|++++
T Consensus 223 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 223 KERTPSEKERFYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred cccChHHHHHHHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 876655443333322 223445667899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=292.08 Aligned_cols=203 Identities=23% Similarity=0.390 Sum_probs=169.9
Q ss_pred CHHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---------------------------------
Q 008303 1 MELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------------------------- 46 (570)
Q Consensus 1 v~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------------------------- 46 (570)
+++|+++. |||||+++++|.+. ..+|||||||.+|+|.++|.+..
T Consensus 91 i~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (400)
T cd05105 91 LKIMTHLGPHLNIVNLLGACTKS-GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVIL 169 (400)
T ss_pred HHHHHhcCCCCCeeeEEEEEccC-CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhh
Confidence 36788895 99999999998654 47899999999999999986531
Q ss_pred -------------------------------------------------------------CCCCCHHHHHHHHHHHHHH
Q 008303 47 -------------------------------------------------------------SKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 47 -------------------------------------------------------------~~~Lse~~i~~I~~QLl~a 65 (570)
...+++..+..++.||+.|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~a 249 (400)
T cd05105 170 SFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARG 249 (400)
T ss_pred hhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence 1247888999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhH
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCI 142 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Il 142 (570)
|+|||++||+||||||+|||++.++.+||+|||+++.+..... .....++..|+|||++.+..++.++|||||||++
T Consensus 250 L~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil 329 (400)
T cd05105 250 MEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329 (400)
T ss_pred HHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHH
Confidence 9999999999999999999999999999999999987643221 2234567889999999988899999999999999
Q ss_pred HHhhc-cCCCCcccCHH-HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 143 YEMTS-LKPAFKAFDMQ-ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 143 yeLlt-G~~pf~~~~~~-~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|+|++ |..||...... .....+......+.+..++.++.++|.+||..+|++||++.+|.+.
T Consensus 330 ~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 330 WEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 99986 88888765433 3344454444455667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=275.61 Aligned_cols=205 Identities=26% Similarity=0.491 Sum_probs=171.9
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +|+||+.++++|..+ ..+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||+
T Consensus 56 ~~l~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~ 132 (290)
T cd05613 56 QVLEHIRQSPFLVTLHYAFQTD-TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIK 132 (290)
T ss_pred HHHHhcccCCChhceeeEeecC-CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 578888 699999999988654 5789999999999999999874 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC--CCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~--~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++.+||+|||++....... ......|+..|++||.+... .++.++||||||+++|+|++|..||....
T Consensus 133 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 133 LENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred HHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 999999999999999999998765432 22345789999999998753 46889999999999999999999986432
Q ss_pred ----HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 157 ----MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 157 ----~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
...+...+.. ...+.+..++..+.+++++||..+|.+|+ ++++++.|+||+..
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 213 EKNSQAEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ccccHHHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 2233333322 23445677899999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=271.46 Aligned_cols=204 Identities=19% Similarity=0.372 Sum_probs=171.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-------KLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-------~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
+++|++++|+||+++++++.+. ...|+|||||.+|+|.+++..... ..+++..+..++.||+.||+|||++|
T Consensus 59 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~ 137 (275)
T cd05046 59 LDMFRKLSHKNVVRLLGLCREA-EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR 137 (275)
T ss_pred HHHHHhcCCcceeeeEEEECCC-CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC
Confidence 3688999999999999987554 478999999999999999986542 15899999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKP 150 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~ 150 (570)
|+||||||+|||++.++.++|+|||++....... ......++..|++||.+.+..++.++||||||+++|+|++ |..
T Consensus 138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred cccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987543222 1223456778999999988888999999999999999998 788
Q ss_pred CCcccCHHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 151 AFKAFDMQALINKINKSI-VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~~-~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||...........+.... ..+.+..++..+.++|.+||..+|.+||++.+++.+.
T Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 218 PFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred CccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 887776666665554322 2334567889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=271.91 Aligned_cols=203 Identities=31% Similarity=0.460 Sum_probs=169.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||+++++++.+. .++|+||||+. ++|.+++.+.. ..+++..++.++.|++.||+|||++||+||||+|
T Consensus 50 ~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~ 126 (282)
T cd07829 50 SLLKELKHPNIVKLLDVIHTE-RKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKP 126 (282)
T ss_pred HHHHhcCCCCHHHHHhhhhcC-CceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 578899999999999988655 57899999998 49999998753 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+||+++.++.+||+|||++....... ......++..|+|||.+... .++.++|||||||++|+|++|+++|...+...
T Consensus 127 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 206 (282)
T cd07829 127 QNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID 206 (282)
T ss_pred heEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 99999999999999999998765432 23344567889999999766 78999999999999999999999998876555
Q ss_pred HHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 160 LINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 160 ~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
...++......+ ....++..+.++|.+||..+|.+||+++++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 444332211100 011347789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=274.37 Aligned_cols=203 Identities=22% Similarity=0.425 Sum_probs=167.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS---------KLFSEEKLCKWLVQLLMALDYLHA 71 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~---------~~Lse~~i~~I~~QLl~aL~yLHs 71 (570)
+++|++++|+||+++++++... ..+|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||+
T Consensus 70 ~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 148 (296)
T cd05095 70 IKIMSRLKDPNIIRLLAVCITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS 148 (296)
T ss_pred HHHHHhCCCCCcceEEEEEecC-CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 3678899999999999988654 478999999999999999976421 247788999999999999999999
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS- 147 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt- 147 (570)
+||+|+||||+|||++.++.++|+|||++..+.... ......++..|++||.+....++.++|||||||++|+|++
T Consensus 149 ~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 149 LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred CCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999998654322 1222344678999999888889999999999999999987
Q ss_pred -cCCCCcccCHHHHHHHHHh-------ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 148 -LKPAFKAFDMQALINKINK-------SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 148 -G~~pf~~~~~~~~~~~i~~-------~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|..||...+..+....... ....+.+..++..+.+||.+||..||++||++.+|++.
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 229 CKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred CCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 6788877666555443321 12234456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=273.40 Aligned_cols=203 Identities=28% Similarity=0.385 Sum_probs=162.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.. ++..|+||||+. ++|.+++.... ..+.+..+..++.||+.||.|||++||+|+||||
T Consensus 55 ~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp 131 (291)
T cd07870 55 SLLKGLKHANIVLLHDIIHT-KETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKP 131 (291)
T ss_pred HHHHhcCCCCEeEEEEEEec-CCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 57889999999999998865 457899999996 68877776543 4578999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH-
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ- 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~- 158 (570)
+|||++.++.+||+|||+++...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus 132 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~ 211 (291)
T cd07870 132 QNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211 (291)
T ss_pred HHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence 99999999999999999987643322 22345678999999998754 5788999999999999999999999765432
Q ss_pred HHHHHHHhccCCC-----------------------------CC--CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 159 ALINKINKSIVAP-----------------------------LP--TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 159 ~~~~~i~~~~~~p-----------------------------~p--~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+....+......+ .+ ...+..+.+++.+||..||.+|||+.|++.|+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 212 EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 2222211100000 00 0125689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=270.06 Aligned_cols=201 Identities=20% Similarity=0.359 Sum_probs=161.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN---SKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~---~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++++++||||+++++++.+. ..+|+||||+.+|+|.+++.... ...+++..+..++.|++.||+|||++||+|+|
T Consensus 47 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 125 (269)
T cd05087 47 QPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSD 125 (269)
T ss_pred HHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccc
Confidence 578899999999999988654 46899999999999999997532 23467788899999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCC-------CCCCcccccchhhhHHHhhc-
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADI-------PYGSKSDIWSLGCCIYEMTS- 147 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-------~~t~ksDIWSLG~IlyeLlt- 147 (570)
|||+||+++.++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 126 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 126 LALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred cCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhC
Confidence 999999999999999999999876443321 1234577889999998642 35789999999999999986
Q ss_pred cCCCCcccCHHHHHHHHHhccCC-----CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 148 LKPAFKAFDMQALINKINKSIVA-----PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~~-----p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|..||......+........... .....++..+.+++++|+ .+|++|||+++|+..
T Consensus 206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 206 GSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred CCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 99999877665554433222211 122356789999999999 689999999999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=282.49 Aligned_cols=205 Identities=21% Similarity=0.432 Sum_probs=169.6
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------------------------
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-------------------------------- 47 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-------------------------------- 47 (570)
+++|.++ +|+||+++++++...+..+|+|||||.+|+|.+++.....
T Consensus 61 ~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (343)
T cd05103 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDS 140 (343)
T ss_pred HHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccc
Confidence 3578888 7899999999887766788999999999999999875321
Q ss_pred ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEE
Q 008303 48 ---------------------------------KLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRL 94 (570)
Q Consensus 48 ---------------------------------~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL 94 (570)
..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 141 ITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred cccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEE
Confidence 24688889999999999999999999999999999999999999999
Q ss_pred eecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH-HHHHHHHHhccC
Q 008303 95 GDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM-QALINKINKSIV 169 (570)
Q Consensus 95 ~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~-~~~~~~i~~~~~ 169 (570)
+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+.....
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 300 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 300 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC
Confidence 99999876532211 112345677999999988889999999999999999986 8889876543 233444444444
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 170 APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 170 ~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
...+..++.++.+++.+||..+|.+||++.+|++|.
T Consensus 301 ~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 455666788999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=274.38 Aligned_cols=203 Identities=20% Similarity=0.367 Sum_probs=167.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS----------KLFSEEKLCKWLVQLLMALDYLH 70 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~----------~~Lse~~i~~I~~QLl~aL~yLH 70 (570)
+++|++++|+||+++++++... ...|+|||||.+++|.+++..... ..+++..++.++.||+.||.|||
T Consensus 68 i~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 146 (295)
T cd05097 68 IKIMSRLKNPNIIRLLGVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA 146 (295)
T ss_pred HHHHHhCCCCCcCeEEEEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH
Confidence 4688999999999999998655 478999999999999999965321 23688999999999999999999
Q ss_pred HCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc
Q 008303 71 ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 71 s~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt 147 (570)
++|++|+||||+|||++.++.+||+|||++..+..... .....++..|+|||++....++.++|||||||++|+|++
T Consensus 147 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 147 SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999999999999876543221 222345678999999998889999999999999999987
Q ss_pred --cCCCCcccCHHHHHHHHHh-------ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 148 --LKPAFKAFDMQALINKINK-------SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 148 --G~~pf~~~~~~~~~~~i~~-------~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+..||......+.+..+.. ......+..++..+.+||.+||..+|++||++++|++.
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 227 LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred cCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6678877766665544422 11222345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=268.94 Aligned_cols=201 Identities=35% Similarity=0.700 Sum_probs=173.9
Q ss_pred Hhh-hcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccce
Q 008303 3 LIS-KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRD 78 (570)
Q Consensus 3 IL~-kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrD 78 (570)
++. .++|+||++++++|.++ .+.|+||||+.|++|.+++.. .....+++..++.++.|++.||.|||+ .||+|+|
T Consensus 61 ~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~d 139 (269)
T cd08528 61 IIKEQLRHPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRD 139 (269)
T ss_pred HHhhcCCCCCeeeEEeeEccC-CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecC
Confidence 344 46999999999988765 478999999999999998854 233568999999999999999999996 7899999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|.|||++.++.+||+|||++.............|+..|++||.+.+..++.++||||||+++|+|++|++||...+..
T Consensus 140 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 140 LTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred CCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 99999999999999999999998876554445667899999999999888999999999999999999999999887777
Q ss_pred HHHHHHHhccCCCCCC-CCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 159 ALINKINKSIVAPLPT-KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~-~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.....+......+... .++..+.++|.+||..||++||++.|+..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 6666666555444444 688999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=275.76 Aligned_cols=205 Identities=29% Similarity=0.472 Sum_probs=166.0
Q ss_pred CHHhhhcCCCcccccceEEEeeC-------cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-------CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-------~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
+++|++++|+||+++++++.+.. ..+|+||||+.+ +|...+... ...+++..++.++.||+.||.|||++|
T Consensus 58 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~ 135 (311)
T cd07866 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH 135 (311)
T ss_pred HHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 36789999999999999876432 357999999975 777777643 346999999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCCC------------CccccCCCCCCCcccccCC-CCCCcccccchhh
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL------------ASSVVGTPSYMCPELLADI-PYGSKSDIWSLGC 140 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~------------~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~ 140 (570)
|+|+||||+|||++.++.+||+|||++........ .....+++.|+|||++.+. .++.++|||||||
T Consensus 136 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 215 (311)
T cd07866 136 ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC 215 (311)
T ss_pred eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence 99999999999999999999999999976543221 1234678899999988654 5789999999999
Q ss_pred hHHHhhccCCCCcccCHHHHHHHHHhccCCC----------------------C-------CCCCcHHHHHHHHHhhccC
Q 008303 141 CIYEMTSLKPAFKAFDMQALINKINKSIVAP----------------------L-------PTKYSGAFRGLVKSMLRKN 191 (570)
Q Consensus 141 IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p----------------------~-------p~~~s~~l~dLI~~~L~~d 191 (570)
++|+|++|++||.+.+.......+......+ . ...+...+.++|.+||..+
T Consensus 216 il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 295 (311)
T cd07866 216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295 (311)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccC
Confidence 9999999999998777655444433211110 0 1234568899999999999
Q ss_pred CCCCcCHHHHHHhhcc
Q 008303 192 PELRPSAAELLRHVHL 207 (570)
Q Consensus 192 P~~RPTa~eIL~hp~f 207 (570)
|.+|||+.+++.|+||
T Consensus 296 p~~R~t~~ell~~~~f 311 (311)
T cd07866 296 PYKRLTASDALEHPYF 311 (311)
T ss_pred cccCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=268.74 Aligned_cols=202 Identities=20% Similarity=0.387 Sum_probs=163.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++++.++||||++++++|... ...|+|||||.+|+|.+++.+.. ...+++..++.++.||+.||+|||++||+||||
T Consensus 47 ~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~di 125 (268)
T cd05086 47 DPYRILQHPNILQCLGQCVEA-IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDL 125 (268)
T ss_pred HHHhccCCcchhheEEEecCC-CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 467889999999999998654 47899999999999999997642 234677889999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccC-------CCCCCcccccchhhhHHHhhc-c
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLAD-------IPYGSKSDIWSLGCCIYEMTS-L 148 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~-------~~~t~ksDIWSLG~IlyeLlt-G 148 (570)
||+|||++.++.+||+|||++....... .....+++..|+|||++.. ..++.++|||||||++|+|++ |
T Consensus 126 kp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred ccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 9999999999999999999986432211 1234578899999999853 235779999999999999985 6
Q ss_pred CCCCcccCHHHHHHHHHhccC-----CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 149 KPAFKAFDMQALINKINKSIV-----APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~-----~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..||...+..+....+..... ..+...++..+.+++..|| .+|++||++++|++.+
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 206 AQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 778887777666555433321 2234467899999999999 6799999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=280.92 Aligned_cols=206 Identities=30% Similarity=0.475 Sum_probs=169.3
Q ss_pred CHHhhhc-CCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKI-RNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|+++ +|+||++++++|... +...|+|||||. ++|..++... .+.+..++.++.||+.||.|||++||+|||
T Consensus 57 ~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~d 132 (337)
T cd07852 57 IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRD 132 (337)
T ss_pred HHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 3678899 999999999988643 457899999997 4999988763 589999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC------CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCC
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD------LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~------~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|||+|||++.++.+||+|||++..+.... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 l~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p 212 (337)
T cd07852 133 LKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212 (337)
T ss_pred CCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998664322 2234578999999998865 4578999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccC------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 152 FKAFDMQALINKINKSIV------------------------------APLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~------------------------------~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
|.+........++..... ......++.++.++|.+||+.+|.+|||+.++
T Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i 292 (337)
T cd07852 213 FPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH
Confidence 976654443332211110 01112368899999999999999999999999
Q ss_pred HHhhccChh
Q 008303 202 LRHVHLQPY 210 (570)
Q Consensus 202 L~hp~fq~~ 210 (570)
++|+|++.+
T Consensus 293 l~~~~~~~~ 301 (337)
T cd07852 293 LEHPYVAQF 301 (337)
T ss_pred hhChhhhhh
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=274.39 Aligned_cols=204 Identities=30% Similarity=0.491 Sum_probs=167.3
Q ss_pred HHhhhcCCCcccccceEEEeeC---------cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 2 ELISKIRNPFIVEYKDSWVERG---------CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~---------~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
+++++++||||+++++++.+.. .++|+|+||+.+ +|..++... ...+++..+..|+.||+.||+|||++
T Consensus 58 ~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~ 135 (302)
T cd07864 58 KILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK 135 (302)
T ss_pred HHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5788999999999999886432 378999999986 777777654 34689999999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccC
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~ 149 (570)
||+|+||||+||+++.++.+||+|||++..+.... ......++..|++||++.+. .++.++|||||||++|+|++|+
T Consensus 136 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998765432 22234567889999988653 5689999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHH
Q 008303 150 PAFKAFDMQALINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAE 200 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~e 200 (570)
+||...+.......+......+ ....++..+.++|.+||..+|.+||++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9998766555444433321111 12246889999999999999999999999
Q ss_pred HHHhhcc
Q 008303 201 LLRHVHL 207 (570)
Q Consensus 201 IL~hp~f 207 (570)
++.|+||
T Consensus 296 il~~~~~ 302 (302)
T cd07864 296 ALNSPWL 302 (302)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=277.40 Aligned_cols=209 Identities=26% Similarity=0.468 Sum_probs=172.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN---SKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~---~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
|.+++.|+||||+.|..+|...+..+++++||.+. +|++.|+.+. ...++...++.|+.||+.|+.|||++-|+||
T Consensus 78 iaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHR 156 (438)
T KOG0666|consen 78 IALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHR 156 (438)
T ss_pred HHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeec
Confidence 45789999999999999998766689999999986 9999997432 2568999999999999999999999999999
Q ss_pred eecCCcEEEcCC----CCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhcc
Q 008303 78 DVKCSNIFLTKD----QDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 78 DLKP~NILld~~----g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG 148 (570)
||||.|||+..+ |.|||+|||+++.+...- ....++-|.||.|||++.+.. |+.+.|||++|||+.||++.
T Consensus 157 DLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 157 DLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999999999988 899999999999886432 234567899999999998765 79999999999999999999
Q ss_pred CCCCcccCH---------HHHHHHHHhccCCCCCCCC------------------------------------cHHHHHH
Q 008303 149 KPAFKAFDM---------QALINKINKSIVAPLPTKY------------------------------------SGAFRGL 183 (570)
Q Consensus 149 ~~pf~~~~~---------~~~~~~i~~~~~~p~p~~~------------------------------------s~~l~dL 183 (570)
.+.|.+... .++..+|......|-...| ++...+|
T Consensus 237 ~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 237 EPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred CccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 998865432 2334444443333321111 2347799
Q ss_pred HHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 184 VKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 184 I~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+.+||.+||.+|+|++++|+|+||...
T Consensus 317 L~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 317 LQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HHHHhccCchhhccHHHHhcccccccC
Confidence 999999999999999999999999753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=275.14 Aligned_cols=202 Identities=30% Similarity=0.592 Sum_probs=170.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.+. ...|+|||||. |+|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|
T Consensus 73 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p 149 (313)
T cd06633 73 KFLQQLKHPNTIEYKGCYLKE-HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149 (313)
T ss_pred HHHHhCCCCCCccEEEEEEeC-CEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCh
Confidence 578899999999999998664 57899999996 58888876543 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+||+++.++.+||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 150 ~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~ 226 (313)
T cd06633 150 GNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226 (313)
T ss_pred hhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999999865332 23467899999999984 355788999999999999999999999877655
Q ss_pred HHHHHHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVA-PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~-p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.....+...... .....++..+++||.+||+.+|.+||++.++++|+||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 227 SALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 555444433222 223467889999999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=283.74 Aligned_cols=206 Identities=27% Similarity=0.459 Sum_probs=171.4
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++++++++|+||+++++++...+ ..+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+
T Consensus 65 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~ 140 (343)
T cd07851 65 LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGII 140 (343)
T ss_pred HHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 36788999999999999876443 2489999999 6699999875 3589999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 141 HRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999876433 344578899999999865 3678999999999999999999999987
Q ss_pred cCHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+......+ ....++..+.+||.+||..+|.+|||+.+|+.|
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 76655444432221110 112468899999999999999999999999999
Q ss_pred hccChhhh
Q 008303 205 VHLQPYVL 212 (570)
Q Consensus 205 p~fq~~~~ 212 (570)
+||+.+..
T Consensus 299 ~~~~~~~~ 306 (343)
T cd07851 299 PYLAEYHD 306 (343)
T ss_pred CCccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=277.10 Aligned_cols=209 Identities=25% Similarity=0.397 Sum_probs=175.0
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
|+++.+. .|+||+.|+++|+++ ..+|+|||-+.||.|...|.++ +.|+|.++..++.+|+.||.|||.+||.||||
T Consensus 126 Ve~f~~Cqgh~nilqLiefFEdd-~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDl 202 (463)
T KOG0607|consen 126 VETFYQCQGHKNILQLIEFFEDD-TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDL 202 (463)
T ss_pred HHHHHHhcCCccHHHHHHHhccc-ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccC
Confidence 4567776 799999999988655 4799999999999999999885 56999999999999999999999999999999
Q ss_pred cCCcEEEcCCC---CEEEeecCCceeccCC--------CCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHH
Q 008303 80 KCSNIFLTKDQ---DIRLGDFGLAKILTSD--------DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 80 KP~NILld~~g---~vKL~DFGla~~~~~~--------~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~Ily 143 (570)
||+|||-.+-. -||||||.++.-+... ....+.+|+..|||||++. ...|+.++|.||||+|+|
T Consensus 203 KPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlY 282 (463)
T KOG0607|consen 203 KPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILY 282 (463)
T ss_pred CccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHH
Confidence 99999987644 4899999987654321 1234568999999999873 345899999999999999
Q ss_pred HhhccCCCCcccC---------------HHHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTSLKPAFKAFD---------------MQALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLltG~~pf~~~~---------------~~~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.|++|.+||.+.- .+.+++.|..+.+. .-|..+|.+.+++|..+|..++.+|.++.++++||
T Consensus 283 ImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 283 IMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 9999999996531 24567777666543 34557899999999999999999999999999999
Q ss_pred ccChhhh
Q 008303 206 HLQPYVL 212 (570)
Q Consensus 206 ~fq~~~~ 212 (570)
|++....
T Consensus 363 w~~~~~~ 369 (463)
T KOG0607|consen 363 WVQRCAP 369 (463)
T ss_pred cccccch
Confidence 9986543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=274.43 Aligned_cols=202 Identities=31% Similarity=0.591 Sum_probs=171.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++.++ ...|+|||||.| +|.+++... ...+++..+..++.||+.||.|||++||+||||+|
T Consensus 77 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p 153 (317)
T cd06635 77 KFLQRIKHPNSIEYKGCYLRE-HTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 153 (317)
T ss_pred HHHHhCCCCCEEEEEEEEeeC-CeEEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCc
Confidence 578889999999999988665 478999999975 888877654 34589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+||+++.++.+||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 230 (317)
T cd06635 154 GNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230 (317)
T ss_pred ccEEECCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 999999999999999999876443 23457889999999984 456789999999999999999999999877766
Q ss_pred HHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIV-APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.....+..... ......++..++++|.+||..+|.+||++.++++|+|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 231 SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 65555544433 2234468899999999999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=302.22 Aligned_cols=202 Identities=23% Similarity=0.432 Sum_probs=183.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------CC----CCCHHHHHHHHHHHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------SK----LFSEEKLCKWLVQLLMALDYL 69 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------~~----~Lse~~i~~I~~QLl~aL~yL 69 (570)
++|..|+|||||+|+|+|.++ +-+|+|+|||..|||.+|+..+. +. .|+..+...|+.||+.|+.||
T Consensus 541 eLla~l~H~nIVrLlGVC~~~-~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL 619 (774)
T KOG1026|consen 541 ELLAELQHPNIVRLLGVCREG-DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL 619 (774)
T ss_pred HHHHhccCCCeEEEEEEEccC-CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 689999999999999999765 48999999999999999997532 22 388999999999999999999
Q ss_pred HHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccc---cCCCCCCCcccccCCCCCCcccccchhhhHHHhh
Q 008303 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV---VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146 (570)
Q Consensus 70 Hs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~---~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl 146 (570)
-++++|||||-..|+||.++-.|||+|||+++.+...+++... .-..+||+||.+..++|+.++||||+||+|||++
T Consensus 620 s~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF 699 (774)
T KOG1026|consen 620 SSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF 699 (774)
T ss_pred HhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence 9999999999999999999999999999999988765544322 2246899999999999999999999999999997
Q ss_pred c-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 147 S-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 147 t-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+ |+.||.+...+++++.|..+...+.|..++.++..|+..||+.+|.+||++.||-.-
T Consensus 700 syG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~ 758 (774)
T KOG1026|consen 700 SYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSR 758 (774)
T ss_pred ccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 6 889999999999999999999999999999999999999999999999999999654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=274.12 Aligned_cols=201 Identities=18% Similarity=0.362 Sum_probs=172.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.++++++||||+++++++... ..++|+||+.+|+|.+++.... ..+++..+..|+.||+.||.|||++||+|+||||
T Consensus 61 ~~~~~l~h~niv~~~~~~~~~--~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp 137 (303)
T cd05110 61 LIMASMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAA 137 (303)
T ss_pred HHHHhCCCCCcccEEEEEcCC--CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeecccccc
Confidence 578889999999999988543 4679999999999999997643 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.+||+|||+++....... .....++..|++||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 138 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 138 RNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred ceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987643221 122345678999999998889999999999999999986 8899988776
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
......+......+.+..++..+.+++.+||..+|++||+++++++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l 265 (303)
T cd05110 218 REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265 (303)
T ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 666666665555556677889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=273.24 Aligned_cols=202 Identities=29% Similarity=0.568 Sum_probs=170.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+||+++++++... +..|+||||+. |+|.+++.... ..+++..+..++.|++.||.|||++|++||||+|
T Consensus 67 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p 143 (308)
T cd06634 67 RFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143 (308)
T ss_pred HHHHhCCCCCcccEEEEEEcC-CeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 578899999999999988764 57899999996 58888776543 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 144 ~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 220 (308)
T cd06634 144 GNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (308)
T ss_pred HhEEECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH
Confidence 9999999999999999998876533 3456889999999985 345788999999999999999999998776655
Q ss_pred HHHHHHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVA-PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~-p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.....+...... .....++..+.+||++||..+|++||+++++++|+|+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 221 SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 444444433322 234468899999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=272.24 Aligned_cols=206 Identities=27% Similarity=0.454 Sum_probs=167.2
Q ss_pred Hhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceec
Q 008303 3 LISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVK 80 (570)
Q Consensus 3 IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLK 80 (570)
++.++ .|+||++++++|.+.+ ..|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||+
T Consensus 66 ~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~ 142 (296)
T cd06618 66 VVLKSHDCPYIVKCYGYFITDS-DVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK 142 (296)
T ss_pred HHHhccCCCchHhhheeeecCC-eEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCc
Confidence 34455 5999999999987654 7899999985 48888876643 368999999999999999999997 599999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCC----CCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+||+++.++.+||+|||++..+..........++..|+|||.+.... ++.++||||||+++|+|++|+.||....
T Consensus 143 p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 143 PSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred HHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 999999999999999999998765444334456788999999987553 7889999999999999999999997643
Q ss_pred H-HHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 157 M-QALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 157 ~-~~~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
. .+....+....... ....++.++.+||.+||..+|.+||+++++++|+||+.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 223 TEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 2 22333333322222 2235789999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=269.45 Aligned_cols=203 Identities=23% Similarity=0.438 Sum_probs=163.3
Q ss_pred CHHhhhcCCCcccccceEEEe-eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVE-RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++||||+++++++.. ++..+|+||||+.+|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||
T Consensus 56 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dl 134 (284)
T cd05081 56 IEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDL 134 (284)
T ss_pred HHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 368899999999999998753 3456899999999999999997643 35899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++|..++...
T Consensus 135 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 135 ATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred CHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 99999999999999999999987643221 11122345699999999888999999999999999999987654322
Q ss_pred CHH----------------HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQ----------------ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~----------------~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
... .+...+......+.+..++.++.+||.+||..+|++|||+.+|++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred chhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111 1112222223334456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=270.14 Aligned_cols=205 Identities=28% Similarity=0.510 Sum_probs=170.7
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +|+||+++++.|..+ ..+|+||||+.+|+|.+++... ..+++..++.++.|++.||.|||+.|++||||+
T Consensus 56 ~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~ 132 (288)
T cd05583 56 QVLEAVRRCPFLVTLHYAFQTD-TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIK 132 (288)
T ss_pred HHHHhccCCcchhhhheeeecC-CEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 578888 699999999988654 5789999999999999998764 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCC--CCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~--~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|.||+++.++.++|+|||++..+..... .....|+..|++||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 133 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 133 LENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred HHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 9999999999999999999877543321 22356899999999987655 6889999999999999999999986432
Q ss_pred ----HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC---HHHHHHhhccChh
Q 008303 157 ----MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS---AAELLRHVHLQPY 210 (570)
Q Consensus 157 ----~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT---a~eIL~hp~fq~~ 210 (570)
.......+... ..+.+..++..+.++|.+||..+|++||| +.++|+|+||+.+
T Consensus 213 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 213 EQNSQSEISRRILKS-KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ccchHHHHHHHHHcc-CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 22333333222 33556778999999999999999999998 5778999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.50 Aligned_cols=206 Identities=30% Similarity=0.456 Sum_probs=165.2
Q ss_pred CHHhhhcCCCcccccceEEEeeC-------------cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-------------CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-------------~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~ 67 (570)
+++|++++||||+++++++...+ ..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.
T Consensus 53 i~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~ 128 (342)
T cd07854 53 IKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLK 128 (342)
T ss_pred HHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHH
Confidence 46789999999999998775432 25789999997 589888864 34899999999999999999
Q ss_pred HHHHCCcccceecCCcEEEcC-CCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccC-CCCCCcccccchhhh
Q 008303 68 YLHANHILHRDVKCSNIFLTK-DQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCC 141 (570)
Q Consensus 68 yLHs~gIvHrDLKP~NILld~-~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~I 141 (570)
|||++||+||||||+|||++. ++.+||+|||++..+.... .....+++..|+|||++.+ ..++.++|||||||+
T Consensus 129 ~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvi 208 (342)
T cd07854 129 YIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 208 (342)
T ss_pred HHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHH
Confidence 999999999999999999985 5578999999998764321 1223467889999998754 457889999999999
Q ss_pred HHHhhccCCCCcccCHHHHHHHHHhccCC-----------------------------CCCCCCcHHHHHHHHHhhccCC
Q 008303 142 IYEMTSLKPAFKAFDMQALINKINKSIVA-----------------------------PLPTKYSGAFRGLVKSMLRKNP 192 (570)
Q Consensus 142 lyeLltG~~pf~~~~~~~~~~~i~~~~~~-----------------------------p~p~~~s~~l~dLI~~~L~~dP 192 (570)
+|+|++|+.||...+.......+...... .....++.++.+||.+||..||
T Consensus 209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 288 (342)
T cd07854 209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288 (342)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc
Confidence 99999999999766543333322211100 0112467899999999999999
Q ss_pred CCCcCHHHHHHhhccChh
Q 008303 193 ELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 193 ~~RPTa~eIL~hp~fq~~ 210 (570)
.+|||+.+++.|+||+.+
T Consensus 289 ~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 289 MDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhccCHHHHhCCCccccc
Confidence 999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.95 Aligned_cols=205 Identities=28% Similarity=0.483 Sum_probs=164.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH---ILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g---IvHr 77 (570)
|++|.+++|||||+|+|||.+.+...+||+||+.+|+|.+++.......++|..+.+|+.+++.||+|||... |+||
T Consensus 122 i~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr 201 (361)
T KOG1187|consen 122 VEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHR 201 (361)
T ss_pred HHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence 5789999999999999999876545889999999999999997644327899999999999999999999864 9999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccC-CCCCccc-cCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTS-DDLASSV-VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~-~~~~~~~-~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||++|||||.+.+.||+|||+++.... ....... .||.+|++||++..+..+.++||||||+++.||++|+.+.+..
T Consensus 202 DiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 202 DIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999999999999999999999977654 3333333 8999999999999989999999999999999999999877643
Q ss_pred C---HHHHHH----HHHhc----cCCC-CC-CCCc-----HHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 D---MQALIN----KINKS----IVAP-LP-TKYS-----GAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~---~~~~~~----~i~~~----~~~p-~p-~~~s-----~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
. ...+.. .+... +..+ +. ..+. ..+..+..+|+..++..||++.|+++.+
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 2 111111 11111 1111 12 2333 2356788899999999999999987764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=256.35 Aligned_cols=203 Identities=37% Similarity=0.668 Sum_probs=177.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||+++++++... ...++++||+.+++|.+++..... +++..++.++.+++.+|.|||+.||+|+||+|
T Consensus 39 ~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~ 115 (244)
T smart00220 39 SILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKP 115 (244)
T ss_pred HHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCH
Confidence 578889999999999988664 478999999999999999986443 89999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc-cCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA-FDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~-~~~~~~ 160 (570)
.||+++.++.++|+|||.+.............++..|++||.+....++.++|||+||+++++|++|..||.. .+....
T Consensus 116 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~ 195 (244)
T smart00220 116 ENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL 195 (244)
T ss_pred HHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999999999987765555667789999999999988899999999999999999999999987 555555
Q ss_pred HHHHHhccCCCCCCC--CcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 161 INKINKSIVAPLPTK--YSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~--~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
...+........... ++.++.+++.+||..+|++||++.++++|+||
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 196 FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 555554443332222 88999999999999999999999999999996
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=276.99 Aligned_cols=207 Identities=25% Similarity=0.426 Sum_probs=167.8
Q ss_pred HHhhhc-CCCcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELISKI-RNPFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
++|+++ +|+||+++++++.. ....+|+++||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 53 ~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~ 129 (332)
T cd07857 53 KLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHR 129 (332)
T ss_pred HHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 567788 69999999987542 2246789999996 5899988753 458999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCC
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
||||+|||++.++.+||+|||++..+.... .....+|+..|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 130 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~p 209 (332)
T cd07857 130 DLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209 (332)
T ss_pred CCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcC
Confidence 999999999999999999999998764322 1234578999999998765 4689999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccC------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 152 FKAFDMQALINKINKSIV------------------------------APLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~------------------------------~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
|...+.......+..... ......++..+.+||.+||+.+|.+|||+.++
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l 289 (332)
T cd07857 210 FKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289 (332)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 987665443332221110 01122457899999999999999999999999
Q ss_pred HHhhccChhh
Q 008303 202 LRHVHLQPYV 211 (570)
Q Consensus 202 L~hp~fq~~~ 211 (570)
+.|+|++.|.
T Consensus 290 l~~~~~~~~~ 299 (332)
T cd07857 290 LEHPYLAIWH 299 (332)
T ss_pred hcChhhhhhc
Confidence 9999997663
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=270.13 Aligned_cols=200 Identities=29% Similarity=0.477 Sum_probs=169.4
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccceecCCcEEE
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDVKCSNIFL 86 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDLKP~NILl 86 (570)
+.|+||+.+|+|..+. .++|.||.+.. .+..++++. .++++|..+-++.+.++.||.||.++ ||+|||+||+|||+
T Consensus 149 dcpyIV~c~GyFi~n~-dV~IcMelMs~-C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl 225 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNT-DVFICMELMST-CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 225 (391)
T ss_pred CCCeeeeeeeEEeeCc-hHHHHHHHHHH-HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE
Confidence 5899999999998664 58899999853 555555543 45799999999999999999999976 79999999999999
Q ss_pred cCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCH-HHHHH
Q 008303 87 TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM-QALIN 162 (570)
Q Consensus 87 d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~-~~~~~ 162 (570)
|+.|+|||||||++..+......+.-.|-+.|||||.+. ...|+.++||||||+.++||.+|+.||.+.+. -++..
T Consensus 226 De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 226 DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 999999999999999887777677778999999999995 34689999999999999999999999998543 34455
Q ss_pred HHHhccCCCCC--CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 163 KINKSIVAPLP--TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 163 ~i~~~~~~p~p--~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
++.+....-++ ..+|+.+++|+..||.+|+.+||.+.++|+|+|+..|
T Consensus 306 kvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 306 KVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 55555443333 3589999999999999999999999999999998654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=264.24 Aligned_cols=204 Identities=19% Similarity=0.369 Sum_probs=171.1
Q ss_pred HHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKAN----SKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~----~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
++|++++||||+++++++.... ...++++||+.+|+|.+++.... ...+++..++.++.||+.||+|||++
T Consensus 53 ~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 132 (273)
T cd05074 53 ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK 132 (273)
T ss_pred HHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 6788999999999999886432 13478999999999998875321 12578999999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-c
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-L 148 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G 148 (570)
||+||||||+||+++.++.+||+|||+++....... .....++..|++||.+....++.++|||||||++|+|++ |
T Consensus 133 ~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 133 NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCC
Confidence 999999999999999999999999999987643221 122345678999999998889999999999999999998 8
Q ss_pred CCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 149 KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+||...+..+....+........+..++..+.+++.+||..+|++||++.+++.+.
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 213 QTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 899988887777766665554455567889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.31 Aligned_cols=206 Identities=24% Similarity=0.429 Sum_probs=167.9
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++|+||++++++|.... ..+|++++++ |++|.++++. ..+++..++.++.||+.||+|||++||+
T Consensus 67 i~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~iv 142 (345)
T cd07877 67 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADII 142 (345)
T ss_pred HHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 36789999999999999885322 3478899987 7799988864 2489999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+||+++.++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||..
T Consensus 143 H~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 143 HRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred ecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998865432 234578999999999866 5678999999999999999999999976
Q ss_pred cCHHHHHHHHHhccC------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIV------------------------------APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~------------------------------~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+..... ......++.++.+||.+||..||.+|+++.++++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 654443332211100 00112467889999999999999999999999999
Q ss_pred hccChhhh
Q 008303 205 VHLQPYVL 212 (570)
Q Consensus 205 p~fq~~~~ 212 (570)
+||+++..
T Consensus 301 ~~f~~~~~ 308 (345)
T cd07877 301 AYFAQYHD 308 (345)
T ss_pred hhhhhcCC
Confidence 99987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.25 Aligned_cols=205 Identities=28% Similarity=0.469 Sum_probs=169.5
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++|+||++++++|..++ ..+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+
T Consensus 65 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~ 140 (343)
T cd07880 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGII 140 (343)
T ss_pred HHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 36789999999999999886443 2468999999 7799988864 3589999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+|||++.++.+||+|||++...... .....+++.|++||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 141 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 141 HRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999875432 234567899999999876 4578999999999999999999999987
Q ss_pred cCHHHHHHHHHhccCC------------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVA------------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~------------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+...... .....++..+.++|.+||..||.+|||+.+++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6654433332221100 1123567889999999999999999999999999
Q ss_pred hccChhh
Q 008303 205 VHLQPYV 211 (570)
Q Consensus 205 p~fq~~~ 211 (570)
+||+.+.
T Consensus 299 ~~~~~~~ 305 (343)
T cd07880 299 PYFEEFH 305 (343)
T ss_pred ccHhhhc
Confidence 9998763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=283.90 Aligned_cols=203 Identities=21% Similarity=0.421 Sum_probs=170.2
Q ss_pred CHHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------------------------
Q 008303 1 MELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-------------------------------- 47 (570)
Q Consensus 1 v~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-------------------------------- 47 (570)
+++|.++. |||||+++++|...+ .+|+|||||.+|+|.+++.+...
T Consensus 91 ~~~l~~l~~H~niv~~~~~~~~~~-~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (401)
T cd05107 91 LKIMSHLGPHLNIVNLLGACTKGG-PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVS 169 (401)
T ss_pred HHHHHhcCCCCCeEEEEEEEccCC-CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchh
Confidence 36788886 999999999987654 68999999999999999975321
Q ss_pred ----------------------------------------------------------------CCCCHHHHHHHHHHHH
Q 008303 48 ----------------------------------------------------------------KLFSEEKLCKWLVQLL 63 (570)
Q Consensus 48 ----------------------------------------------------------------~~Lse~~i~~I~~QLl 63 (570)
..+++..+..|+.||+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 249 (401)
T cd05107 170 LGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVA 249 (401)
T ss_pred hhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHH
Confidence 2467788999999999
Q ss_pred HHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhh
Q 008303 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 140 (570)
Q Consensus 64 ~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~ 140 (570)
.||.|||++||+||||||+|||++.++.+||+|||+++.+.... .....+++..|+|||++.+..++.++|||||||
T Consensus 250 ~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv 329 (401)
T cd05107 250 NGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329 (401)
T ss_pred HHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHH
Confidence 99999999999999999999999999999999999998754322 122345778899999999888999999999999
Q ss_pred hHHHhhc-cCCCCcccCHHH-HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 141 CIYEMTS-LKPAFKAFDMQA-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 141 IlyeLlt-G~~pf~~~~~~~-~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++|||++ |..||......+ ....+..+.....+..++.++.+||.+||..+|.+||++.+|++.
T Consensus 330 il~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 330 LLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999997 888887655444 334444444455667789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.17 Aligned_cols=201 Identities=20% Similarity=0.430 Sum_probs=179.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||++||+.... ..+|||||+|.||+|.+++++..+ .++..+...++.+.+.||+|||+++++||||-.
T Consensus 213 rvMr~l~H~NVVr~yGVa~~~-~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAA 290 (474)
T KOG0194|consen 213 RVMRQLNHPNVVRFYGVAVLE-EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAA 290 (474)
T ss_pred HHHHhCCCCCEEEEEEEEcCC-CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhH
Confidence 589999999999999988765 479999999999999999998654 689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccc-cCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSV-VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~-~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~ 159 (570)
.|+|++.++.+||+|||+++........... --...|+|||.+...-|+.++||||+||++||++. |..||.+....+
T Consensus 291 RNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~ 370 (474)
T KOG0194|consen 291 RNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE 370 (474)
T ss_pred HHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence 9999999999999999998875422222212 23467999999999999999999999999999987 788999999999
Q ss_pred HHHHH-HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 160 LINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 160 ~~~~i-~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+..++ ..+...+.+...+.++..++.+||..+|++|+++.++.+-
T Consensus 371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 99999 6677788888999999999999999999999999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=276.68 Aligned_cols=204 Identities=26% Similarity=0.441 Sum_probs=166.2
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++|+||++++++|.... ..+|+|+||+.+ +|..++. ..++++.+..++.||+.||+|||++||+
T Consensus 65 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~ 139 (342)
T cd07879 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGII 139 (342)
T ss_pred HHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 36788999999999999886432 246899999964 7776652 3589999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+|||++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 140 H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 140 HRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred cCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998765322 234577899999999876 4588999999999999999999999988
Q ss_pred cCHHHHHHHHHhccCC------------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVA------------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~------------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+...... .....++..+.+||.+||+.||.+||++++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 7654443332221100 0112467889999999999999999999999999
Q ss_pred hccChhh
Q 008303 205 VHLQPYV 211 (570)
Q Consensus 205 p~fq~~~ 211 (570)
+||+.+.
T Consensus 298 ~~f~~~~ 304 (342)
T cd07879 298 PYFDSFR 304 (342)
T ss_pred cchhhcc
Confidence 9998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=275.05 Aligned_cols=205 Identities=29% Similarity=0.484 Sum_probs=168.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|...+...|+|+||+ +++|.++++. ..+++..+..++.||+.||.|||++||+||||+
T Consensus 60 ~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~ 135 (328)
T cd07856 60 LKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135 (328)
T ss_pred HHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 368899999999999999876666789999999 5689888864 347899999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|.|||++.++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+...
T Consensus 136 p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 136 PSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred HHHEeECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999998765332 234567889999999865 568999999999999999999999997765432
Q ss_pred HHHHHHhcc---------------------------CCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSI---------------------------VAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~---------------------------~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+.... ..+ ....++..+.++|++||..+|++||++++++.|+||..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 221111100 000 11246789999999999999999999999999999976
Q ss_pred hh
Q 008303 210 YV 211 (570)
Q Consensus 210 ~~ 211 (570)
+.
T Consensus 294 ~~ 295 (328)
T cd07856 294 YH 295 (328)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=264.07 Aligned_cols=204 Identities=24% Similarity=0.437 Sum_probs=168.2
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|+++.|+||+++++++... +.+.|+||||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+|+||
T Consensus 57 i~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl 135 (284)
T cd05038 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDL 135 (284)
T ss_pred HHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 3678999999999999987652 457899999999999999997643 35899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.++.++|+|||++........ .....++..|++||.+....++.++|||||||++|+|++|..|+...
T Consensus 136 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 136 AARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 99999999999999999999987653221 11223456799999998888999999999999999999999887543
Q ss_pred CH---------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DM---------------QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~---------------~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.. ......+......+.+..++.++.+|+.+||..+|.+||++.+|++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred cchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 21 222333333444445567889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=277.62 Aligned_cols=205 Identities=25% Similarity=0.431 Sum_probs=166.9
Q ss_pred CHHhhhc-CCC-----cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKI-RNP-----FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL-~HP-----nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
|++|.+| ++. -+|.+.++|..++ ++|||+|.+ |.+++++++.++-..|+...++.+.+||+.+++|||+.++
T Consensus 136 i~vLqki~~~DP~g~~rcv~m~~wFdyrg-hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl 213 (415)
T KOG0671|consen 136 IEVLQKINESDPNGKFRCVQMRDWFDYRG-HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKL 213 (415)
T ss_pred HHHHHHHHhcCCCCceEEEeeehhhhccC-ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcce
Confidence 4678888 332 3577777775555 899999998 5699999999888899999999999999999999999999
Q ss_pred ccceecCCcEEEcC--------------------CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCccc
Q 008303 75 LHRDVKCSNIFLTK--------------------DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSD 134 (570)
Q Consensus 75 vHrDLKP~NILld~--------------------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksD 134 (570)
+|-||||+|||+.+ +-.|+|+|||.|+.... ....++.|..|.|||++.+.+++.++|
T Consensus 214 ~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCD 291 (415)
T KOG0671|consen 214 THTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCD 291 (415)
T ss_pred eecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccC
Confidence 99999999999842 22389999999988543 346789999999999999999999999
Q ss_pred ccchhhhHHHhhccCCCCcccCHHH---HHHHHHhccCC-----------------CCCC--------------------
Q 008303 135 IWSLGCCIYEMTSLKPAFKAFDMQA---LINKINKSIVA-----------------PLPT-------------------- 174 (570)
Q Consensus 135 IWSLG~IlyeLltG~~pf~~~~~~~---~~~~i~~~~~~-----------------p~p~-------------------- 174 (570)
|||+||||+||.+|...|...+..+ +++.|...++. .++.
T Consensus 292 vWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~ 371 (415)
T KOG0671|consen 292 VWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY 371 (415)
T ss_pred ceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH
Confidence 9999999999999999998776544 33333221110 0010
Q ss_pred -----CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 175 -----KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 175 -----~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.-...+.+||++||..||.+|+|+.|+|.||||..
T Consensus 372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred hccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 01237889999999999999999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=273.93 Aligned_cols=205 Identities=27% Similarity=0.420 Sum_probs=175.8
Q ss_pred HHhhhcCCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
.+|..++|+||+.++.+|... -..+|+||||++. +|...|.. .++-+.+..|++|++.|++|||+.||+|
T Consensus 67 ~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~Iih 141 (369)
T KOG0665|consen 67 KLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIH 141 (369)
T ss_pred hhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceee
Confidence 467788999999999999632 2347999999975 99988873 2688999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||||+||++..++.+||.|||+++.-...-..+.++.|..|.|||++.+.+|...+||||+||++.||+.|.-.|.+.+
T Consensus 142 RdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 142 RDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred cccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 99999999999999999999999998776666778999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHhccCCCCCC-----------------------------------------CCcHHHHHHHHHhhccCCCCC
Q 008303 157 MQALINKINKSIVAPLPT-----------------------------------------KYSGAFRGLVKSMLRKNPELR 195 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~-----------------------------------------~~s~~l~dLI~~~L~~dP~~R 195 (570)
..++..++......+.+. .-...+++++.+||..||++|
T Consensus 222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence 766666654433332110 112468899999999999999
Q ss_pred cCHHHHHHhhccChhh
Q 008303 196 PSAAELLRHVHLQPYV 211 (570)
Q Consensus 196 PTa~eIL~hp~fq~~~ 211 (570)
.+++++|+|||++-|.
T Consensus 302 isv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 302 ISVDDALRHPYIKVWY 317 (369)
T ss_pred ccHHHHhcCCeeeeec
Confidence 9999999999998553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=250.10 Aligned_cols=205 Identities=27% Similarity=0.479 Sum_probs=176.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
-+|+.|+|.|||+++++... +..+-+|+|||+. +|..+....+ +.++.+.++.++.|++.||.|||+++++||||||
T Consensus 53 cllkelkhknivrl~dvlhs-dkkltlvfe~cdq-dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkp 129 (292)
T KOG0662|consen 53 CLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKP 129 (292)
T ss_pred HHHHHhhhcceeehhhhhcc-CceeEEeHHHhhH-HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCc
Confidence 37899999999999998754 4578999999975 9999888765 5689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhh-ccCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMT-SLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLl-tG~~pf~~~~~~ 158 (570)
+|+||+.+|.+||+|||+++.++-.. -....+-|.||.+|.++.+.+ |+...|+||.|||+.||. .|++.|.+.+..
T Consensus 130 qnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 130 QNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred ceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 99999999999999999999887543 234457799999999998765 789999999999999996 588999999999
Q ss_pred HHHHHHHhccCCCCCC----------------------------CCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAPLPT----------------------------KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~----------------------------~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
++..+|.+....+-.. .+...-++|++++|.-+|.+|++++++|+||||..
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 9988887655443211 22346789999999999999999999999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=301.63 Aligned_cols=200 Identities=25% Similarity=0.428 Sum_probs=178.0
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA-----NSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~-----~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
+|++++|||||+++|++.+.+ ..+|++|||+||||..||++. ....|+..++..++.||+.|++||+++++|||
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~-~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHR 826 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSG-PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHR 826 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCC-CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCc
Confidence 688999999999999998854 678999999999999999874 12468999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCCCCccc-cC--CCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV-VG--TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFK 153 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~-~G--T~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~ 153 (570)
||...|+||+....|||+|||+|+.+...+++... .+ ...|||||.+.++.|+.++|||||||++||+++ |..||.
T Consensus 827 DLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 827 DLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred chhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999965544332221 11 246999999999999999999999999999976 889999
Q ss_pred ccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 154 AFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
+.+..+++..+..+-..+.|..|++.+.++|.+||+.+|++||++..|++
T Consensus 907 ~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 907 SRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999998866666688889999999999999999999999999999998
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=292.01 Aligned_cols=208 Identities=29% Similarity=0.554 Sum_probs=183.2
Q ss_pred HHhhhc-CCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKI-RNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+||+.+ +|||++.++++|.- .++.+|||||||.||+.-|+++...+..+.|+.|..|++.++.||.+||.+.++|
T Consensus 67 nil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviH 146 (953)
T KOG0587|consen 67 NMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIH 146 (953)
T ss_pred HHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceee
Confidence 577777 89999999999963 3578999999999999999999887889999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-----CCCCcccccchhhhHHHhhccCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-----PYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-----~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
||||-.|||++.+|.|||+|||++..++... ...+.+||+.|||||++... .|+..+|+||||++..||..|.+
T Consensus 147 RDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 147 RDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred ecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 9999999999999999999999999887654 34567999999999999643 47889999999999999999999
Q ss_pred CCcccCHHHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 151 AFKAFDMQALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
|+-.+-....+..|....... -|..|+..+.+||..||.+|..+||+..++|+|||+..
T Consensus 227 Pl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 998777666555554443322 25689999999999999999999999999999999863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=272.91 Aligned_cols=198 Identities=27% Similarity=0.529 Sum_probs=179.1
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+-|+++.++.+|. ..+.+|+|||||.||+|...|++.+. |.|..+..++..|+-||-|||++||++||||..|||++
T Consensus 408 kppFL~qlHScFQ-TmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd 484 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQ-TMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 484 (683)
T ss_pred CCchHHHHHHHhh-hhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec
Confidence 6789999998775 45589999999999999999998754 89999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHh
Q 008303 88 KDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK 166 (570)
Q Consensus 88 ~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~ 166 (570)
.+|.|||.|||+.+.-- ......+.||||.|+|||++..++|+..+|.|++|++||||+.|++||++.+.++++..|..
T Consensus 485 ~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 485 SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred cCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 99999999999998643 33456678999999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccCh
Q 008303 167 SIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQP 209 (570)
Q Consensus 167 ~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~ 209 (570)
.... .|..+|.++.++++..|.+.|.+|.- -.+|-.|+||+.
T Consensus 565 hnvs-yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 565 HNVS-YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ccCc-CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 6543 68889999999999999999999974 358889999974
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=297.67 Aligned_cols=203 Identities=21% Similarity=0.320 Sum_probs=163.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN---------SKLFSEEKLCKWLVQLLMALDYLHA 71 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~---------~~~Lse~~i~~I~~QLl~aL~yLHs 71 (570)
++++++++||||+++++++.++ +..|+|||||+||+|.+++.... ...++...+..++.||+.||+|||+
T Consensus 53 i~ILs~L~HPNIVkl~~v~~d~-~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs 131 (932)
T PRK13184 53 AKIAADLIHPGIVPVYSICSDG-DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS 131 (932)
T ss_pred HHHHHhCCCcCcCeEEEEEeeC-CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH
Confidence 3678899999999999988654 57899999999999999987421 1235667889999999999999999
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCceeccCC-------------------CCCccccCCCCCCCcccccCCCCCCc
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-------------------DLASSVVGTPSYMCPELLADIPYGSK 132 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-------------------~~~~~~~GT~~Y~APE~l~~~~~t~k 132 (570)
+||+||||||+|||++.+|.+||+|||+++..... ......+||+.|+|||++.+..++.+
T Consensus 132 ~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k 211 (932)
T PRK13184 132 KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES 211 (932)
T ss_pred CCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence 99999999999999999999999999999876211 01123579999999999999999999
Q ss_pred ccccchhhhHHHhhccCCCCcccCHHHHHHHHHhcc--CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 133 SDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI--VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 133 sDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~--~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+|||||||++|+|++|+.||...+............ .......++..+.+++.+||..||++|++..+.+.+
T Consensus 212 SDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 212 TDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999998755443322211111 111124678999999999999999999876665544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=258.82 Aligned_cols=206 Identities=28% Similarity=0.455 Sum_probs=171.3
Q ss_pred CHHhhhcCCCcccccceEEEe-------eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKIRNPFIVEYKDSWVE-------RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-------~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
|+||..|+|+||+.++++|.. +...+|+||.+|+. +|.-++... ...|+..+|.+++.+++.||.|+|.+.
T Consensus 67 ikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k 144 (376)
T KOG0669|consen 67 IKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK 144 (376)
T ss_pred HHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 578999999999999998842 12348999999986 898888654 356999999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCC-----CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhc
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-----DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLlt 147 (570)
|+|||+|+.|+||+.+|.+||+|||+++.+... ...+..+-|.+|.+||.+.+ ..|+.+.|||..|||+.||++
T Consensus 145 ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt 224 (376)
T KOG0669|consen 145 ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT 224 (376)
T ss_pred HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence 999999999999999999999999999776432 22445677999999999875 468999999999999999999
Q ss_pred cCCCCcccCHHHHHHHHHhccCCC---------------------CCC-------------CCcHHHHHHHHHhhccCCC
Q 008303 148 LKPAFKAFDMQALINKINKSIVAP---------------------LPT-------------KYSGAFRGLVKSMLRKNPE 193 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~~p---------------------~p~-------------~~s~~l~dLI~~~L~~dP~ 193 (570)
+.+.|.+...+..+..|..-.... ++. .-.++..+|+.+||..||.
T Consensus 225 rspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~ 304 (376)
T KOG0669|consen 225 RSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT 304 (376)
T ss_pred cCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc
Confidence 999999998887766654322111 110 1134788999999999999
Q ss_pred CCcCHHHHHHhhccC
Q 008303 194 LRPSAAELLRHVHLQ 208 (570)
Q Consensus 194 ~RPTa~eIL~hp~fq 208 (570)
+|++++++|+|.||-
T Consensus 305 kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 305 KRIDADQALNHDFFW 319 (376)
T ss_pred cCcchHhhhchhhhh
Confidence 999999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=292.37 Aligned_cols=97 Identities=33% Similarity=0.613 Sum_probs=88.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+.++|+||+++++++.. ..++|||||||.|++|.++|... ..+++..++.|+.||+.||.|||.+||+||||||
T Consensus 56 ~~l~~l~hp~Iv~~~~~~~~-~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP 132 (669)
T cd05610 56 DALALSKSPFIVHLYYSLQS-ANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP 132 (669)
T ss_pred HHHHhcCCCCcCeEEEEEEE-CCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccH
Confidence 56788899999999988765 45899999999999999999764 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCce
Q 008303 82 SNIFLTKDQDIRLGDFGLAK 101 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~ 101 (570)
+||||+.++.+||+|||+++
T Consensus 133 ~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 133 DNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=281.89 Aligned_cols=199 Identities=24% Similarity=0.451 Sum_probs=181.7
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
||++++|||||+++|++.+. .+|||||+|..|.|..+++.+. ..|+...+..+.+||+.||.|||+.++|||||...
T Consensus 444 iMrnfdHphIikLIGv~~e~--P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaR 520 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQ--PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAAR 520 (974)
T ss_pred HHHhCCCcchhheeeeeecc--ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhh
Confidence 78999999999999999754 5899999999999999999764 46899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceeccCCCCCccccCC--CCCCCcccccCCCCCCcccccchhhhHHHhh-ccCCCCcccCHHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT--PSYMCPELLADIPYGSKSDIWSLGCCIYEMT-SLKPAFKAFDMQA 159 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT--~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl-tG~~pf~~~~~~~ 159 (570)
|||+.....|||+|||+++.+.....+..-.|- .-|||||.++-..++.++|||.||+++||++ .|..||.+....+
T Consensus 521 NiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 521 NILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred heeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 999999999999999999998876655444443 4599999999999999999999999999975 5889999998889
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++..+.++...|+|..|++.+..|+.+||.++|.+||++.+|...
T Consensus 601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 999999999999999999999999999999999999999998754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=293.87 Aligned_cols=202 Identities=28% Similarity=0.487 Sum_probs=173.9
Q ss_pred hhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCc
Q 008303 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSN 83 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~N 83 (570)
|---+.+-|+.++-.|.+ +.++|+||||+.||+|..++.+.. .++++.++.++..|+.||.-||+.|+|||||||+|
T Consensus 129 mv~~ns~Wiv~LhyAFQD-~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDN 205 (1317)
T KOG0612|consen 129 MVFGNSEWIVQLHYAFQD-ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDN 205 (1317)
T ss_pred HHcCCcHHHHHHHHHhcC-ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcce
Confidence 333356678888877755 558999999999999999999875 69999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCccccc----C-CCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 84 IFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLA----D-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 84 ILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~----~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
||||..|.|||+|||.+.....+. .....+|||.|.+||++. + +.|+..+|.|||||++|||+.|..||....
T Consensus 206 vLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 206 VLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred eEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 999999999999999987766433 345679999999999995 3 468999999999999999999999999998
Q ss_pred HHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhccCCCCCcC---HHHHHHhhccCh
Q 008303 157 MQALINKINKS---IVAPLPTKYSGAFRGLVKSMLRKNPELRPS---AAELLRHVHLQP 209 (570)
Q Consensus 157 ~~~~~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT---a~eIL~hp~fq~ 209 (570)
..+.+.+|... +..|-...+|.++++||+++++ +++.|.. +++|.+||||..
T Consensus 286 lveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 286 LVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 88888888654 2223235799999999999887 4678887 999999999974
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=259.24 Aligned_cols=196 Identities=19% Similarity=0.279 Sum_probs=157.1
Q ss_pred hhhcCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 4 ISKIRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+..+.|+||+.+++++.... .+.++++|++. .++.++++.. ..+++..+..|+.||+.||.|||++||+|||||
T Consensus 77 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiK 153 (294)
T PHA02882 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIK 153 (294)
T ss_pred hccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 44568999999998765432 24578889885 4777777653 236889999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|+|||++.++.++|+|||+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 154 p~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~ 233 (294)
T PHA02882 154 PENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233 (294)
T ss_pred HHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999998764221 122357999999999999999999999999999999999999999
Q ss_pred cccCH-HHH--------HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 153 KAFDM-QAL--------INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 153 ~~~~~-~~~--------~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..... ... ...+..... ....++.++.++++.||..+|++||++++|++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 234 KGFGHNGNLIHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred CccccchHHHHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 87632 222 222222111 234568999999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=280.38 Aligned_cols=201 Identities=26% Similarity=0.502 Sum_probs=171.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|.+|++=+|.||+-+.|+|...+ + .||+-+|+|-+|..+|+... ..|......+|++||+.|+.|||.++|||||||
T Consensus 439 Va~lkkTRH~NIlLFMG~~~~p~-~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLK 515 (678)
T KOG0193|consen 439 VAVLKKTRHENILLFMGACMNPP-L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLK 515 (678)
T ss_pred HHHHhhcchhhheeeehhhcCCc-e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcc
Confidence 46788999999999999986554 3 89999999999999997643 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc---CCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT---SDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~---~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
..|||+.+++.|||+|||++..-. .......-.|...|||||++. ..+|++.+|||+||||+|||++|..||..
T Consensus 516 SnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 516 SNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred ccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 999999999999999999997643 223334456778899999995 44689999999999999999999999997
Q ss_pred cCHHHHHHHHHhccCCC----CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVAP----LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p----~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
...+.++..+-.+...+ ....++.++++|+..||.+++++||.+.+||..
T Consensus 596 ~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 596 QNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred CChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHH
Confidence 77776666665553333 234678899999999999999999999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=282.00 Aligned_cols=202 Identities=23% Similarity=0.430 Sum_probs=183.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.||-+..||||++|.|+. .+..-++||+|||++|+|..|++++.++ |...++.-+++.|+.|++||-+.|+|||||..
T Consensus 682 sIMGQFdHPNIIrLEGVV-Tks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAA 759 (996)
T KOG0196|consen 682 SIMGQFDHPNIIRLEGVV-TKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAA 759 (996)
T ss_pred hhcccCCCCcEEEEEEEE-ecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhh
Confidence 378899999999999986 4566899999999999999999998755 99999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC-Ccccc-C--CCCCCCcccccCCCCCCcccccchhhhHHHhh-ccCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVV-G--TPSYMCPELLADIPYGSKSDIWSLGCCIYEMT-SLKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~-G--T~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl-tG~~pf~~~~ 156 (570)
.|||++.+-.+|++|||+++.+.++.. ..+.. | ..+|.|||.+...+++.++||||+|++|||.+ .|..||..+.
T Consensus 760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 999999999999999999998865541 11111 1 36799999999999999999999999999965 5999999999
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+++++.|..+...|.|.+++..+..|+..||++|-.+||.+.||+.++
T Consensus 840 NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 840 NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=272.82 Aligned_cols=206 Identities=28% Similarity=0.484 Sum_probs=170.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+||..-+++-||+||-.|.+++ .+|+||||+.||+|..+|-+. +.|.|+.++.++..|..||++.|+.|+|||||||
T Consensus 681 DILAEADn~WVVrLyySFQDkd-nLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKP 757 (1034)
T KOG0608|consen 681 DILAEADNEWVVRLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 757 (1034)
T ss_pred hhHhhcCCcceEEEEEEeccCC-ceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCc
Confidence 5778888999999998887766 699999999999999998775 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceecc--C-------CC----------------------------------CCccccCCCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILT--S-------DD----------------------------------LASSVVGTPSY 118 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~--~-------~~----------------------------------~~~~~~GT~~Y 118 (570)
+|||||.+|.|||.|||+++-+. . .. .....+||+.|
T Consensus 758 DNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~ny 837 (1034)
T KOG0608|consen 758 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNY 837 (1034)
T ss_pred cceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcc
Confidence 99999999999999999986431 0 00 01236899999
Q ss_pred CCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH-HHHHHhc--cCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 008303 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL-INKINKS--IVAPLPTKYSGAFRGLVKSMLRKNPELR 195 (570)
Q Consensus 119 ~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~-~~~i~~~--~~~p~p~~~s~~l~dLI~~~L~~dP~~R 195 (570)
+|||++...+|+.-+|.|+.|+|||||+.|++||......+. ...+++. +..+...+++.++.+||.++.+ +++.|
T Consensus 838 iapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~R 916 (1034)
T KOG0608|consen 838 IAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSR 916 (1034)
T ss_pred cChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhh
Confidence 999999999999999999999999999999999987665443 2223333 3333456789999999998654 46667
Q ss_pred c---CHHHHHHhhccChhh
Q 008303 196 P---SAAELLRHVHLQPYV 211 (570)
Q Consensus 196 P---Ta~eIL~hp~fq~~~ 211 (570)
. -++++-.||||+.+-
T Consensus 917 LGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 917 LGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hcccchhhhhcCccccccc
Confidence 6 467799999998643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=262.75 Aligned_cols=208 Identities=29% Similarity=0.449 Sum_probs=174.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--Cccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN--HILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~--gIvHrDL 79 (570)
+|-+.|+||.||++||+|.-+.+.+|-|+|||+|.+|.-+++++ +.++|.+++.|+.||+.||.||.+. -|||.||
T Consensus 519 rIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDL 596 (775)
T KOG1151|consen 519 RIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDL 596 (775)
T ss_pred hhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeecc
Confidence 45677899999999999988888999999999999999999986 4599999999999999999999987 4999999
Q ss_pred cCCcEEEcC---CCCEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCC----CCCCcccccchhhhHHH
Q 008303 80 KCSNIFLTK---DQDIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADI----PYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 80 KP~NILld~---~g~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~----~~t~ksDIWSLG~Ilye 144 (570)
||.|||+.. -|.|||.|||++++...+. +.....||.||++||.+.-+ +.+.++||||+|||+|.
T Consensus 597 KPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 597 KPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred CCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 999999854 4679999999999876432 34557899999999998533 36889999999999999
Q ss_pred hhccCCCCcccCHH-HHH--HHHHhc--cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 145 MTSLKPAFKAFDMQ-ALI--NKINKS--IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 145 LltG~~pf~~~~~~-~~~--~~i~~~--~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
++.|+.||...-.+ +++ +.|.+. ...|.-..++.++++||++||.+.-++|....++-.||||.+.+
T Consensus 677 ClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 99999999865433 222 222222 22333457899999999999999999999999999999998754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=270.09 Aligned_cols=201 Identities=22% Similarity=0.408 Sum_probs=183.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.||+.|+|||+|+|+|+|.... .+|||+|||..|+|.+|++..+...++.-.+..++.||..|+.||..+++|||||..
T Consensus 315 AvMKeikHpNLVqLLGVCT~Ep-PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAA 393 (1157)
T KOG4278|consen 315 AVMKEIKHPNLVQLLGVCTHEP-PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAA 393 (1157)
T ss_pred HHHHhhcCccHHHHhhhhccCC-CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence 5899999999999999997655 689999999999999999998888889999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccC---CCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG---TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~G---T~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
.|+|+.++..|||+|||+++....+.+. ...| ..-|.|||-+....++.++|||+||++|||+.+ |-.||.+.+.
T Consensus 394 RNCLVgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 394 RNCLVGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred hhccccccceEEeeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 9999999999999999999987655432 2223 456999999999999999999999999999965 7789999999
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..++..+.+++....|..|++.+..|++.||+++|.+||++.||-+.
T Consensus 473 SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQA 519 (1157)
T ss_pred HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHH
Confidence 99999999999999999999999999999999999999999998654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=274.93 Aligned_cols=203 Identities=20% Similarity=0.409 Sum_probs=184.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|.+|+|+|+|+|||+..+ ..+.+|||+|.+|+|.+.+.+.....|....++.++.||+.|+.||..+++|||||..
T Consensus 163 s~M~~L~H~hliRLyGvVl~--qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAA 240 (1039)
T KOG0199|consen 163 SHMLKLQHPHLIRLYGVVLD--QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAA 240 (1039)
T ss_pred HHHHhccCcceeEEeeeecc--chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 57899999999999998864 4688999999999999999987777899999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccc----cCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSV----VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~----~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
.|||+.....|||+|||+.+-++..+-.... --...|+|||.+....++.++|||++||.||||++ |..||.+..
T Consensus 241 RNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 241 RNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred hhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 9999999999999999999988765433322 22456999999999999999999999999999986 789999999
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
...++++|..+...+.|..|+.++.++++.||..+|.+|||+..|....+
T Consensus 321 g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 321 GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 99999999988888999999999999999999999999999999975544
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=247.51 Aligned_cols=204 Identities=26% Similarity=0.418 Sum_probs=160.9
Q ss_pred HHhhhcCCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 008303 2 ELISKIRNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANH-- 73 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~g-- 73 (570)
+.-++++||||++++++... ..+..||++.|...|+|.+.|+.. .+..++|.++..|+.+|++||++||+..
T Consensus 70 d~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~ 149 (302)
T KOG2345|consen 70 DNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPP 149 (302)
T ss_pred HHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCc
Confidence 45677899999999998752 235689999999999999999753 3457999999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCCC----------CccccCCCCCCCcccccCC---CCCCcccccchhh
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL----------ASSVVGTPSYMCPELLADI---PYGSKSDIWSLGC 140 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~----------~~~~~GT~~Y~APE~l~~~---~~t~ksDIWSLG~ 140 (570)
++||||||.|||+.+.+.++|.|||.++...-.-. -.....|..|.|||++.-. ..++++|||||||
T Consensus 150 yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGC 229 (302)
T KOG2345|consen 150 YAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGC 229 (302)
T ss_pred ccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhH
Confidence 99999999999999999999999999875421100 0113458899999999643 4689999999999
Q ss_pred hHHHhhccCCCCcccCHHH--HHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 141 CIYEMTSLKPAFKAFDMQA--LINKINK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 141 IlyeLltG~~pf~~~~~~~--~~~~i~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
++|+|+.|..||...-.+. +.-.+.. ....|-...++..+.+||++||+.||.+||++.+++.+.
T Consensus 230 tLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 230 TLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred HHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 9999999999996422110 0000111 112223345999999999999999999999999999873
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=292.95 Aligned_cols=203 Identities=12% Similarity=0.141 Sum_probs=152.6
Q ss_pred hhhcCC-CcccccceEEEe------eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 4 ISKIRN-PFIVEYKDSWVE------RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 4 L~kL~H-PnIV~l~~~f~~------~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
.+.+.| .||++++|+|.. ....++++|||+ +++|.++|... ...+++..++.|++||+.||.|||++||+|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvH 103 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVV 103 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 456777 799999998821 123467888987 56999999753 345999999999999999999999999999
Q ss_pred ceecCCcEEEcCC-------------------CCEEEeecCCceeccCCC-----------------CCccccCCCCCCC
Q 008303 77 RDVKCSNIFLTKD-------------------QDIRLGDFGLAKILTSDD-----------------LASSVVGTPSYMC 120 (570)
Q Consensus 77 rDLKP~NILld~~-------------------g~vKL~DFGla~~~~~~~-----------------~~~~~~GT~~Y~A 120 (570)
|||||+||||+.. +.+||+|||+++...... .....+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999653 445666666665321100 0112468999999
Q ss_pred cccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHH
Q 008303 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE 200 (570)
Q Consensus 121 PE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~e 200 (570)
||++.+..|+.++|||||||++|||++|.+++.... ..+..+......+..........+++.+||.++|.+||++.|
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 999999999999999999999999999988865322 222222222222111122456778999999999999999999
Q ss_pred HHHhhccChh
Q 008303 201 LLRHVHLQPY 210 (570)
Q Consensus 201 IL~hp~fq~~ 210 (570)
||+|+||...
T Consensus 262 il~h~~~~~~ 271 (793)
T PLN00181 262 LLQSEFINEP 271 (793)
T ss_pred Hhhchhhhhh
Confidence 9999999753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=266.18 Aligned_cols=203 Identities=21% Similarity=0.377 Sum_probs=175.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
|++|.+|+|||||+|+|+|..++ .+|+|+||+++|+|..|+.++....+.-.....|+.||+.|++||.+.++|||||.
T Consensus 586 IkiLsqLkhPNIveLvGVC~~De-PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a 664 (807)
T KOG1094|consen 586 IKILSRLKHPNIVELLGVCVQDD-PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLA 664 (807)
T ss_pred HHHHhccCCCCeeEEEeeeecCC-chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhcccc
Confidence 57899999999999999998765 79999999999999999998754334556677799999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCc---cccCCCCCCCcccccCCCCCCcccccchhhhHHHh--hccCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLAS---SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM--TSLKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~---~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL--ltG~~pf~~~ 155 (570)
+.|||++.++++||+|||+++.+...+... ..+=...|||+|.+..++++.++|+|++|+.+||+ ++...||...
T Consensus 665 ~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 665 TRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred ccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 999999999999999999999876554332 23446789999999999999999999999999997 4677899988
Q ss_pred CHHHHHHHHHhcc-------CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALINKINKSI-------VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~~~i~~~~-------~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..+++.+....-. +...|..++..+.++|-+||..+-.+||+++++..+
T Consensus 745 t~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 745 TDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred hHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 8888777664432 334677899999999999999999999999999765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=273.05 Aligned_cols=203 Identities=27% Similarity=0.398 Sum_probs=157.8
Q ss_pred Hhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 3 LISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 3 IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
.|+.- +|||||++|+.- .+.++.||..|+|.+ +|.++|+.. ..........+.++.|++.||++||+.+||||||
T Consensus 555 lL~eSD~H~NviRyyc~E-~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDL 632 (903)
T KOG1027|consen 555 LLQESDEHPNVIRYYCSE-QDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDL 632 (903)
T ss_pred HHHhccCCCceEEEEeec-cCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccC
Confidence 34444 899999999764 445689999999976 999999874 1111122456788999999999999999999999
Q ss_pred cCCcEEEcC---CC--CEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhcc-C
Q 008303 80 KCSNIFLTK---DQ--DIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-K 149 (570)
Q Consensus 80 KP~NILld~---~g--~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG-~ 149 (570)
||+||||+. ++ .++|+|||+++.+..+. ......||-+|+|||++....-+.++||||||||+|+.++| .
T Consensus 633 kPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~ 712 (903)
T KOG1027|consen 633 KPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGS 712 (903)
T ss_pred CCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCc
Confidence 999999986 34 58999999999986543 24456899999999999988888899999999999987765 7
Q ss_pred CCCcccCHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 150 PAFKAFDMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.||...-. ...+|..+... .+...-..++.+||.+||+++|..||+|.++|.||+|=.
T Consensus 713 HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 713 HPFGDSLE--RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred cCCCchHH--hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 88875332 22233332221 111112229999999999999999999999999998843
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=248.75 Aligned_cols=207 Identities=27% Similarity=0.419 Sum_probs=169.2
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccce
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK---KANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRD 78 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~---~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrD 78 (570)
+++.-+.||||++||..+.+| ..||.||+++- +|..+-+ ......++|..+-+|..-.+.||.||.+. +|+|||
T Consensus 116 ~mks~~cp~IVkfyGa~F~EG-dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRD 193 (361)
T KOG1006|consen 116 VMKSSNCPNIVKFYGALFSEG-DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRD 193 (361)
T ss_pred HHhhcCCcHHHHHhhhhhcCC-ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhcc
Confidence 345557899999999988766 46899999964 7665533 22335699999999999999999999975 899999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc--CCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
+||+|||++..|.|||||||++..+......+...|-..|||||.+. +.+|+.++||||||+.|||+.+|+.||..++
T Consensus 194 vKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 194 VKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred CChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 99999999999999999999998877665566678899999999995 4469999999999999999999999998876
Q ss_pred H-HHHHHHHHhccCCCC--C---CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 157 M-QALINKINKSIVAPL--P---TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 157 ~-~~~~~~i~~~~~~p~--p---~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
. -+++..+..+....+ + ..++..+..+|+-||.+|-..||.+.++++++|++-|.
T Consensus 274 svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 274 SVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 4 223333333332221 1 24789999999999999999999999999999987664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=269.58 Aligned_cols=188 Identities=22% Similarity=0.257 Sum_probs=137.1
Q ss_pred eCcEEEEEEeccCCCCHHHHHHHhCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCc
Q 008303 22 RGCYVCIIIGFCEGGDMAEAIKKANSK------------------LFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSN 83 (570)
Q Consensus 22 ~~~~i~IV~Ey~~gGsL~d~I~~~~~~------------------~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~N 83 (570)
.+..+||||||+.+++|.+++...... ...+..+..|+.||+.||.|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 345789999999999999998753211 11234577899999999999999999999999999
Q ss_pred EEEcC-CCCEEEeecCCceeccCC--CCCccccCCCCCCCcccccCC----------------------CCCCcccccch
Q 008303 84 IFLTK-DQDIRLGDFGLAKILTSD--DLASSVVGTPSYMCPELLADI----------------------PYGSKSDIWSL 138 (570)
Q Consensus 84 ILld~-~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APE~l~~~----------------------~~t~ksDIWSL 138 (570)
||++. ++.+||+|||+++.+... ......++++.|+|||++... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 578999999999865432 234567899999999976422 24456799999
Q ss_pred hhhHHHhhccCCCCcccCHHHHHHHHHhc----------cCCC----------CCCCCcHHHHHHHHHhhccCCCCCcCH
Q 008303 139 GCCIYEMTSLKPAFKAFDMQALINKINKS----------IVAP----------LPTKYSGAFRGLVKSMLRKNPELRPSA 198 (570)
Q Consensus 139 G~IlyeLltG~~pf~~~~~~~~~~~i~~~----------~~~p----------~p~~~s~~l~dLI~~~L~~dP~~RPTa 198 (570)
||++|||+++..++... .......+... .... ..........+||.+||.+||.+|||+
T Consensus 366 GviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 99999999866554321 11111111100 0000 011123345689999999999999999
Q ss_pred HHHHHhhccChh
Q 008303 199 AELLRHVHLQPY 210 (570)
Q Consensus 199 ~eIL~hp~fq~~ 210 (570)
.++|+||||+..
T Consensus 445 ~e~L~Hpff~~~ 456 (566)
T PLN03225 445 KAALAHPYFDRE 456 (566)
T ss_pred HHHhCCcCcCCC
Confidence 999999999764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=269.45 Aligned_cols=155 Identities=32% Similarity=0.556 Sum_probs=136.5
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKA-NSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~-~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
++||+||+|+|||+++|+-.+.. ..-.+|||||.||+|...+++- +...|++.++..++..++.||.|||++||
T Consensus 62 ieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~I 141 (732)
T KOG4250|consen 62 IEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGI 141 (732)
T ss_pred HHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 58999999999999999754322 1236999999999999999752 23569999999999999999999999999
Q ss_pred ccceecCCcEEEcC--CC--CEEEeecCCceeccCCCCCccccCCCCCCCccccc-CCCCCCcccccchhhhHHHhhccC
Q 008303 75 LHRDVKCSNIFLTK--DQ--DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 75 vHrDLKP~NILld~--~g--~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIWSLG~IlyeLltG~ 149 (570)
+||||||.||++-. +| ..||+|||+|+.+..+....+.+||+.|++||++. ...|+..+|.|||||++|++++|.
T Consensus 142 vHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 142 VHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE 221 (732)
T ss_pred eeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence 99999999998843 34 37999999999999999999999999999999998 478899999999999999999999
Q ss_pred CCCccc
Q 008303 150 PAFKAF 155 (570)
Q Consensus 150 ~pf~~~ 155 (570)
.||..+
T Consensus 222 lPF~p~ 227 (732)
T KOG4250|consen 222 LPFIPF 227 (732)
T ss_pred CCCCcC
Confidence 998543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=269.22 Aligned_cols=203 Identities=25% Similarity=0.474 Sum_probs=177.6
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC------C--------CCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN------S--------KLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~------~--------~~Lse~~i~~I~~QLl~a 65 (570)
+++|+.+ +|+||+.++|++.. .+.+++|+|||..|+|.+++++.. . ..++..+++.+++||+.|
T Consensus 352 l~~m~~~g~H~niv~llG~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~G 430 (609)
T KOG0200|consen 352 LNVLKELGKHPNIVNLLGACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANG 430 (609)
T ss_pred HHHHHHhcCCcchhhheeeecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHH
Confidence 4678888 89999999999877 558999999999999999998754 0 138999999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCcc--ccC--CCCCCCcccccCCCCCCcccccchhhh
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS--VVG--TPSYMCPELLADIPYGSKSDIWSLGCC 141 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~--~~G--T~~Y~APE~l~~~~~t~ksDIWSLG~I 141 (570)
++||++.++|||||-..|||+..+..+||+|||+++.......... -.| ...|||||.+.+..|+.++||||+|++
T Consensus 431 Me~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 431 MEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGIL 510 (609)
T ss_pred HHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHH
Confidence 9999999999999999999999999999999999997655443321 222 234999999999999999999999999
Q ss_pred HHHhhc-cCCCCcccC-HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 142 IYEMTS-LKPAFKAFD-MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 142 lyeLlt-G~~pf~~~~-~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+|||++ |..||.+.. ..++.+.+..+.....|..++.++.++++.||+.+|++||++.++.+.
T Consensus 511 L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 511 LWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred HHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 999976 778898865 677788888888888999999999999999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=261.00 Aligned_cols=206 Identities=22% Similarity=0.424 Sum_probs=168.6
Q ss_pred CHHhhhcC------CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKIR------NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL~------HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
|+||++|+ --|+++|+..|...+ ++|||+|-+. .+|.+.+++.+. ..|....+..++.||+.||..|...|
T Consensus 479 leiLkKL~~AD~Edk~Hclrl~r~F~hkn-HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~ 556 (752)
T KOG0670|consen 479 LEILKKLNDADPEDKFHCLRLFRHFKHKN-HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG 556 (752)
T ss_pred HHHHHHhhccCchhhhHHHHHHHHhhhcc-eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC
Confidence 57899984 248899999997765 8999999996 599999998653 46889999999999999999999999
Q ss_pred cccceecCCcEEEcCC-CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC
Q 008303 74 ILHRDVKCSNIFLTKD-QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 74 IvHrDLKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|+|.||||.|||++.. ..+||||||.|........+ .+.-+..|.|||++.+.+|+...|+||+||+||||.+|+..|
T Consensus 557 vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 557 VLHADIKPDNILVNESKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred eeecccCccceEeccCcceeeeccCcccccccccccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 9999999999999975 46899999999988776654 445578899999999999999999999999999999999999
Q ss_pred cccCHHHHHHHHHh--ccCC----------------C-----------------------CC-----------CCC----
Q 008303 153 KAFDMQALINKINK--SIVA----------------P-----------------------LP-----------TKY---- 176 (570)
Q Consensus 153 ~~~~~~~~~~~i~~--~~~~----------------p-----------------------~p-----------~~~---- 176 (570)
.+.+...++..... +.+. . .| ..+
T Consensus 636 pG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq 715 (752)
T KOG0670|consen 636 PGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ 715 (752)
T ss_pred CCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence 88765443322110 0000 0 00 001
Q ss_pred ---cHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 177 ---SGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 177 ---s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
-..+++|+.+||..||.+|.|..++|.||||+.
T Consensus 716 ~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 716 PKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 137889999999999999999999999999973
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=246.03 Aligned_cols=199 Identities=26% Similarity=0.512 Sum_probs=172.9
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+||++|-++.+|.... .+++|.||++||+|.-.+++.. .|+|+.++.+...|+.||.|||++||++||||..|+|++
T Consensus 309 n~pflvglhscfqtes-rlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 309 NNPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred CCCeEEehhhhhcccc-eEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 8999999999886544 7899999999999988887643 499999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCceec-cCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc-------cCHHH
Q 008303 88 KDQDIRLGDFGLAKIL-TSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA-------FDMQA 159 (570)
Q Consensus 88 ~~g~vKL~DFGla~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~-------~~~~~ 159 (570)
..|.+||.|+|+.+.. ...+...++||||.|.|||++.+..|+..+|.|+||++++||+.|+.||+- .+.++
T Consensus 386 aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted 465 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED 465 (593)
T ss_pred cCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH
Confidence 9999999999999864 456778899999999999999999999999999999999999999999953 22334
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc------CHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP------SAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP------Ta~eIL~hp~fq~ 209 (570)
....+.-...-.+|..++-....+++..|++||.+|. -+.++-.|+||+.
T Consensus 466 ylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 466 YLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred HHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 4434433344457788899999999999999999996 4788999999973
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=237.28 Aligned_cols=207 Identities=27% Similarity=0.422 Sum_probs=169.5
Q ss_pred CHHhhhc-CCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKI-RNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
|.||..| .||||+.++++..+. ...-.+|+||+++.+...+-.. |+.-.|..++.||+.||.|||++||+|||
T Consensus 83 ikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRD 157 (338)
T KOG0668|consen 83 IKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRD 157 (338)
T ss_pred HHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCccccc
Confidence 4688999 499999999988653 2345699999999888776543 78889999999999999999999999999
Q ss_pred ecCCcEEEcCC-CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCC-Cccc
Q 008303 79 VKCSNIFLTKD-QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPA-FKAF 155 (570)
Q Consensus 79 LKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~p-f~~~ 155 (570)
+||.|+||+.. -.++|+|+|+|.+.-...-....+.+..|--||++.+.+ |+...|+|||||++..|+..+.| |.+.
T Consensus 158 VKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 158 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 99999999975 469999999999887777677788899999999998765 79999999999999999776654 5666
Q ss_pred CHHHHHHHHHhccCCC------------C------------------------CCCCcHHHHHHHHHhhccCCCCCcCHH
Q 008303 156 DMQALINKINKSIVAP------------L------------------------PTKYSGAFRGLVKSMLRKNPELRPSAA 199 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p------------~------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~ 199 (570)
+..++..+|.+..... + ..-+++++.||+.++|.+|..+|+|+.
T Consensus 238 dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 238 DNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred CCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence 6555554443321110 0 012468999999999999999999999
Q ss_pred HHHHhhccChhhh
Q 008303 200 ELLRHVHLQPYVL 212 (570)
Q Consensus 200 eIL~hp~fq~~~~ 212 (570)
|+|.||||.+...
T Consensus 318 Eam~HpyF~~~~~ 330 (338)
T KOG0668|consen 318 EAMAHPYFAPVRE 330 (338)
T ss_pred HHhcCchHHHHHH
Confidence 9999999987654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=273.95 Aligned_cols=186 Identities=31% Similarity=0.559 Sum_probs=147.4
Q ss_pred EeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCC
Q 008303 20 VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL 99 (570)
Q Consensus 20 ~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGl 99 (570)
......+||=||||+...|.++|+.+.... ....+|++++||++||.|+|++|||||||||.|||++.++.|||+|||+
T Consensus 665 ~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 665 VQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGL 743 (1351)
T ss_pred cccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeeccccc
Confidence 344568999999999988888887654211 4788999999999999999999999999999999999999999999999
Q ss_pred ceecc-------------------CCCCCccccCCCCCCCcccccCCC---CCCcccccchhhhHHHhhccCCCCc-ccC
Q 008303 100 AKILT-------------------SDDLASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCIYEMTSLKPAFK-AFD 156 (570)
Q Consensus 100 a~~~~-------------------~~~~~~~~~GT~~Y~APE~l~~~~---~t~ksDIWSLG~IlyeLltG~~pf~-~~~ 156 (570)
|+... .....+..+||.-|+|||++.+.. |+.|+||||||+|++||+. ||. .++
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME 820 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME 820 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence 98721 011245679999999999997665 9999999999999999983 353 333
Q ss_pred HHHHHHHHHhccCCCC---CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 157 MQALINKINKSIVAPL---PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~---p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+..+.++..+.. +..--+.-..+|++||+.||.+||||.|+|++-||.+
T Consensus 821 Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 821 RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 3444555554433222 2223355678999999999999999999999999873
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=258.99 Aligned_cols=207 Identities=20% Similarity=0.211 Sum_probs=151.0
Q ss_pred HhhhcCCCc-----ccccceEEEee-------CcEEEEEEeccCCCCHHHHHHHhCC----------------------C
Q 008303 3 LISKIRNPF-----IVEYKDSWVER-------GCYVCIIIGFCEGGDMAEAIKKANS----------------------K 48 (570)
Q Consensus 3 IL~kL~HPn-----IV~l~~~f~~~-------~~~i~IV~Ey~~gGsL~d~I~~~~~----------------------~ 48 (570)
++.+++|.+ +++++++|... ....|+||||+.+++|.++++...+ .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 344555554 46777777531 2357899999999999999864211 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCcc--ccCCCCCCCcccccC
Q 008303 49 LFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS--VVGTPSYMCPELLAD 126 (570)
Q Consensus 49 ~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~--~~GT~~Y~APE~l~~ 126 (570)
.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........... ..+++.|+|||++..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 245678999999999999999999999999999999999999999999999976543322222 234789999999853
Q ss_pred CC--------------------C--CCcccccchhhhHHHhhccCC-CCcccCHHH--------H---HHHHH-hccCCC
Q 008303 127 IP--------------------Y--GSKSDIWSLGCCIYEMTSLKP-AFKAFDMQA--------L---INKIN-KSIVAP 171 (570)
Q Consensus 127 ~~--------------------~--t~ksDIWSLG~IlyeLltG~~-pf~~~~~~~--------~---~~~i~-~~~~~p 171 (570)
.. | ....||||+||++|+|+++.. +|....... . ...+. ......
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~ 464 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS 464 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc
Confidence 22 2 134799999999999999874 554321100 0 00111 111222
Q ss_pred CCCCCcHHHHHHHHHhhccCC---CCCcCHHHHHHhhccCh
Q 008303 172 LPTKYSGAFRGLVKSMLRKNP---ELRPSAAELLRHVHLQP 209 (570)
Q Consensus 172 ~p~~~s~~l~dLI~~~L~~dP---~~RPTa~eIL~hp~fq~ 209 (570)
.....++..++|+.+||.+++ .+|+|++|+|+||||.+
T Consensus 465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 345678999999999999866 68999999999999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=279.18 Aligned_cols=195 Identities=19% Similarity=0.289 Sum_probs=153.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH---ANHILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH---s~gIvHr 77 (570)
+++|++++|||||+++++|.+.+ ..|+|||||++|+|.++++. +++..+..|+.||+.||+||| +.+|+||
T Consensus 734 ~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 807 (968)
T PLN00113 734 IADMGKLQHPNIVKLIGLCRSEK-GAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807 (968)
T ss_pred HHHHhhCCCCCcceEEEEEEcCC-CCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence 36789999999999999987654 68999999999999999963 789999999999999999999 6699999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC-
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD- 156 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~- 156 (570)
||||+||+++.++..++. ||....... .....|+..|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 808 dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred CCCHHhEEECCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 999999999998887775 665543321 123478899999999999999999999999999999999999985321
Q ss_pred ----HHHHHHHHHhc-----cCCC-------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 ----MQALINKINKS-----IVAP-------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ----~~~~~~~i~~~-----~~~p-------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..+........ ...+ .......++.+++.+||..+|++||++.|+++..
T Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 11111110000 0000 0111234678899999999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=220.98 Aligned_cols=160 Identities=25% Similarity=0.363 Sum_probs=131.4
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCC
Q 008303 36 GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115 (570)
Q Consensus 36 GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT 115 (570)
|+|.++++.+ +..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..|+
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCc
Confidence 6899999865 346999999999999999999999999 999999999999999 99998765432 3689
Q ss_pred CCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH-HHHHHHHHhccCCC------CCCCCcH--HHHHHHHH
Q 008303 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM-QALINKINKSIVAP------LPTKYSG--AFRGLVKS 186 (570)
Q Consensus 116 ~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~-~~~~~~i~~~~~~p------~p~~~s~--~l~dLI~~ 186 (570)
+.|+|||++.+..|+.++|||||||++|+|++|+.||..... ......+....... .+..++. +++++|.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999975433 22233332222211 1223344 69999999
Q ss_pred hhccCCCCCcCHHHHHHhhccC
Q 008303 187 MLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 187 ~L~~dP~~RPTa~eIL~hp~fq 208 (570)
||..+|.+||++.++++|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=239.23 Aligned_cols=206 Identities=26% Similarity=0.421 Sum_probs=167.1
Q ss_pred HHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
++|.-.+|.||+..+|...... ..+|+|+|++. .+|..+|-. .+.|+.+.++-+++||++||+|||+.||+||
T Consensus 104 kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHR 180 (449)
T KOG0664|consen 104 KMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHR 180 (449)
T ss_pred HHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhc
Confidence 4666779999999988764322 22678888885 488887764 4679999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||.|+|++.+..+||||||+++....+. ..+..+-|..|.|||++.+. .|+.+.||||+|||+.||+..+-.|..
T Consensus 181 DIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 181 DIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred cCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 999999999999999999999999876543 33445678999999999765 489999999999999999999999988
Q ss_pred cCHHHHHHHHHhccCCCC---------------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 155 FDMQALINKINKSIVAPL---------------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~---------------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
.+..++.+.|..-...+. +..-..+..+++.+||..||++|++.+++
T Consensus 261 q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 261 AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 877666665544333221 01223477889999999999999999999
Q ss_pred HHhhccChh
Q 008303 202 LRHVHLQPY 210 (570)
Q Consensus 202 L~hp~fq~~ 210 (570)
+.|++...-
T Consensus 341 ~~~~~~~e~ 349 (449)
T KOG0664|consen 341 LQHRYLEEG 349 (449)
T ss_pred ccccccccc
Confidence 999987643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=207.94 Aligned_cols=171 Identities=42% Similarity=0.820 Sum_probs=151.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++++|++|+++++++... ...++++||+.|++|.+++.... ..+++..++.++.+++.+|+|||++|++|+||+
T Consensus 42 ~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~ 119 (215)
T cd00180 42 IEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119 (215)
T ss_pred HHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 3678899999999999988655 47899999999999999998752 358999999999999999999999999999999
Q ss_pred CCcEEEcC-CCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTK-DQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~-~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|.||+++. ++.++|+|||.+....... ......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 120 ~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------ 187 (215)
T cd00180 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------ 187 (215)
T ss_pred HhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------
Confidence 99999999 8999999999998765432 13345678899999999877 788999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..+.+++.+||..+|++||+++++++++
T Consensus 188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6889999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=236.72 Aligned_cols=86 Identities=27% Similarity=0.487 Sum_probs=75.8
Q ss_pred CHHhhhc-C----C---CcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKI-R----N---PFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69 (570)
Q Consensus 1 v~IL~kL-~----H---PnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yL 69 (570)
|++|+++ . | .+||+|+|.|.. +|.++|+|+|++ |.+|..+|++.+-+.++...+++|++|||.||.||
T Consensus 125 IklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYL 203 (590)
T KOG1290|consen 125 IKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYL 203 (590)
T ss_pred HHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHH
Confidence 4577777 2 2 379999999975 468999999999 67999999998888899999999999999999999
Q ss_pred HHC-CcccceecCCcEEEc
Q 008303 70 HAN-HILHRDVKCSNIFLT 87 (570)
Q Consensus 70 Hs~-gIvHrDLKP~NILld 87 (570)
|.. ||||-||||+|||+.
T Consensus 204 H~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 204 HRECGIIHTDLKPENVLLC 222 (590)
T ss_pred HHhcCccccCCCcceeeee
Confidence 975 999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-26 Score=246.05 Aligned_cols=205 Identities=33% Similarity=0.550 Sum_probs=172.8
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
+++..+|||||.|++.|.-+ ..++|+||||.||+|.+.-.- .++++|.++....+..+.||+|||++|-+|||||-.
T Consensus 65 ~~~dc~h~nivay~gsylr~-dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGa 141 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRR-DKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGA 141 (829)
T ss_pred eeecCCCcChHHHHhhhhhh-cCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCccccccccc
Confidence 45667999999999999654 468999999999999987543 457999999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccc---cCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELL---ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l---~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|||+++.|.+|+.|||.+-.++..- ....++||+.|||||+. ..+.|+..+|||++|+...||..-++|.-..-..
T Consensus 142 nilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 142 NILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 9999999999999999988776432 34568999999999987 4667999999999999999998877775444444
Q ss_pred HHHHHHHhccCCC----CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAP----LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p----~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.....+.+..+.+ -+..|++.+.+|++.+|.++|++||+++.+|.|+|..+.
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 4444444443332 345899999999999999999999999999999998653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=214.25 Aligned_cols=162 Identities=27% Similarity=0.499 Sum_probs=134.8
Q ss_pred hhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccceecC
Q 008303 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDVKC 81 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDLKP 81 (570)
+....|++|.+||.+...+ .++|.||.++. +|..+-++ ..++.++|..+-+|+..++.||.|||++ .|+|||+||
T Consensus 100 r~~~CPf~V~FyGa~~reg-dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKP 177 (282)
T KOG0984|consen 100 RTVDCPFTVHFYGALFREG-DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKP 177 (282)
T ss_pred cCCCCCeEEEeehhhhccc-cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCc
Confidence 3447899999999887666 69999999975 88777553 2356799999999999999999999987 799999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc----CCCCCCcccccchhhhHHHhhccCCCCccc-C
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA----DIPYGSKSDIWSLGCCIYEMTSLKPAFKAF-D 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~----~~~~t~ksDIWSLG~IlyeLltG~~pf~~~-~ 156 (570)
+||||+.+|+||+||||++..+...-..+...|-..|||||.+. ...|+.++||||||+.++||.+++.||..+ +
T Consensus 178 sNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 178 SNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred ceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 99999999999999999998876655444467888999999984 347899999999999999999999999764 3
Q ss_pred HHHHHHHHHhcc
Q 008303 157 MQALINKINKSI 168 (570)
Q Consensus 157 ~~~~~~~i~~~~ 168 (570)
.-++...+....
T Consensus 258 pF~qLkqvVeep 269 (282)
T KOG0984|consen 258 PFQQLKQVVEEP 269 (282)
T ss_pred HHHHHHHHhcCC
Confidence 444555554443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=240.28 Aligned_cols=149 Identities=26% Similarity=0.426 Sum_probs=134.1
Q ss_pred CHHhhhcC---CCcccccceEEEeeCcEEEEEEecc-CCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIR---NPFIVEYKDSWVERGCYVCIIIGFC-EGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~---HPnIV~l~~~f~~~~~~i~IV~Ey~-~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
|+||..|+ |+||++++++|++ ++++||+||-. +|.+|+++|+.+. .++|.++..|++|++.|+++||++||||
T Consensus 617 IqIla~l~~~sH~NIlKlLdfFEd-dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivh 693 (772)
T KOG1152|consen 617 IQILATLNKHSHENILKLLDFFED-DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVH 693 (772)
T ss_pred HHHHHHhhhcCccchhhhhheeec-CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCcee
Confidence 57899997 9999999998865 45899999986 5779999999754 4999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
||||-+|+.++.+|.+||+|||.+...... ....++||..|.|||++.+.+| +...|||+||+++|.++....||.
T Consensus 694 rdikdenvivd~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 694 RDIKDENVIVDSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cccccccEEEecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999999999998776544 4567899999999999999998 889999999999999988877775
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=239.26 Aligned_cols=199 Identities=18% Similarity=0.351 Sum_probs=177.8
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
+|.+|+||||++|++++... .+.||++|+++|.|.++++.+. ..+-.+....|.+||+.|+.|||++++|||||-..
T Consensus 751 ~masldHpnl~RLLgvc~~s--~~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaR 827 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLS--TLQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAAR 827 (1177)
T ss_pred HHhcCCCchHHHHhhhcccc--hHHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhh
Confidence 57889999999999998654 3789999999999999998753 46888999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecCCceeccCCCCCccc---cCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 83 NIFLTKDQDIRLGDFGLAKILTSDDLASSV---VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~~~~~~~~~---~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
|+||..-..+||.|||+++.+..+...... -..+-|||=|.+....|+.++||||+||.+|||++ |..|+.+...+
T Consensus 828 NVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 828 NVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred heeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 999999999999999999998765433222 22456888899999999999999999999999865 89999999999
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++-+.+.++...+.|..++-++.-++.+||..|+..||+++++...
T Consensus 908 eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 908 EIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred HhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHH
Confidence 9999999998888999999999999999999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=201.77 Aligned_cols=168 Identities=35% Similarity=0.580 Sum_probs=143.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|+||+++++++... ...++++||+.+++|.+++..... .+++..+..++.|++.+|.|||++|++|+||++
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~ 126 (225)
T smart00221 49 RILKKLKHPNIVKLYGVFEDP-EPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKP 126 (225)
T ss_pred HHHHhCCCCChhhheeeeecC-CceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 578888999999999988654 478999999999999999987432 279999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccc-cCCCCCCcccccchhhhHHHhhccCCCCcc--cC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCIYEMTSLKPAFKA--FD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l-~~~~~t~ksDIWSLG~IlyeLltG~~pf~~--~~ 156 (570)
.||+++.++.++|+|||.+....... ......++..|++||.+ ....++.++|||+||+++++|++|+.||.. .+
T Consensus 127 ~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~ 206 (225)
T smart00221 127 ENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEF 206 (225)
T ss_pred HHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchh
Confidence 99999999999999999998876543 33456788899999999 666788899999999999999999999977 34
Q ss_pred HHHHHHHHHhccCCC
Q 008303 157 MQALINKINKSIVAP 171 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p 171 (570)
...+.+.+..+...+
T Consensus 207 ~~~~~~~~~~~~~~~ 221 (225)
T smart00221 207 TSLLSDVWSFGVPLL 221 (225)
T ss_pred HHHHHHHHhcCCccc
Confidence 446666666655443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=214.63 Aligned_cols=201 Identities=19% Similarity=0.289 Sum_probs=178.5
Q ss_pred hhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHH------hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK------ANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~------~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
|..+.|||+..+.++..++...-++++.+..-|+|..|+.. .+.+.++..++..++.|+.+|+.|||++||||.
T Consensus 341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHk 420 (563)
T KOG1024|consen 341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHK 420 (563)
T ss_pred HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 45568999999999999888788899999999999999973 223567788899999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFK 153 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~ 153 (570)
||...|++|++.-+|||+|=.+++.+-+.+.. ...-....||++|.+....|+.++|+||||+++|||++ |+.|+.
T Consensus 421 DiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 421 DIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred hhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 99999999999999999999999887654432 22234567999999999999999999999999999865 899999
Q ss_pred ccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 154 AFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..++.++...+.++.....|-++++++..++-.||...|++||+++|+..-
T Consensus 501 eIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 501 EIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred ccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 999999999999999988899999999999999999999999999999764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=244.15 Aligned_cols=202 Identities=23% Similarity=0.333 Sum_probs=165.8
Q ss_pred hhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcE
Q 008303 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NI 84 (570)
..++|+||+..+..+.+...+.+. ||||++ +|+.++... ..+...++..++.||+.||+|||+.||.|||||++||
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~-mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enl 451 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQS-MEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENL 451 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhh-hhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccE
Confidence 457999999888877655544444 999999 999999874 3589999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecCCceeccCC-----CCCccccCCCCCCCcccccCCCCC-CcccccchhhhHHHhhccCCCCcccCHH
Q 008303 85 FLTKDQDIRLGDFGLAKILTSD-----DLASSVVGTPSYMCPELLADIPYG-SKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 85 Lld~~g~vKL~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~t-~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+++.+|.+||+|||.+..+... ......+|+..|+|||++.+..|. ...||||.|++++.|++|+.||......
T Consensus 452 l~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 452 LVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred EEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 9999999999999999876532 244567899999999999999994 5789999999999999999999765443
Q ss_pred HHH-HHHHh-------ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALI-NKINK-------SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~-~~i~~-------~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+.. ..... .....+...++.+.+.+|.+||+.+|.+|.|+++|++.+||+..
T Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 532 DNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 221 11110 01112334567889999999999999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=216.51 Aligned_cols=203 Identities=28% Similarity=0.398 Sum_probs=155.7
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|..+ .+.||+.+.+++.. ++.+++|+||++-....++... ++..++..+++.++.||.++|.+|||||||
T Consensus 85 l~~L~~~gG~~ni~~~~~~~rn-nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDi 158 (418)
T KOG1167|consen 85 LEMLYRLGGSDNIIKLNGCFRN-NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDI 158 (418)
T ss_pred HHHHHHhccchhhhcchhhhcc-CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCC
Confidence 3567777 79999999998754 5589999999999888888764 678999999999999999999999999999
Q ss_pred cCCcEEEcC-CCCEEEeecCCceeccCC---------------C------------------------------CCcccc
Q 008303 80 KCSNIFLTK-DQDIRLGDFGLAKILTSD---------------D------------------------------LASSVV 113 (570)
Q Consensus 80 KP~NILld~-~g~vKL~DFGla~~~~~~---------------~------------------------------~~~~~~ 113 (570)
||+|+|++. .+.-.|+|||+|...... . ......
T Consensus 159 KpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrA 238 (418)
T KOG1167|consen 159 KPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRA 238 (418)
T ss_pred CccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccC
Confidence 999999985 567899999998721100 0 001246
Q ss_pred CCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCccc-CH-HHHH-----------HHH---------------
Q 008303 114 GTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAF-DM-QALI-----------NKI--------------- 164 (570)
Q Consensus 114 GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~-~~-~~~~-----------~~i--------------- 164 (570)
||++|.|||++...+ -+.++||||.|+|+..+++++.||-.. +. ..+. .+.
T Consensus 239 GT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~ 318 (418)
T KOG1167|consen 239 GTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNI 318 (418)
T ss_pred CCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccc
Confidence 999999999997655 488999999999999999998887321 11 0000 000
Q ss_pred ------------------HhccC-----CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 165 ------------------NKSIV-----APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 165 ------------------~~~~~-----~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+... ....+.++..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 319 ~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 319 PTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00000 0011233458899999999999999999999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-23 Score=216.14 Aligned_cols=195 Identities=22% Similarity=0.389 Sum_probs=151.1
Q ss_pred hcCCCcccccceEEEeeCc----EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------
Q 008303 6 KIRNPFIVEYKDSWVERGC----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN--------- 72 (570)
Q Consensus 6 kL~HPnIV~l~~~f~~~~~----~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~--------- 72 (570)
.|+|+||++++++-. .+. .++||+||.+.|+|.++++.+- +++...++|+..+++||+|||+.
T Consensus 260 ~m~h~nIl~Fi~~ek-r~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp 335 (534)
T KOG3653|consen 260 GMKHENILQFIGAEK-RGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKP 335 (534)
T ss_pred CccchhHHHhhchhc-cCCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCC
Confidence 469999999998643 232 5789999999999999999753 79999999999999999999974
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCC-CC-----CcccccchhhhHH
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIP-YG-----SKSDIWSLGCCIY 143 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~-~t-----~ksDIWSLG~Ily 143 (570)
.|+|||||..||||..|+..-|+|||+|..+..... ....+||.+|||||++.+.- +. .+.||||+|.|+|
T Consensus 336 ~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 336 PIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW 415 (534)
T ss_pred ccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence 599999999999999999999999999999875432 33479999999999996432 22 4689999999999
Q ss_pred HhhccCCC------------Ccc-----cCHHHHHHHHHhc-cCCCCCCCC-----cHHHHHHHHHhhccCCCCCcCHHH
Q 008303 144 EMTSLKPA------------FKA-----FDMQALINKINKS-IVAPLPTKY-----SGAFRGLVKSMLRKNPELRPSAAE 200 (570)
Q Consensus 144 eLltG~~p------------f~~-----~~~~~~~~~i~~~-~~~p~p~~~-----s~~l~dLI~~~L~~dP~~RPTa~e 200 (570)
||++.... |.. -..+++.+.+... ..+.++..| -..+++.+..||+.|++.|.|+.=
T Consensus 416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 99875432 221 1123333333222 233333332 357889999999999999999987
Q ss_pred HHHh
Q 008303 201 LLRH 204 (570)
Q Consensus 201 IL~h 204 (570)
+.+.
T Consensus 496 v~eR 499 (534)
T KOG3653|consen 496 VEER 499 (534)
T ss_pred HHHH
Confidence 7654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=202.83 Aligned_cols=197 Identities=21% Similarity=0.298 Sum_probs=152.6
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
.|.||+.-|++-++..++++++||||+.|+|..-+... .+-|...++++.|++.||.|||++++||||||.+||||-
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif 155 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIF 155 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEe
Confidence 58999988877666666888999999999999988763 378999999999999999999999999999999999995
Q ss_pred C--CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC---CC--CCCcccccchhhhHHHhhccCCCCcccCH---
Q 008303 88 K--DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD---IP--YGSKSDIWSLGCCIYEMTSLKPAFKAFDM--- 157 (570)
Q Consensus 88 ~--~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~---~~--~t~ksDIWSLG~IlyeLltG~~pf~~~~~--- 157 (570)
+ ...|||||||+.+..+... ...-.+..|.+||++.. +. ..+.+|||.||+|+|.+++|++||.....
T Consensus 156 ~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~ 233 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK 233 (378)
T ss_pred cCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence 4 4479999999987755332 22334567999998742 23 36789999999999999999999974321
Q ss_pred -HHHHHHHHhccCCCCC---CCCcHHHHHHHHHhhccCCCCC---cCHHHHHHhhccCh
Q 008303 158 -QALINKINKSIVAPLP---TKYSGAFRGLVKSMLRKNPELR---PSAAELLRHVHLQP 209 (570)
Q Consensus 158 -~~~~~~i~~~~~~p~p---~~~s~~l~dLI~~~L~~dP~~R---PTa~eIL~hp~fq~ 209 (570)
..-..+..++.....| ..+++.+..+.++-|..++++| .++.......|...
T Consensus 234 ~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 234 PYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 1122233333333333 4578999999999999999999 56666667767643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=208.01 Aligned_cols=195 Identities=22% Similarity=0.396 Sum_probs=151.5
Q ss_pred cCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------Ccc
Q 008303 7 IRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN--------HIL 75 (570)
Q Consensus 7 L~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~--------gIv 75 (570)
|+|+||+.+++.-.-++ ..+|||++|.+.|+|+||+... .++.+...++++.++.||++||.. .|.
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIA 338 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIA 338 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhh
Confidence 49999999998653222 4589999999999999999873 489999999999999999999964 499
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCC-----CCCccccCCCCCCCcccccCCC----C--CCcccccchhhhHHH
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-----DLASSVVGTPSYMCPELLADIP----Y--GSKSDIWSLGCCIYE 144 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~----~--t~ksDIWSLG~Ilye 144 (570)
|||||..|||+.++|.+-|+|+|+|-..... ......+||.+|||||++...- + -..+||||||.|+||
T Consensus 339 HRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWE 418 (513)
T KOG2052|consen 339 HRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWE 418 (513)
T ss_pred ccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHH
Confidence 9999999999999999999999999776543 1345679999999999995432 1 246899999999999
Q ss_pred hhc----------cCCCCccc-----CHHHHHHHHHh-ccCCCCCCCCc-----HHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 145 MTS----------LKPAFKAF-----DMQALINKINK-SIVAPLPTKYS-----GAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 145 Llt----------G~~pf~~~-----~~~~~~~~i~~-~~~~p~p~~~s-----~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
++. .++||.+. ..+++..-+.- ...+.+|..|. ..+..||+.||..||.-|.|+--|-+
T Consensus 419 iarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 419 IARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred HHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 864 24566543 23333333322 23344555553 35778999999999999999887755
Q ss_pred h
Q 008303 204 H 204 (570)
Q Consensus 204 h 204 (570)
.
T Consensus 499 t 499 (513)
T KOG2052|consen 499 T 499 (513)
T ss_pred H
Confidence 3
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-21 Score=186.50 Aligned_cols=205 Identities=36% Similarity=0.567 Sum_probs=166.6
Q ss_pred HHhhhcCCC-cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNP-FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HP-nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
.++.++.|+ +|+++++++.. ....+++++|+.+++|.+++..... ..+.+..+..++.|++.++.|+|+.|++|||+
T Consensus 49 ~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~ 127 (384)
T COG0515 49 QILASLNHPPNIVKLYDFFQD-EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127 (384)
T ss_pred HHHHHccCCcceeeEEEEEec-CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 467888887 79999999844 4458999999999999977776431 25899999999999999999999999999999
Q ss_pred cCCcEEEcCCC-CEEEeecCCceeccCCC-------CCccccCCCCCCCcccccC---CCCCCcccccchhhhHHHhhcc
Q 008303 80 KCSNIFLTKDQ-DIRLGDFGLAKILTSDD-------LASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 80 KP~NILld~~g-~vKL~DFGla~~~~~~~-------~~~~~~GT~~Y~APE~l~~---~~~t~ksDIWSLG~IlyeLltG 148 (570)
||+||+++..+ .++++|||.+....... .....+|+..|++||++.+ ..+....|+|++|+++++++.|
T Consensus 128 kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred CHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhC
Confidence 99999999988 69999999998665443 3467789999999999987 5778999999999999999999
Q ss_pred CCCCcccCH----HHHHHHHHhccCC----CCCCCC----cHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 149 KPAFKAFDM----QALINKINKSIVA----PLPTKY----SGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 149 ~~pf~~~~~----~~~~~~i~~~~~~----p~p~~~----s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
..||..... ......+...... ...... ...+.+++..|+..+|..|.+..+...+.+.
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~ 278 (384)
T COG0515 208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278 (384)
T ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHh
Confidence 999877663 3444444333322 111111 2579999999999999999999999888544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-20 Score=203.18 Aligned_cols=196 Identities=30% Similarity=0.518 Sum_probs=169.7
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
.++..++ ||++|++.-.|..++ ..+++++|..||+|...+.+. ..+.+.....+...++.+++++|+.||+|||+|
T Consensus 48 ~il~~~~~~~f~v~lhyafqt~~-kl~l~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k 124 (612)
T KOG0603|consen 48 IILAFVHNTPFLVKLHYAFQTDG-KLYLILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYK 124 (612)
T ss_pred HHHhhccCCCceeeeeeeecccc-chhHhhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhccc
Confidence 3566675 999999998886655 789999999999999988764 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
++||+++.+|.+++.|||+++..-..... |||..|||||++. ++...+|.||+|+++++|++|..||.. +.
T Consensus 125 ~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~ 195 (612)
T KOG0603|consen 125 LENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT 195 (612)
T ss_pred ccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH
Confidence 99999999999999999999887654433 9999999999998 678899999999999999999999987 44
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
...|.+.. ...|...+..+++++.+|+..+|..|.- +.+|++|++|+..
T Consensus 196 ~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 196 MKRILKAE-LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 45554432 3367788999999999999999999984 5799999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=182.25 Aligned_cols=202 Identities=21% Similarity=0.306 Sum_probs=159.2
Q ss_pred HHhhhcCC----CcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELISKIRN----PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL~kL~H----PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
.+|..+.+ .++..+++.+...+.+-||||+.+ |.+|.++.+....+.|+...+..|+.|++.+|++||+.|++||
T Consensus 68 ~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHR 146 (322)
T KOG1164|consen 68 QVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHR 146 (322)
T ss_pred HHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccC
Confidence 45666642 588888887743445789999999 7799999887766789999999999999999999999999999
Q ss_pred eecCCcEEEcCC-----CCEEEeecCCce--eccCCC--------C-CccccCCCCCCCcccccCCCCCCcccccchhhh
Q 008303 78 DVKCSNIFLTKD-----QDIRLGDFGLAK--ILTSDD--------L-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 141 (570)
Q Consensus 78 DLKP~NILld~~-----g~vKL~DFGla~--~~~~~~--------~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~I 141 (570)
||||.|+++... ..+.|.|||+++ .+.... . .....||..|+++....+...+.+.|+||++.+
T Consensus 147 DiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~ 226 (322)
T KOG1164|consen 147 DIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYM 226 (322)
T ss_pred CcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHH
Confidence 999999999865 359999999998 321111 1 223559999999999999999999999999999
Q ss_pred HHHhhccCCCCcccCHHHHHHHH---HhccCCC-CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 142 IYEMTSLKPAFKAFDMQALINKI---NKSIVAP-LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 142 lyeLltG~~pf~~~~~~~~~~~i---~~~~~~p-~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+.+|+.|..||..........++ ....... .....+.++..+...+-..+...+|.+..+...
T Consensus 227 l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 227 LLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 99999999999765532222222 2222211 233456788888888888999999999998876
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.8e-20 Score=195.78 Aligned_cols=177 Identities=31% Similarity=0.518 Sum_probs=139.1
Q ss_pred EEEEEEeccCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 25 YVCIIIGFCEGGDMAEAIKK-ANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 25 ~i~IV~Ey~~gGsL~d~I~~-~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
++||.|++|...+|.+||.. ......+......|+.|+..|++| +|.+|+|+||.||++..++.+||+|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 68999999999999999974 333456788899999999999999 99999999999999999999999999998876
Q ss_pred cCCC-------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCC-CCC
Q 008303 104 TSDD-------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL-PTK 175 (570)
Q Consensus 104 ~~~~-------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~-p~~ 175 (570)
.... ..+..+||.+||+||++.+..|+.++|||+||+|++||+.-.. ..+.-......+..+...+. ..+
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~--T~~er~~t~~d~r~g~ip~~~~~d 484 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFS--TQFERIATLTDIRDGIIPPEFLQD 484 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhc--cHHHHHHhhhhhhcCCCChHHhhc
Confidence 5544 3456789999999999999999999999999999999986210 11112223333444443322 222
Q ss_pred CcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 176 YSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 176 ~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+ +.-..|+.+||.+.|.+||++.+.-.|.|.
T Consensus 485 ~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 485 Y-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred C-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3 344689999999999999977776666654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-18 Score=177.88 Aligned_cols=192 Identities=24% Similarity=0.359 Sum_probs=148.3
Q ss_pred CCCcccccceEEEe--------------------------eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHH
Q 008303 8 RNPFIVEYKDSWVE--------------------------RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61 (570)
Q Consensus 8 ~HPnIV~l~~~f~~--------------------------~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~Q 61 (570)
+|||||+++++|++ .+..+|+||.-++. +|.+++..+. .+-....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 79999999988842 23458899998865 9999997643 577888899999
Q ss_pred HHHHHHHHHHCCcccceecCCcEEEc--CCC--CEEEeecCCceeccCCC-------CCccccCCCCCCCcccccCCC--
Q 008303 62 LLMALDYLHANHILHRDVKCSNIFLT--KDQ--DIRLGDFGLAKILTSDD-------LASSVVGTPSYMCPELLADIP-- 128 (570)
Q Consensus 62 Ll~aL~yLHs~gIvHrDLKP~NILld--~~g--~vKL~DFGla~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~-- 128 (570)
+++|+.|||++||.|||+|.+|||+. +|+ .+.|.|||++---.... ..-..-|.-.-||||+....+
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999984 343 48999999875432211 111234667799999986433
Q ss_pred ----CCCcccccchhhhHHHhhccCCCCcccCHHHH-HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 129 ----YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL-INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 129 ----~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~-~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
.-.++|.|+.|-+.||+++...||.......+ ..........+++..+++.+++++..+|+.||.+|++..-+-+
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 24689999999999999999999876432221 1223444566789999999999999999999999998765544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=181.19 Aligned_cols=199 Identities=21% Similarity=0.346 Sum_probs=159.2
Q ss_pred hhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccceecCC
Q 008303 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHI-LHRDVKCS 82 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI-vHrDLKP~ 82 (570)
|+.+.|.|+.+++|.+.+. ..+++|.+||..|+|.|.+... ...++.-....++++|+.||.|||..-| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 5789999999999999876 4788999999999999999873 4568999999999999999999998866 99999999
Q ss_pred cEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCC-------CCCcccccchhhhHHHhhccCCCC
Q 008303 83 NIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIP-------YGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~-------~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|++++....+||.|||+....... .......-..-|.|||.+.... .+.+.||||+|++++|++....||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 1111222345699999997542 356799999999999999999999
Q ss_pred ccc----CHHHHHHHHHh-ccCCCCCC-----CCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 153 KAF----DMQALINKINK-SIVAPLPT-----KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 153 ~~~----~~~~~~~~i~~-~~~~p~p~-----~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
... +..+++.++.+ ......|. ...+++..+++.||..+|..||+++++-..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 762 33456666555 22111222 345579999999999999999999998654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-18 Score=195.71 Aligned_cols=183 Identities=24% Similarity=0.352 Sum_probs=141.6
Q ss_pred cCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEE
Q 008303 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL 86 (570)
Q Consensus 7 L~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILl 86 (570)
++|||++.+.-+- ..+...|+|-+|... +|.|.|..+. .|.+-+.+-|+.||+.||..||..||+|||||.+||||
T Consensus 78 ~~~pn~lPfqk~~-~t~kAAylvRqyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 78 MKAPNCLPFQKVL-VTDKAAYLVRQYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred hcCCcccchHHHH-HhhHHHHHHHHHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 4899999998754 344567899999965 9999998753 47788888899999999999999999999999999999
Q ss_pred cCCCCEEEeecCCceec--cCCCC--CccccC----CCCCCCcccccCC----------C-CCCcccccchhhhHHHhhc
Q 008303 87 TKDQDIRLGDFGLAKIL--TSDDL--ASSVVG----TPSYMCPELLADI----------P-YGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 87 d~~g~vKL~DFGla~~~--~~~~~--~~~~~G----T~~Y~APE~l~~~----------~-~t~ksDIWSLG~IlyeLlt 147 (570)
+.=+-+.|.||...+.. .++.. ...+.. --.|.|||.+... + .+++.||||+||++.||++
T Consensus 154 TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 154 TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL 233 (1431)
T ss_pred eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence 99888999999876542 22221 111222 2359999988542 2 4678999999999999965
Q ss_pred -cCCCCccc-----------CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 148 -LKPAFKAF-----------DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 148 -G~~pf~~~-----------~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|+++|.-. +.+.+.++| -+..++.||..|++.||.+|.++++.|+.
T Consensus 234 Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 234 EGRPLFTLSQLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCCCcccHHHHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 78888521 222222222 23478999999999999999999999986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-17 Score=188.63 Aligned_cols=148 Identities=30% Similarity=0.474 Sum_probs=127.1
Q ss_pred HHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCC----------------CCCccccCCCCCCCcccccC
Q 008303 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD----------------DLASSVVGTPSYMCPELLAD 126 (570)
Q Consensus 63 l~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~----------------~~~~~~~GT~~Y~APE~l~~ 126 (570)
+.+++|||+.||+|||+||+|.+|+.-|.+|+.|||+++..... -....+|||+.|.|||++..
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 78999999999999999999999999999999999998764211 11234699999999999999
Q ss_pred CCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCc---CHHHH
Q 008303 127 IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRP---SAAEL 201 (570)
Q Consensus 127 ~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RP---Ta~eI 201 (570)
.+|+..+|.|++|+|+|+.+.|+.||.+...++++..+...... .-...+..+++++|.++|+.+|..|- .+-++
T Consensus 233 qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 233 QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEV 312 (1205)
T ss_pred hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhh
Confidence 99999999999999999999999999999999988777554432 22345789999999999999999997 56678
Q ss_pred HHhhccChh
Q 008303 202 LRHVHLQPY 210 (570)
Q Consensus 202 L~hp~fq~~ 210 (570)
.+|.||+..
T Consensus 313 k~h~ff~~L 321 (1205)
T KOG0606|consen 313 KQHGFFQLL 321 (1205)
T ss_pred hhccceeec
Confidence 899999853
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.6e-17 Score=172.04 Aligned_cols=130 Identities=22% Similarity=0.285 Sum_probs=97.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee-
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV- 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL- 79 (570)
+++|++|+|+||+..+..+ + ..|||||||.|++|.. +.. .. ...++.|++.||.|||++||+||||
T Consensus 72 ~~iL~~L~h~~iv~~l~~~---~-~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~ 138 (365)
T PRK09188 72 IRALKTVRGIGVVPQLLAT---G-KDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLA 138 (365)
T ss_pred HHHHHhccCCCCCcEEEEc---C-CcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCC
Confidence 3689999999998533222 2 4689999999999973 211 11 1468899999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC---------CCccccCCCCCCCcccccCCC------CCCccccc-chhhhHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD---------LASSVVGTPSYMCPELLADIP------YGSKSDIW-SLGCCIY 143 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~---------~~~~~~GT~~Y~APE~l~~~~------~t~ksDIW-SLG~Ily 143 (570)
||+|||++.++.+||+|||+++.+.... .....++++.|++||.+.... .+...|-| --|=+.+
T Consensus 139 KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~ 218 (365)
T PRK09188 139 KPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVY 218 (365)
T ss_pred CcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEE
Confidence 9999999999999999999999765332 113567888999999986432 23346666 4444443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=4e-17 Score=167.96 Aligned_cols=161 Identities=21% Similarity=0.304 Sum_probs=108.8
Q ss_pred EEEEeccCCCCHHHHHHH---hCCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCce
Q 008303 27 CIIIGFCEGGDMAEAIKK---ANSK--LFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK 101 (570)
Q Consensus 27 ~IV~Ey~~gGsL~d~I~~---~~~~--~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~ 101 (570)
+++|.-+. ++|.+++.- .... .+.......+..|++..+++||..||+|+||+|+|+|++.+|.+.|+||+...
T Consensus 115 ~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~ 193 (288)
T PF14531_consen 115 FLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV 193 (288)
T ss_dssp EEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred hhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence 57777774 599888652 2222 12233345556899999999999999999999999999999999999999887
Q ss_pred eccCCCCCccccCCCCCCCcccccC--------CCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCCC
Q 008303 102 ILTSDDLASSVVGTPSYMCPELLAD--------IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLP 173 (570)
Q Consensus 102 ~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p 173 (570)
..+..... ...+..|.+||.... ..++.+.|.|+||+++|.|+|+..||........... ....+.
T Consensus 194 r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~ 267 (288)
T PF14531_consen 194 RAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRCR 267 (288)
T ss_dssp ETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTSS
T ss_pred ecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhcC
Confidence 76543322 344578999998743 2478899999999999999999999976543221111 223344
Q ss_pred CCCcHHHHHHHHHhhccCCCCC
Q 008303 174 TKYSGAFRGLVKSMLRKNPELR 195 (570)
Q Consensus 174 ~~~s~~l~dLI~~~L~~dP~~R 195 (570)
++++.++.||..||+.||.+|
T Consensus 268 -~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 268 -DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ----HHHHHHHHHHT-SSGGGS
T ss_pred -CcCHHHHHHHHHHccCCcccC
Confidence 789999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-16 Score=157.20 Aligned_cols=122 Identities=16% Similarity=0.284 Sum_probs=95.7
Q ss_pred HHhhhcCCCcccccceEEEeeC-------cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-------CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-------~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
+.+.++.|++|..+.+++.... +..+||||||+|.+|.++.. ++++ .+.+++.+|..||+.||
T Consensus 87 ~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi 156 (232)
T PRK10359 87 VQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGM 156 (232)
T ss_pred HHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCC
Confidence 3678899999999999876432 34789999999999988732 3332 46699999999999999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
+|||+||+||+++.+| ++|+|||............ .++....|+.++|||+||+.+..+
T Consensus 157 ~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 157 VSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHH
Confidence 9999999999999988 9999999987654322111 134455677899999999977654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.1e-16 Score=151.78 Aligned_cols=140 Identities=14% Similarity=0.092 Sum_probs=106.6
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++| +|++|++++++ + ..|++|||+.|.+|...+.. . ...++.|++.+|.+||++||+||||
T Consensus 52 ~~iL~~L~~~~~vP~ll~~---~--~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL 117 (218)
T PRK12274 52 ALALRQLDGLPRTPRLLHW---D--GRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDL 117 (218)
T ss_pred HHHHHhcCCCCCCCEEEEE---c--CEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCC
Confidence 3689999 56889999885 2 35899999999998754321 1 2357889999999999999999999
Q ss_pred -cCCcEEEcCCCCEEEeecCCceeccCCCC-----C---------ccccCCCCCCCcccccCC-CCC-CcccccchhhhH
Q 008303 80 -KCSNIFLTKDQDIRLGDFGLAKILTSDDL-----A---------SSVVGTPSYMCPELLADI-PYG-SKSDIWSLGCCI 142 (570)
Q Consensus 80 -KP~NILld~~g~vKL~DFGla~~~~~~~~-----~---------~~~~GT~~Y~APE~l~~~-~~t-~ksDIWSLG~Il 142 (570)
||+|||++.+|.++|+|||++........ . ....+++.|+.|+...-. ..+ ...+.++.|+-+
T Consensus 118 ~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~ 197 (218)
T PRK12274 118 AKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPV 197 (218)
T ss_pred CCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchH
Confidence 79999999999999999999986554331 0 112357788888765322 223 456677899999
Q ss_pred HHhhccCCCCcc
Q 008303 143 YEMTSLKPAFKA 154 (570)
Q Consensus 143 yeLltG~~pf~~ 154 (570)
|.+++++.++.+
T Consensus 198 ~~~~~~~~~~~~ 209 (218)
T PRK12274 198 YRFVTRRVLHWE 209 (218)
T ss_pred HHHHhccCCccc
Confidence 999998877654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8e-16 Score=154.07 Aligned_cols=190 Identities=16% Similarity=0.295 Sum_probs=156.4
Q ss_pred hcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccceecCCc
Q 008303 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--ILHRDVKCSN 83 (570)
Q Consensus 6 kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--IvHrDLKP~N 83 (570)
-..||||+.+++.|.... .+.+|..|++.|+|...+....+...+..++.+++.+++.|+.|||+.. |...-|....
T Consensus 243 ifshpnilpvlgacnspp-nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~h 321 (448)
T KOG0195|consen 243 IFSHPNILPVLGACNSPP-NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH 321 (448)
T ss_pred eecCCchhhhhhhccCCC-CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence 347999999999986554 5789999999999999998776667788899999999999999999874 5666788999
Q ss_pred EEEcCCCCEEE--eecCCceeccCCCCCccccCCCCCCCcccccCCCC---CCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 84 IFLTKDQDIRL--GDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY---GSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 84 ILld~~g~vKL--~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
++||++-..+| +|--++.. .......|.||+||.++..+- -.++|+|||.+++|||.+...||......
T Consensus 322 vmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 322 VMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred EEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 99999876555 33222221 112345789999999987664 35799999999999999999999988877
Q ss_pred HHHHHH-HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHH
Q 008303 159 ALINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202 (570)
Q Consensus 159 ~~~~~i-~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL 202 (570)
+.-.+| ..+....+|..++..+..|++-|++.||.+||.++.|+
T Consensus 396 ecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 396 ECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 765555 45567778999999999999999999999999999876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-15 Score=151.84 Aligned_cols=191 Identities=19% Similarity=0.283 Sum_probs=154.6
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
..++|..++ ||-..|.+-.+|||++ |.+|.|+.+-. +..|+...+..++.|++.-++|+|++++|+|||||+|+||.
T Consensus 82 g~~GIP~vY-YFGqeG~~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 82 GTEGIPQVY-YFGQEGKYNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred CCCCCCcee-eeccccchhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 568888888 4555677778999999 78999998865 45799999999999999999999999999999999999997
Q ss_pred CCC-----CEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 88 KDQ-----DIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 88 ~~g-----~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
.-+ .|.|+|||+|+...... -.....||..||+--...+..-+...|+-+||-++++.+.|..||.+
T Consensus 159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 643 49999999999876433 23456799999998888888889999999999999999999999976
Q ss_pred cC---HHHHHHHHHhccCC-C---CCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 155 FD---MQALINKINKSIVA-P---LPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 155 ~~---~~~~~~~i~~~~~~-p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
.. ..+-.++|-..... + +-..++.++..-+...-..+-.+-|.++-+
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 53 34445555332221 1 234678889888888888888888887744
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=5e-15 Score=144.00 Aligned_cols=97 Identities=14% Similarity=0.176 Sum_probs=77.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL-HANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yL-Hs~gIvHrDLK 80 (570)
++|.+|.|++|.....+.. .. .+||||||.|++|...+.+ ...++++.+..++.|++.+|.|| |+.||+|||||
T Consensus 71 ~~l~~l~~~~v~~p~~~~~-~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlk 145 (190)
T cd05147 71 RNLKRLVTAGIPCPEPILL-KS--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLS 145 (190)
T ss_pred HHHHHHHHCCCCCCcEEEe-cC--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4677787777754443322 22 2799999999877655433 24689999999999999999999 79999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~ 104 (570)
|+|||++ ++.++|+|||++....
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccCC
Confidence 9999998 5789999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.7e-15 Score=144.80 Aligned_cols=95 Identities=22% Similarity=0.203 Sum_probs=75.8
Q ss_pred CHHhhhc-----CCCcccccceEEEeeC--cEEE-EEEec--cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHH
Q 008303 1 MELISKI-----RNPFIVEYKDSWVERG--CYVC-IIIGF--CEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL-DYL 69 (570)
Q Consensus 1 v~IL~kL-----~HPnIV~l~~~f~~~~--~~i~-IV~Ey--~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL-~yL 69 (570)
|++|++| .||||++++|++..+. ++++ +|+|| +.+|+|.+++++. .+++. ..++.|++.++ +||
T Consensus 47 i~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yL 121 (210)
T PRK10345 47 LKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYL 121 (210)
T ss_pred HHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHH
Confidence 3567777 6899999999997652 3444 78999 5589999999762 36666 36688888888 999
Q ss_pred HHCCcccceecCCcEEEcCC----CCEEEeecCCc
Q 008303 70 HANHILHRDVKCSNIFLTKD----QDIRLGDFGLA 100 (570)
Q Consensus 70 Hs~gIvHrDLKP~NILld~~----g~vKL~DFGla 100 (570)
|+++|+||||||+|||++.. +.++|+||+.+
T Consensus 122 h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 122 LDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99999999999999999743 37999995444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.8e-16 Score=176.03 Aligned_cols=201 Identities=25% Similarity=0.371 Sum_probs=166.0
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccceecCCcEEE
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH-ANHILHRDVKCSNIFL 86 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH-s~gIvHrDLKP~NILl 86 (570)
+|.|++.+++...+. .+.+++++|..|+++++.+........+......++.|+..+|.|+| ..++.|+||||+|.++
T Consensus 79 ~h~n~~~~~~~~~~~-~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l 157 (601)
T KOG0590|consen 79 KHSNTVHMIEPSSSP-RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL 157 (601)
T ss_pred ccccccccCCccCCC-cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh
Confidence 399999999987554 47789999999999999984222225788889999999999999999 9999999999999999
Q ss_pred cCCC-CEEEeecCCceeccC-C---CCCccccC-CCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 87 TKDQ-DIRLGDFGLAKILTS-D---DLASSVVG-TPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 87 d~~g-~vKL~DFGla~~~~~-~---~~~~~~~G-T~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+..+ .+++.|||+|..+.. . ......+| ++.|+|||...+..| ....|+||+|+++..++.|..||.......
T Consensus 158 ~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 158 DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 9999 999999999988765 2 23445688 999999999988655 789999999999999999999886543322
Q ss_pred --HHHHHHh--ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 --LINKINK--SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 --~~~~i~~--~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+.. ......+..++....+++.+++..+|..|.+.+++-.++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 238 GRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1112222 1123456788999999999999999999999999999999876
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2e-14 Score=139.08 Aligned_cols=97 Identities=14% Similarity=0.149 Sum_probs=78.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHH-HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEA-IKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~-I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDL 79 (570)
+.|.++.|++|.....++.. . .|||||||.|+++... +.. ..+++..+..++.|++.+|.+||. +||+||||
T Consensus 71 ~~l~~l~~~~i~~p~~~~~~-~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDl 144 (190)
T cd05145 71 RNLKRLYEAGVPVPEPILLK-K--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDL 144 (190)
T ss_pred HHHHHHHhCCCCCceEEEec-C--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 45677888887554444332 2 3799999998865443 332 347899999999999999999999 99999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccC
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTS 105 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~ 105 (570)
||+|||++ ++.++|+|||++.....
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.9e-14 Score=137.70 Aligned_cols=188 Identities=19% Similarity=0.255 Sum_probs=144.8
Q ss_pred CcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCC
Q 008303 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKD 89 (570)
Q Consensus 10 PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~ 89 (570)
..|..+..++.+ ..+-.+||+++ |.+|.++..-. ...|+...+.-++-|++.-|+|+|.++++||||||+|+|..-+
T Consensus 71 ~GiP~i~~y~~e-~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg 147 (341)
T KOG1163|consen 71 VGIPHIRHYGTE-KDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG 147 (341)
T ss_pred CCCchhhhhccc-cccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc
Confidence 455566655544 44778999998 78999988654 3568999999999999999999999999999999999998643
Q ss_pred ---CCEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 90 ---QDIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 90 ---g~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
..+.|+|||+++.+-... -.....||..|.+--...+...+...|+-|+|.++.++..|..||.+....
T Consensus 148 rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 148 RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 458999999998764321 123467999999987777777788999999999999999999999876433
Q ss_pred ---HHHHHHHhccC----CCCCCCCcHHHHHHHHHhhccCCCCCcCHHH
Q 008303 159 ---ALINKINKSIV----APLPTKYSGAFRGLVKSMLRKNPELRPSAAE 200 (570)
Q Consensus 159 ---~~~~~i~~~~~----~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~e 200 (570)
.-.++|..... ..+-..++.++.-.+..|-..--++-|...-
T Consensus 228 tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 228 TKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred hHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 22333332221 1234578899999999998887777787553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.6e-14 Score=162.42 Aligned_cols=192 Identities=19% Similarity=0.285 Sum_probs=137.9
Q ss_pred HHhhhcC---CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIR---NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~---HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++.+|+ -+.|+.+...++..+ .-+||+||.+.|+|.+++. ..+.+++..+..++.|++..|+.||..||||+|
T Consensus 743 q~~~RLk~~~~~~~~~~~~a~~~~~-~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgD 819 (974)
T KOG1166|consen 743 QVMERLKPQMLPSIMHISSAHVFQN-ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGD 819 (974)
T ss_pred HHHHhhchhhhcchHHHHHHHccCC-cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceeccc
Confidence 5777777 123333333333322 2469999999999999998 456799999999999999999999999999999
Q ss_pred ecCCcEEEcC-------CCCEEEeecCCceec---cCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhcc
Q 008303 79 VKCSNIFLTK-------DQDIRLGDFGLAKIL---TSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 79 LKP~NILld~-------~g~vKL~DFGla~~~---~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG 148 (570)
|||+|+||.. ..-++|+|||.+... .........++|-.+-++|...+.+|++.+|.|.|.-+++.|+.|
T Consensus 820 iKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 820 IKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred CCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 9999999953 234999999998643 334355667899999999999999999999999999999999987
Q ss_pred CCCCcccCHHHHHHHHHhccCCCCCCCCc-HHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 149 KPAFKAFDMQALINKINKSIVAPLPTKYS-GAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p~p~~~s-~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
+..- +...-.+.....++..+. +.+.+|+..+|+.|-..=|.+.+|..
T Consensus 900 ~y~q-------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~ 948 (974)
T KOG1166|consen 900 KYME-------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRT 948 (974)
T ss_pred HHHH-------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHH
Confidence 5321 000000111111222222 34557888888855555555555543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-12 Score=127.39 Aligned_cols=93 Identities=24% Similarity=0.345 Sum_probs=79.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|.++.|++|+....++...+ ..++||||++|++|.+++... .. ....++.+++.+|.+||..|++|+|++|
T Consensus 51 ~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p 123 (211)
T PRK14879 51 RIMSRARKAGVNVPAVYFVDPE-NFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTT 123 (211)
T ss_pred HHHHHHHHCCCCCCeEEEEeCC-CCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence 4677888999877666665443 568999999999999998653 12 8889999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCcee
Q 008303 82 SNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~ 102 (570)
.|||++ ++.++|+|||++..
T Consensus 124 ~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 124 SNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ccEEEE-CCCEEEEECCcccC
Confidence 999999 78899999999865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-12 Score=131.95 Aligned_cols=95 Identities=22% Similarity=0.295 Sum_probs=76.4
Q ss_pred HHhhhcCCCcc--cccceEEEeeCcEE---EEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKIRNPFI--VEYKDSWVERGCYV---CIIIGFCEG-GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL~HPnI--V~l~~~f~~~~~~i---~IV~Ey~~g-GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++|.+|.|++| ++.+++...+.... ++||||++| .+|.+++.. ..+++.. +.||+.+|.+||++||+
T Consensus 92 ~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~ 164 (239)
T PRK01723 92 RLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVY 164 (239)
T ss_pred HHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCC
Confidence 57888888775 67777654433333 499999997 699998865 2356543 67899999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceec
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
||||||.|||++.++.++|+|||.+...
T Consensus 165 HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 165 HADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 9999999999999899999999998663
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.4e-13 Score=138.53 Aligned_cols=200 Identities=26% Similarity=0.437 Sum_probs=144.3
Q ss_pred hhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Q 008303 4 ISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHANH--IL 75 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--Iv 75 (570)
|-++.|.|||+++.||.+.. -.+.+++||+..|+|..++++ .+...+.+....+|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 45668999999999996432 247799999999999999975 33467889999999999999999999985 99
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceec-----cCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCC
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKIL-----TSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~-----~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
|+++.+..|++..+|-||++----...- ....-.....+-++|.+||.=.-...+.++|||++|.+..+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 9999999999999998887542211110 00111223456789999998877778889999999999999876543
Q ss_pred C-CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 151 A-FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 151 p-f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
- -...........+...... .-.+.-+++|.+||.-.|+.||++.+++.||.+
T Consensus 281 q~tnseS~~~~ee~ia~~i~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVIIG----LENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred ccCCCcceeehhhhhhhheee----ccCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 2 1111111111122111111 011233678999999999999999999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-12 Score=125.75 Aligned_cols=90 Identities=28% Similarity=0.402 Sum_probs=73.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+++.|++|.....++...+ ..++|||||+|++|.+++.... . .++.|++.+|.+||+.|++|+|++|
T Consensus 49 ~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e~~~g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~ 118 (199)
T TIGR03724 49 RLLSRARKAGVNTPVVYDVDPD-NKTIVMEYIEGKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTT 118 (199)
T ss_pred HHHHHHHHCCCCCCEEEEEECC-CCEEEEEEECCccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCc
Confidence 4677888877654444444333 4689999999999999876421 0 8899999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCcee
Q 008303 82 SNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~ 102 (570)
.||+++ ++.++++|||++..
T Consensus 119 ~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 119 SNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ceEEEE-CCcEEEEECCCCcC
Confidence 999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.5e-12 Score=143.66 Aligned_cols=90 Identities=23% Similarity=0.302 Sum_probs=77.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|++|+..+.++.... ..++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||
T Consensus 388 ~~l~~l~~~~i~~p~~~~~~~~-~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp 456 (535)
T PRK09605 388 RLLSEARRAGVPTPVIYDVDPE-EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTT 456 (535)
T ss_pred HHHHhhcccCCCeeEEEEEeCC-CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCCh
Confidence 5788999999988776665433 5689999999999999885 3467899999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceec
Q 008303 82 SNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~ 103 (570)
+|||+ .++.++|+|||+++..
T Consensus 457 ~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 457 SNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred HHEEE-ECCcEEEEeCcccccC
Confidence 99999 5788999999999763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-12 Score=130.19 Aligned_cols=97 Identities=16% Similarity=0.179 Sum_probs=73.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH-ILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g-IvHrDLK 80 (570)
++|++|.+. ++.+..++... ..||||||+.|++|..++.. ...+.+..+..++.||+.+|.+||++| |+|||||
T Consensus 102 ~~L~~L~~~-~i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 102 RNLQRLYEA-GVPVPKPIAWR--RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred HHHHHHHhc-CCCCCeeeEec--CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 356666542 23333333222 24799999999888766532 234667778899999999999999999 9999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~ 104 (570)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2e-12 Score=148.33 Aligned_cols=200 Identities=27% Similarity=0.402 Sum_probs=164.6
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+||.++...-.|.. ....++|++|..|++|...++..+ ..+++-.+..+..+..+++|||...+.|+|++|.|+|+.
T Consensus 862 ~~P~v~~~~~s~~~-rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPC-RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCC-CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhc
Confidence 45666655544322 335789999999999999887654 478888999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCceeccCC--------------------------------CCCccccCCCCCCCcccccCCCCCCcccc
Q 008303 88 KDQDIRLGDFGLAKILTSD--------------------------------DLASSVVGTPSYMCPELLADIPYGSKSDI 135 (570)
Q Consensus 88 ~~g~vKL~DFGla~~~~~~--------------------------------~~~~~~~GT~~Y~APE~l~~~~~t~ksDI 135 (570)
.+|..++.|||......-- ......+||+.|.+||.+.+...+..+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 9999999999843221100 01223578999999999999999999999
Q ss_pred cchhhhHHHhhccCCCCcccCHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHH---HHHHhhccChh
Q 008303 136 WSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAA---ELLRHVHLQPY 210 (570)
Q Consensus 136 WSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~---eIL~hp~fq~~ 210 (570)
|++|+++++.++|.+||.....+..++.|.+.... ..+...+..+++++..+|..++.+|..+. ++-.|++|+..
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 99999999999999999999999988887665432 23456789999999999999999999888 88889999853
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.3e-11 Score=133.67 Aligned_cols=137 Identities=25% Similarity=0.430 Sum_probs=107.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH-ANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH-s~gIvHrDLK 80 (570)
+-|+.|+||||++|++.++.++ .+|||+|-|. .|..++++ +....++-.++||+.||.||| +.+++|++|.
T Consensus 61 k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~ 132 (690)
T KOG1243|consen 61 KRLKTLRHPNILSYLDTTEEEG-TLYLVTERVR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVC 132 (690)
T ss_pred HHhhhccCchhhhhhhhhcccC-ceEEEeeccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEe
Confidence 4578889999999999997766 7999999995 78888877 347888889999999999997 6789999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG 148 (570)
-..|+|+..|..||++|.+......... .....---.|..|+.+.... -..|.|.|||++++++.|
T Consensus 133 ~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 133 KDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 9999999999999999998765432221 11111122355555543222 346999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.9e-12 Score=121.74 Aligned_cols=90 Identities=14% Similarity=0.145 Sum_probs=71.4
Q ss_pred HhhhcCCCc--ccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 3 LISKIRNPF--IVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 3 IL~kL~HPn--IV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++.++.|.+ ++..++ . +..|+||||+.|++|..++.. .....++.+|+.++.++|..||+|||||
T Consensus 86 ~l~~l~~~~i~v~~~~~----~-~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~ 152 (198)
T cd05144 86 ALKALYEEGFPVPKPID----W-NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLS 152 (198)
T ss_pred HHHHHHHcCCCCCceee----c-CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 456666664 334433 1 245899999999999765431 3456789999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS 105 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~ 105 (570)
|+||+++.++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.9e-12 Score=139.39 Aligned_cols=196 Identities=26% Similarity=0.302 Sum_probs=152.1
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHHCCcccceecCCc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM----ALDYLHANHILHRDVKCSN 83 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~----aL~yLHs~gIvHrDLKP~N 83 (570)
-|+|.++.+..|... +..++-+|+|. .+|..+..... ..+++..++.++.+... ||.++|..+|+|-|+||.|
T Consensus 176 ~~~~~v~~~~~~e~~-~~lfiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~ 252 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGS-GILFIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPAN 252 (524)
T ss_pred ccccccccCcccccC-Ccceeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhh
Confidence 589999988888654 47899999996 68888876543 35889999999999999 9999999999999999999
Q ss_pred EEEcCC-CCEEEeecCCceeccCCCCCcc------ccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc-
Q 008303 84 IFLTKD-QDIRLGDFGLAKILTSDDLASS------VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF- 155 (570)
Q Consensus 84 ILld~~-g~vKL~DFGla~~~~~~~~~~~------~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~- 155 (570)
|++..+ ..++++|||+...+....+... ..|...|++||++.+ -++...|||++|.++.+..++...+...
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 999999 8899999999999876654322 256778999999875 6788999999999998877665443222
Q ss_pred -CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 156 -DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 156 -~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+....+..+. +...+-...+.++...+..|++.++..|++++.+++|.++..
T Consensus 332 ~~~W~~~r~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 332 NSSWSQLRQGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CCCcccccccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1111111110 112223345667778999999999999999999999988763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-10 Score=104.17 Aligned_cols=91 Identities=20% Similarity=0.221 Sum_probs=75.5
Q ss_pred HHhhhcCC--CcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Q 008303 2 ELISKIRN--PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN---HILH 76 (570)
Q Consensus 2 ~IL~kL~H--PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~---gIvH 76 (570)
++++.+.| .+++++++++... +..|++|||+.|+.+..+ +......++.+++.+|++||.. +++|
T Consensus 43 ~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H 112 (155)
T cd05120 43 AILQLLARKGLPVPKVLASGESD-GWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCH 112 (155)
T ss_pred HHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEe
Confidence 46777755 5888888766443 468999999998777643 4566778899999999999985 6999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCcee
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
+|++|.|||++..+.++++|||.+..
T Consensus 113 ~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 113 GDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCCcceEEEECCcEEEEEecccccC
Confidence 99999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.7e-10 Score=107.00 Aligned_cols=75 Identities=19% Similarity=0.259 Sum_probs=60.4
Q ss_pred EEEEEeccCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 26 VCIIIGFCEGGDMAE-AIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 26 i~IV~Ey~~gGsL~d-~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
.|+||||+.|+.+.. .+.... .. ..+..++.|++.++.++|. .||+|+||||+||+++ ++.++|+|||.+...
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 489999999954432 122111 11 6788999999999999999 9999999999999999 899999999999765
Q ss_pred cC
Q 008303 104 TS 105 (570)
Q Consensus 104 ~~ 105 (570)
..
T Consensus 165 ~~ 166 (187)
T cd05119 165 DH 166 (187)
T ss_pred cC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.2e-10 Score=124.55 Aligned_cols=192 Identities=28% Similarity=0.327 Sum_probs=144.6
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
-|.+++.++..|.+.. ..||=.|||+++++...+.- ...+.+..++++..|++.++.++|+..++|+|+||+||++.
T Consensus 324 ~~~~~~g~~~~W~~~r-~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~ 400 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLR-QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS 400 (524)
T ss_pred cccccCCCCCCccccc-cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec
Confidence 6889999888887654 46799999999999877733 34689999999999999999999999999999999999998
Q ss_pred CC-CCEEEeecCCceeccCCCCCccccCCCCCC--CcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHH
Q 008303 88 KD-QDIRLGDFGLAKILTSDDLASSVVGTPSYM--CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI 164 (570)
Q Consensus 88 ~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~--APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i 164 (570)
.+ +..+++|||....+.-.. ....+.-+++ +++......+..+.|+++||.-+++.+++...-...... ..|
T Consensus 401 ~~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i 475 (524)
T KOG0601|consen 401 NDGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI 475 (524)
T ss_pred cchhhhhccccccccccceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee
Confidence 86 788999999986532111 1122233344 555566777899999999999999998886543332211 112
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 165 NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 165 ~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
..+... ........+..+.+.|+..++..|+.+.++..|.-|.
T Consensus 476 ~~~~~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 RSGDTP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eccccc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 222222 2333448889999999999999999999999887654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.1e-09 Score=113.06 Aligned_cols=180 Identities=19% Similarity=0.294 Sum_probs=135.8
Q ss_pred CHHhhhcCCCcccccceEEEe---eCcEEEEEEeccCC-CCHHHHHHH-------------hCCCCCCHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVE---RGCYVCIIIGFCEG-GDMAEAIKK-------------ANSKLFSEEKLCKWLVQLL 63 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~---~~~~i~IV~Ey~~g-GsL~d~I~~-------------~~~~~Lse~~i~~I~~QLl 63 (570)
+++|+++.|.|||.+.++|.. .+..+++|++|.++ ++|.++--. ..+...+|+.+|.++.||.
T Consensus 324 ve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLt 403 (655)
T KOG3741|consen 324 VEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLT 403 (655)
T ss_pred HHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHH
Confidence 478999999999999999862 24568999999875 567665311 1234578999999999999
Q ss_pred HHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 64 MALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 64 ~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.||.++|+.|+.-+-|.+.+||++.+.+|+|...|....+..+.. |.+ .-..+-|.-.||.++.
T Consensus 404 aaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~-------------~~l---e~~Qq~D~~~lG~ll~ 467 (655)
T KOG3741|consen 404 AALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT-------------EPL---ESQQQNDLRDLGLLLL 467 (655)
T ss_pred HHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC-------------cch---hHHhhhhHHHHHHHHH
Confidence 999999999999999999999999998999998888777655431 111 1124568889999999
Q ss_pred HhhccCCCC-cccCHHHH-HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTSLKPAF-KAFDMQAL-INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLltG~~pf-~~~~~~~~-~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.|.+|..-- .....+.. ...| -..++.+++++|..+...++++ -++.++|.+-
T Consensus 468 aLAt~~~ns~~~d~~~~s~~~~I--------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 468 ALATGTENSNRTDSTQSSHLTRI--------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHhhcccccccccchHHHHHHHh--------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 999985431 11111111 2222 3468999999999999999887 7888888764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-09 Score=120.44 Aligned_cols=154 Identities=19% Similarity=0.264 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHHHHHC-CcccceecCCcEEEcCCCCEEEeecCCceeccCC-C---------CCccccCCCCCCCccccc
Q 008303 57 KWLVQLLMALDYLHAN-HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-D---------LASSVVGTPSYMCPELLA 125 (570)
Q Consensus 57 ~I~~QLl~aL~yLHs~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~---------~~~~~~GT~~Y~APE~l~ 125 (570)
.=+.+++.|+.|+|.. ++||++|-|++|.++..|..||+.|+++-..... + +..-..-...|.|||++.
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3355667999999976 8999999999999999999999999987554331 1 111123456799999999
Q ss_pred CCCCCCcccccchhhhHHHhh-ccCCCCcccCHHHHHHH---HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 126 DIPYGSKSDIWSLGCCIYEMT-SLKPAFKAFDMQALINK---INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 126 ~~~~t~ksDIWSLG~IlyeLl-tG~~pf~~~~~~~~~~~---i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
....+.++|+|||||++|.+. .|+..+........... ............++.++++-+.++|..+..-||++.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 988899999999999999998 56655554432211111 11111122346788999999999999999999999999
Q ss_pred HHhhccChh
Q 008303 202 LRHVHLQPY 210 (570)
Q Consensus 202 L~hp~fq~~ 210 (570)
+..+||+..
T Consensus 263 ~~~~ff~D~ 271 (700)
T KOG2137|consen 263 LSIPFFSDP 271 (700)
T ss_pred hcccccCCc
Confidence 999998743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.81 E-value=8.4e-09 Score=112.90 Aligned_cols=77 Identities=19% Similarity=0.267 Sum_probs=61.5
Q ss_pred EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH-HHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM-ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 25 ~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~-aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
..+||||||+|++|.++....... +. ...++.+++. .+..+|..|++|+|+||.||+++.+|.++|+|||++..+
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 357999999999999887542211 22 3456666665 478899999999999999999999999999999999877
Q ss_pred cC
Q 008303 104 TS 105 (570)
Q Consensus 104 ~~ 105 (570)
..
T Consensus 308 ~~ 309 (437)
T TIGR01982 308 SE 309 (437)
T ss_pred CH
Confidence 53
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.6e-08 Score=99.30 Aligned_cols=95 Identities=14% Similarity=0.204 Sum_probs=70.1
Q ss_pred HHhhhcCC--CcccccceEEEeeCcEEEEEEeccCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccc
Q 008303 2 ELISKIRN--PFIVEYKDSWVERGCYVCIIIGFCEGGDMAE-AIKKANSKLFSEEKLCKWLVQLLMALDYL-HANHILHR 77 (570)
Q Consensus 2 ~IL~kL~H--PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d-~I~~~~~~~Lse~~i~~I~~QLl~aL~yL-Hs~gIvHr 77 (570)
+.|+++.. -++...+++ .+ -+|||||+.++.+.. .++. ..++++.+..++.|++.+|.+| |+.||+|+
T Consensus 78 r~L~rl~~~Gv~vP~pi~~--~~---~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG 149 (197)
T cd05146 78 HNLKRMQKAGIPCPEVVVL--KK---HVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHA 149 (197)
T ss_pred HHHHHHHHcCCCCCeEEEe--cC---CEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 34566632 355666653 22 369999998754432 2332 2366777888899999999999 89999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccC
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTS 105 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~ 105 (570)
||++.|||+. ++.+.|+|||.+.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 57799999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-08 Score=94.44 Aligned_cols=87 Identities=21% Similarity=0.163 Sum_probs=63.7
Q ss_pred HHhhhcCCCcc-cccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----c
Q 008303 2 ELISKIRNPFI-VEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHI-----L 75 (570)
Q Consensus 2 ~IL~kL~HPnI-V~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI-----v 75 (570)
++|+.+.+.++ .+++++. .. ..++||||++|.++.+. ......++.+++.+|+.||..++ +
T Consensus 44 ~~l~~l~~~~~~P~~~~~~--~~-~~~lv~e~i~G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~ 110 (170)
T cd05151 44 ENSKLAAEAGIGPKLYYFD--PE-TGVLITEFIEGSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPC 110 (170)
T ss_pred HHHHHHHHhCCCCceEEEe--CC-CCeEEEEecCCCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceee
Confidence 35666644444 4555432 22 23699999999887643 01123457899999999999985 9
Q ss_pred cceecCCcEEEcCCCCEEEeecCCcee
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
|+|+++.||+++ ++.++++|||.+..
T Consensus 111 HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 111 HNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCCcCcEEEE-CCeEEEEecccccC
Confidence 999999999999 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.6e-08 Score=99.34 Aligned_cols=78 Identities=17% Similarity=0.109 Sum_probs=66.1
Q ss_pred EEEEEEeccCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcC-------CCCEEEee
Q 008303 25 YVCIIIGFCEGG-DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK-------DQDIRLGD 96 (570)
Q Consensus 25 ~i~IV~Ey~~gG-sL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~-------~g~vKL~D 96 (570)
.-+||||++++. +|.+++........++.....++.+|+..+.-||.+||+|+|+++.|||++. ++.+.|+|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 467999999986 8999986533334567788899999999999999999999999999999985 45799999
Q ss_pred cCCcee
Q 008303 97 FGLAKI 102 (570)
Q Consensus 97 FGla~~ 102 (570)
|+.+..
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.6e-08 Score=93.17 Aligned_cols=68 Identities=29% Similarity=0.420 Sum_probs=58.2
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 26 i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
..|+|||++|..|.++|... ...++..+=..+.-||.+||+|+||.++||++..++ +.++|||++..-
T Consensus 74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 46999999999999998764 245677777888899999999999999999998665 999999999753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.4e-07 Score=97.66 Aligned_cols=182 Identities=16% Similarity=0.212 Sum_probs=131.2
Q ss_pred CcEEEEEEeccCCCCH-HHHH----HHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeec
Q 008303 23 GCYVCIIIGFCEGGDM-AEAI----KKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDF 97 (570)
Q Consensus 23 ~~~i~IV~Ey~~gGsL-~d~I----~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DF 97 (570)
+..+.++|..+.|..= .++. ++..-....+..+...++.|+.+.+-||..|.+-+|++++|+|+.+++.|.|+|-
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence 4447889999887522 2222 1222346789999999999999999999999999999999999999999999986
Q ss_pred CCceeccCCCCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhcc-CCCCcccCHH-----HHHHHHHh
Q 008303 98 GLAKILTSDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQ-----ALINKINK 166 (570)
Q Consensus 98 Gla~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG-~~pf~~~~~~-----~~~~~i~~ 166 (570)
..-.+-..+......+|...|.+||+-. +...+...|.|.||+++++|+.| +.||.+.... .....|..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 6554444555556678999999999864 44567889999999999998665 8898764210 00111111
Q ss_pred c----------cCCC-----CCCCCcHHHHHHHHHhhccC--CCCCcCHHHHHHh
Q 008303 167 S----------IVAP-----LPTKYSGAFRGLVKSMLRKN--PELRPSAAELLRH 204 (570)
Q Consensus 167 ~----------~~~p-----~p~~~s~~l~dLI~~~L~~d--P~~RPTa~eIL~h 204 (570)
+ -..+ .+..+++.+..|..+|+..- +.-|||++..+.-
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 1 0111 12356789999999999754 5689999876643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.2e-07 Score=91.43 Aligned_cols=90 Identities=21% Similarity=0.225 Sum_probs=72.9
Q ss_pred ccccceEEEee---CcEEEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 12 IVEYKDSWVER---GCYVCIIIGFCEG-GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 12 IV~l~~~f~~~---~~~i~IV~Ey~~g-GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+.+.+++.... ....+||+|+++| .+|.+++..... ++......++.++...+.-||.+||+|+|+++.|||++
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~ 152 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVD 152 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEe
Confidence 34555544432 1235799999988 489999987433 67778899999999999999999999999999999999
Q ss_pred CCC---CEEEeecCCceec
Q 008303 88 KDQ---DIRLGDFGLAKIL 103 (570)
Q Consensus 88 ~~g---~vKL~DFGla~~~ 103 (570)
.++ .+.|+||+.+...
T Consensus 153 ~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 153 PDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CCCCceeEEEEcchhceeC
Confidence 887 7999999987663
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.3e-07 Score=105.78 Aligned_cols=75 Identities=21% Similarity=0.369 Sum_probs=56.3
Q ss_pred EEEEEEeccCCCCHHHHH--HHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCC----CEEEee
Q 008303 25 YVCIIIGFCEGGDMAEAI--KKANS--KLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQ----DIRLGD 96 (570)
Q Consensus 25 ~i~IV~Ey~~gGsL~d~I--~~~~~--~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g----~vKL~D 96 (570)
..+||||||+|+.|.++. ...+. ..+.+..+..++.|++ ..|++|+|+||.||+++.+| .++++|
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llD 307 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALD 307 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEe
Confidence 457999999999998753 32210 1244445555555554 59999999999999999888 899999
Q ss_pred cCCceeccCC
Q 008303 97 FGLAKILTSD 106 (570)
Q Consensus 97 FGla~~~~~~ 106 (570)
||+...+...
T Consensus 308 FGivg~l~~~ 317 (537)
T PRK04750 308 FGIVGSLNKE 317 (537)
T ss_pred cceEEECCHH
Confidence 9999887543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3e-07 Score=88.99 Aligned_cols=78 Identities=28% Similarity=0.383 Sum_probs=63.9
Q ss_pred EEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCC---EEEeecCCce
Q 008303 26 VCIIIGFCEG-GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD---IRLGDFGLAK 101 (570)
Q Consensus 26 i~IV~Ey~~g-GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~---vKL~DFGla~ 101 (570)
-+|+|||++| -++.+++..........+....++.+|=..|.-||.++|+|+||..+||++..+|. +.++|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 4699999987 58888887655444444455788999999999999999999999999999987653 5899999986
Q ss_pred ec
Q 008303 102 IL 103 (570)
Q Consensus 102 ~~ 103 (570)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.9e-07 Score=88.24 Aligned_cols=93 Identities=20% Similarity=0.274 Sum_probs=61.7
Q ss_pred HHhhhcCCC--cccccceEEEeeCcEEEEEEeccC--CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCccc
Q 008303 2 ELISKIRNP--FIVEYKDSWVERGCYVCIIIGFCE--GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDY-LHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HP--nIV~l~~~f~~~~~~i~IV~Ey~~--gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~y-LHs~gIvH 76 (570)
+.|.++..- ++.+.+++ .++ +|||||+. |..+..+.... ++.+....++.+++..+.. +|..||+|
T Consensus 60 ~~L~~l~~~Gv~vP~p~~~--~~~---~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givH 130 (188)
T PF01163_consen 60 RNLKRLYEAGVPVPKPYDY--NRN---VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVH 130 (188)
T ss_dssp HHHHHCCCTT-SS--EEEE--ETT---EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEE
T ss_pred HHHHHHHHCCccCCcEEEE--eCC---EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCcee
Confidence 467777555 45666643 333 69999998 65555443321 2245667788888885555 57999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceecc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~ 104 (570)
+||.+.|||++.+ .+.|+|||.+....
T Consensus 131 GDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 131 GDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp SS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred cCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999977 89999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-06 Score=102.70 Aligned_cols=196 Identities=21% Similarity=0.221 Sum_probs=145.8
Q ss_pred HHhhhcCCCcccccceEEEeeCc---EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIRNPFIVEYKDSWVERGC---YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~---~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+.+.++.|+|++.++.|-.++.+ .+.+..|+|.+-++...+...+ ..+.+.++.+..+++.||.|+|+....|.-
T Consensus 234 ~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~ 311 (1351)
T KOG1035|consen 234 ESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLSLEHVV 311 (1351)
T ss_pred HHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhccceeE
Confidence 45778899999999988765432 2345679999999999988753 588999999999999999999999777776
Q ss_pred ecCC---cEEEcCCCCEEEe--ecCCceeccCCCCCccccCCCCCCCcccccCCCCCC--cccccchhhhHHHhhccCCC
Q 008303 79 VKCS---NIFLTKDQDIRLG--DFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGS--KSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 79 LKP~---NILld~~g~vKL~--DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~--ksDIWSLG~IlyeLltG~~p 151 (570)
|... +--.+..+.+.+. ||+....+..........-...+.++|......+.. ..|+|++|.....+..|...
T Consensus 312 L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 312 LSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred EecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 6665 3344556667777 999888877665555556667788888887666654 47999999999988877553
Q ss_pred CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
-... .....+ ++........+++.+|+..+.++|+++.+++.|+|...
T Consensus 392 ~~~~---~~~~~~-------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 392 SEKS---AVPVSL-------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred cccc---cchhhh-------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 2211 001011 12222237889999999999999999999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-06 Score=85.30 Aligned_cols=98 Identities=13% Similarity=0.177 Sum_probs=70.4
Q ss_pred HHhhhcCC--CcccccceEEEeeC--cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------
Q 008303 2 ELISKIRN--PFIVEYKDSWVERG--CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA------ 71 (570)
Q Consensus 2 ~IL~kL~H--PnIV~l~~~f~~~~--~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs------ 71 (570)
++++.|.+ .++.+++.+...++ +..|+||||++|.+|.+.+.. ..++++....++.+++.+|.+||+
T Consensus 47 ~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ 123 (223)
T cd05154 47 RVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAV 123 (223)
T ss_pred HHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhc
Confidence 45666654 34566776553321 246899999999888765431 236677777777777777777773
Q ss_pred --------------------------------------------------CCcccceecCCcEEEcC--CCCEEEeecCC
Q 008303 72 --------------------------------------------------NHILHRDVKCSNIFLTK--DQDIRLGDFGL 99 (570)
Q Consensus 72 --------------------------------------------------~gIvHrDLKP~NILld~--~g~vKL~DFGl 99 (570)
..++|+|+++.|||++. ++.+.|+||+.
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~ 203 (223)
T cd05154 124 GLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWEL 203 (223)
T ss_pred CCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccc
Confidence 23689999999999998 56689999998
Q ss_pred cee
Q 008303 100 AKI 102 (570)
Q Consensus 100 a~~ 102 (570)
+..
T Consensus 204 ~~~ 206 (223)
T cd05154 204 ATL 206 (223)
T ss_pred ccc
Confidence 864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.5e-07 Score=101.72 Aligned_cols=206 Identities=22% Similarity=0.323 Sum_probs=143.0
Q ss_pred CHHhhhcCCCc-ccccceEEEeeCcEEEEEEeccCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKIRNPF-IVEYKDSWVERGCYVCIIIGFCEGG-DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL~HPn-IV~l~~~f~~~~~~i~IV~Ey~~gG-sL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|.|++||| .+.+++.+.. ..+.+|++++|.++ +-...+... ...|-+-+...+.+.-+.+++|||+.--+|+|
T Consensus 284 ~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d 361 (829)
T KOG0576|consen 284 IELLDKVNNPNPVVRYLEDYDG-EDYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD 361 (829)
T ss_pred HHHHHHccCCCCcccccccCCc-ccccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc
Confidence 47899999999 7777777644 35889999999987 222221110 11233445566677778899999999889999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
||+... +..|..||+....+..........+++.+++||+.....+....|+|++|.--.+|.-|.+|-..- .
T Consensus 362 ----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~ 434 (829)
T KOG0576|consen 362 ----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--P 434 (829)
T ss_pred ----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--c
Confidence 777664 679999999998887766667788999999999999999999999999998767776666553220 0
Q ss_pred HHHHHHHhccCCC-C-C-CCCcHHHH-HHHHHhhccCCCCCcCHHHHHHhhccChhhhhhh
Q 008303 159 ALINKINKSIVAP-L-P-TKYSGAFR-GLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215 (570)
Q Consensus 159 ~~~~~i~~~~~~p-~-p-~~~s~~l~-dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~k~~ 215 (570)
.....+..+...+ + . ..++.-.. ++...|+...|..|+....++.|-+|....++++
T Consensus 435 ~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~ 495 (829)
T KOG0576|consen 435 AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIH 495 (829)
T ss_pred cccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcccce
Confidence 0000000000000 0 0 11222222 4788899999999999999999988876655544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.4e-06 Score=82.26 Aligned_cols=66 Identities=18% Similarity=0.350 Sum_probs=53.0
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 26 i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++||||++|..|.++.. +.+ .+...|..++.-||+.|++|+|.+|.|++++.++ ++++||+..+.
T Consensus 118 ~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 458999999988876532 233 2445677789999999999999999999998555 99999988765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.3e-07 Score=110.52 Aligned_cols=204 Identities=15% Similarity=0.094 Sum_probs=152.9
Q ss_pred hhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cc
Q 008303 4 ISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANS--KLFSEEKLCKWLVQLLMALDYLHANH-----IL 75 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~--~~Lse~~i~~I~~QLl~aL~yLHs~g-----Iv 75 (570)
+++.+|+++..+..-.... ....|++++||.+|.+++.|-+.-. ..+.+..+.....+.+.+..-+|... .+
T Consensus 1283 ~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v 1362 (2724)
T KOG1826|consen 1283 LREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNV 1362 (2724)
T ss_pred hhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccch
Confidence 4556899988777644322 3346899999999999999865322 33444445544445477888877652 79
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|++||+-|.+|..+.++|++++|+.++.. ........++++.|+.+++.+...++.++|||..|+.+|++..|..+|-.
T Consensus 1363 ~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1363 SKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred hhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 99999999999999999999999999433 33455667889999999999999999999999999999999988887765
Q ss_pred cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 155 FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
+....+...+.......++..++.+.-.....+|-.....||.-..++..+++
T Consensus 1443 flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1443 FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 44444444444444444555667777777777777778889988888877765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.9e-05 Score=75.83 Aligned_cols=95 Identities=18% Similarity=0.177 Sum_probs=74.1
Q ss_pred HhhhcCC-CcccccceEEEeeCcEEEEEEeccCCCCHHHH---HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcc
Q 008303 3 LISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEA---IKKANSKLFSEEKLCKWLVQLLMALDYLHA---NHIL 75 (570)
Q Consensus 3 IL~kL~H-PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~---I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs---~gIv 75 (570)
+|+.+.+ +++++++|+| |. ++|.||...+++... +.+. ..-++..+.+|+.+++..+.+|+. ..+.
T Consensus 12 ll~~l~~~~~~pk~lG~C---G~--~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 12 LLQLLQGSEPFPKLLGSC---GR--FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred HHHHcCCCCCCCCeeeEC---CC--EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 4555644 5999999987 42 479999987766421 1111 124899999999999999999998 4588
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceecc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~ 104 (570)
-.|++++|+-++++|.+|++|.+.+....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 89999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.5e-05 Score=76.61 Aligned_cols=78 Identities=13% Similarity=0.142 Sum_probs=65.9
Q ss_pred EEEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCC--EEEeecCCce
Q 008303 25 YVCIIIGFCEG-GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD--IRLGDFGLAK 101 (570)
Q Consensus 25 ~i~IV~Ey~~g-GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~--vKL~DFGla~ 101 (570)
.-+||+|-+.| .+|.+++....-...++.....++.+|..+|+-||+.|+.|+|+.+.|||++.+|. |+++||.-++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 35699997753 68998887644345678888999999999999999999999999999999987777 9999998775
Q ss_pred e
Q 008303 102 I 102 (570)
Q Consensus 102 ~ 102 (570)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=5.5e-05 Score=77.50 Aligned_cols=91 Identities=19% Similarity=0.202 Sum_probs=66.5
Q ss_pred HHhhhcCCC--cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNP--FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HP--nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|.+|.-. .|.+-+++ +.-++||||++|-.|...- ++.+....++..|+.-+.-+-..||||+|+
T Consensus 161 ~~L~~L~~~G~~VP~P~~~-----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDl 228 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAW-----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDL 228 (304)
T ss_pred HHHHHhhhcCCCCCCcccc-----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCC
Confidence 456666444 56666652 2347999999997765432 234555666666776666666999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceecc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~ 104 (570)
..-|||++.+|.+.++||-.+....
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred chheEEEecCCCEEEEeCcccccCC
Confidence 9999999999999999998765443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00022 Score=78.54 Aligned_cols=156 Identities=22% Similarity=0.279 Sum_probs=103.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+.+.|+|...++++-........+|||+|. .+|.+.++.+... ... ++ +|+-+.
T Consensus 34 ~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~---~~s-------~~-----------~~~~~~- 90 (725)
T KOG1093|consen 34 QYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLK---DES-------LL-----------AHGVLH- 90 (725)
T ss_pred HHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccc---hhh-------hc-----------ccccce-
Confidence 467888999999999876555556889999995 5999988764321 111 11 232221
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
-|| ++++| -++ ... . ...++++|||++|.++.++..|...+......+..
T Consensus 91 ~~~-------~~~td-~~~---t~~---~----------------~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l 140 (725)
T KOG1093|consen 91 LNI-------IYITD-HFL---TKY---P----------------SPIGPKSDVWSLGFIILELYLGISLEAELTESEYL 140 (725)
T ss_pred ehh-------hhccc-ccc---ccC---C----------------CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 122 22233 000 000 0 11124999999999999999998877766666666
Q ss_pred HHHHhccCCCCC-----------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 162 NKINKSIVAPLP-----------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p-----------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+.+-...+.. ..++..+.++.++|+-..|..||...++++++-|...
T Consensus 141 ~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 141 EILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 555544333211 1346678899999999999999999999999988654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0004 Score=77.64 Aligned_cols=78 Identities=22% Similarity=0.340 Sum_probs=56.6
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccC
Q 008303 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS 105 (570)
Q Consensus 26 i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 105 (570)
-.|+|||++|-.+.+...... ..++...+...+.++. +..+-..|++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 241 ~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 241 RVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 469999999999998843221 2255444333333322 3344458999999999999999999999999999987754
Q ss_pred C
Q 008303 106 D 106 (570)
Q Consensus 106 ~ 106 (570)
.
T Consensus 318 ~ 318 (517)
T COG0661 318 K 318 (517)
T ss_pred H
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0027 Score=63.57 Aligned_cols=29 Identities=21% Similarity=0.197 Sum_probs=25.9
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++|+|++|.||+++.++ +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0021 Score=64.25 Aligned_cols=30 Identities=20% Similarity=0.217 Sum_probs=26.6
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 489999999999999887788999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0013 Score=73.75 Aligned_cols=86 Identities=19% Similarity=0.310 Sum_probs=59.3
Q ss_pred ccccceEEEeeCcEEEEEEeccCCCCHHHH--HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcC-
Q 008303 12 IVEYKDSWVERGCYVCIIIGFCEGGDMAEA--IKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTK- 88 (570)
Q Consensus 12 IV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~--I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~- 88 (570)
|.++|..+. ..-.|+||||+|..+.|. |++.+ ++...+..-+.+... ..|-..|++|+|-+|.||+++.
T Consensus 266 VP~Vy~~~s---t~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~ 337 (538)
T KOG1235|consen 266 VPKVYWDLS---TKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPN 337 (538)
T ss_pred CCeehhhcC---cceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecC
Confidence 555554332 234699999999877654 45433 566655444444432 3344568999999999999994
Q ss_pred ---CCCEEEeecCCceeccC
Q 008303 89 ---DQDIRLGDFGLAKILTS 105 (570)
Q Consensus 89 ---~g~vKL~DFGla~~~~~ 105 (570)
++.+.+.|||+...+..
T Consensus 338 ~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 338 PEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCCCccEEEEcccccccccH
Confidence 66899999999877654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0032 Score=64.14 Aligned_cols=75 Identities=16% Similarity=0.182 Sum_probs=56.6
Q ss_pred EEEEeccCCCC-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceecCCcEEEcCCCCEEEeecCCceecc
Q 008303 27 CIIIGFCEGGD-MAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 27 ~IV~Ey~~gGs-L~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 104 (570)
.|||||+...- -.-.++ ...+..++...+..+++..+.-|-. .|+||+||..-|||+. ++.+.|+|||-+....
T Consensus 142 VLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 142 VLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 59999995431 111111 1223444788888899999988887 8999999999999999 8899999999987655
Q ss_pred C
Q 008303 105 S 105 (570)
Q Consensus 105 ~ 105 (570)
+
T Consensus 218 h 218 (268)
T COG1718 218 H 218 (268)
T ss_pred C
Confidence 3
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.011 Score=57.24 Aligned_cols=31 Identities=29% Similarity=0.377 Sum_probs=21.7
Q ss_pred CCcccceecCCcEEEc-CCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLT-KDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld-~~g~vKL~DFGla~~ 102 (570)
..++|+|+.+.|||++ .++.|-|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 3599999999999999 666678999998755
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.0059 Score=65.25 Aligned_cols=75 Identities=21% Similarity=0.343 Sum_probs=60.0
Q ss_pred eeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccceecCCcEEEcCCCCEEEeecCC
Q 008303 21 ERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDVKCSNIFLTKDQDIRLGDFGL 99 (570)
Q Consensus 21 ~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDLKP~NILld~~g~vKL~DFGl 99 (570)
+.+.|.|++|++- |+.|.- ++. -..+++..|+.+.+..+.-+..+ ..-|||+...||||+ +|+|.|+||-+
T Consensus 296 de~~y~yl~~kdh-gt~is~-ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 296 DETLYLYLHFKDH-GTPISI-IKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CCceEEEEEEecC-Cceeee-eec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence 3456788899986 555542 221 35778899999999888888766 689999999999999 99999999999
Q ss_pred ceec
Q 008303 100 AKIL 103 (570)
Q Consensus 100 a~~~ 103 (570)
++.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9853
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.018 Score=56.80 Aligned_cols=88 Identities=17% Similarity=0.230 Sum_probs=62.0
Q ss_pred cCCCcccccceEEEeeCcEEEEEEeccCC------CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEG------GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 7 L~HPnIV~l~~~f~~~~~~i~IV~Ey~~g------GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
..+.+|.+++|+... +.-..+|+|.+.+ .+|.++++.. .+++ . +...|-.-..||-+++|+.+||+
T Consensus 74 ~~~~~i~r~~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~ 145 (199)
T PF10707_consen 74 VDWSHIPRFYGFVET-NLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDHHIVIRDLN 145 (199)
T ss_pred CcccccccEeEEEec-CCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHcCCeecCCC
Confidence 358899999997654 4456789988733 4688888542 3555 3 33444455678899999999999
Q ss_pred CCcEEEcCCC----CEEEee-cCCcee
Q 008303 81 CSNIFLTKDQ----DIRLGD-FGLAKI 102 (570)
Q Consensus 81 P~NILld~~g----~vKL~D-FGla~~ 102 (570)
|.||++...+ .+.|+| ||....
T Consensus 146 ~~NIv~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred cccEEEEecCCCceEEEEEeCCCCccc
Confidence 9999997532 477777 555433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.016 Score=68.79 Aligned_cols=32 Identities=22% Similarity=0.394 Sum_probs=25.9
Q ss_pred CcccceecCCcEEEcCC-CC-EEEeecCCceecc
Q 008303 73 HILHRDVKCSNIFLTKD-QD-IRLGDFGLAKILT 104 (570)
Q Consensus 73 gIvHrDLKP~NILld~~-g~-vKL~DFGla~~~~ 104 (570)
.+||+|+++.|||++.+ +. +-|+||+++....
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 49999999999999853 33 5799999987643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.012 Score=62.08 Aligned_cols=70 Identities=17% Similarity=0.221 Sum_probs=52.6
Q ss_pred EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 25 ~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.-|+|||++.|-.|...-+- .+ +..+...+..-+--|-.+|+||+|.+--||++++++.++++||--...
T Consensus 182 RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 182 RHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhhc
Confidence 45899999999887654321 12 233344455556678889999999999999999999999999975543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.079 Score=53.44 Aligned_cols=29 Identities=31% Similarity=0.389 Sum_probs=25.8
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++|+|+.+.||+++.++ +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999877 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.14 Score=52.74 Aligned_cols=29 Identities=24% Similarity=0.429 Sum_probs=25.4
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCce
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAK 101 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~ 101 (570)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.12 Score=53.73 Aligned_cols=31 Identities=23% Similarity=0.276 Sum_probs=27.5
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5899999999999999888778999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=92.99 E-value=0.07 Score=53.19 Aligned_cols=30 Identities=20% Similarity=0.308 Sum_probs=25.7
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
+++|+|+++.|||++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 589999999999998766567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.72 E-value=0.093 Score=51.87 Aligned_cols=30 Identities=20% Similarity=0.377 Sum_probs=26.7
Q ss_pred CcccceecCCcEEEcC-CCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTK-DQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~-~g~vKL~DFGla~~ 102 (570)
+++|+|+++.|||++. ++.+.|+||..+..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 5899999999999998 57899999998754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.19 Score=50.79 Aligned_cols=72 Identities=21% Similarity=0.222 Sum_probs=49.3
Q ss_pred cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccceecCCcEEEcC
Q 008303 11 FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA--NHILHRDVKCSNIFLTK 88 (570)
Q Consensus 11 nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs--~gIvHrDLKP~NILld~ 88 (570)
.|+++.. +++..+.+|+|+|-.... + -..++.-=+.+|.-.|+ .+.+|||-.|+|||-|.
T Consensus 117 GilrL~N---Dn~~~yGvIlE~Cy~~~i-----------~----~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~ 178 (308)
T PF07387_consen 117 GILRLKN---DNNYKYGVILERCYKIKI-----------N----FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDK 178 (308)
T ss_pred heeEeec---CCCceeEEEEeeccCccc-----------c----hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecC
Confidence 3555552 356667899999953111 1 11222222566777884 37999999999999999
Q ss_pred CCCEEEeecCCc
Q 008303 89 DQDIRLGDFGLA 100 (570)
Q Consensus 89 ~g~vKL~DFGla 100 (570)
.|.+||.|-+..
T Consensus 179 ~G~lKlVDP~~L 190 (308)
T PF07387_consen 179 FGYLKLVDPVCL 190 (308)
T ss_pred CCCEEecChhhh
Confidence 999999997653
|
The function of this family is unknown. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.41 E-value=0.17 Score=51.98 Aligned_cols=31 Identities=23% Similarity=0.293 Sum_probs=27.2
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887778999998743
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.21 Score=52.01 Aligned_cols=31 Identities=23% Similarity=0.268 Sum_probs=26.4
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.|+||+|+++.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999999666568999998743
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.11 E-value=0.19 Score=51.95 Aligned_cols=49 Identities=29% Similarity=0.295 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHHHHHHHHC--CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 54 KLCKWLVQLLMALDYLHAN--HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 54 ~i~~I~~QLl~aL~yLHs~--gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.+.+.+..+-.++.-+|.. -++|+|+.++|+++++.|.++|+||..|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3444455555555555544 489999999999999989999999998865
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.80 E-value=0.18 Score=53.36 Aligned_cols=32 Identities=19% Similarity=0.315 Sum_probs=28.8
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceecc
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 104 (570)
.++|+|+.+.||+|+..+.+=|+||+++....
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 48999999999999999889999999987644
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=91.80 E-value=0.61 Score=53.79 Aligned_cols=17 Identities=29% Similarity=0.534 Sum_probs=9.1
Q ss_pred CCCCcchhhhhhhhhhh
Q 008303 544 KVSPRETAIWLTKSIKE 560 (570)
Q Consensus 544 kvspretaiwl~ks~~~ 560 (570)
..+||=-||-.-=-|-|
T Consensus 776 rL~pRL~~ilFKl~fse 792 (1102)
T KOG1924|consen 776 RLRPRLSAILFKLTFSE 792 (1102)
T ss_pred ccChhHHHHHHHhhHHH
Confidence 34666666655444444
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.66 E-value=0.29 Score=50.52 Aligned_cols=30 Identities=30% Similarity=0.410 Sum_probs=26.7
Q ss_pred CcccceecCCcEEEcCC----CCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKD----QDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~----g~vKL~DFGla~~ 102 (570)
+++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999985 8899999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=91.03 E-value=0.66 Score=46.15 Aligned_cols=77 Identities=22% Similarity=0.172 Sum_probs=54.5
Q ss_pred hhhcCCCcc--cccceEEEee-----------------CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH
Q 008303 4 ISKIRNPFI--VEYKDSWVER-----------------GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64 (570)
Q Consensus 4 L~kL~HPnI--V~l~~~f~~~-----------------~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~ 64 (570)
|+.+.+.++ |+++||..-. .....||.||+.... .+... -+.+|++
T Consensus 111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~ 175 (207)
T PF13095_consen 111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLR 175 (207)
T ss_pred HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHH
Confidence 555666677 8888877422 112458888886533 12222 3567888
Q ss_pred HHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCc
Q 008303 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA 100 (570)
Q Consensus 65 aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla 100 (570)
-|..+|..||+-+|+++.|.. + -||+|||.+
T Consensus 176 dl~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence 889999999999999999986 3 389999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.03 E-value=0.63 Score=48.51 Aligned_cols=26 Identities=8% Similarity=0.234 Sum_probs=20.2
Q ss_pred CcccceecCCcEEEcCC-CC-EEEeecC
Q 008303 73 HILHRDVKCSNIFLTKD-QD-IRLGDFG 98 (570)
Q Consensus 73 gIvHrDLKP~NILld~~-g~-vKL~DFG 98 (570)
.++|||+++.||+++.+ +. +.|+|..
T Consensus 194 sLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 194 VLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred eeEeCCCCcccEEECCCCCceEEEECch
Confidence 47999999999999864 43 5677654
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.18 E-value=0.2 Score=49.09 Aligned_cols=28 Identities=32% Similarity=0.391 Sum_probs=25.3
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.+|+|+.|.||+++++| ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998777 99999999865
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=89.95 E-value=0.56 Score=45.85 Aligned_cols=30 Identities=33% Similarity=0.533 Sum_probs=21.7
Q ss_pred CcccceecCCcEEE-cCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFL-TKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILl-d~~g~vKL~DFGla~~ 102 (570)
-++|+||.+.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 7889999999999865
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.88 E-value=0.43 Score=46.54 Aligned_cols=31 Identities=35% Similarity=0.521 Sum_probs=26.1
Q ss_pred CCcccceecCCcEEEcCCC-----CEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQ-----DIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g-----~vKL~DFGla~~ 102 (570)
..++|||+++.||++..++ .+.|+||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4689999999999998644 589999998754
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=88.92 E-value=0.5 Score=49.24 Aligned_cols=30 Identities=13% Similarity=0.210 Sum_probs=27.7
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
+++|+|+.+.|||++.++.+-++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=88.72 E-value=1.5 Score=47.09 Aligned_cols=121 Identities=19% Similarity=0.129 Sum_probs=75.8
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~ 82 (570)
+|.+ -.|+|+.-+. ++++.+.|-++-...-.=+..+++ +.....+++++|.+..|.-+ .+--.|-=|.|+
T Consensus 44 lld~-~~~f~~~eit---~~~Ds~vIsy~i~~~~~~F~~~k~-----~~k~~Klr~a~~~I~~l~e~-~~tr~~~~laPe 113 (434)
T COG4499 44 LLDK-SPPFIVAEIT---EDNDSFVISYPIPEAAKSFASAKR-----KEKTRKLRLALQNIATLSEL-NNTRYTFFLAPE 113 (434)
T ss_pred Hhcc-CCCccceeec---ccCceeEEEecCccccchHHHHHH-----HHHHHHHHHHHHHHHHHHHh-hccceeEEecch
Confidence 3444 4456665553 223334454444433222333443 45566777788887777654 344567778999
Q ss_pred cEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 83 NIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 83 NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||+++.++.+-+.-+|+-..+.+-. |.||.+.. .+-|+++.++.|+.+|..
T Consensus 114 Nilf~~~l~p~~vH~Glk~~lpPye-----------~tee~f~~----------~ykA~~~~~fn~k~~Fe~ 164 (434)
T COG4499 114 NILFDGGLTPFFVHRGLKNSLPPYE-----------MTEERFLK----------EYKALAIYAFNGKFSFES 164 (434)
T ss_pred heEEcCCCceEEEecchhccCCCCC-----------CCHHHHHH----------HHHHHHHHHHcCCccHHH
Confidence 9999999999999999876654322 34444432 567778888888888754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.57 E-value=0.89 Score=49.39 Aligned_cols=30 Identities=30% Similarity=0.319 Sum_probs=24.7
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
...+|.|+-+.|||.++ +.+.++||..+..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 35799999999999764 4599999988743
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.27 E-value=0.63 Score=49.87 Aligned_cols=38 Identities=21% Similarity=0.244 Sum_probs=26.9
Q ss_pred HHHHHHHHHHHHHHHHHHH----HCCcccceecCCcEEEcCC
Q 008303 52 EEKLCKWLVQLLMALDYLH----ANHILHRDVKCSNIFLTKD 89 (570)
Q Consensus 52 e~~i~~I~~QLl~aL~yLH----s~gIvHrDLKP~NILld~~ 89 (570)
.+-++.++.||+.-.--+- ..+.+|-||||+|||+-+.
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 315 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS 315 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence 4567777888765443232 3469999999999999643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=88.27 E-value=0.44 Score=50.81 Aligned_cols=30 Identities=23% Similarity=0.443 Sum_probs=26.3
Q ss_pred CcccceecCCcEEEcC-CCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTK-DQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~-~g~vKL~DFGla~~ 102 (570)
.++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986 46799999998854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=87.87 E-value=0.87 Score=44.64 Aligned_cols=88 Identities=17% Similarity=0.127 Sum_probs=57.8
Q ss_pred HHhhhcCCCcc-cccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFI-VEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnI-V~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+.++--++ .+++.|- ...+.|||++|-.|.++-... . .+-+..++++---|-..||-|+.|.
T Consensus 67 kiLeil~g~~~~p~vy~yg-----~~~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~ 132 (201)
T COG2112 67 KILEILAGEGVTPEVYFYG-----EDFIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELS 132 (201)
T ss_pred HHHHHhhhcCCCceEEEec-----hhhhhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhc
Confidence 35555555555 3455432 224679999998887754321 1 2334556666666778899999997
Q ss_pred -CCcEEEcCCCCEEEeecCCceec
Q 008303 81 -CSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 81 -P~NILld~~g~vKL~DFGla~~~ 103 (570)
|..++|..++.+.|+||..|++.
T Consensus 133 ~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 133 RPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred CCceeEEecCCcEEEEEccchhhc
Confidence 55555555668999999999853
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.71 E-value=0.7 Score=49.25 Aligned_cols=42 Identities=38% Similarity=0.483 Sum_probs=32.4
Q ss_pred HHHHHHHHHHHHC--------C--cccceecCCcEEEcCCCC-EEEeecCCce
Q 008303 60 VQLLMALDYLHAN--------H--ILHRDVKCSNIFLTKDQD-IRLGDFGLAK 101 (570)
Q Consensus 60 ~QLl~aL~yLHs~--------g--IvHrDLKP~NILld~~g~-vKL~DFGla~ 101 (570)
.++...+..+.+. + |||+|+.+.||+++.+.. +.++|||-+.
T Consensus 175 a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 175 AALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3455555555543 3 999999999999998875 8999999774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=85.86 E-value=0.46 Score=49.06 Aligned_cols=31 Identities=26% Similarity=0.367 Sum_probs=26.0
Q ss_pred CcccceecCCcEEEcCCCC-EEEeecCCceec
Q 008303 73 HILHRDVKCSNIFLTKDQD-IRLGDFGLAKIL 103 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~-vKL~DFGla~~~ 103 (570)
.++|+|+++.|||++.++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 569999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=83.77 E-value=1.4 Score=46.55 Aligned_cols=29 Identities=21% Similarity=0.419 Sum_probs=25.5
Q ss_pred cccceecCCcEEEcC-CCCEEEeecCCcee
Q 008303 74 ILHRDVKCSNIFLTK-DQDIRLGDFGLAKI 102 (570)
Q Consensus 74 IvHrDLKP~NILld~-~g~vKL~DFGla~~ 102 (570)
++|+|+.+.|||+++ ++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 57899999998854
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.11 E-value=3.7 Score=44.06 Aligned_cols=39 Identities=21% Similarity=0.264 Sum_probs=29.7
Q ss_pred HHHHHHHHHHHHHHHHHHHH----CCcccceecCCcEEEcCCC
Q 008303 52 EEKLCKWLVQLLMALDYLHA----NHILHRDVKCSNIFLTKDQ 90 (570)
Q Consensus 52 e~~i~~I~~QLl~aL~yLHs----~gIvHrDLKP~NILld~~g 90 (570)
.+-++.++.||+.-.-++-+ .+++|-||||.|||+-+..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 45678888898776655533 3699999999999996554
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.56 E-value=1.3 Score=46.65 Aligned_cols=29 Identities=28% Similarity=0.290 Sum_probs=24.3
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=82.20 E-value=2.6 Score=45.87 Aligned_cols=74 Identities=16% Similarity=0.189 Sum_probs=55.2
Q ss_pred EEEEeccCCCCH-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccceecCCcEEEcCCCCEEEeecCCceecc
Q 008303 27 CIIIGFCEGGDM-AEAIKKANSKLFSEEKLCKWLVQLLMALDYLH-ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 27 ~IV~Ey~~gGsL-~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH-s~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 104 (570)
.|||+||.+... .-.|+ ...++...+..+-+|++.-+.-|- ..++||.||.--|+|+- +|.+.|+|.+-+-...
T Consensus 240 VLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 240 VLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSVEHD 315 (520)
T ss_pred eEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEEEccccccCC
Confidence 599999954221 11222 234788888888888888888775 56999999999999986 6789999998775543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.09 E-value=6.9 Score=43.21 Aligned_cols=61 Identities=16% Similarity=0.161 Sum_probs=46.9
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccceecCCcEEEcCC
Q 008303 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDY-LHANHILHRDVKCSNIFLTKD 89 (570)
Q Consensus 26 i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~y-LHs~gIvHrDLKP~NILld~~ 89 (570)
..+|-+|..|..+..+++... .+++...+++.-.+.||-. |--.+++|.|++|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 458889999999999998643 4666677777766777544 445689999999999999643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 570 | ||||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-46 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-38 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-37 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-37 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-32 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-32 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-27 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-27 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-26 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-26 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-26 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-25 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-23 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-22 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-22 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-22 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-22 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-21 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-21 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-21 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-21 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-20 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-20 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-20 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-20 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-20 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-18 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-16 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-15 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-13 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 |
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-110
Identities = 87/234 (37%), Positives = 140/234 (59%), Gaps = 2/234 (0%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ +++ +++P IV+Y++S+ E G + I++ +CEGGD+ + I LF E+++ W V
Sbjct: 74 VAVLANMKHPNIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYM 119
Q+ +AL ++H ILHRD+K NIFLTKD ++LGDFG+A++L S +LA + +GTP Y+
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYL 192
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE+ + PY +KSDIW+LGC +YE+ +LK AF+A M+ L+ KI P+ YS
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYD 252
Query: 180 FRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESN 233
R LV + ++NP RPS +L + + K L + +
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = e-104
Identities = 82/224 (36%), Positives = 125/224 (55%), Gaps = 9/224 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCK 57
+ L+ ++++P IV Y D ++R + I++ +CEGGD+A I K + EE + +
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 58 WLVQLLMALDYLH-----ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASS 111
+ QL +AL H + +LHRD+K +N+FL Q+++LGDFGLA+IL D A +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 112 VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP 171
VGTP YM PE + + Y KSDIWSLGC +YE+ +L P F AF + L KI +
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
+P +YS ++ ML RPS E+L + + + H
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-104
Identities = 55/232 (23%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVE---------------RGCYVCIIIGFCEGGDMAEAIKKA 45
++ ++K+ + IV Y W + + I + FC+ G + + I+K
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 46 NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS 105
+ + + Q+ +DY+H+ +++RD+K SNIFL + +++GDFGL L +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 106 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKIN 165
D + GT YM PE ++ YG + D+++LG + E+ L AF+ +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL--LHVCDTAFETSKFFTDLR 232
Query: 166 KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLK 217
+ + + L++ +L K PE RP+ +E+LR + + + + +
Sbjct: 233 DG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-100
Identities = 74/227 (32%), Positives = 124/227 (54%), Gaps = 7/227 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK--KANSKLFSEEKLCKW 58
++L+ ++ +P +++Y S++E + I++ + GD++ IK K +L E + K+
Sbjct: 83 IDLLKQLNHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPS 117
VQL AL+++H+ ++HRD+K +N+F+T ++LGD GL + +S A S+VGTP
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA--FDMQALINKINKSIVAPLPT- 174
YM PE + + Y KSDIWSLGC +YEM +L+ F ++ +L KI + PLP+
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSP 221
YS R LV + +PE RP + L+ +
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-89
Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 27/248 (10%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-----------YVCIIIGFCEGGDMAEAIKKANSKL 49
++ ++K+ +P IV Y ++W+E+ Y+ I + C ++ + + +
Sbjct: 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 50 FSEEKLC-KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL 108
E +C +Q+ A+++LH+ ++HRD+K SNIF T D +++GDFGL + D+
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 109 ASSV-------------VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
+V VGT YM PE + Y K DI+SLG ++E+ L P
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQM 231
Query: 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
+ + + PL T+ +V+ ML +P RP A ++ + +
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291
Query: 216 LKLNSPRR 223
L R
Sbjct: 292 TVLRQRSR 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 4e-86
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 8/207 (3%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++P V + +W E G + + C G + + + E ++ +L
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGI-LYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDT 166
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
L+AL +LH+ ++H DVK +NIFL +LGDFGL L + G P YM PE
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 123 LLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
LL YG+ +D++SLG I E+ +++ Q L + S R
Sbjct: 227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY---LPPEFTAGLSSELR 282
Query: 182 GLVKSMLRKNPELRPSAAELLRHVHLQ 208
++ ML +P+LR +A LL L+
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 2e-82
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMA 65
++ +V Y +W E ++ I +C GG +A+AI + F E +L L+Q+
Sbjct: 69 QHSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 66 LDYLHANHILHRDVKCSNIFLTKDQDI-------------------RLGDFGLAKILTSD 106
L Y+H+ ++H D+K SNIF+++ ++GD G ++S
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS- 186
Query: 107 DLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKIN 165
G ++ E+L + + K+DI++L + +P + D ++I
Sbjct: 187 --PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIR 241
Query: 166 KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209
+ + +P S F L+K M+ +PE RPSA L++H L
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-79
Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 34/248 (13%)
Query: 1 MELISKIRNPFIVEYKDSWVER------------GCYVCIIIGFCEGGDMAEAIKKANSK 48
+ L++ + + ++V Y +W+ER + I + +CE G + + I N
Sbjct: 53 VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 49 LFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT---- 104
++ + Q+L AL Y+H+ I+HRD+K NIF+ + +++++GDFGLAK +
Sbjct: 113 -QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 105 -----------SDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAF 152
S D +S +GT Y+ E+L Y K D++SLG +EM + P
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFS 229
Query: 153 KAFDMQALINKINK---SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209
+ ++ K+ + +++ ++ +P RP A LL L
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 210 YVLKVHLK 217
+K
Sbjct: 290 KHQDEVIK 297
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 234 bits (597), Expect = 2e-72
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 17/222 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLC-KWL 59
+ + V + + I + C ++ + + + S E +C
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVY-LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV------- 112
+Q+ A+++LH+ ++HRD+K SNIF T D +++GDFGL + D+ +V
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 113 ------VGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK 166
VGT YM PE + Y K DI+SLG ++E+ L + +I +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL--LYSFSTQMERVRIITDVRN 288
Query: 167 SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
L T+ +V+ ML +P RP A +++ + +
Sbjct: 289 LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-64
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 21/235 (8%)
Query: 2 ELISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIK--KANSKLFSEEKLC 56
++ +P I+ + +++ F + G + I+ K +E+++
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS----- 111
L+ + L+ +HA HRD+K +NI L + L D G S
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 112 -----VVGTPSYMCPELLADIPY---GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA--LI 161
T SY PEL + + ++D+WSLGC +Y M + + + +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH-LQPYVLKVH 215
+ + P ++S A L+ SM+ +P RP LL + LQP H
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-58
Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 12/212 (5%)
Query: 1 MELISKIRNPFIVEYKDSWV---ERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
E++ +++P IV + DSW + + ++ G + +K+ K+ + L
Sbjct: 76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRS 133
Query: 58 WLVQLLMALDYLHANH--ILHRDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVG 114
W Q+L L +LH I+HRD+KC NIF+T +++GD GLA + + A +V+G
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-AKAVIG 192
Query: 115 TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI--NKSIVAPL 172
TP +M PE+ + Y D+++ G C+ EM + + + A I + + A
Sbjct: 193 TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ +++ +R+N + R S +LL H
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 7e-55
Identities = 68/230 (29%), Positives = 100/230 (43%), Gaps = 15/230 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ + + +P IV + E +V I + EGG + + IK+ E++ +L
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGP-WVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLG 157
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKD-QDIRLGDFGLAKILTSDDLAS------SVV 113
Q L L+YLH ILH DVK N+ L+ D L DFG A L D L +
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI--NKSIVAP 171
GT ++M PE++ P +K DIWS C + M + + + L KI +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE 277
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSP 221
+P + ++ LRK P R SA EL R V L+ L SP
Sbjct: 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA---LQEVGGLKSP 324
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-53
Identities = 70/293 (23%), Positives = 126/293 (43%), Gaps = 29/293 (9%)
Query: 1 MELISKIR--NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
+ ++K++ + I+ D + Y+ +++ C D+ +KK K + +
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSY 113
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGT 115
+L A+ +H + I+H D+K +N L D ++L DFG+A + D + S VGT
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANF-LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 116 PSYMCPELLADIP-----------YGSKSDIWSLGCCIYEMTSLKPAFKAFD--MQALIN 162
+YM PE + D+ KSD+WSLGC +Y MT K F+ + L
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232
Query: 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPR 222
I+ + P + ++K L+++P+ R S ELL H PYV +N
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH----PYVQIQTHPVNQMA 288
Query: 223 RNSLSHWPESNYARRTRFSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDS 275
+ + + + + P N + + + +S + N S S T +
Sbjct: 289 KGTTEE-MKYVLGQLVGLNSP-NSILKAAKTLYEHYSGGESHNSSSSKTFEKK 339
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-53
Identities = 61/245 (24%), Positives = 109/245 (44%), Gaps = 27/245 (11%)
Query: 1 MELISKIR--NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
+ ++K++ + I+ D + Y+ +++ C D+ +KK S + +
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVME-CGNIDLNSWLKKKKS--IDPWERKSY 132
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGT 115
+L A+ +H + I+H D+K +N + ++L DFG+A + D + S VGT
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 116 PSYMCPELLADIP-----------YGSKSDIWSLGCCIYEMTSLKPAFKAFD--MQALIN 162
+YM PE + D+ KSD+WSLGC +Y MT K F+ + L
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
Query: 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPR 222
I+ + P + ++K L+++P+ R S ELL H PYV +N
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH----PYVQIQTHPVNQMA 307
Query: 223 RNSLS 227
+ +
Sbjct: 308 KGTTE 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 8e-53
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 10/212 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL-FSEEKLCKWL 59
+ L +++ IV+Y S+ E G ++ I + GG ++ ++ L +E+ + +
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLGDFGLAKILTS-DDLASSVVGTPS 117
Q+L L YLH N I+HRD+K N+ + T +++ DFG +K L + + GT
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ 188
Query: 118 YMCPE--LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD--MQALINKINKSIVAP-L 172
YM PE YG +DIWSLGC I EM + KP F A+ K+ V P +
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEI 247
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
P S + + +P+ R A +LL
Sbjct: 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-51
Identities = 65/202 (32%), Positives = 110/202 (54%), Gaps = 7/202 (3%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
S+ +P++ +Y S++ + + II+ + GG + ++ E ++ L ++L
Sbjct: 75 SQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILK 130
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPEL 123
LDYLH+ +HRD+K +N+ L++ +++L DFG+A LT + ++ VGTP +M PE+
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 124 LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPLPTKYSGAFRG 182
+ Y SK+DIWSLG E+ +P M+ L I K+ L YS +
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKE 249
Query: 183 LVKSMLRKNPELRPSAAELLRH 204
V++ L K P RP+A ELL+H
Sbjct: 250 FVEACLNKEPSFRPTAKELLKH 271
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-50
Identities = 61/257 (23%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 8 RNPFIVEYKDSWVER-------GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+P IV++ + ++ C+G + K + S + + K
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 61 QLLMALDYLHANH--ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS------- 111
Q A+ ++H I+HRD+K N+ L+ I+L DFG A ++ S
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 112 ------VVGTPSYMCPELL---ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALIN 162
TP Y PE++ ++ P G K DIW+LGC +Y + + F+ ++N
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263
Query: 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPR 222
P F L+++ML+ NPE R S AE++ + V+ K SP
Sbjct: 264 G---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK--SPI 318
Query: 223 RNSLSHWPESNYARRTR 239
L A +R
Sbjct: 319 TELLEQNGGYGSATLSR 335
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 69/293 (23%), Positives = 129/293 (44%), Gaps = 29/293 (9%)
Query: 1 MELISKIR--NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
+ ++K++ + I+ D + Y+ +++ C D+ +KK S + +
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVME-CGNIDLNSWLKKKKS--IDPWERKSY 160
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL---TSDDLASSVVGT 115
+L A+ +H + I+H D+K +N FL D ++L DFG+A + T+ + S VG
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 116 PSYMCPELLADIP-----------YGSKSDIWSLGCCIYEMTSLKPAFKAFD--MQALIN 162
+YM PE + D+ KSD+WSLGC +Y MT K F+ + L
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPR 222
I+ + P + ++K L+++P+ R S ELL H PYV +N
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH----PYVQIQTHPVNQMA 335
Query: 223 RNSLSHWPESNYARRTRFSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDS 275
+ + + + + P+++ + + + +S + N S S T +
Sbjct: 336 KGTTEE-MKYVLGQLVGLNSPNSI-LKAAKTLYEHYSGGESHNSSSSKTFEKK 386
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-48
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ +NP IV Y DS++ G + +++ + GG + + + + E ++ + L
Sbjct: 72 RENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQ 127
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPEL 123
AL++LH+N ++HRD+K NI L D ++L DFG +T + S++VGTP +M PE+
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 124 LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD---MQALINKINKSIVAPL--PTKYSG 178
+ YG K DIWSLG EM +P + + ++AL I + L P K S
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALY-LIATNGTPELQNPEKLSA 244
Query: 179 AFRGLVKSMLRKNPELRPSAAELLRH 204
FR + L + E R SA ELL+H
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQH 270
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-48
Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 7/204 (3%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ +P +V+Y S+ + + I++ +C G +++ I+ N L +E+++ L L
Sbjct: 79 QQCDSPHVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIIRLRNKTL-TEDEIATILQSTLK 136
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPEL 123
L+YLH +HRD+K NI L + +L DFG+A LT ++V+GTP +M PE+
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 124 LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPL--PTKYSGAF 180
+ +I Y +DIWSLG EM KP + M+A+ I + P +S F
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNF 255
Query: 181 RGLVKSMLRKNPELRPSAAELLRH 204
VK L K+PE R +A +LL+H
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQH 279
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 8 RNPFIVEYKDSWVERGCYVC-----IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
+ I Y +++++ +++ FC G + + IK EE + ++
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCP 121
L L +LH + ++HRD+K N+ LT++ +++L DFG++ L ++ +GTP +M P
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 122 ELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPLPT- 174
E++A D Y KSD+WSLG EM P M+AL I ++ P P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRN---PAPRL 254
Query: 175 ---KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
K+S F+ ++S L KN RP+ +L++H
Sbjct: 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-47
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
++ +VE S++ G + +++ F +GG + + + +EE++ +L
Sbjct: 97 RDYQHFNVVEMYKSYL-VGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQ 152
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPEL 123
AL YLHA ++HRD+K +I LT D ++L DFG ++ D S+VGTP +M PE+
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 212
Query: 124 LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD---MQALINKINKSIVAPL--PTKYSG 178
++ Y ++ DIWSLG + EM +P + F +QA+ ++ S L K S
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPY--FSDSPVQAMK-RLRDSPPPKLKNSHKVSP 269
Query: 179 AFRGLVKSMLRKNPELRPSAAELLRH 204
R ++ ML ++P+ R +A ELL H
Sbjct: 270 VLRDFLERMLVRDPQERATAQELLDH 295
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 77/211 (36%), Positives = 118/211 (55%), Gaps = 16/211 (7%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ +P+IV+ ++ + I+I FC GG + + + + L +E ++ Q+L
Sbjct: 71 ATCDHPYIVKLLGAYY-HDGKLWIMIEFCPGGAVDAIMLELDRGL-TEPQIQVVCRQMLE 128
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPEL 123
AL++LH+ I+HRD+K N+ +T + DIRL DFG++ S +GTP +M PE+
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 124 LA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD---MQALINKINKSIVAPL--P 173
+ D PY K+DIWSLG + EM ++P + M+ L+ KI KS L P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH--HELNPMRVLL-KIAKSDPPTLLTP 245
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+K+S FR +K L KNPE RPSAA+LL H
Sbjct: 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-46
Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA------NSKLFSEEKLCKW 58
S+ +P IV Y S+V + +++ GG + + IK S + E +
Sbjct: 68 SQCHHPNIVSYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS------SV 112
L ++L L+YLH N +HRDVK NI L +D +++ DFG++ L + + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKS--- 167
VGTP +M PE++ + Y K+DIWS G E+ + + + M+ L+ +
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 168 -----IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ KY +FR ++ L+K+PE RP+AAELLRH
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 69/246 (28%), Positives = 106/246 (43%), Gaps = 25/246 (10%)
Query: 1 MEL---ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
M+L + P+IV+ +++ V I + AE +KK E L K
Sbjct: 72 MDLDVVLKSHDCPYIVQCFGTFITNTD-VFIAMELMGTC--AEKLKKRMQGPIPERILGK 128
Query: 58 WLVQLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP 116
V ++ AL YL H ++HRDVK SNI L + I+L DFG++ L D G
Sbjct: 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA 188
Query: 117 SYMCPE-----LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ-ALINKI--NKSI 168
+YM PE Y ++D+WSLG + E+ + + +K ++ K+ +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248
Query: 169 VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH----------VHLQPYVLKVHLKL 218
+ P +SG F+ VK L K+ RP +LL H V + + V K
Sbjct: 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKT 308
Query: 219 NSPRRN 224
SPR
Sbjct: 309 ESPRSG 314
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 23/247 (9%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGG--DMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
P+IV++ + G I + + + + EE L K + + AL+
Sbjct: 81 PYIVQFYGALFREGD-CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 68 YLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE---- 122
+L N I+HRD+K SNI L + +I+L DFG++ L + G YM PE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINK----SIVAPLPTKYS 177
+ Y +SD+WSLG +YE+ + + + ++ + + ++ K + ++S
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH----------VHLQPYVLKVHLKLNSPRRNSLS 227
+F V L K+ RP ELL+H V + YV K+ ++ + + +
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMY 319
Query: 228 HWPESNY 234
++
Sbjct: 320 VDHHHHH 326
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 67/208 (32%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
K+R+P ++Y+ ++ R +++ +C G A + + + K E ++ L
Sbjct: 109 QKLRHPNTIQYRGCYL-REHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQ 165
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL 124
L YLH+++++HRDVK NI L++ ++LGDFG A I+ A+S VGTP +M PE++
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVI 222
Query: 125 A---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPLPT----KY 176
+ Y K D+WSLG E+ KP + M AL I ++ P +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN---ESPALQSGHW 278
Query: 177 SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S FR V S L+K P+ RP++ LL+H
Sbjct: 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 63/204 (30%), Positives = 118/204 (57%), Gaps = 4/204 (1%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++ ++++P I+E + + E YV +++ C G+M +K K FSE + ++ Q
Sbjct: 63 KIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQ 120
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA-KILTSDDLASSVVGTPSYMC 120
++ + YLH++ ILHRD+ SN+ LT++ +I++ DFGLA ++ + ++ GTP+Y+
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE+ +G +SD+WSLGC Y + +P F ++ +NK+ + +P+ S
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-MPSFLSIEA 239
Query: 181 RGLVKSMLRKNPELRPSAAELLRH 204
+ L+ +LR+NP R S + +L H
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDH 263
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-44
Identities = 57/255 (22%), Positives = 92/255 (36%), Gaps = 56/255 (21%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+P IV Y+ +++ + ++ F G + I +E + L +L
Sbjct: 81 KLFNHPNIVPYRATFI-ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA--------KILTSDDLASSVVGTP 116
ALDY+H +HR VK S+I ++ D + L + D V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 117 SYMCPELLA--DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKIN-------- 165
++ PE+L Y +KSDI+S+G E+ + FK Q L+ K+N
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 166 ------------------------------------KSIVAPLPTKYSGAFRGLVKSMLR 189
S P +S F V+ L+
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 190 KNPELRPSAAELLRH 204
+NP+ RPSA+ LL H
Sbjct: 320 RNPDARPSASTLLNH 334
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-44
Identities = 61/241 (25%), Positives = 117/241 (48%), Gaps = 9/241 (3%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+ + + +V + + E +V +++ C + E K+ K +E + +L Q
Sbjct: 93 SIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 149
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMC 120
+++ YLH N ++HRD+K N+FL +D ++++GDFGLA + D + GTP+Y+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE+L+ + + D+WS+GC +Y + KP F+ ++ +I K+ +P +
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVA 268
Query: 181 RGLVKSMLRKNPELRPSAAELLRH----VHLQPYVLKVHLKLNSPRRNSLSHWPESNYAR 236
L++ ML+ +P RP+ ELL P L + PR + + + +
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRK 328
Query: 237 R 237
Sbjct: 329 P 329
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 5/204 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+ + + +V + + E +V +++ C + E K+ K +E + +L Q
Sbjct: 67 SIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 123
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMC 120
+++ YLH N ++HRD+K N+FL +D ++++GDFGLA + D + GTP+Y+
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE+L+ + + D+WS+GC +Y + KP F+ ++ +I K+ +P +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVA 242
Query: 181 RGLVKSMLRKNPELRPSAAELLRH 204
L++ ML+ +P RP+ ELL
Sbjct: 243 ASLIQKMLQTDPTARPTINELLND 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGG-DMAEAIKKANSKLFSEEKLCKWLVQLLMALDY 68
PF V + + G V I + + D + E+ L K V ++ AL++
Sbjct: 66 PFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 69 LHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPE----L 123
LH+ ++HRDVK SN+ + +++ DFG++ L D G YM PE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE 184
Query: 124 LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ-ALINKINKSIVAPLPT-KYSGAFR 181
L Y KSDIWSLG + E+ L+ + ++ + ++ + LP K+S F
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244
Query: 182 GLVKSMLRKNPELRPSAAELLRHVHLQPY 210
L+KN + RP+ EL++H +
Sbjct: 245 DFTSQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 5/203 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
E+ S +R+P I+ + V +I+ + G + ++K F E++ ++ +
Sbjct: 61 EIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITE 117
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
L AL Y H+ ++HRD+K N+ L ++++ DFG + + + GT Y+ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPP 176
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E++ + K D+WSLG YE KP F+A Q +I++ P + R
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-FPDFVTEGAR 235
Query: 182 GLVKSMLRKNPELRPSAAELLRH 204
L+ +L+ NP RP E+L H
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEH 258
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 61/281 (21%)
Query: 1 MEL--ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
EL + + +P+IV + ++ G + I + +GG + + +KKA E+ L K
Sbjct: 80 RELQVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKA--GRIPEQILGKV 136
Query: 59 LVQLLMALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
+ ++ L YL H I+HRDVK SNI + +I+L DFG++ L D +A+S VGT S
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRS 195
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA------------------ 159
YM PE L Y +SDIWS+G + EM + D +
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 160 ------------------------LINKINKSIVAPLPT-KYSGAFRGLVKSMLRKNPEL 194
L++ I LP+ +S F+ V L KNP
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 195 RPSAAELLRH----------VHLQPYVLKVHLKLNSPRRNS 225
R +L+ H V ++ + LN P +
Sbjct: 316 RADLKQLMVHAFIKRSDAEEVDFAGWLCST-IGLNQPSTPT 355
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-41
Identities = 51/258 (19%), Positives = 97/258 (37%), Gaps = 42/258 (16%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-YVCIIIGFCEGGDMAEAI-KKANSKLFSEEKLCKW 58
E++ K+ + IV+ E + +I+ FC G + + + +N+ E +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQD----IRLGDFGLAKILTSDDLASSVVG 114
L ++ +++L N I+HR++K NI +D +L DFG A+ L D+ S+ G
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177
Query: 115 TPSYMCPELLADI--------PYGSKSDIWSLGCCIYEMTSLKPAFKAFDM----QALIN 162
T Y+ P++ YG+ D+WS+G Y + F+ F+ + ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 163 KINK--------------------SIVAPLPTKYSGAFRGLVKS----MLRKNPELRPSA 198
KI S P+ S + L+ +L + E
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 199 AELLRHVHLQPYVLKVHL 216
+ + H
Sbjct: 298 DQFFAETSDILHRGNSHH 315
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 45/203 (22%), Positives = 91/203 (44%), Gaps = 5/203 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
E+ S +R+P I+ + + + +++ F G++ + ++K F E++ ++ +
Sbjct: 66 EIQSHLRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEE 122
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
L AL Y H ++HRD+K N+ + ++++ DFG + ++ GT Y+ P
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTMCGTLDYLPP 181
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E++ + K D+W G YE P F + +I + P S +
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-FPPFLSDGSK 240
Query: 182 GLVKSMLRKNPELRPSAAELLRH 204
L+ +LR +P R ++ H
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEH 263
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 4e-40
Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 5 SKIRNPFIVE----YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
S++ +PF V+ ++D + + + + G++ + I+K F E +
Sbjct: 85 SRLDHPFFVKLYFTFQDDE-----KLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA 137
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL---TSDDLASSVVGTPS 117
+++ AL+YLH I+HRD+K NI L +D I++ DFG AK+L + A+S VGT
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
Y+ PELL + SD+W+LGC IY++ + P F+A + + KI K P K+
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-FPEKFF 256
Query: 178 GAFRGLVKSMLRKNPELR 195
R LV+ +L + R
Sbjct: 257 PKARDLVEKLLVLDATKR 274
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
P ++ Y + + + I I C + E +++ + L Q L +L
Sbjct: 78 PNVIRYFCT-EKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHL 134
Query: 70 HANHILHRDVKCSNI-FLTKDQD----IRLGDFGLAKILTSDDLA----SSVVGTPSYMC 120
H+ +I+HRD+K NI + + DFGL K L + S V GT ++
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 121 PELLADIP---YGSKSDIWSLGCCIYEMTSL-KPAF-KAFDMQALINKINKSIVAPLPTK 175
PE+L++ DI+S GC Y + S F K+ QA I S+ P K
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254
Query: 176 -YSGAFRGLVKSMLRKNPELRPSAAELLRH 204
R L++ M+ +P+ RPSA +L+H
Sbjct: 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKH 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-39
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
K+ + F+V ++ E +C+++ GGD+ I F E + + ++
Sbjct: 239 EKVNSRFVVSLAYAY-ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL 124
L+ LH I++RD+K NI L IR+ D GLA + VGT YM PE++
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 125 ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV---APLPTKYSGAFR 181
+ Y D W+LGC +YEM + + F+ + ++ + + ++S R
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417
Query: 182 GLVKSMLRKNPELR-----PSAAELLRH 204
L +L K+P R SA E+ H
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEH 445
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++L+ ++ +P I++ + + ++G Y ++ GG++ + I FSE + +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKG-YFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIR 133
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L + Y+H N I+HRD+K N+ +K +D IR+ DFGL+ + +GT
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV----APLP 173
Y+ PE+L Y K D+WS G +Y + S P F + ++ K+ K
Sbjct: 194 YIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
A + L++ ML P +R SA + L H
Sbjct: 253 KVSESA-KDLIRKMLTYVPSMRISARDALDH 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 48/248 (19%), Positives = 93/248 (37%), Gaps = 42/248 (16%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-YVCIIIGFCEGGDMAEAI-KKANSKLFSEEKLCKW 58
E++ K+ + IV+ E + +I+ FC G + + + +N+ E +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQD----IRLGDFGLAKILTSDDLASSVVG 114
L ++ +++L N I+HR++K NI +D +L DFG A+ L D+ S+ G
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177
Query: 115 TPSYMCPELLADI--------PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK 166
T Y+ P++ YG+ D+WS+G Y + F+ F+ ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 167 SIVA------------------------PLPTKYSGAFRGLVKS----MLRKNPELRPSA 198
I+ P+ S + L+ +L + E
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 199 AELLRHVH 206
+
Sbjct: 298 DQFFAETS 305
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ +PF+V S+ + + +++ GGD+ +++ + F EE + ++ +L+M
Sbjct: 70 QGLEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVM 126
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL 124
ALDYL I+HRD+K NI L + + + DF +A +L + +++ GT YM PE+
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186
Query: 125 ADIP---YGSKSDIWSLGCCIYEMTSLKPAF---KAFDMQALINKINKSIVAPLPTKYSG 178
+ Y D WSLG YE+ + + + + +++ ++V P+ +S
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-TYPSAWSQ 245
Query: 179 AFRGLVKSMLRKNPELR-PSAAELLRH 204
L+K +L NP+ R +++
Sbjct: 246 EMVSLLKKLLEPNPDQRFSQLSDVQNF 272
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ L+ + +P I++ D + ++ Y ++ F EGG++ E I + F E +
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKK-YFYLVTEFYEGGELFEQIINRHK--FDECDAANIMK 153
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L + YLH ++I+HRD+K NI K+ I++ DFGL+ + D +GT
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV---APLPT 174
Y+ PE+L Y K D+WS G +Y + P F + Q +I K+ K
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + L+K ML + R +A E L
Sbjct: 273 NISDEAKELIKLMLTYDYNKRCTAEEALNS 302
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 12/211 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ KI++ IV +D E + +++ GG++ + I + ++E+ +
Sbjct: 57 IAVLKKIKHENIVTLED-IYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQ 113
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L A+ YLH N I+HRD+K N+ +LT +++ I + DFGL+K+ + + S+ GTP
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM-STACGTPG 172
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY- 176
Y+ PE+LA PY D WS+G Y + P F L KI + + +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-FESPFW 231
Query: 177 ---SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + + + +L K+P R + + L H
Sbjct: 232 DDISESAKDFICHLLEKDPNERYTCEKALSH 262
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-38
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+EL+ K+ +P I++ + + I+ GG++ + I K FSE + +
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIK 128
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+ + Y+H ++I+HRD+K NI +K++D I++ DFGL+ + +GT
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV----APLP 173
Y+ PE+L Y K D+WS G +Y + S P F + ++ ++
Sbjct: 189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
T A + L++ ML +P LR +A + L H
Sbjct: 248 TISDDA-KDLIRKMLTFHPSLRITATQCLEH 277
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-38
Identities = 54/210 (25%), Positives = 107/210 (50%), Gaps = 10/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ + +P I++ D + ++ +++ +GG++ + I F+E +
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKR-NYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIK 143
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L + YLH ++I+HRD+K N+ +K++D I++ DFGL+ + + +GT
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY 203
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV---APLPT 174
Y+ PE+L Y K D+WS+G ++ + + P F Q ++ K+ K +P
Sbjct: 204 YIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + L+K ML+ + + R SA + L H
Sbjct: 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 32/219 (14%), Positives = 61/219 (27%), Gaps = 19/219 (8%)
Query: 15 YKDSWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHAN 72
D V + + + + L QL+ L +
Sbjct: 155 QDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213
Query: 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL--ADIPYG 130
++H N+F+ D + LGD + + +Y E L + +
Sbjct: 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFT 271
Query: 131 SKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY--------SGAFRG 182
+ W LG IY + L F + S+ P +
Sbjct: 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT 331
Query: 183 LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSP 221
L+ L + R E + P L++ +++S
Sbjct: 332 LIGRFLNFDRRRRLLPLEAMET----PEFLQLQNEISSS 366
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 12/212 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ ++ +P I++ K+ + + +++ GG++ + I + +SE +
Sbjct: 99 IGVLLRLSHPNIIKLKEIFETPT-EISLVLELVTGGELFDRIVEKGY--YSERDAADAVK 155
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L A+ YLH N I+HRD+K N+ + T D +++ DFGL+KI+ L +V GTP
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA-FDMQALINKINKSIVAPLPTKY 176
Y PE+L YG + D+WS+G Y + F Q + +I + +
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-FISPW 274
Query: 177 ----SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + LV+ ++ +P+ R + + L+H
Sbjct: 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 2e-37
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 5 SKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++++PFIV+ ++ + + +I+ + GG++ +++ +F E+ C +L ++
Sbjct: 76 EEVKHPFIVDLIYAFQTGGK---LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEI 130
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCP 121
MAL +LH I++RD+K NI L ++L DFGL K + + + GT YM P
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+L + D WSLG +Y+M + P F + + I+KI K + LP + R
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEAR 249
Query: 182 GLVKSMLRKNPELR-----PSAAELLRH 204
L+K +L++N R A E+ H
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAH 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65
K+++P IV DS E + ++ GG++ E I +SE + Q+L +
Sbjct: 61 KLQHPNIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILES 117
Query: 66 LDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
+ Y H+N I+HR++K N+ +K + ++L DFGLA + + GTP Y+ PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----SG 178
+L PY DIW+ G +Y + P F D L +I P+ +
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEWDTVTP 236
Query: 179 AFRGLVKSMLRKNPELRPSAAELLRH---VHLQPYVLKVHL 216
+ L+ SML NP+ R +A + L+ + + +H
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 30/185 (16%), Positives = 52/185 (28%), Gaps = 21/185 (11%)
Query: 33 CEGGDMAEAI--KKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQ 90
E + + K + +Q++ L LH ++H ++ +I L +
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243
Query: 91 DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLG 139
+ L F D + + PEL A D W+LG
Sbjct: 244 GVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 140 CCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA 199
IY + I +S R L++ LR E R
Sbjct: 301 LVIYWIWCADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPL 355
Query: 200 ELLRH 204
+ +
Sbjct: 356 QAMET 360
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 14/208 (6%)
Query: 5 SKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++ +PFIV+ ++ + + +I+ F GGD+ + K +F+EE + +L +L
Sbjct: 81 VEVNHPFIVKLHYAFQTEGK---LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAEL 135
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCP 121
+ALD+LH+ I++RD+K NI L ++ I+L DFGL+K + + A S GT YM P
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E++ + +D WS G ++EM + F+ D + + I K+ + +P S +
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQ 254
Query: 182 GLVKSMLRKNPELR-----PSAAELLRH 204
L++ + ++NP R E+ RH
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRH 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 10 PFIVE----YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65
P IV Y++ + C + II+ EGG++ I++ + F+E + + + + A
Sbjct: 82 PHIVCILDVYENMHHGKRC-LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 66 LDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
+ +LH+++I HRDVK N+ + +K++D ++L DFG AK T + L + TP Y+ PE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPE 199
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA---PLPTKY--- 176
+L Y D+WSLG +Y + P F + QA+ + + I P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 177 -SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + L++ +L+ +P R + + + H
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNH 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 5e-37
Identities = 31/222 (13%), Positives = 76/222 (34%), Gaps = 25/222 (11%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGG---DMAEAIKKANSKLFSEEKLCK 57
ME + +++ + + + ++ G + K K+ + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGS-VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLT-----------KDQDIRLGDFGLA---KIL 103
+ +++L ++ +H I+H D+K N L + L D G + K+
Sbjct: 177 FAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 104 TSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALIN 162
+ ++ T + C E+L++ P+ + D + + +Y M K +
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
Query: 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ + + + + ML + +LLR
Sbjct: 297 GLFRRL------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-36
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 5 SKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSK--LFSEEKLCKWLV 60
+K+ + FIV ++ +C+++ GGD+ I + F E + +
Sbjct: 240 AKVHSRFIVSLAYAFETKTD---LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK-ILTSDDLASSVVGTPSYM 119
Q++ L++LH +I++RD+K N+ L D ++R+ D GLA + GTP +M
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA---PLPTKY 176
PELL Y D ++LG +YEM + + F+A + ++ + ++ P K+
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416
Query: 177 SGAFRGLVKSMLRKNPELR-----PSAAELLRH 204
S A + +++L+K+PE R S L H
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 26/181 (14%), Positives = 48/181 (26%), Gaps = 14/181 (7%)
Query: 33 CEGGDMAEAI--KKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQ 90
E + + K + +Q++ L LH ++H ++ +I L +
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248
Query: 91 DIRLGDFGLAKIL--TSDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIY 143
+ L F ++ P +L D W+LG IY
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 144 EMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
+ I R L++ LR E R + +
Sbjct: 309 WIWCADLPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363
Query: 204 H 204
Sbjct: 364 T 364
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 9/211 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAI--KKANSKLFSEEKLCKW 58
+E++ + +P I++ + + E + I++ CEGG++ E I +A K SE + +
Sbjct: 71 IEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 59 LVQLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGT 115
+ Q++ AL Y H+ H++H+D+K NI F I++ DFGLA++ SD+ +++ GT
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV--APLP 173
YM PE+ K DIWS G +Y + + F ++ + K A
Sbjct: 190 ALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L+K ML K+PE RPSAA++L H
Sbjct: 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+EL+ K+ +P I++ + + I+ GG++ + I K FSE + +
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIK 128
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+ + Y+H ++I+HRD+K NI +K++D I++ DFGL+ + +GT
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY- 176
Y+ PE+L Y K D+WS G +Y + S P F + ++ ++ A
Sbjct: 189 YIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA-FDLPQW 246
Query: 177 ---SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + L++ ML +P LR +A + L H
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65
K+++P IV DS E + ++ GG++ E I +SE + Q+L +
Sbjct: 84 KLQHPNIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILES 140
Query: 66 LDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
+ Y H+N I+HR++K N+ +K + ++L DFGLA + + GTP Y+ PE
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----SG 178
+L PY DIW+ G +Y + P F D L +I P+ +
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEWDTVTP 259
Query: 179 AFRGLVKSMLRKNPELRPSAAELLRH 204
+ L+ SML NP+ R +A + L+
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKV 285
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 6 KIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
K+ +P +V+ + + ++ ++ G + E K SE++ + L+
Sbjct: 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIK 148
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPEL 123
++YLH I+HRD+K SN+ + +D I++ DFG++ SD L S+ VGTP++M PE
Sbjct: 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES 208
Query: 124 LADI--PY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA-PLPTKYSGA 179
L++ + G D+W++G +Y + F + L +KI + P +
Sbjct: 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAED 268
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH 204
+ L+ ML KNPE R E+ H
Sbjct: 269 LKDLITRMLDKNPESRIVVPEIKLH 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+E++ + +P I+ +++ E + +++ C GG++ E + F E + +
Sbjct: 57 IEIMKSLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMK 113
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
+L A+ Y H ++ HRD+K N FLT D ++L DFGLA + + VGTP
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY- 176
Y+ P++L YG + D WS G +Y + P F A ++ KI + P K
Sbjct: 174 YVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT-FPEKDW 231
Query: 177 ---SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S L++ +L K+P+ R ++ + L H
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+E++ K+ +P I++ K+ + Y I++ EGG++ + + E +
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNKR--LKEATCKLYFY 246
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLT---KDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L+A+ YLH N I+HRD+K N+ L+ +D I++ DFG +KIL L ++ GTP+
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306
Query: 118 YMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA-LINKINKSIVAPLP 173
Y+ PE+L + Y D WSLG ++ S P F Q L ++I
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FI 365
Query: 174 TKY----SGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ S LVK +L +P+ R + E LRH
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 49/208 (23%), Positives = 100/208 (48%), Gaps = 6/208 (2%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL-FSEEKLCKWLV 60
++ ++R+P IV + + + I+ + G + + K+ ++ E +
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 61 QLLMALDYLHANH--ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-SVVGTPS 117
+ ++YLH + I+HR++K N+ + K +++ DFGL+++ S L+S S GTP
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE 204
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPLPTKY 176
+M PE+L D P KSD++S G ++E+ +L+ + + Q + K +P
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264
Query: 177 SGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ +++ P RPS A ++
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
R+PF+ K ++ +C ++ + GG++ + + ++F+EE+ + +++
Sbjct: 60 QNTRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVS 116
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPEL 123
AL+YLH+ +++RD+K N+ L KD I++ DFGL K ++ + GTP Y+ PE+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 124 LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGL 183
L D YG D W LG +YEM + F D + L I + P S + L
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSL 235
Query: 184 VKSMLRKNPELR-----PSAAELLRH 204
+ +L+K+P+ R A E++ H
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEH 261
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 10 PFIVE----YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65
P IV Y++ + R C + I++ +GG++ I+ + F+E + + + + A
Sbjct: 115 PHIVRIVDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 66 LDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
+ YLH+ +I HRDVK N+ + +K + ++L DFG AK TS + ++ TP Y+ PE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA---PLPTKY--- 176
+L Y D+WSLG +Y + P F + A+ + I P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 177 -SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + L++++L+ P R + E + H
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65
+++P IV DS E G + +I GG++ E I +SE + Q+L A
Sbjct: 66 LLKHPNIVRLHDSISEEG-HHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEA 122
Query: 66 LDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLA-SSVVGTPSYMCP 121
+ + H ++HR++K N+ +K + ++L DFGLA + + A GTP Y+ P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----S 177
E+L PYG D+W+ G +Y + P F D L +I P+ +
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSPEWDTVT 241
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L+ ML NP R +AAE L+H
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKH 268
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 10/206 (4%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L +PF+ ++ E + ++ + GGD+ I+ F + +
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKEN---LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAA 125
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
++++ L +LH+ I++RD+K NI L KD I++ DFG+ K + D ++ GTP Y+
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 185
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE+L Y D WS G +YEM + F D + L + I P
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKE 244
Query: 180 FRGLVKSMLRKNPELR-PSAAELLRH 204
+ L+ + + PE R ++ +H
Sbjct: 245 AKDLLVKLFVREPEKRLGVRGDIRQH 270
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
P I++ KD++ E + ++ + G++ + + + + SE++ K + LL + L
Sbjct: 84 PNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 140
Query: 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-- 127
H +I+HRD+K NI L D +I+L DFG + L + V GTPSY+ PE++
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 200
Query: 128 ----PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----SGA 179
YG + D+WS G +Y + + P F ++ I + S
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDT 259
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH 204
+ LV L P+ R +A E L H
Sbjct: 260 VKDLVSRFLVVQPQKRYTAEEALAH 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 61/250 (24%), Positives = 95/250 (38%), Gaps = 32/250 (12%)
Query: 1 MELISKIRNPFIVEYKD-----SWVERGCYVCIIIGFCEGGDMAEAI-KKANSKLFSEEK 54
++++ K+ +P +V ++ + + + +CEGGD+ + + + N E
Sbjct: 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 55 LCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD---IRLGDFGLAKILTSDDLASS 111
+ L + AL YLH N I+HRD+K NI L ++ D G AK L +L +
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 112 VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-------------------TSLKPAF 152
VGT Y+ PELL Y D WS G +E K
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
Query: 153 KAFDMQALINKINKSIVAPLPTKYSGAFRGLVKS----MLRKNPELRPSAAELLRHVHLQ 208
L + S V P P SG G ++ ML + R + + Q
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
Query: 209 PYVLKVHLKL 218
+ LKL
Sbjct: 303 ALDSILSLKL 312
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAI--KKANSKLFSEEKLCKWLVQLL 63
+++P IVE +++ G + ++ F +G D+ I + ++SE ++ Q+L
Sbjct: 82 MLKHPHIVELLETYSSDG-MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 64 MALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLA-SSVVGTPSYM 119
AL Y H N+I+HRDVK + +K+ ++LG FG+A L L VGTP +M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY--- 176
PE++ PYG D+W G ++ + S F + L I K + +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY-KMNPRQWSH 258
Query: 177 -SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + + LV+ ML +P R + E L H
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNH 287
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 46/181 (25%), Positives = 87/181 (48%), Gaps = 4/181 (2%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
+ +I+ + GG++ + + + ++ E++ Q++ A+ Y H I+HRD+K N+
Sbjct: 88 TLYLIMEYASGGEVFDYLVA-HGRM-KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145
Query: 85 FLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIY 143
L D +I++ DFG + T + G P Y PEL Y G + D+WSLG +Y
Sbjct: 146 LLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 205
Query: 144 EMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
+ S F +++ L ++ + +P S L+K L NP R + ++++
Sbjct: 206 TLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
Query: 204 H 204
Sbjct: 265 D 265
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 53/255 (20%), Positives = 100/255 (39%), Gaps = 53/255 (20%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK---------------- 44
+ L+ K+ +P I + + + Y+C+++ C GG + + +
Sbjct: 79 VRLMKKLHHPNIARLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 45 ----------------------ANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCS 82
+ + E+ + + Q+ AL YLH I HRD+K
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 83 NIFLTKDQD--IRLGDFGLAKILTSDDLA-----SSVVGTPSYMCPELL--ADIPYGSKS 133
N + ++ I+L DFGL+K + ++ GTP ++ PE+L + YG K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 134 DIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----SGAFRGLVKSMLR 189
D WS G ++ + F + I+++ + S R L+ ++L
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-FENPNYNVLSPLARDLLSNLLN 316
Query: 190 KNPELRPSAAELLRH 204
+N + R A L+H
Sbjct: 317 RNVDERFDAMRALQH 331
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+E++ K+ +P I++ K+ + Y I++ EGG++ + + E +
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNKR--LKEATCKLYFY 121
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L+A+ YLH N I+HRD+K N+ ++++D I++ DFG +KIL L ++ GTP+
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 118 YMCPELLADI---PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA-LINKINKSIVAPLP 173
Y+ PE+L + Y D WSLG ++ S P F Q L ++I
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FI 240
Query: 174 TKY----SGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ S LVK +L +P+ R + E LRH
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L+ +++PF+V S+ ++ + ++ + GG++ +++ + F E + +
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADK---LYFVLDYINGGELFYHLQR--ERCFLEPRARFYAA 146
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK-ILTSDDLASSVVGTPSYM 119
++ AL YLH+ +I++RD+K NI L I L DFGL K + + S+ GTP Y+
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYL 206
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE+L PY D W LG +YEM P F + + + + I + L + +
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNS 265
Query: 180 FRGLVKSMLRKNPELR----PSAAELLRH 204
R L++ +L+K+ R E+ H
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 36/260 (13%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
P I+ KD + + G YV ++ +GG++ + I + FSE + L + ++YL
Sbjct: 76 PNIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYL 132
Query: 70 HANHILHRDVKCSNI-FLTKDQD---IRLGDFGLAKILTSDD-LASSVVGTPSYMCPELL 124
HA ++HRD+K SNI ++ + + IR+ DFG AK L +++ L + T +++ PE+L
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 125 ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM---QALINKINKSIVAPLPTKY----S 177
Y + DIWSLG +Y M + F + ++ +I + L Y S
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS-LSGGYWNSVS 251
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH-----------VHLQPYVLKVHLK--------- 217
+ LV ML +P R +AA +LRH L +K
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSA 311
Query: 218 LNSPRRNSLSHWPESNYARR 237
LN + L S A+R
Sbjct: 312 LNRNQSPVLEPVGRSTLAQR 331
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 9/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ +++ R+ I+ +S+ E + +I F G D+ E I + + +E ++ ++
Sbjct: 52 ISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVH 109
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLT--KDQDIRLGDFGLAKILTSDDLASSVVGTPSY 118
Q+ AL +LH+++I H D++ NI + I++ +FG A+ L D + P Y
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY-- 176
PE+ + +D+WSLG +Y + S F A Q +I I + +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT-FDEEAFK 228
Query: 177 --SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S V +L K + R +A+E L+H
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 49/191 (25%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ PF+V+ + S+ + + +++ + GG+M +++ FSE + Q+++
Sbjct: 96 QAVNFPFLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVL 152
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL 124
+YLH+ +++RD+K N+ + + I++ DFG AK + ++ GTP + PE++
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEII 210
Query: 125 ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLV 184
Y D W+LG IYEM + P F A + KI V P+ +S + L+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-FPSHFSSDLKDLL 269
Query: 185 KSMLRKNPELR 195
+++L+ + R
Sbjct: 270 RNLLQVDLTKR 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 52/191 (27%), Positives = 100/191 (52%), Gaps = 6/191 (3%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
S + +PFI+ ++ + + +I+ + EGG++ ++K+ + F + ++ +
Sbjct: 61 SIVTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCL 117
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL 124
AL+YLH+ I++RD+K NI L K+ I++ DFG AK + D+ ++ GTP Y+ PE++
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 175
Query: 125 ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLV 184
+ PY D WS G IYEM + F + KI + + P ++ + L+
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-FPPFFNEDVKDLL 234
Query: 185 KSMLRKNPELR 195
++ ++ R
Sbjct: 235 SRLITRDLSQR 245
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L + PF+ + + ++R + ++ + GGD+ I++ F E +
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAA 128
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
++ + L +L + I++RD+K N+ L + I++ DFG+ K + + GTP Y+
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE++A PYG D W+ G +YEM + + F+ D L I + V P S
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKE 247
Query: 180 FRGLVKSMLRKNPELR-----PSAAELLRH 204
+ K ++ K+P R ++ H
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 19/216 (8%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+I + ++ + Y+ +++ + GGD+ + K + E +L +++M
Sbjct: 116 VNGDRRWITQLHFAFQDEN-YLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVM 173
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPE 122
A+D +H +HRD+K NI L + IRL DFG L +D + VGTP Y+ PE
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 123 LL-------ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-NKSIVAPLPT 174
+L YG + D W+LG YEM + F A KI + LP
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293
Query: 175 ---KYSGAFRGLVKSMLRKNPELR---PSAAELLRH 204
R ++ +L PE R A + H
Sbjct: 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 30/231 (12%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK------ANSKLFSEEKL 55
++I+ I+N + + + V II + E + + + + + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 56 CKWLVQLLMALDYLHA-NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG 114
+ +L + Y+H +I HRDVK SNI + K+ ++L DFG ++ + + S G
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS-RG 212
Query: 115 TPSYMCPELLADIP--YGSKSDIWSLGCCIYEMTSLKPAFKA-FDMQALINKINKSIVA- 170
T +M PE ++ G+K DIWSLG C+Y M F + L N I +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272
Query: 171 PLPTKYSGAF-----------------RGLVKSMLRKNPELRPSAAELLRH 204
PL + +K LRKNP R ++ + L+H
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ ++ + ++ D + E V +I+ GG++ + + + S SEE+ ++
Sbjct: 66 VSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD---IRLGDFGLAKILTSDDLASSVVGTP 116
Q+L ++YLH I H D+K NI L K+ I+L DFGLA + ++ GTP
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY 176
++ PE++ P G ++D+WS+G Y + S F Q + I Y
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------SY 235
Query: 177 ---SGAFRG-------LVKSMLRKNPELRPSAAELLRH 204
F ++ +L K R + E LRH
Sbjct: 236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 3e-34
Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ +IR+P I+ D + E V +I+ GG++ + + + S +E++ ++L
Sbjct: 59 VNILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLK 115
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD---IRLGDFGLAKILTSDDLASSVVGTP 116
Q+L + YLH+ I H D+K NI L K+ I+L DFG+A + + + ++ GTP
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 175
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY 176
++ PE++ P G ++D+WS+G Y + S F Q + I+ +Y
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD-FDEEY 234
Query: 177 ----SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + ++ +L K+P+ R + A+ L H
Sbjct: 235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 55/216 (25%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L ++PF+V ++ + + +I+ + GG++ + + + F+E ++ ++
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETK---LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVG 166
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAK--ILTSDDLASSVVGTPSY 118
++++AL++LH I++RD+K NI L + + L DFGL+K + + A GT Y
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 119 MCPELLADIPYG-SKS-DIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA---PLP 173
M P+++ G K+ D WSLG +YE+ + F + +I++ I+ P P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286
Query: 174 TKYSGAFRGLVKSMLRKNPELR-----PSAAELLRH 204
+ S + L++ +L K+P+ R A E+ H
Sbjct: 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 54/251 (21%), Positives = 107/251 (42%), Gaps = 16/251 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL-FSEEKLCKWL 59
+ +S++ +P IV+ + + VC+++ + EGG + + A ++ W
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 60 VQLLMALDYLHA---NHILHRDVKCSNIFLTKDQD-IRLGDFGLAKILTSDDLASSVVGT 115
+Q + YLH+ ++HRD+K N+ L +++ DFG A + + ++ G+
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGS 166
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD--MQALINKINKSIVAPLP 173
++M PE+ Y K D++S G ++E+ + + F ++ ++ PL
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRHV-HLQPYVLKVHLKLNSPRRNSL---SHW 229
L+ K+P RPS E+++ + HL Y L P ++SL
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDG 286
Query: 230 PESNYARRTRF 240
Y F
Sbjct: 287 RVEPYVDFAEF 297
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L +PF+ + + +R + ++ F GGD+ I+K S+ F E + +
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDR---LFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAA 131
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
+++ AL +LH I++RD+K N+ L + +L DFG+ K + + ++ GTP Y+
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI 191
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE+L ++ YG D W++G +YEM F+A + L I V PT
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHED 250
Query: 180 FRGLVKSMLRKNPELR 195
G++KS + KNP +R
Sbjct: 251 ATGILKSFMTKNPTMR 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ +I ++ + + +++ + GGD+ + K + EE +L ++++
Sbjct: 129 VNGDSKWITTLHYAFQDDN-NLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVI 186
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPE 122
A+D +H H +HRD+K NI + + IRL DFG L D +S VGTP Y+ PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 123 LLADIP-----YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-NKSIVAPLP--- 173
+L + YG + D WSLG C+YEM + F A + KI N P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306
Query: 174 TKYSGAFRGLVKSMLRKNPE 193
T S + L++ ++
Sbjct: 307 TDVSENAKDLIRRLICSREH 326
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 52/212 (24%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ +I++P ++ + + E V +I+ GG++ + + + S +EE+ ++L
Sbjct: 65 VSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 121
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD---IRLGDFGLAKILTSDDLASSVVGTP 116
Q+L + YLH+ I H D+K NI L ++ I++ DFGLA + + ++ GTP
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY 176
++ PE++ P G ++D+WS+G Y + S F Q + ++ +Y
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-FEDEY 240
Query: 177 ----SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + ++ +L K+P+ R + + L+H
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 71/295 (24%), Positives = 125/295 (42%), Gaps = 36/295 (12%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ ++ +P I+ D + E V +I+ GG++ + + + S SEE+ ++
Sbjct: 66 VSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIK 122
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD---IRLGDFGLAKILTSDDLASSVVGTP 116
Q+L ++YLH I H D+K NI L K+ I+L DFGLA + ++ GTP
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY 176
++ PE++ P G ++D+WS+G Y + S F Q + I Y
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------SY 235
Query: 177 ---SGAFRG-------LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL 226
F ++ +L K R + E LRH P++ V + RR S+
Sbjct: 236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH----PWITPVDTQQAMVRRESV 291
Query: 227 SHWPE--SNYARRTRFSEPDNVPISSYR-----EKQYSFSNNRNLNPSISGTEQD 274
+ Y RR R+ ++ K+ + +L S TE++
Sbjct: 292 VNLENFKKQYVRR-RWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEEN 345
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 11/207 (5%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
R+PF+ K S+ +C ++ + GG++ + + ++FSE++ + +++
Sbjct: 203 QNSRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVS 259
Query: 65 ALDYLHANH-ILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYMCPE 122
ALDYLH+ +++RD+K N+ L KD I++ DFGL K + + GTP Y+ PE
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRG 182
+L D YG D W LG +YEM + F D + L I + P +
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKS 378
Query: 183 LVKSMLRKNPELR----PS-AAELLRH 204
L+ +L+K+P+ R A E+++H
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQH 405
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 55/265 (20%), Positives = 110/265 (41%), Gaps = 25/265 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ +++++ +P ++ D++ E + +I+ F GG++ + I + K SE ++ ++
Sbjct: 99 ISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMR 156
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLT--KDQDIRLGDFGLAKILTSDDLASSVVGTPSY 118
Q L ++H + I+H D+K NI K +++ DFGLA L D++ T +
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY-- 176
PE++ P G +D+W++G Y + S F D + + + +
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------DWEF 269
Query: 177 -SGAFRG-------LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSH 228
AF +K++L+K P R + + L H P++ H L S +S +
Sbjct: 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH----PWLKGDHSNLTSRIPSSRYN 325
Query: 229 WPESNYARRTRFSEPDNVPISSYRE 253
+ I
Sbjct: 326 KIRQKIKEKYADWPAPQPAIGRIAN 350
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ +P++V+ ++ + Y+ +++ + GGD+ + E+ + ++++
Sbjct: 124 AFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVL 179
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD--DLASSVVGTPSYMCPE 122
ALD +H+ +HRDVK N+ L K ++L DFG + + + VGTP Y+ PE
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 123 LL----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI---NKSIVAPLPTK 175
+L D YG + D WS+G +YEM F A + +KI S+ P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
Query: 176 YSGAFRGLVKSMLRKNPELR---PSAAELLRH 204
S + L+ + L + E+R E+ RH
Sbjct: 300 ISKEAKNLICAFL-TDREVRLGRNGVEEIKRH 330
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
P I+ DS E ++ ++ G++ + + + + SE++ + LL A+ +L
Sbjct: 160 PHIITLIDS-YESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFL 216
Query: 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL----- 124
HAN+I+HRD+K NI L + IRL DFG + L + + GTP Y+ PE+L
Sbjct: 217 HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD 276
Query: 125 -ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----SGA 179
YG + D+W+ G ++ + + P F ++ I + + S
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ-FSSPEWDDRSST 335
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH 204
+ L+ +L+ +PE R +A + L+H
Sbjct: 336 VKDLISRLLQVDPEARLTAEQALQH 360
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
L+S PFIV ++ + I+ GGD+ + + +FSE + + +
Sbjct: 244 SLVSTGDCPFIVCMSYAF-HTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE 300
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
+++ L+++H +++RD+K +NI L + +R+ D GLA S + VGT YM P
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAP 359
Query: 122 ELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAF---DMQALINKINKSIVAPLPTKYS 177
E+L + Y S +D +SLGC ++++ F+ D + V LP +S
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFS 418
Query: 178 GAFRGLVKSMLRKNPELR-----PSAAELLRH 204
R L++ +L+++ R A E+
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
P IV+ + + + +++ GG++ E IKK K FSE + + +L+ A+ ++
Sbjct: 66 PNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHM 122
Query: 70 HANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLA 125
H ++HRD+K N+ F ++ + I++ DFG A++ D+ + T Y PELL
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 126 DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALIN---KINKSIVA---PLPTKY--- 176
Y D+WSLG +Y M S + F++ D +I K I +
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 177 -SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + L++ +L +P R + L +
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-32
Identities = 65/324 (20%), Positives = 122/324 (37%), Gaps = 20/324 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ +S +R+P +V D++ E + +I F GG++ E + ++K SE++ +++
Sbjct: 205 IQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMR 262
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD-IRLGDFGLAKILTSDDLASSVVGTPSY 118
Q+ L ++H N+ +H D+K NI F TK + ++L DFGL L GT +
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY-- 176
PE+ P G +D+WS+G Y + S F + + + +
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-MDDSAFS 381
Query: 177 --SGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNY 234
S + ++ +L +P R + + L H P+ L + S + +
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEH----PW-LTPGNAPGRDSQIPSSRYTKIRD 436
Query: 235 ARRTRFSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLS 294
+ +T++ R YS E + +
Sbjct: 437 SIKTKYDAWPEPLPPLGRISNYS------SLRKHRPQEYSIRDAFWDRSEAQPRFIVKPY 490
Query: 295 EVSVESSHEGTVICKPIASKTSFV 318
V C+ IAS V
Sbjct: 491 GTEVGEGQSANFYCRVIASSPPVV 514
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 9 NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDY 68
P ++ + + E + +I+ + GG++ +++ SE + + + Q+L + Y
Sbjct: 88 CPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 69 LHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA 125
LH N+I+H D+K NI + I++ DFG+++ + ++GTP Y+ PE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 126 DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----SGAFR 181
P + +D+W++G Y + + F D Q I++ V + S
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-YSEETFSSVSQLAT 265
Query: 182 GLVKSMLRKNPELRPSAAELLRH 204
++S+L KNPE RP+A L H
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSH 288
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 17/183 (9%)
Query: 34 EGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIR 93
G D+A +++ + + + Q+ ALD HA HRDVK NI ++ D
Sbjct: 117 NGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAY 174
Query: 94 LGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151
L DFG+A T + L + VGT YM PE ++ ++DI++L C +YE + P
Sbjct: 175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 152 FKAFDMQALINK-INKSIVAP------LPTKYSGAFRGLVKSMLRKNPELR-PSAAELLR 203
++ D +++ IN++I P +P AF ++ + KNPE R + +L
Sbjct: 235 YQG-DQLSVMGAHINQAIPRPSTVRPGIPV----AFDAVIARGMAKNPEDRYVTCGDLSA 289
Query: 204 HVH 206
H
Sbjct: 290 AAH 292
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 37/218 (16%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYV---CIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
++S + +P IV+ G +++ F GD+ + + +
Sbjct: 75 FIMSNLNHPNIVKLY------GLMHNPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRL 127
Query: 59 LVQLLMALDYLHANH--ILHRDVKCSNIFLTKDQD-----IRLGDFGLAKILTSDDLASS 111
++ + + ++Y+ + I+HRD++ NIFL + ++ DFGL++ S
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSG 185
Query: 112 VVGTPSYMCPELLA--DIPYGSKSDIWSLGCCIYEMTSLKPAFK---AFDMQALINKINK 166
++G +M PE + + Y K+D +S +Y + + + F ++ + +
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
Query: 167 SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ +P R +++ +P+ RP + +++
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 37/230 (16%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK-----ANSKLFSEEKLCKWLVQLLM 64
P ++ Y S ++ I + C ++ + ++ N KL E L Q+
Sbjct: 69 PNVIRYYCS-ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 65 ALDYLHANHILHRDVKCSNIFLT-------------KDQDIRLGDFGLAKILTSDDLA-- 109
+ +LH+ I+HRD+K NI ++ ++ I + DFGL K L S +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 110 ---SSVVGTPSYMCPELLADI-------PYGSKSDIWSLGCCIYEMTSL-KPAFKA-FDM 157
++ GT + PELL + DI+S+GC Y + S K F +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 158 QALINKIN---KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
++ I + + L+ M+ +P RP+A ++LRH
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 6 KIRNPFIVEYKDSW-VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
++R+ +++ D E + +++ +C G M E + K F + + QL+
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL---TSDDLASSVVGTPSYMCP 121
L+YLH+ I+H+D+K N+ LT +++ G+A+ L +DD + G+P++ P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 122 ELLADI-PY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
E+ + + G K DIWS G +Y +T+ F+ ++ L I K A +P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-IPGDCGPP 239
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH----VHLQPYVLKVHL 216
L+K ML P R S ++ +H P V +
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 46/210 (21%), Positives = 99/210 (47%), Gaps = 9/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ +++++ + +++ D++ E + +++ + +GG++ + I + +E ++
Sbjct: 137 ISVMNQLDHANLIQLYDAF-ESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMK 194
Query: 61 QLLMALDYLHANHILHRDVKCSNI-FLTKDQD-IRLGDFGLAKILTSDDLASSVVGTPSY 118
Q+ + ++H +ILH D+K NI + +D I++ DFGLA+ + GTP +
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY-- 176
+ PE++ +D+WS+G Y + S F + +N I L +
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-LEDEEFQ 313
Query: 177 --SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + + +L K R SA+E L+H
Sbjct: 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 50/211 (23%), Positives = 101/211 (47%), Gaps = 9/211 (4%)
Query: 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66
R+P I++ +++ + GG++ + I K + ++ E + + Q+L A+
Sbjct: 68 FRHPHIIKLYQVI-STPTDFFMVMEYVSGGELFDYICK-HGRV-EEMEARRLFQQILSAV 124
Query: 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD 126
DY H + ++HRD+K N+ L + ++ DFGL+ +++ + + G+P+Y PE+++
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 127 IPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVK 185
Y G + DIWS G +Y + F + L KI + +P + + L+
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSVATLLM 243
Query: 186 SMLRKNPELRPSAAELLRH----VHLQPYVL 212
ML+ +P R + ++ H L Y+
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I+ +CEG + + + +K +KL Q +DYLHA I+HRD+K +NIF
Sbjct: 94 LAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF 152
Query: 86 LTKDQDIRLGDFGLAKILTSDDLAS---SVVGTPSYMCPELLAD---IPYGSKSDIWSLG 139
L +D +++GDFGLA + + + G+ +M PE++ PY +SD+++ G
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 140 CCIYEMTSLKPAFKAFD-MQALINKINKS----IVAPLPTKYSGAFRGLVKSMLRKNPEL 194
+YE+ + + + + +I + + ++ + + + L+ L+K +
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDE 272
Query: 195 RPSAAELLRH 204
RPS +L
Sbjct: 273 RPSFPRILAE 282
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 44/219 (20%), Positives = 86/219 (39%), Gaps = 19/219 (8%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+ R+ +V + + + II C+G + ++ A L K + +
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHL-AIITSLCKGRTLYSVVRDAKIVL-DVNKTRQIAQE 138
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA------SSVVGT 115
++ + YLHA ILH+D+K N+F + + DFGL I G
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 116 PSYMCPELL---------ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK 166
++ PE++ +P+ SD+++LG YE+ + + FK +A+I ++
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 167 SIVAPLP-TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L ++ E RP+ +L+
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L + PF+ + + ++R + ++ + GGD+ I++ F E +
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAA 449
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
++ + L +L + I++RD+K N+ L + I++ DFG+ K + + GTP Y+
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 509
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE++A PYG D W+ G +YEM + + F+ D L I + V P S
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKE 568
Query: 180 FRGLVKSMLRKNPELR 195
+ K ++ K+P R
Sbjct: 569 AVAICKGLMTKHPGKR 584
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 60/205 (29%), Positives = 84/205 (40%), Gaps = 31/205 (15%)
Query: 32 FCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
+ D+ + KA E + + Q L LD+LHAN I+HRD+K NI +T
Sbjct: 100 HVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 158
Query: 92 IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151
++L DFGLA+I + + VV T Y PE+L Y + D+WS+GC EM KP
Sbjct: 159 VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 218
Query: 152 FKAFDMQALINKI-------NKSI---VAPLP----------------TKYSGAFRGLVK 185
F + KI + LP + + L+
Sbjct: 219 FCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL 278
Query: 186 SMLRKNPELRPSAAELLRHVHLQPY 210
ML NP R SA L+H Y
Sbjct: 279 EMLTFNPHKRISAFRALQH----SY 299
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+PF+V + R + +I + GGD+ +++ + EE +
Sbjct: 63 FEQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSA 117
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
++ +AL+YLH I++RD+K N+ L + I+L D+G+ K L D S+ GTP+Y+
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYI 177
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF---------DMQALINKINKSIVA 170
PE+L YG D W+LG ++EM + + F L I + +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 236
Query: 171 PLPTKYSGAFRGLVKSMLRKNPELR 195
+P S ++KS L K+P+ R
Sbjct: 237 RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+L + +++P I+ + ++ C+++ F GG + + K + L W VQ
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQ 113
Query: 62 LLMALDYLHANH---ILHRDVKCSNIFLTKDQD--------IRLGDFGLAKILTSDDLAS 110
+ ++YLH I+HRD+K SNI + + + +++ DFGLA+
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-M 172
Query: 111 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIV 169
S G ++M PE++ + SD+WS G ++E+ + + F+ D + +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 170 APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
P+P+ F L++ +P RPS +L
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 16/234 (6%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++S++ + I++ D + +G + ++ G D+ I + + +L E Q
Sbjct: 81 AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRL-DEPLASYIFRQ 138
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
L+ A+ YL I+HRD+K NI + +D I+L DFG A L L + GT Y P
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 122 ELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
E+L PY G + ++WSLG +Y + + F + + ++ + P P S
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHP-PYLVSKEL 251
Query: 181 RGLVKSMLRKNPELRPSAAELLRH------VHLQPYVLKVHLKLNSPRRNSLSH 228
LV +L+ PE R + +L+ V+L Y + ++N P LS
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 29/216 (13%), Positives = 78/216 (36%), Gaps = 23/216 (10%)
Query: 2 ELISKIRNPFIVEYKDSWVERGC-------YVCIIIGFCEGGDMAEAIKKANSKLFSEEK 54
+ +P ++ G + +I + G + + + + + + +
Sbjct: 59 PRLRIFSHPNVLPVL------GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQ 112
Query: 55 LCKWLVQLLMALDYLHA--NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV 112
K+ + + + +LH I + ++ + +D R+ + S
Sbjct: 113 AVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGR 168
Query: 113 VGTPSYMCPELLADIPYGS---KSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSI 168
+ P+++ PE L P + +D+WS ++E+ + + F M+ + + +
Sbjct: 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228
Query: 169 VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+P S L+K + ++P RP ++
Sbjct: 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/205 (27%), Positives = 83/205 (40%), Gaps = 31/205 (15%)
Query: 32 FCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
+ D+ + K E + + QLL LD+LH++ ++HRD+K NI +T
Sbjct: 100 HVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
Query: 92 IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151
I+L DFGLA+I + +SVV T Y PE+L Y + D+WS+GC EM KP
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 152 FKAFDMQALINKI-------------------NKSIVAPLPTKYSGAFRG-------LVK 185
F+ + KI ++ + L+
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 278
Query: 186 SMLRKNPELRPSAAELLRHVHLQPY 210
L NP R SA L H PY
Sbjct: 279 KCLTFNPAKRISAYSALSH----PY 299
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 3 LISKIRNPFIVEYKDSW--VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+PF+V + R + +I + GGD+ +++ + EE +
Sbjct: 106 FEQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSA 160
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI-LTSDDLASSVVGTPSYM 119
++ +AL+YLH I++RD+K N+ L + I+L D+G+ K L D S+ GTP+Y+
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYI 220
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF---------DMQALINKINKSIVA 170
PE+L YG D W+LG ++EM + + F L I + +
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279
Query: 171 PLPTKYSGAFRGLVKSMLRKNPELR 195
+P S ++KS L K+P+ R
Sbjct: 280 RIPRSLSVKAASVLKSFLNKDPKER 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
S++ + IV D E CY +++ + EG ++E I+ + L S + + Q+L
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIES-HGPL-SVDTAINFTNQILD 122
Query: 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPE 122
+ + H I+HRD+K NI + ++ +++ DFG+AK L+ L + V+GT Y PE
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY----SG 178
+DI+S+G +YEM +P F ++ K + V + T
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242
Query: 179 AFRGLVKSMLRKNPELRP-SAAELLR 203
+ ++ K+ R + E+
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMKD 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 51/237 (21%), Positives = 94/237 (39%), Gaps = 34/237 (14%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD------YLHANHILHRDV 79
+ I + +GG + IK +S+ W ++ A D YLH+ +I+HRD+
Sbjct: 82 LNFITEYIKGGTLRGIIKSMDSQY-------PWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLAS---------------SVVGTPSYMCPELL 124
N + +++++ + DFGLA+++ + +VVG P +M PE++
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 125 ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM--QALINKINKSIVAPLPTKYSGAFRG 182
Y K D++S G + E+ A + + + P +F
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFP 254
Query: 183 LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTR 239
+ +PE RPS +L L+ L++HL + P L + R
Sbjct: 255 ITVRCCDLDPEKRPSFVKLEH--WLET--LRMHLAGHLPLGPQLEQLDRGFWETYRR 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 37/173 (21%), Positives = 75/173 (43%), Gaps = 17/173 (9%)
Query: 32 FCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
+ G + + + + +L+++L AL YLH+ +++ D+K NI LT++Q
Sbjct: 165 YVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ- 219
Query: 92 IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151
++L D G + S + GTP + PE++ P +DI+++G + +T P
Sbjct: 220 LKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
Query: 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-SAAELLR 203
+ L K ++ L++ + +P R +A E+
Sbjct: 276 RNGRYVDGLPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 10 PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
++E + + E ++ GG + I K F+E + + + ALD+L
Sbjct: 71 RNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFL 127
Query: 70 HANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSV--------VGTPSY 118
H I HRD+K NI +Q +++ DF L + + S + G+ Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 119 MCPELL-----ADIPYGSKSDIWSLGCCIY-----------EMTSLKPAFKAFDMQALIN 162
M PE++ Y + D+WSLG +Y S + A N
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 163 KINKSIVA---PLPTKY----SGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ +SI P K S A + L+ +L ++ + R SAA++L+H
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 46/171 (26%), Positives = 93/171 (54%), Gaps = 4/171 (2%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRL 94
GG++ + I + ++ +E++ ++ Q++ A++Y H + I+HRD+K N+ L + ++++
Sbjct: 92 GGELFDYIVE-KKRM-TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKI 149
Query: 95 GDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFK 153
DFGL+ I+T + + G+P+Y PE++ Y G + D+WS G +Y M + F
Sbjct: 150 ADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
Query: 154 AFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L K+N + +P S + L++ M+ +P R + E+ R
Sbjct: 210 DEFIPNLFKKVNSCVY-VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 55/211 (26%), Positives = 84/211 (39%), Gaps = 38/211 (18%)
Query: 32 FCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
+C+ + + + + E + Q L A+++ H ++ +HRDVK NI +TK
Sbjct: 83 YCDH-TVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV 140
Query: 92 IRLGDFGLAKILTS-DDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLK 149
I+L DFG A++LT D V T Y PE L+ D YG D+W++GC E+ S
Sbjct: 141 IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
Query: 150 PAFKAFDMQALINKI--------------------NKSIVAPLPTKY----------SGA 179
P + + I + P P S
Sbjct: 201 PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYP 260
Query: 180 FRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
GL+K L +P R + +LL H PY
Sbjct: 261 ALGLLKGCLHMDPTERLTCEQLLHH----PY 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 38/211 (18%)
Query: 32 FCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
F + + + ++ + + K+L Q++ + + H+++I+HRD+K NI +++
Sbjct: 105 FVDH-TILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV 162
Query: 92 IRLGDFGLAKILTS-DDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLK 149
++L DFG A+ L + ++ V T Y PE L+ D+ YG D+W++GC + EM +
Sbjct: 163 VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
Query: 150 PAFKAFDMQALINKINK----------SIVAPLP--------------------TKYSGA 179
P F + I + P K S
Sbjct: 223 PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV 282
Query: 180 FRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
L K L +P+ RP AELL H +
Sbjct: 283 VIDLAKKCLHIDPDKRPFCAELLHH----DF 309
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 12/182 (6%)
Query: 34 EGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIR 93
+G + + + + + ++ + + AL++ H N I+HRDVK +NI ++ ++
Sbjct: 99 DGVTLRDIVHT-EGPM-TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 94 LGDFGLAKILTSDDLA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLK 149
+ DFG+A+ + + ++V+GT Y+ PE ++SD++SLGC +YE+ + +
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 150 PAFKAFD--MQALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRP-SAAELLRH 204
P F D + + + + P S +V L KNPE R +AAE+
Sbjct: 217 PPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
Query: 205 VH 206
+
Sbjct: 276 LV 277
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66
+ + +V++ E + + +C GG++ + I E ++ QL+ +
Sbjct: 62 LNHENVVKFYGHRREGN-IQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGV 118
Query: 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS---DDLASSVVGTPSYMCPEL 123
YLH I HRD+K N+ L + ++++ DFGLA + + L + + GT Y+ PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 124 LADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFD-----MQALINKINKSIVAPLPTKYS 177
L + D+WS G + M + +D Q + K K
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA---GELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH 204
A L+ +L +NP R + ++ +
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKD 262
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 5/199 (2%)
Query: 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66
R+P I++ + +++ + GG++ + I K N +L E++ + Q+L +
Sbjct: 73 FRHPHIIKLYQVI-STPSDIFMVMEYVSGGELFDYICK-NGRL-DEKESRRLFQQILSGV 129
Query: 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD 126
DY H + ++HRD+K N+ L + ++ DFGL+ +++ + + G+P+Y PE+++
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 189
Query: 127 IPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVK 185
Y G + DIWS G +Y + F + L KI I P + + L+K
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLK 248
Query: 186 SMLRKNPELRPSAAELLRH 204
ML+ +P R + ++ H
Sbjct: 249 HMLQVDPMKRATIKDIREH 267
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66
+R+P IV +K+ ++ II+ + GG++ E I N+ FSE++ + QLL +
Sbjct: 73 LRHPNIVRFKEVI-LTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGV 129
Query: 67 DYLHANHILHRDVKCSNIFLTKDQ--DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL 124
Y H+ I HRD+K N L +++ DFG +K S VGTP+Y+ PE+L
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189
Query: 125 ADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA-----PLPTKYSG 178
Y G +D+WS G +Y M F+ + K + I++ P + S
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 179 AFRGLVKSMLRKNPELRPSAAELLRH 204
L+ + +P R S E+ H
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTH 275
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/267 (19%), Positives = 104/267 (38%), Gaps = 25/267 (9%)
Query: 7 IRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66
+ + +V++ E + + +C GG++ + I E ++ QL+ +
Sbjct: 62 LNHENVVKFYGHRREGN-IQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGV 118
Query: 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS---DDLASSVVGTPSYMCPEL 123
YLH I HRD+K N+ L + ++++ DFGLA + + L + + GT Y+ PEL
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 124 LADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFD-----MQALINKINKSIVAPLPTKYS 177
L + D+WS G + M + +D Q + K K
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA---GELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH----VHLQPYVLKVHLKLNSPRRNSLSHWPESN 233
A L+ +L +NP R + ++ + L+ + + + S
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES------PSG 289
Query: 234 YARRTRFSEPDNVPISSYREKQYSFSN 260
+++ + + + S+ R +S
Sbjct: 290 FSKHIQSNLDFSPVNSASRTPGSGWSK 316
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 38/239 (15%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+ ++ +P IV D C + ++ F E D+ + + + + + ++ +L QL
Sbjct: 72 LLKELHHPNIVSLIDVIHSERC-LTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQL 128
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCP 121
L + + H + ILHRD+K N+ + D ++L DFGLA+ + + V T Y P
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 122 E-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-------NKSI---VA 170
+ L+ Y + DIWS+GC EM + KP F + KI N V
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 171 PLP-------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
LP + L+ +ML +P R SA + + H PY
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH----PY 303
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 53/239 (22%), Positives = 96/239 (40%), Gaps = 39/239 (16%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
++ ++++ IV+ D + + ++ + D+ + + +L+QL
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKR-LVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQL 109
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCP 121
L + Y H +LHRD+K N+ + ++ ++++ DFGLA+ + + T Y P
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 122 E-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI-------NKSI---VA 170
+ L+ Y + DIWS+GC EM + P F + +I N V
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 171 PLPTKYSGAF-------------------RGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
LP KY F L+ ML+ +P R +A + L H Y
Sbjct: 230 ELP-KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH----AY 283
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 36/209 (17%)
Query: 10 PFIVE----YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65
P IV Y++ + R C + I++ +GG++ I+ + F+E + + + + A
Sbjct: 71 PHIVRIVDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 66 LDYLHANHILHRDVKCSNI-FLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPE 122
+ YLH+ +I HRDVK N+ + +K + ++L DFG A E
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KE 169
Query: 123 LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA---PLPTKY--- 176
+ Y D+WSLG +Y + P F + A+ + I P
Sbjct: 170 TTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228
Query: 177 -SGAFRGLVKSMLRKNPELRPSAAELLRH 204
S + L++++L+ P R + E + H
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNH 257
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 24/231 (10%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEG-GDMAEAIKKANSKLFSEEKLCKWL 59
++ +S ++ D W ER +I+ E D+ + I + L EE +
Sbjct: 100 LKKVSS-GFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITE-RGAL-QEELARSFF 155
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLGDFGLAKILTSDDLASSVVGTPSY 118
Q+L A+ + H +LHRD+K NI + +++L DFG +L GT Y
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DGTRVY 214
Query: 119 MCPELLADIPY-GSKSDIWSLGCCIYEMT--SLKPAFKAFDMQALINKINKSIVAPLPTK 175
PE + Y G + +WSLG +Y+M + P F+ +I + V +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI-P----FEHD---EEIIRGQVF-FRQR 265
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRH-----VHLQPYVLKVHLKLNSP 221
S + L++ L P RP+ E+ H V L ++HL SP
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 51/237 (21%), Positives = 92/237 (38%), Gaps = 23/237 (9%)
Query: 1 MELISKIRN-PFIVEYKDSWVERGCYVCIIIGF-CEGGDMAEAIKKANSKLFSEEKLCKW 58
+ + P ++ D W E +++ D+ + I + L E +
Sbjct: 88 LWKVGAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITE-KGPL-GEGPSRCF 144
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
Q++ A+ + H+ ++HRD+K NI + + +L DFG +L + GT
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-DGTRV 203
Query: 118 YMCPELLADIPY-GSKSDIWSLGCCIYEMT--SLKPAFKAFDMQALINKINKSIVAPLPT 174
Y PE ++ Y + +WSLG +Y+M + P F+ +I ++ + P
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDI-P----FERD---QEILEAEL-HFPA 254
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH----VHLQPYVLKVHLKLNSPRRNSLS 227
S L++ L P RPS E+L + L +P SL
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 38/239 (15%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L+ ++++ IV D + ++ FC+ D+ + N E + +L QL
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKK-LTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQL 110
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-SSVVGTPSYMCP 121
L L + H+ ++LHRD+K N+ + ++ +++L +FGLA+ S+ V T Y P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 122 E-LLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKI-------NKSI---V 169
+ L Y + D+WS GC E+ + +P F D+ + +I + +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 170 APLP------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
LP K + R L++++L+ NP R SA E L+H PY
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH----PY 285
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
++ + I+ E++ L Q+L + +LH+ I+HRD+K SNI + D +++ D
Sbjct: 115 NLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156
FGLA+ + + + V T Y PE++ + Y DIWS+GC + EM F D
Sbjct: 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 157 --------MQAL-------INKINKSIVA-----------PLPTKYSGAFRG-------- 182
++ L + K+ ++ +
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 183 -------LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
L+ ML + R S E L+H PY+ +
Sbjct: 291 KASQARDLLSKMLVIDASKRISVDEALQH----PYINVWY 326
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/208 (25%), Positives = 81/208 (38%), Gaps = 39/208 (18%)
Query: 38 MAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDF 97
M + + + QLL L + H N ILHRD+K N+ + K ++LGDF
Sbjct: 93 MDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF 152
Query: 98 GLAKILTSDDLA-SSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
GLA+ SS V T Y P+ L+ Y + DIWS GC + EM + KP F
Sbjct: 153 GLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212
Query: 156 DMQALINKI---------------------NKSIVAPLPTKYSGAFRG------------ 182
+ + + I N +I P +
Sbjct: 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMD 272
Query: 183 LVKSMLRKNPELRPSAAELLRHVHLQPY 210
+ +L+ NP++R SA + L H P+
Sbjct: 273 FLHGLLQLNPDMRLSAKQALHH----PW 296
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + +K ++ S + +C +L Q+L L Y+H+ ++LHRD+K SN+ L D+++ D
Sbjct: 115 DLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 97 FGLAKILTSDDLASSV----VGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPA 151
FGLA++ D + V T Y PE +L Y DIWS+GC + EM S +P
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 152 FKAFD-------------------MQALINKINKSIVAPLPTKYSGAFRG---------- 182
F + +IN ++ + LP K +
Sbjct: 232 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL 291
Query: 183 -LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
L+ ML NP R + L H PY+ + +
Sbjct: 292 DLLDKMLTFNPHKRIEVEQALAH----PYLEQYY 321
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 41/217 (18%), Positives = 74/217 (34%), Gaps = 43/217 (19%)
Query: 27 CIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA--------NHILHRD 78
+I + E G + + +K + + K + L +LH I HRD
Sbjct: 111 YLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 79 VKCSNIFLTKDQDIRLGDFGLAKILTS-----DDLASSVVGTPSYMCPELLA------DI 127
+K NI + K+ + D GLA S D ++ VGT YM PE+L
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 128 PYGSKSDIWSLGCCIYEMTSLKPAFKAFD-----------MQALINKINKSIVA-----P 171
+D++S G ++E+ + + + + +
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPS 287
Query: 172 LPTKYSG-----AFRGLVKSMLRKNPELRPSAAELLR 203
P ++S L+ NP R +A + +
Sbjct: 288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 37/211 (17%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+A+ I + S + + ++ +L+ L LH ++HRD+ NI L + DI + D
Sbjct: 119 DLAQVIHDQRIVI-SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
F LA+ T+D + V Y PE ++ + D+WS GC + EM + K F+
Sbjct: 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 156 D--------MQAL-------INKIN-----KSIVAPLPTKYSGAFRG-----------LV 184
++ + + + + L + A+ L+
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297
Query: 185 KSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
ML NP+ R S + LRH PY +
Sbjct: 298 AKMLEFNPQRRISTEQALRH----PYFESLF 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 40/242 (16%), Positives = 84/242 (34%), Gaps = 46/242 (19%)
Query: 5 SKIRNPFIVEYKDSWVERGCYV---CIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
+R+ I+ + + + ++ + E G + + + + + E + K +
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALS 147
Query: 62 LLMALDYLHANH--------ILHRDVKCSNIFLTKDQDIRLGDFGLAKIL-----TSDDL 108
L +LH I HRD+K NI + K+ + D GLA T D
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 109 ASSVVGTPSYMCPELL------ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD------ 156
+ VGT YM PE+L ++DI+++G +E+ +
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 157 -----MQALINKINKSIVA-----PLPTKYSG-----AFRGLVKSMLRKNPELRPSAAEL 201
+ ++ K + +P ++ +++ N R +A +
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 202 LR 203
+
Sbjct: 328 KK 329
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 43/198 (21%), Positives = 79/198 (39%), Gaps = 35/198 (17%)
Query: 44 KANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103
+ + + +L QLL L Y H +LHRD+K N+ + + +++L DFGLA+
Sbjct: 91 DDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK 150
Query: 104 TSDDLA-SSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161
+ + V T Y P+ LL Y ++ D+W +GC YEM + +P F ++ +
Sbjct: 151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210
Query: 162 NKI-------NKSI---VAPLP-------------------TKYSGAFRGLVKSMLRKNP 192
+ I + + + L+ +L+
Sbjct: 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEG 270
Query: 193 ELRPSAAELLRHVHLQPY 210
R SA + ++H P+
Sbjct: 271 RNRISAEDAMKH----PF 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 40/217 (18%), Positives = 78/217 (35%), Gaps = 43/217 (19%)
Query: 27 CIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--------ILHRD 78
+I + E G + + ++ + ++ + L +LH I HRD
Sbjct: 82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 79 VKCSNIFLTKDQDIRLGDFGLAKILTS-----DDLASSVVGTPSYMCPELLADIP----- 128
+K NI + K+ + D GLA + + D + VGT YM PE+L +
Sbjct: 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF 198
Query: 129 -YGSKSDIWSLGCCIYEMTSLKPAFKAFD-----------MQALINKINKSIVA-----P 171
+ DIW+ G ++E+ + + + K +
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN 258
Query: 172 LPTKYSG-----AFRGLVKSMLRKNPELRPSAAELLR 203
+P ++ + L+K +NP R +A + +
Sbjct: 259 IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLG 95
D+A ++ EE ++ QLL L Y+H+ ++LHRD+K +N+F+ T+D +++G
Sbjct: 107 DLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163
Query: 96 DFGLAKILTSDDLASSV----VGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKP 150
DFGLA+I+ + T Y P LL+ Y D+W+ GC EM + K
Sbjct: 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 151 AFK-------------------AFDMQALINKINKSIVA-------PLPTKYSGAFRG-- 182
F D Q L++ I I PL G R
Sbjct: 224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283
Query: 183 -LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
++ +L +P R +A E L H PY+
Sbjct: 284 DFLEQILTFSPMDRLTAEEALSH----PYMSIYS 313
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 46/239 (19%)
Query: 6 KIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65
++ +P I+ D++ + + ++ F E D+ IK NS + + + +++ L
Sbjct: 68 ELSHPNIIGLLDAFGHKSN-ISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQG 124
Query: 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS--DDLASSVVGTPSYMCPEL 123
L+YLH + ILHRD+K +N+ L ++ ++L DFGLAK S VV T Y PEL
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPEL 183
Query: 124 LADIPYGSKS-----DIWSLGCCIYEMTSLKPAFKAFDMQALINKI-------NKSI--- 168
L +G++ D+W++GC + E+ P + +I +
Sbjct: 184 L----FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 169 VAPLP----------TKYSGAFRG-------LVKSMLRKNPELRPSAAELLRHVHLQPY 210
+ LP F L++ + NP R +A + L+ Y
Sbjct: 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM----KY 294
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 49/201 (24%), Positives = 74/201 (36%), Gaps = 40/201 (19%)
Query: 46 NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD-----IRLGDFGLA 100
+ S + +L QL+ +++ H+ LHRD+K N+ L+ +++GDFGLA
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 101 KILTSDDLA-SSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158
+ + + T Y PE LL Y + DIWS+ C EM P F
Sbjct: 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244
Query: 159 ALINKI-----------------------------NKSIVAPLPTKYSGAFRGLVKSMLR 189
+ KI K++ L L+ +ML
Sbjct: 245 DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLE 304
Query: 190 KNPELRPSAAELLRHVHLQPY 210
+P R SA L H PY
Sbjct: 305 MDPVKRISAKNALEH----PY 321
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 40/210 (19%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ +K + +++ + + Q+L L Y+H+ I+HRD+K SN+ + +D ++++ D
Sbjct: 119 DLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
FGLA+ T+D++ V T Y PE +L + Y DIWS+GC + E+ + + F
Sbjct: 176 FGLARH-TADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 156 D-------------------MQALINKINKSIVAPLPTKYSGAFRG-----------LVK 185
D ++ + ++ ++ + L F L++
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 186 SMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
ML + + R +AA+ L H Y + H
Sbjct: 294 KMLVLDSDKRITAAQALAH----AYFAQYH 319
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 40/210 (19%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + +K + E+++ + Q+L L Y+HA I+HRD+K N+ + +D ++++ D
Sbjct: 115 DLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 171
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
FGLA+ +D + V T Y PE +L + Y DIWS+GC + EM + K FK
Sbjct: 172 FGLAR--QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 156 D-------------------MQALINKINKSIVAPLPTKYSGAFRG-----------LVK 185
D +Q L + K+ + LP F L++
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289
Query: 186 SMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
ML + E R +A E L H PY +H
Sbjct: 290 KMLVLDAEQRVTAGEALAH----PYFESLH 315
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 41/210 (19%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + + K SEEK+ + Q+L L Y+H+ ++HRD+K N+ + +D ++++ D
Sbjct: 114 DLQKIMG---LKF-SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILD 169
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
FGLA+ ++ VV T Y PE +L+ + Y DIWS+GC + EM + K FK
Sbjct: 170 FGLARH-ADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 156 D-------------------MQALINKINKSIVAPLPTKYSGAFRG-----------LVK 185
D +Q L +K KS + LP F L++
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287
Query: 186 SMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
ML + + R +AA+ L H P+
Sbjct: 288 KMLELDVDKRLTAAQALTH----PFFEPFR 313
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 49/220 (22%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
++ + I+ E++ L Q+L + +LH+ I+HRD+K SNI + D +++ D
Sbjct: 152 NLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
Query: 97 FGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156
FGLA+ + + + V T Y PE++ + Y DIWS+GC + EM K F D
Sbjct: 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
Query: 157 --------MQAL-------INKIN---KSIVAPLPTK--------YSGAFRG-------- 182
++ L + K+ ++ V P + +
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327
Query: 183 -------LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH 215
L+ ML +P R S + L+H PY+ +
Sbjct: 328 KASQARDLLSKMLVIDPAKRISVDDALQH----PYINVWY 363
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 55/266 (20%), Positives = 103/266 (38%), Gaps = 62/266 (23%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ I +++ S++ + ++ Q L A+ LH ++++HRD+K SN+ + + D+++ D
Sbjct: 99 DLHRVIS---TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD 155
Query: 97 FGLAKILTSDDLASSV-----------VGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYE 144
FGLA+I+ +S V T Y PE +L Y D+WS GC + E
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215
Query: 145 MTSLKPAFKA--------------------FDMQALINKINKSIVAPLPTKYSGAFRG-- 182
+ +P F D++ + + + + LP +
Sbjct: 216 LFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMF 275
Query: 183 ---------LVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESN 233
L++ ML +P R +A E L H PY+ H + PE
Sbjct: 276 PRVNPKGIDLLQRMLVFDPAKRITAKEALEH----PYLQTYH---------DPNDEPEGE 322
Query: 234 YARRTRFS---EPDNVPISSYREKQY 256
+ F + + ++ +
Sbjct: 323 PIPPSFFEFDHYKEALTTKDLKKLIW 348
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 39/193 (20%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILT----- 104
F+ ++ + + LL L Y+H N ILHRD+K +N+ +T+D ++L DFGLA+ +
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 105 -SDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALIN 162
+ + VV T Y PE LL + YG D+W GC + EM + P + Q +
Sbjct: 181 QPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239
Query: 163 KI----------------------NKSIVAPLPTKYSGAFRGLVKS---------MLRKN 191
I +V K + V+ +L +
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 299
Query: 192 PELRPSAAELLRH 204
P R + + L H
Sbjct: 300 PAQRIDSDDALNH 312
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/297 (19%), Positives = 94/297 (31%), Gaps = 70/297 (23%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD----I 92
+ + L Q+L + YLHAN +LHRD+K +NI + + +
Sbjct: 112 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171
Query: 93 RLGDFGLA-------KILTSDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCIYE 144
++ D G A K L D VV T Y PE LL Y DIW++GC E
Sbjct: 172 KIADMGFARLFNSPLKPLADLD---PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228
Query: 145 MTSLKPAFKA----------------------------------------------FDMQ 158
+ + +P F F
Sbjct: 229 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN 288
Query: 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKL 218
N + K L++ +L +P R ++ + ++ PY L+ L
Sbjct: 289 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD----PYFLEDPL-- 342
Query: 219 NSPRRNSLSHWPESNYARRTRFSEPDNVPISSYREKQYSFSNNRNLNPSISGTEQDS 275
P + + Y +R +E + + +Q NN G + S
Sbjct: 343 --PTSDVFAGCQIP-YPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSS 396
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 49/252 (19%), Positives = 90/252 (35%), Gaps = 58/252 (23%)
Query: 1 MELISKIRNPFIVEY-------KDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEE 53
+ + +++ I+++ V+ +I F E G +++ +K + S
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDL----WLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 54 KLCKWLVQLLMALDYLHAN----------HILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103
+LC + L YLH + I HRD+K N+ L + + DFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 104 TSDDLA---SSVVGTPSYMCPELL-----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155
+ A VGT YM PE+L + D++++G ++E+ S A
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 156 -------------------DMQALINKINKSIVAPLPTKYS-----GAFRGLVKSMLRKN 191
DMQ ++ ++K L + ++ +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVV--VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299
Query: 192 PELRPSAAELLR 203
E R SA +
Sbjct: 300 AEARLSAGCVGE 311
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 64/252 (25%)
Query: 12 IVEYKDSWVERGCY---VCIIIGFCE--GGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66
I++ D + +G V ++ E G ++ IKK + + + QLL+ L
Sbjct: 88 ILKLLDHFNHKGPNGVHVVMV---FEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 67 DYLHAN-HILHRDVKCSNIFLTKDQD------IRLGDFGLAKILTSDDLASSVVGTPSYM 119
DY+H I+H D+K N+ + I++ D G A D+ ++ + T Y
Sbjct: 145 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQTREYR 202
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-------------MQALINKINK 166
PE+L P+G +DIWS C I+E+ + F+ + + L+ ++
Sbjct: 203 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 262
Query: 167 SIVA----------------------------------PLPTKYSGAFRGLVKSMLRKNP 192
++ + + ML+ +P
Sbjct: 263 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322
Query: 193 ELRPSAAELLRH 204
R A L+ H
Sbjct: 323 RKRADAGGLVNH 334
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 60/296 (20%), Positives = 102/296 (34%), Gaps = 85/296 (28%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ I+ + + + QL+ + YLH+ +LHRD+K SNI L + +++ D
Sbjct: 96 DLHAVIR---ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD 152
Query: 97 FGLAKILTSDDLASSVVGTPS----------------------YMCPE-LLADIPYGSKS 133
FGL++ + ++ + Y PE LL Y
Sbjct: 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212
Query: 134 DIWSLGCCIYEMTSLKPAFK-------------------AFDMQALINKINKSIVAPLPT 174
D+WSLGC + E+ KP F D++++ + K+++ L
Sbjct: 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKE 272
Query: 175 KYSGAFRG---------------------------LVKSMLRKNPELRPSAAELLRHVHL 207
K L+ +L+ NP R SA + L+H
Sbjct: 273 KVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH--- 329
Query: 208 QPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPISSYREKQYSFSNNRN 263
P+V H P + + P ++ I YR YS + R
Sbjct: 330 -PFVSIFHNPNEEPNCDHIITIP---------INDNVKHSIDDYRNLVYSEISRRK 375
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 43/205 (20%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQ-DIRLGDFGLAKILTSDDL 108
++ + ++ ++L ALDY H+ I+HRDVK N+ + + +RL D+GLA+
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 109 ASSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCIYEMTSLK-PAFKAFD---------- 156
+ V + + PELL D S D+WSLGC + M K P F D
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246
Query: 157 ------MQALINKIN----KSIVAPLPTKYSGAFRGLVKS----------------MLRK 190
+ I+K N L + V S +LR
Sbjct: 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306
Query: 191 NPELRPSAAELLRHVHLQPYVLKVH 215
+ + R +A E + H PY V
Sbjct: 307 DHQSRLTAREAMEH----PYFYTVV 327
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 34/199 (17%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFL-TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
QL A+ ++H+ I HRD+K N+ + +KD ++L DFG AK L + + + + + Y
Sbjct: 149 QLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR 208
Query: 120 CPEL-LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP------- 171
PEL L Y D+WS+GC E+ KP F + +I + + P
Sbjct: 209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIR 268
Query: 172 ---------LPTK----YSGAFRG--------LVKSMLRKNPELRPSAAELLRHVHLQPY 210
PT + L++ +LR P+LR + E + H P+
Sbjct: 269 MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH----PF 324
Query: 211 VLKVHLKLNSPRRNSLSHW 229
+ S +N+ +
Sbjct: 325 FDHLRNSYESEVKNNSNFP 343
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 49/260 (18%), Positives = 89/260 (34%), Gaps = 63/260 (24%)
Query: 1 MELISKIRNPFIVEY-----KDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
+ + + + I + + + R Y +++ + G + + +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSL---HTSDWVSS 113
Query: 56 CKWLVQLLMALDYLHANH---------ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD 106
C+ + L YLH I HRD+ N+ + D + DFGL+ LT +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 107 DLA---------SSVVGTPSYMCPELLADI-------PYGSKSDIWSLGCCIYEMTS--- 147
L S VGT YM PE+L + D+++LG +E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 148 ----------LKPAFKAF--------DMQALINKINKSIVAPLPTKY---SGAFRGLVKS 186
+ AF+ DMQ L+ + P + S A R L ++
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV--SREKQRPKFPEAWKENSLAVRSLKET 291
Query: 187 MLR---KNPELRPSAAELLR 203
+ ++ E R +A
Sbjct: 292 IEDCWDQDAEARLTAQXAEE 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 53/180 (29%), Positives = 74/180 (41%), Gaps = 34/180 (18%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQD-IRLGDFGLAKILTSDDLASSVVGTPSYM 119
QLL +L Y+H+ I HRD+K N+ L ++L DFG AKIL + + S + + Y
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208
Query: 120 CPEL-LADIPYGSKSDIWSLGCCIYEMTSLKPAFK---AFDMQALINKI-----NKSIVA 170
PEL Y + DIWS GC + E+ +P F D I K+ + I
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 171 PLPTKY------------SGAFRG--------LVKSMLRKNPELRPSAAELLRHVHLQPY 210
P S FR L+ +L P R +A E L H P+
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH----PF 324
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 47/180 (26%), Positives = 70/180 (38%), Gaps = 34/180 (18%)
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDI-RLGDFGLAKILTSDDLASSVVGTPSYM 119
QL +L Y+H+ I HRD+K N+ L D + +L DFG AK L + S + + Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 120 CPEL-LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD--------MQAL-------INK 163
PEL Y S D+WS GC + E+ +P F ++ L I +
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283
Query: 164 IN-KSIVAPLPTK----YSGAFRG--------LVKSMLRKNPELRPSAAELLRHVHLQPY 210
+N P ++ FR L +L P R + E H +
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH----SF 339
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 39/186 (20%)
Query: 61 QLLMALDYLHAN--HILHRDVKCSNIFL-TKDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
QL+ ++ LH ++ HRD+K N+ + D ++L DFG AK L+ + + + +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 118 YMCPEL-LADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD--------MQAL-------I 161
Y PEL + Y + DIWS+GC EM +P F+ + ++ L +
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 162 NKIN-----KSIVAPLPTKYSGAFRG-----------LVKSMLRKNPELRPSAAELLRHV 205
K+N + +S F L+ ++L+ PE R E L H
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH- 315
Query: 206 HLQPYV 211
PY
Sbjct: 316 ---PYF 318
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 19/191 (9%)
Query: 26 VC------IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79
+C +I G + + +++ + + L W VQ+ ++YL ++HRD+
Sbjct: 85 ICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143
Query: 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT--P-SYMCPELLADIPYGSKSDIW 136
N+ + Q +++ DFGLAK+L +++ G P +M E + Y +SD+W
Sbjct: 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 137 SLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KN 191
S G ++E+ + KP + + + + K P P + M + +
Sbjct: 204 SYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQP---PICTIDVYMIMRKCWMID 259
Query: 192 PELRPSAAELL 202
+ RP EL+
Sbjct: 260 ADSRPKFRELI 270
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 11/169 (6%)
Query: 12 IVEYKDSWVERGCYVCIIIGFCE--GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
++ +++ R ++C+ E ++ E IKK + FS + K+ +L LD L
Sbjct: 161 VIHMLENFTFRN-HICMT---FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 70 HANHILHRDVKCSNIFLT--KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI 127
H N I+H D+K NI L I++ DFG + + + + Y PE++
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQSRFYRAPEVILGA 274
Query: 128 PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY 176
YG D+WSLGC + E+ + P D + + ++ K
Sbjct: 275 RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM-IELLGMPSQKL 322
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 7e-19
Identities = 51/267 (19%), Positives = 83/267 (31%), Gaps = 99/267 (37%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVKCSNIFLT------ 87
G + + I K+N + + K + Q+L LDYLH I+H D+K NI L+
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187
Query: 88 -------------------------------------------KDQDIRLGDFGLAKILT 104
+ +++ D G A +
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV- 246
Query: 105 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-------- 156
+ + T Y E+L Y + +DIWS C +E+ + F+
Sbjct: 247 -HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305
Query: 157 -----MQALINKINKSIVA----------------------------PLPTKYSG----- 178
+ L+ K+ + ++ L KY
Sbjct: 306 DHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEA 365
Query: 179 -AFRGLVKSMLRKNPELRPSAAELLRH 204
F + ML PE R +AAE LRH
Sbjct: 366 AGFTDFLLPMLELIPEKRATAAECLRH 392
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 49/225 (21%), Positives = 93/225 (41%), Gaps = 14/225 (6%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+I G + + +++ + + L W VQ+ ++YL ++HRD+ N+ +
Sbjct: 93 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 151
Query: 88 KDQDIRLGDFGLAKILTSDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCIYE 144
Q +++ DFGLAK+L +++ G P +M E + Y +SD+WS G ++E
Sbjct: 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211
Query: 145 MTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL- 201
+ + KP + + + + K P P + ++ + + RP EL
Sbjct: 212 LMTFGSKP-YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
Query: 202 --LRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPD 244
+ P V + R L +SN+ R E D
Sbjct: 271 IEFSKMARDPQRYLV---IQGDERMHLPSPTDSNF-YRALMDEED 311
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 58/324 (17%), Positives = 103/324 (31%), Gaps = 100/324 (30%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
D+ + K +EE + L LL+ +++H + I+HRD+K +N L +D +++ D
Sbjct: 115 DLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172
Query: 97 FGLAKILTSDDLASSVVGTPS-----------------------YMCPE-LLADIPYGSK 132
FGLA+ + S+ + V Y PE +L Y
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 133 SDIWSLGCCIYEM-----------TSLKPAFKAF-------------------------- 155
DIWS GC E+ T+ P F
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNII 292
Query: 156 ----------DMQALINKINKSIVAPLPTKYSGAFRG-----------LVKSMLRKNPEL 194
D++ + + P + + L++SML+ NP
Sbjct: 293 FNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNK 352
Query: 195 RPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPISSYREK 254
R + + L H PY+ V K P F + + + R
Sbjct: 353 RITIDQALDH----PYLKDVRKKKLENFSTKKIILP---------FDDWMVLSETQLRYI 399
Query: 255 QYSFSNNRN---LNPSISGTEQDS 275
+ + + PS+ +++
Sbjct: 400 FLKEVQSFHPELVIPSVFTIHENN 423
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 6/180 (3%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
V II+ C G++ ++ L + QL AL YL + +HRD+ N+
Sbjct: 465 VWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 523
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVG-TP-SYMCPELLADIPYGSKSDIWSLGCCIY 143
++ + ++LGDFGL++ + + G P +M PE + + S SD+W G C++
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
E+ KP F+ +I +I P+P L+ +P RP EL
Sbjct: 584 EILMHGVKP-FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 17/239 (7%)
Query: 12 IVEYKDSWVERGCYVCIIIGFCE--GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
IV K ++ R ++C++ E ++ + ++ N + S K+ Q+ AL +L
Sbjct: 118 IVHLKRHFMFRN-HLCLV---FEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 70 HAN--HILHRDVKCSNIFLT--KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA 125
I+H D+K NI L K I++ DFG + + + Y PE+L
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFYRSPEVLL 231
Query: 126 DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY--SGAFRGL 183
+PY D+WSLGC + EM + +P F + +NKI ++ P
Sbjct: 232 GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI-VEVLGIPPAHILDQAPKARK 290
Query: 184 -VKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHW-PESNYARRTRF 240
+ + L+ + + L L + + A +F
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF 349
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 41/231 (17%), Positives = 92/231 (39%), Gaps = 13/231 (5%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ ++ + G + + +++ + + L W VQ+ + YL + ++HR++ N+
Sbjct: 89 LQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCI 142
L +++ DFG+A +L DD P +M E + Y +SD+WS G +
Sbjct: 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
Query: 143 YEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE 200
+E+ + +P + + + + + K P + ++ + +RP+ E
Sbjct: 208 WELMTFGAEP-YAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKE 266
Query: 201 L---LRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPI 248
L + P V + ++ PE + + E + P
Sbjct: 267 LANEFTRMARDPPRYLV---IKRESGPGIAPGPEPHGLTNKKLEEVELEPE 314
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 42/188 (22%), Positives = 84/188 (44%), Gaps = 3/188 (1%)
Query: 20 VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79
R II F G++ + +++ N + S L Q+ A++YL + +HR++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY--MCPELLADIPYGSKSDIWS 137
N + ++ +++ DFGL++++T D + PE LA + KSD+W+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 138 LGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP 196
G ++E+ + + D+ + + K P L+++ + NP RP
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 464
Query: 197 SAAELLRH 204
S AE+ +
Sbjct: 465 SFAEIHQA 472
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 38/152 (25%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
+E++ +++ IV+YK G + +I+ + G + + ++K + + KL ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYT 120
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPS- 117
Q+ ++YL +HRD+ NI + + +++GDFGL K+L D + S
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 118 --YMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ PE L + + SD+WS G +YE+ +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 37/180 (20%), Positives = 81/180 (45%), Gaps = 3/180 (1%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I+ + G + + +K K +L Q+ + Y+ + +HRD++ +NI
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY--MCPELLADIPYGSKSDIWSLGCCIY 143
+ ++ ++ DFGLA+++ ++ + PE + KSD+WS G +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 144 EMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
E+T+ + + + +++++ + P P + + L+ RK PE RP+ L
Sbjct: 373 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 432
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 38/152 (25%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
+E++ +++ IV+YK G + +I+ + G + + ++K + + KL ++
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYT 151
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPS- 117
Q+ ++YL +HRD+ NI + + +++GDFGL K+L D + S
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 118 --YMCPELLADIPYGSKSDIWSLGCCIYEMTS 147
+ PE L + + SD+WS G +YE+ +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 9/184 (4%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I++ +GGD ++ + L + + ++YL + +HRD+ N
Sbjct: 187 IYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY----MCPELLADIPYGSKSDIWSLGCC 141
+T+ +++ DFG+++ A+S G PE L Y S+SD+WS G
Sbjct: 246 VTEKNVLKISDFGMSREEADGVYAAS-GGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA 199
++E SL P + Q + K P P A L++ P RPS +
Sbjct: 305 LWETFSLGASP-YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFS 363
Query: 200 ELLR 203
+ +
Sbjct: 364 TIYQ 367
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 12/183 (6%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
V II+ C G++ ++ L + QL AL YL + +HRD+ N+
Sbjct: 90 VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIY 143
++ + ++LGDFGL++ + + G P +M PE + + S SD+W G C++
Sbjct: 149 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 208
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSA 198
E+ KP F+ +I +I P+P L M + +P RP
Sbjct: 209 EILMHGVKP-FQGVKNNDVIGRIENGERLPMPPNCPPTLYSL---MTKCWAYDPSRRPRF 264
Query: 199 AEL 201
EL
Sbjct: 265 TEL 267
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 46/248 (18%), Positives = 97/248 (39%), Gaps = 15/248 (6%)
Query: 1 MELISKIRNPFIVE-----YKDSWVERGCYVCIIIGFCEGGDMAEAIKKA----NSKLFS 51
+ + +P + + + R +I+ F + GD+ + + N
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 52 EEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS 111
+ L +++V + ++YL + + +HRD+ N L +D + + DFGL++ + S D
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 112 VVGT--P-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINK 166
+ P ++ E LAD Y SD+W+ G ++E+ + P + + + N +
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYLIG 254
Query: 167 SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSL 226
P + L+ +P+ RPS L + L V P ++
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINI 314
Query: 227 SHWPESNY 234
++
Sbjct: 315 ERAHHHHH 322
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 36/153 (23%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 1 MELISKIRNPFIVEYKD-SWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
++++ + + FIV+Y+ S+ + +++ + G + + +++ ++L +L +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-DASRLLLYS 133
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTP 116
Q+ ++YL + +HRD+ NI + + +++ DFGLAK+L D + +P
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 117 -SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+ PE L+D + +SD+WS G +YE+ +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 40/153 (26%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
+E++ + + IV+YK E G + +I+ F G + E + K N + ++ K+
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYA 132
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPS- 117
VQ+ +DYL + +HRD+ N+ + + +++GDFGL K + +D + + S
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 118 --YMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+ PE L + SD+WS G ++E+ +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 56/318 (17%), Positives = 95/318 (29%), Gaps = 104/318 (32%)
Query: 52 EEKLCKWLV-QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS 110
E K L+ LL+ + Y+H+ ILHRD+K +N + +D +++ DFGLA+ + + +
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 111 SVVGTPS----------------------------YMCPE-LLADIPYGSKSDIWSLGCC 141
S + Y PE +L Y D+WS+GC
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 142 IYEMTSL-----------KPAFK------------------------------------- 153
E+ ++ P F
Sbjct: 274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333
Query: 154 --AFDMQALINKINKSIVAPLPTKYSGAFRG-----------LVKSMLRKNPELRPSAAE 200
D++AL + K + P + L+K ML NP R + E
Sbjct: 334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE 393
Query: 201 LLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPISSYREKQYSFSN 260
L H P+ +V + P F++ N+ R
Sbjct: 394 CLAH----PFFKEVRIAEVETNATEKVRLP---------FNDWMNMDEPQLRYAFVKEIQ 440
Query: 261 NRNLNPSISGTEQDSLCS 278
+ + + S
Sbjct: 441 RYHPEIQLPRRSPNRASS 458
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
II F G++ + +++ N + S L Q+ A++YL + +HRD+ N
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIY 143
+ ++ +++ DFGL++++T D + P + PE LA + KSD+W+ G ++
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 203
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSA 198
E+ + P + D+ + + K P G + + M NP RPS
Sbjct: 204 EIATYGMSP-YPGIDLSQVYELLEKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSF 259
Query: 199 AELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARR 237
AE+ H + + +S+S E +R
Sbjct: 260 AEI--HQAFETMF----------QESSISDEVEKELGKR 286
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 30/127 (23%), Positives = 58/127 (45%), Gaps = 5/127 (3%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ ++ G + + ++K + F L ++ VQ+ + YL + +HRD+ N+
Sbjct: 95 MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153
Query: 86 LTKDQDIRLGDFGLAKILTSDD---LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCC 141
L +++GDFGL + L +D + P ++ PE L + SD W G
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 142 IYEMTSL 148
++EM +
Sbjct: 214 LWEMFTY 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 37/180 (20%), Positives = 81/180 (45%), Gaps = 3/180 (1%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I+ + G + + +K K +L Q+ + Y+ + +HRD++ +NI
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY--MCPELLADIPYGSKSDIWSLGCCIY 143
+ ++ ++ DFGLA+++ ++ + PE + KSD+WS G +
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 144 EMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
E+T+ + + + +++++ + P P + + L+ RK PE RP+ L
Sbjct: 456 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 515
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 14/95 (14%)
Query: 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPE 122
+++LH NH +HRD+K +NI L + ++ DFGLA+ + S +VGT +YM PE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 123 LLADIPY--G---SKSDIWSLGCCIYEMTSLKPAF 152
G KSDI+S G + E+ + PA
Sbjct: 206 ------ALRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 78/265 (29%)
Query: 12 IVEYKDSWVERGCYVCIIIGFCE--GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
IV+Y ++ ++C+I E G + E I + N F E + + +++L AL+YL
Sbjct: 98 IVKYHGKFMYYD-HMCLI---FEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153
Query: 70 HANHILHRDVKCSNIFLT-------------------------KDQDIRLGDFGLAKILT 104
+ H D+K NI L K I+L DFG A
Sbjct: 154 RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-TFK 212
Query: 105 SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-------M 157
SD S++ T Y PE++ ++ + SD+WS GC + E+ + F+ + M
Sbjct: 213 SDYH-GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271
Query: 158 QALINKINKSIVA------------------PLPTKYSG--------------------A 179
+++I I K+++ P S
Sbjct: 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH 204
F + S+L+ +P LRPS AELL+H
Sbjct: 332 FCDFLYSILQIDPTLRPSPAELLKH 356
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 53/257 (20%), Positives = 91/257 (35%), Gaps = 70/257 (27%)
Query: 12 IVEYKDSWVERGCYVCIIIGFCE--GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
V D + G ++CI E G + E +K+ N + + + QL AL +L
Sbjct: 84 CVLMSDWFNFHG-HMCIA---FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 70 HANHILHRDVKCSNIFLT-------------------KDQDIRLGDFGLAKILTSDDLAS 110
H N + H D+K NI K+ IR+ DFG A + +
Sbjct: 140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHT 197
Query: 111 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-------MQALINK 163
++V T Y PE++ ++ + D+WS+GC ++E F+ + M+ ++
Sbjct: 198 TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP 257
Query: 164 INKSIVA-------------PLPTKYSGAFRG-----------------------LVKSM 187
I ++ S L++ M
Sbjct: 258 IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317
Query: 188 LRKNPELRPSAAELLRH 204
L +P R + AE L H
Sbjct: 318 LEFDPAQRITLAEALLH 334
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 12/184 (6%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
II+ G++ +++ N L + +Q+ A+ YL + + +HRD+ NI
Sbjct: 87 TWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIY 143
+ + ++LGDFGL++ + +D + V P +M PE + + + SD+W C++
Sbjct: 146 VASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMW 205
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSA 198
E+ S +P F + + +I + K P P L M R +P RP
Sbjct: 206 EILSFGKQP-FFWLENKDVIGVLEKGDRLPKP---DLCPPVLYTLMTRCWDYDPSDRPRF 261
Query: 199 AELL 202
EL+
Sbjct: 262 TELV 265
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 36/153 (23%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
++++ + + I++YK + G + +++ + G + + + + + +L +
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFA 140
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTP 116
Q+ + YLHA H +HRD+ N+ L D+ +++GDFGLAK + +P
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 117 -SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
+ PE L + + SD+WS G +YE+ +
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 41/184 (22%), Positives = 84/184 (45%), Gaps = 12/184 (6%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I+ + G + ++ + K +L + + + +L ++ +HRD+ N
Sbjct: 78 IYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIY 143
+ +D +++ DFG+ + + D SSV P + PE+ Y SKSD+W+ G ++
Sbjct: 137 VDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMW 196
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSA 198
E+ SL P + + ++ K+++ P A + + M + PE RP+
Sbjct: 197 EVFSLGKMP-YDLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTF 252
Query: 199 AELL 202
+LL
Sbjct: 253 QQLL 256
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 16/151 (10%), Positives = 38/151 (25%), Gaps = 32/151 (21%)
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP 116
+ + L A D H + S + ++ D D+ L
Sbjct: 133 RAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD----MQALINKINKSIVAP- 171
M + DI +G +Y + + + + P
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226
Query: 172 -LPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
+ + ++ + +R ++ L
Sbjct: 227 DIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 40/215 (18%), Positives = 90/215 (41%), Gaps = 15/215 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ +P ++ + +++ + + GD+ I+ + + + L + +
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGL 135
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS--- 117
Q+ + YL + +HRD+ N L + +++ DFGLA+ + + S T +
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 118 --YMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLP 173
+M E L + +KSD+WS G ++E+ + P + + + + + P
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLLQP 254
Query: 174 TKYSGAFRGLVKSMLR---KNPELRPSAAELLRHV 205
+ ML+ E+RPS +EL+ +
Sbjct: 255 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 286
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 50/257 (19%), Positives = 93/257 (36%), Gaps = 70/257 (27%)
Query: 12 IVEYKDSWVERGCYVCIIIGFCE--GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
V+ + + G ++CI+ E G + IK+ F + + K Q+ ++++L
Sbjct: 79 CVQMLEWFEHHG-HICIV---FELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 70 HANHILHRDVKCSNIFLT-------------------KDQDIRLGDFGLAKILTSDDLAS 110
H+N + H D+K NI + DI++ DFG A + S
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TYDDEHH-S 192
Query: 111 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-------MQALINK 163
++V T Y PE++ + + D+WS+GC + E F D M+ ++
Sbjct: 193 TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGP 252
Query: 164 INKSIVA--------------PLPTKYSG----------------------AFRGLVKSM 187
+ K ++ +G L++ M
Sbjct: 253 LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312
Query: 188 LRKNPELRPSAAELLRH 204
L +P R + E L+H
Sbjct: 313 LEYDPAKRITLREALKH 329
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 41/186 (22%), Positives = 75/186 (40%), Gaps = 14/186 (7%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ +++ GG + + + + + + L Q+ M + YL + +HRD+ N+
Sbjct: 84 LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142
Query: 86 LTKDQDIRLGDFGLAKILTSDDLA-SSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 141
L ++ DFGL+K L +DD ++ P + PE + + S+SD+WS G
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRP 196
++E S KP +K ++ I + P L M E RP
Sbjct: 203 MWEALSYGQKP-YKKMKGPEVMAFIEQGKRMECP---PECPPELYALMSDCWIYKWEDRP 258
Query: 197 SAAELL 202
+
Sbjct: 259 DFLTVE 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 41/236 (17%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ +P ++ + +++ + + GD+ I+ + + + L + +
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGL 199
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPS--- 117
Q+ + +L + +HRD+ N L + +++ DFGLA+ + + S T +
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 118 --YMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLP 173
+M E L + +KSD+WS G ++E+ + P + + + + + P
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLLQP 318
Query: 174 TKYSGAFRGLVKSMLR---KNPELRPSAAELLRHVH--LQPYVLKVHLKLNSPRRN 224
+ ML+ E+RPS +EL+ + ++ + ++ +N+ N
Sbjct: 319 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 371
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 12/184 (6%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+C++ F E G +++ ++ LF+ E L + + + YL ++HRD+ N
Sbjct: 78 ICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIY 143
+ ++Q I++ DFG+ + + D SS P + PE+ + Y SKSD+WS G ++
Sbjct: 137 VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 196
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSA 198
E+ S P ++ ++ I+ P S + M + PE RP+
Sbjct: 197 EVFSEGKIP-YENRSNSEVVEDISTGFRLYKPRLASTHVYQI---MNHCWRERPEDRPAF 252
Query: 199 AELL 202
+ LL
Sbjct: 253 SRLL 256
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 17/221 (7%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
V I+ + E G + ++K + F+ +L L + + YL +HRD+ NI
Sbjct: 121 VMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL 179
Query: 86 LTKDQDIRLGDFGLAKILTSD-DLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCC 141
+ + ++ DFGL ++L D + A + G + PE +A + S SD+WS G
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRP 196
++E+ S +P + Q +I +++ P P L + ML K+ RP
Sbjct: 240 LWEVMSYGERP-YWEMSNQDVIKAVDEGYRLPPP---MDCPAALYQLMLDCWQKDRNNRP 295
Query: 197 SAAEL---LRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNY 234
++ L + P LK+ + N L +
Sbjct: 296 KFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDI 336
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 38/184 (20%), Positives = 78/184 (42%), Gaps = 11/184 (5%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ II + E G + + +K + + KL Q+ + ++ + +HRD++ +NI
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIY 143
++ ++ DFGLA+++ ++ + P + PE + + KSD+WS G +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSML---RKNPELRPSA 198
E+ + P + +I + + P L M ++ PE RP+
Sbjct: 202 EIVTHGRIP-YPGMTNPEVIQNLERGYRMVRPDNCPEELYQL---MRLCWKERPEDRPTF 257
Query: 199 AELL 202
L
Sbjct: 258 DYLR 261
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 41/187 (21%), Positives = 83/187 (44%), Gaps = 15/187 (8%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+++ E G + + +++ ++ ++ + + + Q+ M + YL ++ +HRD+ N+
Sbjct: 92 WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 149
Query: 86 LTKDQDIRLGDFGLAKILTSD-DLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 141
L ++ DFGL+K L +D + + P + PE + + SKSD+WS G
Sbjct: 150 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRP 196
++E S KP ++ + + K P +G R + M + E RP
Sbjct: 210 MWEAFSYGQKP-YRGMKGSEVTAMLEKGERMGCP---AGCPREMYDLMNLCWTYDVENRP 265
Query: 197 SAAELLR 203
A +
Sbjct: 266 GFAAVEL 272
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 42/186 (22%), Positives = 84/186 (45%), Gaps = 14/186 (7%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
I+ + E G + ++ + F+ +L L + + YL +HRD+ N+
Sbjct: 125 AMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL 183
Query: 86 LTKDQDIRLGDFGLAKILTSD-DLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCC 141
+ + ++ DFGL+++L D D A + G + PE +A + S SD+WS G
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRP 196
++E+ + +P + + +I+ + + P P G L + ML K+ RP
Sbjct: 244 MWEVLAYGERP-YWNMTNRDVISSVEEGYRLPAP---MGCPHALHQLMLDCWHKDRAQRP 299
Query: 197 SAAELL 202
++++
Sbjct: 300 RFSQIV 305
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 4e-15
Identities = 40/185 (21%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ +++ GG + + + + + + L Q+ M + YL + +HR++ N+
Sbjct: 410 LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468
Query: 86 LTKDQDIRLGDFGLAKILTSDDLA-SSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 141
L ++ DFGL+K L +DD ++ P + PE + + S+SD+WS G
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRP 196
++E S KP +K ++ I + P L M E RP
Sbjct: 529 MWEALSYGQKP-YKKMKGPEVMAFIEQGKRMECP---PECPPELYALMSDCWIYKWEDRP 584
Query: 197 SAAEL 201
+
Sbjct: 585 DFLTV 589
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 41/202 (20%), Positives = 83/202 (41%), Gaps = 34/202 (16%)
Query: 26 VCIIIGFCEGGDM--------AEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77
+I+ GD+ S K+ + ++ + YL+AN +HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162
Query: 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY-------------MCPELL 124
D+ N + +D +++GDFG+ + + D Y M PE L
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETD----------YYRKGGKGLLPVRWMSPESL 212
Query: 125 ADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRG 182
D + + SD+WS G ++E+ +L +P ++ + ++ + + + P
Sbjct: 213 KDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFE 271
Query: 183 LVKSMLRKNPELRPSAAELLRH 204
L++ + NP++RPS E++
Sbjct: 272 LMRMCWQYNPKMRPSFLEIISS 293
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 15/95 (15%)
Query: 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPE 122
L YLH I+HRDVK NI L ++ ++ DFG++K T D L++ V GT Y+ PE
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
Query: 123 LLADIPYGS------KSDIWSLGCCIYEMTSLKPA 151
Y KSD++S G ++E+ + A
Sbjct: 212 ------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 12/184 (6%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ II + G + +++ + ++L + + A++YL + LHRD+ N
Sbjct: 94 IFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL 152
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCIY 143
+ +++ DFGL++ + D+ SSV P + PE+L + SKSDIW+ G ++
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 212
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSA 198
E+ SL P ++ F I + + P S + M + + RP+
Sbjct: 213 EIYSLGKMP-YERFTNSETAEHIAQGLRLYRPHLASEKVYTI---MYSCWHEKADERPTF 268
Query: 199 AELL 202
LL
Sbjct: 269 KILL 272
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 39/186 (20%), Positives = 84/186 (45%), Gaps = 14/186 (7%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ II + E G + + +++ + + S +L L + + YL + +HRD+ NI
Sbjct: 121 MMIITEYMENGALDKFLREKDGEF-SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179
Query: 86 LTKDQDIRLGDFGLAKILTSD-DLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCC 141
+ + ++ DFGL+++L D + + G + PE ++ + S SD+WS G
Sbjct: 180 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 239
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRP 196
++E+ + +P + ++ IN P P + + M++ + RP
Sbjct: 240 MWEVMTYGERP-YWELSNHEVMKAINDGFRLPTPM---DCPSAIYQLMMQCWQQERARRP 295
Query: 197 SAAELL 202
A+++
Sbjct: 296 KFADIV 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 25/153 (16%)
Query: 66 LDYLH--AN-HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMC 120
L YLH + I+HRDVK +NI L ++ + +GDFGLAK++ D + ++V GT ++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 121 PELLADIPYGS------KSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA-PLP 173
PE Y S K+D++ G + E+ + + +AFD+ L N + ++
Sbjct: 204 PE------YLSTGKSSEKTDVFGYGVMLLELITGQ---RAFDLARLANDDDVMLLDWVKG 254
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206
LV L+ N E+ + +
Sbjct: 255 LLKEKKLEALVDVDLQGN----YKDEEVEQLIQ 283
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 18/219 (8%)
Query: 1 MELISKIRNPFIVE------YKDSWVERGCYVCIIIGFCEGGDMAEAIKK----ANSKLF 50
+ +P ++ S +I+ F + GD+ + K
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPM--VILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 51 SEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS 110
+ L K++V + + ++YL + LHRD+ N L D + + DFGL+K + S D
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 111 SVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKIN 165
P ++ E LAD Y SKSD+W+ G ++E+ + P + + + +
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-YPGVQNHEMYDYLL 263
Query: 166 KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
P ++ S R +P RP+ + L
Sbjct: 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 3/115 (2%)
Query: 37 DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGD 96
+ EA + + E L + Q+ +++L + +HRD+ NI L++ +++ D
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 97 FGLAKILTSDD--LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
FGLA+ + D + P +M PE + D Y +SD+WS G ++E+ SL
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 38/188 (20%), Positives = 82/188 (43%), Gaps = 15/188 (7%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87
+++ + GD+ + I+ + + L + +Q+ ++YL +HRD+ N L
Sbjct: 100 VLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD 158
Query: 88 KDQDIRLGDFGLAKILTSDDLASSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCI 142
+ +++ DFGLA+ + + S + + E L + +KSD+WS G +
Sbjct: 159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218
Query: 143 YEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPS 197
+E+ + P ++ D L + + + P P + + M + +P +RP+
Sbjct: 219 WELLTRGAPP-YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV---MQQCWEADPAVRPT 274
Query: 198 AAELLRHV 205
L+ V
Sbjct: 275 FRVLVGEV 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 45/232 (19%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY-VC-------IIIGFCEGGDMAEAIKKANSKLFSE 52
+ISK + IV C V I++ GGD+ +++ +
Sbjct: 84 ALIISKFNHQNIVR---------CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP 134
Query: 53 EKLCKWLVQLL-MALD------YLHANHILHRDVKCSNIFLTKDQD---IRLGDFGLAKI 102
L ++ LL +A D YL NH +HRD+ N LT ++GDFG+A+
Sbjct: 135 SSLA--MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 103 LTSDDLASSVVGTPSY-----MCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAF 155
+ G + M PE + + SK+D WS G ++E+ SL P + +
Sbjct: 193 IYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSK 249
Query: 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSAAELLRH 204
Q ++ + P G + M + PE RP+ A +L
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILER 298
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 35/181 (19%), Positives = 74/181 (40%), Gaps = 5/181 (2%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ II F G + + +K KL + Q+ + ++ + +HRD++ +NI
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY--MCPELLADIPYGSKSDIWSLGCCIY 143
++ ++ DFGLA+++ ++ + PE + + KSD+WS G +
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLM 376
Query: 144 EMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201
E+ + P + +I + + P P ++ + PE RP+ +
Sbjct: 377 EIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI 435
Query: 202 L 202
Sbjct: 436 Q 436
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 40/184 (21%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
+ I+ + G + + ++ + + L K+ + + A++YL N+ +HRD+ N+
Sbjct: 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149
Query: 86 LTKDQDIRLGDFGLAKILTSDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCI 142
+++D ++ DFGL K + +S+ P + PE L + + +KSD+WS G +
Sbjct: 150 VSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204
Query: 143 YEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE 200
+E+ S P + ++ ++ ++ K P A ++K+ + +RPS +
Sbjct: 205 WEIYSFGRVP-YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ 263
Query: 201 LLRH 204
L
Sbjct: 264 LREQ 267
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 41/201 (20%), Positives = 73/201 (36%), Gaps = 42/201 (20%)
Query: 26 VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIF 85
++ F + G + +KK N + + QL A+ +L N ++H +V NI
Sbjct: 87 NILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNIL 145
Query: 86 LTKDQD--------IRLGDFGLAKILTSDDLASSVVGTPSY------MCPELLAD-IPYG 130
L +++D I+L D G++ + D + PE + +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKD---------ILQERIPWVPPECIENPKNLN 196
Query: 131 SKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTK---YSGAFRGLVK 185
+D WS G ++E+ S KP A D Q + P P +
Sbjct: 197 LATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFYEDRHQLPAPKAAELAN-------- 247
Query: 186 SMLR---KNPELRPSAAELLR 203
+ P+ RPS ++R
Sbjct: 248 LINNCMDYEPDHRPSFRAIIR 268
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 29/224 (12%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ISK + IV + I++ GGD+ +++ + L ++
Sbjct: 125 ALIISKFNHQNIVRCIGV-SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA--ML 181
Query: 61 QLL-MALD------YLHANHILHRDVKCSNIFLTKDQD---IRLGDFGLAKILTSDDLAS 110
LL +A D YL NH +HRD+ N LT ++GDFG+A+ +
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--Y 239
Query: 111 SVVGTPSY-----MCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINK 163
G + M PE + + SK+D WS G ++E+ SL P + + Q ++
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEF 298
Query: 164 INKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSAAELLRH 204
+ P G + M + PE RP+ A +L
Sbjct: 299 VTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILER 339
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 33/147 (22%)
Query: 26 VCIIIGFCEGGDM------------AEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH 73
V +I +C GD+ + + S L + Q+ + +L + +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY------------MCP 121
+HRDV N+ LT ++GDFGLA+ + +D +Y M P
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---------NYIVKGNARLPVKWMAP 235
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSL 148
E + D Y +SD+WS G ++E+ SL
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFSL 262
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 39/183 (21%), Positives = 86/183 (46%), Gaps = 11/183 (6%)
Query: 25 YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84
+ I+ + G + + ++ + + L K+ + + A++YL N+ +HRD+ N+
Sbjct: 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 320
Query: 85 FLTKDQDIRLGDFGLAKILTSDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 141
+++D ++ DFGL K + +S+ P + PE L + + +KSD+WS G
Sbjct: 321 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 142 IYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA 199
++E+ S P + ++ ++ ++ K P A ++K+ + RP+
Sbjct: 376 LWEIYSFGRVP-YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFL 434
Query: 200 ELL 202
+L
Sbjct: 435 QLR 437
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 45/229 (19%), Positives = 91/229 (39%), Gaps = 46/229 (20%)
Query: 26 VCIIIGFCEGGDM--------------AEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA 71
+ +I+ + G++ + I + + + + L QL ++YL +
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY------------M 119
+HRD+ N+ +T++ +++ DFGLA+ + + D Y M
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---------YYKKTTNGRLPVKWM 226
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE L D Y +SD+WS G ++E+ +L P + ++ L + + P +
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCT 285
Query: 178 GAFRGLVKSML---RKNPELRPSAAELLRHVH--LQPYVLKVHLKLNSP 221
+ M P RP+ +L+ + L + +L L+ P
Sbjct: 286 NELYMM---MRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQP 331
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 45/234 (19%), Positives = 91/234 (38%), Gaps = 44/234 (18%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAE--------AIKKANSKLFSE 52
EL++ +++ IV + G + ++ + GD+ A A + +
Sbjct: 94 AELLTMLQHQHIVRFFGV-CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 53 EKLCKWLVQLL-MALD------YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS 105
L L QLL +A YL H +HRD+ N + + +++GDFG+++ + S
Sbjct: 153 GPLG--LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 106 DDLASSVVGTPSY-------------MCPELLADIPYGSKSDIWSLGCCIYEMTSL--KP 150
D Y M PE + + ++SD+WS G ++E+ + +P
Sbjct: 211 TD----------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 151 AFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ I+ I + P +++ ++ P+ R S ++
Sbjct: 261 -WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 43/233 (18%), Positives = 94/233 (40%), Gaps = 43/233 (18%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY--------VCIIIGFCEGGDMAE--------AIKK 44
EL++ +++ IV+ Y + ++ + + GD+ + A+
Sbjct: 68 AELLTNLQHEHIVK---------FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 45 ANSKLFSEEKLCKWLVQLLMALD------YLHANHILHRDVKCSNIFLTKDQDIRLGDFG 98
+ + + L +A YL + H +HRD+ N + + +++GDFG
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 178
Query: 99 LAKILTSDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFK 153
+++ + S D T +M PE + + ++SD+WS G ++E+ + +P +
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-WF 237
Query: 154 AFDMQALINKINKSIVAPLPTKYSGAFRGLVKSML---RKNPELRPSAAELLR 203
+I I + V P + ML ++ P+ R + E+ +
Sbjct: 238 QLSNTEVIECITQGRVLERPRVCPKEVYDV---MLGCWQREPQQRLNIKEIYK 287
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 35/149 (23%), Positives = 64/149 (42%), Gaps = 35/149 (23%)
Query: 26 VCIIIGFCEGGDM--------------AEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA 71
+ +I+ FC+ G++ A + + E L + Q+ +++L +
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY------------M 119
+HRD+ NI L++ +++ DFGLA+ + D Y M
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---------DYVRKGDARLPLKWM 217
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSL 148
PE + D Y +SD+WS G ++E+ SL
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSL 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 41/210 (19%), Positives = 83/210 (39%), Gaps = 44/210 (20%)
Query: 26 VCIIIGFCEGGDM--------------AEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA 71
+ +I+ + G++ + I + + + + L QL ++YL +
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY------------M 119
+HRD+ N+ +T++ +++ DFGLA+ + + D Y M
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---------YYKKTTNGRLPVKWM 272
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE L D Y +SD+WS G ++E+ +L P + ++ L + + P +
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCT 331
Query: 178 GAFRGLVKSML---RKNPELRPSAAELLRH 204
+ M P RP+ +L+
Sbjct: 332 NELYMM---MRDCWHAVPSQRPTFKQLVED 358
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 36/151 (23%), Positives = 64/151 (42%), Gaps = 37/151 (24%)
Query: 26 VCIIIGFCEGGDM----------------AEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69
+I +C GD+ + AI + + E L + Q+ + +L
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY----------- 118
+ + +HRD+ NI LT + ++ DFGLA+ + +D +Y
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---------NYVVKGNARLPVK 212
Query: 119 -MCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
M PE + + Y +SD+WS G ++E+ SL
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 39/207 (18%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 26 VCIIIGFCEGGDMAE--------AIKKANSKLFSEEKLCKWLVQLLMALD------YLHA 71
+ +I +C GD+ E + + + + + + + YL +
Sbjct: 87 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP---SYMCPELLADIP 128
+H++H+D+ N+ + ++++ D GL + + + D + + +M PE +
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK 206
Query: 129 YGSKSDIWSLGCCIYEMTSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKS 186
+ SDIWS G ++E+ S +P + + Q ++ I V P P L
Sbjct: 207 FSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYAL--- 262
Query: 187 ML---RKNPELRPSAAELLRHVHLQPY 210
M+ + P RP ++ H L+ +
Sbjct: 263 MIECWNEFPSRRPRFKDI--HSRLRAW 287
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 32/149 (21%), Positives = 62/149 (41%), Gaps = 35/149 (23%)
Query: 26 VCIIIGFCEGGDM--------AEAIKKANSKLFSEEKLCKWLVQLLMALD------YLHA 71
+ +I+ + G++ ++ + + + E+ + A YL +
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY------------M 119
+HRD+ N+ +T+D +++ DFGLA+ + D Y M
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---------YYKKTTNGRLPVKWM 260
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSL 148
PE L D Y +SD+WS G ++E+ +L
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLWEIFTL 289
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 32/189 (16%), Positives = 75/189 (39%), Gaps = 58/189 (30%)
Query: 1 MELISKIRNPFIVEYKDSWVER--GC-----YVCIIIGFCEGGDM--------------- 38
++ ++ +P ++ + G + +I+ + + G +
Sbjct: 77 FNVLKQVNHPHVI--------KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 39 -------AEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD 91
+ ++ + + + L + Q+ + YL ++HRD+ NI + + +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 92 IRLGDFGLAKILTSDDLASSVVGTPSY------------MCPELLADIPYGSKSDIWSLG 139
+++ DFGL++ + +D SY M E L D Y ++SD+WS G
Sbjct: 189 MKISDFGLSRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 140 CCIYEMTSL 148
++E+ +L
Sbjct: 240 VLLWEIVTL 248
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 42/155 (27%)
Query: 27 CIIIGFCEGGDM------------AEAIKKANSKLFSEEKLCKWL--VQLL-MALD---- 67
+I +C GD+ + I+ N K EE+ L LL A
Sbjct: 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184
Query: 68 --YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSY------- 118
+L +HRD+ N+ +T + +++ DFGLA+ + SD +Y
Sbjct: 185 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS---------NYVVRGNAR 235
Query: 119 -----MCPELLADIPYGSKSDIWSLGCCIYEMTSL 148
M PE L + Y KSD+WS G ++E+ SL
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 55/244 (22%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDM----------------AEAIKK 44
L+++ NP IV+ G +C++ + GD+ +
Sbjct: 101 AALMAEFDNPNIVKLLGV-CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 45 ANSKLFSEEKLCKWLVQLLMALD------YLHANHILHRDVKCSNIFLTKDQDIRLGDFG 98
QL +A YL +HRD+ N + ++ +++ DFG
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 99 LAKILTSDDLASSVVGTPSY-------------MCPELLADIPYGSKSDIWSLGCCIYEM 145
L++ + S D Y M PE + Y ++SD+W+ G ++E+
Sbjct: 220 LSRNIYSAD----------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
Query: 146 TSL--KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLR---KNPELRPSAAE 200
S +P + + +I + + P L M K P RPS
Sbjct: 270 FSYGLQP-YYGMAHEEVIYYVRDGNILACPENCPLELYNL---MRLCWSKLPADRPSFCS 325
Query: 201 LLRH 204
+ R
Sbjct: 326 IHRI 329
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 30/120 (25%), Positives = 53/120 (44%), Gaps = 11/120 (9%)
Query: 35 GGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL-TKDQD-I 92
G + A+ + + SE + + +LL AL++LH N +H +V NIF+ +DQ +
Sbjct: 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200
Query: 93 RLGDFGLAK--------ILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCIY 143
L +G A + + S G ++ +L +SD+ SLG C +
Sbjct: 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 35/148 (23%), Positives = 58/148 (39%), Gaps = 24/148 (16%)
Query: 20 VERGCYVCIIIGFCEGGDM---------AEAIKKANSKLFSEEKLCKWLVQLL-MALD-- 67
E Y+ + I + G++ E + L QLL A D
Sbjct: 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS--SQQLLHFAADVA 152
Query: 68 ----YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT--P-SYMC 120
YL +HRD+ NI + ++ ++ DFGL++ ++ P +M
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 209
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSL 148
E L Y + SD+WS G ++E+ SL
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEIVSL 237
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 31/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)
Query: 40 EAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL-TKDQD-IRLGDF 97
+ I +AN+K FS + + + +++L L+Y+H + +H D+K SN+ L K+ D + L D+
Sbjct: 139 QKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDY 198
Query: 98 GLAKILTSD--------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCIY 143
GLA + D GT + + + + D+ LG C I
Sbjct: 199 GLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 24/105 (22%), Positives = 48/105 (45%), Gaps = 11/105 (10%)
Query: 50 FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL-TKDQD-IRLGDFGLAKILTSD- 106
F + + + +++L L+Y+H N +H D+K +N+ L K+ D + L D+GL+ +
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 107 -------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCIY 143
+ GT + + + +SD+ LG C +
Sbjct: 208 NHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 28/113 (24%), Positives = 50/113 (44%), Gaps = 15/113 (13%)
Query: 40 EAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD---IRLGD 96
E + S+ FS + + Q++ ++Y+H+ + +HRDVK N + + + + D
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 151
Query: 97 FGLAK----------ILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLG 139
FGLAK I ++ ++ GT Y I + D+ SLG
Sbjct: 152 FGLAKKYRDARTHQHIPYREN--KNLTGTARYASINTHLGIEQSRRDDLESLG 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 3e-07
Identities = 32/185 (17%), Positives = 57/185 (30%), Gaps = 22/185 (11%)
Query: 28 IIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH-ILHRDVKCSNIFL 86
I++ F GG +++ +KL S L QL +L A+ HRD+ N+ L
Sbjct: 139 IVLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 87 TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146
K +L K T + + I Y +++
Sbjct: 196 KKTSLKKLHYTLNGKSST--------IPSCGLQVSI----IDYTLSRLERDGIVVFCDVS 243
Query: 147 SLKPAFKA-FDMQALINKINKSIVAPLPTKYSGA-----FRGLVKSMLRKNPELRPSAAE 200
+ F D Q I ++ K +Y L ML++
Sbjct: 244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 201 LLRHV 205
++ +
Sbjct: 304 AMKQI 308
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 16/119 (13%)
Query: 40 EAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL------TKDQDIR 93
E + + FS + + Q+L + +H +++RD+K N FL I
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN-FLIGRPNSKNANMIY 151
Query: 94 LGDFGLAKILTSDDLAS--------SVVGTPSYMCPELLADIPYGSKSDIWSLG-CCIY 143
+ DFG+ K ++ GT YM + D+ +LG +Y
Sbjct: 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 25/111 (22%), Positives = 45/111 (40%), Gaps = 11/111 (9%)
Query: 40 EAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD---IRLGD 96
E + S+ S + + Q++ ++++H+ LHRD+K N + + + + D
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149
Query: 97 FGLAKILTSDDLAS--------SVVGTPSYMCPELLADIPYGSKSDIWSLG 139
FGLAK ++ GT Y I + D+ SLG
Sbjct: 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG 200
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 34/272 (12%), Positives = 74/272 (27%), Gaps = 86/272 (31%)
Query: 6 KIRNPFIVEYKDSWVERGCY------------VCIIIG--FCEGGDMA-------EAIKK 44
+ + F + W+ + I + D + +I+
Sbjct: 177 QCKMDFKI----FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 45 ANSKLFSEEKLCKWLVQLLMALDYL-HANHILHRDVKCSNIFLTKDQDI-RLGDFGLAKI 102
+L + L+ L + +A ++ C + T+ + +
Sbjct: 233 ELRRLLKSKPYEN----CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 103 LTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALIN 162
++ D + ++ TP + LL L C L + L
Sbjct: 289 ISLDHHSMTL--TPDEV-KSLLLKY----------LDC---RPQDLPR-------EVL-- 323
Query: 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPR 222
N P ++ +R + + +HV+ KL +
Sbjct: 324 TTN-----PRRL-------SIIAESIRDG----LATWDNWKHVNCD--------KLTTII 359
Query: 223 RNSLSHWPESNYARRTRFSE----PDNVPISS 250
+SL+ + Y R F P + I +
Sbjct: 360 ESSLNVLEPAEY--RKMFDRLSVFPPSAHIPT 389
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 65/458 (14%), Positives = 130/458 (28%), Gaps = 124/458 (27%)
Query: 148 LKPAFKA-FDMQ--------ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA 198
+ AF FD + L + I+ SG R L ++L K E+
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIM-SKDAVSGTLR-LFWTLLSKQEEM---- 78
Query: 199 AELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPISSYREKQYSF 258
+Q +V +V L++N + S R R++ Y
Sbjct: 79 --------VQKFVEEV-LRINYK-------FLMSPIKTEQRQPSMMTRMYIEQRDRLY-- 120
Query: 259 SNNRNLNPSISGTEQDSLCSTKGIHNTPAYLNRRLSEVSVESSHEGTVICKPIAS-KTSF 317
N N + + ++ + L + L E+ + +I + S KT
Sbjct: 121 ----NDNQVFA---KYNVSRLQPYLK----LRQALLELR---PAKNVLIDGVLGSGKTWV 166
Query: 318 VAKTPRLASSKASTNRRGSYAVKKHESHPVS----------RLPSKKSIPSSRRASLPLP 367
+ + + + K+ + P + ++ + S +++ L
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 368 PVAAIREL-------PYRPNTGILHCVKSPDVSVNEPRIDRIAEFPLASYEDTFFPIPKT 420
+ EL PY +L V++ F L+ K
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKA---------WNAFNLSC---------KI 268
Query: 421 SPTSAQGSSSSPLCVDRSITKDKCTVQKCDRASANHK---FTEA--------WQGIQHSM 469
T+ + +T D + S +H T +
Sbjct: 269 LLTTR----------FKQVT-DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC--RP 315
Query: 470 FQVNEEEGSNSSDQNATAGASSRNSSDARRHRFDTSSYQQRAEALEGLLEFSAKLL---- 525
+ E + + + + S R+ +D + + L ++E S +L
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRD----GLATWDNWKHVNC-DKLTTIIESSLNVLEPAE 370
Query: 526 QQERYDELGVLLKPFGPGKVS-PRET--AIWLTKSIKE 560
++ +D L V P P IW +
Sbjct: 371 YRKMFDRLSVF-----PPSAHIPTILLSLIWFDVIKSD 403
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 28/115 (24%), Positives = 49/115 (42%), Gaps = 17/115 (14%)
Query: 40 EAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFL-----TKDQDIRL 94
E + + FS + + +QL+ ++Y+H+ ++++RDVK N + Q I +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHI 151
Query: 95 GDFGLAK----------ILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLG 139
DF LAK I + S+ GT YM + D+ +LG
Sbjct: 152 IDFALAKEYIDPETKKHIPYREHK--SLTGTARYMSINTHLGKEQSRRDDLEALG 204
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 570 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.63 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.03 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.67 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.34 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.17 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.67 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.16 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.2 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 91.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 90.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 90.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 87.88 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 87.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 84.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 81.92 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.24 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=425.37 Aligned_cols=208 Identities=40% Similarity=0.805 Sum_probs=193.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +.+|||||||+||+|.++|....+..+++..++.|+.||+.||+|||++||||||||
T Consensus 74 ~~il~~l~HpnIV~~~~~~~~~-~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 152 (350)
T 4b9d_A 74 VAVLANMKHPNIVQYRESFEEN-GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIK 152 (350)
T ss_dssp HHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCC
T ss_pred HHHHHHCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 4689999999999999999765 589999999999999999988766778999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||||+.+|.+||+|||+++.+... ......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 153 p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 232 (350)
T 4b9d_A 153 SQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232 (350)
T ss_dssp GGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999999999887543 23456789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
++.++......+.+..++.++++||.+||.+||++|||++|||+|+||+.
T Consensus 233 ~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 233 LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 99999888877888899999999999999999999999999999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=415.98 Aligned_cols=206 Identities=30% Similarity=0.559 Sum_probs=187.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++||++|+|||||+++++|.++ +.+|||||||+||+|.+++.+ ..+++..++.|+.||+.||+|||++||||||||
T Consensus 122 i~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 197 (346)
T 4fih_A 122 VVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197 (346)
T ss_dssp HHHHHHCCCTTBCCEEEEEEET-TEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence 4789999999999999999765 489999999999999999976 349999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||||+.+|.+||+|||+++.+... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 198 p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred HHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999999999987643 45667899999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 160 LINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
++..+....... .+..+++++++||.+||.+||++|||++|||+||||+..
T Consensus 278 ~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 278 AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 888887665433 345789999999999999999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=412.25 Aligned_cols=205 Identities=31% Similarity=0.546 Sum_probs=187.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++||++|+|||||+++++|.++ +++|||||||+||+|.++|++.+ .|+|..++.|+.||+.||+|||++||+|||||
T Consensus 83 ~~il~~l~HpnIv~l~~~~~~~-~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlK 159 (311)
T 4aw0_A 83 RDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 159 (311)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 3689999999999999999655 58999999999999999998764 59999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+||||+.+|.+||+|||+|+.+... ......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 160 PeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999987533 345678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHH------HHHhhccCh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE------LLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~e------IL~hp~fq~ 209 (570)
.+++.++..... .+|..+++++++||++||.+||.+|+|++| |++||||+.
T Consensus 240 ~~~~~~i~~~~~-~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 240 GLIFAKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHHHHHTCC-CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHHcCCC-CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 999888877654 467889999999999999999999999987 588999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=399.49 Aligned_cols=204 Identities=27% Similarity=0.546 Sum_probs=174.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +.+||||||| +|+|.++|.+. +.+++..++.|+.||+.||+|||++||+|||||
T Consensus 64 i~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiK 139 (275)
T 3hyh_A 64 ISYLRLLRHPHIIKLYDVIKSK-DEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 139 (275)
T ss_dssp HHHHHHCCCTTBCCEEEEEECS-SEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHHCCCCCCCeEEEEEEEC-CEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence 3689999999999999998654 5899999999 67999999875 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.+|.+||+|||+|+...........+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+...
T Consensus 140 P~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~ 219 (275)
T 3hyh_A 140 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219 (275)
T ss_dssp TTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999999999999999999998877666777899999999999998887 689999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+...+..... .++..+++++++||++||.+||++|||++|+|+||||+.
T Consensus 220 ~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 220 LFKNISNGVY-TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHTCC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHcCCC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 8888876654 467889999999999999999999999999999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=418.79 Aligned_cols=206 Identities=30% Similarity=0.561 Sum_probs=187.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++||++|+|||||+++++|.++ +.+|||||||+||+|.++++.. .|++..++.|+.||+.||+|||++||||||||
T Consensus 199 i~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiK 274 (423)
T 4fie_A 199 VVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274 (423)
T ss_dssp HHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCCCCCceEEEEEEC-CEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 4789999999999999999765 4899999999999999999753 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||||+.+|.|||+|||+++.+... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 275 p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp TTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred HHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999999999987643 45567899999999999999999999999999999999999999999999988
Q ss_pred HHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 160 LINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
++..+...... ..+..++.++++||.+||.+||++|||++|||+||||+..
T Consensus 355 ~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 355 AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 88888766433 3456799999999999999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=404.44 Aligned_cols=206 Identities=30% Similarity=0.509 Sum_probs=185.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +.+|||||||+||+|.++|++.+ .+++..++.|+.||+.||+|||++||+|||||
T Consensus 77 ~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 153 (304)
T 3ubd_A 77 RDILVEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLK 153 (304)
T ss_dssp -CCCCCCCCTTEECEEEEEEET-TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred HHHHHHCCCCCCCeEEEEEEEC-CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 3578999999999999999765 58999999999999999998754 59999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.+|.+||+|||+|+.... .......+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 154 p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 233 (304)
T 3ubd_A 154 PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233 (304)
T ss_dssp GGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence 9999999999999999999987543 345567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
+..++..... ..|..+++++++||++||.+||++||| ++||++||||+..
T Consensus 234 ~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 234 TMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcCCC-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 8888876644 467889999999999999999999998 5899999999853
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=395.49 Aligned_cols=205 Identities=26% Similarity=0.586 Sum_probs=177.8
Q ss_pred CHHhhhcCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Q 008303 1 MELISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--IL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--Iv 75 (570)
+++|++|+|||||+++++|... ...+|||||||+||+|.++|++.. .+++..++.|+.||+.||+|||++| |+
T Consensus 76 ~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~Ii 153 (290)
T 3fpq_A 76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPII 153 (290)
T ss_dssp HHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred HHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEE
Confidence 4689999999999999998642 356899999999999999998754 5999999999999999999999999 99
Q ss_pred cceecCCcEEEcC-CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTK-DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+||||+. +|.+||+|||+|+... .......+||+.|||||++.+ +|+.++|||||||++|||++|++||.+
T Consensus 154 HRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ecccChhheeEECCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999985 7899999999998643 344567899999999999865 699999999999999999999999976
Q ss_pred c-CHHHHHHHHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 F-DMQALINKINKSIVA-PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~-~~~~~~~~i~~~~~~-p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
. +...+...+...... ..+..+++++++||.+||.+||++|||++|||+||||++
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 232 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 4 445555666554332 245568899999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=404.45 Aligned_cols=202 Identities=32% Similarity=0.456 Sum_probs=176.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ .++|||||||+||+|.++|++.+ .|++..++.|+.||+.||+|||++||||||||
T Consensus 101 ~~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 177 (336)
T 4g3f_A 101 LVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177 (336)
T ss_dssp HHTTTTCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred HHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence 3678999999999999998654 58999999999999999998764 59999999999999999999999999999999
Q ss_pred CCcEEEcCCC-CEEEeecCCceeccCCCC------CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCc
Q 008303 81 CSNIFLTKDQ-DIRLGDFGLAKILTSDDL------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 81 P~NILld~~g-~vKL~DFGla~~~~~~~~------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
|+||||+.+| .+||+|||+++.+..... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.
T Consensus 178 p~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~ 257 (336)
T 4g3f_A 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257 (336)
T ss_dssp GGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred HHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 9999999988 599999999998754322 234689999999999999999999999999999999999999998
Q ss_pred ccCHHHHHHHHHhccC--CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 154 AFDMQALINKINKSIV--APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~~--~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.+...+..++..... ..++..+++++++||.+||.+||.+|||+.||++|+
T Consensus 258 ~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l 311 (336)
T 4g3f_A 258 QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV 311 (336)
T ss_dssp TTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 8777666666665443 235778999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=381.09 Aligned_cols=206 Identities=20% Similarity=0.402 Sum_probs=185.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-----------SKLFSEEKLCKWLVQLLMALDYL 69 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-----------~~~Lse~~i~~I~~QLl~aL~yL 69 (570)
+++|++|+|||||+++|+|.+.+ .+|||||||+||+|.++|++.+ ...|++..+..|+.||+.||.||
T Consensus 66 ~~il~~l~HpnIV~l~g~~~~~~-~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 144 (299)
T 4asz_A 66 AELLTNLQHEHIVKFYGVCVEGD-PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL 144 (299)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSS-SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCccEEEEEeeCC-EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999999986554 6899999999999999998642 34699999999999999999999
Q ss_pred HHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhh
Q 008303 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146 (570)
Q Consensus 70 Hs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl 146 (570)
|+++|+||||||+||||+.++.+||+|||+++....... ....+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 145 H~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 145 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999999987654332 23457999999999999999999999999999999999
Q ss_pred c-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 147 S-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 147 t-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+ |+.||.+.+..++...+..+...+.|..++.++.+||.+||+.||++|||+++|+. |++.
T Consensus 225 t~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~ 286 (299)
T 4asz_A 225 TYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQN 286 (299)
T ss_dssp TTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence 8 89999999999999999888888889999999999999999999999999999954 4544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=381.05 Aligned_cols=207 Identities=27% Similarity=0.496 Sum_probs=163.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCc-----------EEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGC-----------YVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDY 68 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~-----------~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~y 68 (570)
+++|++|+|||||+++++|.+.+. ++|||||||.||+|.++++.... ....+..++.|+.||+.||+|
T Consensus 54 ~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~y 133 (299)
T 4g31_A 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133 (299)
T ss_dssp HHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHH
Confidence 468999999999999999976442 58999999999999999986432 234567789999999999999
Q ss_pred HHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC-------------CccccCCCCCCCcccccCCCCCCcccc
Q 008303 69 LHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-------------ASSVVGTPSYMCPELLADIPYGSKSDI 135 (570)
Q Consensus 69 LHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-------------~~~~~GT~~Y~APE~l~~~~~t~ksDI 135 (570)
||++||+||||||+||||+.+|.+||+|||+|+.+..... ....+||+.|||||++.+..|+.++||
T Consensus 134 lH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp HHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred HHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 9999999999999999999999999999999988754321 234689999999999999999999999
Q ss_pred cchhhhHHHhhccCCCCcccC-HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 136 WSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 136 WSLG~IlyeLltG~~pf~~~~-~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
|||||++|||++ ||.... ....+..+......+.+...++.+.+||++||.+||.+|||+.|||+|+||+..
T Consensus 214 wSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 999999999995 565432 223333443333333334556778999999999999999999999999999853
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=382.69 Aligned_cols=204 Identities=19% Similarity=0.359 Sum_probs=178.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-------------CCCCCHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-------------SKLFSEEKLCKWLVQLLMALD 67 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-------------~~~Lse~~i~~I~~QLl~aL~ 67 (570)
+++|++|+|||||+++|+|.+.+ .+|||||||+||+|.++|++.. ...|++..+..|+.||+.||.
T Consensus 94 ~~il~~l~HpnIV~l~g~~~~~~-~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~ 172 (329)
T 4aoj_A 94 AELLTMLQHQHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMV 172 (329)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSS-SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcEEEEEEECC-EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHH
Confidence 46899999999999999986544 6899999999999999997642 246999999999999999999
Q ss_pred HHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHH
Q 008303 68 YLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 68 yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ilye 144 (570)
|||+++||||||||+||||+.++.+||+|||+++...... .....+||+.|||||++.+..|+.++|||||||++||
T Consensus 173 yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 173 YLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 9999999999999999999999999999999998765432 2345689999999999999999999999999999999
Q ss_pred hhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 145 MTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 145 Llt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|++ |+.||.+.+..+++..+..+...+.|..+++++.+||.+||..||++|||++||++++
T Consensus 253 llt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp HHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 998 8999999999999999988887888899999999999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=379.03 Aligned_cols=204 Identities=20% Similarity=0.400 Sum_probs=185.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL 66 (570)
+++|++|+|||||+++|+|.+++ .+|||||||++|+|.++|.... ...|++..+..|+.||+.||
T Consensus 80 ~~il~~l~HpNIV~l~g~~~~~~-~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl 158 (308)
T 4gt4_A 80 AMLRARLQHPNVVCLLGVVTKDQ-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 158 (308)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCcceEEEECC-EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence 36899999999999999986544 6899999999999999997532 24589999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
+|||+++||||||||+||||++++.+||+|||+++.+.... .....+||+.|||||++.+..|+.++|||||||++|
T Consensus 159 ~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 159 EYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 99999999999999999999999999999999998764332 345578999999999999999999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||++ |..||.+.+..++...+..+...+.|..++.++.+||.+||..||.+|||+.||++++
T Consensus 239 El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 239 EVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 8999999999999999988888888999999999999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=389.66 Aligned_cols=207 Identities=28% Similarity=0.473 Sum_probs=179.2
Q ss_pred CHHhhhcCCCcccccceEEEe-----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVE-----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++|+|||||+++++|.. +.+.+|||||||. |+|.++|.+. +.|++..++.|++||+.||+|||++|||
T Consensus 104 i~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~ii 180 (398)
T 4b99_A 104 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVI 180 (398)
T ss_dssp HHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCc
Confidence 468999999999999998753 2357899999996 6899999764 4699999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCC-----CCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccC
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-----DLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~ 149 (570)
||||||+|||++.+|.+||+|||+++.+... ......+||++|||||++.+.. |+.++|||||||++|||++|+
T Consensus 181 HRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~ 260 (398)
T 4b99_A 181 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260 (398)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence 9999999999999999999999999876432 3445689999999999988754 699999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhccCCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCcCHH
Q 008303 150 PAFKAFDMQALINKINKSIVAPL------------------------------PTKYSGAFRGLVKSMLRKNPELRPSAA 199 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~------------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~ 199 (570)
+||.+.+..+++..|......+. ...++.++++||++||.+||.+|||++
T Consensus 261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 99999998888877765433221 124688999999999999999999999
Q ss_pred HHHHhhccChh
Q 008303 200 ELLRHVHLQPY 210 (570)
Q Consensus 200 eIL~hp~fq~~ 210 (570)
|+|+||||+.+
T Consensus 341 e~L~Hp~f~~~ 351 (398)
T 4b99_A 341 AALRHPFLAKY 351 (398)
T ss_dssp HHTTSGGGTTT
T ss_pred HHhcCHhhCcC
Confidence 99999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=379.76 Aligned_cols=204 Identities=23% Similarity=0.314 Sum_probs=168.1
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|+++ +|||||+++++|.++ +++|||||||+||+|.++++ .+++..++.|++||+.||+|||++||+||||
T Consensus 70 ~~~l~~~~~h~nIv~l~~~~~~~-~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDi 143 (361)
T 4f9c_A 70 LQCLTVAGGQDNVMGVKYCFRKN-DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDV 143 (361)
T ss_dssp HHHHHHTCSBTTBCCCSEEEEET-TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHhcCCCCCceEEEEEEEC-CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcC
Confidence 3578888 799999999998654 58999999999999999984 3899999999999999999999999999999
Q ss_pred cCCcEEEcCC-CCEEEeecCCceeccCCC-----------------------------CCccccCCCCCCCcccccCC-C
Q 008303 80 KCSNIFLTKD-QDIRLGDFGLAKILTSDD-----------------------------LASSVVGTPSYMCPELLADI-P 128 (570)
Q Consensus 80 KP~NILld~~-g~vKL~DFGla~~~~~~~-----------------------------~~~~~~GT~~Y~APE~l~~~-~ 128 (570)
||+|||++.+ +.+||+|||+|+...... .....+||++|+|||++.+. .
T Consensus 144 KPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 223 (361)
T 4f9c_A 144 KPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPN 223 (361)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSC
T ss_pred CHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC
Confidence 9999999876 799999999998654321 22346899999999999876 4
Q ss_pred CCCcccccchhhhHHHhhccCCCCc-ccCHHHHHHHHHhcc---------------------------------------
Q 008303 129 YGSKSDIWSLGCCIYEMTSLKPAFK-AFDMQALINKINKSI--------------------------------------- 168 (570)
Q Consensus 129 ~t~ksDIWSLG~IlyeLltG~~pf~-~~~~~~~~~~i~~~~--------------------------------------- 168 (570)
|+.++||||+||++|+|++|+.||. +.+..+++..|....
T Consensus 224 y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 303 (361)
T 4f9c_A 224 QTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDS 303 (361)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----
T ss_pred CCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccc
Confidence 8999999999999999999998874 444444433332100
Q ss_pred --------------CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 169 --------------VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 169 --------------~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
....+..+++++++||++||.+||.+|+|++|+|+||||+..
T Consensus 304 ~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 304 STPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp ------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 011234678999999999999999999999999999999853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=373.57 Aligned_cols=203 Identities=25% Similarity=0.466 Sum_probs=169.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|++.+ + .+|||||||+||+|.++|.... ..+++..+..|+.||+.||+|||++||||||||
T Consensus 83 ~~il~~l~HpNIV~l~g~~~~-~-~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlK 159 (307)
T 3omv_A 83 VAVLRKTRHVNILLFMGYMTK-D-NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK 159 (307)
T ss_dssp HHHHTTCCCTTBCCEEEEECS-S-SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred HHHHHhCCCCCEeeEEEEEEC-C-eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccC
Confidence 468999999999999998743 3 4789999999999999997643 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccC---CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+||||+.++.+||+|||+|+..... ......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+
T Consensus 160 p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 160 SNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp SSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999876532 23456789999999999964 4589999999999999999999999987
Q ss_pred cCHHH-HHHHHHhccCC----CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 155 FDMQA-LINKINKSIVA----PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 155 ~~~~~-~~~~i~~~~~~----p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
.+... +...+...... ..+..++.++.+||.+||..||++|||+.||++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 240 INNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp CCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred CChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 65444 44444444332 245678999999999999999999999999998854
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=378.72 Aligned_cols=205 Identities=20% Similarity=0.415 Sum_probs=181.6
Q ss_pred CHHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~a 65 (570)
+++|++|+ |||||+++|+|.+.+..+|||||||++|+|.++|++.. ...|++..+..|+.||+.|
T Consensus 118 ~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~g 197 (353)
T 4ase_A 118 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 197 (353)
T ss_dssp HHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHH
Confidence 36889995 59999999998766667899999999999999998642 2458999999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhH
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCI 142 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Il 142 (570)
|+|||+++||||||||+|||++.++.+||+|||+|+.+.... .....+||+.|||||++.+..|+.++|||||||++
T Consensus 198 l~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 198 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 999999999999999999999999999999999998775433 23456899999999999999999999999999999
Q ss_pred HHhhc-cCCCCcccC-HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 143 YEMTS-LKPAFKAFD-MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 143 yeLlt-G~~pf~~~~-~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|||++ |+.||.+.+ .+.+...+..+...+.|..+++++.+||.+||..||.+|||+.||++|+
T Consensus 278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 99997 899998865 4556666777777788899999999999999999999999999999984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=398.25 Aligned_cols=207 Identities=24% Similarity=0.426 Sum_probs=188.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+|+++|.++ +.+|||||||+||+|.++|.... ..|++..++.|++||+.||+|||++||+|||||
T Consensus 205 i~il~~l~hpnIv~l~~~~~~~-~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlK 282 (573)
T 3uto_A 205 IQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282 (573)
T ss_dssp HHHHHHTCCTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 4689999999999999998654 58999999999999999996532 469999999999999999999999999999999
Q ss_pred CCcEEEcCC--CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKD--QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~--g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.+ +.+||+|||+++.+.........+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus 283 p~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp GGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred hhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 999999854 899999999999988777777889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+++..+...... ..+..++.++++||++||.+||.+|||++|+|+||||+.
T Consensus 363 ~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 363 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 888888765432 234578999999999999999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=394.30 Aligned_cols=204 Identities=25% Similarity=0.491 Sum_probs=179.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+.++|||||+++++|.+. .++|||||||.||+|.++|.+.+ .|++..++.|+.||+.||+|||++|||||||||
T Consensus 244 ~ll~~~~HP~IV~l~~~f~~~-~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKP 320 (689)
T 3v5w_A 244 SLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 320 (689)
T ss_dssp HHHSSSCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred HHHhhCCCCCEeEEEEEEEEC-CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 466778999999999999655 58999999999999999998764 599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCccc---CH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAF---DM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~---~~ 157 (570)
+||||+.+|.|||+|||+|+.+... ...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+. +.
T Consensus 321 eNILld~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~ 399 (689)
T 3v5w_A 321 ANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399 (689)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH
T ss_pred HHeEEeCCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9999999999999999999987654 3456799999999999974 57999999999999999999999999764 33
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
..+...+.. ....+|..+++++++||.+||.+||.+|++ ++||++||||+..
T Consensus 400 ~~i~~~i~~-~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 400 HEIDRMTLT-MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHhhcC-CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 344444433 334567889999999999999999999998 8999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=348.70 Aligned_cols=206 Identities=23% Similarity=0.460 Sum_probs=187.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++... ..+|+|||||.||+|.+++...+ .+++..++.++.||+.||+|||++||+|||||
T Consensus 65 ~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlk 141 (328)
T 3fe3_A 65 VRIMKILNHPNIVKLFEVIETE-KTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141 (328)
T ss_dssp HHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCCEeeEEEEEEEC-CEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCC
Confidence 3688999999999999998654 57999999999999999998764 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCC-CcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYG-SKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t-~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++............+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+...
T Consensus 142 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp GGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999999887766666778999999999999988874 79999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+...+..... ..|..++.++.+||++||..||.+|||++|+|+|+||+..
T Consensus 222 ~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 222 LRERVLRGKY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHCCC-CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHhCCC-CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 8888876644 4567899999999999999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.95 Aligned_cols=206 Identities=27% Similarity=0.477 Sum_probs=185.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+||||++++++|.+. ..+|+|||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 66 ~~il~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk 142 (361)
T 2yab_A 66 VSILRQVLHPNIITLHDVYENR-TDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142 (361)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCcCCCcEEEEEEeC-CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 3678999999999999998654 5799999999999999999763 469999999999999999999999999999999
Q ss_pred CCcEEEcCCC----CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQ----DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++ .+||+|||++..+.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 143 p~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp GGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred HHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998877 799999999998876666667889999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 157 MQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
..+....+....... .+..++..+++||.+||..||.+|||++|+|+||||+.
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 223 KQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 888888886654332 23578999999999999999999999999999999984
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=343.20 Aligned_cols=205 Identities=29% Similarity=0.567 Sum_probs=184.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+|||||.||+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||
T Consensus 57 ~~l~~l~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 133 (337)
T 1o6l_A 57 RVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp HHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred HHHHhCCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCH
Confidence 578899999999999998654 47999999999999999998753 599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...+
T Consensus 134 ~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999999998643 33345567899999999999999999999999999999999999999999888888
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
...+..... .++..++.++++||++||..||.+|| +++||++|+||+..
T Consensus 214 ~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 214 FELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 877765533 46778999999999999999999999 99999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.97 Aligned_cols=204 Identities=32% Similarity=0.550 Sum_probs=181.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||++++++|... ..+|+|||||.||+|.+++... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 69 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp 144 (297)
T 3fxz_A 69 LVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144 (297)
T ss_dssp HHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHhcCCCCCCCeEeEEEEEC-CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCH
Confidence 578899999999999998765 4789999999999999999864 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+....
T Consensus 145 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 224 (297)
T 3fxz_A 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (297)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999998776443 34456899999999999999999999999999999999999999998887766
Q ss_pred HHHHHhccC--CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIV--APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~--~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+..... ...+..++..+.+||.+||..||.+|||++|+|+|+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 655544332 2345678999999999999999999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=345.05 Aligned_cols=200 Identities=20% Similarity=0.295 Sum_probs=160.7
Q ss_pred HhhhcCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-------
Q 008303 3 LISKIRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN------- 72 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~------- 72 (570)
++.+|+|||||++++++.+++ ..+|||||||+||+|.++|++. .++++.+.+|+.|++.||+|||++
T Consensus 50 ~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~ 126 (303)
T 3hmm_A 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred HHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCC
Confidence 456789999999999997654 3689999999999999999863 489999999999999999999987
Q ss_pred -CcccceecCCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCC------CCCCcccccchhh
Q 008303 73 -HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADI------PYGSKSDIWSLGC 140 (570)
Q Consensus 73 -gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~------~~t~ksDIWSLG~ 140 (570)
||+||||||+||||+.++.+||+|||+++...... .....+||+.|||||++.+. .|+.++|||||||
T Consensus 127 ~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gv 206 (303)
T 3hmm_A 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred CCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHH
Confidence 99999999999999999999999999998875432 12346899999999999764 3677999999999
Q ss_pred hHHHhhccCCCCccc---------------CHHHHHHHHHhcc-CCCCCCC-----CcHHHHHHHHHhhccCCCCCcCHH
Q 008303 141 CIYEMTSLKPAFKAF---------------DMQALINKINKSI-VAPLPTK-----YSGAFRGLVKSMLRKNPELRPSAA 199 (570)
Q Consensus 141 IlyeLltG~~pf~~~---------------~~~~~~~~i~~~~-~~p~p~~-----~s~~l~dLI~~~L~~dP~~RPTa~ 199 (570)
++|||++|.+||... ....+...+.... ...+|.. ++..+.+||.+||..||++|||+.
T Consensus 207 vl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 286 (303)
T 3hmm_A 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 999999998765321 2233343343322 2334433 235789999999999999999999
Q ss_pred HHHHhh
Q 008303 200 ELLRHV 205 (570)
Q Consensus 200 eIL~hp 205 (570)
||++.+
T Consensus 287 ei~~~L 292 (303)
T 3hmm_A 287 RIKKTL 292 (303)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999873
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=332.25 Aligned_cols=205 Identities=31% Similarity=0.434 Sum_probs=178.3
Q ss_pred hhcCCCcccccceEEEeeCc----EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 5 SKIRNPFIVEYKDSWVERGC----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~~~~----~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++||||++++++|..... .+|+|||||. |+|.+++.......+++..++.|+.||+.||+|||++||+|||||
T Consensus 69 ~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk 147 (308)
T 3g33_A 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 147 (308)
T ss_dssp HHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 34459999999999876432 6899999997 599999988666669999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+|||++.++.+||+|||++............+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....
T Consensus 148 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 148 PENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp TTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred HHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999999887766666678999999999999999999999999999999999999999999888877
Q ss_pred HHHHHhccCCCC--------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSIVAPL--------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~--------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+......+. ...++..+.+||.+||..||.+|||+.|+|+|+||+..
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 777654332211 13578899999999999999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.70 Aligned_cols=205 Identities=28% Similarity=0.525 Sum_probs=179.6
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +||||++++++|... ..+|||||||.||+|.+++.+.. .+++..++.|+.||+.||+|||++||+|||||
T Consensus 75 ~il~~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 151 (353)
T 3txo_A 75 RILSLARNHPFLTQLFCCFQTP-DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLK 151 (353)
T ss_dssp HHHHHTTTCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HHHHhccCCCceeeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Confidence 467777 799999999998654 47999999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 152 p~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 231 (353)
T 3txo_A 152 LDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231 (353)
T ss_dssp GGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999998643 2334556789999999999998899999999999999999999999999999998
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH------HHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA------AELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa------~eIL~hp~fq~~ 210 (570)
+...+..... ..+..++..+.+||++||.+||.+|+++ ++|++||||+..
T Consensus 232 ~~~~i~~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 232 LFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 8888876544 3567799999999999999999999998 999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.15 Aligned_cols=208 Identities=25% Similarity=0.352 Sum_probs=186.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|.+. ..+|+|||||.||+|.+++... ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 52 ~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlk 129 (321)
T 1tki_A 52 ISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129 (321)
T ss_dssp HHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCCCCCeEeEEEecC-CEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 3688999999999999998654 5899999999999999999754 2469999999999999999999999999999999
Q ss_pred CCcEEEcC--CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTK--DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++. ++.+||+|||++..+.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 130 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 209 (321)
T 1tki_A 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred HHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH
Confidence 99999997 7899999999999887666566678999999999999888999999999999999999999999999888
Q ss_pred HHHHHHHhccCCCC---CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAPL---PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p~---p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.....+........ +..++.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 88888766554322 24789999999999999999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.33 Aligned_cols=207 Identities=24% Similarity=0.464 Sum_probs=184.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+||||++++++|... ..+|+|||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 65 ~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk 141 (326)
T 2y0a_A 65 VSILKEIQHPNVITLHEVYENK-TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141 (326)
T ss_dssp HHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCCCCCcEEEEEEeC-CEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCC
Confidence 3688999999999999998654 5789999999999999999753 459999999999999999999999999999999
Q ss_pred CCcEEEcCCC----CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQ----DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++ .+||+|||++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 142 p~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred HHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999999887 799999999998866555667789999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 157 MQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+....+....... .+..++..+.+||++||..||.+|||++|+|+||||+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 887777765543322 224689999999999999999999999999999999753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.39 Aligned_cols=203 Identities=26% Similarity=0.524 Sum_probs=184.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||++++++|.+. ..+|+|||||.||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 58 ~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 134 (318)
T 1fot_A 58 LMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 134 (318)
T ss_dssp HHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred HHHhhCCCCCCceEeEEEEeC-CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 578889999999999998654 5899999999999999999875 3599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.+|.+||+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.....
T Consensus 135 ~NIll~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 212 (318)
T 1fot_A 135 ENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212 (318)
T ss_dssp GGEEECTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred heEEEcCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999999987653 334678999999999999999999999999999999999999999998888888
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
.++..... .++..++.++.+||++||..||.+|+ ++++|++||||+..
T Consensus 213 ~~i~~~~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 213 EKILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHhCCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 77766543 45678999999999999999999999 99999999999853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=343.15 Aligned_cols=206 Identities=28% Similarity=0.482 Sum_probs=183.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+. ...|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 79 ~~il~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlk 155 (362)
T 2bdw_A 79 ARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155 (362)
T ss_dssp HHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred HHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCc
Confidence 3688999999999999998654 4789999999999999999764 459999999999999999999999999999999
Q ss_pred CCcEEEcCCC---CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQ---DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++.++ .+||+|||++............+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 156 p~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 156 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999998654 5999999999887766556677899999999999998999999999999999999999999999888
Q ss_pred HHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
..+...+....... .+..++.++++||.+||..||.+||++.++|+|+||..
T Consensus 236 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 236 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 88887776654332 23468999999999999999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.31 Aligned_cols=205 Identities=29% Similarity=0.534 Sum_probs=179.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+|||||.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 73 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp 149 (327)
T 3a62_A 73 NILEEVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149 (327)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred HHHHhCCCCCccceeEEEEcC-CEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence 578999999999999998654 47899999999999999998754 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.+|.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 150 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 229 (327)
T 3a62_A 150 ENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229 (327)
T ss_dssp TTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999999999999976432 2334567899999999999999999999999999999999999999999888888
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
...+..... .++..++.++.+||.+||..||.+|| +++++++||||+..
T Consensus 230 ~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 230 IDKILKCKL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHTCC-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHhCCC-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 777766543 46678999999999999999999999 89999999999853
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=339.50 Aligned_cols=202 Identities=24% Similarity=0.503 Sum_probs=184.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|||||||.||+|.+++.+.. .+++..++.|+.||+.||.|||++||+||||||
T Consensus 93 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 169 (350)
T 1rdq_E 93 RILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169 (350)
T ss_dssp HHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCCCeEEEEEEcC-CEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCcc
Confidence 578899999999999988654 57999999999999999998754 499999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+...+.
T Consensus 170 ~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 247 (350)
T 1rdq_E 170 ENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH
Confidence 9999999999999999999886543 34578999999999999999999999999999999999999999999888888
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccCh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQP 209 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~ 209 (570)
..+.... ..++..++.++.+||.+||..||.+||+ +++|++|+||+.
T Consensus 248 ~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 248 EKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 8887664 3467789999999999999999999998 999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.20 Aligned_cols=207 Identities=29% Similarity=0.464 Sum_probs=184.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+. ..+|+|||||.||+|.+++... ..+++..+..|+.||+.||.|||++||+|||||
T Consensus 61 ~~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlK 137 (444)
T 3soa_A 61 ARICRLLKHPNIVRLHDSISEE-GHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLK 137 (444)
T ss_dssp HHHHHHCCBTTBCCEEEEEECS-SEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred HHHHHhCCCcCCCeEEEEEEEC-CEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 3689999999999999998654 5789999999999999999875 459999999999999999999999999999999
Q ss_pred CCcEEEc---CCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLT---KDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld---~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++ .++.+||+|||++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 138 p~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp STTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 9999998 45789999999998775433 3345789999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 157 MQALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 157 ~~~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+...+...... +.+..+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 218 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 218 QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 88888888766433 2335789999999999999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.82 Aligned_cols=207 Identities=30% Similarity=0.499 Sum_probs=178.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++||||++++++|.++ ..+|||||||+||+|.+++.+. .+..+++..++.|+.||+.||.|||++||+||||
T Consensus 78 ~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDl 156 (351)
T 3c0i_A 78 SICHMLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDV 156 (351)
T ss_dssp HHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHhCCCCCCCcEEEEEEeC-CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 678999999999999998664 5799999999999999888653 2346899999999999999999999999999999
Q ss_pred cCCcEEEcCCCC---EEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQD---IRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~---vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.++. +||+|||++........ ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.
T Consensus 157 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 157 KPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp SGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 999999987655 99999999988765433 45678999999999999999999999999999999999999999875
Q ss_pred CHHHHHHHHHhccCCCC---CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVAPL---PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~---p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
. ......+........ +..++.++++||++||..||.+|||+.++|+|+||+..
T Consensus 237 ~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 237 K-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp H-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred H-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 4 445555544433222 24689999999999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.36 Aligned_cols=205 Identities=25% Similarity=0.478 Sum_probs=183.8
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +||||++++++|.+. ..+|+|||||.||+|.+++.+.. .+++..++.++.||+.||+|||++||+|||||
T Consensus 69 ~il~~~~~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 145 (345)
T 1xjd_A 69 RVLSLAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 145 (345)
T ss_dssp HHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HHHHhcCCCCCCCcEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence 456666 999999999998654 47999999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.+|.+||+|||+++.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...
T Consensus 146 p~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (345)
T 1xjd_A 146 LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225 (345)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999999986532 334556789999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHH-HHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA-ELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~-eIL~hp~fq~~ 210 (570)
+...+..... ..+..++.++++||.+||..||.+||++. +|++||||+..
T Consensus 226 ~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 226 LFHSIRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHHCCC-CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHhCCC-CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 8888766543 45678999999999999999999999998 99999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.20 Aligned_cols=205 Identities=27% Similarity=0.510 Sum_probs=178.0
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
.+|+++ +|||||+++++|... ..+|||||||.||+|.+++.+.. .+++..++.|+.||+.||.|||++||+|||||
T Consensus 104 ~il~~~~~hp~Iv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLK 180 (396)
T 4dc2_A 104 HVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLK 180 (396)
T ss_dssp HHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HHHHhcCCCCCcCeeEEEEEEC-CEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 456666 899999999988654 58999999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceec-cCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc----
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKIL-TSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF---- 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~---- 155 (570)
|+||||+.+|.+||+|||+++.. .........+||+.|+|||++.+..|+.++|||||||++|+|++|++||...
T Consensus 181 p~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred HHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 99999999999999999999863 3344566789999999999999999999999999999999999999999632
Q ss_pred -----CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH------HHHHHhhccChh
Q 008303 156 -----DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA------AELLRHVHLQPY 210 (570)
Q Consensus 156 -----~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa------~eIL~hp~fq~~ 210 (570)
....+...+... ...+|..++.++++||++||.+||.+|+++ +||++||||+..
T Consensus 261 ~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 261 NPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ----CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ccchhhHHHHHHHHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 223344444433 345678899999999999999999999984 899999999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=322.24 Aligned_cols=206 Identities=25% Similarity=0.509 Sum_probs=183.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+ +..+|+|||||.|++|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp 134 (277)
T 3f3z_A 58 EIMKSLDHPNIIRLYETFED-NTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP 134 (277)
T ss_dssp HHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCEeeEEEEEec-CCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCH
Confidence 67899999999999999865 457899999999999999998753 489999999999999999999999999999999
Q ss_pred CcEEE---cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFL---TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|||+ +.++.+||+|||++.............||+.|+|||++.+. ++.++|||||||++|+|++|..||...+..
T Consensus 135 ~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (277)
T 3f3z_A 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213 (277)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence 99999 77889999999999988766666778899999999998754 899999999999999999999999998888
Q ss_pred HHHHHHHhccCCCCC---CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 159 ALINKINKSIVAPLP---TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p---~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
+....+......... ..++..+.+||.+||..||.+|||+.++|+|+||+...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 888777665443222 26899999999999999999999999999999998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=338.05 Aligned_cols=204 Identities=24% Similarity=0.492 Sum_probs=183.3
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|.++ +||||++++++|... ..+|+|||||.||+|.+++.+.+ .+++..++.|+.||+.||.|||++||+|||||
T Consensus 72 ~~l~~~~~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 148 (353)
T 2i0e_A 72 RVLALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148 (353)
T ss_dssp HHHTCTTCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HHHHhcCCCCEEeeEEEEEEcC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 467777 899999999988654 58999999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 149 p~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 228 (353)
T 2i0e_A 149 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228 (353)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH
Confidence 999999999999999999998643 2334556789999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~ 209 (570)
+...+..... ..+..++.++.+||++||..||.+|| ++++|++|+||+.
T Consensus 229 ~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 229 LFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHhCCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 8888876543 46778999999999999999999999 4799999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.20 Aligned_cols=210 Identities=25% Similarity=0.409 Sum_probs=173.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|.+. +.+|+|||||.||+|.+++.......+++..++.|+.||+.||+|||++||+|||||
T Consensus 77 ~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 155 (389)
T 3gni_B 77 LHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK 155 (389)
T ss_dssp HHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCCCCCcEeEEEEEC-CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 3688999999999999998765 479999999999999999988755679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC--------CCCccccCCCCCCCcccccC--CCCCCcccccchhhhHHHhhccCC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD--------DLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~--------~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
|+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.
T Consensus 156 p~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 235 (389)
T 3gni_B 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235 (389)
T ss_dssp GGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 99999999999999999998654321 12234588999999999987 578999999999999999999999
Q ss_pred CCcccCHHHHHHHHHhcc---------------------------------------------CCCCCCCCcHHHHHHHH
Q 008303 151 AFKAFDMQALINKINKSI---------------------------------------------VAPLPTKYSGAFRGLVK 185 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~~---------------------------------------------~~p~p~~~s~~l~dLI~ 185 (570)
||.+.+.......+.... ..+.+..++..+.+||+
T Consensus 236 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 315 (389)
T 3gni_B 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315 (389)
T ss_dssp TTTTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHH
Confidence 997755433322211110 11234567899999999
Q ss_pred HhhccCCCCCcCHHHHHHhhccChhh
Q 008303 186 SMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 186 ~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
+||..||.+|||++|+|+||||+...
T Consensus 316 ~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 316 QCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred HHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 99999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.08 Aligned_cols=207 Identities=27% Similarity=0.444 Sum_probs=167.1
Q ss_pred Hh-hhcCCCcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 3 LI-SKIRNPFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 3 IL-~kL~HPnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
++ +.++||||++++++|.. ++.++|||||||.||+|.++|.......+++..++.|+.||+.||.|||++||+|||
T Consensus 107 ~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 186 (400)
T 1nxk_A 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186 (400)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 44 34599999999999864 245789999999999999999876556799999999999999999999999999999
Q ss_pred ecCCcEEEcC---CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 79 VKCSNIFLTK---DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 79 LKP~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||+|||++. ++.+||+|||+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...
T Consensus 187 lkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp CCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998 7889999999999876655566788999999999999999999999999999999999999999765
Q ss_pred CHHH----HHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 156 DMQA----LINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 156 ~~~~----~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.... ....+.... ..+.+..++.++++||++||..||.+|||++|||+|+||..
T Consensus 267 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 267 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 4221 223333222 22234578999999999999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.54 Aligned_cols=205 Identities=27% Similarity=0.503 Sum_probs=177.9
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +|||||+++++|... ..+|+|||||.||+|.+++.+.. .+++..++.++.||+.||.|||++||+|||||
T Consensus 61 ~~l~~~~~hp~iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 137 (345)
T 3a8x_A 61 HVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLK 137 (345)
T ss_dssp HHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HHHHhcCCCCccCeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 467777 899999999998654 58999999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc-----
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA----- 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~----- 154 (570)
|+|||++.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..
T Consensus 138 p~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 217 (345)
T 3a8x_A 138 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217 (345)
T ss_dssp GGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--
T ss_pred HHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccc
Confidence 999999999999999999998643 33445667999999999999999999999999999999999999999965
Q ss_pred ----cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH------HHHHHhhccChh
Q 008303 155 ----FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA------AELLRHVHLQPY 210 (570)
Q Consensus 155 ----~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa------~eIL~hp~fq~~ 210 (570)
.....+...+... ...++..++.++++||++||..||.+||++ ++|++||||+..
T Consensus 218 ~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 218 NPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp -----CHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ccccccHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 2333444444443 344677899999999999999999999985 899999999853
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.87 Aligned_cols=205 Identities=29% Similarity=0.569 Sum_probs=182.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLK 80 (570)
++|++++||||++++++|... ..+|||||||.||+|.+++.+.. .+++..++.|+.||+.||+|||+ +||+|||||
T Consensus 200 ~~l~~l~h~~iv~l~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlk 276 (446)
T 4ejn_A 200 RVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 276 (446)
T ss_dssp -CCCCCSCTTSCCEEEEEEET-TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCC
T ss_pred HHHHhCCCCeEeeEEEEEeeC-CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCC
Confidence 567888999999999998655 47999999999999999998754 59999999999999999999998 999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||||+.++.+||+|||+++.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+...
T Consensus 277 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 356 (446)
T 4ejn_A 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356 (446)
T ss_dssp GGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999999999986432 334456789999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
+...+..... ..+..+++++.+||.+||..||.+|| +++|+++||||+..
T Consensus 357 ~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 357 LFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhCCC-CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 8877765543 46778999999999999999999999 99999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.36 Aligned_cols=207 Identities=26% Similarity=0.432 Sum_probs=172.2
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++|||||+++++|...+ ..+|||||||.+ +|.+.+.. .+++..++.|++||+.||+|||++||+
T Consensus 112 ~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~ii 186 (464)
T 3ttj_A 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGII 186 (464)
T ss_dssp HHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35889999999999999986432 468999999986 57666642 389999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||||||+|||++.++.+||+|||+++...........+||++|+|||++.+..|+.++|||||||++|+|++|++||.+.
T Consensus 187 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999999887666667789999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhccCCCCCC------------------------------C-----------CcHHHHHHHHHhhccCCCC
Q 008303 156 DMQALINKINKSIVAPLPT------------------------------K-----------YSGAFRGLVKSMLRKNPEL 194 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~------------------------------~-----------~s~~l~dLI~~~L~~dP~~ 194 (570)
+..++..++......+.+. . .+.++++||.+||..||.+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 8887777765543332110 0 1567999999999999999
Q ss_pred CcCHHHHHHhhccChhhh
Q 008303 195 RPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 195 RPTa~eIL~hp~fq~~~~ 212 (570)
|||++|+|+||||+.+..
T Consensus 347 R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 347 RISVDDALQHPYINVWYD 364 (464)
T ss_dssp SCCHHHHHTSTTTGGGCC
T ss_pred CCCHHHHhcChhhhhccC
Confidence 999999999999987643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=324.75 Aligned_cols=206 Identities=27% Similarity=0.479 Sum_probs=173.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.++ ..+|+|||||.+ +|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 53 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp 129 (292)
T 3o0g_A 53 CLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129 (292)
T ss_dssp HHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHhcCCCCCEeeEEeEEEeC-CEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 578999999999999998654 589999999986 6666666533 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCC-CcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPA-FKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~p-f~~~~~~ 158 (570)
+|||++.++.+||+|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..
T Consensus 130 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~ 209 (292)
T 3o0g_A 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp GGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred HHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 9999999999999999999887533 3345568999999999998766 79999999999999999976555 6777777
Q ss_pred HHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.....+......+ ....++..+++||++||..||.+|||++|+|+||||+.+
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 7666664432211 122578899999999999999999999999999999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.32 Aligned_cols=204 Identities=25% Similarity=0.486 Sum_probs=182.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||+++++|.+ +.++|||||||.||+|.++++.. .+++..++.|+.||+.||+|||++||+||||||
T Consensus 121 ~il~~l~hp~Iv~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp 196 (410)
T 3v8s_A 121 DIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196 (410)
T ss_dssp HHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH
Confidence 57889999999999999865 45899999999999999999763 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCC----CCCcccccchhhhHHHhhccCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIP----YGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~----~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
+|||++.+|.+||+|||+++...... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.
T Consensus 197 ~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred HHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 99999999999999999998876543 234678999999999998665 789999999999999999999999999
Q ss_pred CHHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccCh
Q 008303 156 DMQALINKINKS---IVAPLPTKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQP 209 (570)
Q Consensus 156 ~~~~~~~~i~~~---~~~p~p~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~ 209 (570)
+......++... ...+....++.++++||++||..+|.+ |++++||++||||+.
T Consensus 277 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 277 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp SHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred ChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 988888887654 233444579999999999999999988 999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=329.38 Aligned_cols=209 Identities=28% Similarity=0.466 Sum_probs=178.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN----SKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~----~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++||||++++++|.. ++.+|||||||. |+|.+++.... ...+++..++.|+.||+.||.|||++||+|
T Consensus 54 ~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH 131 (317)
T 2pmi_A 54 ISLMKELKHENIVRLYDVIHT-ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131 (317)
T ss_dssp HHHHTTCCBTTBCCEEEEECC-TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHhcCCCCcceEEEEEEE-CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 368899999999999998865 457999999998 59999997643 135899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 132 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp CCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999887533 23445689999999999976 4689999999999999999999999999
Q ss_pred cCHHHHHHHHHhccCCC---------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 155 FDMQALINKINKSIVAP---------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p---------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
.+..+....+......+ ....++.++.+||.+||..||.+|||++|+
T Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 291 (317)
T 2pmi_A 212 TNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291 (317)
T ss_dssp SSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 88877766664322111 123578899999999999999999999999
Q ss_pred HHhhccChhh
Q 008303 202 LRHVHLQPYV 211 (570)
Q Consensus 202 L~hp~fq~~~ 211 (570)
|+||||+.+.
T Consensus 292 l~hp~f~~~~ 301 (317)
T 2pmi_A 292 LHHPWFAEYY 301 (317)
T ss_dssp TTSGGGGGGC
T ss_pred hCChhhhccc
Confidence 9999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.66 Aligned_cols=207 Identities=27% Similarity=0.431 Sum_probs=174.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|.+. ..+|+|||||.| +|.+++.... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 70 ~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik 146 (311)
T 3niz_A 70 ISLLKELHHPNIVSLIDVIHSE-RCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146 (311)
T ss_dssp HHHHHHCCCTTBCCEEEEECCS-SCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHHcCCCCEeeeeeEEccC-CEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 3688999999999999998654 478999999985 8888887643 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 147 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 147 PQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp GGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred hHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999999887533 23445688999999999976 56899999999999999999999999887766
Q ss_pred HHHHHHHhccCCCC-----------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAPL-----------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p~-----------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+....+......+. ...++.++.+||.+||..||.+|||++|+|+||||+.
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 227 DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 55555543222211 1246789999999999999999999999999999986
Q ss_pred h
Q 008303 210 Y 210 (570)
Q Consensus 210 ~ 210 (570)
.
T Consensus 307 ~ 307 (311)
T 3niz_A 307 L 307 (311)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.01 Aligned_cols=205 Identities=29% Similarity=0.504 Sum_probs=183.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ...|+|||||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 57 ~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 133 (284)
T 3kk8_A 57 RICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133 (284)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHHcCCCCcCeEEEEEEcC-CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCH
Confidence 578999999999999998654 57899999999999999998753 599999999999999999999999999999999
Q ss_pred CcEEEcCCCC---EEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFLTKDQD---IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~---vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|||++.++. +||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 134 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 213 (284)
T 3kk8_A 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213 (284)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence 9999987655 9999999998877666666778999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.....+...... +....++.++.+||.+||..||.+|||++|+|+|+||+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 887777655432 233578999999999999999999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.39 Aligned_cols=206 Identities=26% Similarity=0.438 Sum_probs=175.2
Q ss_pred HHhhhcC-CCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIR-NPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
.+|+++. ||||++++++|... +..+|+|||||. |+|.++++.. .+++..+..++.||+.||+|||++||+||||
T Consensus 60 ~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 135 (388)
T 3oz6_A 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDM 135 (388)
T ss_dssp HHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCC
Confidence 5788886 99999999998754 347899999998 5999999863 5899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccC----------------------CCCCccccCCCCCCCcccccC-CCCCCccccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTS----------------------DDLASSVVGTPSYMCPELLAD-IPYGSKSDIW 136 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~----------------------~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIW 136 (570)
||+|||++.++.+||+|||+++.+.. .......+||++|+|||++.+ ..|+.++|||
T Consensus 136 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 215 (388)
T 3oz6_A 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215 (388)
T ss_dssp CGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHH
T ss_pred CHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHH
Confidence 99999999999999999999987532 112345689999999999976 6789999999
Q ss_pred chhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCC--------------------------------------------
Q 008303 137 SLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL-------------------------------------------- 172 (570)
Q Consensus 137 SLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~-------------------------------------------- 172 (570)
||||++|+|++|++||.+.+.......+......+.
T Consensus 216 SlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (388)
T 3oz6_A 216 SLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295 (388)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccc
Confidence 999999999999999999888777766654332221
Q ss_pred --CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 173 --PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 173 --p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
+..++.++.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 296 ~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp CTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred cccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 126788999999999999999999999999999998653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=338.91 Aligned_cols=202 Identities=28% Similarity=0.504 Sum_probs=181.8
Q ss_pred hhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCc
Q 008303 4 ISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSN 83 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~N 83 (570)
++.++|||||+++++|... ..+|+|||||.||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 93 l~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 169 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169 (373)
T ss_dssp BCCCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHhCCCCCCCCEEEEEEeC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence 5668999999999998654 58999999999999999998754 48999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHH
Q 008303 84 IFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALIN 162 (570)
Q Consensus 84 ILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~ 162 (570)
||++.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++..
T Consensus 170 Ill~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 249 (373)
T 2r5t_A 170 ILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249 (373)
T ss_dssp EEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH
T ss_pred EEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 999999999999999998643 3344567899999999999999999999999999999999999999999999888888
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH----HHHHHhhccCh
Q 008303 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA----AELLRHVHLQP 209 (570)
Q Consensus 163 ~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa----~eIL~hp~fq~ 209 (570)
.+..... .++..++..+++||++||.+||.+|+++ ++|++|+||+.
T Consensus 250 ~i~~~~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 250 NILNKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHSCC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHhccc-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 8766533 3567899999999999999999999986 79999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=340.17 Aligned_cols=205 Identities=26% Similarity=0.523 Sum_probs=181.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||+++++|.+. ..+|+|||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 67 ~il~~l~hp~Iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp 143 (384)
T 4fr4_A 67 QIMQGLEHPFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKP 143 (384)
T ss_dssp HHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCCCcEEEEEEeC-CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcH
Confidence 688999999999999998655 4799999999999999999864 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC---CCCCCcccccchhhhHHHhhccCCCCccc---
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCIYEMTSLKPAFKAF--- 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIWSLG~IlyeLltG~~pf~~~--- 155 (570)
+|||++.+|.+||+|||++..+.........+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...
T Consensus 144 ~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~ 223 (384)
T 4fr4_A 144 DNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223 (384)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred HHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence 999999999999999999998877666778899999999999964 45899999999999999999999999743
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-HHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-AAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-a~eIL~hp~fq~~ 210 (570)
........+.. .....+..++..+.+||++||..||.+||+ ++++++|+||+..
T Consensus 224 ~~~~~~~~~~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 224 SSKEIVHTFET-TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred cHHHHHHHHhh-cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 34444444433 334567789999999999999999999998 9999999999854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=327.99 Aligned_cols=206 Identities=26% Similarity=0.447 Sum_probs=184.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.|++|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 67 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp 143 (321)
T 2a2a_A 67 SILRQVLHHNVITLHDVYENR-TDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP 143 (321)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCcceEEEEEecC-CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCh
Confidence 578999999999999998654 5789999999999999999764 4589999999999999999999999999999999
Q ss_pred CcEEEcCCC----CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 82 SNIFLTKDQ----DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+|||++.++ .+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 144 ~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp GGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred HHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999888 7999999999987766555667899999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHhccCCCC---CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 158 QALINKINKSIVAPL---PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~---p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.+....+........ +..++..+.+||.+||..||.+|||++|+++||||+..
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 224 QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 888777765443221 25688999999999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=339.73 Aligned_cols=210 Identities=21% Similarity=0.343 Sum_probs=185.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+. ..+|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 137 ~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 214 (373)
T 2x4f_A 137 ISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214 (373)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence 3689999999999999998654 47899999999999999987643 358999999999999999999999999999999
Q ss_pred CCcEEE--cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFL--TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILl--d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||+ +.++.+||+|||++..+.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 215 p~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 294 (373)
T 2x4f_A 215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294 (373)
T ss_dssp GGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred HHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999 456789999999999887666666778999999999999888999999999999999999999999998888
Q ss_pred HHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhh
Q 008303 159 ALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVL 212 (570)
Q Consensus 159 ~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~ 212 (570)
+....+....... .+..++.++++||.+||..||.+|||++|+|+||||+....
T Consensus 295 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 295 ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred HHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 8777776554322 23468999999999999999999999999999999986543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=341.74 Aligned_cols=203 Identities=26% Similarity=0.531 Sum_probs=178.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+||||| +|+|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 61 ~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp 136 (336)
T 3h4j_B 61 SYLKLLRHPHIIKLYDVITTP-TDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136 (336)
T ss_dssp HHHTTCCCTTBCCEEEEEECS-SEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCST
T ss_pred HHHHhCCCCCCCeEEEEEEeC-CEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCch
Confidence 578899999999999998654 4789999999 689999998754 499999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......+
T Consensus 137 ~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp TTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred hhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 999999999999999999998777766777899999999999988776 7899999999999999999999987654443
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+... ....+..++.++.+||++||..||.+|||++||++||||+.
T Consensus 217 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 217 FKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp BCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 3333222 23456778999999999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.12 Aligned_cols=206 Identities=30% Similarity=0.510 Sum_probs=172.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++||||++++++|.+ ...+|+|||||.||+|.+++... .+..+++..++.|+.||+.||.|||++||+||||
T Consensus 72 ~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~di 150 (285)
T 3is5_A 72 EVLKSLDHPNIIKIFEVFED-YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150 (285)
T ss_dssp HHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHhCCCchHHhHHHheec-CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCC
Confidence 67899999999999999865 45789999999999999998643 2356999999999999999999999999999999
Q ss_pred cCCcEEE---cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 80 KCSNIFL---TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 80 KP~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
||+|||+ +.++.+||+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp SGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 9999999 446789999999998876665566778999999999986 468999999999999999999999999988
Q ss_pred HHHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 157 MQALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.......+....... ....+++++.+||.+||..||.+|||+.|+|+|+||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 887776665443322 22347899999999999999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=322.87 Aligned_cols=206 Identities=22% Similarity=0.423 Sum_probs=172.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|... ..+|+|||||.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 51 ~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 127 (288)
T 1ob3_A 51 ISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127 (288)
T ss_dssp HHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhcCCCCEeeeeeEEccC-CeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 3678999999999999998655 478999999986 9999987643 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..
T Consensus 128 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (288)
T 1ob3_A 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (288)
T ss_dssp GGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999876532 233456789999999999764 5899999999999999999999999988877
Q ss_pred HHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+....+......+ ....++.++.+||.+||..||.+|||++|+|+|+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 6665554321110 12357899999999999999999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=335.60 Aligned_cols=206 Identities=29% Similarity=0.452 Sum_probs=163.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||++++++|... ..+|+|||||.||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||
T Consensus 68 ~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp 144 (361)
T 3uc3_A 68 INHRSLRHPNIVRFKEVILTP-THLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144 (361)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCG
T ss_pred HHHHhCCCCCCCcEEEEEeeC-CEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 578899999999999998654 47999999999999999998754 499999999999999999999999999999999
Q ss_pred CcEEEcCCCC--EEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCc-ccccchhhhHHHhhccCCCCcccCH-
Q 008303 82 SNIFLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSK-SDIWSLGCCIYEMTSLKPAFKAFDM- 157 (570)
Q Consensus 82 ~NILld~~g~--vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k-sDIWSLG~IlyeLltG~~pf~~~~~- 157 (570)
+|||++.++. +||+|||+++...........+||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.....
T Consensus 145 ~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 145 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp GGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred HHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 9999987765 99999999986554445566789999999999988888655 8999999999999999999987543
Q ss_pred ---HHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 158 ---QALINKINKSI-VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 158 ---~~~~~~i~~~~-~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
......+.... ..+....++.++++||.+||..||.+|||+.||++|+||...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 33444443322 223344689999999999999999999999999999999643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=319.64 Aligned_cols=204 Identities=27% Similarity=0.503 Sum_probs=179.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.+|+|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 61 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp 137 (279)
T 3fdn_A 61 EIQSHLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKP 137 (279)
T ss_dssp HHHTTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCG
T ss_pred HHHHcCCCCCCcchhheEecC-CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCCh
Confidence 578899999999999998654 57899999999999999998764 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.++.+||+|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.....
T Consensus 138 ~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 216 (279)
T 3fdn_A 138 ENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216 (279)
T ss_dssp GGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred HhEEEcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 9999999999999999998665433 234568999999999999989999999999999999999999999999888877
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+.... ...+..++..+.+||.+||..||.+|||++||++|+||+..
T Consensus 217 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 217 KRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHHTC-CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHhCC-CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 7775543 34677899999999999999999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=341.01 Aligned_cols=207 Identities=22% Similarity=0.436 Sum_probs=184.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+||||++++++|.+. ..+|+|||||.||+|.+++... ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 99 ~~il~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk 176 (387)
T 1kob_A 99 ISIMNQLHHPKLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176 (387)
T ss_dssp HHHHTTCCSTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCcCCCeEEEEEEeC-CEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 3689999999999999998654 5799999999999999998754 2468999999999999999999999999999999
Q ss_pred CCcEEEcC--CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTK--DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++. ++.+||+|||++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 177 p~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred hHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 99999974 4679999999999887666666678999999999999999999999999999999999999999998887
Q ss_pred HHHHHHHhccC---CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIV---APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~---~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.....+..... ...+..++.++++||++||..||.+|||++|+|+|+||+.
T Consensus 257 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 257 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 77777765432 2234578999999999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=326.15 Aligned_cols=204 Identities=27% Similarity=0.490 Sum_probs=177.7
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++|+||||++++++|.+. +..+|+|||||++++|.+++. ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 678999999999999998753 568999999999999988653 2469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCC---CCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~---~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++.+||+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999998875432 334568999999999998765 3778999999999999999999999888
Q ss_pred HHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 157 MQALINKINKSIV-APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 157 ~~~~~~~i~~~~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.......+..... .+....++.++.+||.+||..||++|||+.|+++||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 7777666655432 233457899999999999999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.68 Aligned_cols=204 Identities=29% Similarity=0.515 Sum_probs=181.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ...|+|||||.||+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 94 ~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 169 (321)
T 2c30_A 94 VIMRDYQHFNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169 (321)
T ss_dssp HHHTTCCCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCcceEEEEEEEC-CEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 578999999999999998765 478999999999999999864 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++..+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999998775432 34456899999999999998999999999999999999999999998888777
Q ss_pred HHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+....... .+..++..+.+||.+||..||.+|||++++++|+||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 250 MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred HHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 77776554332 23468899999999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=324.50 Aligned_cols=206 Identities=27% Similarity=0.432 Sum_probs=171.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+|||||.+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 54 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp 130 (311)
T 4agu_A 54 RMLKQLKHPNLVNLLEVFRRK-RRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130 (311)
T ss_dssp HHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCccchhheeecC-CeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCh
Confidence 678999999999999998654 5789999999999999988754 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus 131 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 131 ENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred hhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999999886532 33456689999999999976 568999999999999999999999999888776
Q ss_pred HHHHHHhccCCC--------------------C----------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAP--------------------L----------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p--------------------~----------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+....... . ...++..+.+||++||..||.+|||++|+|+||||+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 211 QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 655543321110 0 1357889999999999999999999999999999986
Q ss_pred h
Q 008303 210 Y 210 (570)
Q Consensus 210 ~ 210 (570)
.
T Consensus 291 ~ 291 (311)
T 4agu_A 291 I 291 (311)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.16 Aligned_cols=206 Identities=26% Similarity=0.486 Sum_probs=168.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+||||++++++|... ..+|+|||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 99 ~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik 175 (349)
T 2w4o_A 99 IGVLLRLSHPNIIKLKEIFETP-TEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175 (349)
T ss_dssp CHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHhCCCCCCcceeeeEecC-CeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 4789999999999999998654 5789999999999999999764 459999999999999999999999999999999
Q ss_pred CCcEEEcC---CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTK---DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++. ++.+||+|||+++...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 176 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp GGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred cccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999976 889999999999887665556677899999999999998999999999999999999999999976544
Q ss_pred H-HHHHHHHhccC---CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 Q-ALINKINKSIV---APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~-~~~~~i~~~~~---~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
. .....+..... .+.+..++.++.+||++||..||++|||+.|+|+||||+.
T Consensus 256 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred cHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 3 35555544432 2334678999999999999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=334.25 Aligned_cols=206 Identities=31% Similarity=0.538 Sum_probs=178.1
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|.++ +||||++++++|.+ +..+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 67 ~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlk 143 (342)
T 2qr7_A 67 EILLRYGQHPNIITLKDVYDD-GKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLK 143 (342)
T ss_dssp HHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHHhcCCCCcCeEEEEEEc-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCC
Confidence 567777 89999999999865 45899999999999999999764 459999999999999999999999999999999
Q ss_pred CCcEEEcCC-C---CEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc-
Q 008303 81 CSNIFLTKD-Q---DIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA- 154 (570)
Q Consensus 81 P~NILld~~-g---~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~- 154 (570)
|+|||+..+ + .+||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..
T Consensus 144 p~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp GGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred HHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 999998543 3 4999999999876543 344567899999999999888899999999999999999999999975
Q ss_pred --cCHHHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 155 --FDMQALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 155 --~~~~~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.+..++...+...... ..+..++.++++||++||..||.+||++.++++||||..+
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 224 PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4556667777655433 2345789999999999999999999999999999999765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=327.13 Aligned_cols=207 Identities=27% Similarity=0.480 Sum_probs=170.3
Q ss_pred CHHhhhcCCCcccccceEEEeeC--------------------------------------------------------c
Q 008303 1 MELISKIRNPFIVEYKDSWVERG--------------------------------------------------------C 24 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~--------------------------------------------------------~ 24 (570)
+++|++|+|||||+++++|.+.+ .
T Consensus 55 ~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (332)
T 3qd2_B 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKV 134 (332)
T ss_dssp HHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCC
T ss_pred HHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCc
Confidence 36899999999999999986542 2
Q ss_pred EEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 25 YVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 25 ~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
++|+|||||+||+|.++++.... ....+..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 48999999999999999986432 23567779999999999999999999999999999999999999999999999887
Q ss_pred cCCC-------------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCC
Q 008303 104 TSDD-------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA 170 (570)
Q Consensus 104 ~~~~-------------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~ 170 (570)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..++.. .......+......
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~ 292 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP 292 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC
Confidence 6432 23446799999999999999999999999999999999998776532 22233333333222
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 171 PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 171 p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.....+++.+.+||.+||..||.+|||++|+|+|+||+.
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 223456788999999999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.99 Aligned_cols=209 Identities=25% Similarity=0.446 Sum_probs=185.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+. ..+|+|||||.||+|.+++.... .+++..++.|+.||+.||.|||++||+|||||
T Consensus 87 ~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 163 (494)
T 3lij_A 87 VAVLKLLDHPNIMKLYDFFEDK-RNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163 (494)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence 3688999999999999998654 57899999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCC---CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKD---QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++.. +.+||+|||++............+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 164 p~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 164 PENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999764 459999999999887666667788999999999986 4699999999999999999999999999999
Q ss_pred HHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhhh
Q 008303 158 QALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213 (570)
Q Consensus 158 ~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~k 213 (570)
.++...+....... .+..++..+++||++||..||.+|||+.|+|+||||+....+
T Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301 (494)
T ss_dssp HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCccc
Confidence 88888887665432 235789999999999999999999999999999999875433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.61 Aligned_cols=206 Identities=30% Similarity=0.538 Sum_probs=180.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+ ...+|+|||||.||+|.+++.... .+++..++.|+.||+.||.|||++||+|||||
T Consensus 72 ~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk 148 (486)
T 3mwu_A 72 VELLKKLDHPNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148 (486)
T ss_dssp HHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCcCeEEEEEEc-CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCc
Confidence 368999999999999999865 457999999999999999998754 59999999999999999999999999999999
Q ss_pred CCcEEEc---CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLT---KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld---~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++ .++.+||+|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 149 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp GGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999995 456799999999988766665667789999999999976 599999999999999999999999999998
Q ss_pred HHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 158 QALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 158 ~~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.++...+...... +.+..++.++++||++||..||.+|||+.++|+||||+.+
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 8888887765433 2335689999999999999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.28 Aligned_cols=206 Identities=22% Similarity=0.386 Sum_probs=175.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+ +...|+|||||.||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||
T Consensus 57 ~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp 133 (323)
T 3tki_A 57 CINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133 (323)
T ss_dssp HHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhCCCCCCCeEEEEEec-CCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccch
Confidence 57899999999999998865 45789999999999999998653 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+|||++.++.+||+|||++..+... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 134 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred HHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 9999999999999999999876432 23446789999999999987776 7789999999999999999999976554
Q ss_pred H--HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 158 Q--ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 158 ~--~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
. ..............+..++..+.+||.+||..||.+|||++|+++|+||+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 214 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp TSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 2 2222223333333446789999999999999999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.34 Aligned_cols=207 Identities=23% Similarity=0.430 Sum_probs=173.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+|||||.| +|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 52 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp 128 (324)
T 3mtl_A 52 SLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP 128 (324)
T ss_dssp HHHSCCCCTTBCCEEEEEECS-SCEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCG
T ss_pred HHHHhcCCCCCCeeeeEEeeC-CEEEEEeccccc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCH
Confidence 678999999999999998655 468999999975 9999988753 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 129 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 129 QNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp GGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999999876532 23345688999999999976 568999999999999999999999999988887
Q ss_pred HHHHHHhccCCCC-----------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 160 LINKINKSIVAPL-----------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~-----------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
....+......+. ...++.++.+||.+||..||.+|||++|+|+||||...
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 7766655333221 12467899999999999999999999999999999865
Q ss_pred h
Q 008303 211 V 211 (570)
Q Consensus 211 ~ 211 (570)
.
T Consensus 289 ~ 289 (324)
T 3mtl_A 289 G 289 (324)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=328.98 Aligned_cols=203 Identities=30% Similarity=0.515 Sum_probs=174.3
Q ss_pred HHhhhcC-----CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIR-----NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~-----HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|+++. |||||+++++|... ..+|+||||| +++|.+++.......+++..++.|+.||+.||+|||++||+|
T Consensus 83 ~~l~~l~~~~~~h~~iv~~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 160 (360)
T 3llt_A 83 DILKKIQNDDINNNNIVKYHGKFMYY-DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH 160 (360)
T ss_dssp HHHHHTCCCSTTGGGBCCEEEEEEET-TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHhcccCCCCCCeecccceeeEC-CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 4667775 99999999998765 4799999999 899999999876667999999999999999999999999999
Q ss_pred ceecCCcEEEcC-------------------------CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCC
Q 008303 77 RDVKCSNIFLTK-------------------------DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGS 131 (570)
Q Consensus 77 rDLKP~NILld~-------------------------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ 131 (570)
|||||+|||++. ++.+||+|||++..... .....+||+.|+|||++.+..|+.
T Consensus 161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 238 (360)
T 3llt_A 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDV 238 (360)
T ss_dssp SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCT
T ss_pred CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCC
Confidence 999999999975 78899999999987543 334678999999999999999999
Q ss_pred cccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCC-------------------------C-------------
Q 008303 132 KSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL-------------------------P------------- 173 (570)
Q Consensus 132 ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~-------------------------p------------- 173 (570)
++|||||||++|+|++|+.||...+..+....+........ +
T Consensus 239 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 318 (360)
T 3llt_A 239 SSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318 (360)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhh
Confidence 99999999999999999999998887766655543322110 0
Q ss_pred -------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 174 -------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 174 -------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
...+..+.+||.+||..||.+|||++|+|+||||+
T Consensus 319 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp TCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 01237788999999999999999999999999996
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=348.93 Aligned_cols=206 Identities=24% Similarity=0.488 Sum_probs=186.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++... ..+|+|||||.||+|.+++.+. +.+++..++.|+.||+.||.|||++||+|||||
T Consensus 67 i~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLk 143 (476)
T 2y94_A 67 IQNLKLFRHPHIIKLYQVISTP-SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143 (476)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred HHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCccccc
Confidence 3578899999999999998654 4799999999999999999753 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...
T Consensus 144 p~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 144 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred HHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999999999998877666677899999999999988776 789999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+..++..... ..+..++.++.+||++||..||.+|||+++|++|+||+..
T Consensus 224 ~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 224 LFKKICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHTTCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHhcCCc-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 8888776544 3567789999999999999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.65 Aligned_cols=210 Identities=24% Similarity=0.447 Sum_probs=181.3
Q ss_pred CHHhhhcCCCcccccceEEEee-------------------------------------CcEEEEEEeccCCCCHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVER-------------------------------------GCYVCIIIGFCEGGDMAEAIK 43 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-------------------------------------~~~i~IV~Ey~~gGsL~d~I~ 43 (570)
+++|++++|||||+++++|... +.++|+|||||.| +|.+.+.
T Consensus 51 ~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~ 129 (383)
T 3eb0_A 51 LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLK 129 (383)
T ss_dssp HHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHH
T ss_pred HHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHH
Confidence 3689999999999999998532 3458999999985 8888876
Q ss_pred H--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc-CCCCEEEeecCCceeccCCCCCccccCCCCCCC
Q 008303 44 K--ANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120 (570)
Q Consensus 44 ~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~A 120 (570)
. ..+..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...........+||+.|+|
T Consensus 130 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~a 209 (383)
T 3eb0_A 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRA 209 (383)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccC
Confidence 4 3346799999999999999999999999999999999999998 688999999999998876666667889999999
Q ss_pred cccccCCC-CCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCC----------------------------
Q 008303 121 PELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP---------------------------- 171 (570)
Q Consensus 121 PE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p---------------------------- 171 (570)
||++.+.. |+.++|||||||++|+|++|++||.+.+..+....+......+
T Consensus 210 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (383)
T 3eb0_A 210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI 289 (383)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH
T ss_pred HHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh
Confidence 99987654 8999999999999999999999999988877766665432221
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 172 ~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.+..++.++.+||.+||..||.+|||+.|+|+||||+.+.
T Consensus 290 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 3446789999999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.88 Aligned_cols=204 Identities=26% Similarity=0.379 Sum_probs=169.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.++ ..+|||||||.| +|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 85 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp 160 (329)
T 3gbz_A 85 SLLKELQHRNIIELKSVIHHN-HRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP 160 (329)
T ss_dssp HHGGGCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHHcCCCCcceEEEEEecC-CEEEEEEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCH
Confidence 688999999999999998654 579999999985 9999998754 499999999999999999999999999999999
Q ss_pred CcEEEc-----CCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcc
Q 008303 82 SNIFLT-----KDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 82 ~NILld-----~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
+|||++ .++.+||+|||++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 999995 4455999999999876533 234456789999999999875 489999999999999999999999999
Q ss_pred cCHHHHHHHHHhccCCCCC-----------------------------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 155 FDMQALINKINKSIVAPLP-----------------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~p-----------------------------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+..+....+......+.. ..++.++.+||.+||..||.+|||++|+|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 8887776666543322211 11678999999999999999999999999999
Q ss_pred ccCh
Q 008303 206 HLQP 209 (570)
Q Consensus 206 ~fq~ 209 (570)
||+.
T Consensus 321 ~f~~ 324 (329)
T 3gbz_A 321 YFSH 324 (329)
T ss_dssp GGSS
T ss_pred ccCC
Confidence 9975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.17 Aligned_cols=207 Identities=29% Similarity=0.492 Sum_probs=185.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+ +..+|||||||.||+|.+++.... .+++..++.|+.||+.||.|||++||+|||||
T Consensus 97 ~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 173 (504)
T 3q5i_A 97 ISLLKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIK 173 (504)
T ss_dssp HHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhCCCCCCCeEEEEEEc-CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc
Confidence 368899999999999999865 458999999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCC---CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQ---DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++.++ .+||+|||++............+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 174 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp GGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876 69999999999887766667788999999999987 4689999999999999999999999999999
Q ss_pred HHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 158 QALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 158 ~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.++...+....... .+..++.++++||++||..||.+|||++|+|+||||+.+.
T Consensus 253 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 253 QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 98888887765432 2257899999999999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=315.66 Aligned_cols=205 Identities=23% Similarity=0.479 Sum_probs=174.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++... ..+|+|||||.+++|.+++.... .+++..++.++.||+.||.|||++||+|+||||
T Consensus 63 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 139 (276)
T 2h6d_A 63 QNLKLFRHPHIIKLYQVISTP-TDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139 (276)
T ss_dssp HHHHTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCG
T ss_pred HHHhcCCCCCEeEEEEEEecC-CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh
Confidence 578899999999999988654 57899999999999999998754 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++.............|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+....
T Consensus 140 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 219 (276)
T 2h6d_A 140 ENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219 (276)
T ss_dssp GGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 999999999999999999988766555566789999999999988776 6899999999999999999999998888877
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+..... ..+..++..+.+||.+||..||.+|||++++++|+||+..
T Consensus 220 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 220 FKKIRGGVF-YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHhhcCcc-cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 777765543 4567889999999999999999999999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=348.09 Aligned_cols=207 Identities=30% Similarity=0.556 Sum_probs=184.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+. ..+|+|||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 77 ~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 153 (484)
T 3nyv_A 77 VQLLKQLDHPNIMKLYEFFEDK-GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153 (484)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCCCCcEEEEEEeC-CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 3688999999999999998654 5899999999999999999764 459999999999999999999999999999999
Q ss_pred CCcEEE---cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFL---TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||+ +.++.+||+|||++..+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 154 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp GGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999 4678899999999988776665666789999999999976 699999999999999999999999999998
Q ss_pred HHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 158 QALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 158 ~~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.++...+...... +.+..++.++++||++||..||.+|||+.|+|+||||+.+.
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 233 YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 8888888776533 23357899999999999999999999999999999998653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.80 Aligned_cols=206 Identities=26% Similarity=0.472 Sum_probs=180.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|.+++||||++++++|.+. ..+|||||||.||+|.+++.+. ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 126 ~il~~~~hp~Iv~l~~~~~~~-~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp 203 (437)
T 4aw2_A 126 DVLVNGDSKWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203 (437)
T ss_dssp HHHHHSCTTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCEEEEEEEEeeC-CEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCH
Confidence 578889999999999988654 5799999999999999999864 24699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
+||||+.+|.+||+|||+++....... ....+||+.|+|||++. ...|+.++|||||||++|||++|++||.+
T Consensus 204 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987654332 34468999999999997 55689999999999999999999999999
Q ss_pred cCHHHHHHHHHhcc----CCCCCCCCcHHHHHHHHHhhccCCCC--CcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSI----VAPLPTKYSGAFRGLVKSMLRKNPEL--RPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~----~~p~p~~~s~~l~dLI~~~L~~dP~~--RPTa~eIL~hp~fq~ 209 (570)
.+..+...++.... .......++.++++||++||..+|++ |++++||++||||+.
T Consensus 284 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 284 ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 99888887775432 12223458999999999999988888 999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=337.96 Aligned_cols=209 Identities=23% Similarity=0.380 Sum_probs=176.4
Q ss_pred CHHhhhcCCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKIRNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
+++|++|+|||||+++++|... ..++++|||||.+ +|.+++.. .....+++..++.|+.||+.||.|||++|
T Consensus 98 ~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 176 (420)
T 1j1b_A 98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176 (420)
T ss_dssp HHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3689999999999999988642 2357899999986 77776653 23467999999999999999999999999
Q ss_pred cccceecCCcEEEcCC-CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCC
Q 008303 74 ILHRDVKCSNIFLTKD-QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 74 IvHrDLKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|+||||||+||||+.+ +.+||+|||+++.+.........+||++|+|||++.+. .|+.++|||||||++|||++|++|
T Consensus 177 ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999999965 56899999999987666556677899999999999765 689999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 152 FKAFDMQALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
|.+.+..+.+..+.+....+ ++..++.++.+||++||.+||.+|||+.|+|+
T Consensus 257 f~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 99888766665554321111 12356899999999999999999999999999
Q ss_pred hhccChh
Q 008303 204 HVHLQPY 210 (570)
Q Consensus 204 hp~fq~~ 210 (570)
|+||+.+
T Consensus 337 hp~f~~~ 343 (420)
T 1j1b_A 337 HSFFDEL 343 (420)
T ss_dssp SGGGGGG
T ss_pred CHhhccc
Confidence 9999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.56 Aligned_cols=208 Identities=25% Similarity=0.409 Sum_probs=164.8
Q ss_pred CHHhhhcCCCcccccceEEEee----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVER----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++|+|||||+++++|... ...+|+|||||. |+|.++++.. ..+++..++.|++||+.||+|||++||+|
T Consensus 103 ~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiH 179 (458)
T 3rp9_A 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILH 179 (458)
T ss_dssp HHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCC
Confidence 3689999999999999988543 246899999985 6999999763 46999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC----------------------------CCccccCCCCCCCcccc-cCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----------------------------LASSVVGTPSYMCPELL-ADI 127 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~----------------------------~~~~~~GT~~Y~APE~l-~~~ 127 (570)
|||||+||||+.++.+||+|||+++...... .....+||++|+|||++ ...
T Consensus 180 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 259 (458)
T 3rp9_A 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259 (458)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC
T ss_pred CCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC
Confidence 9999999999999999999999998764221 23456899999999986 456
Q ss_pred CCCCcccccchhhhHHHhhc-----------cCCCCcccCH--------------------HHHHHHHHhccCCC-----
Q 008303 128 PYGSKSDIWSLGCCIYEMTS-----------LKPAFKAFDM--------------------QALINKINKSIVAP----- 171 (570)
Q Consensus 128 ~~t~ksDIWSLG~IlyeLlt-----------G~~pf~~~~~--------------------~~~~~~i~~~~~~p----- 171 (570)
.|+.++||||||||+|||++ |+++|.+.+. ...+..+......+
T Consensus 260 ~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~ 339 (458)
T 3rp9_A 260 NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI 339 (458)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHH
T ss_pred CCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHH
Confidence 79999999999999999998 6777765431 12222221111110
Q ss_pred -------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 172 -------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 172 -------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
....++.++.+||++||..||.+|||++|+|+||||+.+.
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 340 EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 1235689999999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.75 Aligned_cols=211 Identities=24% Similarity=0.404 Sum_probs=177.4
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIK-KANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~-~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
+++|++++||||++++++|...+ .++|+|||||.++.+..+.. ......+++..++.|+.||+.||+|||++||
T Consensus 83 ~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 162 (394)
T 4e7w_A 83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162 (394)
T ss_dssp HHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 36899999999999999986543 35889999998754433332 1224579999999999999999999999999
Q ss_pred ccceecCCcEEEc-CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCC
Q 008303 75 LHRDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 75 vHrDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
+||||||+|||++ .++.+||+|||+++...........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||
T Consensus 163 vHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999 7899999999999988666666678899999999999765 5899999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 153 KAFDMQALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.+..+....+.+....+ ++..++.++.+||.+||..||.+|||+.|+|+|
T Consensus 243 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 9988776666554422111 223578999999999999999999999999999
Q ss_pred hccChhh
Q 008303 205 VHLQPYV 211 (570)
Q Consensus 205 p~fq~~~ 211 (570)
|||+.+.
T Consensus 323 p~f~~~~ 329 (394)
T 4e7w_A 323 PFFDELR 329 (394)
T ss_dssp GGGSTTT
T ss_pred hhhhhhc
Confidence 9998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=316.94 Aligned_cols=204 Identities=23% Similarity=0.438 Sum_probs=182.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.+|+|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 66 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 142 (284)
T 2vgo_A 66 EIQSHLRHPNILRMYNYFHDR-KRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKP 142 (284)
T ss_dssp HHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred HHHhcCCCCCEeeEEEEEEcC-CEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 578899999999999998654 57899999999999999998764 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.++.+||+|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.....
T Consensus 143 ~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 221 (284)
T 2vgo_A 143 ENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221 (284)
T ss_dssp GGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred HHEEEcCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH
Confidence 9999999999999999999776543 234568999999999999989999999999999999999999999988877777
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+.... ...+..++.++++||.+||..||.+||+++++++|+||+..
T Consensus 222 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 222 RRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHTTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHhccc-cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 6665543 34567899999999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=329.06 Aligned_cols=208 Identities=26% Similarity=0.463 Sum_probs=178.2
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +||||++++++|.. +..+|+|||||.||+|.+++.......+++..++.|+.||+.||.|||++||+|||||
T Consensus 80 ~~l~~l~~~~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dik 158 (327)
T 3lm5_A 80 AVLELAKSCPRVINLHEVYEN-TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158 (327)
T ss_dssp HHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHhccCCCCEEEEEEEEEe-CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence 567777 67999999999865 4579999999999999999866555679999999999999999999999999999999
Q ss_pred CCcEEEcC---CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTK---DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++. ++.+||+|||++............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999998 789999999999988766555667899999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHhccC---CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 158 QALINKINKSIV---APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 158 ~~~~~~i~~~~~---~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
......+..... ...+..++..+.+||.+||..||.+|||++++|+|+||+.+
T Consensus 239 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 877766655432 23345789999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=315.61 Aligned_cols=207 Identities=26% Similarity=0.477 Sum_probs=178.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ...|+|||||.+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 60 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p 136 (283)
T 3bhy_A 60 NILREIRHPNIITLHDIFENK-TDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKP 136 (283)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhCCCCCeeehhheecCC-CeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh
Confidence 578999999999999998654 57899999999999999998753 589999999999999999999999999999999
Q ss_pred CcEEEcCCC----CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 82 SNIFLTKDQ----DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+|||++.++ .+||+|||++.............|++.|+|||++.+..++.++||||||+++|+|++|..||...+.
T Consensus 137 ~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 999999877 7999999999887665555567899999999999998999999999999999999999999999888
Q ss_pred HHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 158 QALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 158 ~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
......+....... .+..++..+.+||++||..||.+||++.++|+|+||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 87777765543322 1246789999999999999999999999999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.72 Aligned_cols=205 Identities=29% Similarity=0.476 Sum_probs=177.8
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++||||++++++|...+ ..+|+||||| |++|.++++. ..+++..++.|+.||+.||+|||++||+
T Consensus 75 ~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~iv 150 (367)
T 1cm8_A 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGII 150 (367)
T ss_dssp HHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 36889999999999999986542 3469999999 7899999986 3489999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+|||++.++.+||+|||+++..... ....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+
T Consensus 151 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 151 HRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999886532 445789999999999987 6789999999999999999999999999
Q ss_pred cCHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+......+ ....++..+.+||.+||..||.+|||++|+|+|
T Consensus 229 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 88777666654322211 234678999999999999999999999999999
Q ss_pred hccChhh
Q 008303 205 VHLQPYV 211 (570)
Q Consensus 205 p~fq~~~ 211 (570)
|||+.+.
T Consensus 309 p~f~~~~ 315 (367)
T 1cm8_A 309 PYFESLH 315 (367)
T ss_dssp GGGTTTC
T ss_pred hHHHhhc
Confidence 9998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=329.25 Aligned_cols=210 Identities=25% Similarity=0.463 Sum_probs=175.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC----------------------------------
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN---------------------------------- 46 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~---------------------------------- 46 (570)
+++|++++||||++++++|.+. ..+|+|||||.||+|.+++....
T Consensus 79 ~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (345)
T 3hko_A 79 VRLMKKLHHPNIARLYEVYEDE-QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF 157 (345)
T ss_dssp HHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--C
T ss_pred HHHHHhCCCCCcceeehhhccC-CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccc
Confidence 3678999999999999998654 58999999999999999984210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCC--CEEEeecCCceeccCCC-----CCccccCC
Q 008303 47 ----SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQ--DIRLGDFGLAKILTSDD-----LASSVVGT 115 (570)
Q Consensus 47 ----~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g--~vKL~DFGla~~~~~~~-----~~~~~~GT 115 (570)
...+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+.... ......||
T Consensus 158 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 237 (345)
T 3hko_A 158 RESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237 (345)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCC
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCC
Confidence 11246888999999999999999999999999999999998776 89999999998764321 23456799
Q ss_pred CCCCCcccccC--CCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhcc
Q 008303 116 PSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRK 190 (570)
Q Consensus 116 ~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~ 190 (570)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....... ....++.++.+||.+||..
T Consensus 238 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp GGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCS
T ss_pred ccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCC
Confidence 99999999975 678999999999999999999999999988877777765554322 2234799999999999999
Q ss_pred CCCCCcCHHHHHHhhccChhh
Q 008303 191 NPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 191 dP~~RPTa~eIL~hp~fq~~~ 211 (570)
||.+||++.++|+||||+.+.
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTS
T ss_pred ChhHCCCHHHHhcChhhccCh
Confidence 999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.23 Aligned_cols=207 Identities=26% Similarity=0.480 Sum_probs=184.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||+++++|.+. ..+|||||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||||
T Consensus 236 ~iL~~l~hp~Iv~l~~~~~~~-~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKP 314 (576)
T 2acx_A 236 QILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314 (576)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHHHcCCCCEeeEEEEEeeC-CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCch
Confidence 689999999999999988654 5899999999999999999876656699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC----H
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD----M 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~----~ 157 (570)
+||||+.+|.+||+|||+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.... .
T Consensus 315 eNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~ 394 (576)
T 2acx_A 315 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394 (576)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred heEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence 999999999999999999998776655566799999999999999899999999999999999999999998753 3
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
..+...+. .....++..++.++++||++||..||.+|| +++||++||||+..
T Consensus 395 ~~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 395 EEVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 44444443 334456778999999999999999999999 89999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=328.64 Aligned_cols=204 Identities=26% Similarity=0.497 Sum_probs=181.1
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +||||++++++|.. ....|+|||||.|++|.+++.... .+++..++.|+.||+.||.|||++||+|||||
T Consensus 151 ~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlk 227 (365)
T 2y7j_A 151 HILRQVAGHPHIITLIDSYES-SSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLK 227 (365)
T ss_dssp HHHHHHTTCTTBCCEEEEEEB-SSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhcCCCCEeEEEEEEee-CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 567888 89999999998865 458999999999999999998753 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC------CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD------IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.+|.+||+|||++..+.........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 228 p~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 228 PENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998876666667899999999999863 3588999999999999999999999998
Q ss_pred cCHHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 155 FDMQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.+.......+....... .+..++..+.+||.+||..||.+|||++++|+||||+
T Consensus 308 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 308 RRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 88777777766554332 1246889999999999999999999999999999996
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=313.12 Aligned_cols=202 Identities=27% Similarity=0.462 Sum_probs=170.7
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
.++.++ +||||++++++|.+. ..+|+|||||+||+|.+++.... ...+++..++.|+.||+.||.|||++||+|||
T Consensus 62 ~~~~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 140 (289)
T 1x8b_A 62 YAHAVLGQHSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMD 140 (289)
T ss_dssp HHHHHSCSCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHhCCCCCeeeeeeeeecC-CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecC
Confidence 456677 999999999998655 48899999999999999998642 25689999999999999999999999999999
Q ss_pred ecCCcEEEcCC-------------------CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccch
Q 008303 79 VKCSNIFLTKD-------------------QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSL 138 (570)
Q Consensus 79 LKP~NILld~~-------------------g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSL 138 (570)
|||+|||++.+ ..+||+|||++....... ...||+.|+|||++.+. .++.++|||||
T Consensus 141 ikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp CSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred CCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 99999999844 479999999998876433 34699999999999866 56789999999
Q ss_pred hhhHHHhhccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 139 GCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 139 G~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
||++|+|++|.+++.... ....+........+..++.++.+||.+||..||.+|||+.++++|+||+..
T Consensus 218 G~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 999999999998775443 334455555666778899999999999999999999999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=338.09 Aligned_cols=206 Identities=27% Similarity=0.442 Sum_probs=178.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|.+++||||++++++|.+. .++|||||||.||+|.+++.+.+ ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 113 ~il~~~~hp~Iv~l~~~~~~~-~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp 190 (412)
T 2vd5_A 113 DVLVNGDRRWITQLHFAFQDE-NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190 (412)
T ss_dssp HHHHHSCTTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhcCCCCeeeEEEEEeeC-CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCH
Confidence 578889999999999988654 58999999999999999998753 3699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCccccc-------CCCCCCcccccchhhhHHHhhccCCCC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLA-------DIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~-------~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
+|||++.+|.+||+|||+++....... ....+||+.|+|||++. ...|+.++|||||||++|||++|+.||
T Consensus 191 ~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred HHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 999999999999999999988754432 33568999999999997 356899999999999999999999999
Q ss_pred cccCHHHHHHHHHhcc---C-CCCCCCCcHHHHHHHHHhhccCCCCC---cCHHHHHHhhccChh
Q 008303 153 KAFDMQALINKINKSI---V-APLPTKYSGAFRGLVKSMLRKNPELR---PSAAELLRHVHLQPY 210 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~---~-~p~p~~~s~~l~dLI~~~L~~dP~~R---PTa~eIL~hp~fq~~ 210 (570)
.+.+..+...++.... . ...+..++.++++||++||. +|.+| ++++||++||||+..
T Consensus 271 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 9998888877775421 1 22345799999999999999 99998 599999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=320.84 Aligned_cols=205 Identities=26% Similarity=0.421 Sum_probs=167.2
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +||||++++++|.+. ..+|+|||||.||+|.+++.... .+++..++.|+.||+.||+|||++||+|||||
T Consensus 62 ~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 138 (316)
T 2ac3_A 62 EMLYQCQGHRNVLELIEFFEEE-DRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLK 138 (316)
T ss_dssp HHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHhcCCCCeeeEEEEEeeC-CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Confidence 567775 899999999998654 58999999999999999998754 58999999999999999999999999999999
Q ss_pred CCcEEEcCCCC---EEEeecCCceeccCCC--------CCccccCCCCCCCcccccC-----CCCCCcccccchhhhHHH
Q 008303 81 CSNIFLTKDQD---IRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLAD-----IPYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 81 P~NILld~~g~---vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIWSLG~Ilye 144 (570)
|+|||++.++. +||+|||++....... .....+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 139 p~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~ 218 (316)
T 2ac3_A 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218 (316)
T ss_dssp GGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHH
T ss_pred HHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHH
Confidence 99999998776 9999999987654211 1234569999999999975 457899999999999999
Q ss_pred hhccCCCCcccC---------------HHHHHHHHHhccCCCCC----CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 145 MTSLKPAFKAFD---------------MQALINKINKSIVAPLP----TKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 145 LltG~~pf~~~~---------------~~~~~~~i~~~~~~p~p----~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|++|+.||.... ...+...+...... .+ ..++.++++||++||..||.+|||++|+|+||
T Consensus 219 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 219 LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 999999997653 23344445444322 22 46899999999999999999999999999999
Q ss_pred ccChh
Q 008303 206 HLQPY 210 (570)
Q Consensus 206 ~fq~~ 210 (570)
||+..
T Consensus 298 ~~~~~ 302 (316)
T 2ac3_A 298 WVQGC 302 (316)
T ss_dssp TCC--
T ss_pred hhcCC
Confidence 99864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=316.16 Aligned_cols=207 Identities=29% Similarity=0.503 Sum_probs=182.8
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +||||++++++|.. +...|+|||||.+++|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 75 ~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 151 (298)
T 1phk_A 75 DILRKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLK 151 (298)
T ss_dssp HHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhcCCCCEeeeeeeecc-CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 578888 49999999998865 458999999999999999998753 58999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc------CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.++.+||+|||++.............|++.|+|||++. ...++.++|||||||++|+|++|..||..
T Consensus 152 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 152 PENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 999999999999999999999877666566778999999999985 45678999999999999999999999998
Q ss_pred cCHHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 155 FDMQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.+.......+....... ....++..+.+||.+||..||.+|||++++|+|+||+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 232 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 88877777766554332 2246899999999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.04 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=157.0
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++. ||||++++++|.+. ..+|||||||.||+|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 57 ~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 133 (325)
T 3kn6_A 57 TALKLCEGHPNIVKLHEVFHDQ-LHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133 (325)
T ss_dssp HHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhcCCCCeeEEEEEEEcC-CEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Confidence 5788885 99999999998654 5789999999999999999874 459999999999999999999999999999999
Q ss_pred CCcEEEcCCC---CEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQ---DIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g---~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++ .+||+|||++...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+
T Consensus 134 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp GGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred HHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 9999998766 7999999999876543 23456688999999999999999999999999999999999999997644
Q ss_pred H-------HHHHHHHHhccCCCC---CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 157 M-------QALINKINKSIVAPL---PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 157 ~-------~~~~~~i~~~~~~p~---p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
. .+....+........ +..++.++++||.+||..||.+|||++++++|+||+.
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 214 RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp ----CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred cccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 3 455555654433221 1358999999999999999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=318.68 Aligned_cols=204 Identities=30% Similarity=0.435 Sum_probs=178.5
Q ss_pred hcCCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 6 KIRNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 6 kL~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++||||++++++|.. ....+|+||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp 148 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCH
Confidence 3489999999999862 3457899999998 5999999887666799999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.++.+||+|||++.............|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (326)
T 1blx_A 149 QNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 228 (326)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred HHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999999999999998776555555678999999999999999999999999999999999999999988877776
Q ss_pred HHHHhccCC--------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 162 NKINKSIVA--------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~--------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+...... .....++..+++||.+||..||.+|||+.++|+|+||+..
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 666432211 1234678999999999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.92 Aligned_cols=198 Identities=26% Similarity=0.439 Sum_probs=175.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGG-DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gG-sL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||++++++|.+. ..+|+|||||.+| +|.+++... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 81 ~~l~~l~h~~Iv~~~~~~~~~-~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 157 (335)
T 3dls_A 81 AILSRVEHANIIKVLDIFENQ-GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIK 157 (335)
T ss_dssp HHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHhCCCCCEeeEEEEEeeC-CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccC
Confidence 688999999999999998654 5789999999766 999999864 359999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.++.+||+|||++............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 158 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-- 235 (335)
T 3dls_A 158 DENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-- 235 (335)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--
T ss_pred HHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--
Confidence 9999999999999999999998877666667889999999999988887 8899999999999999999999976331
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
. .......+..++.++.+||.+||..||.+|||++++++||||+.
T Consensus 236 ----~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 236 ----T-VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----G-TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----H-HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 1 11222345678999999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=318.14 Aligned_cols=204 Identities=28% Similarity=0.516 Sum_probs=181.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp 134 (304)
T 2jam_A 58 AVLKKIKHENIVTLEDIYEST-THYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134 (304)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCG
T ss_pred HHHHhCCCCCeeehhhhcccC-CEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCH
Confidence 678999999999999988654 57899999999999999998754 489999999999999999999999999999999
Q ss_pred CcEEE---cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFL---TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|||+ +.++.+||+|||++...... .....+|++.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 135 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 213 (304)
T 2jam_A 135 ENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213 (304)
T ss_dssp GGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999 67889999999999765432 334567999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.....+...... +.+..++..+.+||.+||..||.+|||++++|+|+||+.
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 887777665432 344678999999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.26 Aligned_cols=204 Identities=27% Similarity=0.576 Sum_probs=182.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 93 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 169 (335)
T 2owb_A 93 SIHRSLAHQHVVGFHGFFEDN-DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 169 (335)
T ss_dssp HHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHhCCCCCCCeEEEEEecC-CeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCc
Confidence 578899999999999998654 57999999999999999998753 599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++...... ......+|++.|+|||++.+..++.++|||||||++|+|++|+.||......+.
T Consensus 170 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 170 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred hhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 9999999999999999999876532 234456899999999999998999999999999999999999999998887777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+.... ..++..++..+.+||++||..||.+||+++|+|+|+||..
T Consensus 250 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 250 YLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHHHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 66665543 3456789999999999999999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=316.19 Aligned_cols=204 Identities=27% Similarity=0.576 Sum_probs=182.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+ +..+|+|||||.|++|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 67 ~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p 143 (294)
T 2rku_A 67 SIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 143 (294)
T ss_dssp HHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHHhCCCCCEeeeeeeecc-CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 57889999999999999865 457899999999999999998753 589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+.
T Consensus 144 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 144 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred HhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999999876532 234456799999999999988899999999999999999999999999888777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+.... ...+..++..+.+||.+||..||.+|||++++++|+||..
T Consensus 224 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 224 YLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHhhcc-CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 76665543 3456789999999999999999999999999999999964
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=316.64 Aligned_cols=206 Identities=31% Similarity=0.594 Sum_probs=154.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+ +..+|+|||||.+++|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 63 ~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 140 (278)
T 3cok_A 63 KIHCQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140 (278)
T ss_dssp HHHTTBCCTTBCCEEEEEEC-SSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCG
T ss_pred HHHHhCCCCCeEeEEEEEcc-CCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 57889999999999999865 45789999999999999999864 34689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 141 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 220 (278)
T 3cok_A 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220 (278)
T ss_dssp GGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred HHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence 9999999999999999999876532 223356799999999999988899999999999999999999999987665444
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...+... ....+..++.++.+||.+||..||.+|||++++++|+||+..
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 221 LNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ---CCSS-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHhhc-ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 4333222 223566789999999999999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.49 Aligned_cols=206 Identities=26% Similarity=0.406 Sum_probs=166.1
Q ss_pred HHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|++++||||++++++|...+ ..+|+|||||.+ +|.+++.. .+++..++.|+.||+.||.|||++||+|
T Consensus 76 ~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH 150 (371)
T 2xrw_A 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIH 150 (371)
T ss_dssp HHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5789999999999999986443 378999999975 78888853 3899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||||+|||++.++.+||+|||++............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+
T Consensus 151 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp SCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999988766555566789999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHHhccCCCCCC-----------------------------------------CCcHHHHHHHHHhhccCCCCC
Q 008303 157 MQALINKINKSIVAPLPT-----------------------------------------KYSGAFRGLVKSMLRKNPELR 195 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~-----------------------------------------~~s~~l~dLI~~~L~~dP~~R 195 (570)
.......+......+.+. .++.++++||++||..||.+|
T Consensus 231 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 877776665543322110 115689999999999999999
Q ss_pred cCHHHHHHhhccChhhh
Q 008303 196 PSAAELLRHVHLQPYVL 212 (570)
Q Consensus 196 PTa~eIL~hp~fq~~~~ 212 (570)
||++|+|+||||+.+..
T Consensus 311 ~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 311 ISVDEALQHPYINVWYD 327 (371)
T ss_dssp CCHHHHHHSHHHHTTCC
T ss_pred CCHHHHhCCcchhhhcC
Confidence 99999999999986543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.45 Aligned_cols=208 Identities=38% Similarity=0.727 Sum_probs=184.1
Q ss_pred HHhhhcCCCcccccceEEEe-eCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----
Q 008303 2 ELISKIRNPFIVEYKDSWVE-RGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANH----- 73 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~-~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~g----- 73 (570)
++|++++||||++++++|.+ .+..+|+|||||+||+|.+++... ....+++..++.|+.||+.||.|||++|
T Consensus 57 ~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ 136 (279)
T 2w5a_A 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136 (279)
T ss_dssp HHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC-----
T ss_pred HHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCe
Confidence 57899999999999998865 356899999999999999999763 2345999999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
|+||||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 137 ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp -CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999998765432 223457999999999999989999999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 153 KAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+...+...+.......++..++.++.+||.+||..||.+||+++||++|+|+..
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 217 TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 999988888888887777788899999999999999999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=323.03 Aligned_cols=206 Identities=26% Similarity=0.429 Sum_probs=174.8
Q ss_pred HHhhhcCCCcccccceEEEee-------CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 2 ELISKIRNPFIVEYKDSWVER-------GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-------~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
++|++++||||++++++|... ++.+|+|||||.| +|.+.+.... ..+++..++.|+.||+.||.|||++||
T Consensus 68 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i 145 (351)
T 3mi9_A 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKI 145 (351)
T ss_dssp HHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 688999999999999998753 3468999999985 8888876543 459999999999999999999999999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCC-----CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhcc
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-----DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG 148 (570)
+||||||+|||++.++.+||+|||++..+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 146 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred eCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876522 23345688999999999976 4589999999999999999999
Q ss_pred CCCCcccCHHHHHHHHHhccCCCCCC---C----------------------------CcHHHHHHHHHhhccCCCCCcC
Q 008303 149 KPAFKAFDMQALINKINKSIVAPLPT---K----------------------------YSGAFRGLVKSMLRKNPELRPS 197 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p~p~---~----------------------------~s~~l~dLI~~~L~~dP~~RPT 197 (570)
.+||.+.+.......+........+. . .++.+.+||.+||..||.+|||
T Consensus 226 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 305 (351)
T 3mi9_A 226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305 (351)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence 99999988887776665543322111 1 2677999999999999999999
Q ss_pred HHHHHHhhccCh
Q 008303 198 AAELLRHVHLQP 209 (570)
Q Consensus 198 a~eIL~hp~fq~ 209 (570)
++|+|+|+||+.
T Consensus 306 ~~e~l~hp~f~~ 317 (351)
T 3mi9_A 306 SDDALNHDFFWS 317 (351)
T ss_dssp HHHHHTSGGGGS
T ss_pred HHHHhCCCCcCC
Confidence 999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.14 Aligned_cols=203 Identities=20% Similarity=0.425 Sum_probs=181.8
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--------------KLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--------------~~Lse~~i~~I~~QLl~aL 66 (570)
++|+++ +||||++++++|.+.+ .+|+|||||.||+|.+++..... ..+++..++.|+.||+.||
T Consensus 138 ~~l~~l~~hpnIv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 216 (370)
T 2psq_A 138 EMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216 (370)
T ss_dssp HHHHHSCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCEeeEEEEEccCC-CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 678899 8999999999886544 68999999999999999987532 3589999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.+||+|||+++.+.... ......+|+.|+|||++.+..|+.++|||||||++|
T Consensus 217 ~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 217 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp HHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999999999999999998765432 223456788999999999999999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||.+.+..++...+........+..++.++.+||.+||..||.+||++.|+++++
T Consensus 297 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998 9999999888888888877777778889999999999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.68 Aligned_cols=204 Identities=26% Similarity=0.594 Sum_probs=174.0
Q ss_pred HHhhhcCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Q 008303 2 ELISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--ILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--IvH 76 (570)
++|++++||||++++++|... +..+|+|||||.+|+|.+++.... .+++..++.|+.||+.||.|||++| |+|
T Consensus 77 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H 154 (290)
T 1t4h_A 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIH 154 (290)
T ss_dssp HHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred HHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEE
Confidence 578999999999999998653 467899999999999999998753 4899999999999999999999999 999
Q ss_pred ceecCCcEEEc-CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 77 RDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 77 rDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||||+|||++ .++.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 155 ~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp SCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999998 7889999999999765433 3445679999999998874 5899999999999999999999999874
Q ss_pred C-HHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 156 D-MQALINKINKSIV-APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 156 ~-~~~~~~~i~~~~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
. .......+..... ...+..+++++.+||.+||..||.+|||++++|+|+||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 4 4444444443322 2234567889999999999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=319.46 Aligned_cols=209 Identities=27% Similarity=0.523 Sum_probs=173.7
Q ss_pred HHhhhc-CCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKI-RNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++|+++ +||||++++++|... +..+|+|||||.+|+|.+++.......+++..++.|+.||+.||.|||++||+
T Consensus 72 ~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 151 (326)
T 2x7f_A 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 151 (326)
T ss_dssp HHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 578888 899999999999763 45789999999999999999876556799999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccC
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~ 149 (570)
||||||+|||++.++.+||+|||++...... ......+|++.|+|||++. +..++.++|||||||++|+|++|.
T Consensus 152 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 152 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSS
T ss_pred ccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999876533 2234567999999999997 566899999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 150 PAFKAFDMQALINKINKSIV-APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.||...+.......+..... ......++..+.+||.+||..||.+||+++++++|+||+..
T Consensus 232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 232 PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 99988877666655544432 22356789999999999999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=333.26 Aligned_cols=209 Identities=24% Similarity=0.421 Sum_probs=163.4
Q ss_pred CHHhhhcCCCcccccceEEEe-eCcEEEEEEeccCCCCHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 1 MELISKIRNPFIVEYKDSWVE-RGCYVCIIIGFCEGGDMAEAIKKAN-------SKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-~~~~i~IV~Ey~~gGsL~d~I~~~~-------~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
+++|++|+|||||+++++|.. .+..+|||||||.| +|.+++.... ...+++..++.|+.||+.||.|||++
T Consensus 69 ~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 147 (405)
T 3rgf_A 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147 (405)
T ss_dssp HHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 368999999999999999975 35689999999975 8888886422 12499999999999999999999999
Q ss_pred CcccceecCCcEEE----cCCCCEEEeecCCceeccCC----CCCccccCCCCCCCcccccCC-CCCCcccccchhhhHH
Q 008303 73 HILHRDVKCSNIFL----TKDQDIRLGDFGLAKILTSD----DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIY 143 (570)
Q Consensus 73 gIvHrDLKP~NILl----d~~g~vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~Ily 143 (570)
||+||||||+|||| +.++.+||+|||+++.+... ......+||+.|+|||++.+. .|+.++|||||||++|
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 99999999999999 67789999999999876532 233457899999999999874 4899999999999999
Q ss_pred HhhccCCCCcccCHH---------HHHHHHHhccCCCCCC-------------------------------------CCc
Q 008303 144 EMTSLKPAFKAFDMQ---------ALINKINKSIVAPLPT-------------------------------------KYS 177 (570)
Q Consensus 144 eLltG~~pf~~~~~~---------~~~~~i~~~~~~p~p~-------------------------------------~~s 177 (570)
+|++|++||.+.... +.+..+......+... ..+
T Consensus 228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (405)
T 3rgf_A 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307 (405)
T ss_dssp HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence 999999999765432 3333333322222111 126
Q ss_pred HHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 178 GAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 178 ~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..+.+||.+||..||.+|||++|+|+||||+..
T Consensus 308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp SHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 789999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=336.24 Aligned_cols=208 Identities=27% Similarity=0.450 Sum_probs=166.4
Q ss_pred CHHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++||||+++++++...+ ..+|||||||. |+|.++++.. ..+++..++.|++||+.||+|||++||+|
T Consensus 76 ~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givH 152 (432)
T 3n9x_A 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIH 152 (432)
T ss_dssp HHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence 36899999999999999986543 46899999997 5999999763 45999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC-----------------------CCccccCCCCCCCcccc-cCCCCCCc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-----------------------LASSVVGTPSYMCPELL-ADIPYGSK 132 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~-----------------------~~~~~~GT~~Y~APE~l-~~~~~t~k 132 (570)
|||||+||||+.++.+||+|||+++...... .....+||++|+|||++ ....|+.+
T Consensus 153 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~ 232 (432)
T 3n9x_A 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232 (432)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH
T ss_pred CCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc
Confidence 9999999999999999999999998865432 23567899999999986 55669999
Q ss_pred ccccchhhhHHHhhc-----------cCCCCcccC-----------------HHHHHHHHHhccCCC-------------
Q 008303 133 SDIWSLGCCIYEMTS-----------LKPAFKAFD-----------------MQALINKINKSIVAP------------- 171 (570)
Q Consensus 133 sDIWSLG~IlyeLlt-----------G~~pf~~~~-----------------~~~~~~~i~~~~~~p------------- 171 (570)
+|||||||++|+|++ |.++|.+.+ ....+..+......+
T Consensus 233 ~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~ 312 (432)
T 3n9x_A 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH
Confidence 999999999999997 555554432 112222221111111
Q ss_pred -----------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 172 -----------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 172 -----------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
....+++++.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 0135799999999999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=319.34 Aligned_cols=195 Identities=29% Similarity=0.488 Sum_probs=163.5
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+|+||++++++|.+ +..+|+||||| +++|.+++...+ ..+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 115 ~h~~iv~l~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 115 QHPCCVRLEQAWEE-GGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp CCTTBCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CCCcEEEEEEEEEe-CCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 89999999999865 45899999999 679999988764 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhc
Q 008303 88 KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKS 167 (570)
Q Consensus 88 ~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~ 167 (570)
.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..+|..... ...+...
T Consensus 192 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~ 267 (311)
T 3p1a_A 192 PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG 267 (311)
T ss_dssp GGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT
T ss_pred CCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc
Confidence 999999999999988776666666789999999999876 799999999999999999999766654322 2222222
Q ss_pred cC-CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 168 IV-APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 168 ~~-~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.. ...+..++.++.+||.+||..||++|||++|+|+||||++
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 21 1234578999999999999999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=352.50 Aligned_cols=204 Identities=24% Similarity=0.490 Sum_probs=184.5
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|.++ +||||+.++++|.+ ...+|||||||.||+|.+++++.. .+++..++.|+.||+.||.|||++||+|||||
T Consensus 393 ~~l~~~~~~~~i~~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLK 469 (674)
T 3pfq_A 393 RVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469 (674)
T ss_dssp HHHTCTTCCTTBCCEEEECBC-SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCC
T ss_pred HHHHhccCCCeEEEEEEEEEe-CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCC
Confidence 456666 89999999998854 458999999999999999998764 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceecc-CCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILT-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+||||+.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 470 p~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~ 549 (674)
T 3pfq_A 470 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549 (674)
T ss_dssp STTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH
Confidence 999999999999999999998743 3344566899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCH-----HHHHHhhccCh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSA-----AELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa-----~eIL~hp~fq~ 209 (570)
+...|..... .++..++.++.+||++||.+||.+|+++ +||++|+||+.
T Consensus 550 ~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 550 LFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHHSSCC-CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHHHhCCC-CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 8888876543 4677899999999999999999999997 99999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.02 Aligned_cols=207 Identities=25% Similarity=0.476 Sum_probs=180.1
Q ss_pred HHhhhcCCCcccccceEEEe-eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVE-RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~-~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||+++++++.. .+..+|+|||||.++ |.+++.......+++..++.|+.||+.||.|||++||+|||||
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlk 136 (305)
T 2wtk_C 58 QLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIK 136 (305)
T ss_dssp HHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 67899999999999998853 345789999999886 8888887666779999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCC--CCcccccchhhhHHHhhccCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPY--GSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~--t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|+|||++.++.+||+|||++...... .......|++.|+|||++.+... +.++|||||||++|+|++|..||...
T Consensus 137 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999876532 22345679999999999976543 77999999999999999999999998
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+.......+..... ..+..++..+.+||.+||..||.+|||++++++|+||+..
T Consensus 217 ~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 217 NIYKLFENIGKGSY-AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp SHHHHHHHHHHCCC-CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred hHHHHHHHHhcCCC-CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 88888777766543 4677899999999999999999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.49 Aligned_cols=204 Identities=31% Similarity=0.600 Sum_probs=184.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ..+|+|||||.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 72 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 147 (303)
T 3a7i_A 72 TVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKA 147 (303)
T ss_dssp HHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCEeEEEEEEecC-CeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh
Confidence 578899999999999998765 478999999999999999864 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 148 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 227 (303)
T 3a7i_A 148 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227 (303)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred heEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH
Confidence 99999999999999999998875443 23456799999999999999999999999999999999999999998888877
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+........+..++..+.+||.+||..||.+|||++++++|+||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 228 LFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 7777776666677889999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=324.50 Aligned_cols=205 Identities=31% Similarity=0.503 Sum_probs=173.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDLK 80 (570)
++|++++||||++++++|... ..+|+|||||+||+|.+++.... .+++..++.|+.||+.||.|||++ ||+|||||
T Consensus 83 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk 159 (360)
T 3eqc_A 83 QVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 159 (360)
T ss_dssp GGGGGCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred HHHHHCCCCCEEEEeEEEEEC-CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCcc
Confidence 578899999999999988764 57999999999999999998764 489999999999999999999996 99999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+|||++.++.+||+|||++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 160 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 160 PSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp GGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred HHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999999765432 23456899999999999999999999999999999999999999987665443
Q ss_pred HH------------------------------------------HHHhccCCCC-CCCCcHHHHHHHHHhhccCCCCCcC
Q 008303 161 IN------------------------------------------KINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPS 197 (570)
Q Consensus 161 ~~------------------------------------------~i~~~~~~p~-p~~~s~~l~dLI~~~L~~dP~~RPT 197 (570)
.. .+........ ...++.++.+||.+||..||.+|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 318 (360)
T 3eqc_A 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318 (360)
T ss_dssp HHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC
Confidence 22 2222222222 2357899999999999999999999
Q ss_pred HHHHHHhhccChh
Q 008303 198 AAELLRHVHLQPY 210 (570)
Q Consensus 198 a~eIL~hp~fq~~ 210 (570)
++|+|+||||+..
T Consensus 319 ~~ell~hp~~~~~ 331 (360)
T 3eqc_A 319 LKQLMVHAFIKRS 331 (360)
T ss_dssp HHHHHTSHHHHHH
T ss_pred HHHHhhChHhhcc
Confidence 9999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.26 Aligned_cols=206 Identities=32% Similarity=0.578 Sum_probs=180.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++... ..+|+|||||.+++|.+++... ...+++..++.|+.||+.||.|||++||+|+||||
T Consensus 76 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p 153 (314)
T 3com_A 76 SIMQQCDSPHVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKA 153 (314)
T ss_dssp HHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCCccEEEEEEeC-CEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCH
Confidence 678999999999999998664 4789999999999999999754 35699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 154 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp GGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999999999999998765432 23456799999999999998999999999999999999999999998877666
Q ss_pred HHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+...... ..+..++..+.+||.+||..||.+|||+.++|+|+||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 234 IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 5555443322 234568999999999999999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.99 Aligned_cols=207 Identities=28% Similarity=0.519 Sum_probs=181.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++||||++++++|... ..+|+|||||.||+|.+++.... ...+++..++.|+.||+.||.|||++||+||||
T Consensus 237 ~iL~~l~hp~Iv~l~~~~~~~-~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDL 315 (543)
T 3c4z_A 237 KILAKVHSRFIVSLAYAFETK-TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315 (543)
T ss_dssp HHHHHCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHhcCCCCEeeEEEEEeeC-CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCC
Confidence 578999999999999988654 57999999999999999998643 346999999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCC-CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc---
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF--- 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~--- 155 (570)
||+|||++.+|.+||+|||+++.+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||...
T Consensus 316 KP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~ 395 (543)
T 3c4z_A 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395 (543)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC
T ss_pred ChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc
Confidence 99999999999999999999988765433 34569999999999999999999999999999999999999999775
Q ss_pred -CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 156 -DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 156 -~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
....+...+.... ...+..++.++++||++||.+||.+||+ +++|++||||+..
T Consensus 396 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 396 VENKELKQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp CCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred hhHHHHHHHHhhcc-cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 3455555554433 3467789999999999999999999995 5899999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=321.79 Aligned_cols=209 Identities=26% Similarity=0.428 Sum_probs=169.1
Q ss_pred HHhhhcCCCcccccceEEEee----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELISKIRNPFIVEYKDSWVER----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
++|++++||||++++++|... ...+|+|||||. |+|.+++... ...+++..++.|+.||+.||.|||++||+||
T Consensus 81 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 158 (362)
T 3pg1_A 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHR 158 (362)
T ss_dssp HHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEec
Confidence 678999999999999998642 347899999998 5898888754 3469999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
||||+|||++.++.+||+|||++............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999987666555666789999999999977 678999999999999999999999999888
Q ss_pred HHHHHHHHHhccCCC-------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAP-------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p-------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.......+......+ ....++..+.+||.+||..||.+|||+.|+|+||
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 776666554322111 1235688999999999999999999999999999
Q ss_pred ccChhhh
Q 008303 206 HLQPYVL 212 (570)
Q Consensus 206 ~fq~~~~ 212 (570)
||+.+..
T Consensus 319 ~f~~~~~ 325 (362)
T 3pg1_A 319 YFESLFD 325 (362)
T ss_dssp GGTTTCC
T ss_pred hhhhccC
Confidence 9987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=324.33 Aligned_cols=205 Identities=26% Similarity=0.453 Sum_probs=176.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.+ +|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 64 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 140 (346)
T 1ua2_A 64 KLLQELSHPNIIGLLDAFGHK-SNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140 (346)
T ss_dssp HHHHHCCCTTBCCEEEEECCT-TCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HHHhhCCCCCCCeEEEEEeeC-CceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCH
Confidence 678999999999999998654 468999999986 899888754 34689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|||++.++.+||+|||++..+... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+...
T Consensus 141 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~ 220 (346)
T 1ua2_A 141 NNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220 (346)
T ss_dssp GGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999999999999999999876533 334557899999999999754 58999999999999999999999999988877
Q ss_pred HHHHHHhccCCCC---------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAPL---------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p~---------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+......+. ...++.++++||++||..||.+|||++|+|+|+||+.
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 221 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred HHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 7666654322211 1356789999999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=323.31 Aligned_cols=206 Identities=26% Similarity=0.411 Sum_probs=170.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 76 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp 152 (331)
T 4aaa_A 76 KLLKQLRHENLVNLLEVCKKK-KRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152 (331)
T ss_dssp HHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HHHhhCCCCCEeeEEEEeecC-CEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcCh
Confidence 578999999999999998654 5789999999999998887653 3599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|||++.++.+||+|||++...... ......+|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+...
T Consensus 153 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (331)
T 4aaa_A 153 ENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232 (331)
T ss_dssp GGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred heEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999999876542 334456899999999999875 68999999999999999999999999887766
Q ss_pred HHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 160 LINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 160 ~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
....+....... ....++..+.+||.+||..||.+|||++|+|+|+||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred HHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 555443221110 01257899999999999999999999999999999975
Q ss_pred h
Q 008303 210 Y 210 (570)
Q Consensus 210 ~ 210 (570)
.
T Consensus 313 ~ 313 (331)
T 4aaa_A 313 D 313 (331)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=313.36 Aligned_cols=206 Identities=27% Similarity=0.457 Sum_probs=162.2
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccccee
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDV 79 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDL 79 (570)
+++.++||||++++++|.+.+ ..|+|||||.| +|.+++.. ..+..+++..++.|+.||+.||.|||++ ||+||||
T Consensus 59 ~~~~~~h~~iv~~~~~~~~~~-~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 136 (290)
T 3fme_A 59 SMRTVDCPFTVTFYGALFREG-DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 136 (290)
T ss_dssp HHTTCCCTTBCCEEEEEECSS-SEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCC
T ss_pred HHHhCCCCeEEEEeeeeeccC-CEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCC
Confidence 367789999999999987654 68999999975 88888764 2345799999999999999999999998 9999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccc----cCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.++.+||+|||++.............||+.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 137 KPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp SGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred CHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 999999999999999999999887666555566899999999996 5567899999999999999999999999863
Q ss_pred -CHHH-HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 -DMQA-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 -~~~~-~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.... ....+...........++.++.+||.+||..||.+|||++|+++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 217 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp SCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 3333 333333333333445789999999999999999999999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=320.65 Aligned_cols=203 Identities=21% Similarity=0.348 Sum_probs=180.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC----------------------CCCCCHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN----------------------SKLFSEEKLCKWL 59 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~----------------------~~~Lse~~i~~I~ 59 (570)
++|++++||||++++++|.+. ..+|+|||||.+|+|.+++.... ...+++..++.|+
T Consensus 102 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 180 (343)
T 1luf_A 102 ALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180 (343)
T ss_dssp HHHHTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHH
T ss_pred HHHHhCCCCCEEEEEEEEccC-CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHH
Confidence 678999999999999988654 46899999999999999998742 1569999999999
Q ss_pred HHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCccccc
Q 008303 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 60 ~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||
T Consensus 181 ~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 260 (343)
T 1luf_A 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260 (343)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccH
Confidence 999999999999999999999999999999999999999998764332 23345688999999999988999999999
Q ss_pred chhhhHHHhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 137 SLGCCIYEMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 137 SLG~IlyeLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||||++|+|++ |..||.+.+..+....+........+..++..+.+||++||..||.+||++.+++++.
T Consensus 261 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 99999999998 9999999998888888887777777889999999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.84 Aligned_cols=202 Identities=24% Similarity=0.464 Sum_probs=181.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+.+ .+|+|||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 57 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp 134 (269)
T 4hcu_A 57 EVMMKLSHPKLVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 134 (269)
T ss_dssp HHHHTCCCTTBCCEEEEECSSS-SEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHhCCCCCEeeEEEEEecCC-ceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcch
Confidence 6889999999999999886544 6899999999999999997643 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 135 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 135 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp GGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred heEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999998654322 2234456788999999998999999999999999999998 99999999999
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.....+........+..++..+.+||.+||..||.+||++.+++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 215 EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 99888888777777888999999999999999999999999999984
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.95 Aligned_cols=205 Identities=20% Similarity=0.428 Sum_probs=177.8
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------------------------
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-------------------------------- 47 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-------------------------------- 47 (570)
+++|+++ +|||||+++++|.+.+..+|+|||||.||+|.++++....
T Consensus 76 ~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (359)
T 3vhe_A 76 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155 (359)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------
T ss_pred HHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccc
Confidence 3678888 8999999999997766678999999999999999986432
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEe
Q 008303 48 --------------------------------KLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLG 95 (570)
Q Consensus 48 --------------------------------~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~ 95 (570)
..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp ----------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred cCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEE
Confidence 128999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH-HHHHHHHHhccCC
Q 008303 96 DFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM-QALINKINKSIVA 170 (570)
Q Consensus 96 DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~-~~~~~~i~~~~~~ 170 (570)
|||++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+... ......+......
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 315 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC
Confidence 999998764332 2334678899999999999999999999999999999998 9999987653 4445555556666
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 171 PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 171 p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..+..++.++.++|.+||..||.+|||+.|+++|+
T Consensus 316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 67888999999999999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=314.98 Aligned_cols=210 Identities=31% Similarity=0.579 Sum_probs=169.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA------NSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~------~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
+++|++++||||++++++|...+ ..|+|||||.|++|.+++... ....+++..++.|+.||+.||.|||++||
T Consensus 64 ~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 142 (303)
T 2vwi_A 64 IQAMSQCHHPNIVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142 (303)
T ss_dssp --CCCCCCCTTBCCEEEEEESSS-CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhcCCCCEeeEEEEEeecC-CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35678889999999999987655 689999999999999999752 23468999999999999999999999999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCC------CCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhc
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD------DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~------~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLlt 147 (570)
+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 143 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222 (303)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999998765432 12334679999999999975 568999999999999999999
Q ss_pred cCCCCcccCHHHHHHHHHhccCC---------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 148 LKPAFKAFDMQALINKINKSIVA---------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~~---------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
|..||.................. .....++.++.+||.+||..||.+||++.++++|+||+...
T Consensus 223 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 223 GAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp SSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 99999887655544433332221 12346789999999999999999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.53 Aligned_cols=208 Identities=30% Similarity=0.496 Sum_probs=175.7
Q ss_pred CHHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++||||+++++++.... ..+|+|||||.| +|.++++.. .+++..++.|+.||+.||.|||++||+|
T Consensus 76 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH 151 (364)
T 3qyz_A 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLH 151 (364)
T ss_dssp HHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 36889999999999999886432 468999999975 999999763 4899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++|
T Consensus 152 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 231 (364)
T 3qyz_A 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231 (364)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999998765332 2345689999999998754 4589999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 152 FKAFDMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
|.+.+..+....+......+ ....++.++.+||.+||..||.+|||++|+
T Consensus 232 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 311 (364)
T 3qyz_A 232 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311 (364)
T ss_dssp SCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 98877665555543322111 124578999999999999999999999999
Q ss_pred HHhhccChhhh
Q 008303 202 LRHVHLQPYVL 212 (570)
Q Consensus 202 L~hp~fq~~~~ 212 (570)
|+||||+.+..
T Consensus 312 l~hp~~~~~~~ 322 (364)
T 3qyz_A 312 LAHPYLEQYYD 322 (364)
T ss_dssp HTSGGGTTTCC
T ss_pred hcCcchhhccC
Confidence 99999987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=316.85 Aligned_cols=203 Identities=19% Similarity=0.415 Sum_probs=180.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC----------------------CCCCHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS----------------------KLFSEEKLCKWL 59 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~----------------------~~Lse~~i~~I~ 59 (570)
++|++|+||||++++++|.+.+ .+|+|||||.||+|.+++..... ..+++..++.|+
T Consensus 78 ~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 156 (314)
T 2ivs_A 78 NVLKQVNHPHVIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156 (314)
T ss_dssp HHHTTCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHH
T ss_pred HHHhhCCCCceeeEEEEEecCC-ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHH
Confidence 6789999999999999886544 68999999999999999987532 348999999999
Q ss_pred HHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCccccc
Q 008303 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 60 ~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+++.|+|||++.+..++.++|||
T Consensus 157 ~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 236 (314)
T 2ivs_A 157 WQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236 (314)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHH
Confidence 999999999999999999999999999999999999999998765432 22344678889999999988899999999
Q ss_pred chhhhHHHhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 137 SLGCCIYEMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 137 SLG~IlyeLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||||++|+|++ |..||.+.+...+...+........+..++..+.+||.+||..||.+||++.+++++.
T Consensus 237 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999998 9999998888888888877777777889999999999999999999999999999883
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=328.17 Aligned_cols=206 Identities=22% Similarity=0.342 Sum_probs=183.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-----KLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-----~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
.+|++++|||||+++++|.+.+ ..|+|||||.||+|.+++..... ..+++..++.|+.||+.||.|||++||+|
T Consensus 126 ~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 204 (367)
T 3l9p_A 126 LIISKFNHQNIVRCIGVSLQSL-PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIH 204 (367)
T ss_dssp HHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhCCCCCCCeEEEEEecCC-CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 5789999999999999986544 67899999999999999987542 35899999999999999999999999999
Q ss_pred ceecCCcEEEcCCC---CEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 77 RDVKCSNIFLTKDQ---DIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 77 rDLKP~NILld~~g---~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
|||||+|||++.+| .+||+|||+++.+... .......||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 205 rDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999655 4999999999865322 23345678999999999999999999999999999999997 99
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.||...+..++...+........+..++..+.+||.+||..||.+||++.+|++++++.
T Consensus 285 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 285 MPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99999999999988888777777889999999999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.16 Aligned_cols=205 Identities=22% Similarity=0.375 Sum_probs=172.4
Q ss_pred HHhhhcCCCcccccceEEEeeC-cEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++||||+++++++...+ ..+|+|||||.||+|.++++.... ..+++..++.|+.||+.||.|||++||+||||
T Consensus 59 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 138 (319)
T 4euu_A 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138 (319)
T ss_dssp HHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 5889999999999999887543 478999999999999999986433 34999999999999999999999999999999
Q ss_pred cCCcEEE----cCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc--------CCCCCCcccccchhhhHHHhhc
Q 008303 80 KCSNIFL----TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA--------DIPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 80 KP~NILl----d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~t~ksDIWSLG~IlyeLlt 147 (570)
||+|||+ +.++.+||+|||+++...........+||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 139 kp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~ 218 (319)
T 4euu_A 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (319)
T ss_dssp SGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH
T ss_pred CHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999 777789999999999887766666778999999999986 5678999999999999999999
Q ss_pred cCCCCcccC----HHHHHHHHHhccCC------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHH
Q 008303 148 LKPAFKAFD----MQALINKINKSIVA------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAA 199 (570)
Q Consensus 148 G~~pf~~~~----~~~~~~~i~~~~~~------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~ 199 (570)
|+.||.... ..+...++...... .+...++..+.+||.+||..||.+|||++
T Consensus 219 g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (319)
T 4euu_A 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (319)
T ss_dssp SSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHH
Confidence 999996432 23444444433221 11224467899999999999999999999
Q ss_pred HHHHhhc
Q 008303 200 ELLRHVH 206 (570)
Q Consensus 200 eIL~hp~ 206 (570)
|+|+|+-
T Consensus 299 ell~h~~ 305 (319)
T 4euu_A 299 QFFAETS 305 (319)
T ss_dssp HHHHHHH
T ss_pred HhhhccH
Confidence 9999963
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=319.45 Aligned_cols=206 Identities=24% Similarity=0.409 Sum_probs=171.6
Q ss_pred HHhhhcCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
++|++++||||+++++++...+ ...|+|||||+||+|.++++... .+++..++.|+.||+.||.|||++||+|||
T Consensus 64 ~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 141 (311)
T 3ork_A 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRD 141 (311)
T ss_dssp TTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCC
Confidence 4678889999999999987542 34699999999999999998754 599999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|||+|||++.++.+||+|||++..+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 142 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp CCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998765332 23346799999999999999999999999999999999999999999
Q ss_pred cCHHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+.......+......+ ....++.++.+||.+||..||.+||++.++|.|+|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 222 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp SSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 88777665555443322 23468999999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.78 Aligned_cols=205 Identities=22% Similarity=0.383 Sum_probs=173.3
Q ss_pred HHhhhcCCC------cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKIRNP------FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL~HP------nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++|++++|+ +|++++++|... ..+|+||||| +++|.+++.......+++..++.|+.||+.||+|||++||+
T Consensus 63 ~~l~~l~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 140 (339)
T 1z57_A 63 QVLEHLNTTDPNSTFRCVQMLEWFEHH-GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLT 140 (339)
T ss_dssp HHHHHHHHHCTTCTTCBCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHhhhcCCCCceeeEeeecccccC-CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 466666655 499999988655 4899999999 88999999887666799999999999999999999999999
Q ss_pred cceecCCcEEEcC-------------------CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCccccc
Q 008303 76 HRDVKCSNIFLTK-------------------DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 76 HrDLKP~NILld~-------------------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
||||||+|||++. ++.+||+|||++..... .....+||+.|+|||++.+..++.++|||
T Consensus 141 H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 218 (339)
T 1z57_A 141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVW 218 (339)
T ss_dssp CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHH
T ss_pred CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhH
Confidence 9999999999987 66899999999987543 23456899999999999999999999999
Q ss_pred chhhhHHHhhccCCCCcccCHHHHHHHHHhccCC-------------------------------------------CCC
Q 008303 137 SLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA-------------------------------------------PLP 173 (570)
Q Consensus 137 SLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~-------------------------------------------p~p 173 (570)
||||++|+|++|..||...+..+....+...... ...
T Consensus 219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (339)
T 1z57_A 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298 (339)
T ss_dssp HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence 9999999999999999988776655444332111 011
Q ss_pred CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 174 ~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..++.++.+||.+||..||.+|||++|+|+||||+..
T Consensus 299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 2335789999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=334.72 Aligned_cols=207 Identities=31% Similarity=0.519 Sum_probs=166.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|. . ..+|+|||||.+|+|.+++... ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 191 ~~~l~~l~hpniv~l~~~~~-~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk 266 (419)
T 3i6u_A 191 IEILKKLNHPCIIKIKNFFD-A-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 266 (419)
T ss_dssp HHHHHHCCCTTBCCCCEEEE-S-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCCEeeEEEEEe-c-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 36899999999999999874 3 3578999999999999988653 459999999999999999999999999999999
Q ss_pred CCcEEEcCCC---CEEEeecCCceeccCCCCCccccCCCCCCCcccccC---CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQ---DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.++ .+||+|||+++...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..
T Consensus 267 p~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp GGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999997644 599999999998876666677899999999999863 5678899999999999999999999976
Q ss_pred cCHH-HHHHHHHhccCCCC---CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 155 FDMQ-ALINKINKSIVAPL---PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 155 ~~~~-~~~~~i~~~~~~p~---p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.... .+...+........ +..++..+.+||++||..||.+|||++|+|+||||+...
T Consensus 347 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp CSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred CcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 5432 23334433333222 246899999999999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.34 Aligned_cols=205 Identities=27% Similarity=0.508 Sum_probs=174.4
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|+++ +||||++++++|... ..+|||||||.+|+|.+++.... .+++..++.|+.||+.||.|||++||+|||||
T Consensus 110 ~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk 186 (355)
T 1vzo_A 110 QVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK 186 (355)
T ss_dssp HHHHHHHTCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHccCCCceeEEEEEEeeC-ceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 578888 799999999988654 47899999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC--CCCccccCCCCCCCcccccC--CCCCCcccccchhhhHHHhhccCCCCccc-
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD--DLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKPAFKAF- 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~pf~~~- 155 (570)
|+|||++.++.+||+|||+++.+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 187 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 187 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp GGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred HHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 99999999999999999999876432 22345689999999999985 34789999999999999999999999643
Q ss_pred ---CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 156 ---DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 156 ---~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
....+...+.. ...+.+..++..+.+||.+||..||.+|| +++++++|+||+..
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 267 EKNSQAEISRRILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp SCCCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ccchHHHHHHHHhc-cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 23334444433 33456778999999999999999999999 99999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=311.34 Aligned_cols=206 Identities=22% Similarity=0.385 Sum_probs=174.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+ +...|+|||||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 57 ~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p 133 (276)
T 2yex_A 57 CINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133 (276)
T ss_dssp HHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhcCCCCceeeeeEEEc-CCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCh
Confidence 57889999999999998865 45789999999999999998653 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
+|||++.++.+||+|||++...... ......+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 134 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred HHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 9999999999999999999876432 23445689999999999987775 7799999999999999999999977553
Q ss_pred H-HHHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 158 Q-ALINKINK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 158 ~-~~~~~i~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
. .....+.. ......+..++..+.+||.+||..||.+|||++|+++|+||+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 214 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp TSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 2 22222222 22223345789999999999999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.71 Aligned_cols=202 Identities=19% Similarity=0.377 Sum_probs=179.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++|+||||++++++|.+ +..+|||||||+||+|.++++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 102 ~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 179 (325)
T 3kul_A 102 SIMGQFDHPNIIRLEGVVTR-GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAA 179 (325)
T ss_dssp HHHTTCCCTTBCCEEEEECG-GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhCCCCCCCcEEEEEEe-CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCc
Confidence 68899999999999998854 457899999999999999997643 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 180 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 180 RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp GGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999988754321 223456778999999998899999999999999999998 999999999
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.......+......+.+..++..+.+||.+||..||.+|||+.+|++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 260 NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999988888877788889999999999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=331.28 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=171.5
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEc
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLT 87 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld 87 (570)
+|+||++++++|... ..+|+|||||. ++|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+
T Consensus 157 ~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~ 234 (429)
T 3kvw_A 157 NTMNVIHMLENFTFR-NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK 234 (429)
T ss_dssp SCSCBCCEEEEEEET-TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES
T ss_pred CCcCEEEEEeecccC-CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc
Confidence 678999999998655 58999999996 5999999987666799999999999999999999999999999999999999
Q ss_pred CCCC--EEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHH
Q 008303 88 KDQD--IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKIN 165 (570)
Q Consensus 88 ~~g~--vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~ 165 (570)
.++. +||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 235 ~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 235 QQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp STTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9887 999999999875432 345789999999999999999999999999999999999999999988777666554
Q ss_pred hccCCC----------------------------------------------------------CCCCCcHHHHHHHHHh
Q 008303 166 KSIVAP----------------------------------------------------------LPTKYSGAFRGLVKSM 187 (570)
Q Consensus 166 ~~~~~p----------------------------------------------------------~p~~~s~~l~dLI~~~ 187 (570)
.....+ ++...++.+.+||++|
T Consensus 313 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~ 392 (429)
T 3kvw_A 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392 (429)
T ss_dssp HHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHH
T ss_pred HHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHH
Confidence 322111 1113478899999999
Q ss_pred hccCCCCCcCHHHHHHhhccChhh
Q 008303 188 LRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 188 L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
|..||.+|||++|+|+||||+...
T Consensus 393 L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 393 LEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp TCSSTTTSCCHHHHHTSTTTC---
T ss_pred CCCChhhCCCHHHHhCChhhccCC
Confidence 999999999999999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.52 Aligned_cols=205 Identities=25% Similarity=0.388 Sum_probs=171.4
Q ss_pred HHhhhcC-CCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIR-NPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++|+ ||||+++++++.+. +...|+|||||.+++|.++++. +++..++.|+.||+.||.|||++||+||||
T Consensus 82 ~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Di 156 (330)
T 3nsz_A 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDV 156 (330)
T ss_dssp HHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 6788996 99999999998753 4578999999999999998853 899999999999999999999999999999
Q ss_pred cCCcEEEcCCC-CEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc-cC
Q 008303 80 KCSNIFLTKDQ-DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA-FD 156 (570)
Q Consensus 80 KP~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~-~~ 156 (570)
||+|||++.++ .+||+|||++............+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+
T Consensus 157 kp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 157 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 99999999777 899999999998776666667789999999999987 6689999999999999999999988843 23
Q ss_pred HHHHHHHHHh-------------cc-----------------------CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHH
Q 008303 157 MQALINKINK-------------SI-----------------------VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE 200 (570)
Q Consensus 157 ~~~~~~~i~~-------------~~-----------------------~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~e 200 (570)
..+....+.. .. ....+..++.++.+||.+||..||.+|||++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 2222222111 00 00112237899999999999999999999999
Q ss_pred HHHhhccChhh
Q 008303 201 LLRHVHLQPYV 211 (570)
Q Consensus 201 IL~hp~fq~~~ 211 (570)
+|+||||+...
T Consensus 317 ~l~hp~f~~~~ 327 (330)
T 3nsz_A 317 AMEHPYFYTVV 327 (330)
T ss_dssp HHTSGGGTTCC
T ss_pred HhcCccHhhhc
Confidence 99999998653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.58 Aligned_cols=204 Identities=28% Similarity=0.466 Sum_probs=166.7
Q ss_pred CHHhhhcCC--CcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKIRN--PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL~H--PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|++|+| +||+++++++... .++||||| |.+|+|.+++... ..+++..++.|+.||+.||.|||++||+|||
T Consensus 58 ~~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrD 133 (343)
T 3dbq_A 58 IAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133 (343)
T ss_dssp HHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHhhhhcCCceEEEeeeEeeC-CEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 357888866 9999999988654 58999999 5578999999874 4599999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccC-----------CCCCCcccccchhhhHHH
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~-----------~~~t~ksDIWSLG~Ilye 144 (570)
|||+|||++ ++.+||+|||+++.+.... .....+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 134 ikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~e 212 (343)
T 3dbq_A 134 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212 (343)
T ss_dssp CCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHH
T ss_pred CCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHH
Confidence 999999997 6789999999998765432 2345689999999999865 678999999999999999
Q ss_pred hhccCCCCcccCH-HHHHHH-HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 145 MTSLKPAFKAFDM-QALINK-INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 145 LltG~~pf~~~~~-~~~~~~-i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
|++|+.||..... ...... +........+...+.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 213 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 213 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 9999999976432 222333 3333444567778899999999999999999999999999999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=309.20 Aligned_cols=208 Identities=28% Similarity=0.513 Sum_probs=174.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||++++++|... ..+|+|||||.+++|.+++.... ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 71 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 149 (295)
T 2clq_A 71 ALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149 (295)
T ss_dssp HHHHTCCCTTBCCEEEEEEET-TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHhCCCCCEeeEeeEEEeC-CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCC
Confidence 578899999999999998655 47899999999999999998753 2357899999999999999999999999999999
Q ss_pred CCcEEEcC-CCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCC--CCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTK-DQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~-~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~--~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++. ++.+||+|||++....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus 150 p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp GGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred hhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 99999997 8999999999998765432 234567999999999997643 7899999999999999999999997654
Q ss_pred HH-H-HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 157 MQ-A-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 157 ~~-~-~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.. . .............+..++.++.+||.+||..||++||+++++|+|+||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 230 EPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp SHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred chhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 32 2 222222334455677899999999999999999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.66 Aligned_cols=203 Identities=22% Similarity=0.401 Sum_probs=179.8
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL 66 (570)
++|+++ +||||++++++|.+. ..+|+|||||++|+|.+++.... ...+++..++.|+.||+.||
T Consensus 77 ~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 155 (327)
T 1fvr_A 77 EVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155 (327)
T ss_dssp HHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHH
T ss_pred HHHHhccCCCchhhhceeeeeC-CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 578899 999999999998654 57999999999999999997643 24699999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhh
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMT 146 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLl 146 (570)
.|||++||+||||||+|||++.++.+||+|||++.............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 156 ~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (327)
T 1fvr_A 156 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235 (327)
T ss_dssp HHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred HHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH
Confidence 99999999999999999999999999999999998654333344556788999999999888999999999999999999
Q ss_pred c-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 147 S-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 147 t-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+ |..||.+.+.......+........+..++..+.+||.+||..||.+|||++++++++
T Consensus 236 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 236 SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp TTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 8 9999999998888888877766677788999999999999999999999999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=307.34 Aligned_cols=202 Identities=19% Similarity=0.385 Sum_probs=181.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 55 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 132 (268)
T 3sxs_A 55 QTMMKLSHPKLVKFYGVCSKE-YPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132 (268)
T ss_dssp HHHHHCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSG
T ss_pred HHHHhCCCCCEeeEEEEEccC-CceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCc
Confidence 678999999999999988544 46899999999999999998753 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 133 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 133 RNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp GGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 999999999999999999987654432 223456678999999998889999999999999999998 99999999988
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.....+........+..++..+.+||.+||..||.+|||+.+++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 213 EVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 88888887777777888999999999999999999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.95 Aligned_cols=208 Identities=19% Similarity=0.381 Sum_probs=169.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcE-----EEEEEeccCCCCHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCY-----VCIIIGFCEGGDMAEAIKKANS----KLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~-----i~IV~Ey~~gGsL~d~I~~~~~----~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
++|++++||||+++++++...+.. .|+|||||.+|+|.+++..... ..+++..++.|+.||+.||.|||++
T Consensus 77 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 156 (323)
T 3qup_A 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR 156 (323)
T ss_dssp HHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC
Confidence 578999999999999998754322 3899999999999999975431 2589999999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-c
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-L 148 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G 148 (570)
||+||||||+|||++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 157 ~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 157 NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCC
Confidence 999999999999999999999999999987654332 223456788999999999999999999999999999999 9
Q ss_pred CCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-------HHHHHHhhccCh
Q 008303 149 KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-------AAELLRHVHLQP 209 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-------a~eIL~hp~fq~ 209 (570)
..||.+.+.......+........+..++.++.+||.+||..||.+||| +++++.|+|+..
T Consensus 237 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 237 QTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 9999998888888888777777778899999999999999999999999 667777777754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.40 Aligned_cols=203 Identities=21% Similarity=0.429 Sum_probs=183.3
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--------------KLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--------------~~Lse~~i~~I~~QLl~aL 66 (570)
++|+++ +|||||+++++|...+ .+|+|||||.||+|.+++..... ..+++..++.|+.||+.||
T Consensus 126 ~~l~~l~~hpnIv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 204 (382)
T 3tt0_A 126 EMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204 (382)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCchhhhheeeeccCC-ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 678888 9999999999986544 68999999999999999987542 3599999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|
T Consensus 205 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 205 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred HHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 99999999999999999999999999999999998765432 233456788999999999999999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||...+..++...+........+..++.++.+||.+||..||.+|||+.||++++
T Consensus 285 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 285 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998 9999999999999888888877778889999999999999999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=318.24 Aligned_cols=209 Identities=23% Similarity=0.390 Sum_probs=175.7
Q ss_pred HHhhhcCCCcccccceEEEeeC------cEEEEEEeccCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH--H
Q 008303 2 ELISKIRNPFIVEYKDSWVERG------CYVCIIIGFCEGGDMAEAIKK--ANSKLFSEEKLCKWLVQLLMALDYLH--A 71 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~------~~i~IV~Ey~~gGsL~d~I~~--~~~~~Lse~~i~~I~~QLl~aL~yLH--s 71 (570)
+.|++++||||++++++|...+ .++|+|||||.+ +|.+.+.. .....+++..++.|+.||+.||.||| +
T Consensus 71 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 149 (360)
T 3e3p_A 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS 149 (360)
T ss_dssp HHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT
T ss_pred HHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 4567789999999999986532 248899999986 55555443 23456899999999999999999999 9
Q ss_pred CCcccceecCCcEEEcC-CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccC
Q 008303 72 NHILHRDVKCSNIFLTK-DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~ 149 (570)
+||+||||||+|||++. ++.+||+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 150 ~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 150 VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999997 8999999999999887666666778999999999997654 899999999999999999999
Q ss_pred CCCcccCHHHHHHHHHhccCC-------------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCH
Q 008303 150 PAFKAFDMQALINKINKSIVA-------------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSA 198 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~-------------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa 198 (570)
.||.+.+.......+...... .....++.++.+||.+||..||.+|||+
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 309 (360)
T 3e3p_A 230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309 (360)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH
Confidence 999998877766665432211 1122367899999999999999999999
Q ss_pred HHHHHhhccChhh
Q 008303 199 AELLRHVHLQPYV 211 (570)
Q Consensus 199 ~eIL~hp~fq~~~ 211 (570)
.|+|+||||+...
T Consensus 310 ~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 310 YEALCHPYFDELH 322 (360)
T ss_dssp HHHTTSGGGGGGG
T ss_pred HHHhcCccccccC
Confidence 9999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.46 Aligned_cols=206 Identities=32% Similarity=0.537 Sum_probs=173.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++...+ +|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 67 ~~l~~l~h~~i~~~~~~~~~~~--~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 142 (322)
T 2ycf_A 67 EILKKLNHPCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142 (322)
T ss_dssp HHHHHCCCTTBCCEEEEEESSS--EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCCceEeeEEcCCc--eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 6789999999999999885433 78999999999999998753 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCC---EEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 82 SNIFLTKDQD---IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~---vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
+|||++.++. +||+|||++............+||+.|+|||++. ...++.++|||||||++|+|++|..||...
T Consensus 143 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp GGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred HHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999987664 9999999998876554445678999999999974 456899999999999999999999999765
Q ss_pred CHH-HHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 156 DMQ-ALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 156 ~~~-~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
... .+...+....... .+..++..+.+||.+||..||.+||+++++|+|+||+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred chHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 432 2333333332222 2346899999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.25 Aligned_cols=203 Identities=30% Similarity=0.571 Sum_probs=176.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|... ...|||||||. |+|.+++.... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 105 ~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 181 (348)
T 1u5q_A 105 VRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181 (348)
T ss_dssp HHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred HHHHHhCCCCCEeeEEEEEEEC-CeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 3678999999999999998765 47899999997 58888887543 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||++...... ...+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.
T Consensus 182 p~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 182 AGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp GGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999876432 3568999999999985 56789999999999999999999999988877
Q ss_pred HHHHHHHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVA-PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~-p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
......+...... ..+..++..+.+||.+||..||.+|||++++++|+||..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 259 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 6666665554332 335678999999999999999999999999999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=308.93 Aligned_cols=205 Identities=29% Similarity=0.507 Sum_probs=180.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+. ..+|+|||||.+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 73 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p 149 (287)
T 2wei_A 73 ELLKKLDHPNIMKLFEILEDS-SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149 (287)
T ss_dssp HHHHTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHhccCCCccEEEEEEeCC-CeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCh
Confidence 678999999999999988654 57899999999999999987754 489999999999999999999999999999999
Q ss_pred CcEEEcCC---CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 82 SNIFLTKD---QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~---g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
+|||++.+ +.+||+|||++.............|++.|+|||++.+ .++.++||||||+++|+|++|..||...+..
T Consensus 150 ~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp GGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999764 4699999999987765555556678999999999875 4899999999999999999999999998888
Q ss_pred HHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.....+....... ....++.++.+||.+||..||.+|||+.++|+|+||+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 8777776654322 225789999999999999999999999999999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.85 Aligned_cols=206 Identities=28% Similarity=0.439 Sum_probs=179.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHH------HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEA------IKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHI 74 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~------I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gI 74 (570)
++|++|+||||++++++|.+. ..+|+|||||.||+|.++ +.......+++..++.|+.||+.||.|||+ +||
T Consensus 95 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i 173 (348)
T 2pml_X 95 QIITDIKNEYCLTCEGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI 173 (348)
T ss_dssp HHHTTCCCTTBCCCSEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCE
T ss_pred HHHHhCCCCCcceEEEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCE
Confidence 678999999999999998654 579999999999999998 655445679999999999999999999999 999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCC-cccccchhhhHHHhhccCCCC
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGS-KSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~-ksDIWSLG~IlyeLltG~~pf 152 (570)
+||||||+|||++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||
T Consensus 174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999999886544 34456899999999999877 5666 999999999999999999999
Q ss_pred cccCH-HHHHHHHHhccCCCCC-------------------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 153 KAFDM-QALINKINKSIVAPLP-------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 153 ~~~~~-~~~~~~i~~~~~~p~p-------------------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
..... ......+..... ..+ ..++.++.+||.+||..||.+|||++|+++|+||+..
T Consensus 253 ~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 253 SLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCSSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CCCCcHHHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 88766 666666654432 223 5689999999999999999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=308.88 Aligned_cols=202 Identities=20% Similarity=0.363 Sum_probs=181.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 71 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 148 (283)
T 3gen_A 71 KVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148 (283)
T ss_dssp HHHHTCCCTTBCCEEEEECSS-SSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred HHHhcCCCCCEeeEEEEEecC-CCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCcc
Confidence 688999999999999988654 46899999999999999998643 3599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 149 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp GGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 99999999999999999998664332 1223456788999999998899999999999999999998 99999999998
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.....+........+..++..+.+||.+||..+|.+|||+.++++|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 229 ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 88888888877777888999999999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.12 Aligned_cols=205 Identities=24% Similarity=0.442 Sum_probs=162.1
Q ss_pred CHHhhhcCCCcccccceEEEee-----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVER-----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++||||++++++|... ...+|+||||+ +++|.++++. ..+++..++.|+.||+.||+|||++||+
T Consensus 79 ~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giv 154 (367)
T 2fst_X 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADII 154 (367)
T ss_dssp HHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3688999999999999998643 24579999999 6899999875 3599999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+|||++.++.+||+|||+++..... ....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+
T Consensus 155 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 155 HRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999875432 345689999999999987 6789999999999999999999999999
Q ss_pred cCHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+......+ ....++..+.+||++||..||.+|||++|+|+|
T Consensus 233 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 88777666654432211 112467899999999999999999999999999
Q ss_pred hccChhh
Q 008303 205 VHLQPYV 211 (570)
Q Consensus 205 p~fq~~~ 211 (570)
|||+.+.
T Consensus 313 p~~~~~~ 319 (367)
T 2fst_X 313 AYFAQYH 319 (367)
T ss_dssp GGGTTTC
T ss_pred hhhhhcc
Confidence 9998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.43 Aligned_cols=207 Identities=36% Similarity=0.654 Sum_probs=176.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|...+ .+|+|||||.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 68 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 145 (302)
T 2j7t_A 68 EILATCDHPYIVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 145 (302)
T ss_dssp HHHHHCCCTTBCCEEEEEECC--CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred HHHhcCCCCCEeeeeeeeeeCC-eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH
Confidence 5788999999999999987654 7899999999999999987643 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccc-----cCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELL-----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l-----~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
+|||++.++.+||+|||++...... .......|++.|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 146 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 146 GNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp GGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999999999999999987543211 122345799999999998 3667899999999999999999999999998
Q ss_pred CHHHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+.......+....... .+..++..+.+||.+||..||.+|||++++++|+||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 226 NPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp CHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred CHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 8877776665554332 356789999999999999999999999999999999754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.77 Aligned_cols=202 Identities=23% Similarity=0.480 Sum_probs=168.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccce
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANH--ILHRD 78 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~g--IvHrD 78 (570)
++|++++||||++++++|... ..+|+|||||.||+|.+++.+... ..+++..++.|+.||+.||+|||++| |+|||
T Consensus 86 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~D 164 (309)
T 3p86_A 86 AIMKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164 (309)
T ss_dssp HHHHHCCCTTBCCEEEEECST-TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTT
T ss_pred HHHHhCCCCCEeeEEEEEEEC-CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCC
Confidence 679999999999999988654 468999999999999999976321 23899999999999999999999999 99999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 165 ikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp CCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred CChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999998654432 23456899999999999999999999999999999999999999999888
Q ss_pred HHHHHHHH-hccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKIN-KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~-~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
......+. .......+..++.++.+||.+||..||.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77776664 334456778899999999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=304.22 Aligned_cols=202 Identities=26% Similarity=0.515 Sum_probs=176.1
Q ss_pred CHHhhhcCCCcccccceEEEe---------------eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVE---------------RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~---------------~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~a 65 (570)
+++|++++||||++++++|.. ....+|+|||||.+|+|.+++.......+++..++.|+.||+.|
T Consensus 55 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~ 134 (284)
T 2a19_B 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134 (284)
T ss_dssp HHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence 368899999999999998854 23458999999999999999987655679999999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
|.|||++||+||||||+|||++.++.+||+|||++.............|++.|+|||++.+..++.++|||||||++|+|
T Consensus 135 l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 214 (284)
T 2a19_B 135 VDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214 (284)
T ss_dssp HHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHH
T ss_pred HHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHH
Confidence 99999999999999999999999999999999999987766555667899999999999999999999999999999999
Q ss_pred hccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 146 TSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 146 ltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
++|..+|... ......+.. ...+..++..+.+||.+||..||.+|||+.|++++++.
T Consensus 215 ~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 215 LHVCDTAFET--SKFFTDLRD---GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HSCCSSHHHH--HHHHHHHHT---TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcCCcchhH--HHHHHHhhc---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999887532 223333332 23456789999999999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.99 Aligned_cols=202 Identities=17% Similarity=0.101 Sum_probs=163.9
Q ss_pred HHhhhcCCCcccccc-------eEEEeeCc----------------EEEEEEeccCCCCHHHHHHHhCC-----CCCCHH
Q 008303 2 ELISKIRNPFIVEYK-------DSWVERGC----------------YVCIIIGFCEGGDMAEAIKKANS-----KLFSEE 53 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~-------~~f~~~~~----------------~i~IV~Ey~~gGsL~d~I~~~~~-----~~Lse~ 53 (570)
++|++++|||||+++ +++...+. ..||||||| +|+|.+++..... ..+++.
T Consensus 128 ~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~ 206 (377)
T 3byv_A 128 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHH 206 (377)
T ss_dssp GGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHH
T ss_pred HhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHH
Confidence 567777999999998 65543321 278999999 6799999986532 112248
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC------
Q 008303 54 KLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI------ 127 (570)
Q Consensus 54 ~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~------ 127 (570)
.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+.
T Consensus 207 ~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~ 283 (377)
T 3byv_A 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYH 283 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhccccccccc
Confidence 8889999999999999999999999999999999999999999999987443 3445678 999999999887
Q ss_pred -----CCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHH
Q 008303 128 -----PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202 (570)
Q Consensus 128 -----~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL 202 (570)
.|+.++|||||||++|+|++|+.||...+.......+. ..+..++.++.+||.+||..||.+|||+.++|
T Consensus 284 ~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 284 RDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred ccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 89999999999999999999999997765433322222 22357899999999999999999999999999
Q ss_pred HhhccChhhh
Q 008303 203 RHVHLQPYVL 212 (570)
Q Consensus 203 ~hp~fq~~~~ 212 (570)
+|+||+....
T Consensus 359 ~hp~f~~~~~ 368 (377)
T 3byv_A 359 ETPEYEQLRT 368 (377)
T ss_dssp TSHHHHHHHH
T ss_pred hChHHHHHHH
Confidence 9999987644
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=331.05 Aligned_cols=202 Identities=20% Similarity=0.420 Sum_probs=181.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++|+|||||++++++.+....+|||||||.+|+|.+++++.....+++..+..|+.||+.||.|||++||+||||||
T Consensus 238 ~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 317 (450)
T 1k9a_A 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317 (450)
T ss_dssp HHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH
Confidence 68999999999999999877665789999999999999999987666689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..++
T Consensus 318 ~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 395 (450)
T 1k9a_A 318 RNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395 (450)
T ss_dssp GGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred hhEEECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999999998654322 23467889999999999999999999999999999998 9999998888888
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
...+..+...+.+..++..+.+||.+||..||.+|||+.+|++.+
T Consensus 396 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 396 VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 888888777778889999999999999999999999999998763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.20 Aligned_cols=201 Identities=24% Similarity=0.439 Sum_probs=168.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||+++++++. + +.+|+|||||.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 68 ~~l~~l~h~~iv~~~~~~~-~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 144 (281)
T 1mp8_A 68 LTMRQFDHPHIVKLIGVIT-E-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 144 (281)
T ss_dssp HHHHTCCCTTBCCEEEEEC-S-SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCCCCccceEEEEEc-c-CccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 5788999999999999874 3 35789999999999999998653 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 145 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 145 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp GGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred HHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 999999999999999999987654332 233456788999999998899999999999999999986 99999988877
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+....+......+.+..++..+.+||.+||..||.+|||+.+++++.
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 225 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 78888877777778889999999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.92 Aligned_cols=201 Identities=19% Similarity=0.345 Sum_probs=177.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||+++++++. + ...|+|||||.+|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 67 ~~l~~l~h~~iv~~~~~~~-~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 67 LAIGSLDHAHIVRLLGLCP-G-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp HHHHTCCCTTBCCEEEEEC-B-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred HHHhcCCCCCcCeEEEEEc-C-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 5788899999999999874 3 3578999999999999999764 24689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.+||+|||+++.+.... ......|+..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 144 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp TTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred heEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 99999999999999999998765432 2345678889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
......+........+..++.++.+||.+||..||.+||++.+++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 224 AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp THHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 888888877777777888999999999999999999999999999984
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.84 Aligned_cols=204 Identities=27% Similarity=0.455 Sum_probs=168.3
Q ss_pred CHHhhhcC--CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKIR--NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL~--HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|++|+ |||||++++++... ..+||||| |.+++|.+++.... .+++..++.|+.||+.||.|||++||+|||
T Consensus 105 i~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrD 180 (390)
T 2zmd_A 105 IAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180 (390)
T ss_dssp HHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred HHHHHHcccCCCeEEEEEEEEecC-CEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 35788885 59999999988655 47999999 56789999998753 589999999999999999999999999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccC-----------CCCCCcccccchhhhHHH
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~-----------~~~t~ksDIWSLG~Ilye 144 (570)
|||+|||++ ++.+||+|||+++.+.... .....+||+.|+|||++.+ ..|+.++|||||||++|+
T Consensus 181 lkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e 259 (390)
T 2zmd_A 181 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259 (390)
T ss_dssp CCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence 999999995 6899999999998765432 2345689999999999975 368899999999999999
Q ss_pred hhccCCCCcccC-HHHHHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 145 MTSLKPAFKAFD-MQALINKINK-SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 145 LltG~~pf~~~~-~~~~~~~i~~-~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
|++|+.||.... .......+.. ......+...+.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 260 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 260 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 999999997653 3233333333 3334556677899999999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.98 Aligned_cols=204 Identities=27% Similarity=0.443 Sum_probs=167.1
Q ss_pred HHhhhcC--------CCcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 008303 2 ELISKIR--------NPFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH 70 (570)
Q Consensus 2 ~IL~kL~--------HPnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH 70 (570)
++|++++ |+||++++++|.. .+.++|+||||| +++|.+++.+.....+++..++.|+.||+.||+|||
T Consensus 85 ~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH 163 (397)
T 1wak_A 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163 (397)
T ss_dssp HHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566664 8899999999863 345799999999 668888777665567999999999999999999999
Q ss_pred HC-CcccceecCCcEEEcCCC-------------------------------------------------CEEEeecCCc
Q 008303 71 AN-HILHRDVKCSNIFLTKDQ-------------------------------------------------DIRLGDFGLA 100 (570)
Q Consensus 71 s~-gIvHrDLKP~NILld~~g-------------------------------------------------~vKL~DFGla 100 (570)
++ ||+||||||+|||++.++ .+||+|||++
T Consensus 164 ~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a 243 (397)
T 1wak_A 164 TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243 (397)
T ss_dssp HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGC
T ss_pred HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccc
Confidence 99 999999999999999775 7999999999
Q ss_pred eeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC------HHHHHHHHHhccCC----
Q 008303 101 KILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD------MQALINKINKSIVA---- 170 (570)
Q Consensus 101 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~------~~~~~~~i~~~~~~---- 170 (570)
...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+ .......+......
T Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 321 (397)
T 1wak_A 244 CWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321 (397)
T ss_dssp EETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHH
T ss_pred cccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChH
Confidence 886543 345689999999999999999999999999999999999999997543 22222222111100
Q ss_pred -------------------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 171 -------------------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 171 -------------------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
..+..++..+.+||.+||..||.+|||++|||+||||+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred HhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 11223456889999999999999999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=309.18 Aligned_cols=202 Identities=22% Similarity=0.331 Sum_probs=167.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.. +..+|+|||||+||+|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 63 ~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp 139 (294)
T 4eqm_A 63 HNSSQLSHQNIVSMIDVDEE-DDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKP 139 (294)
T ss_dssp HHHTTCCBTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HHHhcCCCCCCceEEEeeee-CCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 57889999999999998865 457899999999999999998764 599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|||++.++.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 140 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 140 QNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp GGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred HHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999999998765432 2334679999999999999999999999999999999999999999888766
Q ss_pred HHHHHHhccCCC----CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 160 LINKINKSIVAP----LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 160 ~~~~i~~~~~~p----~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
...+........ .+..++..+.++|.+||..||.+||+..+.+.+.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 220 IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 554444333222 34678999999999999999999994444444443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.10 Aligned_cols=203 Identities=22% Similarity=0.403 Sum_probs=182.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+. ..+|+|||||.|++|.+++.......+++..++.|+.||+.||.|||++||+||||||
T Consensus 61 ~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp 139 (288)
T 3kfa_A 61 AVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139 (288)
T ss_dssp HHHHHCCCTTBCCEEEEECSS-SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSG
T ss_pred HHHHhCCCCCEeeEEEEEccC-CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCc
Confidence 678999999999999988654 4689999999999999999987667799999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 140 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 140 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp GGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999987654332 233467889999999998899999999999999999999 99999988888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.....+........+..++..+.+||.+||..||.+|||++++++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 88888877777777889999999999999999999999999998864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.62 Aligned_cols=204 Identities=27% Similarity=0.550 Sum_probs=164.7
Q ss_pred HHhhhcCCCcccccceEEEee------------CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Q 008303 2 ELISKIRNPFIVEYKDSWVER------------GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYL 69 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~------------~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yL 69 (570)
++|++++||||++++++|.+. +..+|+|||||+||+|.+++... ...+++..++.++.||+.||.||
T Consensus 54 ~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~L 132 (303)
T 1zy4_A 54 MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYI 132 (303)
T ss_dssp HHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHH
Confidence 578999999999999988652 45789999999999999999864 34588999999999999999999
Q ss_pred HHCCcccceecCCcEEEcCCCCEEEeecCCceeccCC---------------CCCccccCCCCCCCcccccCC-CCCCcc
Q 008303 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD---------------DLASSVVGTPSYMCPELLADI-PYGSKS 133 (570)
Q Consensus 70 Hs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~---------------~~~~~~~GT~~Y~APE~l~~~-~~t~ks 133 (570)
|++||+||||||+|||++.++.+||+|||++...... ......+|++.|+|||++.+. .++.++
T Consensus 133 H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 212 (303)
T 1zy4_A 133 HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212 (303)
T ss_dssp HHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHH
T ss_pred HhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchh
Confidence 9999999999999999999999999999999875421 123456799999999999865 689999
Q ss_pred cccchhhhHHHhhccCCCCc-ccCHHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 134 DIWSLGCCIYEMTSLKPAFK-AFDMQALINKINKSI---VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 134 DIWSLG~IlyeLltG~~pf~-~~~~~~~~~~i~~~~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
|||||||++|+|++ ||. ..+.......+.... ....+..++..+.+||.+||..||.+|||++++++||||+.
T Consensus 213 Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 213 DMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 99999999999997 343 333344444443322 22344567788999999999999999999999999999974
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=312.30 Aligned_cols=203 Identities=19% Similarity=0.377 Sum_probs=180.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------SKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
++|++++||||+++++++.+. ...|+|||||.||+|.+++.... ...+++..++.|+.||+.||.|||++|
T Consensus 80 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 158 (322)
T 1p4o_A 80 SVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158 (322)
T ss_dssp HHGGGCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhcCCCCEeeeEEEEccC-CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999988554 46899999999999999997632 135799999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
|+||||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 159 i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 238 (322)
T 1p4o_A 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238 (322)
T ss_dssp CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999998764432 1234467889999999999899999999999999999998 89
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.||...+.......+........+..++..+.+||.+||..||.+|||+.+++++.
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 239 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999998888888877776677888999999999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=315.34 Aligned_cols=201 Identities=20% Similarity=0.376 Sum_probs=179.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|...+ .++|+||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 69 ~~l~~l~h~~iv~~~~~~~~~~--~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp 145 (327)
T 3poz_A 69 YVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp HHHHHCCBTTBCCEEEEEESSS--EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHhCCCCCEeEEEEEEecCC--eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence 5789999999999999986543 679999999999999998753 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 146 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred heEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 999999999999999999987754332 223456889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..+...+......+.+..++.++.+||.+||..||.+||++.+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 226 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 888888877777777888999999999999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.00 Aligned_cols=208 Identities=27% Similarity=0.439 Sum_probs=152.0
Q ss_pred HhhhcCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 3 LISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
.++.++||||++++++|... +..+|||||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||
T Consensus 75 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dl 154 (336)
T 3fhr_A 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDV 154 (336)
T ss_dssp HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 35667999999999998651 346899999999999999999876667999999999999999999999999999999
Q ss_pred cCCcEEEcC---CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 80 KCSNIFLTK---DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 80 KP~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
||+|||++. ++.+||+|||++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 155 kp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999999986 455999999999876533 3345688999999999988889999999999999999999999997765
Q ss_pred HHHHHH----HHHh---ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 157 MQALIN----KINK---SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 157 ~~~~~~----~i~~---~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
...... .+.. ....+.+..++.++.+||.+||..||.+|||++|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred chhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 443321 1111 122233457899999999999999999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.08 Aligned_cols=206 Identities=25% Similarity=0.390 Sum_probs=172.2
Q ss_pred HHhhhcCCCc------ccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKIRNPF------IVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL~HPn------IV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++|++|+|++ |+.++++|... ..+||||||| +++|.+++.......+++..++.|+.||+.||.|||++||+
T Consensus 68 ~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~iv 145 (355)
T 2eu9_A 68 NVLKKIKEKDKENKFLCVLMSDWFNFH-GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLT 145 (355)
T ss_dssp HHHHHHHHHCTTSCSCBCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHhhcCCCCceeEEEeeeeeeeC-CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 4677776665 88999888654 4899999999 66888888776656799999999999999999999999999
Q ss_pred cceecCCcEEE-------------------cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCccccc
Q 008303 76 HRDVKCSNIFL-------------------TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 76 HrDLKP~NILl-------------------d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
||||||+|||+ +.++.+||+|||++...... ....+||+.|+|||++.+..++.++|||
T Consensus 146 H~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 223 (355)
T 2eu9_A 146 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVW 223 (355)
T ss_dssp CCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred cCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchH
Confidence 99999999999 56789999999999875432 3456899999999999999999999999
Q ss_pred chhhhHHHhhccCCCCcccCHHHHHHHHHhccCCC-------------------------------------------CC
Q 008303 137 SLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP-------------------------------------------LP 173 (570)
Q Consensus 137 SLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p-------------------------------------------~p 173 (570)
||||++|+|++|..||...+.......+....... ..
T Consensus 224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (355)
T 2eu9_A 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303 (355)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccccc
Confidence 99999999999999999887766555443322110 01
Q ss_pred CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 174 ~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
...+..+.+||++||..||.+|||++|+|+|+||+...
T Consensus 304 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred chhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 12245899999999999999999999999999998653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.70 Aligned_cols=202 Identities=21% Similarity=0.424 Sum_probs=173.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+.+..+|+|||||.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||
T Consensus 66 ~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 145 (278)
T 1byg_A 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145 (278)
T ss_dssp HHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCc
Confidence 67899999999999998766655789999999999999999876544589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~~ 160 (570)
+|||++.++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+....
T Consensus 146 ~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 223 (278)
T 1byg_A 146 RNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223 (278)
T ss_dssp GGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred ceEEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999999865433 234467899999999998899999999999999999998 9999998887777
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
...+........+..++..+.++|.+||..||.+||++.++++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 224 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 777777766677888999999999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.23 Aligned_cols=206 Identities=27% Similarity=0.433 Sum_probs=172.6
Q ss_pred CHHhhhcCCCcccccceEEEee----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVER----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++++||||+++++++... ...+|+|||||. |+|.+++.. ..+++..++.|+.||+.||.|||++||+|
T Consensus 60 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 135 (353)
T 2b9h_A 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135 (353)
T ss_dssp HHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 3678999999999999987543 256899999997 599999976 35899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCC-----------CccccCCCCCCCcccccC-CCCCCcccccchhhhHHH
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-----------ASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYE 144 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~-----------~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~Ilye 144 (570)
|||||+|||++.++.+||+|||++........ ....+||+.|+|||++.. ..++.++|||||||++|+
T Consensus 136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 215 (353)
T 2b9h_A 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215 (353)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHH
Confidence 99999999999999999999999987653221 223578999999998764 678999999999999999
Q ss_pred hhccCCCCcccCHHHHHHHHHhccCCC-------------------------------CCCCCcHHHHHHHHHhhccCCC
Q 008303 145 MTSLKPAFKAFDMQALINKINKSIVAP-------------------------------LPTKYSGAFRGLVKSMLRKNPE 193 (570)
Q Consensus 145 LltG~~pf~~~~~~~~~~~i~~~~~~p-------------------------------~p~~~s~~l~dLI~~~L~~dP~ 193 (570)
|++|++||.+.+.......+......+ .+..++.++.+||.+||..||.
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 295 (353)
T 2b9h_A 216 LFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295 (353)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGG
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcc
Confidence 999999999888766554443221111 1236789999999999999999
Q ss_pred CCcCHHHHHHhhccChh
Q 008303 194 LRPSAAELLRHVHLQPY 210 (570)
Q Consensus 194 ~RPTa~eIL~hp~fq~~ 210 (570)
+|||++|+|+||||+.+
T Consensus 296 ~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 296 KRITAKEALEHPYLQTY 312 (353)
T ss_dssp GSCCHHHHHTSGGGTTT
T ss_pred cCCCHHHHhcCcccccc
Confidence 99999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=302.10 Aligned_cols=202 Identities=24% Similarity=0.462 Sum_probs=180.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|.+.+ .+|+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 55 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p 132 (267)
T 3t9t_A 55 EVMMKLSHPKLVQLYGVCLEQA-PICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 132 (267)
T ss_dssp HHHHTCCCTTBCCEEEEECSSS-SCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG
T ss_pred HHHHhCCCCCEeeEEEEEccCC-CeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCch
Confidence 6789999999999999886544 6899999999999999998753 4689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 133 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (267)
T 3t9t_A 133 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212 (267)
T ss_dssp GGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred heEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence 99999999999999999998754321 2234467788999999998899999999999999999999 89999999888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.....+........+..++..+.+||.+||..||.+||++.+++++.
T Consensus 213 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 213 EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 88888887776667788999999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=307.72 Aligned_cols=203 Identities=18% Similarity=0.349 Sum_probs=178.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++...+...|+|||||.+|+|.++++.. ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 78 ~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp 156 (298)
T 3f66_A 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAA 156 (298)
T ss_dssp HHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCch
Confidence 57899999999999998766666789999999999999999764 35689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC-----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ +.+||...
T Consensus 157 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred heEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 999999999999999999987654321 233567789999999999999999999999999999999 77888887
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.......+........+..++..+.++|.+||..||.+|||+.++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 237 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp CTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 77777777777776677888999999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.57 Aligned_cols=202 Identities=20% Similarity=0.403 Sum_probs=167.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||++++++|.++ ..+|+|||||.||+|.++++... ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 58 ~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlk 135 (310)
T 3s95_A 58 VKVMRCLEHPNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135 (310)
T ss_dssp HHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhCCCcCcccEEEEEecC-CeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 3678999999999999998754 57899999999999999998743 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC---------------ccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA---------------SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~---------------~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
|+|||++.++.+||+|||++......... ...+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 136 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 215 (310)
T 3s95_A 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215 (310)
T ss_dssp TTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999999876533221 156899999999999999999999999999999999
Q ss_pred hccCCCCcccCHHHH--HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 146 TSLKPAFKAFDMQAL--INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 146 ltG~~pf~~~~~~~~--~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++|..+|........ ...+........+..++..+.+||.+||..||.+|||+.++++.
T Consensus 216 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~ 276 (310)
T 3s95_A 216 IGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276 (310)
T ss_dssp HHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999988865321100 00000001112456788999999999999999999999999984
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=307.18 Aligned_cols=202 Identities=21% Similarity=0.377 Sum_probs=180.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++ ..+ .+|+|||||.+++|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 62 ~~l~~l~h~~i~~~~~~~-~~~-~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 138 (287)
T 1u59_A 62 QIMHQLDNPYIVRLIGVC-QAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138 (287)
T ss_dssp HHHHHCCCTTBCCEEEEE-ESS-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHhCCCCCEeEEEEEe-cCC-CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCch
Confidence 678999999999999988 333 589999999999999999753 34699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...+
T Consensus 139 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 139 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp GGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred heEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999988754321 233456889999999998889999999999999999998 999999988
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
..+....+........+..++.++.+||.+||..||.+||++.+++++++
T Consensus 219 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 219 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp THHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 88888888777777778899999999999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=323.12 Aligned_cols=202 Identities=20% Similarity=0.353 Sum_probs=179.7
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||++++++... ..+|||||||+||+|.++++..+ ..+++..+..++.||+.||+|||++||+||||||
T Consensus 164 ~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 241 (377)
T 3cbl_A 164 RILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241 (377)
T ss_dssp HHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhCCCCCEEEEEEEEecC-CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCH
Confidence 688999999999999998654 46899999999999999998653 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCC---ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.+||+|||+++........ ....++..|+|||++.+..++.++|||||||++|||++ |..||...+.
T Consensus 242 ~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred HHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999875433211 12235678999999998889999999999999999998 9999999998
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
......+......+.+..++.++.+||.+||..||.+|||+++|++.+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 322 QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 888888888777788889999999999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.31 Aligned_cols=206 Identities=29% Similarity=0.424 Sum_probs=172.1
Q ss_pred CHHhhhcCCCcccccceEEEe-------------eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVE-------------RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-------------~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~ 67 (570)
+++|++++||||+++++++.. ....+|+|||||. |+|.+++++ ..+++..++.|+.||+.||+
T Consensus 59 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~ 134 (320)
T 2i6l_A 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLK 134 (320)
T ss_dssp HHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHH
Confidence 367899999999999998732 2357899999998 599999864 45899999999999999999
Q ss_pred HHHHCCcccceecCCcEEEc-CCCCEEEeecCCceeccCC----CCCccccCCCCCCCcccccC-CCCCCcccccchhhh
Q 008303 68 YLHANHILHRDVKCSNIFLT-KDQDIRLGDFGLAKILTSD----DLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCC 141 (570)
Q Consensus 68 yLHs~gIvHrDLKP~NILld-~~g~vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~I 141 (570)
|||++||+||||||+|||++ .++.+||+|||++...... .......++..|+|||++.+ ..++.++|||||||+
T Consensus 135 ~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 214 (320)
T 2i6l_A 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 214 (320)
T ss_dssp HHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHH
T ss_pred HHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHH
Confidence 99999999999999999997 5678999999999876432 22344578999999999865 678999999999999
Q ss_pred HHHhhccCCCCcccCHHHHHHHHHhccCCC-----------------------------CCCCCcHHHHHHHHHhhccCC
Q 008303 142 IYEMTSLKPAFKAFDMQALINKINKSIVAP-----------------------------LPTKYSGAFRGLVKSMLRKNP 192 (570)
Q Consensus 142 lyeLltG~~pf~~~~~~~~~~~i~~~~~~p-----------------------------~p~~~s~~l~dLI~~~L~~dP 192 (570)
+|+|++|+.||.+.+.......+....... ....++.++.+||++||..||
T Consensus 215 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (320)
T 2i6l_A 215 FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294 (320)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCc
Confidence 999999999999888766665554332110 124589999999999999999
Q ss_pred CCCcCHHHHHHhhccChh
Q 008303 193 ELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 193 ~~RPTa~eIL~hp~fq~~ 210 (570)
.+|||++|+|+||||+.+
T Consensus 295 ~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 295 MDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp GGSCCHHHHHTSHHHHTT
T ss_pred cccCCHHHHhCCcccccc
Confidence 999999999999999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.76 Aligned_cols=201 Identities=23% Similarity=0.414 Sum_probs=175.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.++ ..|+|||||.+++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 65 ~~l~~l~h~~i~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 141 (281)
T 3cc6_A 65 VIMKNLDHPHIVKLIGIIEEE--PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAV 141 (281)
T ss_dssp HHHHHHCCTTBCCEEEEECSS--SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred HHHHhCCCCCcceEEEEEcCC--CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCcc
Confidence 578899999999999987533 3589999999999999998753 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||......
T Consensus 142 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 142 RNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp GGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred ceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 999999999999999999987654332 234467889999999998899999999999999999998 99999877777
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.....+......+.+..++..+.+||.+||..||.+||++.++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 222 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp GHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 77777777766777888999999999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.93 Aligned_cols=203 Identities=28% Similarity=0.476 Sum_probs=169.5
Q ss_pred HHhhhcCCCcccccceEEEeeCc-----EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGC-----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~-----~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|++++||||++++++|...+. .+|+|||||. ++|.+++. ..+++..++.|+.||+.||+|||++||+|
T Consensus 93 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 167 (371)
T 4exu_A 93 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVH 167 (371)
T ss_dssp HHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence 57899999999999999865442 2389999997 58888773 34899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||||+|||++.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 168 RDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp SCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999876433 345688999999999987 67899999999999999999999999988
Q ss_pred CHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+..+....+......+ .+..++..+.+||.+||..||.+|||++|+|+||
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 8776665554322111 1235789999999999999999999999999999
Q ss_pred ccChhh
Q 008303 206 HLQPYV 211 (570)
Q Consensus 206 ~fq~~~ 211 (570)
||+.+.
T Consensus 326 ~f~~~~ 331 (371)
T 4exu_A 326 FFEPFR 331 (371)
T ss_dssp GGTTTC
T ss_pred ccccCC
Confidence 998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=314.25 Aligned_cols=204 Identities=22% Similarity=0.368 Sum_probs=175.5
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC---------------------CCCCHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS---------------------KLFSEEKLCKWL 59 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~---------------------~~Lse~~i~~I~ 59 (570)
++|++| +||||++++++|...+ .+|+|||||+||+|.+++..... ..+++..++.|+
T Consensus 100 ~~l~~l~~hp~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 178 (344)
T 1rjb_A 100 KMMTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178 (344)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred HHHHhhcCCCCeeeEEEEEeeCC-ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHH
Confidence 578899 9999999999886544 68999999999999999986532 238999999999
Q ss_pred HHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCccccc
Q 008303 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 60 ~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .....||+.|+|||++.+..++.++|||
T Consensus 179 ~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 179 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 9999999999999999999999999999999999999999987654322 2345678899999999998999999999
Q ss_pred chhhhHHHhhc-cCCCCcccCHHH-HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 137 SLGCCIYEMTS-LKPAFKAFDMQA-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 137 SLG~IlyeLlt-G~~pf~~~~~~~-~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
||||++|+|++ |..||.+..... ....+........+..++.++.+||.+||..||.+|||+.+|++++.
T Consensus 259 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 99999999997 999998765433 34444555555667789999999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.94 Aligned_cols=203 Identities=20% Similarity=0.415 Sum_probs=181.1
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--------------KLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--------------~~Lse~~i~~I~~QLl~aL 66 (570)
++|+++ +||||++++++|... ..+|+|||||.+|+|.+++..... ..+++..++.|+.||+.||
T Consensus 92 ~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 170 (334)
T 2pvf_A 92 EMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170 (334)
T ss_dssp HHHHHHCCCTTBCCEEEEECSS-SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCEeeEEEEEccC-CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 578888 999999999988654 478999999999999999986432 3489999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|
T Consensus 171 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp HHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 999999999999999999999999999999999987754332 23346788899999999888999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||.+.+..++...+........+..++.++.+||.+||..||.+|||+.++++++
T Consensus 251 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 251 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9998 9999999998888888877777777888999999999999999999999999999984
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.49 Aligned_cols=203 Identities=21% Similarity=0.393 Sum_probs=175.1
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCC----------------CCCHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSK----------------LFSEEKLCKWLVQLLM 64 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~----------------~Lse~~i~~I~~QLl~ 64 (570)
++|++| +||||++++++|...+ ..|+|||||.+|+|.+++...... .+++..++.++.||+.
T Consensus 78 ~~l~~l~~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 156 (313)
T 1t46_A 78 KVLSYLGNHMNIVNLLGACTIGG-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (313)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred HHHhhcccCCCeeeEEEEEecCC-CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 578899 9999999999886544 689999999999999999875432 4899999999999999
Q ss_pred HHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhh
Q 008303 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 141 (570)
Q Consensus 65 aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~I 141 (570)
||.|||++||+||||||+|||++.++.+||+|||++........ .....|++.|+|||++.+..++.++|||||||+
T Consensus 157 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 157 GMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 99999999999999999999999999999999999987754432 234567889999999999899999999999999
Q ss_pred HHHhhc-cCCCCcccCHHH-HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 142 IYEMTS-LKPAFKAFDMQA-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 142 lyeLlt-G~~pf~~~~~~~-~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|+|++ |..||....... ....+........+..++..+.+||.+||..||.+|||+.+++++.
T Consensus 237 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999998 999998765433 3344444445556778999999999999999999999999999973
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.98 Aligned_cols=202 Identities=21% Similarity=0.385 Sum_probs=169.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++|+||||++++++|.+. ..+|||||||.||+|.+++++.. ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 98 ~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 175 (373)
T 2qol_A 98 SIMGQFDHPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175 (373)
T ss_dssp HHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHhCCCCCCCeEEEEEeeC-CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCc
Confidence 678999999999999988654 46899999999999999998643 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+
T Consensus 176 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp GGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987654321 112345778999999999999999999999999999987 999999999
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..++...+......+.+..++..+.+||.+||..||.+||++.+|++.+
T Consensus 256 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp HHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 8888888887777777888999999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=310.26 Aligned_cols=204 Identities=21% Similarity=0.422 Sum_probs=177.0
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--------------KLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--------------~~Lse~~i~~I~~QLl~aL 66 (570)
++|+++ +||||++++++|...+..+|+|||||.||+|.+++..... ..+++..++.|+.||+.||
T Consensus 82 ~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 161 (316)
T 2xir_A 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 161 (316)
T ss_dssp HHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHH
Confidence 578888 7999999999987766678999999999999999986432 2289999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
.|||++||+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|
T Consensus 162 ~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 241 (316)
T 2xir_A 162 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241 (316)
T ss_dssp HHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHH
Confidence 999999999999999999999999999999999987654321 23456789999999999999999999999999999
Q ss_pred Hhhc-cCCCCcccCH-HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDM-QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~-~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++ |..||..... ......+........+..++..+.++|.+||..||.+|||+.++++|+
T Consensus 242 ~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 242 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998 9999977653 344555555555667778999999999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.63 Aligned_cols=204 Identities=22% Similarity=0.382 Sum_probs=173.0
Q ss_pred HHhhhcCCCcccccceEEEeeCc----EEEEEEeccCCCCHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGC----YVCIIIGFCEGGDMAEAIKKA----NSKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~----~i~IV~Ey~~gGsL~d~I~~~----~~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
++|++++||||+++++++.+.+. ..|+|||||.+|+|.+++... ....+++..++.|+.||+.||.|||++|
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 167 (313)
T 3brb_A 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167 (313)
T ss_dssp HHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 57899999999999999875432 358999999999999999642 3356999999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
|+||||||+|||++.++.+||+|||++..+.... ......+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 168 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 247 (313)
T 3brb_A 168 FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247 (313)
T ss_dssp CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999998765432 1233467889999999999999999999999999999999 89
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.||...........+........+..++..+.+||.+||..||.+|||+.+++++.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 248 TPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99998888777777777777777888999999999999999999999999999984
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.49 Aligned_cols=199 Identities=21% Similarity=0.381 Sum_probs=177.3
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++ .. ..+|+|||||.+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 70 ~~l~~l~h~~i~~~~~~~-~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp 145 (291)
T 1xbb_A 70 NVMQQLDNPYIVRMIGIC-EA-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 145 (291)
T ss_dssp HHHHTCCCTTBCCEEEEE-ES-SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhCCCCCEEEEEEEE-CC-CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCc
Confidence 578999999999999988 33 3578999999999999999874 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 146 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 146 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999987754332 223456788999999998889999999999999999998 999999999
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.......+........+..++..+.++|.+||..||.+||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 226 GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 888888888777777788999999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.44 Aligned_cols=206 Identities=22% Similarity=0.347 Sum_probs=180.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-----KLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-----~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|++++||||+++++++.+.+ ..|||||||.||+|.+++..... ..+++..++.|+.||+.||.|||++||+|
T Consensus 85 ~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 163 (327)
T 2yfx_A 85 LIISKFNHQNIVRCIGVSLQSL-PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIH 163 (327)
T ss_dssp HHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHhhCCCCCCCeEEEEEcCCC-CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 5788999999999999886544 67999999999999999987542 35899999999999999999999999999
Q ss_pred ceecCCcEEEcCC---CCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cC
Q 008303 77 RDVKCSNIFLTKD---QDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LK 149 (570)
Q Consensus 77 rDLKP~NILld~~---g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~ 149 (570)
|||||+|||++.+ +.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 164 ~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 243 (327)
T 2yfx_A 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 243 (327)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9999999999954 469999999997654322 2334578999999999998899999999999999999998 99
Q ss_pred CCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 150 PAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 150 ~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.||...+.......+........+..++..+.+||.+||..||.+||++.+|++++|+-
T Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 244 MPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999888888888877776677888999999999999999999999999999998753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.64 Aligned_cols=203 Identities=19% Similarity=0.366 Sum_probs=179.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|...+...|+||||+.+|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 74 ~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp 152 (298)
T 3pls_A 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAA 152 (298)
T ss_dssp HHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence 57899999999999999976665668999999999999999763 35689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
+|||++.++.+||+|||++..+.... ......+++.|+|||.+.+..++.++|||||||++|+|++ +.++|...
T Consensus 153 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp GGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 99999999999999999998654322 2334567889999999999999999999999999999999 66777777
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.......+......+.+..++..+.+||.+||..||.+|||+.++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 233 DPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 77777777877777777888999999999999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=307.98 Aligned_cols=203 Identities=23% Similarity=0.426 Sum_probs=169.3
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||++++++|... ...+|+|||||.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 63 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik 141 (295)
T 3ugc_A 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141 (295)
T ss_dssp HHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 688999999999999988543 345889999999999999998753 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 142 TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp GGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred HhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 999999999999999999998765432 2233456778999999999999999999999999999999998876432
Q ss_pred HH----------------HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQ----------------ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~----------------~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.. .....+......+.+..++.++.+||.+||..||.+|||+.|+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 222 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 21 23344445556667888999999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.17 Aligned_cols=201 Identities=18% Similarity=0.375 Sum_probs=179.0
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+ + ..|+|||||.|++|.+++....+..+++..++.|+.||+.||.|||++||+||||||
T Consensus 60 ~~l~~l~h~~i~~~~~~~~~-~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 137 (279)
T 1qpc_A 60 NLMKQLQHQRLVRLYAVVTQ-E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137 (279)
T ss_dssp HHHHHCCCTTBCCEEEEECS-S-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhCCCcCcceEEEEEcC-C-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 68899999999999998753 3 478999999999999999754434589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 138 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 217 (279)
T 1qpc_A 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (279)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence 999999999999999999988754432 233457889999999998889999999999999999998 99999998888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+....+........+..++.++.+||.+||..||.+|||++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263 (279)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 8888887776667778899999999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=299.05 Aligned_cols=201 Identities=13% Similarity=0.291 Sum_probs=174.8
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccc
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--ILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--IvHr 77 (570)
+++|++++||||++++++|.+. +..+|+|||||+||+|.+++.......+++..++.|+.||+.||.|||++| |+||
T Consensus 58 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~ 137 (271)
T 3kmu_A 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH 137 (271)
T ss_dssp GGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTC
T ss_pred HHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecC
Confidence 3578899999999999988654 256899999999999999998766557999999999999999999999999 9999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCC---cccccchhhhHHHhhccCCCCcc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGS---KSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~---ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||+|||++.++.++|+|||++.... .....||+.|+|||++.+..++. ++|||||||++|+|++|+.||..
T Consensus 138 dikp~Nil~~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 138 ALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp CCSGGGEEECTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred CCccceEEEcCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999999875533 23457899999999998766544 79999999999999999999998
Q ss_pred cCHHHHHHHHH-hccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 155 FDMQALINKIN-KSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 155 ~~~~~~~~~i~-~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+.......+. .......+..++.++.++|.+||..||.+|||++++++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 214 LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp SCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 88777655554 3445567788999999999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=305.42 Aligned_cols=205 Identities=29% Similarity=0.493 Sum_probs=162.6
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccceecC
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDVKC 81 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDLKP 81 (570)
+++.++||||++++++|... ..+|+||||| ++.+..++... ...+++..++.|+.||+.||.|||++ ||+||||||
T Consensus 77 ~~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp 153 (318)
T 2dyl_A 77 VLKSHDCPYIVQCFGTFITN-TDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153 (318)
T ss_dssp HHHTTTCTTBCCEEEEEECS-SEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCG
T ss_pred HHHhcCCCceeeEEEEEecC-CcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCH
Confidence 56777999999999998655 4799999999 55666666543 35699999999999999999999995 999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccCCCCccc-
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKAF- 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~~pf~~~- 155 (570)
+|||++.++.+||+|||++.............|++.|+|||++. ...++.++|||||||++|+|++|+.||...
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 154 SNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp GGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred HHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998776555555678999999999994 456889999999999999999999999863
Q ss_pred CHHHHHHHHHhccCCCCC--CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 156 DMQALINKINKSIVAPLP--TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p--~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
........+........+ ..++.++.+||.+||..||.+||++++|++|+||+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 234 TDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp SHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 445555555554433333 4689999999999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.66 Aligned_cols=202 Identities=17% Similarity=0.360 Sum_probs=180.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++|+|||||++++++. ...+|||||||.+|+|.++++......+++..++.|+.||+.||+|||++||+||||||
T Consensus 235 ~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 312 (454)
T 1qcf_A 235 NVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312 (454)
T ss_dssp HHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred HHHhhCCCCCEeeEEEEEe--CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence 6899999999999999874 33579999999999999999865444689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||+++...... ......++..|+|||++....++.++|||||||++|||++ |+.||.+.+..
T Consensus 313 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp GGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred HHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998764322 1223456788999999998899999999999999999998 99999999998
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
++...+......+.+..++.++.+||.+||..||.+|||+++|++.+
T Consensus 393 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 393 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 88888888877778889999999999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.25 Aligned_cols=202 Identities=20% Similarity=0.364 Sum_probs=174.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.. ...+|||||||.||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 98 ~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 98 GIMGQFSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp HHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHhCCCCCCCcEEEEEec-CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 57899999999999998855 44689999999999999999864 34699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 176 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp GGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred heEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999987654321 122346788999999999999999999999999999998 999999988
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..++...+......+.+..++..+.+||.+||..||.+||++.++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 8888888887777777888999999999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.49 Aligned_cols=205 Identities=14% Similarity=0.139 Sum_probs=155.1
Q ss_pred HhhhcCCCcccccc-------eEEEeeC----------------cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHH----
Q 008303 3 LISKIRNPFIVEYK-------DSWVERG----------------CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKL---- 55 (570)
Q Consensus 3 IL~kL~HPnIV~l~-------~~f~~~~----------------~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i---- 55 (570)
+|++ +||||++++ +++...+ ..+|||||||. |+|.++++..+. .+.+..+
T Consensus 118 ~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~ 194 (371)
T 3q60_A 118 RLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGIL 194 (371)
T ss_dssp HHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHH
T ss_pred Hhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhh
Confidence 4455 799988755 4443322 35899999999 799999987532 3455555
Q ss_pred --HHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC--CCCCC
Q 008303 56 --CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD--IPYGS 131 (570)
Q Consensus 56 --~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ 131 (570)
..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++...... ....+|+.|+|||++.+ ..|+.
T Consensus 195 vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~ 272 (371)
T 3q60_A 195 ALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTH 272 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCH
T ss_pred hHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCc
Confidence 6777999999999999999999999999999999999999999998765322 24567799999999987 67999
Q ss_pred cccccchhhhHHHhhccCCCCcccCHHHHH--HH------HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 132 KSDIWSLGCCIYEMTSLKPAFKAFDMQALI--NK------INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 132 ksDIWSLG~IlyeLltG~~pf~~~~~~~~~--~~------i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
++|||||||++|+|++|+.||......... .. .......+.+..++..+.+||.+||..||++|||+.++|+
T Consensus 273 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999999876422100 00 0001112233578999999999999999999999999999
Q ss_pred hhccChhhh
Q 008303 204 HVHLQPYVL 212 (570)
Q Consensus 204 hp~fq~~~~ 212 (570)
||||+....
T Consensus 353 hp~f~~~~~ 361 (371)
T 3q60_A 353 TPEFLQLQN 361 (371)
T ss_dssp SHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=321.63 Aligned_cols=203 Identities=17% Similarity=0.348 Sum_probs=169.2
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+.+...|+|||||.+|+|.++++.. ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 142 ~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 220 (373)
T 3c1x_A 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 220 (373)
T ss_dssp TTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccch
Confidence 47888999999999998766556789999999999999999764 34689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC-----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
+|||++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 221 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp GGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred heEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 999999999999999999987643321 223457788999999999999999999999999999998 78888877
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+..+....+........+..++..+.++|.+||..||.+|||+.+++++.
T Consensus 301 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 301 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp CSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 66666666766666667788999999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.04 Aligned_cols=200 Identities=25% Similarity=0.408 Sum_probs=163.9
Q ss_pred CCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccceecCCcE
Q 008303 9 NPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRDVKCSNI 84 (570)
Q Consensus 9 HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrDLKP~NI 84 (570)
|+||++++++|...+ .++|+||||+ +++|.+++.......+++..++.|+.||+.||.|||++ ||+||||||+||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence 899999999987542 3789999999 88999999986666799999999999999999999998 999999999999
Q ss_pred EEcC------CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH-
Q 008303 85 FLTK------DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM- 157 (570)
Q Consensus 85 Lld~------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~- 157 (570)
|++. .+.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred EEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 9954 347999999999876543 3456899999999999999999999999999999999999999986542
Q ss_pred -----HHHHHHHHhcc-----------------------------------------CCCCCCCCcHHHHHHHHHhhccC
Q 008303 158 -----QALINKINKSI-----------------------------------------VAPLPTKYSGAFRGLVKSMLRKN 191 (570)
Q Consensus 158 -----~~~~~~i~~~~-----------------------------------------~~p~p~~~s~~l~dLI~~~L~~d 191 (570)
......+.... ....+..++.++.+||.+||..|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence 22222221111 01123345788999999999999
Q ss_pred CCCCcCHHHHHHhhccChhh
Q 008303 192 PELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 192 P~~RPTa~eIL~hp~fq~~~ 211 (570)
|.+|||++|+|+||||+...
T Consensus 322 P~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 322 PRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred ccccCCHHHHhhChhhhccc
Confidence 99999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.99 Aligned_cols=199 Identities=26% Similarity=0.569 Sum_probs=166.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccce
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH---ILHRD 78 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g---IvHrD 78 (570)
++|++++||||++++++|... ..+|+|||||.|++|.+++.. ..+++..++.|+.||+.||.|||++| |+|||
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~d 133 (271)
T 3dtc_A 58 KLFAMLKHPNIIALRGVCLKE-PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133 (271)
T ss_dssp HHHHHCCCTTBCCEEEEECCC---CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSC
T ss_pred HHHHhcCCCCEeeEEEEEecC-CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Confidence 578899999999999988654 478999999999999999853 46999999999999999999999999 89999
Q ss_pred ecCCcEEEcC--------CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCC
Q 008303 79 VKCSNIFLTK--------DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 79 LKP~NILld~--------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
|||+|||++. ++.+||+|||++....... .....|++.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 134 ikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (271)
T 3dtc_A 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212 (271)
T ss_dssp CSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCC
T ss_pred CchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999986 6789999999998765433 235679999999999999899999999999999999999999
Q ss_pred CCcccCHHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 151 AFKAFDMQALINKINKS-IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 151 pf~~~~~~~~~~~i~~~-~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||...+.......+... ...+.+..++..+.+||.+||..||.+|||+.|+++++
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 213 PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp TTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 99988877666555443 34456778999999999999999999999999999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.82 Aligned_cols=200 Identities=17% Similarity=0.259 Sum_probs=165.5
Q ss_pred HhhhcCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 3 LISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++++++|+||+++++++... ..++||||||| |++|.+++... ...+++..++.|+.||+.||.|||++||+||||
T Consensus 101 ~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDl 178 (364)
T 3op5_A 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDI 178 (364)
T ss_dssp HHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecC
Confidence 46678999999999998764 25689999999 99999999874 356999999999999999999999999999999
Q ss_pred cCCcEEEc--CCCCEEEeecCCceeccCCCC--------CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccC
Q 008303 80 KCSNIFLT--KDQDIRLGDFGLAKILTSDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLK 149 (570)
Q Consensus 80 KP~NILld--~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~ 149 (570)
||+|||++ .++.+||+|||+++.+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 889999999999987653321 23456999999999999999999999999999999999999
Q ss_pred CCCcccCH-HHHHHHHHhccCCC---------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 150 PAFKAFDM-QALINKINKSIVAP---------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 150 ~pf~~~~~-~~~~~~i~~~~~~p---------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.||.+... .............. ....++.++.+||..||..+|.+||++.+|++.
T Consensus 259 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 259 LPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 99986322 11111111000000 125679999999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.49 Aligned_cols=203 Identities=22% Similarity=0.399 Sum_probs=182.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++|+|||||+++++|... ..+|||||||.+|+|.++++......+++..++.|+.||+.||+|||++||+||||||
T Consensus 268 ~~l~~l~hpniv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 346 (495)
T 1opk_A 268 AVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346 (495)
T ss_dssp HHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHhcCCCCEeeEEEEEecC-CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 689999999999999988654 4689999999999999999986666799999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 347 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 347 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp GGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999987654322 223456778999999998899999999999999999998 99999998888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+...+......+.+..++..+.+||.+||..||.+|||+.+|++.+
T Consensus 427 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 427 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 88888887777778889999999999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.39 Aligned_cols=205 Identities=27% Similarity=0.436 Sum_probs=170.5
Q ss_pred HHhhhc-CCC-----cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCC
Q 008303 2 ELISKI-RNP-----FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH--ANH 73 (570)
Q Consensus 2 ~IL~kL-~HP-----nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH--s~g 73 (570)
++|+.+ +|+ +|+.++++|... ..+|||||||.| +|.+++.......+++..++.|+.||+.||.||| +.|
T Consensus 102 ~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ 179 (382)
T 2vx3_A 102 RLLELMNKHDTEMKYYIVHLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS 179 (382)
T ss_dssp HHHHHHHHCSSGGGGGBCCEEEEEEET-TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred HHHHHHHhcccccceeEEEeeeeeccC-CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC
Confidence 355555 344 599999988665 489999999965 9999998876567999999999999999999999 579
Q ss_pred cccceecCCcEEEc--CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCC
Q 008303 74 ILHRDVKCSNIFLT--KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 74 IvHrDLKP~NILld--~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|+||||||+|||++ .++.+||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|++|
T Consensus 180 ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999995 4778999999999887533 3457899999999999999999999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCCC-----------------CC---------------------C------------------
Q 008303 152 FKAFDMQALINKINKSIVAPL-----------------PT---------------------K------------------ 175 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~-----------------p~---------------------~------------------ 175 (570)
|.+.+..+....+......+. +. .
T Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 337 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337 (382)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccc
Confidence 999888777666654322110 00 0
Q ss_pred -------CcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 176 -------YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 176 -------~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
...++++||.+||..||.+|||++|+|+||||+..
T Consensus 338 ~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 01378999999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=310.05 Aligned_cols=201 Identities=20% Similarity=0.383 Sum_probs=173.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|...+ .++|+||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 69 ~~l~~l~hp~iv~~~~~~~~~~--~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 145 (327)
T 3lzb_A 69 YVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp HHHTTCCBTTBCCCCEEEESSS--EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHhCCCCCeeEEEEEEecCC--ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCH
Confidence 5789999999999999986543 689999999999999998753 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
+|||++.++.+||+|||++........ .....+|+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.+.
T Consensus 146 ~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred HHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 999999999999999999987654322 223456788999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
..+...+......+.+..++.++.+||++||..||.+||++.|+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 226 SEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 888888888777778888999999999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.35 Aligned_cols=203 Identities=28% Similarity=0.470 Sum_probs=169.2
Q ss_pred HHhhhcCCCcccccceEEEeeCc-----EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGC-----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~-----~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|++++||||++++++|...+. .+|+|||||. |+|.+++. ..+++..++.|+.||+.||.|||++||+|
T Consensus 75 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH 149 (353)
T 3coi_A 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVH 149 (353)
T ss_dssp HHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 57899999999999999865432 3589999997 58887763 34899999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||||+|||++.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 150 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 150 RDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp SSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred CCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999875432 345688999999999977 67899999999999999999999999988
Q ss_pred CHHHHHHHHHhcc------------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSI------------------------------VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~------------------------------~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+..+....+.... .......++.++.+||.+||..||.+|||++++|+||
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 8766655543321 1122346799999999999999999999999999999
Q ss_pred ccChhh
Q 008303 206 HLQPYV 211 (570)
Q Consensus 206 ~fq~~~ 211 (570)
||+.+.
T Consensus 308 ~f~~~~ 313 (353)
T 3coi_A 308 FFEPFR 313 (353)
T ss_dssp GGTTTC
T ss_pred chhhcc
Confidence 998653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=303.24 Aligned_cols=202 Identities=23% Similarity=0.438 Sum_probs=174.2
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||++++++|... +..+|+|||||.+|+|.+++.... ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 75 ~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik 153 (302)
T 4e5w_A 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153 (302)
T ss_dssp HHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCc
Confidence 678999999999999998765 246899999999999999997653 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc--
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA-- 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~-- 154 (570)
|+|||++.++.+||+|||++....... ......||..|+|||++.+..++.++|||||||++|+|++|..|+..
T Consensus 154 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 999999999999999999998876443 23446788889999999998899999999999999999999887532
Q ss_pred -------------cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 -------------FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 -------------~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.........+......+.+..++..+.+||.+||..||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 12334455555566667788999999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.73 Aligned_cols=200 Identities=17% Similarity=0.259 Sum_probs=166.9
Q ss_pred HHhhhcCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
.++++++||||+++++++... +.++|+||||| |++|.+++.... .+++..++.|+.||+.||+|||++||+|||
T Consensus 100 ~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 176 (345)
T 2v62_A 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176 (345)
T ss_dssp HHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 356778999999999998763 56899999999 999999997654 599999999999999999999999999999
Q ss_pred ecCCcEEEcCCC--CEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhcc
Q 008303 79 VKCSNIFLTKDQ--DIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL 148 (570)
Q Consensus 79 LKP~NILld~~g--~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG 148 (570)
|||+|||++.++ .+||+|||+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999887 99999999998764322 12446899999999999999999999999999999999999
Q ss_pred CCCCccc--CHHHHHHHHHhccCCCCC---------CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 149 KPAFKAF--DMQALINKINKSIVAPLP---------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 149 ~~pf~~~--~~~~~~~~i~~~~~~p~p---------~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.||... +...... .........+ ..++.++.+||.+||..||++||++++|++.+
T Consensus 257 ~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 257 KLPWEQNLKDPVAVQT-AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp SCTTGGGTTCHHHHHH-HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CCCccccccccHHHHH-HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 9999652 2222211 1111111111 27899999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.04 Aligned_cols=204 Identities=21% Similarity=0.417 Sum_probs=176.6
Q ss_pred CHHhhhcCCCcccccceEEEe-eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVE-RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++||||+++++++.. ++..+|+|||||+|++|.+++.... ..+++..++.|+.||+.||.|||++||+||||
T Consensus 75 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Di 153 (327)
T 3lxl_A 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDL 153 (327)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 368899999999999998864 4567899999999999999998753 35899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.++.+||+|||++....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 154 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 154 AARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp SGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999998875433 233456888899999999888999999999999999999999998654
Q ss_pred CH---------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DM---------------QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~---------------~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.. ......+......+.+..++..+.+||.+||..||.+|||+.++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 234 SAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp HHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 33 233445555566667788999999999999999999999999998874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.44 Aligned_cols=199 Identities=19% Similarity=0.277 Sum_probs=168.7
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++| +||||+++++++.. +...|+||||| +++|.+++... ...+++..++.|+.||+.||+|||++||+|||||
T Consensus 56 ~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk 132 (330)
T 2izr_A 56 RFYKQLGSGDGIPQVYYFGPC-GKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVK 132 (330)
T ss_dssp HHHHHHCSCTTSCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhhCCCCCCEEEEEEec-CCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 678999 99999999998865 45889999999 99999999875 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCC-----EEEeecCCceeccCCCC--------CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc
Q 008303 81 CSNIFLTKDQD-----IRLGDFGLAKILTSDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 81 P~NILld~~g~-----vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt 147 (570)
|+|||++.++. +||+|||+++.+..... ....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 133 p~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 212 (330)
T 2izr_A 133 PENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR 212 (330)
T ss_dssp GGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc
Confidence 99999998887 99999999987654322 246789999999999999999999999999999999999
Q ss_pred cCCCCccc---CHHHHHHHHHhccCC-C---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 148 LKPAFKAF---DMQALINKINKSIVA-P---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 148 G~~pf~~~---~~~~~~~~i~~~~~~-p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|..||.+. +..+.+..+...... + ....++ ++.+||.+||..||.+||++++|++.
T Consensus 213 g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~ 275 (330)
T 2izr_A 213 GSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKL 275 (330)
T ss_dssp SSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHH
Confidence 99999874 333444444222111 1 123455 99999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.81 Aligned_cols=201 Identities=20% Similarity=0.391 Sum_probs=175.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++|+||||+++++++.+ ..+|||||||.+|+|.++++...+..+++..+..|+.||+.||+|||++||+||||||
T Consensus 231 ~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 308 (452)
T 1fmk_A 231 QVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308 (452)
T ss_dssp HHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCCCCCEeeEEEEEcC--CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 68999999999999998754 3578999999999999999765445699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||+++....... .....++..|+|||++....++.++|||||||++|+|++ |+.||.+....
T Consensus 309 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp GGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999987654322 223456788999999998899999999999999999999 99999999988
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++...+..+...+.+..++..+.+||.+||..||++|||+++|++.
T Consensus 389 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 389 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888888887777888999999999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.60 Aligned_cols=197 Identities=21% Similarity=0.343 Sum_probs=168.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|... ...|+|||||.||+|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 64 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 141 (289)
T 4fvq_A 64 SMMSKLSHKHLVLNYGVCVCG-DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCA 141 (289)
T ss_dssp HHHHTSCCTTBCCEEEEECCT-TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HHHHhCCCCCEeEEEEEEEeC-CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCc
Confidence 578999999999999998654 46789999999999999998753 3489999999999999999999999999999999
Q ss_pred CcEEEcCCCC--------EEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhc-cCCC
Q 008303 82 SNIFLTKDQD--------IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTS-LKPA 151 (570)
Q Consensus 82 ~NILld~~g~--------vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLlt-G~~p 151 (570)
+|||++.++. +||+|||++...... ....|++.|+|||++.+ ..++.++|||||||++|+|++ +.+|
T Consensus 142 ~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp GGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999998887 999999998665332 34568999999999987 678999999999999999999 5666
Q ss_pred CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|...+.......... ....+..++.++.+||.+||..||.+|||+.+++++.
T Consensus 219 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 219 LSALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp TTTSCHHHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccchHHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 766666555544433 3345566789999999999999999999999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=296.27 Aligned_cols=201 Identities=15% Similarity=0.184 Sum_probs=169.6
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++++++ +|+||+++++++.. +...|+||||| +++|.+++.... ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 57 ~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 133 (298)
T 1csn_A 57 RTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 133 (298)
T ss_dssp HHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred HHHHHHhcCCCCCeEEeecCC-CceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 577888 89999999998754 55889999999 999999998753 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCC-----EEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc
Q 008303 81 CSNIFLTKDQD-----IRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 81 P~NILld~~g~-----vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt 147 (570)
|+|||++.++. +||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 134 p~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 213 (298)
T 1csn_A 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 213 (298)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc
Confidence 99999987776 9999999998875432 2345679999999999999999999999999999999999
Q ss_pred cCCCCccc---CHHHHHHHHHhccC----CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 148 LKPAFKAF---DMQALINKINKSIV----APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 148 G~~pf~~~---~~~~~~~~i~~~~~----~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
|+.||... ........+..... ......++.++.+||.+||..||.+||++++|++..
T Consensus 214 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 214 GSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp SSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 99999874 33343333322211 112347899999999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.77 Aligned_cols=203 Identities=21% Similarity=0.387 Sum_probs=173.4
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN------------SKLFSEEKLCKWLVQLLMALDY 68 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~------------~~~Lse~~i~~I~~QLl~aL~y 68 (570)
++|++| +||||++++++|... ..+|+|||||.+|+|.+++.... ...+++..++.|+.||+.||.|
T Consensus 101 ~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 179 (333)
T 2i1m_A 101 KIMSHLGQHENIVNLLGACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179 (333)
T ss_dssp HHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCeeeEEEEEecC-CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 678899 899999999988654 46899999999999999997642 3468999999999999999999
Q ss_pred HHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 69 LHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 69 LHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
||++||+||||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|
T Consensus 180 lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp HHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998764332 22345678899999999998999999999999999999
Q ss_pred hc-cCCCCcccCHHHH-HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 146 TS-LKPAFKAFDMQAL-INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 146 lt-G~~pf~~~~~~~~-~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
++ |..||.+...... ...+........+..++..+.+||.+||..||.+|||+.++++++
T Consensus 260 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp TTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 98 9999987654333 333444445556777899999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=308.01 Aligned_cols=201 Identities=21% Similarity=0.345 Sum_probs=164.6
Q ss_pred HHhhhcCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC------
Q 008303 2 ELISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN------ 72 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~------ 72 (570)
.+|++++|||||+++++|... ...+|+|||||.+|+|.++++.. .+++..++.|+.||+.||.|||++
T Consensus 70 ~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~ 146 (322)
T 3soc_A 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKD 146 (322)
T ss_dssp HTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETT
T ss_pred HHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhcccccc
Confidence 468889999999999999764 34589999999999999999763 489999999999999999999999
Q ss_pred ----CcccceecCCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCC-----CCCCcccccchhh
Q 008303 73 ----HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADI-----PYGSKSDIWSLGC 140 (570)
Q Consensus 73 ----gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~-----~~t~ksDIWSLG~ 140 (570)
||+||||||+|||++.++.+||+|||+++.+..... ....+||+.|+|||++.+. .++.++|||||||
T Consensus 147 ~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp EEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 999999999999999999999999999987754332 3346899999999999863 4566889999999
Q ss_pred hHHHhhccCCCCccc----------------CHHHHHHHHHhccCCCC-CC-----CCcHHHHHHHHHhhccCCCCCcCH
Q 008303 141 CIYEMTSLKPAFKAF----------------DMQALINKINKSIVAPL-PT-----KYSGAFRGLVKSMLRKNPELRPSA 198 (570)
Q Consensus 141 IlyeLltG~~pf~~~----------------~~~~~~~~i~~~~~~p~-p~-----~~s~~l~dLI~~~L~~dP~~RPTa 198 (570)
++|+|++|+.||.+. ........+......+. +. ..+.++.+||.+||..||.+|||+
T Consensus 227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (322)
T 3soc_A 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306 (322)
T ss_dssp HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence 999999999998653 22233333333222221 21 124569999999999999999999
Q ss_pred HHHHHhh
Q 008303 199 AELLRHV 205 (570)
Q Consensus 199 ~eIL~hp 205 (570)
.++++.+
T Consensus 307 ~ell~~L 313 (322)
T 3soc_A 307 GCVGERI 313 (322)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=298.54 Aligned_cols=201 Identities=19% Similarity=0.387 Sum_probs=174.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++...+ .++|||||.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 73 ~~l~~l~h~~i~~~~~~~~~~~--~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 149 (291)
T 1u46_A 73 NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA 149 (291)
T ss_dssp HHHHHCCCTTBCCEEEEECSSS--CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHhCCCCCcccEEEEEccCC--ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCch
Confidence 5788999999999999886543 789999999999999998753 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 150 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 150 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 99999999999999999998875432 2234567889999999998889999999999999999998 999999988
Q ss_pred HHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSI-VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~-~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.......+.... ..+.+..++.++.++|.+||..||.+|||+.+++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 230 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp HHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 888777775543 3445678999999999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.39 Aligned_cols=201 Identities=25% Similarity=0.377 Sum_probs=163.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||++++++|..+ ..+|+|||||+|++|.+++.... .+++..++.|+.||+.||.|||++||+||||||
T Consensus 86 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 162 (309)
T 2h34_A 86 RTAGRLQEPHVVPIHDFGEID-GQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKP 162 (309)
T ss_dssp HHHTTCCCTTBCCEEEEEEET-TEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHhhcCCCCeeEEEEEEeeC-CeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCCh
Confidence 578899999999999988664 57899999999999999998753 589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (309)
T 2h34_A 163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242 (309)
T ss_dssp GGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred HHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence 99999999999999999998765432 2335679999999999999899999999999999999999999998877665
Q ss_pred HHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCc-CHHHHHHhh
Q 008303 160 LINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRP-SAAELLRHV 205 (570)
Q Consensus 160 ~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RP-Ta~eIL~hp 205 (570)
....+...... ..+..++.++.+||.+||..||++|| +++++++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 243 MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 55555443322 24567899999999999999999999 899988763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.71 Aligned_cols=201 Identities=17% Similarity=0.269 Sum_probs=168.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
+++++++|++++..++++...+...|+||||| +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 56 ~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 133 (296)
T 4hgt_A 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 133 (296)
T ss_dssp HHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 57889999998888888877777899999999 899999998643 4599999999999999999999999999999999
Q ss_pred CcEEE---cCCCCEEEeecCCceeccCCCC--------CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCC
Q 008303 82 SNIFL---TKDQDIRLGDFGLAKILTSDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 82 ~NILl---d~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
+|||+ +.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 134 ~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 4hgt_A 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCC
Confidence 99999 7889999999999988754322 235689999999999999999999999999999999999999
Q ss_pred CCcccCHH---HHHHHHHhc-cCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 151 AFKAFDMQ---ALINKINKS-IVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 151 pf~~~~~~---~~~~~i~~~-~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
||...+.. .....+... ... .....++.++.+||.+||..||.+|||++++++.
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 274 (296)
T 4hgt_A 214 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp TTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred CCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence 99764321 111121111 111 1235689999999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.59 Aligned_cols=201 Identities=21% Similarity=0.432 Sum_probs=173.4
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++||||++++++|.+. ...+|+|||||++|+|.+++... .+++..++.|+.||+.||.|||++||+||||
T Consensus 84 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Di 160 (318)
T 3lxp_A 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDL 160 (318)
T ss_dssp HHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 3688999999999999999765 46889999999999999999763 3899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.++.+||+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 161 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred chheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 9999999999999999999998876432 233456888899999999888999999999999999999999998654
Q ss_pred CHH---------------HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQ---------------ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~---------------~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
... .....+......+.+..++.++.+||++||..||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 304 (318)
T 3lxp_A 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304 (318)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 321 2334445555666778899999999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.27 Aligned_cols=203 Identities=20% Similarity=0.387 Sum_probs=181.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|+|||++++++.+ ..+|||||||.+|+|.++++...+..+++..++.|+.||+.||+|||++||+|||||
T Consensus 313 ~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 390 (535)
T 2h8h_A 313 AQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390 (535)
T ss_dssp HHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCEeeEEEEEee--ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 368999999999999998754 357899999999999999976544569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||||+.++.+||+|||+++.+.... ......++..|+|||++....++.++|||||||++|+|++ |+.||.+...
T Consensus 391 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp GGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred HhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998764322 1223456788999999998899999999999999999999 9999999998
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.++...+......+.+..++..+.+||.+||..||++|||+++|++.+
T Consensus 471 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 471 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 888888888877778889999999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=306.88 Aligned_cols=207 Identities=27% Similarity=0.448 Sum_probs=150.6
Q ss_pred HhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccce
Q 008303 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK---ANSKLFSEEKLCKWLVQLLMALDYLHAN-HILHRD 78 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~---~~~~~Lse~~i~~I~~QLl~aL~yLHs~-gIvHrD 78 (570)
+++.++||||+++++++... ...|+|||||.| +|.+++.. .....+++..++.|+.|++.||.|||++ ||+|||
T Consensus 74 ~~~~~~h~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~d 151 (327)
T 3aln_A 74 VMRSSDCPYIVQFYGALFRE-GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 151 (327)
T ss_dssp HHSSCCCTTBCCEEEEEECS-SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSC
T ss_pred HHHcCCCCcEeeeeeEEEeC-CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECC
Confidence 56677999999999998765 478999999986 88888763 2245799999999999999999999999 999999
Q ss_pred ecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccc----cCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 79 VKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 79 LKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|||+|||++.++.+||+|||++.............||+.|+|||++ .+..++.++|||||||++|+|++|+.||..
T Consensus 152 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 152 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp CCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred CCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999887655444556899999999999 456789999999999999999999999987
Q ss_pred cCHH-HHHHHHHhccCCCC----CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 155 FDMQ-ALINKINKSIVAPL----PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 155 ~~~~-~~~~~i~~~~~~p~----p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.... +....+.......+ ...++..+.+||.+||..||.+||++.+|++|+||....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 232 WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp C-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 5421 22222222211111 236899999999999999999999999999999997543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.28 Aligned_cols=203 Identities=20% Similarity=0.310 Sum_probs=169.4
Q ss_pred HHhhhcCCCcccc---------------cceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKIRNPFIVE---------------YKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL~HPnIV~---------------l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL 66 (570)
++|++++||||++ +++++...+..+||||||| +++|.+++.......+++..++.|+.||+.||
T Consensus 94 ~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L 172 (352)
T 2jii_A 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDAL 172 (352)
T ss_dssp HHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHH
Confidence 5788899999887 6777766567899999999 99999999976445699999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCC--CEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCccccc
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQ--DIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g--~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
.|||++||+||||||+|||++.++ .+||+|||+++.+.... ......||+.|+|||++.+..++.++|||
T Consensus 173 ~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 252 (352)
T 2jii_A 173 EFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQ 252 (352)
T ss_dssp HHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHH
T ss_pred HHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHH
Confidence 999999999999999999999988 89999999998765322 12345899999999999999999999999
Q ss_pred chhhhHHHhhccCCCCcccC--HHHHHHHHHh--ccCCCC------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 137 SLGCCIYEMTSLKPAFKAFD--MQALINKINK--SIVAPL------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 137 SLG~IlyeLltG~~pf~~~~--~~~~~~~i~~--~~~~p~------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||||++|+|++|+.||.... ...+...... .....+ +..++.++.+||.+||..||.+||++++|++..
T Consensus 253 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 253 SLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 99999999999999998763 3333222221 111111 125789999999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=296.72 Aligned_cols=203 Identities=35% Similarity=0.673 Sum_probs=163.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++||||++++++|...+ ..|+|||||.+|+|.+++... ....+++..++.|+.||+.||.|||++||+||||
T Consensus 84 ~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl 162 (310)
T 2wqm_A 84 DLLKQLNHPNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDI 162 (310)
T ss_dssp HHHHTCCCTTBCCEEEEEEETT-EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHhCCCCCEeeEEEEEEcCC-cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCC
Confidence 5789999999999999987654 789999999999999999752 3456999999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc--C
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF--D 156 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~--~ 156 (570)
||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+. +
T Consensus 163 ~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 242 (310)
T 2wqm_A 163 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242 (310)
T ss_dssp CGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred cHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 9999999999999999999998765432 234567999999999999999999999999999999999999999654 3
Q ss_pred HHHHHHHHHhccCCCC-CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 157 MQALINKINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~-p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.......+......+. ...++.++.+||.+||..||.+|||+.+++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 243 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp HHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 3445555554443333 367899999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.53 Aligned_cols=198 Identities=20% Similarity=0.435 Sum_probs=167.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--ILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--IvHrDL 79 (570)
++|++++||||++++++|.+.. ++|||||.+|+|.+++.... ..+++..++.|+.||+.||+|||++| |+||||
T Consensus 75 ~~l~~l~h~~i~~~~~~~~~~~---~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~di 150 (287)
T 4f0f_A 75 FIMSNLNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150 (287)
T ss_dssp HHHTTCCCTTBCCEEEEETTTT---EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCC
T ss_pred HHHHhCCCCCchhhheeecCCC---eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCC
Confidence 5788999999999999884433 69999999999999987643 46999999999999999999999999 999999
Q ss_pred cCCcEEEcCCCC-----EEEeecCCceeccCCCCCccccCCCCCCCccccc--CCCCCCcccccchhhhHHHhhccCCCC
Q 008303 80 KCSNIFLTKDQD-----IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 80 KP~NILld~~g~-----vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
||+|||++.++. +||+|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 228 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999988776 99999999986443 234568999999999994 455789999999999999999999999
Q ss_pred cccCHHH--HHHHH-HhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 153 KAFDMQA--LINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 153 ~~~~~~~--~~~~i-~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
....... ....+ ........+..++.++.+||.+||..||.+|||++++++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 229 DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp TTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 7654332 23333 33344556788999999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.26 Aligned_cols=204 Identities=26% Similarity=0.367 Sum_probs=166.9
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--SKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++||||++++++|.+. ..+|+|||||.||+|.+++.... ...+++..++.|+.||+.||.|||++||+||||
T Consensus 87 ~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 165 (321)
T 2qkw_B 87 ETLSFCRHPHLVSLIGFCDER-NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165 (321)
T ss_dssp HGGGSCCCTTBCCEEEECCCT-TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHhCCCCCEeeEEEEEcCC-CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCC
Confidence 578899999999999988654 46899999999999999986543 235899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 166 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 166 KSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp CSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred CHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 9999999999999999999998754322 2344578999999999998899999999999999999999999986543
Q ss_pred HHHH------H-HHHHhc---------cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 157 MQAL------I-NKINKS---------IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 157 ~~~~------~-~~i~~~---------~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
.... . ...... .....+..++..+.++|.+||..||++|||+.|+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 2111 0 111111 011122345678999999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=293.75 Aligned_cols=201 Identities=17% Similarity=0.271 Sum_probs=168.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|++++..+.++...+...|+||||| +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 56 ~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 133 (296)
T 3uzp_A 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 133 (296)
T ss_dssp HHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 57889999988888877777777899999999 899999998543 4699999999999999999999999999999999
Q ss_pred CcEEE---cCCCCEEEeecCCceeccCCCC--------CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCC
Q 008303 82 SNIFL---TKDQDIRLGDFGLAKILTSDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 82 ~NILl---d~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
+|||+ +.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 134 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 3uzp_A 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999 4788999999999988764432 245689999999999999999999999999999999999999
Q ss_pred CCcccCH---HHHHHHHHhc-cC---CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 151 AFKAFDM---QALINKINKS-IV---APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 151 pf~~~~~---~~~~~~i~~~-~~---~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
||..... ......+... .. ......++.++.+||.+||..||.+|||++++++.
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 214 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp TTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred CCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 9976421 1122222111 11 11236789999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.83 Aligned_cols=201 Identities=20% Similarity=0.377 Sum_probs=177.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.. + .+|||||||.+|+|.++++.. ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 421 ~~il~~l~hpnIv~l~~~~~~-~-~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLk 496 (635)
T 4fl3_A 421 ANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 496 (635)
T ss_dssp HHHHHHCCCTTBCCEEEEEES-S-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCEeeEEEEEec-C-CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCC
Confidence 368999999999999998853 3 478999999999999999764 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+||||+.++.+||+|||+++.+.... ......+|+.|+|||++.+..|+.++|||||||++|+|++ |+.||.+.
T Consensus 497 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 497 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp GGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred hHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998765432 1223456788999999999999999999999999999998 99999999
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+..++...+........+..++.++.+||.+||..||++||++++|++.+
T Consensus 577 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 577 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999988888888899999999999999999999999999998763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=300.42 Aligned_cols=204 Identities=22% Similarity=0.368 Sum_probs=168.7
Q ss_pred HHhhhcCCCcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKIRNPFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|++++||||+++++++.. .....|+|||||.+|+|.+++... .+..+++..++.|+.||+.||.|||++||+|
T Consensus 78 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 157 (317)
T 2buj_A 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157 (317)
T ss_dssp HHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 67899999999999999873 234789999999999999999863 3456999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCC----------CccccCCCCCCCcccccCCC---CCCcccccchhhhHH
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL----------ASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCIY 143 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~----------~~~~~GT~~Y~APE~l~~~~---~t~ksDIWSLG~Ily 143 (570)
|||||+|||++.++.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|
T Consensus 158 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237 (317)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999876532111 12346799999999997654 688999999999999
Q ss_pred HhhccCCCCcccCH--HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTSLKPAFKAFDM--QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLltG~~pf~~~~~--~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+|++|+.||..... ......+......+.+..++.++.+||.+||..||.+|||+.++++++
T Consensus 238 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 238 AMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 99999999964211 122233333344445567899999999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.22 Aligned_cols=202 Identities=26% Similarity=0.512 Sum_probs=159.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++ .. ..+++|||||.|++|.+++... ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 71 ~~~l~~l~h~~iv~~~~~~-~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlk 147 (289)
T 3og7_A 71 VGVLRKTRHVNILLFMGYS-TA-PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147 (289)
T ss_dssp HHHHTTCCCTTBCCEEEEE-CS-SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCcEEEEEeec-cC-CccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 3678999999999999965 33 3578999999999999999654 3469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC---CCCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS---DDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~---~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.++.+||+|||++..... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||..
T Consensus 148 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp GGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999976543 22234567999999999996 56688899999999999999999999987
Q ss_pred cCH-HHHHHHHHhccCCC----CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 155 FDM-QALINKINKSIVAP----LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 155 ~~~-~~~~~~i~~~~~~p----~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
... ......+......+ ....++..+.+||.+||..||.+|||+.++++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp CCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 544 44444444433322 3347889999999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.44 Aligned_cols=204 Identities=28% Similarity=0.462 Sum_probs=164.9
Q ss_pred HHhhhcC--CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIR--NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~--HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++ |+||+++++++... ..+|+||| +.+++|.+++... ..+++..++.|+.||+.||.|||++||+||||
T Consensus 78 ~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 153 (313)
T 3cek_A 78 AYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153 (313)
T ss_dssp HHHHHHGGGCTTBCCEEEEEECS-SEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHhccccCCceEEEEEEeecC-CEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 5788886 59999999988654 47999999 5678999999874 35899999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccC-----------CCCCCcccccchhhhHHHh
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~-----------~~~t~ksDIWSLG~IlyeL 145 (570)
||+|||++ ++.+||+|||++....... .....+|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 154 kp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 232 (313)
T 3cek_A 154 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232 (313)
T ss_dssp CGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred CcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence 99999996 5899999999998765432 2235679999999999875 4688899999999999999
Q ss_pred hccCCCCcccC-HHHHHHH-HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 146 TSLKPAFKAFD-MQALINK-INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 146 ltG~~pf~~~~-~~~~~~~-i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
++|+.||.... ....... +........+..++.++.+||.+||..||.+||++.|+|+|+||+..
T Consensus 233 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 233 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 99999997653 2222233 33333345567789999999999999999999999999999999743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.84 Aligned_cols=202 Identities=22% Similarity=0.395 Sum_probs=170.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+++++++.+.+ .+|+|||||.|++|.+++... ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 80 ~~~l~~l~h~~iv~~~~~~~~~~-~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlk 157 (319)
T 2y4i_B 80 VMAYRQTRHENVVLFMGACMSPP-HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157 (319)
T ss_dssp GGGGTTCCCTTBCCCCEEEECSS-CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHhcCCCCCEeEEEEEEecCC-ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence 36788999999999999987654 689999999999999999764 3468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccC------CCCCccccCCCCCCCcccccC---------CCCCCcccccchhhhHHHh
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTS------DDLASSVVGTPSYMCPELLAD---------IPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~------~~~~~~~~GT~~Y~APE~l~~---------~~~t~ksDIWSLG~IlyeL 145 (570)
|+|||++ ++.+||+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 158 p~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 236 (319)
T 2y4i_B 158 SKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236 (319)
T ss_dssp STTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHH
T ss_pred hhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHH
Confidence 9999998 78999999999876532 122334568999999999864 4578899999999999999
Q ss_pred hccCCCCcccCHHHHHHHHHhccCCCC-CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 146 TSLKPAFKAFDMQALINKINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 146 ltG~~pf~~~~~~~~~~~i~~~~~~p~-p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
++|+.||...........+........ ...++.++.+||.+||..||.+|||+.++++..
T Consensus 237 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp HHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 999999999888888777766554433 346899999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.10 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=171.3
Q ss_pred HHhhhcC--CCcccccceEEEeeCcEEEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIR--NPFIVEYKDSWVERGCYVCIIIGFCEG-GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~--HPnIV~l~~~f~~~~~~i~IV~Ey~~g-GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
++|++++ |+||++++++|... ..+|+||||+.+ ++|.+++.... .+++..++.|+.||+.||.|||++||+|||
T Consensus 98 ~~l~~l~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 174 (320)
T 3a99_A 98 VLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRD 174 (320)
T ss_dssp HHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHhhccCCCCceEEEEEEecC-CcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCC
Confidence 5788885 69999999988654 478999999986 89999998753 589999999999999999999999999999
Q ss_pred ecCCcEEEc-CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccC
Q 008303 79 VKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 79 LKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||+|||++ .++.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+
T Consensus 175 lkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 175 IKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred CCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 999999999 7889999999999887643 3345679999999999987766 688999999999999999999997642
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
. +... ....+..++.++.+||.+||..||.+|||+++|++|+||+...
T Consensus 254 ~------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 254 E------IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp H------HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred h------hhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 1 1111 2235677899999999999999999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.05 Aligned_cols=200 Identities=23% Similarity=0.508 Sum_probs=165.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHA---NHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs---~gIvH 76 (570)
+++|++++||||+++++++.+ ..|+|||||+||+|.+++..... ..+++..++.|+.||+.||.|||+ +||+|
T Consensus 52 ~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH 128 (307)
T 2eva_A 52 LRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128 (307)
T ss_dssp HHHHHHCCCTTBCCEEEBCTT---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCC
T ss_pred HHHHhcCCCCCcCeEEEEEcC---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeec
Confidence 367899999999999998742 36899999999999999986432 247899999999999999999999 89999
Q ss_pred ceecCCcEEEcCCCC-EEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 77 RDVKCSNIFLTKDQD-IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 77 rDLKP~NILld~~g~-vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||||+|||++.++. +||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 129 ~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp CCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred CCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 999999999998887 799999999765432 23457999999999999999999999999999999999999999754
Q ss_pred --CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 --DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 --~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
........+......+.+..++..+.+||.+||..||.+|||+++++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 207 GGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp CSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 33344445555556666778999999999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.44 Aligned_cols=199 Identities=23% Similarity=0.362 Sum_probs=167.4
Q ss_pred HHhhhc----CCCcccccceEEEeeCcEEEEEEec-cCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 2 ELISKI----RNPFIVEYKDSWVERGCYVCIIIGF-CEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 2 ~IL~kL----~HPnIV~l~~~f~~~~~~i~IV~Ey-~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
++|+++ +|+||++++++|...+ ..|+|||| +.+++|.+++.... .+++..++.|+.||+.||.|||++||+|
T Consensus 86 ~~l~~l~~~~~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H 162 (312)
T 2iwi_A 86 ALLWKVGAGGGHPGVIRLLDWFETQE-GFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVH 162 (312)
T ss_dssp HHHHHHHSSCCCSSBCCEEEEC------CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEEC
T ss_pred HHHHhhcccCCCCCeeeEEEEEecCC-eEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 456677 8999999999886554 67899999 78999999998754 4899999999999999999999999999
Q ss_pred ceecCCcEEEc-CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcc
Q 008303 77 RDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 77 rDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|||||+|||++ .++.+||+|||++....... .....|+..|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 163 ~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 163 RDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999 78999999999998876543 345679999999999987766 4589999999999999999999975
Q ss_pred cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 155 FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.. . +.. .....+..++..+.+||.+||..||++|||++|+++|+||+...
T Consensus 242 ~~--~----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 242 DQ--E----ILE-AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HH--H----HHH-TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred hH--H----Hhh-hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 42 1 111 22345678999999999999999999999999999999998643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.45 Aligned_cols=205 Identities=22% Similarity=0.349 Sum_probs=167.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS--KLFSEEKLCKWLVQLLMALDYLHAN---HILH 76 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~--~~Lse~~i~~I~~QLl~aL~yLHs~---gIvH 76 (570)
++|++++||||++++++|...+ ..|+|||||.||+|.+++..... ..+++..++.|+.||+.||.|||++ ||+|
T Consensus 79 ~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 157 (326)
T 3uim_A 79 EMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH 157 (326)
T ss_dssp HGGGTCCCTTBCCCCEEECCSS-CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEEC
T ss_pred HHHHhccCCCccceEEEEecCC-ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Confidence 5788999999999999986544 67899999999999999986432 3599999999999999999999999 9999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp CCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred CCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 9999999999999999999999998765332 23445699999999999888899999999999999999999999953
Q ss_pred cCH-----HHHHHHHHhccC-------------CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 155 FDM-----QALINKINKSIV-------------APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 155 ~~~-----~~~~~~i~~~~~-------------~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
... ......+..... ...+..++..+.+||.+||..||.+|||+.++++|+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 211 011111111000 11122335789999999999999999999999999754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=330.32 Aligned_cols=201 Identities=20% Similarity=0.366 Sum_probs=176.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.. + .+|||||||.||+|.+++... ...+++..++.|+.||+.||+|||++||+|||||
T Consensus 387 ~~il~~l~hpniv~l~~~~~~-~-~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 463 (613)
T 2ozo_A 387 AQIMHQLDNPYIVRLIGVCQA-E-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463 (613)
T ss_dssp HHHHTTCCCTTBCCEEEEEES-S-SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCEeeEEEEecc-C-CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCC
Confidence 368999999999999998854 3 489999999999999999754 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+||||+.++.+||+|||+++.+..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 464 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp GGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred HHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999987643321 122345689999999999999999999999999999997 99999998
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+..++...+..+...+.+..++.++.+||.+||..+|.+||++.+|++.
T Consensus 544 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~ 592 (613)
T 2ozo_A 544 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 592 (613)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8888888888887778888999999999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.44 Aligned_cols=200 Identities=23% Similarity=0.385 Sum_probs=161.1
Q ss_pred Hhhh--cCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-------
Q 008303 3 LISK--IRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH------- 70 (570)
Q Consensus 3 IL~k--L~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH------- 70 (570)
++.. ++||||+++++++... +..+|+|||||.+|+|.++++. ..+++..++.|+.||+.||.|||
T Consensus 53 ~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ 129 (301)
T 3q4u_A 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129 (301)
T ss_dssp HHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTT
T ss_pred HHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence 4444 7999999999987653 3568999999999999999954 35899999999999999999999
Q ss_pred -HCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCC-----CccccCCCCCCCcccccCC------CCCCcccccch
Q 008303 71 -ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVVGTPSYMCPELLADI------PYGSKSDIWSL 138 (570)
Q Consensus 71 -s~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~------~~t~ksDIWSL 138 (570)
++||+||||||+|||++.++.+||+|||++........ ....+||+.|+|||++.+. .++.++|||||
T Consensus 130 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp CBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred CCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 99999999999999999999999999999987654322 2345899999999999876 34578999999
Q ss_pred hhhHHHhhcc----------CCCCccc-----CHHHHHHHHHhcc-CCCCCC-----CCcHHHHHHHHHhhccCCCCCcC
Q 008303 139 GCCIYEMTSL----------KPAFKAF-----DMQALINKINKSI-VAPLPT-----KYSGAFRGLVKSMLRKNPELRPS 197 (570)
Q Consensus 139 G~IlyeLltG----------~~pf~~~-----~~~~~~~~i~~~~-~~p~p~-----~~s~~l~dLI~~~L~~dP~~RPT 197 (570)
||++|+|++| ..||... ........+.... ....+. .++..+.+||.+||..||.+|||
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 9999999999 7787542 2222322222221 122222 25678999999999999999999
Q ss_pred HHHHHHhh
Q 008303 198 AAELLRHV 205 (570)
Q Consensus 198 a~eIL~hp 205 (570)
+.+|++.+
T Consensus 290 ~~~i~~~L 297 (301)
T 3q4u_A 290 ALRIKKTL 297 (301)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.52 Aligned_cols=207 Identities=24% Similarity=0.344 Sum_probs=160.9
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|+++ +|||||++++++.+ +..+|||||||. |+|.+++.... ..+.+..++.|+.||+.||.|||++||+||||
T Consensus 68 ~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 144 (432)
T 3p23_A 68 VQLLRESDEHPNVIRYFCTEKD-RQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144 (432)
T ss_dssp HHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHhccCCCCcCeEEEEEec-CCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCC
Confidence 3678888 89999999998865 458899999996 59999998654 34566677899999999999999999999999
Q ss_pred cCCcEEEcC---C--CCEEEeecCCceeccCC----CCCccccCCCCCCCccccc---CCCCCCcccccchhhhHHHhhc
Q 008303 80 KCSNIFLTK---D--QDIRLGDFGLAKILTSD----DLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 80 KP~NILld~---~--g~vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIWSLG~IlyeLlt 147 (570)
||+|||++. + ..+||+|||+++.+... ......+||+.|+|||++. ...++.++|||||||++|+|++
T Consensus 145 Kp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp STTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHT
T ss_pred CHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHc
Confidence 999999953 2 35889999999876543 2334568999999999997 4567889999999999999999
Q ss_pred -cCCCCcccCHHHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 148 -LKPAFKAFDMQALINKINKSIVAP--LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 148 -G~~pf~~~~~~~~~~~i~~~~~~p--~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
|..||...........+....... .....+..+.+||.+||..||.+|||++++++||||...
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred CCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 899997654433322222111111 122346678999999999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.14 Aligned_cols=205 Identities=27% Similarity=0.423 Sum_probs=156.8
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSK-----LFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~-----~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
++|+++ +|||||++++++.+ +..+|||||||. |+|.++++..... ...+..++.|+.||+.||.|||++||+
T Consensus 60 ~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 137 (434)
T 2rio_A 60 KLLTESDDHPNVIRYYCSETT-DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137 (434)
T ss_dssp HHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHhccCCCCcCeEEEEEec-CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCcc
Confidence 567776 89999999998865 458999999996 5999999864321 113335678999999999999999999
Q ss_pred cceecCCcEEEcCC-------------CCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccC-------CCCC
Q 008303 76 HRDVKCSNIFLTKD-------------QDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLAD-------IPYG 130 (570)
Q Consensus 76 HrDLKP~NILld~~-------------g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~-------~~~t 130 (570)
||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+ ..++
T Consensus 138 HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 217 (434)
T 2rio_A 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217 (434)
T ss_dssp CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC
T ss_pred ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc
Confidence 99999999999754 379999999999876432 1234689999999999975 5689
Q ss_pred CcccccchhhhHHHhhc-cCCCCcccCHHHHHHHHHhccC-CCC-----CCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 131 SKSDIWSLGCCIYEMTS-LKPAFKAFDMQALINKINKSIV-APL-----PTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 131 ~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~~~~~i~~~~~-~p~-----p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
.++|||||||++|+|++ |..||....... ..+..... .+. ...++.++.+||.+||..||.+|||+.++++
T Consensus 218 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99999999999999998 999997654332 12222211 111 1235689999999999999999999999999
Q ss_pred hhccChh
Q 008303 204 HVHLQPY 210 (570)
Q Consensus 204 hp~fq~~ 210 (570)
||||...
T Consensus 296 hp~f~~~ 302 (434)
T 2rio_A 296 HPLFWPK 302 (434)
T ss_dssp SGGGSCH
T ss_pred CCccCCc
Confidence 9999753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=297.81 Aligned_cols=202 Identities=23% Similarity=0.395 Sum_probs=166.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN-SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~-~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||+++++++.+. ...|+|||||.+|+|.+++.... ...+++..++.|+.||+.||.|||++||+|||||
T Consensus 82 ~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk 160 (307)
T 2nru_A 82 KVMAKCQHENLVELLGFSSDG-DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIK 160 (307)
T ss_dssp HHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHhcCCCCeEEEEEEEecC-CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 578999999999999988654 46899999999999999997533 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 999999999999999999998765422 2334679999999998865 588999999999999999999999976543
Q ss_pred HH----HHHHHHh----------ccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QA----LINKINK----------SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~----~~~~i~~----------~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.. +...+.. ......+..++..+.++|.+||..||.+|||+.++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp SSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred hHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 21 1111111 111223344567899999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.24 Aligned_cols=204 Identities=22% Similarity=0.367 Sum_probs=170.2
Q ss_pred HHhhhcCCCcccccceEEEeeC-cEEEEEEeccCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 2 ELISKIRNPFIVEYKDSWVERG-CYVCIIIGFCEGGDMAEAIKKANS-KLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~-~~i~IV~Ey~~gGsL~d~I~~~~~-~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
++|++++||||+++++++.+.+ ..+|+|||||.||+|.++++.... ..+++..++.|+.||+.||.|||++||+||||
T Consensus 59 ~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 138 (396)
T 4eut_A 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138 (396)
T ss_dssp HHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCc
Confidence 6899999999999999987543 368999999999999999976432 34999999999999999999999999999999
Q ss_pred cCCcEEE----cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC--------CCCCCcccccchhhhHHHhhc
Q 008303 80 KCSNIFL----TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD--------IPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 80 KP~NILl----d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~t~ksDIWSLG~IlyeLlt 147 (570)
||+|||+ +.++.+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 kp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t 218 (396)
T 4eut_A 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218 (396)
T ss_dssp CGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH
Confidence 9999999 6777899999999998876666667789999999999865 467889999999999999999
Q ss_pred cCCCCccc----CHHHHHHHHHhccCCC------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHH
Q 008303 148 LKPAFKAF----DMQALINKINKSIVAP------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAA 199 (570)
Q Consensus 148 G~~pf~~~----~~~~~~~~i~~~~~~p------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~ 199 (570)
|+.||... ...+.+.++....... +...++..+.++|++||..||++||+++
T Consensus 219 g~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (396)
T 4eut_A 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (396)
T ss_dssp SSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence 99999743 2234444444332211 1123567899999999999999999999
Q ss_pred HHHHhh
Q 008303 200 ELLRHV 205 (570)
Q Consensus 200 eIL~hp 205 (570)
+++++.
T Consensus 299 e~l~~l 304 (396)
T 4eut_A 299 QFFAET 304 (396)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.39 Aligned_cols=196 Identities=21% Similarity=0.362 Sum_probs=159.3
Q ss_pred cCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------Ccc
Q 008303 7 IRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN--------HIL 75 (570)
Q Consensus 7 L~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~--------gIv 75 (570)
++||||+++++++.... ..+|+|||||.+|+|.++++.. .+++..++.|+.||+.||.|||++ ||+
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 164 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEE
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEE
Confidence 49999999999987652 5799999999999999999763 489999999999999999999999 999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCC-----CccccCCCCCCCcccccCCCCCCc------ccccchhhhHHH
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVVGTPSYMCPELLADIPYGSK------SDIWSLGCCIYE 144 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~t~k------sDIWSLG~Ilye 144 (570)
||||||+|||++.++.+||+|||++..+..... ....+||+.|+|||++.+..+... +|||||||++|+
T Consensus 165 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 244 (337)
T 3mdy_A 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244 (337)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHH
T ss_pred ecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHH
Confidence 999999999999999999999999987654322 235689999999999988776665 999999999999
Q ss_pred hhcc----------CCCCccc-----CHHHHHHHHHhcc-CCCCCC-----CCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 145 MTSL----------KPAFKAF-----DMQALINKINKSI-VAPLPT-----KYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 145 LltG----------~~pf~~~-----~~~~~~~~i~~~~-~~p~p~-----~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
|++| ..||... ........+.... ....+. .++.++.+||.+||..||.+|||+.++++
T Consensus 245 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 9999 5666442 1222322222222 222222 45678999999999999999999999999
Q ss_pred hh
Q 008303 204 HV 205 (570)
Q Consensus 204 hp 205 (570)
++
T Consensus 325 ~L 326 (337)
T 3mdy_A 325 TL 326 (337)
T ss_dssp HH
T ss_pred HH
Confidence 84
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=296.86 Aligned_cols=201 Identities=28% Similarity=0.487 Sum_probs=150.3
Q ss_pred HHhhhcC-CCcccccceEEE-------eeCcEEEEEEeccCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 2 ELISKIR-NPFIVEYKDSWV-------ERGCYVCIIIGFCEGGDMAEAIKK-ANSKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~-------~~~~~i~IV~Ey~~gGsL~d~I~~-~~~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
.+|+++. ||||+++++++. .....+|+|||||. |+|.+++.. .....+++..++.|+.||+.||.|||++
T Consensus 77 ~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 155 (337)
T 3ll6_A 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155 (337)
T ss_dssp HHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5788885 999999999985 33456899999996 699999875 2345699999999999999999999999
Q ss_pred C--cccceecCCcEEEcCCCCEEEeecCCceeccCCCCC-------------ccccCCCCCCCcccc---cCCCCCCccc
Q 008303 73 H--ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA-------------SSVVGTPSYMCPELL---ADIPYGSKSD 134 (570)
Q Consensus 73 g--IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~-------------~~~~GT~~Y~APE~l---~~~~~t~ksD 134 (570)
| |+||||||+|||++.++.+||+|||++......... ...+||+.|+|||++ .+..++.++|
T Consensus 156 ~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D 235 (337)
T 3ll6_A 156 KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235 (337)
T ss_dssp SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHH
T ss_pred CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHh
Confidence 9 999999999999999999999999999876543211 145689999999998 5667889999
Q ss_pred ccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 135 IWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 135 IWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
||||||++|+|++|+.||......... ......+....++..+.+||.+||..||.+|||+.|++++++
T Consensus 236 v~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 236 IWALGCILYLLCFRQHPFEDGAKLRIV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHHHHHHHHHHSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcchhHHHhh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999999999999999999765544332 222333445677889999999999999999999999999964
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.10 Aligned_cols=202 Identities=23% Similarity=0.408 Sum_probs=170.3
Q ss_pred HHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++++||||+++++++... ...+|+|||||.+++|.+++.+.. ..+++..++.|+.||+.||.|||++||+|||||
T Consensus 94 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik 172 (326)
T 2w1i_A 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172 (326)
T ss_dssp HHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC
Confidence 678999999999999988643 246789999999999999998753 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 173 p~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 252 (326)
T 2w1i_A 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 252 (326)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred cceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence 9999999999999999999988754432 233467788999999998889999999999999999999998876431
Q ss_pred H----------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 157 M----------------QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 157 ~----------------~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
. ..+...+......+.+..++.++.+||.+||..||.+|||+.+|++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 12223334444456678899999999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=292.29 Aligned_cols=188 Identities=27% Similarity=0.448 Sum_probs=153.7
Q ss_pred HHh-hhcCCCcccccceEEEe---eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELI-SKIRNPFIVEYKDSWVE---RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL-~kL~HPnIV~l~~~f~~---~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
+++ +.++||||++++++|.. ++..+|||||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||
T Consensus 62 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 141 (299)
T 3m2w_A 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141 (299)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 344 45599999999999865 24578999999999999999998766679999999999999999999999999999
Q ss_pred eecCCcEEEcC---CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 78 DVKCSNIFLTK---DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 78 DLKP~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||+|||++. ++.+||+|||++..... ..|+.++|||||||++|+|++|..||..
T Consensus 142 dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---------------------~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTG---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEECTT---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCHHHEEEecCCCCCcEEEecccccccccc---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999998 78899999999876432 3467899999999999999999999977
Q ss_pred cCHHHHHHHHHhccC---CCCC----CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 155 FDMQALINKINKSIV---APLP----TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~---~p~p----~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.........+..... ...+ ..++.++.+||.+||..||.+|||++|+|+||||+..
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 201 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp -------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred CcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 654433222211111 1112 4689999999999999999999999999999999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=324.03 Aligned_cols=201 Identities=24% Similarity=0.441 Sum_probs=177.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|++++||||+++++++. ++ .+|+|||||.+|+|.++++... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 443 ~~l~~l~HpnIv~l~~~~~-~~-~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp 519 (656)
T 2j0j_A 443 LTMRQFDHPHIVKLIGVIT-EN-PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 519 (656)
T ss_dssp HHHHHCCCTTBCCEEEEEC-SS-SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCCCCCCCeEEEEEe-cC-ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccch
Confidence 5788999999999999884 33 4789999999999999998643 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQ 158 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~ 158 (570)
+|||++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 520 ~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 599 (656)
T 2j0j_A 520 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599 (656)
T ss_dssp GGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred HhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999999999999999999987654332 223456789999999998899999999999999999986 99999999988
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+....+......+.+..++..+.+||.+||..||.+|||+.+|++.+
T Consensus 600 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 600 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 88888888777778889999999999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.81 Aligned_cols=196 Identities=15% Similarity=0.247 Sum_probs=160.2
Q ss_pred HHhhhcC---CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 2 ELISKIR---NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA---NSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 2 ~IL~kL~---HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~---~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++++|+ |+||+.+++++...+ ..|||||||.||+|.+++... ....+++..++.|+.||+.||+|||++||+
T Consensus 116 ~~~~~l~~~~~~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~iv 194 (365)
T 3e7e_A 116 QLMERLKPSMQHMFMKFYSAHLFQN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEII 194 (365)
T ss_dssp HHHHHSCGGGGGGBCCEEEEEECSS-CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHhhhhhhhhhhhhheeeecCC-CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 3455564 999999999987655 678999999999999999753 245699999999999999999999999999
Q ss_pred cceecCCcEEEcC-----------CCCEEEeecCCceecc---CCCCCccccCCCCCCCcccccCCCCCCcccccchhhh
Q 008303 76 HRDVKCSNIFLTK-----------DQDIRLGDFGLAKILT---SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 141 (570)
Q Consensus 76 HrDLKP~NILld~-----------~g~vKL~DFGla~~~~---~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~I 141 (570)
||||||+||||+. ++.+||+|||+++.+. ........+||+.|+|||++.+..|+.++|||||||+
T Consensus 195 HrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 274 (365)
T 3e7e_A 195 HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274 (365)
T ss_dssp CCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHH
T ss_pred cCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHH
Confidence 9999999999998 8999999999997654 2334456789999999999999999999999999999
Q ss_pred HHHhhccCCCCcccCHHHHHHHHHhccCCCC-CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 142 IYEMTSLKPAFKAFDMQALINKINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 142 lyeLltG~~pf~~~~~~~~~~~i~~~~~~p~-p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+|+|++|+.||....... ....... ....++.+.+++..||+.+|.+|++..+.|.+
T Consensus 275 l~elltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 275 VYCMLFGTYMKVKNEGGE------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp HHHHHHSSCCCEEEETTE------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCccccCCCCc------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 999999999986543211 0011111 11347889999999999999999755544444
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.90 Aligned_cols=201 Identities=20% Similarity=0.327 Sum_probs=164.5
Q ss_pred HHhhh--cCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH------
Q 008303 2 ELISK--IRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH------ 70 (570)
Q Consensus 2 ~IL~k--L~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH------ 70 (570)
++++. ++||||+++++++...+ ..+|+|||||.+|+|.+++.+. .+++..++.|+.||+.||.|||
T Consensus 86 ~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 162 (342)
T 1b6c_B 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGT 162 (342)
T ss_dssp HHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred HHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 45555 79999999999987654 2689999999999999999763 4899999999999999999999
Q ss_pred --HCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCCC------CCCcccccc
Q 008303 71 --ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADIP------YGSKSDIWS 137 (570)
Q Consensus 71 --s~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~------~t~ksDIWS 137 (570)
++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+.. ++.++||||
T Consensus 163 ~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~s 242 (342)
T 1b6c_B 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242 (342)
T ss_dssp TCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHH
T ss_pred cccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHH
Confidence 8999999999999999999999999999998776443 234568999999999997653 336899999
Q ss_pred hhhhHHHhhcc----------CCCCccc-----CHHHHHHHHHhcc-CCCCCC-----CCcHHHHHHHHHhhccCCCCCc
Q 008303 138 LGCCIYEMTSL----------KPAFKAF-----DMQALINKINKSI-VAPLPT-----KYSGAFRGLVKSMLRKNPELRP 196 (570)
Q Consensus 138 LG~IlyeLltG----------~~pf~~~-----~~~~~~~~i~~~~-~~p~p~-----~~s~~l~dLI~~~L~~dP~~RP 196 (570)
|||++|+|++| ..||... ........+.... ....+. .++..+.+||.+||..||.+||
T Consensus 243 lG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 243 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp HHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence 99999999999 6677553 2344444443322 222332 3346899999999999999999
Q ss_pred CHHHHHHhh
Q 008303 197 SAAELLRHV 205 (570)
Q Consensus 197 Ta~eIL~hp 205 (570)
|+.++++++
T Consensus 323 s~~~i~~~L 331 (342)
T 1b6c_B 323 TALRIKKTL 331 (342)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.73 Aligned_cols=198 Identities=19% Similarity=0.287 Sum_probs=155.5
Q ss_pred hhhcCCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-------
Q 008303 4 ISKIRNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN------- 72 (570)
Q Consensus 4 L~kL~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~------- 72 (570)
+..++|+||+++++++.. ....+|+|||||++|+|.++++... +++..++.|+.||+.||.|||++
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~ 137 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHY 137 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGC
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 345799999999986642 2346789999999999999997643 58999999999999999999999
Q ss_pred --CcccceecCCcEEEcCCCCEEEeecCCceeccCCC---------CCccccCCCCCCCcccccC-------CCCCCccc
Q 008303 73 --HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---------LASSVVGTPSYMCPELLAD-------IPYGSKSD 134 (570)
Q Consensus 73 --gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---------~~~~~~GT~~Y~APE~l~~-------~~~t~ksD 134 (570)
||+||||||+|||++.++.+||+|||+++.+.... .....+||+.|+|||++.+ ..++.++|
T Consensus 138 ~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 138 KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp BCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred ccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 99999999999999999999999999998765322 2234579999999999986 34567899
Q ss_pred ccchhhhHHHhhccCCCCc-ccC-----------------HHHHHHHHHhc-cCCCCCCC------CcHHHHHHHHHhhc
Q 008303 135 IWSLGCCIYEMTSLKPAFK-AFD-----------------MQALINKINKS-IVAPLPTK------YSGAFRGLVKSMLR 189 (570)
Q Consensus 135 IWSLG~IlyeLltG~~pf~-~~~-----------------~~~~~~~i~~~-~~~p~p~~------~s~~l~dLI~~~L~ 189 (570)
||||||++|+|++|..||. ... .......+... ....++.. ++..+.+||.+||.
T Consensus 218 iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (336)
T 3g2f_A 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297 (336)
T ss_dssp HHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhc
Confidence 9999999999999966542 211 11111111111 12223332 44589999999999
Q ss_pred cCCCCCcCHHHHHHh
Q 008303 190 KNPELRPSAAELLRH 204 (570)
Q Consensus 190 ~dP~~RPTa~eIL~h 204 (570)
.||++|||+.|+++.
T Consensus 298 ~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 298 QDAEARLTAQXAEER 312 (336)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcchHHHHHH
Confidence 999999999999876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.39 Aligned_cols=201 Identities=17% Similarity=0.272 Sum_probs=166.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+.|+|.+++..+.+|...+.+.||||||| +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 54 ~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP 131 (483)
T 3sv0_A 54 KIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131 (483)
T ss_dssp HHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCc
Confidence 67888977665555555656677899999999 899999998643 4699999999999999999999999999999999
Q ss_pred CcEEE---cCCCCEEEeecCCceeccCCCC--------CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCC
Q 008303 82 SNIFL---TKDQDIRLGDFGLAKILTSDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 82 ~NILl---d~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
+|||| +.++.+||+|||+++.+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 132 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~ 211 (483)
T 3sv0_A 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211 (483)
T ss_dssp GGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999 6789999999999988764332 225789999999999999999999999999999999999999
Q ss_pred CCcccC---HHHHHHHHHhcc----CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 151 AFKAFD---MQALINKINKSI----VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 151 pf~~~~---~~~~~~~i~~~~----~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
||.+.. ....+.++.... ...+...++.++.+||.+||..+|++||++++|++.
T Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~ 272 (483)
T 3sv0_A 212 PWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL 272 (483)
T ss_dssp TTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 997643 233333332221 112235789999999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-33 Score=320.16 Aligned_cols=211 Identities=25% Similarity=0.363 Sum_probs=172.5
Q ss_pred CHHhhhcCCCcccccceEEEe-----eCcEEEEEEeccCCCCHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKIRNPFIVEYKDSWVE-----RGCYVCIIIGFCEGGDMAEAIKKAN-SKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-----~~~~i~IV~Ey~~gGsL~d~I~~~~-~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
+++|++++||||+++++++.. .+...|+|||||.||+|.+++.... ...+++..++.|+.||+.||.|||++||
T Consensus 63 i~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gI 142 (676)
T 3qa8_A 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI 142 (676)
T ss_dssp HHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTB
T ss_pred HHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 368999999999999998643 2456789999999999999998643 2369999999999999999999999999
Q ss_pred ccceecCCcEEEcCCCC---EEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCC
Q 008303 75 LHRDVKCSNIFLTKDQD---IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 75 vHrDLKP~NILld~~g~---vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
+||||||+|||++.++. +||+|||++............+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 143 VHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~P 222 (676)
T 3qa8_A 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222 (676)
T ss_dssp CCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 99999999999997765 999999999988776666778999999999999999999999999999999999999999
Q ss_pred CcccCHHHHHH---------HHH-----hc-----c----CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 152 FKAFDMQALIN---------KIN-----KS-----I----VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 152 f~~~~~~~~~~---------~i~-----~~-----~----~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
|.......... .+. .+ . ...+...++..+.+||.+||..||.+|||+.++++|+||+
T Consensus 223 f~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp CCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred CCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 97643221100 000 00 0 0012234678999999999999999999999999999998
Q ss_pred hhh
Q 008303 209 PYV 211 (570)
Q Consensus 209 ~~~ 211 (570)
.+.
T Consensus 303 ~l~ 305 (676)
T 3qa8_A 303 ALD 305 (676)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-34 Score=293.42 Aligned_cols=173 Identities=21% Similarity=0.214 Sum_probs=141.1
Q ss_pred CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccceecCCcEEEcCCC-----------
Q 008303 23 GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH-ANHILHRDVKCSNIFLTKDQ----------- 90 (570)
Q Consensus 23 ~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH-s~gIvHrDLKP~NILld~~g----------- 90 (570)
+..+|||||||.+|++.+.+.+ ..+++..++.|+.||+.||.||| ++||+||||||+||||+.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred cCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCc
Confidence 4679999999999977666643 45899999999999999999999 99999999999999999887
Q ss_pred ---------CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhh-HHHhhccCCCCcccCH-HH
Q 008303 91 ---------DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC-IYEMTSLKPAFKAFDM-QA 159 (570)
Q Consensus 91 ---------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~I-lyeLltG~~pf~~~~~-~~ 159 (570)
.+||+|||+++..... ..+||+.|+|||++.+.. +.++||||||++ .++++.|..||..... ..
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~ 285 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY 285 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH
T ss_pred cccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH
Confidence 8999999999887543 458999999999998766 889999998776 7789999999865322 22
Q ss_pred HHHHHHhccCCC------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHH-HhhccC
Q 008303 160 LINKINKSIVAP------LPTKYSGAFRGLVKSMLRKNPELRPSAAELL-RHVHLQ 208 (570)
Q Consensus 160 ~~~~i~~~~~~p------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL-~hp~fq 208 (570)
....+....... .+..+++++++||++||.+| |++|+| +||||+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 286 LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 333333221111 12257889999999999987 999999 999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=293.61 Aligned_cols=179 Identities=16% Similarity=0.115 Sum_probs=149.4
Q ss_pred EEEEEeccCCCCHHHHHHH-----hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCc
Q 008303 26 VCIIIGFCEGGDMAEAIKK-----ANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLA 100 (570)
Q Consensus 26 i~IV~Ey~~gGsL~d~I~~-----~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla 100 (570)
+|++|+++ +++|.++++. .....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 180 ~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a 258 (413)
T 3dzo_A 180 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258 (413)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred eEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccce
Confidence 56778876 5799999862 22345788899999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCccccCCCCCCCcccc----------cCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCC
Q 008303 101 KILTSDDLASSVVGTPSYMCPELL----------ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA 170 (570)
Q Consensus 101 ~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~ 170 (570)
+..... ....+| +.|+|||++ ....|+.++|||||||++|+|++|+.||...+.......+.
T Consensus 259 ~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~----- 330 (413)
T 3dzo_A 259 VRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF----- 330 (413)
T ss_dssp EETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG-----
T ss_pred eecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH-----
Confidence 876543 455678 999999999 55568889999999999999999999998765433322221
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhhhh
Q 008303 171 PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213 (570)
Q Consensus 171 p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~~k 213 (570)
.....++.++.+||.+||..||.+||++.++++|+||+.....
T Consensus 331 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 331 RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373 (413)
T ss_dssp SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence 1234688999999999999999999999999999999876443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=304.37 Aligned_cols=191 Identities=20% Similarity=0.310 Sum_probs=157.2
Q ss_pred HHhhhcCCCcccccceEEEeeCc----EEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELISKIRNPFIVEYKDSWVERGC----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~----~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
++|++|+|||||+++++|...+. ..|||||||.|++|.+++.. .+++..++.|+.||+.||.|||++||+||
T Consensus 131 ~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHr 206 (681)
T 2pzi_A 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYN 206 (681)
T ss_dssp GGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeec
Confidence 57899999999999999976543 26999999999999988754 58999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
||||+|||++.+ .+||+|||+++..... ...+||+.|+|||++.+. ++.++|||||||++|+|++|.++|.+...
T Consensus 207 Dlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~ 281 (681)
T 2pzi_A 207 DLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV 281 (681)
T ss_dssp CCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC
T ss_pred ccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc
Confidence 999999999875 8999999999887543 456899999999999764 48899999999999999999988765321
Q ss_pred HHHHHHHHhccCCC-CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVAP-LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p-~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
. ..... ....++..+.+||.+||..||.+||+..+++.|.|+..
T Consensus 282 ~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 282 D--------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp S--------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c--------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 00000 00123578999999999999999999999999987653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-31 Score=265.98 Aligned_cols=172 Identities=16% Similarity=0.153 Sum_probs=140.6
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++||||+++++++.+. +..|+|||||+|++|.++++. + .....+..|+.||+.||+|||++||+||||||
T Consensus 83 ~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~--~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp 157 (286)
T 3uqc_A 83 LRLSRIDKPGVARVLDVVHTR-AGGLVVAEWIRGGSLQEVADT--S--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHP 157 (286)
T ss_dssp HHHHTCCCTTBCCEEEEEEET-TEEEEEEECCCEEEHHHHHTT--C--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred HHHhcCCCCCcceeeEEEEEC-CcEEEEEEecCCCCHHHHHhc--C--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCc
Confidence 568899999999999998665 478999999999999999953 1 46667899999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+|||++.+|.+||+++| |++ .++.++|||||||++|+|++|+.||.+.+....+
T Consensus 158 ~NIll~~~g~~kl~~~~-------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 158 SRVRVSIDGDVVLAYPA-------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp GGEEEETTSCEEECSCC-------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred ccEEEcCCCCEEEEecc-------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 99999999999998543 333 3789999999999999999999999875432211
Q ss_pred H---HHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 162 N---KINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 162 ~---~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
. +....... .....++.++.+||.+||..||.+| |+.|+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 0 00001001 1235689999999999999999999 999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-30 Score=283.57 Aligned_cols=187 Identities=14% Similarity=0.081 Sum_probs=132.8
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|+++ .|+||++++++|.++ +.+|||||||+|++|.++|++. +.+++. .|+.||+.||+|||++|||||||
T Consensus 292 ~~~l~~~~~~~~i~~~~~~~ed~-~~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDI 365 (569)
T 4azs_A 292 IKFLTQPPAGFDAPAVLAHGENA-QSGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDV 365 (569)
T ss_dssp HHHHHSCCTTCCCCCEEEEEECS-SEEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCC
T ss_pred HHHHHhcCCCCCeeEEEEEEEEC-CEEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccC
Confidence 4689999 899999999988654 5899999999999999999874 457765 47899999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
||+||||+.+|.+||+|||+++..... ......+||++|||||++.+ .+..++|+|++|+++++|..+..++.
T Consensus 366 KPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~----- 439 (569)
T 4azs_A 366 RPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWL----- 439 (569)
T ss_dssp CGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHHH-----
T ss_pred chHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchhH-----
Confidence 999999999999999999999877543 34556799999999999975 46778999999999999876644321
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 159 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 159 ~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
..+... .+. ...+..++..++..++..|+.......++|..
T Consensus 440 ---~~l~~~----~~~--~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 440 ---YAVWQE----PVE--RWNFVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp ---HHHHTS----CGG--GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred ---HHhhcC----CCC--CCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 111110 011 11345677777888888888777666666653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-22 Score=224.51 Aligned_cols=139 Identities=20% Similarity=0.243 Sum_probs=116.8
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++||||+.+..++...+ ..|||||||+|++|.++++. +..|+.||+.||.|||++||+|||||
T Consensus 390 ~~il~~l~h~nIv~~~~~~~~~~-~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiK 458 (540)
T 3en9_A 390 ARYLALVKDFGIPAPYIFDVDLD-NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLT 458 (540)
T ss_dssp HHHHHHGGGGTCCCCCEEEEETT-TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCC
T ss_pred HHHHHhcCCCCcCceEEEEEeCC-ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCC
Confidence 36899999999996665555443 46899999999999999864 56899999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--------CccccCCCCCCCcccccC--CCCCCcccccchhhhHHHhhccCC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--------ASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~l~~--~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
|+|||++. .+||+|||+++....... ....+||+.|||||++.. ..|+..+|+|+..+-..+.+.++.
T Consensus 459 p~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~ 536 (540)
T 3en9_A 459 TSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA 536 (540)
T ss_dssp TTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred HHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence 99999998 999999999998765321 246789999999999976 568888999999887777766655
Q ss_pred CC
Q 008303 151 AF 152 (570)
Q Consensus 151 pf 152 (570)
.|
T Consensus 537 rY 538 (540)
T 3en9_A 537 RY 538 (540)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5.9e-17 Score=164.63 Aligned_cols=97 Identities=13% Similarity=0.185 Sum_probs=80.1
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++ | +++.+++..+ ..|+|||||+||+|.+ +. ......++.||+.||.|||++||+||||||
T Consensus 156 ~~l~~l~--~-~~v~~~~~~~--~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp 221 (282)
T 1zar_A 156 RALQKLQ--G-LAVPKVYAWE--GNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRGIVHGDLSQ 221 (282)
T ss_dssp HHHHHTT--T-SSSCCEEEEE--TTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred HHHHhcc--C-CCcCeEEecc--ceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCH
Confidence 5778888 5 7777765433 3589999999999987 41 123557999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA 125 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~ 125 (570)
+|||++ +|.+||+|||+++. +..|+|||++.
T Consensus 222 ~NILl~-~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred HHEEEE-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 999999 99999999999964 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-13 Score=137.85 Aligned_cols=91 Identities=13% Similarity=0.166 Sum_probs=71.1
Q ss_pred HHhhhcCCCcc--cccceEEEeeCcEEEEEEeccCC-C----CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCC
Q 008303 2 ELISKIRNPFI--VEYKDSWVERGCYVCIIIGFCEG-G----DMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLH-ANH 73 (570)
Q Consensus 2 ~IL~kL~HPnI--V~l~~~f~~~~~~i~IV~Ey~~g-G----sL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLH-s~g 73 (570)
++|++|+|++| +.+++ .+ ..|||||||.+ | .|.+++.. +++..+..++.||+.||.||| ++|
T Consensus 122 ~~l~~l~~~~i~~p~~~~---~~--~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 122 RNLERAKEAGVSVPQPYT---YM--KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHTTCCCCCEEE---EE--TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHhCCCCCCeEEE---cC--CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 46788888765 33332 12 34799999942 3 77766432 245678899999999999999 999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceecc
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILT 104 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~ 104 (570)
|+||||||+|||++. .++|+|||++....
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999999998 89999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.03 E-value=8.5e-11 Score=125.20 Aligned_cols=70 Identities=16% Similarity=0.220 Sum_probs=58.6
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcEEEcCCCC----------EEEee
Q 008303 27 CIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQD----------IRLGD 96 (570)
Q Consensus 27 ~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~----------vKL~D 96 (570)
|||||||+|+.|..+. ..+....++.||+.+|.|||++|||||||||.|||++.+|. +.|+|
T Consensus 187 ~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp EEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred eEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 6999999998886532 22345678999999999999999999999999999998773 89999
Q ss_pred cCCceecc
Q 008303 97 FGLAKILT 104 (570)
Q Consensus 97 FGla~~~~ 104 (570)
|+-+-...
T Consensus 259 ~~Q~V~~~ 266 (397)
T 4gyi_A 259 FPQMVSMD 266 (397)
T ss_dssp CTTCEETT
T ss_pred eCCcccCC
Confidence 99876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.4e-08 Score=98.39 Aligned_cols=93 Identities=14% Similarity=0.122 Sum_probs=73.0
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---------
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA--------- 71 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs--------- 71 (570)
++|+.| .|..|.++++++.. ++..|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 61 ~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~ 132 (263)
T 3tm0_A 61 DMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYT 132 (263)
T ss_dssp HHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCB
T ss_pred HHHHHHhcCCCCCeEEEEEec-CCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCc
Confidence 456667 46778889987755 457899999999999987531 222345788999999999998
Q ss_pred --------------------------------------------------CCcccceecCCcEEEcCCCCEEEeecCCce
Q 008303 72 --------------------------------------------------NHILHRDVKCSNIFLTKDQDIRLGDFGLAK 101 (570)
Q Consensus 72 --------------------------------------------------~gIvHrDLKP~NILld~~g~vKL~DFGla~ 101 (570)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 133 NSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876566799999875
Q ss_pred e
Q 008303 102 I 102 (570)
Q Consensus 102 ~ 102 (570)
.
T Consensus 213 ~ 213 (263)
T 3tm0_A 213 R 213 (263)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.8e-07 Score=95.35 Aligned_cols=98 Identities=11% Similarity=0.175 Sum_probs=75.3
Q ss_pred HHhhhcC--CCcccccceEEEeeC--cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH------
Q 008303 2 ELISKIR--NPFIVEYKDSWVERG--CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA------ 71 (570)
Q Consensus 2 ~IL~kL~--HPnIV~l~~~f~~~~--~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs------ 71 (570)
++|+.|. +..|+++++++.+.. +..|+||||++|..+.+.. -..++......++.+++.+|..||.
T Consensus 88 ~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~ 163 (359)
T 3dxp_A 88 RVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAI 163 (359)
T ss_dssp HHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTT
T ss_pred HHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhc
Confidence 4566664 455788887664431 2468999999998774311 1236788899999999999999997
Q ss_pred ----------------------------------------------------CCcccceecCCcEEEcCCCC--EEEeec
Q 008303 72 ----------------------------------------------------NHILHRDVKCSNIFLTKDQD--IRLGDF 97 (570)
Q Consensus 72 ----------------------------------------------------~gIvHrDLKP~NILld~~g~--vKL~DF 97 (570)
.+++|+|+++.|||++.++. +.|+||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDw 243 (359)
T 3dxp_A 164 GLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDW 243 (359)
T ss_dssp TCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCC
T ss_pred cccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECc
Confidence 36899999999999997753 699999
Q ss_pred CCceec
Q 008303 98 GLAKIL 103 (570)
Q Consensus 98 Gla~~~ 103 (570)
+.+...
T Consensus 244 e~a~~g 249 (359)
T 3dxp_A 244 ELSTLG 249 (359)
T ss_dssp TTCEEE
T ss_pred cccccC
Confidence 998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.34 E-value=2.1e-07 Score=90.35 Aligned_cols=90 Identities=17% Similarity=0.142 Sum_probs=64.1
Q ss_pred HHhhhcCCCc--ccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC------
Q 008303 2 ELISKIRNPF--IVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH------ 73 (570)
Q Consensus 2 ~IL~kL~HPn--IV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g------ 73 (570)
++|+.|.+.+ |.++++++... +..|+||||++|.+|. .. . .. ...++.++...|..||...
T Consensus 65 ~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~e~i~G~~l~--~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~ 133 (264)
T 1nd4_A 65 ARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQDLL--SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPF 133 (264)
T ss_dssp HHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSEETT--TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCC
T ss_pred HHHHHHHhCCCCCCeEEEeccCC-CCCEEEEEecCCcccC--cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4566774334 55688766544 4578999999998874 11 0 12 2255667777777777643
Q ss_pred ----------------------------------------------------cccceecCCcEEEcCCCCEEEeecCCce
Q 008303 74 ----------------------------------------------------ILHRDVKCSNIFLTKDQDIRLGDFGLAK 101 (570)
Q Consensus 74 ----------------------------------------------------IvHrDLKP~NILld~~g~vKL~DFGla~ 101 (570)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 134 DHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp BCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999986
Q ss_pred e
Q 008303 102 I 102 (570)
Q Consensus 102 ~ 102 (570)
.
T Consensus 214 ~ 214 (264)
T 1nd4_A 214 V 214 (264)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.17 E-value=6.9e-07 Score=90.36 Aligned_cols=145 Identities=16% Similarity=0.157 Sum_probs=92.6
Q ss_pred HHhhhc-CCCcc--cccceEEEeeC--cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-----
Q 008303 2 ELISKI-RNPFI--VEYKDSWVERG--CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA----- 71 (570)
Q Consensus 2 ~IL~kL-~HPnI--V~l~~~f~~~~--~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs----- 71 (570)
++|+.| .+..| .+++......+ ...|+||||++|..|.+.... .++.++...++.|+...|..||.
T Consensus 62 ~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~ 137 (304)
T 3sg8_A 62 NILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISG 137 (304)
T ss_dssp HHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 456666 33333 34443322222 134789999999888754332 26788888899999999999986
Q ss_pred -----------------------------------------------------CCcccceecCCcEEEcC--CCCEEEee
Q 008303 72 -----------------------------------------------------NHILHRDVKCSNIFLTK--DQDIRLGD 96 (570)
Q Consensus 72 -----------------------------------------------------~gIvHrDLKP~NILld~--~g~vKL~D 96 (570)
..++|+|+++.||+++. .+.+.|+|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD 217 (304)
T 3sg8_A 138 FKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIID 217 (304)
T ss_dssp SCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECC
T ss_pred CCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEe
Confidence 13699999999999998 45688999
Q ss_pred cCCceeccCCCCCccccCCCCC---CCcccccC--CCCC------------CcccccchhhhHHHhhccCCCCc
Q 008303 97 FGLAKILTSDDLASSVVGTPSY---MCPELLAD--IPYG------------SKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 97 FGla~~~~~~~~~~~~~GT~~Y---~APE~l~~--~~~t------------~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
|+.+....... .......+ ..++.... ..|. .-.++|++|.++|.+.+|..+|.
T Consensus 218 ~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 218 FGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCccCChHH---HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 99987643211 00011111 23332210 0111 12588999999999999987664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=8.7e-05 Score=75.40 Aligned_cols=98 Identities=16% Similarity=0.131 Sum_probs=65.0
Q ss_pred HHhhhcCCC---cccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC------
Q 008303 2 ELISKIRNP---FIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN------ 72 (570)
Q Consensus 2 ~IL~kL~HP---nIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~------ 72 (570)
++|+.|.+. .|.+++.+.....+..|+||||++|..|.+..-. .++......++.|+...|..||..
T Consensus 61 ~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~ 136 (306)
T 3tdw_A 61 QLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAI 136 (306)
T ss_dssp HHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHH
T ss_pred HHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCccccc
Confidence 466777442 3556666554334456799999999888763211 134555555555555555555542
Q ss_pred ------------------------------------------------------CcccceecCCcEEEcC---CCC-EEE
Q 008303 73 ------------------------------------------------------HILHRDVKCSNIFLTK---DQD-IRL 94 (570)
Q Consensus 73 ------------------------------------------------------gIvHrDLKP~NILld~---~g~-vKL 94 (570)
.++|+|+++.|||++. ++. +.|
T Consensus 137 ~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~ 216 (306)
T 3tdw_A 137 SAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGI 216 (306)
T ss_dssp HTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEE
T ss_pred ccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEE
Confidence 3589999999999987 455 489
Q ss_pred eecCCceec
Q 008303 95 GDFGLAKIL 103 (570)
Q Consensus 95 ~DFGla~~~ 103 (570)
+||+.+...
T Consensus 217 iD~~~a~~g 225 (306)
T 3tdw_A 217 IDFGDAAIS 225 (306)
T ss_dssp CCCTTCEEE
T ss_pred EehhhcCCC
Confidence 999988763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00027 Score=69.37 Aligned_cols=138 Identities=17% Similarity=0.142 Sum_probs=94.3
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccC
Q 008303 36 GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVG 114 (570)
Q Consensus 36 GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~G 114 (570)
-+|.+.++..+ .+++|+++|.+++|.+.+|.-+-. +.-..+=+.+..|+|..+|.|-+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 47999998875 689999999999999999887622 2222344557899999999988764 1111 11
Q ss_pred CCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhcc----
Q 008303 115 TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRK---- 190 (570)
Q Consensus 115 T~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~---- 190 (570)
...+.+||... ...+.+.-|||||+++|.-+-. +.....+..+|+.+..||..|...
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy------------------gL~e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY------------------GLKENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTT------------------TCCTTEEECCCHHHHHHHHHHTTCCC--
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc------------------CCCcccchhhCHHHHHHHHHHHhccccc
Confidence 23456787763 3456788899999999976532 222233557899999999999865
Q ss_pred ---------------------CCCCCcCHHHHHHhh
Q 008303 191 ---------------------NPELRPSAAELLRHV 205 (570)
Q Consensus 191 ---------------------dP~~RPTa~eIL~hp 205 (570)
.+..|.++++||+..
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C 196 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLC 196 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHHHH
T ss_pred ccccccccccccccccccccccccCcCCHHHHHHHH
Confidence 246888999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00017 Score=70.88 Aligned_cols=93 Identities=14% Similarity=0.069 Sum_probs=65.1
Q ss_pred Hhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------
Q 008303 3 LISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHAN--------- 72 (570)
Q Consensus 3 IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~--------- 72 (570)
+|+.| .+--|.++++++.+. +..|+|||+++|.++.+..... ......+..++...|..||..
T Consensus 72 ~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~ 144 (272)
T 4gkh_A 72 RLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNS 144 (272)
T ss_dssp HHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBC
T ss_pred HHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCc
Confidence 45555 222356788776554 4788999999999888766432 122334556666666666631
Q ss_pred -------------------------------------------------CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 -------------------------------------------------HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 -------------------------------------------------gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++|+|+++.|||++.++.+-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 145 DRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999877777999999865
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0019 Score=64.99 Aligned_cols=31 Identities=19% Similarity=0.346 Sum_probs=27.9
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00058 Score=70.02 Aligned_cols=31 Identities=16% Similarity=0.318 Sum_probs=26.5
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
..++|+|+++.|||+++++.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999999644579999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.0095 Score=59.68 Aligned_cols=30 Identities=17% Similarity=0.324 Sum_probs=25.6
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
.++|+|+.+.||| ..++.+.|+||..+...
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 3899999999999 56778899999988653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.015 Score=58.95 Aligned_cols=32 Identities=25% Similarity=0.352 Sum_probs=27.9
Q ss_pred CCcccceecCCcEEEcCC----CCEEEeecCCceec
Q 008303 72 NHILHRDVKCSNIFLTKD----QDIRLGDFGLAKIL 103 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~----g~vKL~DFGla~~~ 103 (570)
..++|||+++.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67999999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.16 E-value=0.043 Score=57.78 Aligned_cols=30 Identities=27% Similarity=0.450 Sum_probs=27.0
Q ss_pred CcccceecCCcEEEcCC----CCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKD----QDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~----g~vKL~DFGla~~ 102 (570)
.++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 48999999999999876 7899999998865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.036 Score=58.40 Aligned_cols=33 Identities=18% Similarity=0.302 Sum_probs=28.6
Q ss_pred HHCCcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 70 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 70 Hs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
+...++|+|+++.|||++.++ ++|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356799999999999998776 999999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=91.82 E-value=0.22 Score=50.79 Aligned_cols=25 Identities=24% Similarity=0.278 Sum_probs=22.7
Q ss_pred CcccceecCCcEEEcCCCCEEEeecC
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFG 98 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFG 98 (570)
.++|+|+.+.||+++.++ +.|+||+
T Consensus 208 ~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 208 SILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp EEECSSCSGGGEEEETTE-EEECSCC
T ss_pred eeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 589999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.85 E-value=0.086 Score=52.76 Aligned_cols=41 Identities=32% Similarity=0.400 Sum_probs=31.5
Q ss_pred HHHHHHHHHH-------CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 62 LLMALDYLHA-------NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 62 Ll~aL~yLHs-------~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
+...+.+++. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3444555553 3699999999999999776668999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.48 E-value=0.17 Score=50.66 Aligned_cols=29 Identities=28% Similarity=0.253 Sum_probs=25.3
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3589999999999998 4 899999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.02 E-value=0.26 Score=50.37 Aligned_cols=32 Identities=16% Similarity=0.365 Sum_probs=28.3
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCceec
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 103 (570)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999987664
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=87.88 E-value=0.4 Score=49.17 Aligned_cols=29 Identities=31% Similarity=0.413 Sum_probs=24.7
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++|+|+++.|||++.++ +.|+||+.+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999998654 89999998865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=87.11 E-value=0.39 Score=49.65 Aligned_cols=31 Identities=23% Similarity=0.399 Sum_probs=26.3
Q ss_pred HCCcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 71 ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 71 s~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
...++|||+++.|||++.+ .++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3579999999999999865 489999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=84.74 E-value=0.56 Score=50.42 Aligned_cols=15 Identities=40% Similarity=0.403 Sum_probs=14.1
Q ss_pred CcccceecCCcEEEc
Q 008303 73 HILHRDVKCSNIFLT 87 (570)
Q Consensus 73 gIvHrDLKP~NILld 87 (570)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=81.92 E-value=0.48 Score=50.23 Aligned_cols=30 Identities=33% Similarity=0.448 Sum_probs=24.9
Q ss_pred CcccceecCCcEEEcCC----------------------------CCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKD----------------------------QDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~----------------------------g~vKL~DFGla~~ 102 (570)
.++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999875 6789999988765
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.24 E-value=2.6 Score=41.00 Aligned_cols=114 Identities=14% Similarity=0.063 Sum_probs=72.9
Q ss_pred CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH-HHHHCCcccceecCCcEEE
Q 008303 8 RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD-YLHANHILHRDVKCSNIFL 86 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~-yLHs~gIvHrDLKP~NILl 86 (570)
.||++ ..- .....+.+.|.++.-+++.=+..|++ ++....++++.+|+.... ++ ..-+|--|+|+||++
T Consensus 48 ~~~~f-~~~--I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI-VRD--IDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS-EEE--EEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE
T ss_pred cCCCC-CeE--EEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE
Confidence 67777 222 22334456666666544333445543 688899998888887665 44 455788899999999
Q ss_pred cCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCccccc-chhhhHHHhhccCCCCc
Q 008303 87 TKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIW-SLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 87 d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIW-SLG~IlyeLltG~~pf~ 153 (570)
+.++.++|.-.|+-..+. |.-+ ...|.| .+=|++..++.++.-|.
T Consensus 118 ~~~~~p~i~hRGi~~~lp----------------P~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKESLP----------------PDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETTTBS----------------SCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCcccCC----------------CCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999998877643322 2111 112222 56678888887766553
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 570 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-14 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-60
Identities = 81/213 (38%), Positives = 122/213 (57%), Gaps = 9/213 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCK 57
+ L+ ++++P IV Y D ++R + I++ +CEGGD+A I K + EE + +
Sbjct: 54 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113
Query: 58 WLVQLLMALDYLH-----ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASS 111
+ QL +AL H + +LHRD+K +N+FL Q+++LGDFGLA+IL D A +
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
Query: 112 VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP 171
VGTP YM PE + + Y KSDIWSLGC +YE+ +L P F AF + L KI +
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233
Query: 172 LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+P +YS ++ ML RPS E+L +
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-56
Identities = 75/237 (31%), Positives = 124/237 (52%), Gaps = 17/237 (7%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++++ +P IV+ D++ + I+I FC GG + + + + +E ++
Sbjct: 60 IDILASCDHPNIVKLLDAFYYEN-NLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCK 117
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYM 119
Q L AL+YLH N I+HRD+K NI T D DI+L DFG++ T S +GTP +M
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177
Query: 120 CPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL-- 172
PE++ D PY K+D+WSLG + EM ++P + ++ KI KS L
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHW 229
P+++S F+ +K L KN + R + ++LL+H P+V N P R ++
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH----PFVTV---DSNKPIRELIAEA 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-56
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 5/204 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+E+ S +R+P I+ + + V +I+ + G + ++K + F E++ ++
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT 113
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
+L AL Y H+ ++HRD+K N+ L ++++ DFG + S +++ GT Y+
Sbjct: 114 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLP 172
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE++ + K D+WSLG YE KP F+A Q +I++ + P +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGA 231
Query: 181 RGLVKSMLRKNPELRPSAAELLRH 204
R L+ +L+ NP RP E+L H
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLEH 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 186 bits (474), Expect = 1e-54
Identities = 55/277 (19%), Positives = 124/277 (44%), Gaps = 16/277 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ +++++ +P ++ D++ ++ + +I+ F GG++ + I + K+ SE ++ ++
Sbjct: 77 ISIMNQLHHPKLINLHDAFEDKY-EMVLILEFLSGGELFDRIAAEDYKM-SEAEVINYMR 134
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSY 118
Q L ++H + I+H D+K NI + +++ DFGLA L D++ T +
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK---SIVAPLPTK 175
PE++ P G +D+W++G Y + S F D + + + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYA 235
S + +K++L+K P R + + L H L+ + ++ S R N + + YA
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 314
Query: 236 RRTRFSE-----PDNVPISSYREKQY----SFSNNRN 263
+ + +R ++Y S+ + +
Sbjct: 315 DWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-54
Identities = 53/215 (24%), Positives = 103/215 (47%), Gaps = 14/215 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ K R+ I+ + + I+ +CEG + + +K F KL
Sbjct: 55 VGVLRKTRHVNILLFMG--YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIAR 111
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPS 117
Q +DYLHA I+HRD+K +NIFL +D +++GDFGLA + + + G+
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 118 YMCPELL---ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-MQALINKINKSIVAP-- 171
+M PE++ PY +SD+++ G +YE+ + + + + +I + + ++P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 172 --LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ + A + L+ L+K + RP ++L
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (466), Expect = 1e-53
Identities = 54/249 (21%), Positives = 109/249 (43%), Gaps = 8/249 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ +S +R+P +V D++ + + +I F GG++ E + ++K+ SE++ +++
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDN-EMVMIYEFMSGGELFEKVADEHNKM-SEDEAVEYMR 131
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSY 118
Q+ L ++H N+ +H D+K NI T + ++L DFGL L GT +
Sbjct: 132 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF 191
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK---SIVAPLPTK 175
PE+ P G +D+WS+G Y + S F + + + ++ +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVH-LKLNSPRRNSLSHWPESNY 234
S + ++ +L +P R + + L H L P ++ S R + ++ Y
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKY 311
Query: 235 ARRTRFSEP 243
P
Sbjct: 312 DAWPEPLPP 320
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 180 bits (458), Expect = 2e-53
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 13/221 (5%)
Query: 1 MELISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
++++ K+ P I++ KD E + ++ + G++ + + + SE++ K +
Sbjct: 60 VDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 116
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
LL + LH +I+HRD+K NI L D +I+L DFG + L + V GTPSY+
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 120 CPELLA------DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKI---NKSIVA 170
PE++ YG + D+WS G +Y + + P F ++ I N +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 171 PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211
P YS + LV L P+ R +A E L H Q YV
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 2e-53
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ + K+R+P ++Y+ ++ +++ +C G + K E ++
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTH 122
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
L L YLH+++++HRDVK NI L++ ++LGDFG A I+ A+S VGTP +M
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMA 179
Query: 121 PELLA---DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY- 176
PE++ + Y K D+WSLG E+ KP + + + I ++ L + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239
Query: 177 SGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLK 213
S FR V S L+K P+ RP++ LL+H +VL+
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKH----RFVLR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-52
Identities = 41/205 (20%), Positives = 97/205 (47%), Gaps = 3/205 (1%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++++R+ +V+ VE + I+ + G + + ++ + + L K+ +
Sbjct: 51 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 110
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
+ A++YL N+ +HRD+ N+ +++D ++ DFGL K +S + +
Sbjct: 111 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTA 168
Query: 121 PELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE L + + +KSD+WS G ++E+ + + + ++ ++ ++ K P A
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 180 FRGLVKSMLRKNPELRPSAAELLRH 204
++K+ + +RPS +L
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-52
Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 7/211 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ + +NP IV Y DS++ + +++ + GG + + + + E ++
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCR 123
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYM 119
+ L AL++LH+N ++HRD+K NI L D ++L DFG +T + S++VGTP +M
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPL--PTKYS 177
PE++ YG K DIWSLG EM +P + + + I + L P K S
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
FR + L + E R SA ELL+H L+
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 8e-52
Identities = 66/243 (27%), Positives = 120/243 (49%), Gaps = 14/243 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ KI++P IV D + G ++ +I+ GG++ + I + ++E + +
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGG-HLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIF 114
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLT---KDQDIRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L A+ YLH I+HRD+K N+ +D I + DFGL+K+ + S+ GTP
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG 174
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIV---APLPT 174
Y+ PE+LA PY D WS+G Y + P F + L +I K+ +P
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNY 234
S + + ++ ++ K+PE R + + L+H P+ + L+ S+S + N+
Sbjct: 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQH----PW-IAGDTALDKNIHQSVSEQIKKNF 289
Query: 235 ARR 237
A+
Sbjct: 290 AKS 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 1e-51
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 1 MELISKIRNPFIVEYKDSW---VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
E++ +++P IV + DSW V+ + ++ G + +K+ K+ + L
Sbjct: 59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRS 116
Query: 58 WLVQLLMALDYLHANH--ILHRDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVG 114
W Q+L L +LH I+HRD+KC NIF+T +++GD GLA + A +V+G
Sbjct: 117 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIG 175
Query: 115 TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP--L 172
TP +M PE+ + Y D+++ G C+ EM + + + A I + S V P
Sbjct: 176 TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234
Query: 173 PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
+ +++ +R+N + R S +LL H Q
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-51
Identities = 64/211 (30%), Positives = 113/211 (53%), Gaps = 7/211 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++S++ +PF V+ ++ + + + + + G++ + I+K S F E +
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTA 115
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPS 117
+++ AL+YLH I+HRD+K NI L +D I++ DFG AK+L+ + A+S VGT
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
Y+ PELL + SD+W+LGC IY++ + P F+A + + KI K P K+
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFF 234
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208
R LV+ +L + R E+ + L+
Sbjct: 235 PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-51
Identities = 46/210 (21%), Positives = 91/210 (43%), Gaps = 9/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ + + + +V++ G + + +C GG++ + I+ E ++
Sbjct: 54 ICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFH 110
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPS 117
QL+ + YLH I HRD+K N+ L + ++++ DFGLA + ++ L + + GT
Sbjct: 111 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 118 YMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFD--MQALINKINKSIVAPLPT 174
Y+ PELL + D+WS G + M + + + Q + K
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
K A L+ +L +NP R + ++ +
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDIKKD 260
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-51
Identities = 55/238 (23%), Positives = 109/238 (45%), Gaps = 11/238 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ +++ R+ I+ +S+ + +I F G D+ E I + +L +E ++ ++
Sbjct: 52 ISILNIARHRNILHLHESFESME-ELVMIFEFISGLDIFERINTSAFEL-NEREIVSYVH 109
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQD--IRLGDFGLAKILTSDDLASSVVGTPSY 118
Q+ AL +LH+++I H D++ NI + I++ +FG A+ L D + P Y
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK---SIVAPLPTK 175
PE+ + +D+WSLG +Y + S F A Q +I I + +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESN 233
S V +L K + R +A+E L+H P++ + ++++ +L H +
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQH----PWLKQKIERVSTKVIRTLKHRRYYH 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-50
Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 59/273 (21%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++++ + +P+IV + ++ G + I + +GG + + +KK + E+ L K +
Sbjct: 55 LQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSI 111
Query: 61 QLLMALDYLH-ANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
++ L YL + I+HRDVK SNI + +I+L DFG++ L D +A+S VGT SYM
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYM 170
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ--------------------- 158
PE L Y +SDIWS+G + EM + D +
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 159 ---------------------ALINKINKSIVAPLPTK-YSGAFRGLVKSMLRKNPELRP 196
L++ I LP+ +S F+ V L KNP R
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 197 SAAELLRH----------VHLQPYVLKVHLKLN 219
+L+ H V ++ + LN
Sbjct: 291 DLKQLMVHAFIKRSDAEEVDFAGWLCST-IGLN 322
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-49
Identities = 58/236 (24%), Positives = 106/236 (44%), Gaps = 17/236 (7%)
Query: 3 LISKIRNPFIVEYKDSW---VERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWL 59
+ P IV D + + I++ +GG++ I+ + F+E + + +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQD---IRLGDFGLAKILTSDDLASSVVGTP 116
+ A+ YLH+ +I HRDVK N+ T + ++L DFG AK TS + ++ TP
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA------ 170
Y+ PE+L Y D+WSLG +Y + P F + A+ + I
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 171 -PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNS 225
P ++ S + L++++L+ P R + E + H P++++ +P S
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH----PWIMQSTKVPQTPLHTS 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 42/209 (20%), Positives = 92/209 (44%), Gaps = 5/209 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++ K+R+ +V+ E Y I+ + G + + +K K +L
Sbjct: 63 AQVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSY 118
Q+ + Y+ + +HRD++ +NI + ++ ++ DFGLA+++ ++ +
Sbjct: 121 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE + KSD+WS G + E+ T + + + +++++ + P P +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRHVH 206
+ L+ RK PE RP+ L +
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 41/209 (19%), Positives = 87/209 (41%), Gaps = 8/209 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++ ++ NP+IV + + +++ GG + + + ++ + + L
Sbjct: 60 AQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLH 116
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTP 116
Q+ M + YL + +HRD+ N+ L ++ DFGL+K L +DD S+
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTK 175
+ PE + + S+SD+WS G ++E + + +K ++ I + P +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRH 204
L+ E RP + +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-47
Identities = 44/208 (21%), Positives = 94/208 (45%), Gaps = 5/208 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++ + + +V+ ++ + II + G + +++ + F ++L +
Sbjct: 50 AKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCK 107
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS--VVGTPSY 118
+ A++YL + LHRD+ N + +++ DFGL++ + D+ SS +
Sbjct: 108 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE+L + SKSDIW+ G ++E+ SL K ++ F I + + P S
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRHV 205
++ S + + RP+ LL ++
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-47
Identities = 47/254 (18%), Positives = 101/254 (39%), Gaps = 7/254 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++ + NP + + +I G + + +++ + + L W V
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCV 118
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPS 117
Q+ ++YL ++HRD+ N+ + Q +++ DFGLAK+L +++ A
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 118 YMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKY 176
+M E + Y +SD+WS G ++E+ T + + + + K P P
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 238
Query: 177 SGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYAR 236
+ ++ + + RP EL+ + +L + R L +SN+ R
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYR 298
Query: 237 RTRFSEPDNVPISS 250
E + + +
Sbjct: 299 ALMDEEDMDDVVDA 312
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-47
Identities = 39/211 (18%), Positives = 88/211 (41%), Gaps = 9/211 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ ++ NP+IV +++ E G + + +++ ++ ++ + + +
Sbjct: 59 ANVMQQLDNPYIVRMIGICEAESWM--LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVH 114
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTP 116
Q+ M + YL ++ +HRD+ N+ L ++ DFGL+K L +D+ +
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTK 175
+ PE + + SKSD+WS G ++E + + ++ + + K P
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 234
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206
L+ + E RP A + +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-46
Identities = 39/209 (18%), Positives = 87/209 (41%), Gaps = 5/209 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
L+ ++++ +V + Y II + E G + + +K + + KL
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSY 118
Q+ + ++ + +HRD++ +NI ++ ++ DFGLA+++ ++ +
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE + + KSD+WS G + E+ T + + +I + + P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRHVH 206
L++ ++ PE RP+ L +
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-46
Identities = 49/207 (23%), Positives = 98/207 (47%), Gaps = 5/207 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
E++ K+ +P +V+ +E+ +C++ F E G +++ + LF+ E L +
Sbjct: 51 AEVMMKLSHPKLVQLYGVCLEQA-PICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCL 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS--VVGTPSY 118
+ + YL ++HRD+ N + ++Q I++ DFG+ + + D SS +
Sbjct: 109 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE+ + Y SKSD+WS G ++E+ + K ++ ++ I+ P S
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH 204
++ ++ PE RP+ + LLR
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-45
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 6/204 (2%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQL 62
L +PF+ ++ + + ++ + GGD+ I+ + F + + ++
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEI 112
Query: 63 LMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCP 121
++ L +LH+ I++RD+K NI L KD I++ DFG+ K D ++ GTP Y+ P
Sbjct: 113 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+L Y D WS G +YEM + F D + L + I P +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAK 231
Query: 182 GLVKSMLRKNPELRPSAA-ELLRH 204
L+ + + PE R ++ +H
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQH 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 4e-44
Identities = 50/214 (23%), Positives = 97/214 (45%), Gaps = 12/214 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
+ + + +P IV D+ G I++ + +G + + + + ++ +
Sbjct: 58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIE 115
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVV 113
+ AL++ H N I+HRDVK +NI ++ +++ DFG+A+ + ++V+
Sbjct: 116 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 114 GTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP-- 171
GT Y+ PE ++SD++SLGC +YE+ + +P F ++ + + P
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
Query: 172 -LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
S +V L KNPE R A +R
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-44
Identities = 46/231 (19%), Positives = 93/231 (40%), Gaps = 28/231 (12%)
Query: 1 MELISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL---------- 49
+++++++ + IV + G + +I +C GD+ ++ K
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149
Query: 50 -----------FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFG 98
+ E L + Q+ +++L +HRD+ N+ +T + +++ DFG
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 99 LAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKA 154
LA+ + SD + + +M PE L + Y KSD+WS G ++E+ SL +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 155 FDMQALINKI-NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ A K+ P + +++S + RPS L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-44
Identities = 38/232 (16%), Positives = 94/232 (40%), Gaps = 9/232 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ +P ++ + +++ + + GD+ + + + + L + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGL 137
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-----SVVGT 115
Q+ + +L + +HRD+ N L + +++ DFGLA+ + + S
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPT 174
+M E L + +KSD+WS G ++E+ T P + + + + + P
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 257
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELLRHVH--LQPYVLKVHLKLNSPRRN 224
++ E+RPS +EL+ + ++ + ++ +N+ N
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 309
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-44
Identities = 45/220 (20%), Positives = 92/220 (41%), Gaps = 17/220 (7%)
Query: 1 MELISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--------------A 45
+E++ K+ + P I+ + RG Y+ + I + G++ + ++K +
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
Query: 46 NSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTS 105
+ S ++L + + +DYL +HRD+ NI + ++ ++ DFGL++
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
Query: 106 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKI 164
+ +M E L Y + SD+WS G ++E+ + + L K+
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
Query: 165 NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ P L++ R+ P RPS A++L
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (393), Expect = 7e-44
Identities = 46/209 (22%), Positives = 95/209 (45%), Gaps = 4/209 (1%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ +I++P +V+ + II F G++ + +++ N + S L
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASS--VVGTPSY 118
Q+ A++YL + +HRD+ N + ++ +++ DFGL++++T D + +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
PE LA + KSD+W+ G ++E+ T + D+ + + K P
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRHVH 206
L+++ + NP RPS AE+ +
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 8e-44
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 6/207 (2%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ + +P IV+ E V II+ C G++ ++ L L +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSL-DLASLILYAY 115
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSY 118
QL AL YL + +HRD+ N+ ++ + ++LGDFGL++ + AS +
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 119 MCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTKYS 177
M PE + + S SD+W G C++E+ F+ +I +I P+P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 178 GAFRGLVKSMLRKNPELRPSAAELLRH 204
L+ +P RP EL
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 51/217 (23%), Positives = 107/217 (49%), Gaps = 10/217 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ +I++P ++ + + + V +I+ GG++ + + + S +EE+ ++L
Sbjct: 64 VSILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFLAEKES--LTEEEATEFLK 120
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQD----IRLGDFGLAKILTSDDLASSVVGTP 116
Q+L + YLH+ I H D+K NI L I++ DFGLA + + ++ GTP
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK---SIVAPLP 173
++ PE++ P G ++D+WS+G Y + S F Q + ++
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
+ S + ++ +L K+P+ R + + L+H ++P
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 6e-43
Identities = 41/229 (17%), Positives = 86/229 (37%), Gaps = 27/229 (11%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL----------- 49
L+++ NP IV+ +C++ + GD+ E ++ +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 50 -----------FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFG 98
S + Q+ + YL +HRD+ N + ++ +++ DFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 99 LAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKA 154
L++ + S D + +M PE + Y ++SD+W+ G ++E+ + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 155 FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
+ +I + + P L++ K P RPS + R
Sbjct: 246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-43
Identities = 40/208 (19%), Positives = 82/208 (39%), Gaps = 9/208 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ + + + ++ + ++ G + + ++K F L ++ V
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 118
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTP 116
Q+ + YL + +HRD+ N+ L +++GDFGL + L +D +
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVA-PLPT 174
++ PE L + SD W G ++EM T + + + +++KI+K P P
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
Query: 175 KYSGAFRGLVKSMLRKNPELRPSAAELL 202
++ PE RP+ L
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 8e-43
Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 31/234 (13%)
Query: 1 MELISKIRNPFIVEYKDSWV----ERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLC 56
+ + +P +V D +R + ++ + + + K E +
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIK 119
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP 116
+ QLL LD+LH++ ++HRD+K NI +T I+L DFGLA+I + +SVV T
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 179
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP----- 171
Y PE+L Y + D+WS+GC EM KP F+ + KI I P
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 172 ---------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
T + L+ L NP R SA L H
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 3e-42
Identities = 45/211 (21%), Positives = 88/211 (41%), Gaps = 9/211 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ + +P ++ + + V II F E G + ++ + N F+ +L L
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKST-PVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLR 135
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSV------VG 114
+ + YL + +HRD+ NI + + ++ DFGL++ L D +
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195
Query: 115 TPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLP 173
+ PE + + S SD+WS G ++E+ S + + Q +IN I + P P
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 255
Query: 174 TKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
A L+ +K+ RP +++
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-42
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 10/210 (4%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ R+PF+ K ++ +C ++ + GG++ + + ++F+EE+ +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSR--ERVFTEERARFYGA 112
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYM 119
+++ AL+YLH+ +++RD+K N+ L KD I++ DFGL K SD + GTP Y+
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGA 179
PE+L D YG D W LG +YEM + F D + L I + P S
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPE 231
Query: 180 FRGLVKSMLRKNPELRPS-----AAELLRH 204
+ L+ +L+K+P+ R A E++ H
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (381), Expect = 2e-41
Identities = 53/212 (25%), Positives = 104/212 (49%), Gaps = 12/212 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ L+S PFIV ++ + I+ GGD+ + + +FSE + +
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAA 114
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
++++ L+++H +++RD+K +NI L + +R+ D GLA S + VGT YM
Sbjct: 115 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMA 173
Query: 121 PELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM--QALINKINKSIVAPLPTKYS 177
PE+L + Y S +D +SLGC ++++ F+ + I+++ ++ LP +S
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 178 GAFRGLVKSMLRKNPELRPS-----AAELLRH 204
R L++ +L+++ R A E+
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 4e-41
Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQ 61
++S + +PFI+ ++ + +I+ + EGG++ ++ S+ F + +
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQI-FMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAE 112
Query: 62 LLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP 121
+ +AL+YLH+ I++RD+K NI L K+ I++ DFG AK + D+ ++ GTP Y+ P
Sbjct: 113 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAP 170
Query: 122 ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAFR 181
E+++ PY D WS G IYEM + F + KI + + P ++ +
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVK 229
Query: 182 GLVKSMLRKNPELR-----PSAAELLRH 204
L+ ++ ++ R ++ H
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNH 257
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-40
Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 19/225 (8%)
Query: 1 MELISKIRN--PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKW 58
+ L+ K+ + ++ D + +V I+ D+ + I + EE +
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSF 115
Query: 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQ-DIRLGDFGLAKILTSDDLASSVVGTPS 117
Q+L A+ + H +LHRD+K NI + ++ +++L DFG +L D + + GT
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRV 174
Query: 118 YMCPELLADIPYGSKS-DIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKY 176
Y PE + Y +S +WSLG +Y+M F+ +I + V +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQV-FFRQRV 227
Query: 177 SGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYVL-----KVHL 216
S + L++ L P RP+ E+ H +Q +L ++HL
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHL 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 43/208 (20%), Positives = 88/208 (42%), Gaps = 7/208 (3%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ + + I+ + + + II + E G + + +++ FS +L L
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYK-PMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLR 117
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA----SSVVGTP 116
+ + YL + +HRD+ NI + + ++ DFGL+++L D A S
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 117 SYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSIVAPLPTK 175
+ PE ++ + S SD+WS G ++E+ T + + ++ IN P P
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 176 YSGAFRGLVKSMLRKNPELRPSAAELLR 203
A L+ ++ RP A+++
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-39
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 32/233 (13%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++L+ ++ +P I+ D++ + + ++ F E E I K NS + + + +++
Sbjct: 51 IKLLQELSHPNIIGLLDAFGHKS-NISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYML 107
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYM 119
L L+YLH + ILHRD+K +N+ L ++ ++L DFGLAK S + V T Y
Sbjct: 108 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 167
Query: 120 CPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP------- 171
PELL YG D+W++GC + E+ P + +I +++ P
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227
Query: 172 --------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ + L++ + NP R +A + L+
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 4e-39
Identities = 42/222 (18%), Positives = 89/222 (40%), Gaps = 18/222 (8%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIK--------------KAN 46
ME++ I + + + +I+ + G++ E ++
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 47 SKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD 106
+ S + L Q+ ++YL + +HRD+ N+ +T+D +++ DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 107 DLASS---VVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALIN 162
D +M PE L D Y +SD+WS G ++E+ T + ++ L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 163 KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ + P+ + +++ P RP+ +L+
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (361), Expect = 1e-38
Identities = 48/209 (22%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ + PF+V+ + S+ + ++ G + + FSE +
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAA 148
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMC 120
Q+++ +YLH+ +++RD+K N+ + + I++ DFG AK + ++ GTP +
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALA 206
Query: 121 PELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPTKYSGAF 180
PE++ Y D W+LG IYEM + P F A + KI V P+ +S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDL 265
Query: 181 RGLVKSMLRKNPE-----LRPSAAELLRH 204
+ L++++L+ + L+ ++ H
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 42/221 (19%), Positives = 91/221 (41%), Gaps = 19/221 (8%)
Query: 3 LISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL------------- 49
LI + +V + + G + +I+ FC+ G+++ ++ ++
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 50 -FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD- 107
+ E L + Q+ +++L + +HRD+ NI L++ +++ DFGLA+ + D
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 108 --LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFD-MQALINK 163
+M PE + D Y +SD+WS G ++E+ + + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 164 INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ + P + + P RP+ +EL+ H
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 49/240 (20%), Positives = 88/240 (36%), Gaps = 36/240 (15%)
Query: 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSK-LFSEEK 54
++++ K+ + IV + + G Y+ +++ + A + +K
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 55 LCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKD-QDIRLGDFGLAKILTSDDLASSVV 113
+ ++ QL +L Y+H+ I HRD+K N+ L D ++L DFG AK L + S +
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 114 GTPSYMCP-ELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP- 171
+ Y P + Y S D+WS GC + E+ +P F + +I K + P
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 172 ---------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L +L P R + E H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 33/249 (13%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ L+ ++ +P IV+ D ++ D+ + + + + +L
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYM 119
QLL L + H++ +LHRD+K N+ + + I+L DFGLA+ + V T Y
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 120 CPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP------- 171
PE+L Y + DIWSLGC EM + + F + +I +++ P
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 172 ---------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210
+ R L+ ML +P R SA L H Q
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
Query: 211 VLKV-HLKL 218
V HL+L
Sbjct: 290 TKPVPHLRL 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 2e-38
Identities = 35/226 (15%), Positives = 74/226 (32%), Gaps = 23/226 (10%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
++ ++ + G Y +++ S+ FS + +
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLAD 110
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQD---IRLGDFGLAKILTSDDL--------A 109
Q++ ++Y+H+ + +HRDVK N + + + + DFGLAK
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 110 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSI- 168
++ GT Y I + D+ SLG + ++ K +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 169 ------VAPLPTKYSGAFRGLVKSMLRKNPELRPSAA---ELLRHV 205
+ L Y F + + +P + +L R++
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 65/294 (22%), Positives = 114/294 (38%), Gaps = 55/294 (18%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCY---VCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
++++ + R+ I+ D ++ G D+ + +K + S + +C
Sbjct: 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICY 113
Query: 58 WLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD----DLASSVV 113
+L Q+L L Y+H+ ++LHRD+K SN+ L D+++ DFGLA++ D + V
Sbjct: 114 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 114 GTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP- 171
T Y PE++ Y DIWS+GC + EM S +P F +N I + +P
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 172 -----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELL 202
L L+ ML NP R + L
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 203 RHVHLQPYVLKVHLKLNSPRRNSLSHWPESNYARRTRFSEPDNVPISSYREKQY 256
H PY+ + + + P + + E D++P +E +
Sbjct: 294 AH----PYLEQYYDPSDEPIAEAPFKFDM----------ELDDLPKEKLKELIF 333
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-37
Identities = 43/224 (19%), Positives = 97/224 (43%), Gaps = 15/224 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKL--------FSE 52
++ + +V V +G +I+ GD+ ++ + S
Sbjct: 74 ASVMKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 53 EKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL---A 109
K+ + ++ + YL+AN +HRD+ N + +D +++GDFG+ + + D
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 110 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM-TSLKPAFKAFDMQALINKINKSI 168
+ +M PE L D + + SD+WS G ++E+ T + ++ + ++ + +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 169 VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV--HLQPY 210
+ P L++ + NP++RPS E++ + ++P
Sbjct: 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (345), Expect = 4e-37
Identities = 45/234 (19%), Positives = 87/234 (37%), Gaps = 33/234 (14%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ ++ ++++ IV+ D + ++ + +L+
Sbjct: 51 ISILKELKHSNIVKLYDVIHT-KKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLL 107
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLAS-SVVGTPSYM 119
QLL + Y H +LHRD+K N+ + ++ ++++ DFGLA+ + T Y
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 120 CPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP------- 171
P++L Y + DIWS+GC EM + P F + +I + + P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 172 ---------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ L+ ML+ +P R +A + L H
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 4e-37
Identities = 51/248 (20%), Positives = 97/248 (39%), Gaps = 46/248 (18%)
Query: 1 MELISKIRNPFIVEYKDSWVERG-------CYVCIIIGFCEGGDMAEAIKKANSKLFSEE 53
++++ +++ +V + + + ++ FCE F+
Sbjct: 60 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLS 117
Query: 54 KLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLA---- 109
++ + + LL L Y+H N ILHRD+K +N+ +T+D ++L DFGLA+ + +
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 110 -SSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKS 167
++ V T Y PELL + YG D+W GC + EM + P + Q + I++
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 168 IVAPLPTKY-------------------------------SGAFRGLVKSMLRKNPELRP 196
+ P + L+ +L +P R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 197 SAAELLRH 204
+ + L H
Sbjct: 298 DSDDALNH 305
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-37
Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 14/216 (6%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+++ IR + + + +I+ + GG++ + + F+E ++ ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVG 136
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSY 118
++++AL++LH I++RD+K NI L + + L DFGL+K +D+ A GT Y
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 119 MCPELL--ADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVA---PLP 173
M P+++ D + D WSLG +YE+ + F + +I++ I+ P P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 174 TKYSGAFRGLVKSMLRKNPELRPS-----AAELLRH 204
+ S + L++ +L K+P+ R A E+ H
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-37
Identities = 46/225 (20%), Positives = 96/225 (42%), Gaps = 23/225 (10%)
Query: 1 MELISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKK--------------- 44
++++S + N IV + G +I +C GD+ +++
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGG-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 45 -ANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL 103
+ E L + Q+ + +L + + +HRD+ NI LT + ++ DFGLA+ +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 104 TSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDMQA 159
+D + + +M PE + + Y +SD+WS G ++E+ SL + + +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 160 LINKINKSIVAPL-PTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
K+ K L P ++K+ +P RP+ ++++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 41/246 (16%), Positives = 89/246 (36%), Gaps = 46/246 (18%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC---YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCK 57
+ +R+ I+ + + + + ++ + E G + + + + + E + K
Sbjct: 48 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 104
Query: 58 WLVQLLMALDYLHA--------NHILHRDVKCSNIFLTKDQDIRLGDFGLAKIL-----T 104
+ L +LH I HRD+K NI + K+ + D GLA T
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 105 SDDLASSVVGTPSYMCPELLAD------IPYGSKSDIWSLGCCIYEMTSLKPAFKAFD-- 156
D + VGT YM PE+L D ++DI+++G +E+ +
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 157 -------------MQALINKINKSIVAP-LPTKYSG-----AFRGLVKSMLRKNPELRPS 197
++ + + + + P +P ++ +++ N R +
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 198 AAELLR 203
A + +
Sbjct: 285 ALRIKK 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 5e-35
Identities = 49/236 (20%), Positives = 87/236 (36%), Gaps = 45/236 (19%)
Query: 9 NPFIVEYKDSWVERGC-YVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALD 67
P I+ D + ++ D + + ++ + ++ ++L ALD
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALD 143
Query: 68 YLHANHILHRDVKCSNIFLT-KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD 126
Y H+ I+HRDVK N+ + + + +RL D+GLA+ + V + + PELL D
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 127 IP-YGSKSDIWSLGCCIYEMTSLKPAFKA----FDMQALINKI----------------- 164
Y D+WSLGC + M K F +D I K+
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 165 ----------------NKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ + + S + +LR + + R +A E + H
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 2e-34
Identities = 30/223 (13%), Positives = 65/223 (29%), Gaps = 22/223 (9%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ + + + G + ++I G E + + FS + +
Sbjct: 51 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAK 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTK-----DQDIRLGDFGLAKILTSDD-------- 107
Q+L + +H +++RD+K N + + I + DFG+ K
Sbjct: 109 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168
Query: 108 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINK- 166
++ GT YM + D+ +LG ++ K +
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 167 ------SIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203
+ + L + F + + P L
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 54/242 (22%), Positives = 105/242 (43%), Gaps = 34/242 (14%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLV 60
+ L+ ++++ IV D + ++ FC+ + + + E + +L
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 61 QLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYM 119
QLL L + H+ ++LHRD+K N+ + ++ +++L +FGLA+ S+ V T Y
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 120 CPELLADIP-YGSKSDIWSLGCCIYEMTSLK-PAFKAFDMQALINKINKSIVAP------ 171
P++L Y + D+WS GC E+ + P F D+ + +I + + P
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 172 ----------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209
+ K + R L++++L+ NP R SA E L+H +
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
Query: 210 YV 211
+
Sbjct: 289 FC 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 54/268 (20%), Positives = 102/268 (38%), Gaps = 51/268 (19%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
+ L+ + + I+ + + + V +++ + + E++
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERM 121
Query: 56 CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115
L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + + V T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 116 PSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLPT- 174
Y PE++ + Y DIWS+GC + EM K F D NK+ + + P P
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 175 ----------------------------------------KYSGAFRGLVKSMLRKNPEL 194
+ R L+ ML +P
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 195 RPSAAELLRHVHLQPYVLKVHLKLNSPR 222
R S + L+H ++ + ++ P+
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPPQ 329
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-33
Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 46/262 (17%)
Query: 1 MELISKIRNPFIVEYKDSWVERGC-----YVCIIIGFCEGGDMAEAIKKANSKLFSEEKL 55
+ L+ +R+ ++ D + +++ F G D+ + +K + E+++
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRI 123
Query: 56 CKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGT 115
+ Q+L L Y+HA I+HRD+K N+ + +D ++++ DFGLA+ D + V T
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVT 181
Query: 116 PSYMCPE-LLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAP--- 171
Y PE +L + Y DIWS+GC + EM + K FK D + +I K P
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 172 ---------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204
+ T S L++ ML + E R +A E L H
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
Query: 205 VHLQPYVLKVHLKLNSPRRNSL 226
PY +H + P+
Sbjct: 302 ----PYFESLHDTEDEPQVQKY 319
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 9e-29
Identities = 55/268 (20%), Positives = 109/268 (40%), Gaps = 44/268 (16%)
Query: 1 MELISKIRNPFIVEYKDSWVERGCYV----CIIIGFCEGGDMAEAIKKANSKLFSEEKLC 56
+ L+ +++ ++ D + ++ G D+ +K + +++ +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQ 124
Query: 57 KWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTP 116
+ Q+L L Y+H+ I+HRD+K SN+ + +D ++++ DFGLA+ DD + V T
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATR 182
Query: 117 SYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINKINKSIVAPLP-- 173
Y PE++ + + Y DIWS+GC + E+ + + F D + I + + P
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 174 ----------------------------TKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205
+ L++ ML + + R +AA+ L H
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH- 301
Query: 206 HLQPYVLKVHLKLNSPRRNSLSHWPESN 233
Y + H + P + ES
Sbjct: 302 ---AYFAQYHDPDDEPVADPYDQSFESR 326
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.9 bits (237), Expect = 4e-22
Identities = 51/281 (18%), Positives = 99/281 (35%), Gaps = 58/281 (20%)
Query: 7 IRNPFIVEYKDSWVER--GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLM 64
+ I++ D + + +++ G ++ IKK + + + QLL+
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 65 ALDYLHANH-ILHRDVKCSNIFLTKD----QDIRLGDFGLAKILTSDDLASSVVGTPSYM 119
LDY+H I+H D+K N+ + I++ L D+ ++ + T Y
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 120 CPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA------------------------- 154
PE+L P+G +DIWS C I+E+ + F+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 155 ------------FDMQALINKINKSIVAPL----------PTKYSGAFRGLVKSMLRKNP 192
F+ + L+ I+K PL + + ML+ +P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 193 ELRPSAAELLRHVHLQPYVLKVHLKL----NSPRRNSLSHW 229
R A L+ H L+ + +++ + + W
Sbjct: 317 RKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGW 357
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 4e-14
Identities = 23/133 (17%), Positives = 45/133 (33%), Gaps = 23/133 (17%)
Query: 22 RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81
+G V + + + E I E + L +L + + I+H D+
Sbjct: 72 QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131
Query: 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA-DI---------PYGS 131
N+ ++ ++ I + DF + V E+L D+ Y +
Sbjct: 132 YNVLVS-EEGIWIIDFPQS------------VEVGEEGWREILERDVRNIITYFSRTYRT 178
Query: 132 KSDIWSLGCCIYE 144
+ DI S I +
Sbjct: 179 EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 570 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.06 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 85.07 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=385.85 Aligned_cols=204 Identities=27% Similarity=0.514 Sum_probs=186.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|.++ +.+|||||||+||+|.++|.+.. .+++..++.|+.||+.||+|||++||+|||||
T Consensus 57 ~~il~~l~hpnIv~~~~~~~~~-~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiK 133 (263)
T d2j4za1 57 VEIQSHLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIK 133 (263)
T ss_dssp HHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHhcCCCCCCeEEEEEEEC-CEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeec
Confidence 3689999999999999998754 47999999999999999998754 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+|||++.+|.+||+|||+++..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++
T Consensus 134 p~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 212 (263)
T d2j4za1 134 PENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212 (263)
T ss_dssp GGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cccceecCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999999999876543 34567899999999999999999999999999999999999999999999888
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
...+..... .+|..+++++++||.+||.+||++|||++|+|+||||+.
T Consensus 213 ~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 213 YKRISRVEF-TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHTTCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHcCCC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 888766543 467789999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=385.56 Aligned_cols=204 Identities=32% Similarity=0.562 Sum_probs=182.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|.+.+ ++|||||||+||+|.+++.+. .+++..++.|+.||+.||+|||++||+|||||
T Consensus 68 ~~il~~l~HpnIv~~~~~~~~~~-~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiK 143 (293)
T d1yhwa1 68 ILVMRENKNPNIVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143 (293)
T ss_dssp HHHHHHCCCTTBCCEEEEEEETT-EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCCCEeeEeEEEEECC-EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCc
Confidence 36899999999999999997654 799999999999999988763 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
|+|||++.+|.+||+|||+++.+... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...
T Consensus 144 p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred HHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 99999999999999999999987543 34556789999999999999999999999999999999999999999888777
Q ss_pred HHHHHHhccC--CCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 160 LINKINKSIV--APLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 160 ~~~~i~~~~~--~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
....+..... ...+..++.++++||.+||.+||++|||++|+|+||||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp HHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred HHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 6666554432 234567899999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=384.36 Aligned_cols=207 Identities=39% Similarity=0.744 Sum_probs=177.0
Q ss_pred CHHhhhcCCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC----
Q 008303 1 MELISKIRNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKA--NSKLFSEEKLCKWLVQLLMALDYLHANH---- 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~--~~~~Lse~~i~~I~~QLl~aL~yLHs~g---- 73 (570)
+++|++++|||||+++++|.+. ++.+|||||||+||+|.+++.+. .+..+++..++.|+.||+.||+|||++|
T Consensus 54 ~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~ 133 (269)
T d2java1 54 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 133 (269)
T ss_dssp HHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---
T ss_pred HHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3689999999999999998753 45689999999999999999753 3467999999999999999999999976
Q ss_pred -cccceecCCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCC
Q 008303 74 -ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 74 -IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|+||||||+||||+.+|.+||+|||+++.+... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.|
T Consensus 134 ~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~P 213 (269)
T d2java1 134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213 (269)
T ss_dssp ------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCC
Confidence 999999999999999999999999999887643 344568899999999999999999999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhcc
Q 008303 152 FKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHL 207 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~f 207 (570)
|.+.+..++..++.......++..+++++.+||++||..||++|||++|||+|||+
T Consensus 214 f~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 214 FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999988887777888999999999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-46 Score=384.49 Aligned_cols=206 Identities=29% Similarity=0.531 Sum_probs=171.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +++|||||||+||+|.++|.+. +.+++..++.|+.||+.||+|||++||+|||||
T Consensus 58 i~il~~l~HpnIv~l~~~~~~~-~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK 134 (307)
T d1a06a_ 58 IAVLHKIKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134 (307)
T ss_dssp HHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEec
Confidence 3689999999999999998654 5899999999999999999764 459999999999999999999999999999999
Q ss_pred CCcEEEc---CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLT---KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld---~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||+. .++.+||+|||+++...........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 135 p~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp GGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 9999995 4788999999999988776666778999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.++...+...... +.+..+++++++||++||.+||.+|||++|+|+||||+.
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 8888887765433 344679999999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=385.16 Aligned_cols=206 Identities=22% Similarity=0.385 Sum_probs=177.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +.+|||||||+||+|.++|++. ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 54 i~~l~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiK 130 (271)
T d1nvra_ 54 ICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 130 (271)
T ss_dssp HHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHHhCCCCCEeeEeeeeccC-ceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCccc
Confidence 3689999999999999998765 5899999999999999999653 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++.+||+|||+++.+... ......+||+.|||||++.+..+ +.++|||||||++|+|++|++||....
T Consensus 131 p~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp GGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred HHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986433 23456789999999999988876 678999999999999999999997654
Q ss_pred HHH-HHHH-HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 157 MQA-LINK-INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 157 ~~~-~~~~-i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
... .... .........+..++.++++||++||+.||++|||++|+|+||||+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 211 DSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred hHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 322 2222 2222333344678999999999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=381.62 Aligned_cols=207 Identities=33% Similarity=0.606 Sum_probs=182.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+.+ .+|||||||+||+|.+++.+.. +.+++..++.|+.||+.||.|||++||+|||||
T Consensus 60 ~~il~~l~HpnIv~l~~~~~~~~-~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiK 137 (288)
T d2jfla1 60 IDILASCDHPNIVKLLDAFYYEN-NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137 (288)
T ss_dssp HHHHHHCCCTTBCCEEEEEEETT-EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCCCCCeEEEEEeeCC-eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecC
Confidence 46899999999999999987654 7999999999999999987653 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCccccc-----CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.+|.+||+|||+++..... ......+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+
T Consensus 138 p~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 138 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp GGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999999876432 2334678999999999984 45689999999999999999999999998
Q ss_pred cCHHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSIVA--PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~--p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+..+...++...... ..+..++.++++||++||+.||.+|||++|||+||||+.
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 8887777777665433 335678999999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=381.32 Aligned_cols=205 Identities=31% Similarity=0.547 Sum_probs=182.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +.+|||||||+||+|.+++...+ .+++..++.|+.||+.||+|||++||+|||||
T Consensus 59 ~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK 135 (288)
T d1uu3a_ 59 RDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 135 (288)
T ss_dssp HHHHHHCCSTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHcCCCCeeEEEEEEEEC-CEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCC
Confidence 3689999999999999998654 57999999999999999998764 49999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+|||++.+|.+||+|||+++.+... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.
T Consensus 136 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 136 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 99999999999999999999987533 234457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHH------HHHhhccCh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAE------LLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~e------IL~hp~fq~ 209 (570)
.++..++..... .++..+++++++||++||.+||.+|||++| |++||||+.
T Consensus 216 ~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 216 YLIFQKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHHHHHHHTTCC-CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHHcCCC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 888888876543 467889999999999999999999999987 577888865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=372.94 Aligned_cols=204 Identities=26% Similarity=0.592 Sum_probs=177.3
Q ss_pred CHHhhhcCCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Q 008303 1 MELISKIRNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH--IL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g--Iv 75 (570)
+++|++|+|||||+++++|... +..+|||||||+||+|.+++++.. .+++..++.|+.||+.||+|||++| |+
T Consensus 59 ~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~Ii 136 (270)
T d1t4ha_ 59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPII 136 (270)
T ss_dssp HHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred HHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEE
Confidence 4689999999999999998652 457899999999999999998754 5999999999999999999999999 99
Q ss_pred cceecCCcEEEcC-CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTK-DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+|||++. ++.+||+|||+++.... ......+||+.|||||++.+ +|+.++|||||||++|+|++|+.||..
T Consensus 137 HrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCCcChhhceeeCCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 9999999999974 78999999999986443 34456789999999999875 699999999999999999999999976
Q ss_pred c-CHHHHHHHHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 155 F-DMQALINKINKSIVA-PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 155 ~-~~~~~~~~i~~~~~~-p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
. +...+...+...... ..+..+++++++||.+||.+||++|||++|||+||||+
T Consensus 215 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 215 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 5 455556666554332 24456889999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=382.59 Aligned_cols=205 Identities=29% Similarity=0.563 Sum_probs=187.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||+++++|.++ +.+|+|||||.||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||
T Consensus 57 ~il~~l~hp~Iv~l~~~~~~~-~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP 133 (337)
T d1o6la_ 57 RVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp HHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred HHHHhCCCCCEEEEEeeeccc-cccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCH
Confidence 689999999999999998655 58999999999999999998864 499999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccC-CCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.+|.+||+|||+++.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..++
T Consensus 134 ~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence 999999999999999999987654 3455678999999999999999999999999999999999999999999999988
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
...+.... ..+|..+++++++||++||++||.+|+ +++||++||||+..
T Consensus 214 ~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 214 FELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 88887665 356788999999999999999999999 49999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=381.76 Aligned_cols=206 Identities=32% Similarity=0.549 Sum_probs=173.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccee
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDL 79 (570)
+++|++|+|||||+++++|.+.+ .+|||||||.||+|.+++.+.+ .+++..++.++.||+.||.|||+ +||+||||
T Consensus 55 i~il~~l~HpnIv~l~~~~~~~~-~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDi 131 (322)
T d1s9ja_ 55 LQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131 (322)
T ss_dssp GGGGGGCCCTTBCCEEEEEECSS-EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCC
T ss_pred HHHHHhCCCCCCCcEEEEEEECC-EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcccc
Confidence 46899999999999999997654 7999999999999999998764 49999999999999999999997 59999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHH
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQA 159 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~ 159 (570)
||+||||+.+|.+||+|||+|+.+... .....+||++|+|||++.+..|+.++|||||||++|||++|+.||.+.+...
T Consensus 132 KP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 132 KPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred CHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999999999999999876533 3456799999999999999999999999999999999999999997644221
Q ss_pred H------------------------------------------HHHHHhccCCCCC-CCCcHHHHHHHHHhhccCCCCCc
Q 008303 160 L------------------------------------------INKINKSIVAPLP-TKYSGAFRGLVKSMLRKNPELRP 196 (570)
Q Consensus 160 ~------------------------------------------~~~i~~~~~~p~p-~~~s~~l~dLI~~~L~~dP~~RP 196 (570)
. ...+........+ ..++.++++||.+||..||.+||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 290 (322)
T d1s9ja_ 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290 (322)
T ss_dssp HHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc
Confidence 1 1111111111222 24689999999999999999999
Q ss_pred CHHHHHHhhccChh
Q 008303 197 SAAELLRHVHLQPY 210 (570)
Q Consensus 197 Ta~eIL~hp~fq~~ 210 (570)
|++|+|+||||+..
T Consensus 291 ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 291 DLKQLMVHAFIKRS 304 (322)
T ss_dssp CHHHHHTSHHHHHH
T ss_pred CHHHHhhCHhhCcC
Confidence 99999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=373.62 Aligned_cols=206 Identities=24% Similarity=0.469 Sum_probs=187.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+. ..+|||||||+||+|.++|.+.+ .+++..++.|+.||+.||+|||++||+|||||
T Consensus 64 ~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiK 140 (293)
T d1jksa_ 64 VSILKEIQHPNVITLHEVYENK-TDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140 (293)
T ss_dssp HHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccc
Confidence 3689999999999999998655 58999999999999999998764 59999999999999999999999999999999
Q ss_pred CCcEEEcCCC----CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccC
Q 008303 81 CSNIFLTKDQ----DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g----~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|+|||++.++ .+||+|||++............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+
T Consensus 141 p~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 9999998876 499999999999877766777899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 157 MQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
..+....+....... .+..++.++++||++||..||.+|||++|||+||||+.
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 888888876654332 23578999999999999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-45 Score=386.31 Aligned_cols=208 Identities=23% Similarity=0.434 Sum_probs=188.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ ..+|||||||+||+|.+++.+. +..|++..++.|+.||+.||+|||++||+|||||
T Consensus 77 i~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiK 154 (352)
T d1koba_ 77 ISIMNQLHHPKLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 154 (352)
T ss_dssp HHHHTTCCSTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 4689999999999999998754 5799999999999999987654 3469999999999999999999999999999999
Q ss_pred CCcEEEc--CCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLT--KDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld--~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+||||+ .++.+||+|||+++.+.........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 155 p~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 155 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred cccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998 57899999999999988777777789999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
++...+...... ..+..+++++++||++||.+||.+|||++|+|+||||+..
T Consensus 235 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 888888665432 2346789999999999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-45 Score=384.42 Aligned_cols=208 Identities=24% Similarity=0.413 Sum_probs=187.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +.+|||||||+||+|.++|.+.. +.+++..++.|+.||+.||+|||++||+|||||
T Consensus 74 ~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiK 151 (350)
T d1koaa2 74 IQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 151 (350)
T ss_dssp HHHHHHTCCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeec
Confidence 4689999999999999998765 57999999999999999996533 459999999999999999999999999999999
Q ss_pred CCcEEEcC--CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTK--DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++. ++.+||+|||+++.+.........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 152 p~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 152 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 99999964 5789999999999988777777789999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
++...+....... ....++.++++||.+||..||.+|||++|||+||||+..
T Consensus 232 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 8888886654432 234689999999999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-44 Score=372.61 Aligned_cols=203 Identities=26% Similarity=0.515 Sum_probs=185.8
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|||||+++++|.+. ..+|+|||||.||+|..++.... .+++..++.|+.||+.||+|||++||+||||||
T Consensus 56 ~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp 132 (316)
T d1fota_ 56 LMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 132 (316)
T ss_dssp HHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred HHHHhccCcChhheeeeEeeC-CeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCc
Confidence 588999999999999998654 58999999999999999998754 489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALI 161 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~ 161 (570)
+||||+.+|.+||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++.
T Consensus 133 ~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 133 ENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210 (316)
T ss_dssp GGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred hheeEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH
Confidence 9999999999999999999987543 34679999999999999999999999999999999999999999999998888
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 162 NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 162 ~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
.++..... ..+..++.+++++|++||.+||.+|+ |+++||+||||+..
T Consensus 211 ~~i~~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 211 EKILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 88876643 46778999999999999999999996 99999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-45 Score=374.50 Aligned_cols=203 Identities=30% Similarity=0.546 Sum_probs=179.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.++ +.+|||||||.||+|..++... +.+++..++.|+.||+.||.|||++||+|||||
T Consensus 66 i~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiK 142 (309)
T d1u5ra_ 66 VRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142 (309)
T ss_dssp HHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred HHHHHHCCCCCEeeEEEEEEEC-CEEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC
Confidence 3689999999999999998765 4799999999999998776654 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC---CCCCCcccccchhhhHHHhhccCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~ 157 (570)
|+||||+.++.+||+|||++..... ....+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+.
T Consensus 143 p~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 143 AGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp GGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cceEEECCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999999987643 345689999999999864 4589999999999999999999999998888
Q ss_pred HHHHHHHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVA-PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~-p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+.+.++...... ..+..+++++++||.+||..||.+|||++|+|+||||..
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 7777776655443 345578999999999999999999999999999999853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-44 Score=365.87 Aligned_cols=206 Identities=29% Similarity=0.519 Sum_probs=185.1
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
++|++|+ |||||+++++|.+ ++++|||||||+||+|.++|+..+ .+++..++.|+.||+.||+|||++||+|||||
T Consensus 61 ~~l~~l~~hpnIv~~~~~~~~-~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlk 137 (277)
T d1phka_ 61 DILRKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLK 137 (277)
T ss_dssp HHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhcCCCCeEEEEeeccc-CcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccc
Confidence 5788885 9999999999865 458999999999999999998754 59999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCccccc------CCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+|||++.++.+||+|||+++.+.........+||+.|+|||++. ...++.++||||+||++|+|++|+.||.+
T Consensus 138 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 138 PENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 999999999999999999999987766667789999999999985 33478899999999999999999999999
Q ss_pred cCHHHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 155 FDMQALINKINKSIVA---PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~---p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
.+.......+...... +....+|+++++||++||+.||.+|||++|||+|+||+++
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 9988887777655432 2334799999999999999999999999999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-44 Score=374.01 Aligned_cols=204 Identities=25% Similarity=0.498 Sum_probs=186.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|.+. ..+|+|||||.||+|.+++.+.+ .+++..++.|+.||+.||.|||++||||||||
T Consensus 92 ~~il~~l~hpnIv~~~~~~~~~-~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIK 168 (350)
T d1rdqe_ 92 KRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168 (350)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHcCCCcEeecccccccc-cccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCC
Confidence 3689999999999999998654 47899999999999999998764 59999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
|+||||+.+|.+||+|||+++.+... ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+...+
T Consensus 169 P~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 169 PENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHHcccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 99999999999999999999987543 3467899999999999999999999999999999999999999999998888
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 161 INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 161 ~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
..++..... ..+..+++++.+||++||.+||.+|+ |+++|++||||+..
T Consensus 247 ~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 247 YEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHCCC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHhcCCC-CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 888876654 45778999999999999999999995 99999999999853
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=376.53 Aligned_cols=208 Identities=27% Similarity=0.461 Sum_probs=176.4
Q ss_pred HHhhhc-CCCcccccceEEEee---CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 2 ELISKI-RNPFIVEYKDSWVER---GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~---~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
+++.++ +|||||+++++|.+. +.++|||||||+||+|.++|++.+...|++..++.|+.||+.||+|||++||+||
T Consensus 56 ~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHR 135 (335)
T d2ozaa1 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 135 (335)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccc
Confidence 466555 899999999998642 4578999999999999999987666679999999999999999999999999999
Q ss_pred eecCCcEEEcC---CCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 78 DVKCSNIFLTK---DQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 78 DLKP~NILld~---~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||+|||++. ++.+||+|||+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+
T Consensus 136 DiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred cccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 99999999986 457999999999988777777788999999999999999999999999999999999999999987
Q ss_pred cCHHHHHHHHHhccC---CCCC----CCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 155 FDMQALINKINKSIV---APLP----TKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~---~p~p----~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+.......+..... ..++ ..+++++++||++||.+||.+|||++|||+||||+.
T Consensus 216 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp TTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 665444333322211 1112 357899999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-44 Score=374.03 Aligned_cols=205 Identities=25% Similarity=0.501 Sum_probs=177.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|+.++|||||+++++|.+. +.+|||||||.||+|.++|.+.. .+++..++.|+.||+.||+|||++||+||||||
T Consensus 59 ~~l~~~~hpnIv~l~~~~~~~-~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP 135 (364)
T d1omwa3 59 SLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 135 (364)
T ss_dssp HHHSSSCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHhcCCCCcEEEEEEEEEEC-CEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeecc
Confidence 467778999999999998655 47999999999999999998754 589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCCcccCHHHH
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQAL 160 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~ 160 (570)
+|||++.+|.+||+|||+++.+.... ....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+....
T Consensus 136 ~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 214 (364)
T d1omwa3 136 ANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214 (364)
T ss_dssp GGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred ceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999999876543 456789999999999974 5689999999999999999999999987543322
Q ss_pred H--HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcC-----HHHHHHhhccChh
Q 008303 161 I--NKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPS-----AAELLRHVHLQPY 210 (570)
Q Consensus 161 ~--~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPT-----a~eIL~hp~fq~~ 210 (570)
. ...........+..+++++++||.+||.+||.+||| ++||++||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 215 HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 2 222223344567789999999999999999999999 8999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=371.07 Aligned_cols=207 Identities=25% Similarity=0.358 Sum_probs=186.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|.++ +++|||||||+||+|.++|+..+ ..+++.+++.|+.||+.||+|||++||+|||||
T Consensus 52 i~il~~l~HpnIv~~~~~~~~~-~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlK 129 (321)
T d1tkia_ 52 ISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129 (321)
T ss_dssp HHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHhCCCCCCCeEEEEEEEC-CEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCccccc
Confidence 4689999999999999998655 58999999999999999997643 469999999999999999999999999999999
Q ss_pred CCcEEEcCC--CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKD--QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~--g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.+ +.+||+|||+++...........+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..
T Consensus 130 p~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 999999854 479999999999887766667788999999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
++...+....... .+..++.++++||++||.+||.+|||++|+|+||||++
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 8888887654432 22468999999999999999999999999999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-44 Score=368.03 Aligned_cols=202 Identities=24% Similarity=0.464 Sum_probs=183.3
Q ss_pred hhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecCCcE
Q 008303 5 SKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNI 84 (570)
Q Consensus 5 ~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP~NI 84 (570)
+.++|||||+++++|.++ +++|||||||+||+|.++|.... .+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 58 ~~~~hp~Iv~~~~~~~~~-~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~Ni 134 (320)
T d1xjda_ 58 LAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 134 (320)
T ss_dssp HHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HhCCCCcEEEEEEEEccC-CceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccce
Confidence 468999999999998665 47999999999999999998754 489999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHHHHHHH
Q 008303 85 FLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQALINK 163 (570)
Q Consensus 85 Lld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~~~~~~ 163 (570)
|++.+|.+||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++..+
T Consensus 135 L~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~ 214 (320)
T d1xjda_ 135 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214 (320)
T ss_dssp EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999999876543 334557899999999999999999999999999999999999999999999998888
Q ss_pred HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHH-HHHHhhccChh
Q 008303 164 INKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA-ELLRHVHLQPY 210 (570)
Q Consensus 164 i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~-eIL~hp~fq~~ 210 (570)
+..... ..|..+++++++||++||.+||.+||++. ++++||||+..
T Consensus 215 i~~~~~-~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 215 IRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHCCC-CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHcCCC-CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 876543 56778999999999999999999999995 89999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=365.35 Aligned_cols=207 Identities=25% Similarity=0.418 Sum_probs=178.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|..+ +++|||||||.|+++..++.. +..+++..++.|++||+.||+|||++||+|||||
T Consensus 51 i~il~~l~hpnIv~~~~~~~~~-~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiK 127 (299)
T d1ua2a_ 51 IKLLQELSHPNIIGLLDAFGHK-SNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 127 (299)
T ss_dssp HHHHHHCCCTTBCCEEEEECCT-TCCEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHhCCCCCEeEEEeeeccC-CceeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCC
Confidence 3689999999999999998655 478999999998877766543 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||+++...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..
T Consensus 128 p~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 207 (299)
T d1ua2a_ 128 PNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207 (299)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH
Confidence 999999999999999999998765433 34557899999999998754 5799999999999999999999999999888
Q ss_pred HHHHHHHhccCCCC---------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAPL---------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p~---------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+++.++......+. ...+++++++||++||..||++|||++|+|+||||+..
T Consensus 208 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 88777755332211 12467899999999999999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=360.03 Aligned_cols=199 Identities=20% Similarity=0.374 Sum_probs=178.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|+|.. + ..|||||||+||+|.+++++. ..+++..+..|+.||+.||+|||++||+|||||
T Consensus 59 ~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlK 134 (277)
T d1xbba_ 59 ANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134 (277)
T ss_dssp HHHHHTCCCTTBCCEEEEEES-S-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhCCCCCCceEEEEecc-C-CEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCc
Confidence 368999999999999998853 3 368999999999999999874 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+|||++.++.+||+|||+++.+..... .....||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.
T Consensus 135 p~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred chhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 9999999999999999999988654321 234578999999999999999999999999999999987 89999999
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
+..++...+..+...+.|..++.++.+||.+||..||++|||+++|+.
T Consensus 215 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 998888888888888888999999999999999999999999999954
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-43 Score=362.69 Aligned_cols=203 Identities=22% Similarity=0.392 Sum_probs=173.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|+|.+.+ .+|||||||+||+|.+++.... +.+++..+..|+.||+.||+|||++||+|||||
T Consensus 78 ~~~l~~l~HpnIv~l~g~~~~~~-~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlK 155 (299)
T d1jpaa_ 78 ASIMGQFDHPNVIHLEGVVTKST-PVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA 155 (299)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSS-SCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCCCccEEEEEeeCC-EEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccc
Confidence 36899999999999999986554 6899999999999999988643 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCC------ccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLA------SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFK 153 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~------~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~ 153 (570)
|+||||+.++.+||+|||+++.+...... ....||+.|||||++.+..|+.++|||||||++|||++ |++||.
T Consensus 156 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp GGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 99999999999999999999877543221 12457899999999999999999999999999999997 899999
Q ss_pred ccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 154 AFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.+..++...+..+...+.+..++.++.+||.+||..||++|||+.||++++
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 236 DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp TCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999988888888889999999999999999999999999999873
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=353.02 Aligned_cols=203 Identities=24% Similarity=0.460 Sum_probs=173.5
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++|+|.+.+ .+|||||||.+|+|.+++... ...++++.+..|+.||+.||+|||++||+|||||
T Consensus 51 ~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlK 128 (263)
T d1sm2a_ 51 AEVMMKLSHPKLVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128 (263)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCS
T ss_pred HHHHHhcCCCCcccccceeccCC-ceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccc
Confidence 36899999999999999987654 688999999999999998764 3568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+.
T Consensus 129 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~ 208 (263)
T d1sm2a_ 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208 (263)
T ss_dssp GGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH
T ss_pred hhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH
Confidence 9999999999999999999987754432 234678999999999999999999999999999999998 6788888888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.++...+........|..++.++.+||.+||..||++|||++||++|+
T Consensus 209 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 209 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 888888888877778889999999999999999999999999999983
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=353.90 Aligned_cols=208 Identities=30% Similarity=0.417 Sum_probs=179.2
Q ss_pred HHhhhc---CCCcccccceEEEe----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 2 ELISKI---RNPFIVEYKDSWVE----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 2 ~IL~kL---~HPnIV~l~~~f~~----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
++|++| +|||||+++++|.. .+.++|++||||.++.+..... .....+++..++.|+.||+.||+|||++||
T Consensus 59 ~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~i 137 (305)
T d1blxa_ 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRV 137 (305)
T ss_dssp HHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 345544 89999999999863 2457899999999876654443 345679999999999999999999999999
Q ss_pred ccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 75 LHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 75 vHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
+||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+
T Consensus 138 vHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999999887766667788999999999999999999999999999999999999999999
Q ss_pred cCHHHHHHHHHhccCCC--------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccC
Q 008303 155 FDMQALINKINKSIVAP--------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQ 208 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p--------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq 208 (570)
.+..+....+......+ .+..+++.+++||++||.+||++|||++|+|+||||+
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred CCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 88887777664432111 2345788999999999999999999999999999998
Q ss_pred hh
Q 008303 209 PY 210 (570)
Q Consensus 209 ~~ 210 (570)
..
T Consensus 298 ~i 299 (305)
T d1blxa_ 298 DL 299 (305)
T ss_dssp TC
T ss_pred Cc
Confidence 53
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=358.76 Aligned_cols=204 Identities=21% Similarity=0.365 Sum_probs=182.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|++.. + .+|||||||+||+|.+++... +..+++..+..|+.||+.||+|||++||+|||||
T Consensus 60 ~~il~~l~HpnIv~l~g~~~~-~-~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK 136 (285)
T d1u59a_ 60 AQIMHQLDNPYIVRLIGVCQA-E-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 136 (285)
T ss_dssp HHHHHHCCCTTBCCEEEEEES-S-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhCCCCCEeeEeeeecc-C-eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCc
Confidence 368999999999999998854 3 478999999999999998653 3469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+|||++.++.+||+|||+++.+.... ......||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.
T Consensus 137 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876433 2334578999999999999999999999999999999987 89999998
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHH---Hhhcc
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELL---RHVHL 207 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL---~hp~f 207 (570)
+..++...+..+...+.|..+++++.+||.+||..||++|||+.+|+ +|+|+
T Consensus 217 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 88888888888888888899999999999999999999999999995 45554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=356.16 Aligned_cols=206 Identities=18% Similarity=0.365 Sum_probs=183.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++|++.+ + .+|||||||.+|+|.+++....+..+++..+..|+.||+.||.|||++||+|||||
T Consensus 59 ~~~l~~l~HpnIv~~~g~~~~-~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiK 136 (272)
T d1qpca_ 59 ANLMKQLQHQRLVRLYAVVTQ-E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136 (272)
T ss_dssp HHHHHHCCCTTBCCEEEEECS-S-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHhCCCCCEeEEEeeecc-C-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccc
Confidence 368999999999999998744 3 46899999999999998865544569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||||+.++.+||+|||+++.+.... ......||+.|+|||++.+..|+.++|||||||++|||++ |.++|...+.
T Consensus 137 p~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~ 216 (272)
T d1qpca_ 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (272)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999999876543 3345678999999999998899999999999999999998 5677888888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH--hhccC
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR--HVHLQ 208 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~--hp~fq 208 (570)
.++...+........+..++.++.+||.+||..||++|||+++|++ ++||.
T Consensus 217 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 217 PEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 8888888888888888999999999999999999999999999998 55653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-43 Score=357.56 Aligned_cols=203 Identities=22% Similarity=0.411 Sum_probs=182.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+.+ .+|||||||++|+|.+++.+.....+++..+..|+.||+.||+|||++||+|||||
T Consensus 64 ~~il~~l~HpnIv~~~~~~~~~~-~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlK 142 (287)
T d1opja_ 64 AAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 142 (287)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCEecCCccEeeCC-eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccc
Confidence 46899999999999999986544 68999999999999999988767789999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhcc-CCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL-KPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG-~~pf~~~~~ 157 (570)
|+||||+.++.+||+|||+++....... .....|++.|+|||++.+..|+.++|||||||++|||++| .++|.+.+.
T Consensus 143 p~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~ 222 (287)
T d1opja_ 143 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222 (287)
T ss_dssp GGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH
Confidence 9999999999999999999987654432 2334688999999999999999999999999999999985 556777788
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
..+...+......+.+..++.++.+||.+||..||++|||++||++.
T Consensus 223 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 88888888887778888999999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=363.92 Aligned_cols=203 Identities=22% Similarity=0.380 Sum_probs=176.8
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCC---------------------CCCCHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANS---------------------KLFSEEKLCKWL 59 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~---------------------~~Lse~~i~~I~ 59 (570)
++|+++ +|||||+++++|.+.+ .+|||||||+||+|.++|+.... ..+++..++.|+
T Consensus 92 ~~l~~l~~HpnIv~l~~~~~~~~-~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 170 (325)
T d1rjba_ 92 KMMTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170 (325)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred HHHHHhcCCCcEeEEEEEEeeCC-eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHH
Confidence 578888 8999999999986554 68999999999999999976432 358999999999
Q ss_pred HHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCccccc
Q 008303 60 VQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIW 136 (570)
Q Consensus 60 ~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIW 136 (570)
.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|||||++.+..|+.++|||
T Consensus 171 ~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 171 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 999999999999999999999999999999999999999998765433 23356789999999999999999999999
Q ss_pred chhhhHHHhhc-cCCCCcccCHHH-HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 137 SLGCCIYEMTS-LKPAFKAFDMQA-LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 137 SLG~IlyeLlt-G~~pf~~~~~~~-~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||||++|||++ |.+||.+.+... +...+......+.|..+++++++||.+||+.||++|||++||++|+
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999997 899998866544 4444555566677889999999999999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=353.34 Aligned_cols=203 Identities=26% Similarity=0.489 Sum_probs=169.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||++++++. ++ .+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++||||||||
T Consensus 55 ~~~l~~l~HpnIv~~~~~~~-~~-~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlK 131 (276)
T d1uwha_ 55 VGVLRKTRHVNILLFMGYST-AP-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131 (276)
T ss_dssp HHHHTTCCCTTBCCEEEEEC-SS-SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCCEeeeeEEEe-cc-EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccC
Confidence 36899999999999999764 33 4789999999999999997643 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC---CCCccccCCCCCCCcccccC---CCCCCcccccchhhhHHHhhccCCCCcc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD---DLASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
|+||||+.++.+||+|||+++..... .......||+.|||||++.. ..|+.++|||||||++|||++|+.||.+
T Consensus 132 p~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp GGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 99999999999999999999876532 23445789999999999964 3589999999999999999999999988
Q ss_pred cCHHH-HHHHHHhccCCC----CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 155 FDMQA-LINKINKSIVAP----LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 155 ~~~~~-~~~~i~~~~~~p----~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
.+... +...+......+ .+..+++++.+||.+||..||++|||++||++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 212 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp CCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 66444 444444443332 45678999999999999999999999999999853
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=350.40 Aligned_cols=208 Identities=27% Similarity=0.421 Sum_probs=177.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|.++ +.+|+|||||.+ .+.+++.......+++..++.|+.||+.||+|||++||||||||
T Consensus 52 i~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiK 129 (298)
T d1gz8a_ 52 ISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129 (298)
T ss_dssp HHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCcEEEeccccccc-cceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccC
Confidence 4689999999999999999664 579999999975 56666665556679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCC-CCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSD-DLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||+++..... ......+||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..
T Consensus 130 peNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~ 209 (298)
T d1gz8a_ 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209 (298)
T ss_dssp GGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred chheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence 99999999999999999999877543 34556789999999999877665 78999999999999999999999988877
Q ss_pred HHHHHHHhccCCCC----------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChh
Q 008303 159 ALINKINKSIVAPL----------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPY 210 (570)
Q Consensus 159 ~~~~~i~~~~~~p~----------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~ 210 (570)
+...++......+. ...++.++++||++||..||++|||++|||+|+||+..
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 76666543221110 12457899999999999999999999999999999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=348.68 Aligned_cols=199 Identities=25% Similarity=0.371 Sum_probs=171.5
Q ss_pred HHhhhcC--CCcccccceEEEeeCcEEEEEEeccCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 2 ELISKIR--NPFIVEYKDSWVERGCYVCIIIGFCEG-GDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 2 ~IL~kL~--HPnIV~l~~~f~~~~~~i~IV~Ey~~g-GsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
++|++++ |||||+++++|.+. +.+|+|||||.+ +++.+++.+.. .+++..++.|+.||+.||+|||++||+|||
T Consensus 59 ~il~~l~~~h~nIv~~~~~~~~~-~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrD 135 (273)
T d1xwsa_ 59 VLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRD 135 (273)
T ss_dssp HHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHhccCCCCccEEEEEEeeC-CeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 5788885 89999999998654 478999999976 68889888754 599999999999999999999999999999
Q ss_pred ecCCcEEEcCC-CCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCC-CCcccccchhhhHHHhhccCCCCcccC
Q 008303 79 VKCSNIFLTKD-QDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 79 LKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||+|||++.+ +.+||+|||+++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+
T Consensus 136 iKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 136 IKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred CcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 99999999854 78999999999876543 4456789999999999987765 677999999999999999999997642
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccChhh
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~~~ 211 (570)
.+... ...++..+|.++++||++||.+||.+|||++|||+||||+...
T Consensus 215 ------~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 215 ------EIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ------HHHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------HHhhc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 12222 2345678999999999999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=343.96 Aligned_cols=203 Identities=20% Similarity=0.366 Sum_probs=184.3
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++|+|.+++ .+|+|||||.+|+|.+++.... ..+++..+..|+.||+.||+|||++||+|||||
T Consensus 50 v~~~~~l~HpnIv~~~g~~~~~~-~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk 127 (258)
T d1k2pa_ 50 AKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127 (258)
T ss_dssp HHHHHTCCCTTBCCEEEEECCSS-SEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCS
T ss_pred HHHHHhcCCCceeeEEEEEeeCC-ceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCccccccc
Confidence 36899999999999999986654 6899999999999999987543 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC--CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||+++.+..... .....||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+.
T Consensus 128 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp GGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 9999999999999999999987654433 234678999999999999999999999999999999997 8999999999
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.++..++......+.|..++.++.+||++||+.||++|||+++|++|+
T Consensus 208 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 208 SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 999999988888888899999999999999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=347.86 Aligned_cols=202 Identities=24% Similarity=0.436 Sum_probs=171.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++|+|. ++ .+|||||||.+|+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 59 ~~~l~~l~HpnIv~l~~~~~-~~-~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlK 135 (273)
T d1mp8a_ 59 ALTMRQFDHPHIVKLIGVIT-EN-PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135 (273)
T ss_dssp HHHHHTCCCTTBCCEEEEEC-SS-SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCEeeEEEEEe-cC-eEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccc
Confidence 36899999999999999884 33 5789999999999999887643 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+|||++.++.+||+|||+++.+.... ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.
T Consensus 136 p~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp GGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred hhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999998765432 2345678999999999999999999999999999999986 8999999988
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.++..++..+...+.+..+++++.+||.+||..||++|||+.||++++
T Consensus 216 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 216 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 888888888887888999999999999999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=352.19 Aligned_cols=211 Identities=23% Similarity=0.357 Sum_probs=178.0
Q ss_pred CHHhhhcCCCcccccceEEEe-----eCcEEEEEEeccCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 008303 1 MELISKIRNPFIVEYKDSWVE-----RGCYVCIIIGFCEGGDMAEAIKK-ANSKLFSEEKLCKWLVQLLMALDYLHANHI 74 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-----~~~~i~IV~Ey~~gGsL~d~I~~-~~~~~Lse~~i~~I~~QLl~aL~yLHs~gI 74 (570)
+++|++|+|||||+++++|.. +..++|||||||.++.+..+... .....+++..++.|++||+.||+|||++||
T Consensus 64 i~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~I 143 (350)
T d1q5ka_ 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143 (350)
T ss_dssp HHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred HHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 468999999999999999863 23578999999987644444332 334579999999999999999999999999
Q ss_pred ccceecCCcEEEcCCC-CEEEeecCCceeccCCCCCccccCCCCCCCcccccC-CCCCCcccccchhhhHHHhhccCCCC
Q 008303 75 LHRDVKCSNIFLTKDQ-DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCIYEMTSLKPAF 152 (570)
Q Consensus 75 vHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIWSLG~IlyeLltG~~pf 152 (570)
+||||||+|||++.++ .+||+|||++..+.........+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||
T Consensus 144 iHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf 223 (350)
T d1q5ka_ 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223 (350)
T ss_dssp ECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred cccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC
Confidence 9999999999999875 899999999998877777778899999999998865 46899999999999999999999999
Q ss_pred cccCHHHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 153 KAFDMQALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 153 ~~~~~~~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
...+..+.+..+.+....+ ....+++++.+||.+||.+||++|||+.|+|+|
T Consensus 224 ~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9888777666654321110 123578999999999999999999999999999
Q ss_pred hccChhh
Q 008303 205 VHLQPYV 211 (570)
Q Consensus 205 p~fq~~~ 211 (570)
|||+...
T Consensus 304 p~f~~~~ 310 (350)
T d1q5ka_ 304 SFFDELR 310 (350)
T ss_dssp GGGGGGG
T ss_pred Hhhcccc
Confidence 9998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=343.85 Aligned_cols=203 Identities=20% Similarity=0.373 Sum_probs=174.7
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|+|.+.+ .+++|||||.+|+|.+++.... ..+++..+..|+.||+.||+|||++||+|||||
T Consensus 60 ~~il~~l~H~nIv~~~g~~~~~~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlK 137 (283)
T d1mqba_ 60 AGIMGQFSHHNIIRLEGVISKYK-PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137 (283)
T ss_dssp HHHHHTCCCTTBCCEEEEECSSS-SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhcCCCCEeeeeEEEecCC-ceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccc
Confidence 36899999999999999986554 6889999999999999887653 569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+||||+.++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++ |.+++...
T Consensus 138 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 138 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 999999999999999999998765432 2233568999999999999999999999999999999998 56677778
Q ss_pred CHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+..++...+..+...+.+..++.++.+||.+||..||++|||+.||++.+
T Consensus 218 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 218 SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 88888888888888888899999999999999999999999999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-42 Score=346.83 Aligned_cols=206 Identities=20% Similarity=0.378 Sum_probs=177.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++|+|.+ + .+|+|||||.+|+|..++.....+.+++..+..|+.||+.||+|||++||+|||||
T Consensus 63 ~~~l~~l~h~nIv~~~g~~~~-~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlK 140 (285)
T d1fmka3 63 AQVMKKLRHEKLVQLYAVVSE-E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 140 (285)
T ss_dssp HHHHHHCCCTTBCCEEEEECS-S-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhcccCCEeEEEEEEec-C-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheeccccc
Confidence 368999999999999998844 3 36899999999999999876555679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC--CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~ 157 (570)
|+||||+.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |.+++.....
T Consensus 141 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~ 220 (285)
T d1fmka3 141 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220 (285)
T ss_dssp GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998775433 2334678999999999999999999999999999999998 5677788888
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH--hhccC
Q 008303 158 QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR--HVHLQ 208 (570)
Q Consensus 158 ~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~--hp~fq 208 (570)
.++...+......+.+..++.++++||.+||..||++||++++|+. +.||.
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 221 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 8888888888878889999999999999999999999999999987 55664
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=344.51 Aligned_cols=203 Identities=21% Similarity=0.421 Sum_probs=177.0
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++|+|.+..+.+|+|||||++|+|.++|.+.....+++..+..|+.||+.||.|||+++|+|||||
T Consensus 51 ~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlk 130 (262)
T d1byga_ 51 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 130 (262)
T ss_dssp HHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccc
Confidence 46899999999999999987655568999999999999999977554568999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccCHHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFDMQA 159 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~~~~ 159 (570)
|+|||++.+|.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||++ |++||...+..+
T Consensus 131 p~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 131 ARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp GGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred hHhheecCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 99999999999999999999876543 334578999999999999999999999999999999997 799999988888
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 160 LINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 160 ~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+...+..+...+.+..+++++++||++||..||.+|||+.+|++++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 209 VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 8999988888888999999999999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=345.97 Aligned_cols=204 Identities=21% Similarity=0.438 Sum_probs=170.7
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL 66 (570)
++|.++ +|+|||.+++++.+.+..+|+|||||+||+|.++|+... ...+++..+..|+.||+.||
T Consensus 68 ~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl 147 (299)
T d1ywna1 68 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147 (299)
T ss_dssp HHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHH
Confidence 356666 799999999988776667899999999999999997542 23589999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
+|||++||+||||||+||||+.++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 148 ~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ 227 (299)
T d1ywna1 148 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227 (299)
T ss_dssp HHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHH
Confidence 99999999999999999999999999999999998765332 334568999999999999999999999999999999
Q ss_pred Hhhcc-CCCCcccCH-HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTSL-KPAFKAFDM-QALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLltG-~~pf~~~~~-~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||++| .+||.+.+. ..+...+..+...+.+..+++++++||.+||..||++|||++||++|+
T Consensus 228 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 228 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp HHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99976 567876553 445556666667778889999999999999999999999999999984
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-41 Score=341.88 Aligned_cols=206 Identities=22% Similarity=0.377 Sum_probs=171.9
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++++|.+.+ .+|++|||+.++.+..+.+. .+.+++..++.|+.||+.||+|||++||+|||||
T Consensus 51 ~~il~~l~hpnIv~~~~~~~~~~-~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiK 127 (286)
T d1ob3a_ 51 ISILKELKHSNIVKLYDVIHTKK-RLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127 (286)
T ss_dssp HHGGGGCCCTTBCCEEEEEECSS-CEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCcEEeeeeecccCC-ceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCC
Confidence 36899999999999999997655 68999999988766666544 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
|+|||++.++.+||+|||++....... .....+|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..
T Consensus 128 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp GGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 999999999999999999998876433 34456799999999999765 4699999999999999999999999988877
Q ss_pred HHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 159 ALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 159 ~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
+...++......+ ....+++.+++||++||.+||++|||++|||+||||++
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 7766654322111 12356889999999999999999999999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=347.74 Aligned_cols=203 Identities=20% Similarity=0.370 Sum_probs=180.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|+|.+++ .++|+|||.+|+|.+++... ...+++..++.|+.||+.||+|||++||+|||||
T Consensus 62 ~~~l~~l~HpnIv~l~g~~~~~~--~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlK 138 (317)
T d1xkka_ 62 AYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 138 (317)
T ss_dssp HHHHHHCCCTTBCCEEEEEESSS--EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHhCCCCCEeeEEEEEecCC--eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcch
Confidence 36899999999999999986543 57889999999999998775 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC---CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCcccC
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAFD 156 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~~ 156 (570)
|+|||++.++.+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 139 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 139 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp GGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred hhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 9999999999999999999988754332 234578999999999999999999999999999999997 899999988
Q ss_pred HHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhc
Q 008303 157 MQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVH 206 (570)
Q Consensus 157 ~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~ 206 (570)
..++...+..+...+.+..++.++.+||.+||..||.+|||+.||++|+.
T Consensus 219 ~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp GGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 88888888888878888999999999999999999999999999999954
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-41 Score=339.05 Aligned_cols=204 Identities=25% Similarity=0.417 Sum_probs=169.3
Q ss_pred CHHhhhcCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHR 77 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHr 77 (570)
+++|++++|||||++++++...+ ..+|||||||+||+|.+++...+ .+++..++.|+.||+.||+|||++||+||
T Consensus 58 ~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHr 135 (277)
T d1o6ya_ 58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHR 135 (277)
T ss_dssp HHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCc
Confidence 36889999999999999997643 46899999999999999998764 59999999999999999999999999999
Q ss_pred eecCCcEEEcCCCCEEEeecCCceeccCC----CCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCc
Q 008303 78 DVKCSNIFLTKDQDIRLGDFGLAKILTSD----DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFK 153 (570)
Q Consensus 78 DLKP~NILld~~g~vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~ 153 (570)
||||+|||++.++.++|+|||.+...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.
T Consensus 136 DiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp CCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 99999999999999999999998765432 23455789999999999999999999999999999999999999999
Q ss_pred ccCHHHHHHHHHhccCCC---CCCCCcHHHHHHHHHhhccCCCCCc-CHHHHHHhhcc
Q 008303 154 AFDMQALINKINKSIVAP---LPTKYSGAFRGLVKSMLRKNPELRP-SAAELLRHVHL 207 (570)
Q Consensus 154 ~~~~~~~~~~i~~~~~~p---~p~~~s~~l~dLI~~~L~~dP~~RP-Ta~eIL~hp~f 207 (570)
+.+..+...++......+ ....+++++.+||++||.+||.+|| |+++++ |.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp CSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred CcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence 988887776665544322 3467899999999999999999999 666655 4443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=344.98 Aligned_cols=203 Identities=23% Similarity=0.417 Sum_probs=181.9
Q ss_pred CHHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHH
Q 008303 1 MELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKA--------------NSKLFSEEKLCKWLVQLLMA 65 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~--------------~~~~Lse~~i~~I~~QLl~a 65 (570)
+++|+++ +|||||+++++|.++ +.+|||||||+||+|.++|.+. ....|++..+..++.||+.|
T Consensus 61 ~~~l~~l~~HpnIv~~~~~~~~~-~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~g 139 (309)
T d1fvra_ 61 LEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 139 (309)
T ss_dssp HHHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCEeeEEEEEecC-CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHH
Confidence 3688998 799999999998765 4799999999999999999753 23579999999999999999
Q ss_pred HHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHh
Q 008303 66 LDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEM 145 (570)
Q Consensus 66 L~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeL 145 (570)
|.|||++||+||||||+|||++.++.+||+|||+++............||..|+|||.+.+..|+.++|||||||++|||
T Consensus 140 l~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 140 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp HHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred HHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHH
Confidence 99999999999999999999999999999999999876655555566799999999999999999999999999999999
Q ss_pred hcc-CCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 146 TSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 146 ltG-~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
++| .+||.+.+..++...+..+...+.+..+++++++||.+||..||++|||++||+++
T Consensus 220 l~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 220 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 986 56899999999999888877777888999999999999999999999999999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=343.19 Aligned_cols=204 Identities=28% Similarity=0.463 Sum_probs=174.3
Q ss_pred CHHhhhcCCCcccccceEEEeeC-----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG-----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~-----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++|+|||||+++++|...+ .++||||||| |++|..+++. ..|++..++.|+.||+.||+|||++||+
T Consensus 68 i~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~Ii 143 (346)
T d1cm8a_ 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGII 143 (346)
T ss_dssp HHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 46899999999999999996543 2579999999 6688887765 3499999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhccCCCCcc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTSLKPAFKA 154 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLltG~~pf~~ 154 (570)
||||||+|||++.++.+||+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+
T Consensus 144 HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 144 HRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCcchhhcccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 9999999999999999999999999886543 4567899999999998765 468999999999999999999999998
Q ss_pred cCHHHHHHHHHhccCC------------------------------CCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 155 FDMQALINKINKSIVA------------------------------PLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~------------------------------p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
.+.......+...... .....+++++++||++||..||.+|||++|||+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 8766655444322111 1234678999999999999999999999999999
Q ss_pred hccChh
Q 008303 205 VHLQPY 210 (570)
Q Consensus 205 p~fq~~ 210 (570)
|||+..
T Consensus 302 p~f~~~ 307 (346)
T d1cm8a_ 302 PYFESL 307 (346)
T ss_dssp GGGTTT
T ss_pred hhhCcC
Confidence 999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=339.40 Aligned_cols=203 Identities=21% Similarity=0.428 Sum_probs=183.0
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------------SKLFSEEKLCKWLVQLLMAL 66 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------------~~~Lse~~i~~I~~QLl~aL 66 (570)
.+|.++ +|||||+++++|.+++ .+|+|||||++|+|.++|.... ...+++..+..|+.||+.||
T Consensus 70 ~~l~~~~~HpnIv~~~~~~~~~~-~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al 148 (299)
T d1fgka_ 70 EMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148 (299)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSS-SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCeEEecccccccCC-eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence 456677 8999999999997654 6899999999999999997543 24589999999999999999
Q ss_pred HHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHH
Q 008303 67 DYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIY 143 (570)
Q Consensus 67 ~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~Ily 143 (570)
+|||++|||||||||+|||++.++.+||+|||+++...... .....+|++.|+|||.+.+..|+.++|||||||++|
T Consensus 149 ~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ 228 (299)
T d1fgka_ 149 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHH
Confidence 99999999999999999999999999999999998875433 234467899999999999999999999999999999
Q ss_pred Hhhc-cCCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 144 EMTS-LKPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 144 eLlt-G~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
||++ |.+||.+.+...+...+..+...+.+..+++++++||.+||..||.+|||+.||++.+
T Consensus 229 ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 9997 7999999999999888888888888899999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=336.79 Aligned_cols=207 Identities=25% Similarity=0.392 Sum_probs=171.6
Q ss_pred CHHhhhcCCCcccccceEEEee-------CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008303 1 MELISKIRNPFIVEYKDSWVER-------GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANH 73 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~-------~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~g 73 (570)
+++|++|+||||++++++|... .+.+|+|||||.++.+..+... ...+++..++.|++||+.||+|||++|
T Consensus 60 ~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ 137 (318)
T d3blha1 60 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK 137 (318)
T ss_dssp HHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC
Confidence 3689999999999999988542 2458999999988766544333 356999999999999999999999999
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCceeccCC-----CCCccccCCCCCCCcccccCC-CCCCcccccchhhhHHHhhc
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSD-----DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIWSLG~IlyeLlt 147 (570)
|+||||||+|||++.++.+||+|||+++.+... ......+||++|+|||++.+. .|+.++|||||||++|+|++
T Consensus 138 ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~ 217 (318)
T d3blha1 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217 (318)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh
Confidence 999999999999999999999999999876532 233456899999999998765 68999999999999999999
Q ss_pred cCCCCcccCHHHHHHHHHhccCCCCCC-------------------------------CCcHHHHHHHHHhhccCCCCCc
Q 008303 148 LKPAFKAFDMQALINKINKSIVAPLPT-------------------------------KYSGAFRGLVKSMLRKNPELRP 196 (570)
Q Consensus 148 G~~pf~~~~~~~~~~~i~~~~~~p~p~-------------------------------~~s~~l~dLI~~~L~~dP~~RP 196 (570)
|++||.+.+.......+........+. ..++++++||.+||..||++||
T Consensus 218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 297 (318)
T d3blha1 218 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297 (318)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc
Confidence 999999888777766664443322111 1256788999999999999999
Q ss_pred CHHHHHHhhccCh
Q 008303 197 SAAELLRHVHLQP 209 (570)
Q Consensus 197 Ta~eIL~hp~fq~ 209 (570)
|++|+|+||||+.
T Consensus 298 sa~elL~Hpff~~ 310 (318)
T d3blha1 298 DSDDALNHDFFWS 310 (318)
T ss_dssp CHHHHHHSGGGSS
T ss_pred CHHHHHcChhhcc
Confidence 9999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=334.10 Aligned_cols=201 Identities=19% Similarity=0.386 Sum_probs=175.4
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|+|.+ + .+|+|||||++|+|.+++.... +.+++..+..++.||+.||.|||++||+|||||
T Consensus 62 i~~l~~l~H~nIv~~~g~~~~-~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDik 138 (273)
T d1u46a_ 62 VNAMHSLDHRNLIRLYGVVLT-P-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 138 (273)
T ss_dssp HHHHHHCCCTTBCCEEEEECS-S-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHHhCCCCCEEEEEEEEee-c-chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeec
Confidence 368999999999999998854 3 4689999999999999887654 459999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc-cCCCCccc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS-LKPAFKAF 155 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt-G~~pf~~~ 155 (570)
|+|||++.++.+||+|||+++.+.... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 139 p~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred HHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 999999999999999999999875432 2334568889999999999999999999999999999997 89999999
Q ss_pred CHHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 156 DMQALINKINKS-IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 156 ~~~~~~~~i~~~-~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+..+...++... ...+.+..++.++.+||++||..||++|||+++|++.
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~ 268 (273)
T d1u46a_ 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268 (273)
T ss_dssp CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999988887655 3455678899999999999999999999999999753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-40 Score=335.20 Aligned_cols=203 Identities=21% Similarity=0.351 Sum_probs=180.2
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC----------------------CCCCCHHHHHHH
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN----------------------SKLFSEEKLCKW 58 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~----------------------~~~Lse~~i~~I 58 (570)
+++|++|+||||++++++|... ..+++|||||.+|+|.++|.... ...+++..+..|
T Consensus 67 ~~il~~l~h~niv~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 145 (301)
T d1lufa_ 67 AALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 145 (301)
T ss_dssp HHHHHTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHH
T ss_pred HHHHHhcCCCCcccceeeeccC-CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHH
Confidence 3689999999999999998654 46889999999999999997532 235899999999
Q ss_pred HHHHHHHHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccc
Q 008303 59 LVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDI 135 (570)
Q Consensus 59 ~~QLl~aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDI 135 (570)
+.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... ......|++.|+|||++.+..|+.++||
T Consensus 146 ~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 146 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 9999999999999999999999999999999999999999998764432 3345678999999999999999999999
Q ss_pred cchhhhHHHhhcc-CCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 136 WSLGCCIYEMTSL-KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 136 WSLG~IlyeLltG-~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
|||||++|||++| .+||.+.+..++...+..+...+.+..++.++.+||.+||..+|.+|||+.||++.
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~ 295 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999888 47899999999999998888888888999999999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=338.33 Aligned_cols=207 Identities=29% Similarity=0.502 Sum_probs=171.2
Q ss_pred CHHhhhcCCCcccccceEEEeeC----cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVERG----CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~----~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++|+|||||++++++.... .++|++ +||.||+|.++++.. .+++..++.|+.||+.||+|||++||+|
T Consensus 57 i~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiH 132 (345)
T d1pmea_ 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLH 132 (345)
T ss_dssp HHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence 47899999999999999986542 234555 556689999999763 4999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCC----CCccccCCCCCCCccccc-CCCCCCcccccchhhhHHHhhccCCC
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDD----LASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCIYEMTSLKPA 151 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APE~l~-~~~~t~ksDIWSLG~IlyeLltG~~p 151 (570)
|||||+||||+.++.+||+|||++....... .....+||+.|+|||++. +..|+.++||||+||++|+|++|+.|
T Consensus 133 RDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p 212 (345)
T d1pmea_ 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212 (345)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence 9999999999999999999999998765432 245578999999999985 45678999999999999999999999
Q ss_pred CcccCHHHHHHHHHhccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHH
Q 008303 152 FKAFDMQALINKINKSIVAP------------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAEL 201 (570)
Q Consensus 152 f~~~~~~~~~~~i~~~~~~p------------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI 201 (570)
|.+.+..............+ ....++.++++||.+||..||.+|||++|+
T Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~ 292 (345)
T d1pmea_ 213 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292 (345)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 98877655444332211110 123568899999999999999999999999
Q ss_pred HHhhccChhh
Q 008303 202 LRHVHLQPYV 211 (570)
Q Consensus 202 L~hp~fq~~~ 211 (570)
|+||||+...
T Consensus 293 L~hpf~~~~~ 302 (345)
T d1pmea_ 293 LAHPYLEQYY 302 (345)
T ss_dssp HTSGGGTTTC
T ss_pred hcCHhhccCC
Confidence 9999998653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=335.47 Aligned_cols=207 Identities=26% Similarity=0.475 Sum_probs=176.0
Q ss_pred CHHhhhcCC-CcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccee
Q 008303 1 MELISKIRN-PFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDV 79 (570)
Q Consensus 1 v~IL~kL~H-PnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDL 79 (570)
+++|++++| |||++++++|.+. ..+|+|||||.||+|.+++.... .+++..++.++.||+.||+|||++||+||||
T Consensus 79 ~~il~~l~h~pnIv~~~~~~~~~-~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDi 155 (322)
T d1vzoa_ 79 RQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 155 (322)
T ss_dssp HHHHHHHHTCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHhccCCCeEEEeeeeeccC-CceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccC
Confidence 368999966 8999999988655 47999999999999999998764 4889999999999999999999999999999
Q ss_pred cCCcEEEcCCCCEEEeecCCceeccCC--CCCccccCCCCCCCcccccCCC--CCCcccccchhhhHHHhhccCCCCccc
Q 008303 80 KCSNIFLTKDQDIRLGDFGLAKILTSD--DLASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 80 KP~NILld~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APE~l~~~~--~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||+|||++.+|.+||+|||+++.+... .......|++.|++||.+.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus 156 Kp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 156 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp CGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876433 2345678999999999997653 688999999999999999999999775
Q ss_pred CHHHHHH---HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCc-----CHHHHHHhhccChh
Q 008303 156 DMQALIN---KINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRP-----SAAELLRHVHLQPY 210 (570)
Q Consensus 156 ~~~~~~~---~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RP-----Ta~eIL~hp~fq~~ 210 (570)
+...... ........+.+..++.++.+||++||.+||.+|| |++|+++||||+..
T Consensus 236 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 236 GEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp TSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 4333222 2223334556778999999999999999999999 58999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=334.09 Aligned_cols=204 Identities=17% Similarity=0.315 Sum_probs=175.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++|+|||||+++|++.+..+..|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||+.||+|||||
T Consensus 79 ~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK 157 (311)
T d1r0pa_ 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 157 (311)
T ss_dssp HHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCcc
Confidence 3689999999999999998776668899999999999999987643 457889999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCCC-----CccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCC-cc
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDDL-----ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAF-KA 154 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf-~~ 154 (570)
|+||||++++.+||+|||+++....... .....||+.|+|||.+....++.++|||||||++|||++|..|| ..
T Consensus 158 ~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 158 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp GGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred HHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999987654322 22357899999999999999999999999999999999866555 44
Q ss_pred cCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 155 FDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 155 ~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+..++...+..+.....+..+++++.+||.+||..||++||++.||++|+
T Consensus 238 ~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 238 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp -----CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 455556667777777777888999999999999999999999999999983
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-40 Score=337.11 Aligned_cols=205 Identities=23% Similarity=0.377 Sum_probs=170.3
Q ss_pred CHHhhhc-CCCcccccceEEEee-CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccce
Q 008303 1 MELISKI-RNPFIVEYKDSWVER-GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRD 78 (570)
Q Consensus 1 v~IL~kL-~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrD 78 (570)
+++|+++ .||||++++++|... ...+|+|||||.+++|..+. +.|++..++.+++||+.||+|||++||+|||
T Consensus 80 i~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrD 154 (328)
T d3bqca1 80 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRD 154 (328)
T ss_dssp HHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhccccccc
Confidence 3689999 599999999998743 45689999999999997653 3599999999999999999999999999999
Q ss_pred ecCCcEEEcCCC-CEEEeecCCceeccCCCCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCcccC
Q 008303 79 VKCSNIFLTKDQ-DIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAFD 156 (570)
Q Consensus 79 LKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~~ 156 (570)
|||+|||++.++ .+||+|||+++...........+||+.|+|||.+.+.. |+.++|||||||++|+|++|+.||....
T Consensus 155 iKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 155 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 999999999765 59999999999887777777889999999999987654 7999999999999999999999986543
Q ss_pred -HHHHHHHHHhc------------------------------------cCCCCCCCCcHHHHHHHHHhhccCCCCCcCHH
Q 008303 157 -MQALINKINKS------------------------------------IVAPLPTKYSGAFRGLVKSMLRKNPELRPSAA 199 (570)
Q Consensus 157 -~~~~~~~i~~~------------------------------------~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~ 199 (570)
.......+... ........+++++++||++||.+||.+|||++
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 22222111110 00011234688999999999999999999999
Q ss_pred HHHHhhccChh
Q 008303 200 ELLRHVHLQPY 210 (570)
Q Consensus 200 eIL~hp~fq~~ 210 (570)
|||+||||+..
T Consensus 315 e~L~Hp~F~~v 325 (328)
T d3bqca1 315 EAMEHPYFYTV 325 (328)
T ss_dssp HHHTSGGGTTS
T ss_pred HHhcCcccCCC
Confidence 99999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=340.14 Aligned_cols=206 Identities=26% Similarity=0.426 Sum_probs=164.1
Q ss_pred CHHhhhcCCCcccccceEEEe-----eCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 008303 1 MELISKIRNPFIVEYKDSWVE-----RGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHIL 75 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~-----~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIv 75 (570)
+++|++++|||||+++++|.. ...++|+|||||.|+ |.+.+. ..+++..++.++.||+.||.|||++||+
T Consensus 67 i~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~gii 141 (355)
T d2b1pa1 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGII 141 (355)
T ss_dssp HHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccc
Confidence 368899999999999999863 236899999999765 444442 3589999999999999999999999999
Q ss_pred cceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCccc
Q 008303 76 HRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 76 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
||||||+|||++.++.+|++|||+++...........+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.
T Consensus 142 HrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 99999999999999999999999999887777777789999999999999999999999999999999999999999888
Q ss_pred CHHHHHHHHHhccCCCCC-----------------------------------------CCCcHHHHHHHHHhhccCCCC
Q 008303 156 DMQALINKINKSIVAPLP-----------------------------------------TKYSGAFRGLVKSMLRKNPEL 194 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~p-----------------------------------------~~~s~~l~dLI~~~L~~dP~~ 194 (570)
+......++......+.+ ...+.++++||++||..||++
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 301 (355)
T d2b1pa1 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhH
Confidence 776665555332221100 123568899999999999999
Q ss_pred CcCHHHHHHhhccChhh
Q 008303 195 RPSAAELLRHVHLQPYV 211 (570)
Q Consensus 195 RPTa~eIL~hp~fq~~~ 211 (570)
|||++|||+||||+.+.
T Consensus 302 R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 302 RISVDDALQHPYINVWY 318 (355)
T ss_dssp SCCHHHHHTSTTTGGGC
T ss_pred CcCHHHHhcCcccCCCC
Confidence 99999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=325.51 Aligned_cols=207 Identities=26% Similarity=0.429 Sum_probs=175.6
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++|++++|||||+++++|.+. ..+++|+||+.|++|..++... +.+++..++.++.|++.||+|||++||+|||||
T Consensus 52 ~~il~~l~h~niv~~~~~~~~~-~~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiK 128 (292)
T d1unla_ 52 ICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128 (292)
T ss_dssp HHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhcCcCCEEeeccccccc-cceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeeccc
Confidence 3689999999999999998655 4789999999999998887654 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecCCceeccCCC-CCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCC-CcccCH
Q 008303 81 CSNIFLTKDQDIRLGDFGLAKILTSDD-LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPA-FKAFDM 157 (570)
Q Consensus 81 P~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~p-f~~~~~ 157 (570)
|+|||++.++.+||+|||.++...... ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.| |.+.+.
T Consensus 129 P~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred CcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH
Confidence 999999999999999999999876543 344556788999999997665 58999999999999999998876 566666
Q ss_pred HHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhhccCh
Q 008303 158 QALINKINKSIVAP----------------------------LPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHVHLQP 209 (570)
Q Consensus 158 ~~~~~~i~~~~~~p----------------------------~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp~fq~ 209 (570)
.+...++......+ ....++..+.+||++||..||.+|||++|+|+||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred HHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 66666554322211 22356789999999999999999999999999999986
Q ss_pred h
Q 008303 210 Y 210 (570)
Q Consensus 210 ~ 210 (570)
+
T Consensus 289 ~ 289 (292)
T d1unla_ 289 F 289 (292)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=334.90 Aligned_cols=205 Identities=24% Similarity=0.411 Sum_probs=169.7
Q ss_pred CHHhhhcCCCcccccceEEEee----CcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 008303 1 MELISKIRNPFIVEYKDSWVER----GCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILH 76 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~----~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvH 76 (570)
+++|++|+|||||+++++|... +...++||+||.||+|.+++.. +.+++..++.|+.||+.||+|||++||+|
T Consensus 68 i~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiH 144 (348)
T d2gfsa1 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIH 144 (348)
T ss_dssp HHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcc
Confidence 4689999999999999998532 1234566777789999999854 35999999999999999999999999999
Q ss_pred ceecCCcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCcccccCCC-CCCcccccchhhhHHHhhccCCCCccc
Q 008303 77 RDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCIYEMTSLKPAFKAF 155 (570)
Q Consensus 77 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIWSLG~IlyeLltG~~pf~~~ 155 (570)
|||||+|||++.+|.+|++|||++..... ......|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.
T Consensus 145 rDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 145 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCccccccccccccccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999977543 334568899999999977665 589999999999999999999999988
Q ss_pred CHHHHHHHHHhccCCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 156 DMQALINKINKSIVAPL------------------------------PTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 156 ~~~~~~~~i~~~~~~p~------------------------------p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
+.......+......+. ...++.++++||++||..||.+|||++|||+||
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 87776666544322211 135789999999999999999999999999999
Q ss_pred ccChh
Q 008303 206 HLQPY 210 (570)
Q Consensus 206 ~fq~~ 210 (570)
||+++
T Consensus 303 ~f~~~ 307 (348)
T d2gfsa1 303 YFAQY 307 (348)
T ss_dssp GGTTT
T ss_pred hhCCC
Confidence 99875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=328.59 Aligned_cols=204 Identities=20% Similarity=0.385 Sum_probs=182.1
Q ss_pred CHHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 008303 1 MELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN--------SKLFSEEKLCKWLVQLLMALDYLHAN 72 (570)
Q Consensus 1 v~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~--------~~~Lse~~i~~I~~QLl~aL~yLHs~ 72 (570)
+++|++++|||||+++++|..++ .+++|||||.+|+|.+++.... ...+++..+..|+.||+.||.|||++
T Consensus 74 ~~il~~l~h~nIv~~~~~~~~~~-~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~ 152 (308)
T d1p4oa_ 74 ASVMKEFNCHHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN 152 (308)
T ss_dssp HHHGGGCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCEeeeeeEEecCC-ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 36899999999999999986544 6899999999999999986432 13478999999999999999999999
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhcc-
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSL- 148 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG- 148 (570)
+|+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus 153 ~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 153 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 99999999999999999999999999998765432 23345789999999999999999999999999999999987
Q ss_pred CCCCcccCHHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHhh
Q 008303 149 KPAFKAFDMQALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHV 205 (570)
Q Consensus 149 ~~pf~~~~~~~~~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~hp 205 (570)
.+||.+.+..+....+..+...+.+..++..+.+||.+||+.+|++|||+++|++++
T Consensus 233 ~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 233 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 588999999999988888887788889999999999999999999999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=328.20 Aligned_cols=202 Identities=20% Similarity=0.373 Sum_probs=174.9
Q ss_pred HHhhhc-CCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhC----------------CCCCCHHHHHHHHHHHHH
Q 008303 2 ELISKI-RNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKAN----------------SKLFSEEKLCKWLVQLLM 64 (570)
Q Consensus 2 ~IL~kL-~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~----------------~~~Lse~~i~~I~~QLl~ 64 (570)
++++++ +|||||+++++|.+. ..+|||||||++|+|.++|+... ...+++..+..|+.||+.
T Consensus 78 ~~~~~l~~HpnIv~~~g~~~~~-~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 156 (311)
T d1t46a_ 78 KVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156 (311)
T ss_dssp HHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHhccCCCCEEEEEEEEeeC-CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHH
Confidence 577888 799999999998654 46899999999999999997643 235899999999999999
Q ss_pred HHHHHHHCCcccceecCCcEEEcCCCCEEEeecCCceeccCCC---CCccccCCCCCCCcccccCCCCCCcccccchhhh
Q 008303 65 ALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 141 (570)
Q Consensus 65 aL~yLHs~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~I 141 (570)
||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||+
T Consensus 157 gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 157 GMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (311)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHH
Confidence 9999999999999999999999999999999999998775432 2344688999999999999999999999999999
Q ss_pred HHHhhc-cCCCCcccCHHHH-HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHHh
Q 008303 142 IYEMTS-LKPAFKAFDMQAL-INKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRH 204 (570)
Q Consensus 142 lyeLlt-G~~pf~~~~~~~~-~~~i~~~~~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~h 204 (570)
+|||++ |.++|...+.... ...+........+..++..+.+||.+||..||++|||++||++.
T Consensus 237 l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999997 6777777655444 44555666666778899999999999999999999999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-37 Score=314.70 Aligned_cols=200 Identities=20% Similarity=0.305 Sum_probs=160.0
Q ss_pred HhhhcCCCcccccceEEEeeC---cEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--------
Q 008303 3 LISKIRNPFIVEYKDSWVERG---CYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-------- 71 (570)
Q Consensus 3 IL~kL~HPnIV~l~~~f~~~~---~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-------- 71 (570)
.+++++|||||++++++.+.+ ..+|+|||||++|+|.++|++. .+++..+..++.|++.||.|||.
T Consensus 50 ~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~ 126 (303)
T d1vjya_ 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred HHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 345789999999999998654 3689999999999999999874 48999999999999999999996
Q ss_pred CCcccceecCCcEEEcCCCCEEEeecCCceeccCCC-----CCccccCCCCCCCcccccCCC------CCCcccccchhh
Q 008303 72 NHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDD-----LASSVVGTPSYMCPELLADIP------YGSKSDIWSLGC 140 (570)
Q Consensus 72 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~------~t~ksDIWSLG~ 140 (570)
+||+||||||+||||+.++.+||+|||+++...... .....+||+.|+|||++.+.. ++.++|||||||
T Consensus 127 ~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred CCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHH
Confidence 599999999999999999999999999998875432 234578999999999987643 567899999999
Q ss_pred hHHHhhccCCCCccc---------------CHHHHHHHHHhccC-CCCCCCC-----cHHHHHHHHHhhccCCCCCcCHH
Q 008303 141 CIYEMTSLKPAFKAF---------------DMQALINKINKSIV-APLPTKY-----SGAFRGLVKSMLRKNPELRPSAA 199 (570)
Q Consensus 141 IlyeLltG~~pf~~~---------------~~~~~~~~i~~~~~-~p~p~~~-----s~~l~dLI~~~L~~dP~~RPTa~ 199 (570)
++|||++|.+||... ........+..... ..++..+ ...+.+||.+||..||.+|||+.
T Consensus 207 vl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 286 (303)
T d1vjya_ 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 999999998876331 12233333322222 2233322 34689999999999999999999
Q ss_pred HHHHhh
Q 008303 200 ELLRHV 205 (570)
Q Consensus 200 eIL~hp 205 (570)
||++++
T Consensus 287 ei~~~L 292 (303)
T d1vjya_ 287 RIKKTL 292 (303)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-36 Score=304.98 Aligned_cols=203 Identities=18% Similarity=0.272 Sum_probs=161.4
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
++|++++|+|+|.+++.+...+...++||||| +++|.+.+... ...+++..+..++.||+.||+|||++||+||||||
T Consensus 54 ~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp 131 (299)
T d1ckia_ 54 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKP 131 (299)
T ss_dssp HHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCH
Confidence 68899988887777666666677899999999 45777776654 35699999999999999999999999999999999
Q ss_pred CcEEEcC---CCCEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCC
Q 008303 82 SNIFLTK---DQDIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKP 150 (570)
Q Consensus 82 ~NILld~---~g~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~ 150 (570)
+|||++. +..+||+|||+++.+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 132 ~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred hhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCC
Confidence 9999864 4579999999999875432 2345689999999999999999999999999999999999999
Q ss_pred CCcccCHHHHHHHHH---hc-c---CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHH---HHhhc
Q 008303 151 AFKAFDMQALINKIN---KS-I---VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAEL---LRHVH 206 (570)
Q Consensus 151 pf~~~~~~~~~~~i~---~~-~---~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eI---L~hp~ 206 (570)
||...........+. .. . .......+++++.+||++||..+|++||++++| |+|+|
T Consensus 212 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 212 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp TTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 998765443322221 11 1 111345789999999999999999999999866 45544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7e-35 Score=295.70 Aligned_cols=199 Identities=16% Similarity=0.191 Sum_probs=163.6
Q ss_pred HHhhhcC-CCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceec
Q 008303 2 ELISKIR-NPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVK 80 (570)
Q Consensus 2 ~IL~kL~-HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLK 80 (570)
+++++|. |+||+.+++++.. +...|+||||| |++|.+++...+ ..+++..+..|+.|++.||+|||++||+|||||
T Consensus 52 ~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiK 128 (293)
T d1csna_ 52 RTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 128 (293)
T ss_dssp HHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred HHHHHhcCCCCCCEEEEEeec-CCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence 5778885 4899999998765 45789999999 689999987653 469999999999999999999999999999999
Q ss_pred CCcEEEcC-----CCCEEEeecCCceeccCCC--------CCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhc
Q 008303 81 CSNIFLTK-----DQDIRLGDFGLAKILTSDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTS 147 (570)
Q Consensus 81 P~NILld~-----~g~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLlt 147 (570)
|+|||++. ++.+||+|||+++.+.... .....+||+.|||||++.+..++.++|||||||++|+|++
T Consensus 129 p~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt 208 (293)
T d1csna_ 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 208 (293)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh
Confidence 99999974 5789999999998865321 2345689999999999999999999999999999999999
Q ss_pred cCCCCcccC---HHHHHHHHHhcc----CCCCCCCCcHHHHHHHHHhhccCCCCCcCHHHHHH
Q 008303 148 LKPAFKAFD---MQALINKINKSI----VAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLR 203 (570)
Q Consensus 148 G~~pf~~~~---~~~~~~~i~~~~----~~p~p~~~s~~l~dLI~~~L~~dP~~RPTa~eIL~ 203 (570)
|..||.+.. ......++.... ...+...+++++.+++..|+..+|++||+++.+.+
T Consensus 209 g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 209 GSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 999997543 222222222111 11234568899999999999999999999888765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-33 Score=290.20 Aligned_cols=202 Identities=24% Similarity=0.380 Sum_probs=156.2
Q ss_pred CCCcccccceEEEee-CcEEEEEEeccCCCC-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccceecCCcE
Q 008303 8 RNPFIVEYKDSWVER-GCYVCIIIGFCEGGD-MAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHA-NHILHRDVKCSNI 84 (570)
Q Consensus 8 ~HPnIV~l~~~f~~~-~~~i~IV~Ey~~gGs-L~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs-~gIvHrDLKP~NI 84 (570)
.|+|||++++++... ..+.+++|+++.++. ............+++..++.++.||+.||+|||+ .||+||||||+||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 468999999998653 356677777765543 4444445555679999999999999999999998 8999999999999
Q ss_pred EEcCCCC------EEEeecCCceeccCCCCCccccCCCCCCCcccccCCCCCCcccccchhhhHHHhhccCCCCcccCHH
Q 008303 85 FLTKDQD------IRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 158 (570)
Q Consensus 85 Lld~~g~------vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIWSLG~IlyeLltG~~pf~~~~~~ 158 (570)
||+.++. ++++|||.+..... .....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...+..
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 9987654 99999999987643 335678999999999999999999999999999999999999999754321
Q ss_pred ------HHHHHHHhcc-----------------------------------------CCCCCCCCcHHHHHHHHHhhccC
Q 008303 159 ------ALINKINKSI-----------------------------------------VAPLPTKYSGAFRGLVKSMLRKN 191 (570)
Q Consensus 159 ------~~~~~i~~~~-----------------------------------------~~p~p~~~s~~l~dLI~~~L~~d 191 (570)
.......... ........+.++++||.+||.+|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 1111111000 00112234678999999999999
Q ss_pred CCCCcCHHHHHHhhccChhh
Q 008303 192 PELRPSAAELLRHVHLQPYV 211 (570)
Q Consensus 192 P~~RPTa~eIL~hp~fq~~~ 211 (570)
|.+|||++|+|+||||+...
T Consensus 316 P~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred hhHCcCHHHHhcCcccCCCC
Confidence 99999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.60 E-value=7.3e-17 Score=151.78 Aligned_cols=118 Identities=13% Similarity=0.123 Sum_probs=87.5
Q ss_pred HHhhhcCCCcccccceEEEeeCcEEEEEEeccCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccceecC
Q 008303 2 ELISKIRNPFIVEYKDSWVERGCYVCIIIGFCEGGDMAEAIKKANSKLFSEEKLCKWLVQLLMALDYLHANHILHRDVKC 81 (570)
Q Consensus 2 ~IL~kL~HPnIV~l~~~f~~~~~~i~IV~Ey~~gGsL~d~I~~~~~~~Lse~~i~~I~~QLl~aL~yLHs~gIvHrDLKP 81 (570)
.+|.++.|.+++..+++. .+ ++||||+.++.+.+ +++..+..++.||+.+|.|||++||+||||||
T Consensus 66 ~~l~~l~~~~v~~~~~~~--~~---~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 66 RALQKLQGLAVPKVYAWE--GN---AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp HHHHHTTTSSSCCEEEEE--TT---EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred HHHHHccCCCcceEEEec--CC---EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCCh
Confidence 357788999999887642 22 69999999865432 56667788999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecCCceeccCCCCCccccCCCCCCCc--cc---ccCCCCCCcccccchhhh
Q 008303 82 SNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCP--EL---LADIPYGSKSDIWSLGCC 141 (570)
Q Consensus 82 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~AP--E~---l~~~~~t~ksDIWSLG~I 141 (570)
+|||+++++ ++|+|||++......... .|... +. +....|..++|+||+.--
T Consensus 132 ~NILv~~~~-~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 132 YNVLVSEEG-IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TSEEEETTE-EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred hheeeeCCC-EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 999999654 899999999876533211 01110 00 113467889999998643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.13 E-value=0.00031 Score=66.18 Aligned_cols=29 Identities=28% Similarity=0.319 Sum_probs=25.4
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCceEEEeechhccc
Confidence 78999999999999776667999998865
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.06 E-value=0.0016 Score=60.72 Aligned_cols=29 Identities=21% Similarity=0.237 Sum_probs=25.7
Q ss_pred cccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 74 ILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 74 IvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999999876678999998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.91 E-value=0.0094 Score=60.19 Aligned_cols=29 Identities=21% Similarity=0.377 Sum_probs=25.5
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
.++|||+++.|||++.++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998664 89999998865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.71 E-value=0.015 Score=58.46 Aligned_cols=15 Identities=40% Similarity=0.629 Sum_probs=13.2
Q ss_pred cccceecCCcEEEcC
Q 008303 74 ILHRDVKCSNIFLTK 88 (570)
Q Consensus 74 IvHrDLKP~NILld~ 88 (570)
++|+|+.+.|||+..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 689999999999854
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.44 E-value=0.029 Score=53.94 Aligned_cols=30 Identities=30% Similarity=0.338 Sum_probs=27.1
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
|+||+|+.+.||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 799999999999999887778999998854
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=85.07 E-value=0.24 Score=47.81 Aligned_cols=28 Identities=25% Similarity=0.226 Sum_probs=23.3
Q ss_pred CcccceecCCcEEEcCCCCEEEeecCCcee
Q 008303 73 HILHRDVKCSNIFLTKDQDIRLGDFGLAKI 102 (570)
Q Consensus 73 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 102 (570)
++||+|+++.|||+++ + ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 6899999999999974 3 46899998754
|